<SEC-DOCUMENT>0001493152-24-010637.txt : 20240320
<SEC-HEADER>0001493152-24-010637.hdr.sgml : 20240320
<ACCEPTANCE-DATETIME>20240320132051
ACCESSION NUMBER:		0001493152-24-010637
CONFORMED SUBMISSION TYPE:	F-1/A
PUBLIC DOCUMENT COUNT:		32
FILED AS OF DATE:		20240320
DATE AS OF CHANGE:		20240320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mobile-health Network Solutions
		CENTRAL INDEX KEY:			0001976695
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		F-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277254
		FILM NUMBER:		24767240

	BUSINESS ADDRESS:	
		STREET 1:		CRICKET SQUARE, HUTCHINS DRIVE,
		STREET 2:		P.O. BOX 2681, GRAND CAYMAN, KY1-1111,
		CITY:			CAYMAN ISLANDS
		STATE:			E9
		ZIP:			000000
		BUSINESS PHONE:		65 6222 5223

	MAIL ADDRESS:	
		STREET 1:		2 VENTURE DR,
		STREET 2:		#07-06 VISION EXCHANGE,
		CITY:			SINGAPORE
		STATE:			U0
		ZIP:			608526
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1/A
<SEQUENCE>1
<FILENAME>formf-1a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
filed with the Securities and Exchange Commission on March 20, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333-277254</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AMENDMENT NO.2 TO</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
F-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>UNDER
THE SECURITIES ACT OF 1933</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Mobile-health
Network Solutions </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Exact
name of Registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not
Applicable</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Translation
of Registrant&rsquo;s name into English)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cayman
    Islands</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7372</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not
    Applicable</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State or other jurisdiction of</B></FONT></P>
                                                                             <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation or organization)</B></FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Primary Standard Industrial</B></FONT></P>
                                                                             <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Classification Code Number)</B></FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(I.R.S.
Employer</B></FONT></P>
                                                                             <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT><B>Identification Number)</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2
Venture Drive, #07-06/07 Vision Exchange</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Singapore
608526</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>+65
6222 5223</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address,
including zip code, and telephone number, including area code, of Registrant&rsquo;s principal executive offices)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Cogency Global Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>122 East 42nd Street, 18th Floor </B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>New York, NY 10168</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>+1 212 947 7200</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Name,
address, including zip code, and telephone number, including area code, of agent for service)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meng
                                            Ding, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sidley
    Austin</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>c/o
    39/F, Two Int&rsquo;l Finance Centre</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8
    Finance St, Central, Hong Kong</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>+852
    2509-7888</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><B>Lawrence
                                            Venick, Esq.</B></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><B>David
                                            J. Levine, Esq.</B></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><B>Loeb
                                            &amp; Loeb LLP</B></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><B>345
                                            Park Avenue</B></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><B>New
                                            York, NY 10154</B></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><B>+1 212
                                            407-4000 </B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public: as soon as practicable after the effective date of this registration statement.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933. Emerging growth
company &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards&dagger; provided
pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;
The term &ldquo;new or revised financial accounting standard&rdquo; refers to any update issued by the Financial Accounting Standards
Board to its Accounting Standards Codification after April 5, 2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 40%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective
on such date as the Securities and Exchange Commission, acting pursuant to such Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXPLANATORY
NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
registration statement on Form F-1 (the &ldquo;Registration Statement&rdquo;) contains two prospectuses, as set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering prospectus. A prospectus to be used for the public offering of 2,250,000 Class A Ordinary Shares, par value US$0.000004 per
    share of the Registrant (the &ldquo;Public Offering Prospectus&rdquo;) through the underwriter named on the cover page of the Public
    Offering Prospectus.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resale
    prospectus. A prospectus to be used for the resale by the selling shareholders of 2,574,750 Class A Ordinary Shares of the
    Registrant (the &ldquo;Resale Prospectus&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Resale Prospectus is substantively identical to the Public Offering Prospectus, except for the following principal points:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">They
    contain different outside and inside front covers and back covers&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">They
    contain different Offering sections&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">They
    contain different Use of Proceeds sections&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    Selling Shareholder section is included in the Resale Prospectus&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Underwriting section from the Public Offering Prospectus is deleted from the Resale Prospectus and a Selling Shareholders Plan of
    Distribution section is included in the Resale Prospectus&#894; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Legal Matters section in the Resale Prospectus on page ALT-3 deletes the reference to counsel for the underwriter, among others.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Registrant has included in this Registration Statement a set of alternate pages after the back-cover page of the Public Offering Prospectus
(the &ldquo;Alternate Pages&rdquo;) to reflect the foregoing differences in the Resale Prospectus as compared to the Public Offering
Prospectus. The Public Offering Prospectus will exclude the Alternate Pages and will be used for the public offering by the Registrant.
The Resale Prospectus will be substantively identical to the Public Offering Prospectus except for the addition or substitution of the
Alternate Pages and will be used for the resale offering by the Selling Shareholders.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this preliminary prospectus is not complete and may be changed. The securities may not be sold until the registration
statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell nor does it seek an
offer to buy the securities in any jurisdiction where such offer or sale is not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
Prospectus (Subject to Completion)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated
March 20, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><IMG SRC="logo_001.jpg" ALT="" STYLE="height: 99px; width: 300px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mobile-health
Network Solutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,250,000
Class A Ordinary Shares being offered by Mobile-health Network Solutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,574,750
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class A Ordinary Shares being sold by the
Selling Shareholders</B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is the initial public offering of Class A Ordinary Shares, by Mobile-health Network Solutions. We are offering 2,250,000 Class A Ordinary
Shares, par value US$0.000004 per share, and the registration of an additional 2,574,750 Class A Ordinary Shares held by the Selling
Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has been no public market for our Class A Ordinary Shares. We anticipate the initial public offering price of
our Class A Ordinary Shares will be between US$4.00 and US$5.00. We have applied to list our Class A Ordinary Shares on the Nasdaq Capital
Market under the symbol &ldquo;MNDR.&rdquo; Of the total securities being offered under this prospectus, we are offering 2,250,000 Class
A Ordinary Shares, and the selling shareholders named in the section entitled &ldquo;Selling Shareholders&rdquo; in this prospectus (the
&ldquo;Selling Shareholders&rdquo;) are offering 2,574,750 Class A Ordinary Shares. No shares offered by the Selling Shareholders
will be sold until after our Class A Ordinary Shares have begun trading on the NASDAQ Capital Market. The underwriter is not underwriting
the shares of the Selling Shareholders. Any sales will occur from time to time at prevailing market prices or in privately negotiated
prices. The distribution of securities offered hereby may be effected in one or more transactions that may take place in ordinary brokers&rsquo;
transactions, privately negotiated transactions or through sales to one or more dealers for resale of such securities as principals.
Usual and customary or specifically negotiated brokerage fees or commissions may be paid by the Selling Shareholders. Neither we nor
the underwriter will receive any proceeds from the sales of any of the Class A ordinary shares being offered by the Selling Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are both an &ldquo;emerging growth company&rdquo;
and a &ldquo;foreign private issuer&rdquo; as defined under the applicable U.S. federal securities laws and, as such, may elect to comply
with certain reduced public company reporting requirements for this and future filings. See &ldquo;Prospectus Summary&mdash;Implications
of Being an Emerging Growth Company&rdquo; and &ldquo;Prospectus Summary&mdash;Implications of Being a Foreign Private Issuer.&rdquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the completion of this offering, our issued and outstanding share capital will consist of Class A Ordinary Shares and Class
B Ordinary Shares. Siaw Tun Mine, Denis Christopher Nyam Ngian Kwong, Siaw Tung Yeng, and Teoh Pui Pui beneficially own all of our then
issued and outstanding Class B Ordinary Shares. These Class B Ordinary Shares will constitute approximately 35.5% of our total
issued and outstanding share capital immediately after the completion of this offering and approximately 84.6% of the aggregate
voting power of our total issued and outstanding share capital immediately after the completion of this offering, assuming that the underwriter
does not exercise their option to purchase additional Class A Ordinary Shares. Holders of Class A Ordinary Shares and Class B Ordinary
Shares have the same rights except for voting and conversion rights. Each holder of our Class A Ordinary Share is entitled to one vote
per share. Each holder of our Class B Ordinary Share is entitled to 10 votes per share. Our Class A Ordinary Shares and Class B Ordinary
Shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by
law. Our Class B Ordinary Shares are convertible at any time into Class A Ordinary Shares on a one-for-one basis by the holder thereof.
Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances. Upon any transfer of Class B Ordinary
Shares by a holder thereof or a change of ultimate beneficial ownership of any Class B Ordinary Shares to any person other than an affiliate
of such person or a beneficial owner of Class B Ordinary Shares, such Class B Ordinary Shares are automatically and immediately converted
into the same number of Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 40%"><DIV STYLE="margin-top: 0pt; font-size: 1pt; border-top: Black 1.5pt solid; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in the Class A Ordinary Shares involves a high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 11.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="margin-top: 0pt; font-size: 1pt; border-top: Black 1.5pt solid; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRICE
US$</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B>PER CLASS A ORDINARY SHARE </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="margin-top: 0pt; font-size: 1pt; border-top: Black 1.5pt solid; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price to Public</B></FONT></P>

</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underwriting Discounts and Commissions<SUP>(1)</SUP></B></FONT></P>

</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><P STYLE="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceeds, before Expenses</B></FONT></P>

</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: justify">Per Share</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">US$</TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">US$</TD><TD STYLE="width: 14%; text-align: right">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">US$</TD><TD STYLE="width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">US$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: white"></FONT></FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">US$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">US$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="color: white"></FONT></FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    a description of compensation payable to the underwriter, see &ldquo;Underwriting.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter has an option to purchase up to 337,500 additional Class A Ordinary Shares from us at the initial public offering
price, less the underwriting discounts and commissions, within 45 days from the date of closing of this offering, to cover any over-allotments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter expects to deliver the Class A Ordinary Shares against payment in U.S. dollars in New York, NY to purchasers on or about
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="netw1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">Network 1 Financial Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#sl_001">Prospectus Summary</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#sl_002">The Offering</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#sl_004">Risk Factors</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_001">Special Note regarding Forward-Looking Statements and Industry Data</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_002">Use of Proceeds</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_003">Dividend Policy</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_004">Capitalization</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_005">Dilution</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_006">Enforceability of Civil Liabilities</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_007">Corporate History and Structure</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_008">Selected
    Consolidated Financial And Other Data</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_009">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_010">Industry Overview</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">60</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_011">Business</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">69</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_012">Regulation</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">90</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#agh_013">Management</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">94</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_001">Principal Shareholders</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">102</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_002">related
party transactions</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">103</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_003">Description of Share Capital</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">104</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_004">Shares Eligible For Future Sale</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">112</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_005">Taxation</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">113</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_006">Underwriting</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">119</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_007">Expenses Related To This Offering</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">129</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_008">Legal Matters</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">130</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_009">Experts</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">131</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#loi_010">Where You Can Find Additional Information</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">132</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><A HREF="#t_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Index to Consolidated Financial Statements</B></FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#la_001">The offering</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALT-1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A HREF="#la_002">Use of proceeds</A></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALT-2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A HREF="#la_003"><B>Selling
    Shareholders</B></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALT-2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A HREF="#la_004"><B>Selling
    Shareholders Plan of Distribution</B></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALT-3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A HREF="#la_005"><B>Legal matters</B></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALT-3</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 40%"><DIV STYLE="margin-top: 0pt; font-size: 1pt; border-top: Black 1.5pt solid; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains certain estimates and information concerning our industry, including market position, market size, and growth rates
of the markets in which we participate. This information involves a number of assumptions and limitations, and you are cautioned not
to give undue weight to these estimates. We have not independently verified the accuracy or completeness of the data contained in these
industry publications and reports. The industry in which we operate is subject to a high degree of uncertainty and risk due to a variety
of factors, including those described in the &ldquo;Risk Factors&rdquo; section. These and other factors could cause results to differ
materially from those expressed in these publications and reports.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this prospectus or in any related free-writing prospectus. We have not authorized anyone
to provide you with information different from that contained in this prospectus or in any related free-writing prospectus. We are offering
to sell, and seeking offers to buy, the Class A Ordinary Shares offered hereby, but only under circumstances and in jurisdictions where
offers and sales are permitted and lawful to do so. The information contained in this prospectus is current only as of the date of this
prospectus, regardless of the time of delivery of this prospectus or of any sale of the Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the underwriter have taken any action that would permit a public offering of the Class A Ordinary Shares outside the United States
or permit the possession or distribution of this prospectus or any related free-writing prospectus outside the United States. Persons
outside the United States who come into possession of this prospectus or any related free-writing prospectus must inform themselves about
and observe any restrictions relating to the offering of the Class A Ordinary Shares and the distribution of the prospectus outside the
United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Until
</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>, 2024 (the 25th day after the date of this prospectus),
all dealers that buy, sell or trade Class A Ordinary Shares, whether or not participating in this offering, may be required to deliver
a prospectus. This is in addition to the obligation of dealers to deliver a prospectus when acting as underwriter and with respect to
their unsold allotments or subscriptions.</B></FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="sl_001"></A>Prospectus
Summary</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information and financial
statements and notes appearing elsewhere in this prospectus. In addition to this summary, we urge you to read the entire prospectus carefully,
especially the risks of investing in the Class A Ordinary Shares discussed under &ldquo;Risk Factors,&rdquo; before deciding whether
to buy the Class A Ordinary Shares. This prospectus contains information from a report that was commissioned by us and prepared by Frost
&amp; Sullivan, an independent market research firm, to provide information regarding our industry and our market position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Mission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
be our users&rsquo; trusted companion on their lifelong healthcare journey by providing a seamless healthcare experience from start to
finish, which is affordable, accessible and easy to understand to both users and healthcare providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">We have set up one of the smartest integrated
all-in-one patient care-centric platforms in the region to deliver affordable care to users. We are a leading telehealth solutions provider
in Singapore in terms of the number of countries covered by our MaNaDr platform, including countries in the APAC region.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a leading telehealth solutions provider in Singapore  in terms of various matrices, such as the number of patient
consultations per day and the ranking of our mobile application, according to Frost &amp; Sullivan. According to Frost &amp;
Sullivan, we have the largest number of teleconsultations per day in the six months ending May 2023, and are amongst the
fastest-growing telehealth solutions providers in Singapore. Our MaNaDr mobile application has received a 4.8 and 4.9 star rating on
the Apple App Store and Google Play Store in Singapore respectively as of June 14, 2023. According to Frost &amp; Sullivan, on a
combined basis, MaNaDr was the most reviewed and highest rated mobile application in Singapore as of June 14, 2023 and has the
largest number of teleconsultations per day in the six months ending May 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
our services on our MaNaDr platform, which is accessible via our mobile application and website. We serve both the community
of users, by offering personalized and reliable medical attention to users worldwide, as well as the community of healthcare
providers, by allowing them to have a broader reach to users through virtual clinics without any start-up costs and the ability to
connect to a global network of peer-to-peer support groups and partners.  Through our mobile application, we offer users with a
range of seamless and hassle-free telehealth solutions, which encompasses teleconsultation services, including the issuance of
electronic medical certificates and delivery of medications to users&rsquo; homes, as well as other personalized services such as
weight management programs. Furthermore, we have set up  one of the smartest 24/7 virtual care ecosystems and support groups to
help users navigate the complexities faced in receiving correct and timely care, according to Frost &amp; Sullivan. With MaNaChat,
the 24/7 customer support service, we operate Singapore&rsquo;s only in-app live group chat service and have one of the fastest
response times in Singapore and globally to support users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed our business with the aim of addressing each of these global healthcare concerns and issues, and this problem-solving
approach is one of our Group&rsquo;s key unique features and competitive strengths:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrs_1.jpg" ALT="" STYLE="height: 137px; width: 460px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inequalities
    in healthcare</I>: We have set up one of the smartest integrated all-in-one patient care-centric platforms in the region to deliver
    affordable care to users. According to Frost &amp; Sullivan, as at May 31, 2023, we offered the most affordable care to nearly 100,000
    teleconsultation activities per month through our MaNaDr platform and we continue to strive to deliver quality, timely and
    seamless care.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inaccessibility
    in healthcare</I>: To alleviate inaccessibility in healthcare encountered, we have capitalized on the ubiquity of mobile technology
    and the rise in social platforms to set up MaNaForum, which is a social forum with multimedia capabilities within our MaNaDr
    mobile application, to empower our users and providers from all around the world to share and transmit information on medical conditions,
    interact with one another freely and ask questions at no charge. The MaNaForum is supported by doctors, healthcare professionals
    and other key players in the healthcare sector such as dieticians and gym instructors. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Complexities
    in obtaining correct healthcare in a timely manner</I>: To break down and simplify the complexities in healthcare faced by users,
    we seek to provide simplified care. This is achieved by breaking down barriers in time, place, and space with the setting up of
    one of the smartest 24/7 virtual care ecosystems and support groups  to help users navigate the complexities faced in receiving
    correct and timely care. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Confusion
                                            due to the wide range of healthcare products and services available</I>: With the volume
                                            of healthcare products and services available on the market, users often face difficulties
                                            in finding the products and services they need, which could result in confusion and adverse
                                            outcomes. To address this, we have set up a web store, MaNaShop/MaNaStore, containing more
                                            than 2,000 curated products and services from reliable suppliers and service providers
                                            worldwide, so as to deliver quality trusted products to users at affordable prices. We offer
                                            targeted products which meet our quality standards for our users across different genders
                                            and age brackets to address their specific healthcare and wellness needs.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Global
                                            healthcare burden of obesity and chronic diseases</I>: To alleviate chronic healthcare conditions,
                                            we have identified the needs of users and developed a 360-degree healthcare ecosystem offering
                                            holistic, comprehensive, continuing and long-term preventive and pre-emptive care centered
                                            around such needs. The ecosystem is supported by a community of healthcare providers, patient
                                            support groups, healthcare coordinators, pharmaceutical companies and paramedical service
                                            providers whom we partner with.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Main Business Activities </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr platform is a 360-degree healthcare ecosystem
which connects users and service providers through the range of healthcare services and product offerings that can be accessed through
our mobile application and website:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_2.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
platform primarily encompasses the following components:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaDr
    Mobile Application</I></B>: Our MaNaDr mobile application is an avenue for us to provide timely, curated and personalized
    care to our users. It primarily involves the provision of teleconsultation services via online video consultation, which allows users
    to chat in real-time with, and send photos or videos to, doctors online, as well as hospital and/or clinic referral and appointment
    and inpatient arrangement by our in-house medical team and doctors from our network of clinic service providers.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaDr
    Clinic &ndash; Primary healthcare services via our brick-and-mortar clinic</I></B>: We have one GP clinic in Singapore which offers
    a comprehensive range of primary healthcare services. We also derive revenue from collecting transaction fees for appointments,
    issuing electronic medical certificates, laboratory review fees and memorandum fees. The clinic also serves as our Innovative Hub
    where we pioneer various models of care such as gender-affirming service and aesthetic care.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaPharma
                                            &ndash; B2B sales to clinics and other healthcare service providers</I></B>: We procure pharmaceutical
                                            products and medical devices, as well as engage in the wholesale distribution of pharmaceutical
                                            products to clinics in Singapore.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaShop/MaNaStore
                                            &ndash; B2C sales of products and services to users</I></B>: We offer a diversified
                                            and evolving range of products to users on the MaNaShop/MaNaStore
                                            online e-commerce platform (via both the website and mobile application), including healthcare
                                            products (such as medicines, health supplements, skincare, nutrition products and medical
                                            devices) and wellness products (such as personal care products and health screening packages).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaCare
                                            </I></B>&ndash; <B>Corporate healthcare and wellness services, which is focused on corporate
                                            customers</B>: We provide comprehensive corporate healthcare and wellness services, ranging
                                            from GP, specialist and allied healthcare panel services to tele-consultation, in-person
                                            clinics, on-site health screening, online marketplace and wellness programs.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collectively,
we believe that our holistic ecosystem enhances the utilization efficiency of medical and healthcare resources, while providing a positive
user experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Market Opportunities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
as an evolved model of telehealth, the integrated smart health-tech service market overcomes the limitations of traditional telehealth
approaches. This market encompasses a wide range of offerings, including convenient online consultations, walk-in clinics, chronic disease
management, online retail pharmacies, health knowledge forums, enterprise telehealth services, as well as wholesale services for pharmaceutical
and healthcare products. It represents a more advanced and holistic approach as compared to traditional telehealth methods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smart
health-tech service market players in Singapore can be divided into three types. The first type of players are tech-first doctor-led
healthcare delivery innovators. The second type of players are brick &amp; mortar hospitals/clinic chain operators. The third type of
players are generally entities or individuals outside the medical industry. The growth drivers of the smart health-tech service market
include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">online
    and offline integrated fulfillment in one network;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increasing
    prevalence of chronic disease;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">growing
    population and service needs of aging population;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">growing
    health awareness;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">technology
    updates and service improvement; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">wide
    coverage of the internet and high popularity of smartphones.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that the future trends of the smart health-tech service market will focus on: (1) integration of online retail pharmacy and
healthcare services: (2) building a user-centered ecosystem; (3) customized and intelligent telehealth solutions; (4) specialized
chronic disease management; and (5) better user experience empowered by advanced technology.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strengths</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are well-positioned to achieve our strategic goals through several key business strengths, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Leading
position in Singapore&rsquo;s rapidly growing telehealth solutions industry</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We are a leading
telehealth solutions provider in Singapore, in terms of various matrices, according to Frost &amp; Sullivan. According to Frost
&amp; Sullivan, we had the largest number of teleconsultations per day in the six months ending May 2023, and are amongst the
fastest-growing telehealth solutions providers in Singapore. Our MaNaDr mobile application has received a 4.8 and 4.9 star rating on
the Apple App Store and Google Play Store in Singapore respectively as of June 14, 2023. According to Frost &amp; Sullivan, on a
combined basis, MaNaDr was the most reviewed and highest rated mobile application in Singapore as of June 14, 2023 and had the
largest number of teleconsultations per day in the six months ending May 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As at October 31, 2023,
we had recorded more than 1 million registered users on our MaNaDr platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Multi-faceted
business model that offers a one-stop portal connecting our users with both online and offline healthcare resources</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
multi-faceted business model positions us as a one-stop portal to the healthcare ecosystem, connecting users to online and offline healthcare
resources. We offer a comprehensive suite of medical-related and other services including teleconsultations and health check-up services,
vaccinations, skin and aesthetics services and other services on our MaNaDr platform and at the MaNaDr Clinic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Innovative
technological solutions empowered by an experienced in-house medical team </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have digitalized all of our core operations, building a full suite of digital operations systems solutions to ensure end-to-end quality
control. In addition, we offer 24/7 quality teleconsultation services with minimal waiting time through our self-developed mobile application,
which also allows optimizing of delivery routes by matching the closest clinic from our network of service providers to the user, such
that the prescription submitted by the doctor following the teleconsultation will be quickly fulfilled by the dispatch and home delivery
of the medications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><FONT STYLE="background-color: white">See</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> the section entitled
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Business&rdquo; for more details on our strengths.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strategies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will adopt and implement the following strategies to build upon our strengths and expand the outreach of our business:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Expand
our user base and systematically enhance our user engagement, including through technological tools, to strengthen our market position</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to continue to expand our user base through natural traffic, external marketing and promotional activities. Expansion through external
marketing will be achieved by the acquisition of new users through mobile application stores, as well as online and offline marketing
activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Expand
our service and product offerings to cover the healthcare value chain</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to further improve user stickiness through expanding service offerings to serve differentiated user needs on our platform and
improving the quality of the products and services offered on our MaNaDr platform, and offer a broader range of healthcare services
and products along the healthcare value chain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Selectively
pursue strategic partnerships, investments and acquisitions to expand and scale up our affordable and high-quality platform beyond Singapore
to other countries in the APAC region</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to continue to grow our user base, expand our service offerings, enhance our technological leadership, and optimize our ecosystem
through selected partnerships, investments, and acquisitions covering our comprehensive medical and wellness service offerings. Additionally,
we plan to expand our reach to other countries in the APAC region, through strategic partnerships, investments, mergers and acquisitions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><FONT STYLE="background-color: white">See</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> the section entitled
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Business&rdquo; for more details on these strategies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
Factors </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in our Class A Ordinary Shares involves risks. The risks summarized below are qualified by reference to the section entitled &ldquo;Risk Factors&rdquo;,
which you should carefully consider before deciding to purchase our Class A Ordinary Shares. If any of these risks actually occurs, our business,
financial condition, or results of operations would likely be materially and adversely affected. In such cases, the trading price of
our Class A Ordinary Shares would likely decline, and you may lose all or part of your investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe some of the major risks and uncertainties that may materially and adversely affect us include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
Related to Our Business and Industry</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintaining
    users&rsquo; trust is critical to our success, and any failure to do so could severely damage our reputation and
    brand;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to manage the growth of our business and operations or implement our business strategies on schedule or within our
    budget, or at all;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we fail to effectively estimate, price and manage our costs, or if our fees and charges are regulated, prescribed or otherwise required
    to be reduced, the profitability of our Group could decline;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    our healthcare solutions do not drive users&rsquo; engagement or if we fail to provide superior user experience, our business
    and reputation may be materially and adversely affected;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to develop our existing technology infrastructure or recoup the investments we have made for such development, and
    failure to continue to innovate or adapt to industry changes may materially and adversely affect our business, financial condition,
    results of operations and prospects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    self-developed technologies are complex and may contain undetected errors or may not operate properly, which could adversely affect
    our business, financial condition, results of operations and prospects;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    failure to properly manage participants and stakeholders in our MaNaDr ecosystem may materially and adversely affect our business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have limited or no control over our suppliers and the quality of products supplied to us and if such products are not manufactured
    in accordance with the applicable quality standards, our business and reputation could be materially and adversely affected;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
    liability claims in respect of defective products sold to our customers in our pharmaceutical business could adversely affect our
    reputation and our financial prospects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    lack of requisite approvals, licenses or permits applicable to our business may have a material and adverse effect on our business,
    financial condition, results of operations and prospects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    failure to properly manage the registration of our in-house doctors may materially and adversely affect our business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    failure</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> to maintain optimal inventory levels
    and the risk of inventory obsolescence could increase our operating costs or lead to unfulfilled customer orders, either of which
    could have a material and adverse effect on our business, financial condition, results of operations and prospects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may be adversely affected by negative publicity, litigation and regulatory investigations and proceedings, and may not always be
    successful in defending ourselves against such claims or proceedings;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Security breaches and attacks against our systems and
    network, and any potential resultant breach or failure to otherwise protect confidential and proprietary information, and network
    disruptions in general could damage our reputation and adversely affect our business, financial condition, results of operations
    and prospects;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our business generates and processes a large amount
    of data, and the improper use or disclosure of such data could harm our reputation as well as have a material adverse effect on our
    business and prospects;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not have sufficient insurance coverage to cover our business risks and face the risk of becoming subject to medical liability
    claims, which could cause us to incur significant expenses and be liable for significant damages if not covered by insurance;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to prevent others from unauthorized use of our intellectual property, which could harm our business and competitive
    position;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may be subject to intellectual property infringement claims, which may be expensive to defend and may disrupt our business and operations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">User
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">growth and activity depend
    upon effective use of operating systems, networks and standards that we do not control;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">A limited number of customers have accounted for, and
    are expected to continue to account for, a significant portion of our revenues. The failure to maintain or to increase revenues <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">from
    these customers could adversely affect our prospects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to conduct our marketing activities cost-effectively and we are subject to limitations in promoting our business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are subject to limitations in promoting healthcare-related services and products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we fail to maintain adequate internal controls, we may not be able to effectively manage our business and may experience errors or
    information lapses affecting our business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    performance depends on key management as well as skilled and qualified medical professional and support staff generally, and any
    failure to attract, motivate and retain such medical professionals and our support staff could hinder our ability to maintain and
    grow our business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to detect or prevent fraud or other misconduct committed by our employees or third parties;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    rely on assumptions and estimates to calculate certain key operating metrics, and inaccuracies in such metrics may harm our reputation
    and adversely affect our business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may need additional capital but may not be able to obtain such on favorable terms or at all;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    strategic alliances, investments or acquisitions may have a material adverse effect on our business, financial condition, results
    of operations and prospects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">We are subject to credit risk with respect to trade
    receivables;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    face risks relating to the political, economic, regulatory, social and legal environments in the jurisdictions in which we currently
    or may in the future operate;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COVID-19
    or any other infectious and communicable diseases, as well as the occurrence of any acts of God, war, terrorist attacks and other
    catastrophic events may have a material adverse effect on our business, financial condition, results of operations and prospects;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fluctuations
    in exchange rates could have a material and adverse effect on our results of operations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
Related to Doing Business in Vietnam</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geopolitical
    risks may have an adverse impact on our business, financial condition and results of operations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    economy in Vietnam may be subject to periods of high inflation which could materially and adversely affect our business, financial
    condition and results of operations as well as our growth prospects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in the economic, political and legal environment of Vietnam, and Vietnam&rsquo;s less developed legal system, may adversely affect
    our business, financial condition and results of operations; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset
    realization in bankruptcy proceedings may be time-consuming and expensive; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vietnamese
    foreign exchange control may limit our ability to utilize our revenue effectively and affect our ability to receive dividends and
    other payments from our Vietnamese subsidiary; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            VND may be subject to foreign exchange controls imposed by the Vietnamese government.</FONT></P></TD></TR>
  </TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
related to Regulations and Litigations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are subject to extensive and evolving regulatory requirements, non-compliance with which, or changes in which, may materially and
    adversely affect our business and prospects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    we expand our international operations, we will increasingly face political, legal and compliance, operational, regulatory, economic
    and other risks that we do not face or are more significant than in our domestic operations. Our exposure to these risks is expected
    to increase;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are subject to evolving laws, regulations, standards and policies, and any actual or perceived failure to comply could harm our brand
    and reputation, subject us to significant fines and liability, or otherwise adversely affect our business; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may be involved in certain legal proceedings from time to time. Any adverse decision in such proceedings may render us liable to
    liabilities and may adversely affect our business, financial condition, results of operations and prospects.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
Related to Our Class A Ordinary Shares and this Offering </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    has been no public market for our Class A Ordinary Shares prior to the completion of this offering, and you may not be able
    to resell our Class A Ordinary Shares at or above the price you pay for them, or at all;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">The validity of certain issuances and transfers of shares
    of our Company cannot be verified;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    initial public offering price for our Class A Ordinary Shares may not be indicative of prices that will prevail in the trading market and
    such market prices may be volatile;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    will experience immediate and substantial dilution in the net tangible book value of Class A Ordinary Shares purchased;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we fail to implement and maintain an effective system of internal controls, we may be unable to accurately or timely report our results
    of operations or prevent fraud, and investor confidence and the market price of our Class A Ordinary Shares may be materially and adversely
    affected;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are an &ldquo;emerging growth company&rdquo; within the meaning of the Securities Act, and may take advantage of certain reduced
    reporting requirements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will incur substantial increased costs as a result of being a public company;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantial
    future sales of our Class A Ordinary Shares or the anticipation of future sales of our Class A Ordinary Shares in the public market could cause the
    price of our Class A Ordinary Shares to decline;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    do not intend to pay dividends for the foreseeable future;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    securities or industry analysts do not publish research or reports about our business, or if they publish a negative report
    regarding our Class A Ordinary Shares, the price of our Class A Ordinary Shares and trading volume could decline;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    trading price of our Class A Ordinary Shares may be volatile or may decline regardless of our operating performance,
    which could result in substantial losses to investors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our dual-class voting structure will limit your ability
    to influence corporate matters and could discourage others from pursuing any change of control transactions that holders of our Class
    A Ordinary Shares may view as beneficial;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    management has broad discretion to determine how to use the funds raised in the offering and may use them in ways that may not enhance
    our results of operations or the price of our Class A Ordinary Shares;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we cease to qualify as a foreign private issuer, we would be required to comply fully with the reporting requirements of the Exchange
    Act applicable to U.S. domestic issuers, and we would incur significant additional legal, accounting and other expenses that we would
    not incur as a foreign private issuer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    we are a foreign private issuer and are exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, you
    will have less protection than you would have if we were a domestic issuer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
    as a foreign private issuer we are exempt from certain corporate governance standards applicable to U.S. issuers, if we cannot
    satisfy, or continue to satisfy, the initial listing requirements and other rules of the Nasdaq Capital Market, our securities may
    not be listed or may be delisted, which could negatively impact the price of our securities and your ability to sell them;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Board may decline to register transfers of Class A Ordinary Shares in certain circumstances;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    may be unable to present proposals before annual general meetings or extraordinary general meetings not called by shareholders;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we are classified as a passive foreign investment company, U.S. taxpayers who own our Class A Ordinary Shares may have adverse
    U.S. federal income tax consequences;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption
    of their shares; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    may face difficulties in protecting your interests as a shareholder, as Cayman Islands law provides substantially less protection
    when compared to the laws of the U.S. and it may be difficult for a shareholder of ours to effect service of process or to
    enforce judgements obtained in the U.S. courts.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we face risks and uncertainties related to our compliance with applicable regulations and policies in our principal markets
and operations. See &ldquo;Risk Factors&rdquo; and other information included in this prospectus for a detailed discussion of the above
and other challenges and risks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
History and Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Group&rsquo;s history began in 2016 when we were founded by Dr. Siaw Tung Yeng and Dr. Teoh Pui Pui along with a group of doctors in
Singapore with considerable experience in healthcare, government policy and IT. We launched our MaNaDr mobile application in October
2016 and our website in January 2019. We have achieved a global reach on our mobile application and website and as at September 2023,
we had active users from more than 18 various jurisdictions across the world, including Singapore, Vietnam, Malaysia, Australia, India
and the Philippines. As at October 31, 2023, we had onboarded more than 700 Singapore clinics and more than 1,500
medical professionals comprising GPs, specialized and allied health providers. We have also recorded more than 120,000 teleconsultation
requests in October 2023 and as at October 31, 2023, have completed more than 1,600,000 tele-consultation requests since our
inception in 2016. As at October 31, 2023, we had more than 1 million registered users on our MaNaDr platform, having grown
from a handful of registered users since our inception in 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Company was incorporated in the Cayman Islands on July 28, 2016, under the Companies Act as an exempted company with limited liability.
Our authorized share capital is US$50,000 divided into 6,250,000,000 Class A Ordinary Shares and 6,250,000,000 Class B
Ordinary Shares, with par value of US$0.000004 each. Our Company is the holding company of our Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Corporate
Information</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at 2 Venture Drive, #07-06/07 Vision Exchange, Singapore 608526. Our telephone number at this
address is +65 6222 5223. Our registered office in the Cayman Islands is located at Harneys Fiduciary (Cayman) Limited, 4th Floor,
Harbour Place, 103 South Church Street, PO Box 10240, Grand Cayman, KY1-1002, Cayman Islands. Our agent for service of process in
the United States is Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY 10168.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
should contact us for any inquiries through the address and telephone number of our principal executive offices. Our corporate website
is https://manadr.com/. The information contained on our website is not a part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Corporate
Structure</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">following diagram illustrates our corporate structure,
including our principal subsidiaries:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrs_16.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Implications of Being an Emerging Growth Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a company with less than
US$1.235 billion in revenue for our last fiscal year, we qualify as an &ldquo;emerging growth company&rdquo; pursuant to the Jumpstart
Our Business Startups Act of 2012, or the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and
other requirements compared to those that are otherwise applicable generally to public companies. These provisions include exemption
from the auditor attestation requirement under Section 404 of the Sarbanes-Oxley Act of 2002 in the assessment of the emerging growth
company&rsquo;s internal control over financial reporting. The JOBS Act also provides that an emerging growth company does not need to
comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply
with such new or revised accounting standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will remain an emerging
growth company until the earliest of&thinsp; (a) the last day of the fiscal year during which we have total annual gross revenue of at
least US$1.235 billion; (b) the last day of our fiscal year following the fifth anniversary of the completion of this offering; (c) the
date on which we have, during the preceding three-year period, issued more than US$1.0 billion in non-convertible debt; or (d) the date
on which we are deemed to be a &ldquo;large accelerated filer&rdquo; under the Exchange Act, which would occur if the market value of
the Class A Ordinary Shares that are held by non-affiliates exceeds US$700 million as of the last business day of our most recently completed
second fiscal quarter. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS
Act discussed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being a Foreign Private Issuer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of this offering, we will report under the Exchange Act as a non-U.S. company with foreign private issuer status. Even after
we no longer qualify as an emerging growth company, as long as we qualify as a foreign private issuer under the Exchange Act, we will
be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -21pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered
    under the Exchange Act;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability
    for insiders who profit from trades made in a short period of time; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    rules under the Exchange Act requiring the filing with the Securities and Exchange Commission of quarterly reports on Form 10-Q containing
    unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant
    events.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
foreign private issuers and emerging growth companies are also exempt from certain more stringent executive compensation disclosure rules.
Thus, even if we no longer qualify as an emerging growth company but remain a foreign private issuer, we will continue to be exempt from
the more stringent compensation disclosures required of companies that are neither emerging growth companies nor foreign private issuers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as a company incorporated in the Cayman Islands, we are permitted to adopt certain home country practices in relation to corporate
governance matters that differ significantly from the corporate governance requirements of the Nasdaq. For example, if we elect to adopt
home country practice, a majority of the Directors is not required to be independent directors, and neither our compensation committee
nor our nomination committee is required to be comprised entirely of independent directors. These practices may afford less protection
to shareholders than they would enjoy if we complied fully with corporate governance requirements of the Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conventions
Which Apply to This Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
we indicate otherwise, all information in this prospectus reflects no exercise by the underwriter of its option to purchase up to 337,500 additional
Class A Ordinary Shares from us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
where the context otherwise requires:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -21.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;AI&rdquo; means artificial intelligence;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;APAC&rdquo; means Asia-Pacific;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;ART&rdquo; means antigen rapid test;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;AWS&rdquo; means Amazon Web Services;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;B2B&rdquo; means business-to-business;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;B2C&rdquo;
                                            means business-to-consumer;</P>
</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;CAGR&rdquo;
                                            means compound annual growth rate;</P>
</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;CEO&rdquo;
                                            means chief executive officer;</P>
</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;COO&rdquo;
                                            means chief operating officer;</P>
</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Class
    A Ordinary Shares&rdquo; refer to our Class A ordinary shares in the capital of the Company of a nominal or par value of US$0.000004
    each designated as Class A Ordinary Shares, and having the rights provided for in our amended and restated memorandum and articles
    of association; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Class
    B Ordinary Shares&rdquo; refer to our Class B ordinary shares in the capital of the Company of a nominal or par value of US$0.000004
    each designated as Class B Ordinary Shares, and having the rights provided for in our amended and restated memorandum and articles
    of association;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;COVID-19&rdquo; means Coronavirus disease 2019,
    a contagious respiratory disease caused by the virus SARS-CoV-2;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Directors&rdquo;
    means the directors of our Company as at the date of this prospectus;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Exchange
    Act&rdquo; means the Securities Exchange Act of 1934, as amended;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;GDP&rdquo;
                                            means gross domestic product;</P>
</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;GP&rdquo; means general practitioner;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;H5N1&rdquo; means Influenza A virus subtype H5N1, a subtype
    of the influenza A virus;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;IT&rdquo; means information technology;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;MAU&rdquo;
    means monthly active users;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Mobile-health
    Network Solutions&rdquo;, &ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;our company&rdquo; and &ldquo;our&rdquo; refer to Mobile-health
    Network Solutions, a Cayman Islands company, its consolidated subsidiaries, and its consolidated affiliated entities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;MPU&rdquo; means monthly paying users;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Ordinary
    Shares&rdquo; refers to our Class A Ordinary Shares and Class B Ordinary Shares collectively;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;OTC&rdquo; means over-the-counter;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;PCR&rdquo; means polymerase chain reaction;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&ldquo;ROU&rdquo;
                                            means right-of-use;</P>
</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SEC&rdquo;
    or &ldquo;Securities and Exchange Commission&rdquo; means the United States Securities and Exchange Commission;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Singapore&rdquo;
    refers to the Republic of Singapore;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;S$&rdquo;
    or &ldquo;SGD&rdquo; refer to Singapore dollar(s), the legal currency of Singapore;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;U.S.&rdquo;
                                            means the United States;</P>
</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&ldquo;US$,&rdquo;
    &ldquo;U.S. dollars,&rdquo; &ldquo;$&rdquo; and &ldquo;dollars&rdquo; refer to United States dollar(s), the legal currency of the
    United States; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&ldquo;VND&rdquo; means Vietnamese dong, the legal currency
    of Vietnam.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="margin-top: 0pt; padding: 0.1in; border: Black 1.5pt solid; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="sl_002"></A>The
Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following assumes that the underwriter will not exercise its option to purchase additional Class A Ordinary Shares in the offering, unless
otherwise indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
    Price</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 65%; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    expect that the initial public offering price will be between US$4.00 and US$5.00 per Class A Ordinary Share.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares Offered by Us</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250,000
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A Ordinary Shares (or 2,587,500
    Class A Ordinary Shares if the underwriter exercises its option to purchase additional Class A Ordinary Shares in full).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares Outstanding Immediately After This Offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,921,750 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares (or 22,259,250 Class A Ordinary Shares if the underwriter exercises its option to purchase additional
    337,500 Class A Ordinary Shares in full).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ordinary
                                            Shares Issued and Outstanding Prior to This Offering</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char">19,671,750 Class A Ordinary
    Shares and 12,078,250 Class B Ordinary Shares.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares Outstanding Immediately After This Offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,000,000 </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares (or 34,337,500 Ordinary Shares if the underwriter exercises its option to purchase additional Class A Ordinary Shares
    in full).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
    Rights</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    holder of Class A Ordinary Shares is entitled to one vote per share. Each holder of Class B Ordinary Shares is entitled
    to 10 votes per share. Each Class B Ordinary Share is convertible into one Class A Ordinary Share at any time by the holder thereof.
    Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char">Listing</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char">We have applied to have
    our Class A Ordinary Shares listed on the Nasdaq Capital Market. The closing of this offering is conditioned upon Nasdaq&rsquo;s
    final approval of our listing application, and there is no guarantee or assurance that our Ordinary Shares will be approved for listing
    on Nasdaq.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Capital Market symbol</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MNDR</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
    to Purchase Additional Class A Ordinary Shares</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have granted to the underwriter an option, exercisable within 45 days from the date of closing of this offering, to purchase up to
    337,500 additional Class A Ordinary Shares.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of Proceeds</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    estimate that we will receive net proceeds from this offering of approximately US$8.6 million (or US$10.0 million if
    the underwriter exercises its option to purchase additional Class A Ordinary Shares in full), after deducting the underwriting discounts,
    commissions and estimated offering expenses payable by us and assuming an initial public offering price of US$4.50 </FONT>per
    Class A Ordinary Share, being the mid-point of the estimated range of the initial public offering price shown on the front cover
    of this prospectus. We will not receive any of the proceeds from the sale of Class A ordinary shares being offered by the Selling
    Shareholders. See &ldquo;Use of Proceeds&rdquo; for additional information.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-up</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
    each of our directors, executive officers, shareholders, and all option holders have agreed with the underwriter, subject to certain
    exceptions, not to sell, transfer or otherwise dispose of any Class A Ordinary Shares or similar securities or any securities convertible
    into or exchangeable or exercisable for our Class A Ordinary Shares for a period of 180 days from the date of this prospectus.
    See &ldquo;Underwriting&rdquo; for more information.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    Factors</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in the Class A Ordinary Shares is highly speculative and involves a high degree of risk. As an investor you should be able to bear
    a complete loss of your investment.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> See &ldquo;Risk
    Factors&rdquo; and other information included in this prospectus for a discussion of risks you should carefully consider before investing
    in the Class A Ordinary Shares.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
    Agent</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vstock
    Transfer, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    and settlement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; layout-grid-mode: char"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    underwriter expects to deliver the Class A Ordinary Shares against payment therefor through the facilities of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024.</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="sl_004"></A>Risk
Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
in our Class A Ordinary Shares entails a significant level of risk. Before investing in the Class A Ordinary Shares, you should carefully
consider all of the risks and uncertainties mentioned in this section, in addition to all of the other information in this prospectus,
including the financial statements and related notes. We may face additional risks and uncertainties aside from the ones mentioned below.
There may be risks and uncertainties that we are unaware of, or that we currently do not consider material, that may become important
factors that could adversely affect our business in the future. Any of the following risks and uncertainties could have a material adverse
effect on our business, financial condition, results of operations and prospects. In such case, the market prices of the Class A Ordinary
Shares could decline, and you may lose part or all of your investment.</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to Our Business and Industry</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Maintaining
users&rsquo; trust is critical to our success, and any failure to do so could damage our reputation and brand.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed a comprehensive ecosystem that connects users with our healthcare solutions. We have been building our brand name and
reputation for our ecosystem as we believe that our ability to maintain users&rsquo; trust in our MaNaDr ecosystem is critical to our
success in the rapidly expanding telehealth solutions market in Singapore. Our ability to maintain users&rsquo; trust in the services
and product offerings on our MaNaDr platform is primarily affected by the following factors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to maintain superior user experience and the quality of services and products provided through our ecosystem;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    breadth of offerings of our services and products and their efficacy in addressing our users&rsquo; needs and meeting their expectations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    reliability, security and functionality of our ecosystem;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to adopt new technologies or adapt our technology infrastructure to changing user requirements or emerging industry standards;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    strength of our consumer protection measures; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to increase brand awareness among existing and potential users through various marketing and promotional activities.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
loss of trust could harm the value of our brand and reputation, and result in users ceasing to utilize our ecosystem or reducing the
demand for the services and product offerings available on our platforms, which could materially and adversely affect our business, financial
condition, results of operations and prospects. Furthermore, there can be no assurance that our brand promotion and marketing efforts
would be effective. Such efforts may be expensive, which may, in turn, materially and adversely affect our business, financial condition,
results of operations and prospects, without any corresponding increase in user demand and/or sales for the services and products offered
over our ecosystem.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
negative review, comment or allegation about us, our in-house medical team, external doctors, clinic network and/or service providers,
among others, or services and products offered over our ecosystem by the media, on social media or other public online forums may harm
our brand, reputation and public image. We may also face challenges from others seeking to profit from, or defame, our reputation and
brand. Any of the foregoing may result in the loss of potential and existing users or other stakeholders and, in turn, have a material
adverse effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to manage the growth of our business and operations or implement our business strategies on schedule or within our budget,
or at all.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business has become increasingly complex in terms of both the type and scale of business we operate. Any expansion may increase the complexity
of our operations and place a significant strain on our managerial, operational, financial and human resources. Our current and planned
personnel, systems, procedures and controls may not be adequate to support our future operations. There can be no assurance that we will
be able to effectively manage our growth or implement all these systems, procedures and control measures successfully. If we are not
able to manage our growth effectively, our business, financial condition, results of operations and prospects may be materially and adversely
affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of our business strategies, we expect to further expand our business to new jurisdictions, which may expose us to additional risks,
including, among other things: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    with managing operations into new geographical regions, including complying with the various regulatory and legal requirements of
    different jurisdictions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">different
    approval or licensing requirements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recruiting
    sufficient personnel in these new markets;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
    in providing services and products as well as support in these new markets;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
    in attracting business partners and users and remaining competitive;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    adverse tax consequences;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign
    exchange losses;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited
    protection for intellectual property rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inability
    to effectively enforce contractual or legal rights; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">local
    political, regulatory and economic instability or civil unrest.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to effectively avoid or mitigate these risks, our ability to expand our business to these new jurisdictions will be affected,
which could have a material adverse effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
anticipated benefits from these efforts are based on assumptions that may prove to be inaccurate. Moreover, we may not be able to successfully
complete these growth initiatives, strategies and operating plans and realize all of the benefits that we expect to achieve or it may
be more costly to do so than we anticipate. If, for any reason, the benefits we realize are less than our estimates or the implementation
of these growth initiatives, strategies and operating plans adversely affect our operations or cost more or take longer to effectuate
than we expect, or if our assumptions prove inaccurate, our business, financial condition, results of operations and prospects may be
materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to effectively estimate, price and manage our costs, or if our fees and charges are regulated, prescribed or otherwise required
to be reduced, the profitability of our Group could decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the risks of rising business costs. While we seek to impute these costs in our fee pricing, we may not always be able
to do so due to our contractual arrangements, or if unanticipated costs arise that we have not priced into our contracts, or for any
number of reasons beyond our control. These costs include payments to our staff, overheads and various other costs incurred for the provision
of our services and product offerings under our ecosystem. Many other factors may cause a rise in actual operating expenses, including,
but not limited to increased employee compensation (including economic arrangements and share-based compensation), catastrophes, including
acts of terrorism, public health epidemics or severe weather, general inflation and government-mandated benefits or other regulatory
changes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
we may face higher costs associated with inflationary pressure in the economic environment in which we operate and changes in laws and
regulations may also adversely affect our cost basis. Any such increases in operating expenses may affect our profits adversely if we
are unable to raise our fees commensurately due to regulatory restrictions or the competitive nature of our business. Any changes in
the amount and manner in which we are able to charge for our services, including the amount and manner in which we are able to charge
our service providers, may have a material adverse impact on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our healthcare solutions do not drive users&rsquo; engagement or if we fail to provide superior user experience, our business and reputation
may be materially and adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is highly dependent on the receptiveness of our users to our services and products as well as their willingness to use, and
to increase the frequency and extent of their utilization of our solutions. Their degree of receptiveness to our services and products
depends on a number of factors, including the demonstrated accuracy and efficacy of our services and product offerings compared to that
offered by our competitors, turnaround time, cost-effectiveness, convenience and marketing support. Additionally, negative publicity
concerning our healthcare solutions, our brand or our MaNaDr ecosystem in general, or the telehealth solutions market as a whole, could
limit market acceptance and demand for our healthcare solutions. Furthermore, there can be no assurance that our efforts and ability
to demonstrate the value of our solutions and the relative benefits of our services and products over those of our competitors to our
users would be successful. We may fail to achieve an adequate level of acceptance by the users of our services and products, and
we may not be able to effectively expand the registered user base, promote user engagement or convert existing registered users to active
users. Consequently, our business may not develop as expected, or at all, and our business, financial condition, results of operations
and prospects may be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of our business also hinges on our ability to provide superior user experience, which depends on our ability to continue to deliver
quality care to our users, to maintain the quality of our services and products, to source for and provide services and products that
are responsive to user demands, and to provide timely and reliable delivery, flexible payment options and superior after-sales services.
Such ability, in turn, depends on a variety of factors beyond our control. In particular, we rely on a number of third parties, and
in particular doctors in our network of clinical service providers who are independent contractors and logistics partners who despatch
the medication to our patients, in the provision of our services and products. Their failure to provide high-quality customer experience
to our users may adversely affect our users&rsquo; receptiveness of, and willingness to utilize, our solutions, which may damage our
reputation and cause us to lose users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we operate a user service center to provide real-time assistance to our customers via WhatsApp. If our customer service representatives
fail to provide satisfactory service, or if waiting times are too long due to the high volume of inquiries from users at peak times,
our brand and customer loyalty may be adversely affected. Furthermore, any negative publicity or poor feedback on our customer service
may harm our brand and reputation and, in turn, cause us to lose users and market share, all of which may materially and adversely affect
our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to develop our existing technology infrastructure or recoup the investments we have made for such development, and failure
to continue to innovate or adapt to industry changes may materially and adversely affect our business, financial condition, results of
operations and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
telehealth solutions industry is characterized by rapidly changing technology, evolving industry standards and regulatory requirements,
introduction of new services and products as well as changing user demands. We are also subject to other changes and developments in
the telehealth solutions, Internet and healthcare industries and other industries in which we operate. These changes and developments
may require us to continue to innovate, and failure to do so would have a material adverse effect on our business, financial condition,
results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may need to constantly upgrade our technology infrastructure to provide increased scale, improved performance and additional built-in
functionality of our mobile application and website, and to keep pace with our business development, which may require significant investments
in time and resources, including adding new hardware, updating software and recruiting and training new engineering personnel. Failure
to improve our technology infrastructure accordingly may materially affect our ability to adopt new services and products, and could
result in unanticipated system disruptions, slower response times and impaired quality of our users&rsquo; and other participants&rsquo;
experiences, which may, in turn, materially and adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have been enhancing our technological capabilities and developing a number of technologies to support our ecosystem, if we experience
problems with the functionality and effectiveness of our technologies in the course of development, or if we are unable to continually
improve our technologies to handle our business needs as expected, our business, financial condition, results of operations and prospects
could be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
we have invested, and are expected to continually invest, significant amounts in upgrading our technological infrastructure and
developing our technologies. We are likely to recognize costs associated with these investments earlier than some of the anticipated
benefits and the return on these investments may be lower, or may develop more slowly, than we expected. We may not be able to recover
our capital expenditures or investments, in part or in full, or the recovery of these capital expenditures or investments may take longer
than expected. As a result, the carrying value of the related assets may be subject to an impairment charge, which may materially and
adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
self-developed technologies are complex and may contain undetected errors or may not operate properly, which could adversely affect our
business, financial condition, results of operations and prospects. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
self-developed technology platform, and in particular, our MaNaDr mobile application, provides our users and other participants
in our ecosystem with the ability to conduct a variety of actions essential to the operations of our business and the delivery of our
healthcare solutions. Self-developed technology development is time-consuming, expensive and complex, and may involve unforeseen difficulties.
We may encounter technical obstacles, and it is possible that we may discover additional problems that prevent our technologies from
operating properly and consequently adversely affect our technology infrastructure and other aspects of our business where our technologies
are applied. If our solutions do not function reliably or fail to achieve users&rsquo; and business partners&rsquo; expectations in terms
of performance, we may lose existing, or fail to attract new users or business partners, which may damage our reputation and adversely
affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
data services are complex and those we offer may develop or contain undetected defects or errors. Material performance problems, defects
or errors in our existing or new software and applications and services may arise in the future and may result from interface between
our healthcare solutions and systems and data that we did not develop and the function of which is beyond our control or undetected in
our testing. These defects and errors, and any failure by us to identify and address them, could result in a loss of revenue or market
share, diversion of development resources, harm to our reputation and increased service and maintenance costs. Defects or errors may
discourage existing or potential users from utilizing our solutions. Correction of defects or errors could prove to be impossible or
impracticable. The costs incurred in correcting any defects or errors may be substantial and could have a material adverse effect on
our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
failure to properly manage participants and stakeholders in our MaNaDr ecosystem may materially and adversely affect our business.
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on various participants and stakeholders, including, but not limited to, medical professionals, service providers and product suppliers
and vendors, in the provision of services and products on our platform, and the success of our business depends on our ability to properly
manage them. We consider a variety of factors before entering into contractual arrangements with them. Nevertheless, we have limited
control over the quality of work and performance of these participants and stakeholders in their provision of services and products over
our MaNaDr mobile application and website, and they may breach such contractual arrangements and subject us to claims and liabilities
that may affect our business operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also implemented quality control standards and procedures to manage their work and performance on our MaNaDr platform. However,
there can be no assurance that our monitoring of their work and performance would be sufficient to control the quality of their work.
In the event that a third party fails to meet our quality and operating standards contracted in our agreements or as required by relevant
Singapore laws and regulations, our operations may suffer and our business, financial condition, results of operations and prospects
may be materially and adversely affected. Furthermore, because of the contractual relationships, we could be perceived as being responsible
for the actions of such participants and, as a result, suffer reputational damage. This may adversely affect our ability to attract new
business partners and to engage them as providers of the healthcare solutions that we offer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, our in-house medical team, external doctors, clinics and other medical institutions, as well as healthcare institutions,
may provide sub-standard services, mishandle sensitive information, engage in other misconduct or commit medical malpractice, which could
subject us to medical liability or other legal claims. Our business, financial condition, results of operations and prospects may be
materially and adversely affected if any claims are made against us and are not fully covered by insurance. With respect to external
doctors, as they are not working physically with us, we have limited control over them as well as the quality of their online consultation
services. Despite our background checks relating to their qualification and their contractual obligations to strictly adhere to the specified
work scope and quality requirements and comply with applicable laws, there can be no assurance that our risk management procedures would
be sufficient to monitor their performance and control the quality of their work. In the event that the external doctors fail to comply
with the contractual obligations and applicable laws in relation to the provision of our teleconsultation services, our user experience
could deteriorate, and we may suffer as a result of any actual or alleged misconduct by them, which could materially and adversely affect
our business, financial condition, results of operations and prospects. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
MaNaShop and MaNaPharma, we manage inventories of certain medicines and health supplements, and we do not have as much control over the
storage and delivery of the other products sold. Many of our suppliers and vendors use their own facilities to store their products and
utilize their own or third-party delivery systems to deliver their products to our users, which makes it difficult for us to ensure that
our users get uniformly high-quality service for all products sold through ManaShop and MaNaPharma. If any supplier or vendor does not
deliver the products or delivers them late or delivers products that are materially different from their description or of poor quality,
or if it sells counterfeit or unlicensed products despite our background checks, the reputation of our MaNaShop and MaNaPharma
businesses and our brand may be materially and adversely affected and we could face claims and may be held liable for any losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
for those products of which we actively manage inventories, we rely primarily on contracted third-party couriers to deliver our products.
Interruptions or failures in our delivery services could prevent the timely and successful delivery of our products. These interruptions
may be due to unforeseen events that are beyond our control or the control of our third-party couriers, such as inclement weather, natural
disasters, transportation disruptions, inadequate manpower or labor unrest. If our products are not delivered on time or are delivered
in a damaged state, users may refuse to accept our products and have less confidence in our services. Any failure to provide high-quality
delivery services to our users may adversely affect the user experience for MaNaShop and MaNaPharma, and adversely affect our business,
financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have limited or no control over our suppliers and the quality of products supplied to us and if such products are not manufactured in
accordance with the applicable quality standards, our business and reputation could be materially and adversely affected</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
manufacturing processes for pharmaceutical products are required to meet good manufacturing practice and/or other applicable quality
standards. We source all of our products from third party suppliers, including brand principals and wholesalers. We have limited or no
control over the operations of such third-party suppliers and the quality of the products which they supply to us, and there cannot be
any assurance that such products will be free of defects and meet the applicable quality standards. From time to time, the pharmaceutical
products that we market have been subject to recalls by the manufacturers. While such recalls did not have a material adverse impact
on our business, financial condition, results of operations and prospects for the years ended June 30, 2023 and 2022, there
cannot be any assurance that future recalls, if any, will not have such an impact.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
to detect quality defects in our products or to prevent defective products from being delivered to our customers could result in injuries
or even deaths, product recalls or withdrawals, license revocations or fines, or lead to other problems that could adversely affect
our business and reputation, and materially and adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Product
liability claims in respect of defective products sold to our customers in our pharmaceutical business could adversely affect our reputation
and our financial prospects</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not maintain any insurance policy which covers us for product liability. Our business involves an inherent risk of product liability,
product recalls and exposure to public liability claims. Although our suppliers may, on a case-by-case basis, provide us with a written
indemnity covering the full extent of any third party liability we may incur as a result of the sale of their products, we cannot assure
you that we will be successful in obtaining such indemnity payment (if any) or that any such indemnity payment will fully cover all of
our losses associated with the original liability. If we were found responsible for damage caused by defective products, our reputation
may be adversely affected, which could result in the erosion of customer confidence in the brands that we sell and a consequent reduction
in sales. In such circumstances, our business, financial condition, results of operations and prospects may be materially and adversely
affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2023, we had not encountered any incidents in relation to the foregoing that have materially and adversely affected
our business, financial condition, results of operations and prospects, but this is no assurance that any such incidents will not occur
in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Any
lack of requisite approvals, licenses or permits applicable to our business may have a material and adverse effect on our business, financial
condition, results of operations and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to governmental supervision and regulation by various governmental and regulatory authorities in
Singapore, including but not limited to, the Ministry of Health, the Health Sciences Authority and the Singapore Medical Council,
and in other jurisdictions where we conduct our business operations. Such government authorities, statutory board, agencies and
bodies promulgate and enforce laws and regulations that cover a variety of business activities that our operations relate to, such
as the provision of medical services online, retail, sales and online operation of pharmaceutical products and medical devices, and
software development, among other things. These regulations in general regulate the entry into, the permitted scope of, as well
as approvals, licenses and permits for, the relevant business activities. Due to uncertainties in the regulatory environment of the
industries and/or jurisdictions in which we operate, there can be no assurance that we have obtained or applied for all the
approvals, permits and licenses required for conducting our business in Singapore or elsewhere, or would be able to maintain
our existing approvals, permits and licenses or obtain any new approvals, permits and licenses if required by any future laws or
regulations. If we fail to obtain and maintain the necessary approvals, licenses or permits required for our business, we
could be subject to liabilities, penalties and operational disruption and our business, financial condition, results of operations
and prospects could be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
failure to properly manage the registration of our in-house doctors may materially and adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
practice of doctors is strictly regulated under Singapore laws, rules and regulations. Under applicable Singapore regulations, a person
must not practice medicine or do any act as a medical practitioner without a valid practicing certificate in place. If a person is found
to be practicing medicine without a valid practicing certificate, he or she shall be guilty of an offense and shall be liable
on conviction to a fine not exceeding S$100,000 or to imprisonment for a term not exceeding 12 months or to both and, in the case of
a second or subsequent conviction, to a fine not exceeding S$200,000 or to imprisonment for a term not exceeding two years or to both.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that our future in-house doctors will obtain and/or maintain the relevant certification in a timely manner, or at
all, or that our in-house doctors will not practice outside the permitted scope of their respective licenses. Our failure to properly
manage the registration of our in-house doctors may materially and adversely affect our business. Furthermore, if any of our in-house
doctors are found to have deficient registration or found to be practicing beyond the scope permitted by relevant authorities, they may
be disciplined and lose their practicing licenses. As a result, we may no longer be able to employ them in offering our teleconsultation
and other services. In addition, there can be no assurance that we can timely find qualified replacements on commercially reasonable
terms, or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, all of our practicing in-house doctors in our team had obtained and maintained valid practicing
certificates under the relevant Singapore laws, rules and regulations. Nevertheless, there can be no assurance that the relevant
healthcare administrative authorities would not retrospectively find deficiency in the registration of these in-house doctors and
subject the relevant medical professionals to penalties, all of which could materially and adversely affect our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
failure</I></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I> to maintain optimal inventory
levels and the risk of inventory obsolescence could increase our operating costs or lead to unfulfilled customer orders, either of which
could have a material and adverse effect on our business, financial condition, results of operations and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
need to ensure optimal inventory levels for both our MaNaShop and MaNaPharma businesses. We manage inventories of certain medicines and
health supplements, while direct sales suppliers and vendors manage inventories of some of our other products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the medicines and health supplements of which we manage inventories, we are exposed to inventory risk as a result of rapid changes in
product life cycles, changing consumer preferences, uncertainty of product developments and launches, manufacturer back orders and other
related problems as well as the general volatile economic environment globally. There can be no assurance that we can accurately predict
these trends and events and avoid over-stocking or under-stocking of products. Furthermore, demand for products could change significantly
between the time when the products are ordered and the time when they are ready for delivery. When we begin to sell a new product, it
is particularly difficult to forecast product demand accurately. We may be unable to sell such inventory in sufficient quantities or
during the relevant sales seasons. Inventory levels in excess of customer demand may result in inventory write-downs, expiration of products
or an increase in inventory holding costs and a potential negative effect on our liquidity. Conversely, if we underestimate customer
demand or if our suppliers fail to provide products to us or deliver products to our customers in a timely manner, we may experience
inventory shortages, which may, in turn, result in unfulfilled customer orders, leading to an adverse effect on our customer relationships.
Our customers, such as clinics, do not have an obligation to drawdown on the inventory that we stock for them and as such, we
bear the risk of inventory obsolescence in the event that the demand from our customers fall short of the inventory that we stockpile
to cater to their needs. In addition, we may have to reduce the sale price of our products in order to reduce our inventory level, which
may lead to lower gross margins. In such circumstances, our business, results of operations, financial condition and prospects may be
materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we closely monitor the inventory levels of other products of which our direct sales suppliers and vendors manage inventories. However,
there can be no assurance that our monitoring and related measures would be effective in ensuring fulfillment of our customers&rsquo;
orders. Our failure to maintain proper inventory levels for our businesses under MaNaShop and/or MaNaPharma may have a material and adverse
effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be adversely affected by negative publicity, litigation and regulatory investigations and proceedings, and may not always be successful
in defending ourselves against such claims or proceedings.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business operations entail substantial litigation and regulatory risks, including the risk of lawsuits and other legal actions relating
to medical disputes, fraud and misconduct, sales and customer services and control procedures deficiencies, as well as the protection
of personal and confidential information of our users and business partners, among others. We may be subject to claims and lawsuits in
the ordinary course of our business. We may also be subject to inquiries, inspections, investigations and proceedings by relevant regulatory
and other governmental agencies. Actions brought against us may result in settlements, injunctions, fines, penalties or other results
adverse to us that could harm our business, financial condition, results of operations and prospects and reputation. Even if we are successful
in defending ourselves against these actions, the costs of such defense may be significant to us. A significant judgement or regulatory
action against us or a material disruption in our business arising from adverse adjudications in proceedings against our Directors, officers
or employees would have a material adverse effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Security
                                            breaches and attacks against our systems and network, and any potential resultant breach
                                            or failure to otherwise protect confidential and proprietary information, and network disruptions
                                            in general could damage our reputation and adversely affect our business, financial condition,
                                            results of operations and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely heavily on technology, particularly the Internet, to provide high-quality online services. However, our technology operations are
vulnerable to disruptions arising from human error, natural disasters, power failure, computer viruses, spam attacks, unauthorized access,
network disruptions and other similar events. Disruptions to, or instability of, our technology or external technology that allows our
customers to use our online services and products could materially harm our business and reputation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have employed significant resources to develop security measures against breaches, our cybersecurity measures may not detect or prevent
all attempts to compromise our systems, including distributed denial-of-service attacks, viruses, malicious software, break-ins, phishing
attacks, social engineering, security breaches or other attacks and similar disruptions that may jeopardize the security of information
stored in and transmitted by our systems or that we otherwise maintain. Breaches of our cybersecurity measures could result in unauthorized
access to our systems, misappropriation of information or data, deletion or modification of user information, or a denial-of-service
or other interruption to our business operations. As techniques used to obtain unauthorized access to or sabotage systems change frequently
and may not be known until launched against us, we may be unable to anticipate, or implement adequate measures to protect against, these
attacks. While we had not been subject to these types of attacks that had materially and adversely affected our business operations since
the inception of our business operations, there can be no assurance that we would not in the future be subject to such attacks that
may result in material damages or remediation costs. If we are unable to avert these attacks and security breaches, we could be subject
to significant legal and financial liability, our reputation would be harmed and we could sustain substantial revenue loss from lost
sales and customer dissatisfaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we may not have the resources or technical sophistication to anticipate or prevent rapidly evolving types of cyber-attacks.
Cyber-attacks may target us, our users or other participants of our ecosystem, or the information infrastructure on which we depend.
Actual or anticipated attacks and risks may cause us to incur significantly higher costs, including costs to deploy additional personnel
and network protection technologies, train employees, and engage third-party experts and consultants. Cybersecurity breaches may harm
our reputation, and materially and adversely affect our business, financial condition, results of operations and prospects. Furthermore,
despite any precautions we may take, the occurrence of a flood or fire, or other unanticipated incidents at our information infrastructure
facilities in Singapore, including power outages, telecommunications delays or failures, break-ins to our systems or computer viruses,
could result in delays or interruptions to our platform and operations as well as loss of our users&rsquo; and other participants&rsquo;
data. Any of these events could damage our reputation, materially disrupt our ecosystem and subject us to liability and claims, which
may materially and adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business generates and processes a large amount of data, and the improper use or disclosure of such data could harm our reputation as
well as have a material adverse effect on our business and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
platform generates and processes a large amount of personal, transaction, demographic and behavioral data. Sensitive user information
in our business operations is stored in third party datacenters. Such information includes, but is not limited to, personal information
(such as users&rsquo; name, cell phone number, delivery address, age and gender, consultation record, order record and activity log).
We have kept all sensitive user information in our database such as order records and consultation records since inception. We face risks
inherent in handling large volumes of data and in securing and protecting such data. In particular, we face a number of data-related
challenges from consultations, transactions and other activities on our platform, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">protecting
    the data in and hosted on our system, including against attacks on our system by external parties or improper behavior by our employees;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">addressing
    concerns related to privacy and sharing, safety, security and other factors; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">complying
    with applicable laws, rules and regulations relating to the collection, use, disclosure or security of personal information, including
    any requests from regulatory and government authorities relating to such data.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
systems failure or security breach or lapse that results in the unauthorized release of our user data could harm our reputation and brand
and, consequently, our business, in addition to exposing us to potential legal liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
terms of service concerning the collection, use and disclosure of user data are posted on our MaNaDr mobile application and website.
Any failure, or perceived failure, by us to comply with our privacy policies or any applicable regulatory requirements or privacy protection-related
laws, rules and regulations could result in proceedings or actions against us by governmental or regulatory authorities or others. These
proceedings or actions may subject us to significant penalties and negative publicity, require us to change our business model or practices,
increase our costs and disrupt our business. As we expand our operations, we may be subject to additional laws in other jurisdictions
where our users and business partners of our ecosystem are located. The laws, rules and regulations of other jurisdictions may impose
on us more stringent or conflicting requirements with financial penalties for non-compliance higher than those in Singapore, and the
compliance with such requirements could require significant resources and result in substantial costs, which may materially and adversely
affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not have sufficient insurance coverage to cover our business risks and face the risk of becoming subject to medical liability claims,
which could cause us to incur significant expenses and be liable for significant damages if not covered by insurance.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face risks of medical liability claims against our in-house medical team, external doctors and ourselves. We have obtained insurance
to cover certain potential risks and liabilities, such as professional liability insurance for our in-house medical team and external
doctors in connection with their provision of GP services over our platform and product liability insurance for us and our suppliers
with respect to products sold under MaNaShop and MaNaPharma. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
we may not be able to acquire any insurance for certain types of risks such as business liability or service disruption insurance for
all of our operations in Singapore, and our coverage may not be adequate to compensate for all losses that may occur, particularly with
respect to loss of business or operations. For example, we do not maintain business interruption insurance, nor do we maintain key-man
life insurance. Any business disruption, litigation, regulatory action, outbreak of epidemic disease or natural disaster may also expose
us to substantial costs and diversion of resources. Any claims made against us that are not fully covered by insurance could be costly
to defend against, result in substantial damage awards against us and divert the attention of our management and our in-house medical
team and external doctors from our operations, which could have a material adverse effect on our business, financial condition, results
of operations, and prospects. There can be no assurance that our insurance coverage is sufficient to prevent us from any loss or that
we will be able to successfully claim our losses under our current insurance policies on a timely basis, or at all. If we incur any loss
that is not covered by our insurance policies, or if the compensated amount is significantly less than our actual loss, our business,
financial condition, results of operations and prospects could be materially and adversely affected. In addition, professional liability
insurance premiums may increase significantly in the future, particularly as we expand our services. Further, adequate professional
liability insurance may not be available to our in-house medical team, external doctors or ourselves in the future on commercially acceptable
terms, or at all. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to prevent others from unauthorized use of our intellectual property, which could harm our business and competitive position.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
regard our trademarks, patents and similar intellectual property as critical to our success, and we rely on a combination of
intellectual property laws and contractual arrangements, including confidentiality agreements with our employees and third parties,
to protect our proprietary rights. Despite these measures, any of our intellectual property rights could be challenged, invalidated,
circumvented or misappropriated, or such intellectual property may not be sufficient to provide us with competitive advantages. In
addition, although we are not aware of any imitation websites or mobile applications that attempt to cause confusion or traffic
diversion from us at the moment, we may become an attractive target to such attacks in the future because of our brand recognition
in the Singapore telehealth solutions industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, there can be no assurance that our patent applications would be approved, that any issued patents would adequately protect
our intellectual property, or that such patents would not be challenged by third parties or found by a judicial or regulatory
authority to be invalid or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidentiality
agreements may be breached by counterparties, and there may not be adequate remedies available to us for any such breach. Accordingly,
we may not be able to effectively protect our intellectual property rights or to enforce our contractual rights in Singapore. Policing
any unauthorized use of our intellectual property is difficult and costly and the steps that we take may be inadequate to prevent the
infringement or misappropriation of our intellectual property. In the event that we resort to litigation to enforce our intellectual
property rights, such litigation could result in substantial costs and a diversion of our managerial and financial resources, and could
put our intellectual property at risk of being invalidated or narrowed in scope. There can be no assurance that we would prevail in such
litigation, and even if we manage to prevail, we may not obtain a meaningful recovery. In addition, our trade secrets may be leaked or
otherwise become available to, or be independently discovered by, our competitors. Any failure in maintaining, protecting or enforcing
our intellectual property rights could have a material adverse effect on our business, financial condition, results of operations and
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to intellectual property infringement claims, which may be expensive to defend and may disrupt our business and operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot be certain that our operations or any aspects of our business do not or would not infringe upon or otherwise violate patents,
copyrights or other intellectual property rights held by third parties. We have been, and from time to time in the future may be, subject
to legal proceedings and claims relating to the intellectual property rights of others. In addition, there may be other third-party intellectual
property that is infringed by our products, services or other aspects of our business. There could also be existing patents of which
we are not aware that our products may inadvertently infringe. There can be no assurance that holders of patents purportedly relating
to some aspect of our technology infrastructure or business, if any such holders exist, would not seek to enforce such patents against
us in Singapore, or any other jurisdictions as applicable. Furthermore, the application and interpretation of Singapore patent laws and
the procedures and standards for granting patents in Singapore are still evolving, and there can be no assurance that
Singapore courts or regulatory authorities would agree with our analysis. If we are found to have violated the intellectual property
rights of others, we may be subject to liability for our infringement activities or may be prohibited from using such intellectual property,
and we may incur licensing fees or be forced to develop alternatives of our own. In addition, we may incur significant expenses, and
may be forced to divert management&rsquo;s time and other resources from our business and operations to defend against these third-party
infringement claims, regardless of their merits. Successful infringement or licensing claims made against us may result in significant
monetary liabilities and may materially disrupt our business and operations by restricting or prohibiting our use of the intellectual
property in question, which may materially and adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>User
growth and activity depend upon effective use of operating systems, networks and standards that we do
not control.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Users
access our MaNaDr platform through the mobile application and the website on their devices. To optimize the user mobile experience, we
are, to some extent, dependent on our users downloading our MaNaDr mobile application and website for their particular devices.
As new mobile devices and platforms are released, it is difficult to predict the problems we may encounter in developing the software
required to operate our MaNaDr mobile application for these alternative devices and platforms, and we may need to devote significant
resources to the development, support and maintenance of the mobile application and/or the website. In addition, our future growth and
results of operations could suffer if we experience difficulties in the future in integrating our MaNaDr mobile application into mobile
devices or if problems arise with our relationships with providers of mobile operating systems or mobile application stores, if our MaNaDr
mobile application receive unfavorable reviews compared to competing applications by other telehealth solutions service providers, or
if we face increased costs to distribute or have users use our MaNaDr mobile application and/or website.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that it becomes more difficult for our users to access and use our MaNaDr platform and healthcare solution on their mobile
devices, or if our users choose not to access or use our MaNaDr platform and healthcare solutions on their mobile devices or to use mobile
devices that do not offer access to our MaNaDr platform and healthcare solutions, the growth of our user base could be harmed and our
business, financial condition, results of operations and prospects may be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>A limited number of customers have accounted
for, and are expected to continue to account for, a significant portion of our revenues. The failure to maintain or to increase revenues
from these customers could adversely affect our prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the years ended June
30, 2023 and 2022, revenue from a customer in the public sector, Customer A, accounted for 1.17% and 66.04% of our
total revenues respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Due to our revenue concentration
attributable to a limited number of customers, should any of the following events, among others, occur, our business, financial condition,
results of operations and prospects may be adversely affected:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">contract
    reduction, delay or cancellation by any significant customer and our failure to identify and acquire additional or replacement customers;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a substantial reduction
    by any significant customer in the price they are willing to pay for our services and/or products; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial difficulty
    of any significant customer who become unable to make timely payment for the services and/or products that such customer purchases
    from us.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into an agreement
with Customer A pursuant to which Customer A would fund the provision of certain medical services, including telemedicine, mobile medicine
and home medical and nursing services provided by us (the &ldquo;<B>Medical Services Agreement</B>&rdquo;). Such agreement has been extended
and the current term of the agreement is for the period commencing on April, 1 2023 and ending on March, 31 2024, unless
we are otherwise notified. Pursuant to the Medical Service Agreement, we will be directed to provide certain medical services to certain
patients. The cost of our services is based on an agreed set of rates, and following the provision of our services we would then be reimbursed
by Customer A within 30 days from the date of approval of the claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The above is a brief summary
of the material provisions of the Medical Services Agreement and does not purport to be a complete statement of its terms and conditions.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to conduct our marketing activities cost-effectively and we are subject to limitations in promoting our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred expenses on a variety of different marketing and brand promotion efforts designed to enhance our brand recognition and
increase sales of our services and products. However, our brand promotion and marketing activities may not be well received by users
and may not result in the levels of sales that we anticipate. Additionally, marketing approaches and tools in the Singapore telehealth
solutions market are evolving, which may further require us to enhance our marketing approaches and experiment with new marketing methods
to keep pace with industry developments and user preferences. Failure to refine our existing marketing approaches or to introduce new
marketing approaches in a cost-effective manner could reduce our market share and materially and adversely affect our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to limitations in promoting healthcare-related services and products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to certain limitations in promoting healthcare-related services and products. Our in-house medical team and other relevant
parties in the provision of our medical and wellness services have to comply with rules and regulations that restrict the promotion or
dissemination of information about the professional healthcare services and practice provided by licensed doctors, and the publication
or marketing efforts for the predominant purpose of promoting the products or services of doctors to users or potential users. Such restrictions
may affect our ability to further enhance our brand recognition or secure new business opportunities in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
there can be no assurance that our existing practices of monitoring our information dissemination process and publication would continue
to be effective. Should there be any change in the relevant rules and regulations, or change of interpretation thereof, we, our in-house
medical team and other relevant third parties may be regarded as breaching the relevant rules and regulations and may be subject to regulatory
penalties or disciplinary actions, which may materially and adversely affect our reputation, business, financial condition, results of
operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to maintain adequate internal controls, we may not be able to effectively manage our business and may experience errors or information
lapses affecting our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends on our ability to effectively utilize our standardized management system, information systems, resources and internal
controls. As we continue to expand, we will need to modify and improve our financial and managerial controls, reporting systems and procedures
and other internal controls and compliance procedures to meet our evolving business needs. If we are unable to improve or maintain our
internal controls, systems and procedures, they may become ineffective and adversely affect our ability to manage our business and cause
errors or information lapses that affect our business. Our efforts in improving our internal control system may not result in the elimination
of all risks. If we are not successful in discovering and eliminating weaknesses in our internal controls, our ability to effectively
manage our business may be affected, which may materially and adversely affect our business, financial condition, results of operations
and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
performance depends on key management as well as skilled and qualified medical professional and support staff generally, and any failure
to attract, motivate and retain such medical professionals and our support staff could hinder our ability to maintain and grow our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future success is significantly dependent upon the continued service of our management and key personnel, including skilled and qualified
medical professionals such as doctors, support staff such as nurses and assistants, as well as other healthcare professionals. We rely
on the services of these medical professionals and support staff to provide the comprehensive range of services we offer through our
self-owned GP clinics and specialist clinics, and we face intense competition from other medical services providers to recruit skilled
and qualified medical professionals and support staff. If we lose the services of any member of management or key personnel, we may not
be able to locate suitable or qualified replacements, and may incur additional expenses to recruit and train new staff, which could disrupt
our business and growth, thereby materially and adversely affecting our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the size and scope of our ecosystem and our expansion plans may require us to hire and retain a wide range of effective and experienced
personnel who can adapt to a dynamic, competitive and challenging business environment. We will need to continue to attract and retain
experienced and capable personnel at all levels, including qualified healthcare professionals for our in-house medical team, as we expand
our business and operations. Competition for talent in the Singapore telehealth solutions industry is intense, and the availability of
suitable and qualified candidates in Singapore is limited. Competition for these individuals could cause us to offer higher compensation
and other benefits to attract and retain them. In addition, even if we were to offer higher compensation and other benefits, there can
be no assurance that these individuals would choose to join or continue working for us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
if</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> any of our senior management or other key personnel
joins or establishes a competing business, we may lose some of our users, which may have a material adverse effect on our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to detect or prevent fraud or other misconduct committed by our employees or third parties.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fraud
or other misconduct by our employees, such as unauthorized business transactions, bribery and breach of our internal policies and procedures,
or by third parties, such as breach of law, may be difficult to detect or prevent. It could subject us to financial loss and sanctions
imposed by governmental authorities while seriously damaging our reputation. This may also impair our ability to effectively attract
prospective users, develop user loyalty, obtain financing on favorable terms and conduct other business activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we had not encountered any incidents in relation to the foregoing that had materially and adversely affected our business, financial
condition, results of operations and prospects for the years ended June 30, 2023 and 2022, and our risk management systems,
IT systems and internal control procedures are designed to monitor our operations and overall compliance, we may be unable to identify
non-compliance or suspicious transactions promptly, or at all. Furthermore, it is not always possible to detect and prevent fraud or
other misconduct committed by our employees or third parties, and the precautions we take to prevent and detect such activities may not
be effective. Therefore, we are subject to the risk that fraud or other misconduct may have previously occurred but was undetected, or
may occur in the future. This may materially and adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
rely on assumptions and estimates to calculate certain key operating metrics, and inaccuracies in such metrics may harm our reputation
and adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
key operating metrics, such as the MAU by age group and MPU by age group in this prospectus
are calculated using our internal data that has not been independently verified by third parties. While these numbers are based on what
we believe to be reasonable calculations for the applicable periods of measurement, there are inherent challenges in measuring usage
and user engagement across our user base. In addition, our key operating metrics are derived and calculated based on different assumptions
and estimates, and you should be cautious of such assumptions and estimates when assessing our operating performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
measures of user growth and user engagement may differ from estimates published by third parties or from similarly titled metrics used
by our competitors due to differences in data availability, sources and methodology. If third parties do not perceive our user metrics
to be accurate representations of our user base or user engagement, or if we discover material inaccuracies in our user metrics, our
reputation may be harmed and third parties may be less willing to allocate their resources or spending to us, which could adversely affect
our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may need additional capital but may not be able to obtain such on favorable terms or at all.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may require additional cash resources due to operating losses or future growth and development of our business, including any investments
or acquisitions we may decide to pursue. If our cash resources are insufficient to satisfy our cash requirements, we may seek to issue
additional equity or debt securities or obtain new or expanded credit facilities. Our ability to obtain external financing in the future
is subject to a variety of uncertainties, including our future financial condition, results of operations, cash flows, share price performance
and the liquidity of international capital and lending markets. In addition, incurring indebtedness would subject us to increased debt
service obligations and could result in operating and financing covenants that would restrict our operations. There can be no assurance
that financing would be available in a timely manner or in amounts or on terms favorable to us, or at all. Any failure to raise needed
funds on terms favorable to us, or at all, could restrict our liquidity as well as have a material adverse effect on our business, financial
condition, results of operations and prospects. Furthermore, any issuance of equity or equity-linked securities could result in significant
dilution to our existing shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
strategic alliances, investments or acquisitions may have a material adverse effect on our business, financial condition, results of
operations and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may evaluate and consider strategic investments and acquisitions or enter into strategic alliances to develop new services or solutions
and enhance our competitive position. Investments or acquisitions involve numerous risks, including the potential failure to achieve
the expected benefits of the combination or acquisition; difficulties in, and the cost of, integrating operations, technologies, services
and personnel; potential write-offs of acquired assets or investments; and downward effect on our operating results. These transactions
will also divert the management&rsquo;s time and resources from our normal operations, and we may have to incur unexpected liabilities
or expenses. We may also in the future enter into strategic alliances with various third parties. Strategic alliances with third parties
could subject us to a number of risks, including risks associated with potential leakage of proprietary information, non-performance
by the counterparty and an increase in expenses incurred in establishing new strategic alliances, any of which may materially and adversely
affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to credit risk with respect to trade receivables.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generally allow a credit period of 30 days to our customers, in particular other clinics that purchase medicine from us. As of June 30,
2023 and 2022, our trade receivables turnover days were 7 days and 6 days, respectively. As of the same dates, trade receivables of approximately
US$30,000 and US$34,000, respectively, were past due but not impaired. These mainly relate to a number of customers whom there is no
significant financial difficulty for and, based on our past experience, the overdue amounts can be recovered from. Nevertheless, there
can be no assurance that all such amounts due to us will be settled on time, or that such amounts will not continue to increase
in the future. Accordingly, we face credit risk in collecting trade receivables due from customers. Our performance, liquidity and profitability
would be adversely affected if significant amounts due to us are not settled on time or substantial impairment is incurred. The bankruptcy
or deterioration of the credit condition of any of these customers could also materially and adversely affect our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
face risks relating to the political, economic, regulatory, social and legal environments in the jurisdictions in which we currently
or may in the future operate.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have operations and a presence in Singapore and may expand into other jurisdictions in the future. We are subject to certain risks
inherent in conducting business, such as political, economic, regulatory, social and legal developments in each jurisdiction in which
we currently or may in the future operate, many of which are beyond our control. These risks include but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws
    and policies affecting trade, investment, foreign ownership restrictions and taxes, including laws and policies relating to the repatriation
    of funds and withholding taxes, and changes in these laws;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">differing
    degrees of protection for intellectual property;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inflation,
    interest rates and general conditions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in laws, regulations, local regulatory requirements and accounting standards and the interpretation, application and/or enforcement
    thereof, including any unexpected changes thereto. In particular, changes in social and/or health insurance requirements and standards
    as well as healthcare subsidies and support by local governments;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    political and/or regulatory climate in such jurisdictions, including any instability of foreign economies and governments and any
    social unrest or political instability;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuating
    foreign exchange rates;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expropriation
    or nullification of contracts;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    spread of communicable diseases in such jurisdictions, which may impact local business operations; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">climate
    change, natural disasters, demonstrations, riots, coups, wars and acts of terrorism.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
jurisdictions in which we currently or may in the future operate may be in a state of rapid political, economic and social changes, and
may also be subject to unforeseeable circumstances such as natural disasters and other uncontrollable events, which will entail risks
to our business and operations. There can also be no assurance that we will be able to adapt to the local conditions, regulations and
business practices and customs. Any changes implemented by the government of these jurisdictions resulting in, among other things, currency
and interest rate fluctuations, capital restrictions and changes in duties and taxes detrimental to our business could materially and
adversely affect our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
political and/or economic conditions of the jurisdictions in which we operate may also be affected by geopolitical risks, including lingering
trade tensions and other political disputes which have resulted in and may continue to lead to, among other things, the imposition of
sanctions on or blacklisting of politically connected persons and corporations, or persons and corporations perceived to be politically
connected. As at December 31, 2023, we did not, to our knowledge, have business dealings with any person or corporation which
is currently the subject of political sanctions. However, the geopolitical environment is constantly evolving and there can be no assurance
that we will not in the future be found to be in contravention of political sanctions, for example, should it transpire that any of our
business partners or other persons or corporations with whom we have business dealings are or become the subject of political sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business may also be affected by macroeconomic factors, such as general economic conditions, market sentiment and consumer confidence
in the jurisdictions we operate in, social and political unrest, regulatory, fiscal and other governmental policies, all of which are
beyond our control. Any adverse developments related to any of the abovementioned factors or other associated risks may have a material
adverse effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>COVID-19
or any other infectious and communicable diseases, as well as the occurrence of any acts of God, war, terrorist attacks and other catastrophic
events may have a material adverse effect on our business, financial condition, results of operations and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Group faces risks from the outbreak of communicable or virulent diseases and pandemics or epidemics such as severe acute respiratory
syndrome, H5N1 avian flu, Middle East respiratory syndrome, Ebola and more recently, the outbreak of COVID-19 in countries which we operate,
which may materially and adversely affect our operations. While our Group has put in place measures and protocols to contain the spread
of contagious and virulent diseases, our medical doctors, healthcare practitioners and other employees nonetheless remain susceptible
to infection as frontline workers in the event of disease outbreaks. Despite our strict infection control protocols, there can be no
assurance that our patients, employees, medical doctors and other healthcare professionals will not be infected with such diseases. We
may, as a result, be required to temporarily shut down our clinics and offices for an uncertain period
of time to contain the spread of such diseases. Such disruptions to our business and operations may have a negative impact on our business,
financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acts
of God, such as natural disasters which are beyond our control, may materially and adversely affect the economy, infrastructure and livelihood
of the local population. Similarly, man-made catastrophes, such as terrorist attacks and wars may disrupt the economies of the countries
we operate in. A catastrophic event or multiple catastrophic events may cause unexpected large losses and may have a material adverse
effect on our business, financial condition, results of operations and prospects. There can be no assurance that our efforts to protect
ourselves against catastrophic losses would be adequate. In addition, other events that are outside the control of our Group, such as
fire, deliberate acts of sabotage, vendor failure or negligence, blackouts, terrorist attacks or criminal acts, could damage, cause operational
interruptions to, or otherwise adversely affect our operating facilities and activities, as well as potentially cause injury or death
to our employees, patients and/or customers. We cannot give any assurance that the occurrence of any catastrophic events, wars, terrorist
attacks or other hostilities in any part of the world, potential, threatened or otherwise, will not, directly or indirectly, have a material
and adverse effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fluctuations
in exchange rates could have a material and adverse effect on our results of operations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We currently purchase a proportion
of our pharmaceutical products and medical equipment from our suppliers in foreign currency (namely, U.S. dollars and SGD). Our Group
is also exposed to fluctuations in VND as our representative office is located in Vietnam. Accordingly, our Group is exposed to fluctuations
in the U.S. dollar and VND, against the SGD. An appreciation of any such foreign currency may result in an increase in
the costs of our supplies. It is difficult to predict how market forces or government / international policy may impact fluctuations
of the U.S. dollar, VND and/or SGD in the future, and there can be no assurance that the U.S. dollar, VND and/or
SGD will not appreciate significantly in value in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that such fluctuations in the relevant foreign currency are substantial, and we are unable to pass on our costs to users, our
earnings, financial position and results of operations may be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, we do not have a formal policy for hedging against our foreign exchange exposure to the U.S. dollar, VND and/or SGD and
have not used any hedging instruments due to the high associated costs. However, we will continue to monitor our foreign exchange exposure
to the U.S. dollar, VND and/or SGD and we may employ hedging instruments to manage our foreign exchange exposure should the need
arise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
Related to Doing Business in Vietnam</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Geopolitical
risks may have an adverse impact on our business, financial condition and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
aspects of our business operations are conducted in Vietnam, including the software development for our mobile application. The social
conditions and political stability of Vietnam will also have a direct impact on the feasibility in conducting such business operations
in Vietnam. Our future business operations in Vietnam where the economy and legal systems remain susceptible to risks associated with
an emerging economy may be subject to higher geopolitical risks than developed countries. Unexpected social and political events such
as the social unrests in Vietnam targeting Chinese-related businesses, and territorial and other disputes among neighboring countries
in Asia may adversely affect our operations in Vietnam. Any social and political unrest, which are beyond our control, may give rise
to various risks, such as loss of employment and safety and security risks to persons and properties and in turn adversely affect the
Vietnam economy. Any such event may in turn have an adverse impact on our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
economy in Vietnam may be subject to periods of high inflation which could materially and adversely affect our business, financial condition
and results of operations as well as our growth prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
anti-inflation policies and a decline in commodity and petroleum prices have led to a decrease in Vietnam&rsquo;s inflation rate. While
these inflation rates are lower than rates of earlier years, there can be no assurance that the Vietnamese economy will not be subject
to future periods of high inflation. Should inflation in Vietnam increase significantly, our costs, including labor costs and transportation
costs, are expected to increase. Furthermore, high inflation rates could have an adverse effect on Vietnam&rsquo;s economic growth, business
climate and dampen consumer purchasing power. As a result, a high inflation rate in Vietnam could materially and adversely affect our
business, financial condition and results of operations as well as our growth prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changes
in the economic, political and legal environment of Vietnam, and Vietnam&rsquo;s less developed legal system, may adversely affect our
business, financial condition and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future business operations in Vietnam are subject to the economic, political and legal environment in Vietnam. Vietnam&rsquo;s economy
differs from the economies of many countries in such respects as governmental involvement, level of development, growth rate, allocation
of resources and inflation rate. Prior to the 1990s, Vietnam&rsquo;s economy was largely a planned economy. Since about 1987, increasing
emphasis has been placed on the utilization of market forces in the development of the economy. Although state-owned enterprises still
account for a substantial portion of Vietnam&rsquo;s industrial output, the Vietnamese government in general is reducing the level of
direct control that it exercises over the economy through state plans and other measures. It is our understanding that there is an increasing
level of freedom and autonomy in areas such as resource allocation, production and management and a gradual shift in emphasis to a market
economy and enterprise reform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legal system of Vietnam also differs from most common law jurisdictions, in that it is a system in which decided legal cases have little
precedential value. The laws and regulations are subject to broad and varying interpretations by government officials and courts. For
vague regulations, the courts of Vietnam have the power to read implied terms into contracts, adding a further layer of uncertainty.
As a result, government officials and courts often express different views from lawyers on the legality, validity and effect of
a particular legal document. In addition, the views of governmental authority received on a particular issue have no binding effect or
finality, so there can be no assurance that similar issues will be dealt with in a similar way by other governmental authorities. Furthermore,
recognition and enforcement of legal rights through Vietnam courts, arbitration centers and administrative agencies in the event of a
dispute is uncertain. As part of its transition from a planned economy to a more market-oriented one, the Vietnamese government has implemented
a series of economic reforms. In preparation for Vietnam&rsquo;s accession to the World Trade Organization in 2007, the Vietnamese government
had also promulgated a series of laws and regulations on local and foreign investment, including the law on investment, which regulates
investments in Vietnam, and the law on enterprises, which sets out the types of corporate vehicle investors may establish to carry out
their investment projects. However, conflicting interpretations between local regulators in different provinces and between different
ministries may create confusion over key issues. In the context of pursuing and maintaining economic reforms, the Vietnamese government
has promulgated other laws and regulations in recent years designed to attract foreign investment and business development in Vietnam,
which may intensify the competition in our industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Vietnamese government has made progress in economic reform and the development of laws and regulations, there remain inherent uncertainties
and inconsistencies in the interpretation, implementation and enforcement of laws and government policies. Many of the reforms are unprecedented
or experimental and may be subject to revision, change or abolition, depending upon the outcome of these experiments. Furthermore, there
can be no assurance that the Vietnamese government will continue to pursue policies of economic reform or that any reforms will be successful
or the impetus to reform will continue. If any of the changes adversely affect us or our business, or we are unable to capitalize on
the economic reform measures of the Vietnamese government, our business, financial condition and results of operations could be adversely
affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Asset
realization in bankruptcy proceedings may be time-consuming and expensive.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the improved Vietnamese law on bankruptcy that came into effect on January 1, 2015, there is significant uncertainty on its implementation
and interpretation due to the lack of regulatory guidance and political sensitivities. Accordingly, the bankruptcy process in Vietnam
may be complex, uncertain and time-consuming. After bankruptcy is declared, the general meeting of creditors may, subject to certain
provisions of law, decide to apply either business rehabilitation or asset liquidation on the enterprise. However, in the event that
any creditor or any participant in the general meeting of creditors has any objection to the resolution passed by the general meeting
of creditors, it can request for a judicial review of the resolution. Upon review, the judge may convene another general meeting of the
creditors if he finds reasonable grounds to do so. The decision to apply either business rehabilitation or asset liquidation on the enterprise
must be confirmed by the judge before being implemented by the parties. Due to these complexities, a significant amount of time may pass
before a creditor is able to recover from a Vietnamese debtor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Vietnamese
foreign exchange control may limit our ability to utilize our revenue effectively and affect our ability to receive dividends and other
payments from our Vietnamese subsidiary.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are also based in Vietnam and therefore faces the risk of foreign exchange controls limiting our ability to receive dividends
from our Vietnamese subsidiary in the future. At present, foreign invested enterprises in Vietnam are, subject to conditions, generally
permitted to exchange VND into foreign currency at credit institutions licensed to provide foreign exchange services in Vietnam to repatriate
profits and make outward remittances of foreign currency for the purchase of supplies and services, among others, provided that such
foreign invested enterprise declares the intended use of the money and provides appropriate supporting documents. Such remittances are
restricted to being made through registered accounts at authorized banks which are licensed to operate in Vietnam, and profits must first
be converted into foreign currency prior to remittance. While under the Vietnamese government&rsquo;s current foreign exchange policy,
there is a low risk of foreign exchange controls restricting our ability to freely utilize our revenue and to receive dividends from
our Vietnamese subsidiary, there can be no assurance that the Vietnamese government will not, in future, extend its foreign exchange
controls to restrict or prevent profits from being repatriated by foreign invested entities. Such a change would limit our ability to
receive dividends from our Vietnamese subsidiary, through which all of our revenue is generated, and would cause a material and adverse
effect on our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
VND may be subject to foreign exchange controls imposed by the Vietnamese government.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Vietnam, the currency is VND, which is not generally freely convertible into other currencies. Under certain conditions, such as fulfilment
of Vietnam&rsquo;s financial obligations, the Vietnamese government allows foreign invested enterprises to convert VND into other currencies
for repatriation of profits from their Vietnam operations abroad. However, there can be no assurance that such rules and regulations
will not be subject to change in the future and any tightening of foreign control laws in Vietnam may impair our ability to repatriate
profits from our Vietnamese operations to our Company. If any of the above occurs, our business, results of operations and financial
condition may be materially and adversely affected.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to Regulations and Litigations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to extensive and evolving regulatory requirements, non-compliance with which, or changes in which, may materially and adversely
affect our business and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our business operations are highly regulated. See &ldquo;Regulation.&rdquo; Our business is subject to laws, regulations, licensing
and accreditation requirements in Singapore and other countries where we may operate. Such laws, regulations, licensing and accreditation
requirements cover many aspects of our business, including, but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    conduct of our operations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provision of services;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    quality of medical facilities, equipment and services;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    purchase and sale of medications and pharmaceutical drugs;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    handling and disposal of regulated items and associated environmental regulations for medical facilities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    qualifications of medical and other clinical personnel; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    confidentiality and maintenance of, and security issues associated with, health-related information and medical records.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
qualifications and practicing activities of our medical professionals, nurses and assistants are strictly regulated under the laws and
regulations of the jurisdictions in which we may operate, as well as by other applicable codes of professional conduct or ethics. If
our medical professionals and nurses fail to comply with their professional licensing requirements, we may be subject to administrative
penalties including fines, loss of licenses or restrictions on our medical facility operations, which could materially and adversely
affect our business and reputation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, there are various licensing requirements governing different aspects of our business with which we must comply and
which may impose conditions that may restrict our operations. Regulatory authorities may exercise broad discretion in assessing our compliance
with licensing requirements, varying licensing requirements or introducing new licensing requirements, and we may incur significant costs
and suffer operational restrictions that could be harmful to our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pharmaceutical services business is also regulated by various healthcare laws and regulations and we are subject to, among others, licensing
and certification requirements, product registration requirements, quality and safety standards and periodic renewal and reassessment
procedures. For example, we are required to possess various permits, licenses or certifications to provide our services and products,
and the third parties on whom we rely to sell and distribute our products are subject to similar requirements. If we or these third parties
are unable to obtain or renew such permits, licenses or certifications in a timely manner, or at all, we and/or such third parties may
not be able to provide the relevant services and/or sell or distribute the relevant products in the relevant jurisdiction and our business
operations in such jurisdiction may be materially disrupted. As a licensed wholesaler of pharmaceutical products, we are required by
the relevant laws and regulations to only supply such products to certain specified persons, such as licensed retail pharmacies, licensed
healthcare institutions and qualified healthcare professionals. While we have implemented measures to prevent unauthorized persons from
purchasing pharmaceutical products from us (for example, we require persons who wish to open a purchasing account with us to provide
us with copies of the relevant licenses to establish that they are registered healthcare professionals and we only deliver to the address
of the account holder), there is a risk that unauthorized persons may nevertheless, fraudulently or otherwise, manage to create a purchasing
account with us and/or acquire pharmaceutical products from us. In such an event, we may be exposed to civil and criminal liability under
the relevant laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the introduction of new services and products may require us to comply with additional, yet undetermined, laws and regulations. Compliance
may require obtaining appropriate permits, licenses or certificates as well as expending additional resources to monitor developments
in the relevant regulatory environment. The failure to adequately comply with these future laws and regulations may delay, or possibly
prevent, some of our products or services from being offered to users, which may have a material adverse effect on our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
to existing laws, regulations and guidelines, or the introduction of new laws, regulations and guidelines could also have a negative
impact on our operations, even if such laws and regulations are not directly applicable to us. Should there be any subsequent modifications,
additions or new restrictions to the current compliance standards, we may incur additional costs or administrative burdens in complying
with the new or modified standards which may materially and adversely affect our profitability and, consequently, our business, financial
condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
we expand our international operations, we will increasingly face political, legal and compliance, operational, regulatory, economic
and other risks that we do not face or are more significant than in our domestic operations. Our exposure to these risks is expected
to increase.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we expand our international operations, we will increasingly face political, legal and compliance, operational, regulatory, economic
and other risks that we do not face or that are more significant than in our domestic operations. These risks vary widely by country
and include varying regional and geopolitical business conditions and demands, government intervention and censorship,
discriminatory regulation, nationalization or expropriation of assets and pricing constraints. Our international services and
products need to meet country-specific user preferences as well as country-specific legal requirements, including those related
to licensing, digital health, privacy, data storage, location, protection and security. Our ability to conduct digital health
services internationally is subject to the applicable laws governing remote healthcare and the practice of medicine in such
location, and the interpretation of these laws is evolving and vary significantly from country to county and are enforced by
governmental, judicial and regulatory authorities with broad discretion. Nonetheless, we cannot be certain that our interpretation
of such laws and regulations is correct in how we structure our operations, our arrangements with physicians, services agreements
and customer arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
international operations increase our exposure to, and require us to devote significant management resources to implement controls and
systems to comply with the privacy and data protection laws of non-U.S. jurisdictions and the anti-bribery, anti-corruption and anti-money
laundering laws of the U.S. (including the Foreign Corrupt Practices Act of 1977) and the United Kingdom (including the
Bribery Act) and similar laws in other jurisdictions. Implementing our compliance policies, internal controls and other systems upon
our expansion into new countries and geographies may require the investment of considerable management time and financial and other resources
over a number of years before any significant revenues or profits are generated. Violations of these laws and regulations could result
in fines, criminal sanctions against us, our officers or employees, restrictions or outright prohibitions on the conduct of our business
and significant brand and reputational harm. We must regularly reassess the size, capability and location of our global infrastructure
and make appropriate changes, and must have effective change management processes and internal controls in place to address changes in
our business and operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends, in part, on our ability to anticipate these risks and manage these difficulties, and the failure to do so could have
a material adverse effect on our business, operating results, financial position, brand, reputation and/or long-term growth. Our international
operations require us to overcome logistical and other challenges based on differing languages, cultures, legal and regulatory schemes
and time zones. Our international operations encounter labor laws, customs and employee relationships that can be difficult, less flexible
than in our domestic operations and expensive to modify or terminate. In some countries where we are required to, or choose to,
operate with local business partners in the future, this may require us to manage our partner relationships and may reduce our operational
flexibility and ability to quickly respond to business challenges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to evolving laws, regulations, standards and policies, and any actual or perceived failure to comply could harm our brand
and reputation, subject us to significant fines and liability, or otherwise adversely affect our business. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws, regulations, standards and policies governing the telehealth solutions business vary from jurisdiction to jurisdiction. The application
of these types of laws to our operations continues to be difficult to predict but could pose operational challenges for us in the future.
As laws vary from jurisdiction to jurisdiction, our services must be continually monitored for compliance with the various rules and
requirements, which may change from time to time. Furthermore, the costs of compliance, including remediation of any discovered issues
and any changes to our operations mandated by new or amended laws, may be significant, and any failures to comply could result in additional
expenses, delays or fines. The applicable laws, regulations, standards and policies in the different jurisdictions in which our users
are located continue to rapidly change, which increases the likelihood of a patchwork of complex or conflicting regulations, or which
could adversely increase our compliance costs or otherwise materially and adversely affect our business, financial condition, results
of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be involved in certain legal proceedings from time to time. Any adverse decision in such proceedings may render us liable to liabilities
and may adversely affect our business, financial condition, results of operations and prospects.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be involved in legal proceedings from time to time.  In addition to the related costs, managing and defending in legal proceedings
can divert our management&rsquo;s attention from our business. We may also need to pay damages to settle claims with a substantial amount
of cash. Any of these could have a material adverse effect on our business, financial condition, results of operations and prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to Our Class A Ordinary Shares and This Offering</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
has been no public market for our Class A Ordinary Shares prior to the completion of this offering, and you may not be able to
resell our Class A Ordinary Shares at or above the price you pay for them, or at all.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the completion of this offering, there has not been a public market for our Class A Ordinary Shares. We plan to apply for the
listing of our Class A Ordinary Shares on the Nasdaq Capital Market. An active public market for our Class A Ordinary Shares,
however, may not develop or be sustained after the offering, in which case the market price and liquidity of our Class A Ordinary
Shares will be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
validity of certain issuances and transfers of shares of our Company cannot be verified.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to laws and regulations governing our corporate administration and management, including corporate laws and regulations
in relation to the issuances and transfers of shares of our Company, and there is no assurance that we will be able to maintain at
all times full compliance with such laws and regulations. We have in the past encountered and may encounter corporate secretarial
irregularities, which may conflict with or affect the validity of corporate actions we take or have taken. These past corporate
secretarial irregularities include records of waivers or approvals of shareholders of their rights of pre-emption and rights of
first refusal under the memorandum and articles of association of our Company effective at the relevant time and/or under the
shareholder agreement, subscription agreement or investment agreement entered into with such shareholders not having been
obtained prior to issuances and transfers of shares of our Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event such legal proceedings or claims are commenced against our Company, we may have to devote substantial time and resources to
defending such proceedings and such proceedings may also divert the attention of our management from our core business. Further, in the
event a claimant successfully challenges the validity of a transfer or allotment, certain corporate actions may be considered void or
we may be required to issue or transfer certain shares to the claimant. If the foregoing events occur, it could adversely affect our
business, financial condition, results of operations and prospects.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In view of such past corporate
secretarial irregularities, we have put in place measures to prevent and/or minimize the recurrence of such issues, including but not
limited to, engaging professional staff, including legal and financial personnel where necessary, to handle such corporate secretarial
matters, and performing close follow-ups with the professional corporate secretarial agents to assist with the day-to-day oversight of
such corporate secretarial matters. Accordingly, we are of the view that such internal controls and procedures established and maintained
by our Company are adequate and effective in order to prevent and/or minimize the recurrence of such issues going forward.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
initial public offering price for our Class A Ordinary Shares may not be indicative of prices that will prevail in the trading market and such
market prices may be volatile.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial public offering price for our Class A Ordinary Shares will be determined by negotiations between us and the Underwriters,
and may not bear a direct relationship to our earnings, book value, or any other indicia of value. We cannot assure you that the market
price of our Class A Ordinary Shares will not decline significantly below the initial public offering price. The financial markets
in the United States and other countries have experienced significant price and volume fluctuations in the last few years. Volatility
in the price of our Class A Ordinary Shares may be caused by factors outside of our control and may be unrelated or disproportionate
to changes in our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
will experience immediate and substantial dilution in the net tangible book value of Class A Ordinary Shares purchased.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial public offering price of our Class A Ordinary Shares is substantially higher than the (pro forma) net tangible book value per
share of our Class A Ordinary Shares. Consequently, when you purchase our Class A Ordinary Shares in the offering, upon completion of
the offering, you will incur immediate dilution of $4.19 per share, assuming an initial public offering price of $4.50.
See &ldquo;Dilution&rdquo;. In addition, you may experience further dilution to the extent that additional Class A Ordinary Shares are
issued upon exercise of outstanding options we may grant from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to implement and maintain an effective system of internal controls, we may be unable to accurately or timely report our results
of operations or prevent fraud, and investor confidence and the market price of our Class A Ordinary Shares may be materially and adversely affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the completion of this offering, we have been a private company with limited accounting personnel. Furthermore, prior to the completion
of this offering, our management has not performed an assessment of the effectiveness of our internal control over financial reporting,
and our independent registered public accounting firm has not conducted an audit of our internal control over financial reporting. Effective
internal control over financial reporting is necessary for us to provide reliable financial reports and, together with adequate disclosure
controls and procedures, is designed to prevent fraud.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
failure to implement and maintain effective internal controls over financial reporting could result in errors in our financial statements
that could result in a restatement of our financial statements, cause us to fail to meet our reporting obligations and cause investors
to lose confidence in our reported financial information, which may result in volatility in and a decline in the market price of our
Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of this offering, we will become a public company in the United States subject to the Sarbanes-Oxley Act of 2002. Section
404 of the Sarbanes-Oxley Act of 2002, or Section 404, will require that we include a report of management on our internal control over
financial reporting in our annual report on Form 20-F. In addition, if we cease to be an &ldquo;emerging growth company&rdquo; as such
term is defined in the JOBS Act, our independent registered public accounting firm must attest to and report on the effectiveness of
our internal control over financial reporting on an annual basis. Our management may conclude that our internal control over financial
reporting is not effective. Moreover, even if our management concludes that our internal control over financial reporting is effective,
our independent registered public accounting firm, after conducting its own independent testing, may issue a report that is qualified
if it is not satisfied with our internal controls or the level at which our controls are documented, designed, operated or reviewed,
or if it interprets the relevant requirements differently from us. In addition, after we become a public company, our reporting obligations
may place a burden on our management, operational and financial resources and systems for the foreseeable future. We may be unable to
timely complete our evaluation testing and any required remediation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the course of documenting and testing our internal control procedures, in order to satisfy the requirements of Section 404, we may identify
material weaknesses and deficiencies in our internal control over financial reporting. The Public Company Accounting Oversight Board,
or PCAOB, has defined a material weakness as &ldquo;a deficiency, or a combination of deficiencies in internal control over financial
reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim statements will not be prevented
or detected on a timely basis&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we fail to maintain the adequacy of our internal control over financial reporting, as these standards are modified, supplemented
or amended from time to time, we may not be able to conclude on an ongoing basis that we have effective internal control over financial
reporting in accordance with Section 404. Generally speaking, if we fail to achieve and maintain an effective internal control environment,
we could suffer material misstatements in our financial statements and fail to meet our reporting obligations, which would likely cause
investors to lose confidence in our reported financial information. This could in turn limit our access to capital markets, harm our
results of operations and lead to a decline in the trading price of our Class A Ordinary Shares. Additionally, ineffective internal control over
financial reporting could expose us to increased risk of fraud, misuse of corporate assets and legal actions under the United States
securities laws and subject us to potential delisting from Nasdaq, to regulatory investigations and to civil or criminal sanctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting
requirements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;emerging growth company&rdquo;, as defined in the JOBS Act, and we may take advantage of certain exemptions from various
requirements applicable to other public companies that are not emerging growth companies including, most significantly, not being required
to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act for so long as we are an emerging growth
company. As a result, if we elect not to comply with such auditor attestation requirements, our investors may not have access to certain
information they may deem important.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards
until such date that a private company is otherwise required to comply with such new or revised accounting standards. In other words,
an &ldquo;emerging growth company&rdquo; can delay the adoption of certain accounting standards until those standards would otherwise
apply to private companies. We have elected to take advantage of the extended transition period, although we have already adopted certain
new and revised accounting standards based on transition guidance permitted under such standards. As a result of this election, our future
financial statements may not be comparable to other public companies that comply with the public company effective dates for these new
or revised accounting standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will incur substantial increased costs as a result of being a public company.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of this offering, we will incur significant legal, accounting, and other expenses as a public company that we did not incur
as a private company. The Sarbanes-Oxley Act, as well as rules subsequently implemented by the SEC and Nasdaq, impose various requirements
on the corporate governance practices of public companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
with these rules and regulations increases our legal and financial compliance costs and makes some corporate activities more time-consuming
and costlier. In addition, we incur additional costs associated with our public company reporting requirements. It may also be more difficult
for us to find qualified persons to serve on our Board or as executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;emerging growth company,&rdquo; as defined in the JOBS Act and will remain an emerging growth company until the earlier of
(a) the last day of the fiscal year in which the fifth anniversary of the completion of this offering occurs; (b) the last day of
the fiscal year in which we have total annual gross revenue of at least US$1.235 billion; (c) the date on which we are deemed to be a
&ldquo;large accelerated filer&rdquo; under the Exchange Act, which means the market value of our Class A Ordinary Shares that are held
by non-affiliates is US$700.00 million or more as of the last business day of our most recently completed second fiscal quarter; and
(d) the date on which we have issued more than US$1.0 billion in non-convertible debt during the prior three-year period. We may choose
to take advantage of some, but not all, of the available exemptions. An emerging growth company may take advantage of specified reduced
reporting and other requirements that are otherwise applicable generally to public companies. These provisions include exemption from
the auditor attestation requirement under Section&nbsp;404 in the assessment of the emerging growth company&rsquo;s internal control
over financial reporting and permission to delay adopting new or revised accounting standards until such time as those standards apply
to private companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
we are no longer an &ldquo;emerging growth company&rdquo;, or until five years following the completion of our initial public offering,
whichever is earlier, we expect to incur significant additional expenses and devote substantial management effort toward ensuring compliance
with the requirements of Section 404 and the other rules and regulations of the SEC. For example, as a public company, we have been required
to increase the number of independent directors and adopt policies regarding internal controls and disclosure controls and procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently evaluating and monitoring developments with respect to these rules and regulations, and we cannot predict or estimate with
any degree of certainty the amount of additional costs we may incur or the timing of such costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Substantial
future sales of our Class A Ordinary Shares or the anticipation of future sales of our Class A Ordinary Shares in the public market could cause the price
of our Class A Ordinary Shares to decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of substantial amounts of our Class A Ordinary Shares in the public market after this offering, or the perception that these sales could
occur, could cause the market price of our Class A Ordinary Shares to decline. An aggregate of 19,671,750 Class A Ordinary Shares are
issued and outstanding before the consummation of this offering and 2,250,000 Class A Ordinary Shares will be issued and outstanding
immediately after the consummation of this offering. Sales of these shares into the market could cause the market price of our Class
A Ordinary Shares to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not intend to pay dividends for the foreseeable future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare
or pay any dividends in the foreseeable future. As a result, you may only receive a return on your investment in our Class A Ordinary
Shares if the market price of our Class A Ordinary Shares increases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
securities or industry analysts do not publish research or reports about our business, or if they publish a negative report regarding
our Class A Ordinary Shares, the price of our Class A Ordinary Shares and trading volume could decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
trading market for our Class A Ordinary Shares may depend in part on the research and reports that industry or securities analysts publish about
us or our business. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade us, the price
of our Class A Ordinary Shares would likely decline. If one or more of these analysts cease coverage of our company or fail to regularly publish
reports on us, we could lose visibility in the financial markets, which could cause the price of our Class A Ordinary Shares and the trading
volume to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
trading price of our Class A Ordinary Shares may be volatile or may decline regardless of our operating performance, which
could result in substantial losses to investors.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been instances of extreme stock price run-ups followed by rapid price declines and strong stock price volatility with a number of
recent initial public offerings, especially among companies with relatively smaller public floats. As a relatively small-capitalized
company with relatively small public float after this offering, we may experience greater stock price volatility, lower trading volume
and less liquidity than large-capitalized companies. In particular, our Class A Ordinary Shares may be subject to rapid and substantial
price volatility, low volumes of trades and large spreads in bid and ask prices due to factors beyond our control. Such volatility, including
any stock-run up, may be unrelated to our actual or expected operating performance and financial condition or prospects, making it difficult
for prospective investors to assess the rapidly changing value of our Class A Ordinary Shares. In addition to market and industry factors,
the price and trading volume for our shares may be highly volatile for factors specific to our own operations, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated fluctuations in our revenue and other operating results;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    financial projections we may provide to the public, any changes in these projections or our failure to meet these projections;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
    of securities analysts who initiate or maintain coverage of us, changes in financial estimates by any securities analysts who follow
    our company, or our failure to meet these estimates or the expectations of investors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of significant products or features, technical innovations, acquisitions, strategic partnerships, joint
    ventures, or capital commitments;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
    or departures of key personnel;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">release
    of lock-up or other transfer restrictions on our issued and outstanding equity securities or sales of additional equity securities;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    litigation or regulatory investigations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market
prices of equity securities of many companies. Stock prices of many companies have fluctuated in a manner unrelated or disproportionate
to the operating performance of those companies. In the past, stockholders have filed securities class action litigation following periods
of market volatility. If we were to become involved in securities litigation, it could subject us to substantial costs, divert resources
and the attention of management from our business, and adversely affect our business, financial condition, results of operations and
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
dual-class voting structure will limit your ability to influence corporate matters requiring shareholder approval, and could discourage
others from pursuing any change of control transactions that holders of our Class A Ordinary Shares may view as beneficial.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized share capital is divided into Class A Ordinary Shares and Class B Ordinary Shares. Holders of Class A Ordinary Shares will
be entitled to one vote per share, while holders of Class B Ordinary Shares will be entitled to 10 votes per share. Each Class B Ordinary
Share is convertible into one Class A Ordinary Share at any time by the holder thereof, while Class A Ordinary Shares are not convertible
into Class B Ordinary Shares under any circumstances. We will issue Class A Ordinary Shares in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of this offering, Siaw Tung Yeng, Teoh Pui Pui, Siaw Tun Mine and Denis Christopher Nyam Ngian Kwong will beneficially
own all of our then issued and outstanding Class B Ordinary Shares. These Class B Ordinary Shares will constitute approximately 35.5%
of our total issued and outstanding share capital immediately after the completion of this offering and approximately 84.6%
of the aggregate voting power of our total issued and outstanding share capital immediately after the completion of this offering, assuming
the underwriter does not exercise the over-allotment option. As a result of the dual-class share structure and the concentration of ownership,
holders of Class B Ordinary Shares will have considerable influence over corporate matters requiring shareholder approval, such as election
of directors, amendment of constitutional documents including our memorandum and articles of association, and significant corporate transactions.
Such holders may take actions that are not in the best interest of us or our other shareholders. This concentration of ownership may
also discourage, delay or prevent a change in control of our Company, which could have the effect of depriving our other shareholders
of the opportunity to receive a premium for their shares as part of a sale of our Company and may reduce the price of our Class A Ordinary
Shares. This concentrated control will limit your ability to influence corporate matters and could discourage others from pursuing any
potential merger, takeover or other change of control transactions that holders of Class A Ordinary Shares may view as beneficial.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
management has broad discretion to determine how to use the funds raised in the offering and may use them in ways that may not enhance
our results of operations or the price of our Class A Ordinary Shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that we will use the net proceeds from this offering for working capital and other corporate purposes. See &ldquo;Use of
Proceeds.&rdquo; However, our management will have significant discretion as to the use of the net proceeds to us from this offering
and could spend the net proceeds in ways that do not improve our results of operations or enhance the trading price of our Class
A Ordinary Shares. The net proceeds from this offering may be placed in investments that do not produce income or that lose value.
You will not have the opportunity, as part of your investment decision, to assess whether proceeds are being used appropriately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we cease to qualify as a foreign private issuer, we would be required to comply fully with the reporting requirements of the Exchange
Act applicable to U.S. domestic issuers, and we would incur significant additional legal, accounting and other expenses that we would
not incur as a foreign private issuer.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to qualify as a foreign private issuer upon the completion of this offering. As a foreign private issuer, we will be exempt from
the rules under the Exchange Act prescribing the furnishing and content of proxy statements, and our officers, directors and principal
shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.
In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently
or as promptly as United States domestic issuers, and we will not be required to disclose in our periodic reports all of the information
that United States domestic issuers are required to disclose. While we currently expect to qualify as a foreign private issuer immediately
following the completion of this offering, we may cease to qualify as a foreign private issuer in the future, in which case we would
incur significant additional expenses that could have a material adverse effect on our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
we are a foreign private issuer and are exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, you will
have less protection than you would have if we were a domestic issuer.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
listing rules&nbsp;require listed companies to have, among other things, a majority of its board members be independent. As a
foreign private issuer, however, we are permitted to, and we may follow home country practice in lieu of the above requirements, or
we may choose to comply with the above requirement within one year of listing. The corporate governance practice in our home
country, the Cayman Islands, does not require a majority of our Board to consist of independent directors. Thus, although a
director must act in the best interests of the Company, it is possible that fewer Board members will be exercising
independent judgment and the level of Board oversight on the management of our company may decrease as a result. In addition,
Nasdaq listing rules&nbsp;also require U.S. domestic issuers to have a compensation committee, a nominating/corporate governance
committee composed entirely of independent directors, and an audit committee with a minimum of three members. We, as a foreign
private issuer, are not subject to these requirements. Nasdaq listing rules&nbsp;may require shareholder approval for certain
corporate matters, such as requiring that shareholders be given the opportunity to vote on all equity compensation plans and
material revisions to those plans, certain ordinary share issuances. We intend to comply with the requirements of Nasdaq listing
rules&nbsp;in determining whether shareholder approval is required on such matters and to appoint a nominating and corporate
governance committee. We may, however, consider following home country practice in lieu of the requirements under Nasdaq listing
rules&nbsp;with respect to certain corporate governance standards which may afford less protection to investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Although
as a foreign private issuer we are exempt from certain corporate governance standards applicable to U.S. issuers, if we cannot
satisfy, or continue to satisfy, the initial listing requirements and other rules of the Nasdaq Capital Market, our securities may not
be listed or may be delisted, which could negatively impact the price of our securities and your ability to sell them.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will seek to have our securities approved for listing on the Nasdaq Capital Market upon consummation of this offering. We cannot assure
you that we will be able to meet those initial listing requirements at that time. Even if our securities are listed on the Nasdaq Capital
Market, we cannot assure you that our securities will continue to be listed on the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, following this offering, in order to maintain our listing on the Nasdaq Capital Market, we will be required to comply with
certain rules of the Nasdaq Capital Market, including those regarding minimum stockholders&rsquo; equity, minimum share price, minimum
market value of publicly held shares, and various additional requirements. Even if we initially meet the listing requirements and other
applicable rules of the Nasdaq Capital Market, we may not be able to continue to satisfy these requirements and applicable rules. If
we are unable to satisfy the Nasdaq Capital Market criteria for maintaining our listing, our securities could be subject to delisting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Nasdaq Capital Market does not list our securities, or subsequently delists our securities from trading, we could face significant
consequences, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    limited availability for market quotations for our Class A Ordinary Shares;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    liquidity with respect to our Class A Ordinary Shares;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    determination that our Class A Ordinary Shares are &ldquo;penny stock&rdquo;, which will require brokers trading in
    our Class A Ordinary Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity
    in the secondary trading market for our Class A Ordinary Shares;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited amount of news and analyst coverage;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decreased ability to issue additional securities or obtain additional financing in the future.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Board may decline to register transfers of Class A Ordinary Shares in certain circumstances.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
in connection with the settlement of trades, transactions or transfers of Class A Ordinary Shares entered into through the facilities
of a stock exchange or automated quotation system on which our Class A Ordinary Shares are listed or traded from time to time,
our Board may, in its sole discretion, decline to register any transfer of any Ordinary Share which is not fully paid up or on which
we have a lien. Our directors may also decline to register any transfer of any Ordinary Share unless (i)&nbsp;the instrument of transfer
is lodged with us, accompanied by the certificate for the shares to which it relates and such other evidence as our board of directors
may reasonably require to show the right of the transferor to make the transfer; (ii)&nbsp;the instrument of transfer is in respect of
only one class of shares; (iii)&nbsp;the instrument of transfer is properly stamped, if required; (iv)&nbsp;in the case of a transfer
to joint holders, the number of joint holders to whom the share is to be transferred does not exceed four; (v)&nbsp;the shares transferred
are free of any lien in favor of us; and (vi)&nbsp;a fee of such maximum sum as the Nasdaq Capital Market may determine to be payable,
or such lesser sum as our Board may from time to time require, is paid to us in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our directors refuse to register a transfer they shall, within two months
after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal.
The registration of transfers may, after compliance with any notice required in accordance with the rules of the relevant stock exchange,
be suspended and our register of members closed at such times and for such periods as our Board may from time to time determine, provided,
however, that the registration of transfers shall not be suspended nor the register of members closed for more than 30 days in any year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This,
however, is unlikely to affect market transactions of the Class A Ordinary Shares purchased by investors in the public offering.
Once the Class A Ordinary Shares have been listed on the Nasdaq Capital Market, the legal title to such Class A Ordinary
Shares and the registration details of those Class A Ordinary Shares in the Company&rsquo;s register of members will remain with
Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;)/Cede&nbsp;&amp; Co. All market transactions with respect to those Class A Ordinary
Shares will then be carried out without the need for any kind of registration by the directors, as the market transactions will all be
conducted through the &ldquo;DTC&rdquo; systems.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
may be unable to present proposals before annual general meetings or extraordinary general meetings not called by shareholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands law provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any
right to put any proposal before a general meeting. These rights, however, may be provided in a company&rsquo;s articles of association.
Our Articles of Association allow our shareholders holding shares which carry in aggregate not less than one-third of all votes attaching
to the issued and outstanding shares of the Company entitled to vote at general meetings to requisition an extraordinary general meeting
of our shareholders, in which case our board is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned
to a vote at such meeting. Advance notice of not less than seven days is required for the convening of our annual general shareholders&rsquo;
meeting (if any) and any other general meeting of our shareholders. A quorum required for a general meeting of shareholders consists
of, at the time when the meeting proceeds to business, at least one shareholder present or by proxy, representing not less than one-third
of all votes attaching to the issued and outstanding shares in the Company entitled to vote at such general meeting of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are classified as a passive foreign investment company, U.S. taxpayers who own our Class A Ordinary Shares may have adverse
U.S. federal income tax consequences.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-U.S. corporation such as ourselves will be classified as a passive foreign investment company, which is known as a PFIC, for any
taxable year if, for such year, either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    least 75% of our gross income for the year is passive income; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    average percentage of our assets (determined at the end of each quarter) during the taxable year which produce passive income or
    which are held for the production of passive income is at least 50%. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Passive
income generally includes dividends, interest, rents and royalties (other than rents or royalties derived from the active conduct of
a trade or business), and gains from the disposition of passive assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Based on the current and projected
composition of our income and assets (including the amount of cash we raise in this offering), and the expected value of our assets,
including goodwill, which is based in part on the expected price of our Class A Ordinary Shares in the offering, we do not expect to
be a PFIC for the current taxable year. However, because PFIC status is determined on an annual basis, and therefore our PFIC status
for the current taxable year and any future taxable year will depend upon the future composition of our income and assets, there can
be no assurance that we will not be a PFIC for any taxable year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If we are a PFIC for any
taxable year (or portion thereof) during which a U.S. taxpayer holds Class A Ordinary Shares, we generally would continue to be treated
as a PFIC with respect to that U.S. taxpayer for all succeeding years during which the U.S. taxpayer holds such Class A Ordinary Shares,
even if we ceased to meet the threshold requirements for PFIC status. In such case, such a U.S. taxpayer generally will be subject to
adverse U.S. federal income tax consequences, including (i) the treatment of all or a portion of any gain on disposition as ordinary
income, (ii) the application of a deferred interest charge on such gain and the receipt of certain dividends and (iii) compliance with
certain reporting requirements. We do not intend to provide the information that would enable investors to make a qualified electing
fund election that could mitigate the adverse U.S. federal income tax consequences should we be a PFIC. You are urged to consult your
tax advisor concerning the U.S. federal income tax consequences of owning and disposing of Class A Ordinary Shares if we are to become
classified as a PFIC.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a more detailed discussion of the application of the PFIC rules to us and the consequences to U.S. taxpayers if we were determined to
be a PFIC, see &ldquo;Taxation&mdash; United States Federal Income Tax Considerations.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption
of their shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we make a liquidating distribution, any distributions received by shareholders could be viewed as an unlawful payment if it was proved
that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall due in the ordinary
course of business. As a result, a liquidator could seek to recover some or all amounts received by our shareholders. Furthermore, our
directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad faith, thereby
exposing themselves and our company to claims, by paying public shareholders prior to addressing the claims of creditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that claims will not be brought against us for these reasons. Under Cayman Islands law, a Cayman Islands company may
pay a dividend out of either profit or its share premium account, provided that in no circumstances may a dividend be paid out of the
share premium account if this would result in the company being unable to pay its debts as they fall due in the ordinary course of business.
Our Company and any director or manager of the Company who knowingly and willfully authorizes or permits any distribution or dividend
to be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course of business
would commit an offense and may be liable to a fine of Cayman Islands dollars 15,000 and to imprisonment for five years in the
Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
may face difficulties in protecting your interests as a shareholder, as Cayman Islands law provides substantially less protection when
compared to the laws of the U.S. and it may be difficult for a shareholder of ours to effect service of process or to enforce
judgements obtained in the U.S. courts.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an exempted company incorporated under the laws of the Cayman Islands. Our corporate affairs are governed by our Memorandum and Articles
of Association, as amended and by the Companies Act (As Revised) and common law of the Cayman Islands. The rights of shareholders to
take legal action against our directors, officers and us, actions by minority shareholders and the fiduciary duties of our directors
to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands
is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from English common law. Decisions
of the English courts are generally of persuasive authority but are not binding on the courts of the Cayman Islands. The rights of our
shareholders and the fiduciary duties of our directors under Cayman Islands law are not as clearly established as they would be under
statutes or judicial precedents in the United States. In particular, the Cayman Islands has a different body of securities laws as compared
to the United States, and provides significantly less protection to investors. In addition, Cayman Islands companies may not have standing
to initiate a shareholder derivative action before the U.S. federal courts. There is no statutory recognition in the Cayman Islands of
judgments obtained in the United States, although the courts of the Cayman Islands will generally recognize and enforce a non-penal judgment
of a foreign court of competent jurisdiction without retrial on the merits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
courts of the Cayman Islands are unlikely (i) to recognize or enforce judgments of courts of the United States predicated upon the civil
liability provisions of the federal securities laws of the United States or any state securities laws; and (ii) in original actions brought
in the Cayman Islands, to impose liabilities predicated upon the civil liability provisions of the federal securities laws of the United
States or any state securities laws, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances,
although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman
Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits
based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for
which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such
judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent
with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a
kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple
damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings
are being brought elsewhere.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
all of our operations are conducted outside the United States, and substantially all of our assets are located outside the United States.
All of our directors and officers are nationals or residents of jurisdictions other than the United States and all or a substantial portion
of their assets are located outside the United States. As a result, it may be difficult or impossible for a shareholder to bring an action
against us or against these individuals outside of the United States, or to enforce against us or them judgments obtained in U.S. courts,
including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state in the United
States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
of Cayman Islands exempted companies like us have no general rights under Cayman Islands law to inspect corporate records (other than
the memorandum and articles of association, a list of the current directors of the company, the register of mortgages and charges and
any special resolutions passed by our shareholders) or to obtain copies of lists of shareholders of these companies. Our directors are
not required under our memorandum and articles of association to make our corporate records available for inspection by our shareholders.
This may make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder resolution
or to solicit proxies from other shareholders in connection with a proxy contest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
corporate governance practices in the Cayman Islands, which is our home country, differ significantly from requirements for companies
incorporated in other jurisdictions such as the United States. To the extent we choose to follow home country practice with respect to
corporate governance matters, our shareholders may be afforded less protection than they otherwise would under rules and regulations
applicable to U.S. domestic issuers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of all of the above, our shareholders may have more difficulty in protecting their interests through actions against us or our
officers, directors or major shareholders than would shareholders of a corporation incorporated in the United States. For a discussion
of significant differences between the provisions of the Companies Act and the laws applicable to companies incorporated in a U.S. state
and their shareholders, see &ldquo;Description of Share Capital &mdash; Differences in Corporate Law.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
offering price of the primary offering and resale offering could differ.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering price of our Class A Ordinary Shares in the initial public offering has been determined by negotiations between the Company
and the underwriter. The offering price in the initial public offering bears no relationship to our assets, earnings or book value, or
any other objective standard of value. The selling shareholders may sell the resale shares at prevailing market prices or privately negotiated
prices after close of the offering and listing of the Class A Ordinary Shares on Nasdaq. Therefore, the offering prices of the initial
public offering and resale offering could differ. As a result, the purchasers in the resale offering could pay more or less than the
offering price in the primary offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Resales
of our Class A Ordinary Shares in the public market by the Selling Shareholders may cause the market price of our Ordinary Shares to
decline.</I></B></FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resales
of 2,574,750 Class A Ordinary Shares by our Selling Shareholders from time to time, after the closing of this offering, could
compete with the resale of the Class A Ordinary Shares purchased from this offering and have the effect of depressing the market price
for our Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_001"></A>Special
Note regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements that reflect our current expectations and views of future events. The forward-looking
statements are contained principally in the sections entitled &ldquo;Prospectus Summary,&rdquo; &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and &ldquo;Business.&rdquo; Known and unknown risks,
uncertainties and other factors, including those listed under &ldquo;Risk Factors,&rdquo; may cause our actual results, performance or
achievements to be materially different from those expressed or implied by the forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
can identify some of these forward-looking statements by words or phrases such as &ldquo;aim,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;continue,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;hope,&rdquo; &ldquo;intend,&rdquo; &ldquo;is/are likely
to,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;target,&rdquo; &ldquo;will,&rdquo;
or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about
future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These
forward-looking statements include statements relating to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to execute our strategies, manage growth and maintain our corporate culture;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            future business development, financial conditions and results of operations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations regarding demand for and market acceptance of our products and services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to successfully compete in the highly competitive markets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expectations regarding our relationships with service partners;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            safety, affordability, and convenience of our platform and our offerings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            anticipated investments in new products and offerings, and the effect of these investments
                                            on our results of operations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to successfully enter into new geographies, expand our presence in countries in which
                                            we are limited by regulatory restrictions, and manage our international expansion;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            expected growth in the number of platform users, and our ability to promote our brand and
                                            attract and retain platform users;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">anticipated
                                            technology trends and developments and our ability to address those trends and developments
                                            with our products and offerings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to identify, recruit, and retain skilled personnel, including key members of senior
                                            management;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to maintain, protect, and enhance our intellectual property rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to successfully acquire and integrate companies and assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the need for capital and the availability of financing and capital to fund these needs;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to prevent disturbance to our IT systems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to successfully defend litigation brought against us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">relevant
                                            government policies and regulations relating to our industry;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">man-made
                                            or natural disasters, including war, acts of international or domestic terrorism, civil disturbances,
                                            occurrences of catastrophic events and acts of God such as floods, earthquakes, wildfires,
                                            typhoons and other adverse weather and natural conditions that affect our business or assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to implement, maintain, and improve effective internal controls;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            anticipated uses of net proceeds from this offering; and</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                                            <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">other
                                            matters beyond our control.</TD></TR>
                                                                                                                            </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements involve various risks and uncertainties. Although we believe that our expectations expressed in these forward-looking
statements are reasonable, our expectations may later be found to be incorrect. Our actual results could be materially different from
our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are
generally set forth in &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations,&rdquo; &ldquo;Business,&rdquo; &ldquo;Regulation&rdquo; and
other sections in this prospectus. You should read thoroughly this prospectus and the documents that we refer to with the understanding
that our actual future results may be materially different from and worse than what we expect. We qualify all of our forward-looking
statements by these cautionary statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains certain data and information that we obtained from various government and private publications. Statistical data
in these publications also include projections based on a number of assumptions. The industries in which we operate may not grow at the
rate projected by market data, or at all. Failure of those industries to grow at the projected rate may have a material and adverse effect
on our business and the market price of the Class A Ordinary Shares. In addition, the rapidly evolving nature of this industry results
in significant uncertainties for any projections or estimates relating to the growth prospects or future condition of our market. Furthermore,
if any one or more of the assumptions underlying the market data are later found to be incorrect, actual results may differ from the
projections based on these assumptions. You should not place undue reliance on these forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements made in this prospectus relate only to events or information as of the date on which the statements are made
in this prospectus. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements,
whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the
occurrence of unanticipated events. You should read this prospectus and the documents that we refer to in this prospectus and have filed
as exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding that our actual
future results may be materially different from what we expect.<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_002"></A>Use
of Proceeds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We estimate that we will
receive net proceeds from this offering of approximately US$8.6 million, or approximately US$10.0 million if the
underwriter exercises its option to purchase additional Class A Ordinary Shares in full, after deducting underwriting discounts and
commissions and the estimated offering expenses payable by us. These estimates are based upon an assumed initial offering price of US$4.50 per Class A Ordinary Share, the mid-point of the estimated range of the initial public offering price shown on the front
cover page of this prospectus. Each US$1.00 increase (decrease) in the assumed initial public offering price of US$4.50 per
Class A Ordinary Share would increase (decrease) the net proceeds of this offering by US$2.1 million, or approximately US$3.8 million if the underwriter exercises its option to purchase additional Class A Ordinary Shares in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We plan to use the net proceeds
of this offering as follows: </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    20%</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> for product development to expand the functionality
    and value of our core technology platform; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    25%</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> for development and expansion of business
    and operations; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    30%</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> for potential merger and acquisitions although
    we have no commitments with respect to any such acquisitions at this time; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
    25%</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> for general corporate purposes, including
    working capital, operating expenses and capital expenditures. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
precise amounts and percentage of the net proceeds we would devote to particular categories of activity will depend on prevailing
market and business conditions as well as particular opportunities that may arise from time to time. This foregoing expected use of
the net proceeds from this offering represents our intentions based upon our current plans and business conditions, which could
change in the future as our plans and business conditions evolve. The amounts and timing of our actual expenditures may vary
significantly depending on numerous factors, including any unforeseen cash needs. Similarly, the priority of our prospective uses of
the net proceeds will depend on business and market conditions as they develop. Accordingly, our management will have significant
flexibility and broad discretion in applying the net proceeds of the offering. If an unforeseen event occurs or business conditions
change, we may use the net proceeds of this offering differently than as described in this prospectus. See &ldquo;Risk Factors
&mdash; Risks Related to Our Class A Ordinary Shares and This Offering &mdash; Our Management Has Broad Discretion to Determine How
to Use the Funds Raised in the Offering and May Use Them in Ways that May not Enhance our Results of Operations or the Price of Our
Class A Ordinary Shares.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending
any use of proceeds described above, we plan to invest the net proceeds from this offering in short-term, interest-bearing, debt instruments
or demand deposits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we may use a portion of the net proceeds for the acquisition of, or investment in, companies, technologies, products or assets that complement
our business, we have no present understandings, commitments or agreements to enter into any acquisitions or make any investments. We
cannot assure you that we will make any acquisitions or investments in the future.</FONT></P>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale of the Class A Ordinary Shares being offered by the Selling Shareholders.</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_003"></A>Dividend
Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors (&ldquo;<B>Board</B>&rdquo;) has discretion on whether to distribute dividends, subject to certain requirements of
Cayman Islands law. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount
recommended by the Board. In either case, all dividends are subject to certain restrictions under Cayman Islands law, namely that our
Company may only pay dividends out of profits or share premium, and provided always that, in no circumstances may a dividend be
paid if this would result in our Company being unable to pay its debts as they fall due in the ordinary course of business. Even
if we decide to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements
and surplus, general financial condition, contractual restrictions and other factors that the Board may deem relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not previously declared or paid any cash dividends and we do not have any present plan to pay any cash dividends on our Class A
Ordinary Shares in the foreseeable future after this offering. We currently intend to retain most, if not all, of our available funds
and any future earnings to operate and expand our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_004"></A>Capitalization</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our capitalization as of June 30, 2023:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                            an actual basis;</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                             <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">on a pro forma basis to give effect to the 1 for 250 forward share split, change in par value and increase in authorized
shares, and the issuance of 6,268,000 Class A Ordinary Shares at par under share allotment post share split as at the date of the registration
statement of which this prospectus forms a part; and;</TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                            a pro forma basis to give effect to the issuance and sale of Class A Ordinary Shares by us
                                            in this offering at an assumed initial public offering price of US$4.50 per Class
                                            A Ordinary Share, the mid-point of the estimated range of the initial public offering price
                                            shown on the front cover of this prospectus, after deducting underwriting discounts and commissions
                                            and estimated offering expenses payable by us.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this table together with our consolidated financial statements and the related notes included elsewhere in this prospectus
and the information under &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of June 30, 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Actual</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma Adjustment</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(US$ thousands, except for</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>share and per share data)</B></FONT></P></TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">2,225,806</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">1,722,030</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; font-weight: bold; text-align: right">12,512,211</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term borrowings:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Interest bearing loans</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total long-term borrowings</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders&rsquo; equity/(deficit)<SUP>(2)</SUP>:</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Class A Ordinary Shares (of nominal or par value of US$0.000004 per share;
    6,250,000,000 Class A Ordinary Shares authorized and 19,671,750 Class A Ordinary Shares issued and outstanding, actual;
    21,921,750 Class A Ordinary Shares issued and outstanding, pro forma as of June 30, 2023, respectively)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Class B Ordinary Shares (of nominal or par value of US$0.000004 per share;
    6,250,000,000 Class B Ordinary Shares authorized and 12,078,250 Class B Ordinary Shares issued and outstanding, actual
    and pro forma as of June 30, 2023, respectively)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional paid-in capital<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,496,710</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,446,005</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,648,381</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,153,001</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(23,724,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(33,018,301</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288,990</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288,990</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total shareholders&rsquo; equity <SUP>(1)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(367,199</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,722,030</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,919,207</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total capitalization<SUP>(1)</SUP></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(367,199</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,722,030</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9,919,207</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; width: 25%; margin-bottom: 0pt"><DIV STYLE="margin-top: 0pt; font-size: 1pt; border-top: Black 1.5pt solid; margin-bottom: 0pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            US$1.00 increase (decrease) in the assumed initial public offering price of US$4.50
                                            per Class A Ordinary Share, the mid-point of the estimated range of the initial public offering
                                            price shown on the front cover of this prospectus, would increase (decrease) each of additional
                                            paid-in capital, total shareholders&rsquo; equity and total capitalization by US$2.1
                                            million, assuming the number of Class A Ordinary Shares offered by us, as set forth on
                                            the front cover of this prospectus, remains the same and after deducting underwriting discounts
                                            and commissions and estimated offering expenses payable by us.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                                           <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">(2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">On February 14, 2024, the Company completed the
                                                                                                                                              sub-division of the issued Class A and Class B Ordinary Shares of a nominal or par value of $0.001 each in the capital of the
                                                                                                                                              Company into 250 ordinary shares of a nominal or par value of $0.000004 each. Before the subdivision and further issuance of shares,
                                                                                                                                              the Company&rsquo;s ordinary shares issued and outstanding was 53,615 Class A Ordinary Shares of a nominal or par value of $0.001
                                                                                                                                              each and 48,313 Class B Ordinary Shares of a nominal or par value of $0.001 each as at 30 June 2023. After the subdivision and further issuance of shares, the
                                                                                                                                              Company&rsquo;s ordinary shares issued and outstanding was 19,671,750 Class A Ordinary Shares of a nominal or par value of $0.000004
                                                                                                                                              each and 12,078,250 Class B Ordinary Shares of a nominal or par value of $0.000004 each.</P>
</TD></TR>
                                                                                                                           </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
discussion and table above exclude exercise of any outstanding options pursuant to our share incentive plan after June 30, 2023.
See &ldquo;Management&mdash;2023 Employee Incentive Plan&rdquo; for details of these awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_005"></A>Dilution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in our Class A Ordinary Shares, your interest will be diluted to the extent of the difference between the initial public offering
price per Class A Ordinary Share and our net tangible book value per both Class A and Class B Ordinary Share after this
offering. Dilution results from the fact that the initial public offering price per Class A Ordinary Share is substantially in excess
of the book value per both Class A and Class B Ordinary Share attributable to the existing shareholders for our presently
outstanding Class A and Class B Ordinary Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net tangible book value as of June 30, 2023 was US$1.3 million, or US$0.04 per both Class A and Class
B Ordinary Share as of that date. Net tangible book value represents the amount of our total consolidated tangible assets, less
the amount of our total consolidated liabilities. Dilution is determined by subtracting net tangible book value per both
Class A and Class B Ordinary Share, after giving effect to the additional proceeds we will receive from this offering, from
the assumed initial public offering price of US$4.50 per Class A Ordinary Share, which is the mid-point of the estimated
initial public offering price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and
commissions and estimated offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
taking into account any other changes in net tangible book value after June 30, 2023, other than to give effect to our sale of the
Class A Ordinary Shares offered in this offering at the assumed initial public offering price of US$4.50 per Class A
Ordinary Share, the mid-point of the estimated range of the initial public offering price, after deduction of the underwriting
discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of
June 30, 2023 would have been US$9.8 million, or US$0.29 per both Class A and Class B Ordinary
Share. This represents an immediate increase in net tangible book value of US$0.25 per both Class A and Class
B Ordinary Share to the existing shareholders and an immediate dilution in net tangible book value of US$4.19 per Class
A Ordinary Share to investors purchasing Class A Ordinary Shares in this offering. The following table illustrates such
dilution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering
                                            Without Over-Allotment</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%; text-align: left">Assumed initial public offering price per Class A Ordinary Share</TD>
    <TD STYLE="width: 2%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD>
                                                       <TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.50</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net tangible book value per both Class A and Class B Ordinary Share as of June 30, 2023</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD>
                                            <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.04</FONT></TD><TD STYLE="text-align: left"></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Pro forma net tangible book value per both Class A and Class B Ordinary Share after this offering</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD>
                                            <TD STYLE="text-align: right">0.29</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Amount of dilution in net tangible book value per Class A Ordinary Share to new investors in
    this offering</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD>
                                            <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
US$1.00 increase (decrease) in the assumed public offering price of US$4.50 per Class A Ordinary Share would increase
(decrease) our pro forma as adjusted net tangible book value after giving effect to this offering by US$2.1 million, the pro
forma as adjusted net tangible book value per Class A and Class B Ordinary Share after giving effect to this offering by US$0.06
per both Class A and Class B Ordinary Share and the dilution in pro forma as adjusted net tangible book value per
Class A Ordinary Share to new investors in this offering by US$0.06 per both Class A and Class B Ordinary
Share, assuming no change to the number of Class A Ordinary Shares offered by us as set forth on the cover page of this prospectus,
and after deducting underwriting discounts and commissions and other offering expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes, on a pro forma as adjusted basis as of June 30, 2023, the differences between existing shareholders and the
new investors with respect to the number of both Class A and Class B Ordinary Shares purchased from us, the total consideration
paid and the average price per Class A Ordinary Share paid before deducting the underwriting discounts and commissions and estimated
offering expenses. The total number of Class A Ordinary Shares does not include Class A Ordinary Shares issuable upon the exercise of
the over-allotment option granted to the underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary
Shares</B></FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><B>Purchased</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>Total Consideration</B></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><B>Average</B></P>
                                                                                         <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><B>Price
                                            Per</B></P>
                                                                                         <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><B>Ordinary</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>Number</B></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>Percent</B></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>Amount</B></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>Percent</B></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><B>Share</B></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
    shareholders (Class A and Class B Ordinary Shares)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,750,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.38</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,218,842</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.23</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.32</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    investors</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.62</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,125,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49.77</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.50</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,000,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,343,842</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma as adjusted information discussed above is illustrative only. Our net tangible book value following the completion of this
offering is subject to adjustment based on the actual initial public offering price of our Class A Ordinary Shares and other terms of
this offering determined at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_006"></A>Enforceability
of Civil Liabilities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are incorporated under the laws of the Cayman Islands as an exempted company with limited liability. We are incorporated in the Cayman
Islands to take advantage of certain benefits associated with being a Cayman Islands exempted company, such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">political
                                            and economic stability; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            effective judicial system; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            favorable tax system; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            absence of exchange control or currency restrictions; and </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            availability of professional and support services. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
certain disadvantages accompany incorporation in the Cayman Islands. These disadvantages include, but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Cayman Islands has a less developed body of securities laws as compared to the United States
                                            and these securities laws provide significantly less protection to investors as compared
                                            to the United States; and </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
                                            Islands companies may not have standing to sue before the federal courts of the United States.
                                            </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
constituent documents do not contain provisions requiring that disputes, including those arising under the securities laws of the United
States, between us, our officers, directors and shareholders, be arbitrated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our operations are conducted in Singapore, and substantially all of our assets are located in Singapore. A majority of our directors
and officers are nationals or residents of jurisdictions other than the United States and most of their assets are located outside the
United States. As a result, it may be difficult for a shareholder to effect service of process within the United States upon these individuals,
or to bring an action against us or these individuals in the United States, or to enforce against us or them judgments obtained in United
States courts, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any
state in the United States. See &ldquo;Risk Factors &ndash; Risks Related to Our Class A Ordinary Shares and This Offering &ndash;
You may face difficulties in protecting your interests as a shareholder, as Cayman Islands law provides substantially less protection
when compared to the laws of the United States and it may be difficult for a shareholder of ours to effect service of process or to enforce
judgements obtained in the U.S. courts.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have appointed Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY 10168, as our agent upon
whom process may be served in any action brought against us under the securities laws of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harney
Westwood &amp; Riegels Singapore LLP, our counsel as to Cayman Islands law, has advised us that there is uncertainty as to whether the
courts of the Cayman Islands will allow shareholders of our company to originate actions in the Cayman Islands based upon securities
laws of the United States. In addition, there is uncertainty regarding Cayman Islands law related to whether a judgment obtained from
the U.S. courts under civil liability provisions of U.S. securities laws will be determined by the courts of the Cayman Islands as penal
or punitive in nature. If such a determination is made, the courts of the Cayman Islands will not recognize or enforce the judgment against
a Cayman Islands company, such as our company. As the courts of the Cayman Islands have yet to rule on making such a determination in
relation to judgments obtained from U.S. courts under civil liability provisions of U.S. securities laws, it is uncertain whether such
judgments would be enforceable in the Cayman Islands. We have been further advised that although there is no statutory enforcement in
the Cayman Islands of judgments obtained in the United States, a final and conclusive monetary judgment for a definite sum obtained in
such jurisdiction will be recognized and enforced in the courts of the Cayman Islands at common law, without any re-examination of the
merits of the underlying dispute, by an action commenced on the foreign judgment debt in the Grand Court of the Cayman Islands, provided
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the foreign court had jurisdiction in the matter and the Company either submitted to such jurisdiction or was resident or carrying on
business within such jurisdiction and was duly served with process;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the judgment given by the foreign court was not in respect of penalties, fines, taxes or similar fiscal or revenue obligations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
in obtaining judgment there was no fraud on the part of the person in whose favor judgment was given or on the part of the foreign court;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
recognition or enforcement in the Cayman Islands would not be contrary to public policy; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
the proceedings pursuant to which judgment was obtained were not contrary to the principles of natural justice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is uncertainty as to whether the courts of Singapore would (i) recognize or enforce judgments of United States courts obtained against
us or our Directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any state
in the United States or (ii) entertain original actions brought in Singapore against us or our directors or officers predicated upon
the securities laws of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making a determination as to enforceability of a judgment of the courts of the United States, and subject to the Singapore courts having
jurisdiction over the judgment debtor, the Singapore courts would have regard to whether the judgment was final and conclusive and on
the merits of the case, given by a court of law of competent jurisdiction, and was expressed to be for a fixed sum of money. In general,
an <I>in personam</I> foreign judgment that is final and conclusive (that is, in general, a judgment that makes a final determination
of rights between the parties and cannot be re-opened or altered by the court that delivered it, or be overridden by another body not
being an appellate or supervisory body, although it may be subject to an appeal), given by a competent court of law having jurisdiction
over the parties subject to such judgment, and for a fixed and ascertainable sum of money, may be enforceable as a debt in the Singapore
courts under common law unless procured by fraud, or the proceedings in which such judgments were obtained were not conducted in accordance
with principles of natural justice, or the enforcement thereof would be contrary to fundamental public policy, or if the judgment would
conflict with earlier judgment(s) from Singapore or earlier foreign judgment(s) recognized in Singapore, or if the judgment would amount
to the direct or indirect enforcement of foreign penal, revenue or other public laws (save where any such component of the judgment can
be duly severed from the rest of the judgment sought to be enforced). Civil liability provisions of the federal and state securities
law of the United States permit the award of punitive damages against us, our Directors and officers. The Singapore courts do not
allow the enforcement of foreign judgments which amount to the direct or indirect enforcement of foreign penal, revenue or other public
laws. It is uncertain as to whether a judgment of the courts of the United States awarding punitive damages would be regarded by the
Singapore courts as being pursuant to foreign, penal, revenue or other public laws. Such determination has yet to be conclusively made
by a Singapore court in a reported decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_007"></A>Corporate
History and Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
History</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Group&rsquo;s history began in 2016 when we were founded by Dr. Siaw Tung Yeng and Dr. Teoh Pui Pui along with a group of doctors in
Singapore with considerable experience in healthcare, government policy and IT. We launched our MaNaDr mobile application in October
2016 and our website in January 2019. Since September 2023, our MaNaDr mobile application and website have a global reach and
we had active users from more than 18 various jurisdictions across the world, including Singapore, Vietnam, Malaysia, Australia, India
and the Philippines. As at October 31, 2023, we had onboarded more than 700 Singapore clinics and more than 1,500 medical professionals
comprising GPs, specialized and allied health providers. We had also recorded more than 120,000 teleconsultation requests in October
2023 and as at October 31, 2023, we have completed more than 1,600,000 tele-consultation requests since our inception in 2016. As at
October 31, 2023, we had more than 1 million registered users on our MaNaDr platform, having grown from a handful of registered users
since our inception in 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Company was incorporated in the Cayman Islands on July 28, 2016, under the Companies Act as an exempted company with limited liability.
Our authorized share capital is US$50,000 divided into 6,250,000,000 Class A Ordinary Shares and 6,250,000,000 Class B
Ordinary Shares, with par value of US$0.000004 each.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Structure</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">following diagram illustrates our corporate structure,
including our principal subsidiaries:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrs_17.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
Milestones </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the key development milestones in our Group&rsquo;s history.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Milestones</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2009</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Group was founded</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launched
    our MaNaDr mobile application</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018
                                            to 2019</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Group first expanded our operations overseas, in Australia followed by Cambodia in year 2019</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 3%">&#9679;<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 85%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launched
                           our MaNaDr website</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Group was awarded the Data Protection Trustmark
    (DPTM) by the Infocomm Media Development Authority of Singapore (IMDA)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">2020</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">Launched our MaNaShop online e-commerce platform to
    sell a diversified range of curated healthcare and wellness products</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">Awarded government contracts by the Ministry of Manpower
    in 2020 for the provision of telehealth solutions to foreign migrant workers and patients under the COVID-19 home recovery program</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
launched MaNaCare, to provide comprehensive corporate healthcare and wellness services to our corporate customers</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            successfully raised S$13.2 million through our Series A funding, led by ICHAM Master
                                            Fund VCC &ndash; ICH Gemini Global Fund</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">We received a Certificate of Appreciation
    by the Singapore Ministry of Manpower for our services rendered during the COVID-19 pandemic.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    were awarded The President&rsquo;s Certificate of Commendation (COVID-19) for our services rendered during the COVID-19 pandemic.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">We
    received a Certificate of Conformance demonstrating our conformance to the requirements of the Cyber Security Agency of Singapore
    (CSA) Cyber Security Certification Cyber Essentials mark</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our subsidiary in Vietnam was established.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_008"></A>Selected
Consolidated Financial And Other Data</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following selected consolidated financial data for the years ended June 30, 2023 and 2022 have been derived from our audited
consolidated financial statements included elsewhere in this prospectus. The selected financial data set forth below should be read in
conjunction with, and are qualified by reference to &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results
of Operations&rdquo; and our consolidated financial statements and notes thereto included elsewhere in this prospectus. Our consolidated
financial statements are prepared and presented in accordance with U.S. GAAP. Our historical results do not necessarily indicate results
expected for any future period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF INCOME AND COMPREHENSIVE LOSS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><B>For the year</B></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ended June 30,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2023</B></FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For the year</B></FONT></P>
                                                                                                                           <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ended June 30,</B></FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022</B></FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>USD</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>USD</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    revenue</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,874,886</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,988,849</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    profit</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,094,994</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,935,106</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    operating expenses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,383,694</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,741,444</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Loss)
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income from operations</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,288,700</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">193,662</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other income, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,340</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,810</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    tax expense</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(165,775</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    (LOSS) INCOME </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,213,360</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,697</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency translation adjustment, net of income tax</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">396,262</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(114,433</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
                                            loss</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,817,098</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,736</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average number of ordinary shares - Basic and diluted</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,311</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86,402</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    (LOSS) INCOME PER SHARE &ndash; BASIC AND DILUTED</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29.67</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.07</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY CONSOLIDATED BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2022</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">USD</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid">USD</TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; font-size: 10pt; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; font-size: 10pt; text-align: right">2,225,806</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; font-size: 10pt; text-align: right">10,243,088</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,717,809</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,541,603</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Property and equipment, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">178,799</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">34,350</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total non-current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">724,730</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">214,021</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Total assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,442,539</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,775,624</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total current liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,500,088</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,269,252</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Total non-current liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,309,650</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,050,243</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,809,738</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,319,495</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Total shareholders&rsquo; equity</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(367,199</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,436,129</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_009"></A>Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with the
information presented in &ldquo;Selected Consolidated Financial and Other Data&rdquo; and our historical consolidated financial
statements and the related notes included elsewhere in this prospectus. In addition to historical information, the following
discussion contains forward-looking statements, such as statements regarding our expectation for future performance, liquidity and
capital resources, that involve risks, uncertainties and assumptions that could cause actual results to differ materially from our
expectations. Our actual results may differ materially from those contained in or implied by any forward-looking statements. Factors
that could cause such differences include those identified below and those described in &ldquo;Special Note Regarding
Forward-Looking Statements,&rdquo; &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus. We assume no obligation to update
any of these forward-looking statements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a leading telehealth solutions provider in Singapore in terms of various matrices, such as the number of patient consultations per
day and the ranking of our mobile application. We focus on delivering superior in-app experiences to both our healthcare providers and
patients. We have the largest number of teleconsultations per day in August 2023, and are amongst the fastest-growing telehealth
solutions providers in Singapore, according to the industry market research by Frost &amp; Sullivan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
enable and empower healthcare professionals to focus on the delivery of care to their patients through our unified, hybrid
and AI-enabled care platform, developed by our founders who collectively have over 30 years of healthcare and medical informatics experiences.
We are passionate about solving global healthcare challenges, and concentrate our efforts to provide simple, easy-to-understand, affordable
and accessible healthcare solutions regionally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
Factors that Affect Operating Results</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the key factors affecting our financial condition and results of operations include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
ability to maintain users&rsquo; trust.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to maintain users&rsquo; trust in the services and product offerings on our MaNaDr platform is primarily affected by the following
factors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 21pt">&#9679;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to maintain superior user experience and the quality of services and products provided
                                            through our ecosystem; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 21pt">&#9679;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            breadth of offerings of our services and products and their efficacy in addressing our users&rsquo;
                                            needs and meeting their expectations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 21pt">&#9679;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            reliability, security and functionality of our ecosystem;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 21pt">&#9679;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to adopt new technologies or adapt our technology infrastructure to changing user
                                            requirements or emerging industry standards;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 21pt">&#9679;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            strength of our consumer protection measures; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 18pt"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 21pt">&#9679;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to increase brand awareness among existing and potential users through various marketing
                                            and promotional activities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
ability to manage the growth of our business and operations or implement our business strategies on schedule or within our budget.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business has become increasingly complex in terms of both the type and scale of business we operate. Our ability to successfully execute
our plans, including product development roll-out, marketing and branding, obtaining and continued compliance with relevant regulatory
laws, regulations and requirements in Singapore and other jurisdictions where we may operate will significantly impact our financial results and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
ability to price our products and services or manage our cost effectively.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to risks of rising business costs due to, amongst others, tight labor market conditions for talents. Depending on our ability
to price and manage our costs of operations, our margins may be subject to changes going forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><B><I>Fluctuations in <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">exchange
rates.</FONT></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate mainly in multiple markets, which exposes us to the effects of fluctuations in currency exchange rates as we report our financials
and key operational metrics in USD. In the event that such fluctuations in the relevant foreign currency are substantial, and we are
unable to pass on our costs to users, our earnings, financial position and results of operations may be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Number
of MAU and MPU.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAU
by age group and MPU by age group are the key metrics used by us. MAU by age group refers to the count of users with specific age segments
who have engaged with a product and service within a given month. This metric is used by us to understand the distribution of user engagement
across different age categories and to customize the strategies accordingly. It provides insights into the popularity of a product among
different age segments, aiding in the assessment of user engagement trends and potential growth opportunities. By understanding which
age groups are most active, we can customize the marketing campaigns, user experiences, and product features to better cater to the preferences
and needs of specific age cohorts. The formula for calculating MAU by age group involves identifying users within each age category who
have interacted with the product or service in a given month. The steps involved are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Divide the users into different age groups.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
For each age group, count the number of users who have engaged with the product and service within the past month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Sum up the user counts from each age group to get the total MAU by age group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MPU
by age group provides valuable insights into the spending behavior and preferences of different age segments. We use this information
to optimize the pricing strategies, tailor marketing efforts, and develop products or features that resonate with specific age groups.
Understanding which age categories contribute the most to revenue allows us to allocate resources effectively and prioritize customer
retention strategies. The formula for calculating MPU by age group involves identifying users within each age category who have made
payments or transactions within a given month. The steps involved are similar to those for MAU:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Divide the users into different age groups.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
For each age group, count the number of users who have made payments or transactions within the past month. (3) Sum up the user counts
from each age group to get the total MPU by age group.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discussion
of Consolidated Results of Operations for Years ended June 30, 2023 and 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our summarized consolidated statement of operations data for the years ended June 30, 2023 and 2022
and the dollar and percentage change between the respective periods:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ended June 30,</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Variance</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
    Change</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,874,866</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,988,849</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">886,037</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
    of revenue</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,779,892</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,053,743</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,726,149</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    Profit</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,094,994</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,935,106</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(840,112</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    expenses:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries
    and benefits</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,389,892</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,038,877</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,351,015</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">130.0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
                                            and amortisation</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,816</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,094</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,722</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
                                            general and administrative expenses</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,898,986</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">615,473</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,283,513</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">208.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Total operating expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,383,694</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,741,444</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,642,250</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">151.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    income:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
                                            incentives</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,892</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,357</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,535</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,083.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    income, net</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,448</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,453</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,005</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24.0</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other income, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,340</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,810</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,530</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Loss)
    income</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> before income tax expense</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,213,360</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">258,472</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,471,832</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,343.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
                                            tax expense</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(165,775</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)&nbsp;</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100.0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    (loss) income </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,213,360</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0pt 0">)</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,697</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,306,057</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,566.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency translation adjustment, net of income tax</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">396,262</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(114,433</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">510,695</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(446.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
                                            loss</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,817,098</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(21,736</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,795,362</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,860.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  </TABLE>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>Revenue</I></B></P>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenues are derived mainly from the provision of telemedicine and other services, sale of medicine and medical devices.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Our revenue increased by 12.7% to $7.9 million for financial year ended June 30, 2023, as compared to $7.0
million for financial year ended June 30, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
$0.9 million increases  in our revenue between financial year ended June 30, 2023 and 2022 was mainly due
to the increased revenue contribution of $0.8 million from our telemedicine segment and $0.1 million from sale of medicine
and medical devices segment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarized our revenue breakdowns for the financial year ended June 30, 2023 and 2022:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="18" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ended June 30,</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentage</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percentage</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
    Change</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telemedicine
    - Private sector</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,704,414</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">85.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,509,843</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">344.0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telemedicine
    - Public sector</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,689</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,615,595</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66.0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other services</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0">68,063</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0">0.9</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0">100.0</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telemedicine
    and other services - sub-total</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,898,166</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87.6</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,125,438</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87.6</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.6</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
                                            of medicine and medical devices</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">976,720</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">863,411</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">13.1</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    revenue</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,874,886</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,988,849</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.0</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.7</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Telemedicine
and other services</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in telemedicine revenue was driven by revenue contribution from private sector as following.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Financial Year Ended June 30, 2023</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Financial Year Ended June 30, 2022</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Change</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; font-weight: bold; text-align: justify">Number of new users</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">214,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">69,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">210.1</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Number of private telemedicine transactions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">908,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">176,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">415.9</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Number of public telemedicine transactions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(95.6</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Total telemedicine transactions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">913,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">289,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">215.9</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telemedicine
revenue derived from public sector represents revenue generated from contracts with the relevant authorities and departments of the Singapore
government. The decrease in revenue from the public sector was primarily driven by the lower patient volumes infected with COVID-19 who
were using our telemedicine services through the relevant authorities and departments. As the COVID-19 infection numbers fell over the
periods, the demand for COVID-19 related telemedicine services had fallen from about 113,000 cases for the financial year ended June
30, 2022 to about 5,000 cases for the financial year ended June 30, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
the drop in the telemedicine revenue derived from public sector, we manage to convert patients who have used our services through the
relevant Singapore authorities and departments to continue using our services through our MaNaDr platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, telemedicine revenue derived from private sector increased to $6.7 million for the financial year ended June 30, 2023, as compared
to $1.5 million for the financial year ended June 30, 2022. This more than offsets the decrease in telemedicine revenue derived from
public sector, resulting in an overall increase in revenue from our telemedicine segment. The number of private telemedicine transactions
on our MaNaDr platform increased by about 515.9% when compared with the financial year ended June 30, 2022. The majority of these private
telemedicine transactions are paid immediately with credit cards, which differs from other companies which might require reimbursement
 from&nbsp;other&nbsp;payors. The increase was primarily attributable to the increase in the number of users as well as the
higher usage rate per user in our MaNaDr platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the stable global and local COVID-19 situation, Singapore&rsquo;s multi-ministry taskforce had announced that from February 13, 2023,
Singapore will lower its Disease Outbreak Response System Condition level from Yellow to Green. As a result, we expect telemedicine revenue
from the public sector to continue to decline and will not report the split between telemedicine revenue from the public sector and the
private sector going forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
other services mainly refer to the Company&rsquo;s clinic business which only started the operation from September 1, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><I>Sale of medicine
and medical devices</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
derived from sale of medicine and medical devices increased by about $0.1 million due mainly to higher medicine
product sales in line with an increase in revenue contribution from in-app medicine sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cost
of revenue</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue increased by $1.7 million for the financial year ended June 30, 2023. The increase was mainly due to an increase in healthcare provider and medicine costs, resulting in a lower gross
margin when compared to the financial year ended June 30, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Salaries
and benefits</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries
and benefits were about $2.4 million for the financial year ended June 30, 2023, as compared to about $1.0 million
for the financial year ended June 30, 2022. The increase was mainly due to the increase in staffing from 57 as at June
30, 2022 to 92 as at June 30, 2023 to support our increased needs in staffing for our operations, software development,
business development departments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B><I>Depreciation
and amortization expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Depreciation and amortization
expenses remained stable at approximately $95,000 and $87,000 for the financial years ended June 30, 2023 and 2022 respectively. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Selling,
general and administrative expenses</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
general and administrative expenses increased by $1.3 million to $1.9 million for the financial year ended June 30, 2023.
The increase was mainly due to the increase in IPO-related professional fees incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Other
income, net</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income, net remained stable at approximately $75,000 and $65,000 for the financial years ended June 30, 2023
and 2022 respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
tax expense </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not incur any income tax expense for the financial year ended June 30, 2023 as we incurred a loss before income tax of $3.2 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
(loss) income</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, we incurred a net loss of $3.2 million for the financial year ended June 30, 2023 as
compared to  a net income of $0.1 million for the financial year ended June 30, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Since inception, we have financed
our operations primarily through proceeds received from shareholder loan (see the section headed &ldquo;Index to Consolidated Financial
Statements&rdquo; in the prospectus for further details), sales of equity securities and payments received from our customers. As of
June 30, 2023, our principal sources of liquidity were cash and cash equivalents of approximately $2.2 million.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our existing sources of liquidity, along with cash expected to be generated from sales and services, will be sufficient
to fund our operations, anticipated capital expenditures, working capital and other financing requirements for at least the next twelve
months from the issuance of the financial statements included elsewhere in this prospectus. In the event we are unable to achieve profitable
operations in the near term, we may require additional equity and/or debt financing; however, we cannot provide assurance that such financing
will be available to us on favorable terms, or at all. See the section headed &ldquo;Risk Factors &ndash; Risks Related to Our Business
and Industry &ndash; We May Need Additional Capital but May Not Be Able to Obtain Such on Favorable Terms or at All&rdquo; in the prospectus
for further details.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
primary uses of cash have been used in the furtherance of growing our business, development of operations, establishing our staffing
and investment in our technology platform. The following trends are reasonably likely to result in a material decrease in our liquidity
over the near to long term:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            substantial increase in working capital requirements to finance our operations;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addition
                                            of administrative and professional personnel as our business continues to grow;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            cost of being a public company; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
                                            for seeking and securing quality staffing personnel.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents a summary of our cash flow activity for the periods set forth below:</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years
    Ended June 30,</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD</FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD</FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Cash Flows Data:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            cash (used in) provided by operating activities</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,248,626</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">975,656</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in investing activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(186,001</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,211</FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash (used in) provided by financing activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,800,452</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">9,233,896</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">(8,235,079</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">10,194,341</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash
Flow Activities for the Years Ended June 30, 2023 and 2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
Cash (Used in) Provided by Operating Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended June 30, 2023, cash used in operating activities was approximately $2.2 million. This consisted of net loss of approximately
$3.2 million, adjusted for non-cash items of approximately $0.3 million and net changes in operating assets and liabilities of approximately
$0.7 million. Non-cash items primarily consisted of depreciation and amortization expense of approximately $0.2 million and allowance
for doubtful debts of approximately $0.1 million. The net changes in operating assets and liabilities were primarily driven by an increase
of approximately $0.7 million in account payable and an increase of $0.4 million in accruals and other current liabilities, partially
offset by the increase of approximately $0.2 million in other current assets, a decrease in operating lease assets and liabilities, net
of approximately $0.1 million and the decrease in income taxes payable of approximately $0.1 million. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the year ended June 30,
2022, cash provided by operating activities was approximately $1.0 million. This consisted of net income of approximately $0.1 million,
adjusted for non-cash items of approximately $0.1 million and net changes in operating assets and liabilities of approximately $0.8 million.
Non-cash items primarily consisted of depreciation and amortization expense of approximately $0.1 million. The net changes in operating
assets and liabilities were primarily driven by a decrease of approximately $0.1 million in accounts receivable due to timing of collections,
an increase of approximately $0.3 million in accounts payable, an increase of $0.3 million in accruals and other current liabilities
and an increase of approximately $0.1 million in income taxes payable.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
Cash Used in Investing Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
used in investing activities was approximately $0.2 million for the year ended June 30, 2023, which primarily consisted
of purchase of property and equipment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash used in investing activities
was approximately $15,000 for the year ended June 30, 2022, which primarily consisted of purchase of property and equipment.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Net
Cash (Used in) Provided by Financing Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
used in financing activities for the year ended June 30, 2023 was approximately $5.8 million, which primarily consisted
of repurchase of Class A Ordinary Shares issued amounting to approximately $6.6 million, and partially offset by proceeds from sale
of our Class A Ordinary Shares of approximately $0.8 million. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash provided by financing
activities for the year ended June 30, 2022 was approximately $9.2 million, which primarily consisted of approximately $9.7 million of
proceeds from the sale of our Class A Ordinary Shares, and partially offset by repayments on advances due to our director of approximately
$0.5 million.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Commitments
and Contingencies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our contractual obligations and commitments as of June 30, 2023:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="11" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Payment Due by Period</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Less than 1 Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">1 to 3 Years</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">USD</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">USD</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">USD</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 55%; text-align: left; padding-bottom: 1.5pt">Operating lease commitments</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 1.5pt solid; text-align: right">411,018</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 1.5pt solid; text-align: right">164,038</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 11%; border-bottom: Black 1.5pt solid; text-align: right">246,980</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">411,018</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">164,038</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">246,980</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Off-Balance
Sheet Arrangements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the periods presented, we did not have, nor do we currently have, significant off-balance sheet arrangements that have or are reasonably
likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results
of operations, liquidity, capital expenditures or capital resources that are material to our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Accounting Policies and Estimates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management&rsquo;s discussion and analysis of our financial condition and results of operations is based on our financial statements,
which have been prepared in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires management
to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The
Company bases its estimates on historical experience, current business factors, and various other assumptions that the Company believes
are necessary to consider to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts
of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the
impact of future events, economic and political factors, and changes in the Company&rsquo;s business environment; therefore, actual results
could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company&rsquo;s consolidated
financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the
Company&rsquo;s operating environment evolves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies
relate to the more significant areas involving management&rsquo;s judgments and estimates. See Note 2 to our consolidated financial statements
appearing at the end of this prospectus for a description of our other significant accounting policies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><B><I>Revenue Recognition</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Company follows the revenue requirements
of Accounting Standards Update (&ldquo;ASU&rdquo;) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (&ldquo;Accounting
Standards Codification (&ldquo;ASC&rdquo;) 606&rdquo;). The core principle underlying the revenue recognition of this ASC allows the Company to
recognize revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which
the Company expect to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether
revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
achieve that core principle, the Company applies a five-step model to recognize revenue from customer contracts. The five-step
model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract,
(iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal
will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue
when (or as) the Company satisfies the performance obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Company derives revenue
from two main segments: (1) telemedicine and other services; and (2) sale of medicine and medical devices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><I>Telemedicine and other
services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telemedicine
services are provided to both the private sector and public sector. The Company earns telemedicine services revenue from private
sector by providing teleconsultation services to patients who have subscribed to MaNadr APP by contractual service providers and sale
of prescribed medicine. Telemedicine revenue derived from public sector represents revenue generated from contracts with the relevant
authorities and departments of the Singapore government by providing teleconsultation services to patients identified by the authorities
and departments of the Singapore government. Telemedicine services with prescribed medicine are two distinct performance obligations
with standalone prices that are fixed and paid post rendering of teleconsultation service with patients. Prescribed medicine will be
delivered to the customer on the same day. The amount paid by the patient is then allocated to each performance obligation in a contract
based on its relative standalone selling price (&ldquo;SSP&rdquo;). The SSP is the observable price at which we sell the product or service
separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from teleconsultation services and sale of prescribed medicine are recognized at a point in time when the services are rendered and the
products are delivered to the customers respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company
considers the following indicators amongst others when determining whether it is acting as a principal in the contract where revenue would
be recorded on a gross basis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.3in">(i)</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company is primarily responsible for fulfilling
  the promise to provide the specified products or services;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>(ii)</TD>
  <TD STYLE="text-align: justify">the Company has control over services provided in which the prescription issued by our service providers is under the clinic
  name of the Company; and</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>(iii)</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company has discretion in establishing the price
  for the specified products or services.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
services are rendered by the Company&rsquo;s in-house doctors and external providers who are registered and credentialed to deliver
care on MaNaDr platform. The Company contracts with the external service providers who are paid based on the consultation fee set by
the Company. Patient contracts with the Company and make payment on the MaNadr platform. In these arrangements, as the Company
assumes a principal role in the transaction, revenue is recognized gross. The Company has the right to determine the service price
to patients and is responsible for the holding and fulfilment of prescribed medicine to the patients, the Company assumes the credit
risk and rewards of ownership of the inventory. Accordingly, the Company accounts for the telemedicine service contracts on a gross
basis.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also provided the medical consultation services for the physical walk-in patients in its own clinic. The services are rendered
by the Company&rsquo;s in-house doctor who is registered and credentialed to deliver care for the physical walk-in patients, as well
as sale of prescribed medicine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><I>Sale of medicine and medical devices</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">The Company sells prescription
drugs, non-prescription drugs and healthcare products to clinics and end customers offline and online. The online transactions are performed
through MaNaShop/MaNaStore. These products are purchased by the Company as inventory for onward sale to customers. Revenue from sale
of these products under direct sales model is recognized on a gross basis upon delivery of the medicines or products to the customers.
For products that are not purchased by the Company as inventory for onward sale to customers through online market model , the Company
facilitates setting product prices with vendors. The Company is not responsible for fulfilling the contracts being provided to the customers
nor does the Company have inventory risk related to the contracts. Revenue from sales of these products is recognized on a net
basis upon delivery of the medicines or products to the customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Intangible
Assets, net</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets represent the MaNadr platform, patents and trademarks. These intangible assets arise primarily from the determination of their
respective fair market values at the date of acquisition. The useful life of the intangible assets is assessed to be finite and amortization
is computed using the straight-line method over the estimated useful lives or 3 to 10 years based upon the future cash flows attributable
to the asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Impairment
of Long-Lived Assets</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the recoverability of its long-lived assets (asset groups), including property and equipment, definite-lived intangible
assets and operating lease right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying
amount of its asset (asset group) may not be fully recoverable. When these events occur, the Company measures impairment by comparing
the carrying amount of the assets to the estimated undiscounted future cash flows expected to result from the use of the asset (asset
group) and their eventual disposition. If the sum of the expected undiscounted cash flows is less than the carrying amount of the asset
(asset group), the Company recognizes an impairment loss based on the excess of the carrying amount of the asset (asset group) over their
fair value. Fair value is generally determined by discounting the cash flows expected to be generated by the asset (asset group), when
the market prices are not readily available. The adjusted carrying amount of the asset is the new cost basis and is depreciated over
the asset&rsquo;s remaining useful life. Long-lived assets are grouped with other assets and liabilities at the lowest level for which
identifiable cash flows are largely independent of the cash flows of other assets and liabilities. For the years ended June 30, 2023
and 2022, no impairment of long-lived assets was recognized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Leases</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a lessee of non-cancellable operating leases for its corporate office premise. The Company determines if an arrangement is
a lease at inception. Lease assets and liabilities are recognized at the present value of the future lease payments at the lease commencement
date. The interest rate used to determine the present value of the future lease payments is the Company&rsquo;s incremental borrowing rate
based on the information available at the lease commencement date. The Company generally uses the base, non-cancellable lease term in calculating
the right-of-use assets and liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less.
The Company recognizes the lease payments associated with its short-term leases as an expense on a straight-line basis over the lease
term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The assessment
of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax
cash flows of the related operations. The Company has elected to include the carrying amount of finance and operating lease liabilities
in any tested asset group and include the associated lease payments in the undiscounted future pre-tax cash flows. For the years ended
June 30, 2023 and 2022, the Company did not have any impairment loss against its operating lease ROU assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Share-Based
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the valuation of our common stock, we employed a comprehensive approach that combines both market and income methodologies
to determine the enterprise value, or fair value of our business. The market approach involves estimating value by comparing our company
to similar publicly traded entities within the same business sector, as well as examining secondary transactions involving our capital
stock. A representative market value multiple is derived from comparable companies and applied to our company&rsquo;s financial results to
estimate its value. This approach also takes into account transaction prices from secondary sales of our capital stock by investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversely,
the income approach calculates the fair value by considering the present value of the company&rsquo;s anticipated future cash flows and the
residual value beyond the forecast period. These future cash flows, including those beyond the forecast period for residual value, are
discounted to their present values using an appropriate discount rate to reflect the inherent risks associated with the company achieving
these estimated cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the completion of this offering, our common stock will be publicly traded, and we will rely on the closing price of our common stock,
as reported on the date of grant, to determine the fair value of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">In our financial disclosures, we report
option-based compensation expenses connected to option awards, recognizing these expenses based on the fair value of the granted awards.
The determination of each option award&rsquo;s fair value is conducted at the grant date, utilizing the Black-Scholes option pricing model.
This model depends on subjective factors such as the fair value of our common stock, the expected lifespan of the option, the projected
volatility of our stock price, prevailing risk-free interest rates, and the anticipated dividend yield. These factors, guided by management&rsquo;s
estimates, inherently involve uncertainties and the need for sound managerial judgment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">For the recognition
of compensation expense, we adopt a straight-line approach throughout the required service period of the awards. Notably, our initial
assumption for the rate of award forfeitures is set at 0%, allowing for a more precise allocation of compensation costs. We then adjust
this cost to reflect the actual rate of forfeitures as they transpire. This methodology is in strict adherence to ASC 718 &ldquo;Stock
Compensation,&rdquo; which necessitates the accurate measurement and recording of expenses for equity-based awards that are expected to
vest, taking into account real forfeitures throughout the service period.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">The application
of the Black-Scholes model is sensitive to changes in its underlying assumptions. Variations in these assumptions could lead to significant
adjustments in our reported stock-based compensation expenses in future periods.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            the successful completion of our IPO, the vesting of options awarded to employees and other
                                            stakeholders undergoes specific accounting treatment. This treatment is essential for accurately
                                            reflecting the impact of the IPO on our financial statements and ensuring compliance with
                                            Generally Accepted Accounting Principles (GAAP). Our proposed accounting approach is outlined
                                            to establish the Fair Value and Properly Recognize the Expense through to Proper Disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
vesting of options upon the IPO triggers an accounting recognition event. Any previously unrecognized option-based compensation expenses
related to these vested options will be recognized on our income statement. This expense represents the cumulative compensation cost
associated with the options that have now become fully vested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of our financial disclosures for the financial year 2024, we will provide comprehensive information about the option granted on
August 1, 2023 and December 18, 2023 and the impact of the IPO on our option-based compensation. This includes details on the
number of options vested, the fair value at the date of vesting, and the corresponding expense recognized in the income statement. Our
disclosures will ensure transparency and allow stakeholders to understand the financial implications of the IPO on our equity-based compensation
programs. Any future vesting events will trigger similar accounting treatments, ensuring that our financial reporting remains accurate
and in compliance with accounting standards.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Concentration
and Credit Risks</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash with banks in Singapore (&ldquo;SGN&rdquo;). Should any bank holding cash become insolvent, or if the Company
is otherwise unable to withdraw funds, the Company would lose the cash with that bank; however, the Company has not experienced any losses
in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts. In Singapore, a depositor has
up to S$75,000 insured by Singapore Deposit Insurance Corporation (&ldquo;SDIC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially expose the Company to concentration of credit risk consist primarily of cash and cash equivalent and accounts
receivable. The Company has designed its credit policies with an objective to minimize their exposure to credit risk. The Company&rsquo;s
accounts receivable are short term in nature and the associated risk is minimal. The Company conducts credit evaluations on its clients
and generally does not require collateral or other security. The Company periodically evaluates the creditworthiness of the existing
clients in determining the allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the
credit risk of specific clients.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>For
the years ended June 30, 2023 and 2022</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentration
of customers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">None
</FONT>of the customers consisted of more than 10% of account receivables as of June 30, 2023 and 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">None of the customers accounted
more than 10% of the Company&rsquo;s total revenue for the year ended June 30, 2023. For the year ended June 30, 2022, customer
A accounted for 66.04% of the Company&rsquo;s total revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentration
of vendors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the suppliers accounted more than 10% of account payable as</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
of June 30, 2023. As of June 30, 2022, supplier A and B, accounted for 14.21% and 15.77% of the account payable respectively.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended June 30, 2023, none of the suppliers accounted more than 10% of the Company&rsquo;s total purchases. For the
year ended June 30, 2022, supplier F, accounted for 19.33% of the Company&rsquo;s total purchases. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Accounting Pronouncement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &ldquo;emerging growth company&rdquo; (&ldquo;<B>EGC</B>&rdquo;) as defined in the Jumpstart Our Business Startups Act
of 2012 (the &ldquo;<B>JOBS Act</B>&rdquo;). Under the JOBS Act, EGC can delay adopting new or revised accounting standards issued subsequent
to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company made the election to delay
the adoption of new or revised accounting standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-10, &ldquo;Codification Improvements to Subtopic 205-10, presentation of financial statements&rdquo;.
The amendments in this Update improve the codification by ensuring that all guidance that requires or provides an option for an entity
to provide information in the notes to financial statements is codified in the disclosure section of the codification that reduce the
likelihood that the disclosure requirements would be missed. The amendments also clarify guidance so that an entity can apply the guidance
more consistently. Early application of the amendments is permitted for any annual or interim period which financial statements are available
to be issued. The amendments in this Update should be applied retrospectively. An entity should apply the amendments at the beginning
of the period that includes the adoption date. The adoption of this standard is not expected to have a significant impact on the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted,
would have a material effect on the Company&rsquo;s consolidated balance sheets, statements of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_010"></A>Industry
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>All
the information and data presented in this section have been derived from a report that was commissioned by us and prepared by Frost
&amp; Sullivan unless otherwise noted. Frost &amp; Sullivan has advised us that the statistical and graphical information contained herein
is drawn from its database and other sources. The following discussion contains projections for future growth, which may not occur at
the rates that are projected or at all.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview
of the Integrated Smart Health-Tech Service Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Definition
and Limitation of Telehealth</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telehealth
refers to the utilization of electronic information and telecommunications technologies to provide remote clinical healthcare, health-related
education, public health services, and other healthcare functions. It encompasses various methods such as video conferencing, store-and-forward
(which allows users to submit clinical information for evaluation without an in-person visit), and remote user monitoring. However, while
telehealth offers valuable support, it is not a comprehensive solution for managing user care coordination, addressing healthcare costs,
or alleviating the burden of diseases. It should not be considered a complete substitute for in-person visits, as it may not be suitable
for all types of illnesses or clinical situations. Additionally, telehealth does not seamlessly integrate with offline health services.
Compared to in-person interactions, remote communication lacks the natural physical presence, which can lead to potential misunderstandings
and misinformation, especially in the making of critical medical decisions. As healthcare technology becomes more ingrained in standard
care, the terms &ldquo;telehealth&rdquo; and &ldquo;telemedicine&rdquo; may gradually be replaced by the overarching concept of integrated
smart health-tech services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Overview
of the Smart Health-Tech Service Market</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
as an evolved model of telehealth, the integrated smart health-tech service market overcomes the limitations of traditional telehealth
approaches. It provides users with comprehensive direct-to-consumer healthcare solutions for managing their complete health journey.
This market encompasses a wide range of offerings, including convenient online consultations, walk-in clinics, chronic disease management,
online retail pharmacies, health knowledge forums, enterprise telehealth services, as well as wholesale services for pharmaceutical and
healthcare products. It represents a more advanced and holistic approach as compared to traditional telehealth methods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_18.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Coverage of Smart Health-Tech Service Market</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
integrated smart health-tech service market encompasses a broad spectrum of health-related services and products delivered through digital
platforms and in-person settings. This includes telemedicine video conferencing software, remote user assessment tools, wearable monitoring
devices and software, on-demand virtual healthcare portals, walk-in clinics, and various other offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Advantages of Smart Health-Tech Service Market</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
its unique hybrid model, the integrated smart health-tech service market offers an intelligent and integrated solution that combines
app-based telehealth with physical clinics. It caters to both B2B and B2C sectors through well-established commercial networks, which
involve intricate interactions and transactions between users, providers, payors, and other stakeholders. Leveraging on digital technology,
this market provides a more accessible means of delivering precise medicine and managing healthcare. By increasing access to physicians
and specialists, these services ensure that users receive appropriate care at the right location and time. Moreover, the integrated smart
health-tech service market fosters an ecosystem where users and healthcare professionals can engage in dialogue and share views on various
healthcare issues and concerns. Effective communication, discussion, and consultation play a vital role in developing optimal treatment
plans in the medical field. Consequently, integrated smart health-tech services promote more effective communication, precise diagnosis,
and well-informed decision-making among experts, clinicians, and users alike.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pain
Points of Current Southeast Asia/General Overview of Singapore&rsquo;s Healthcare Industry</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Southeast
Asia (&ldquo;<B>SEA</B>&rdquo;) consists of 11 independent nations situated along Asia&rsquo;s continental curves and island archipelagos,
including Brunei Darussalam, Timor-Leste, Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, Laos, Cambodia, and Myanmar.
Ten nations in SEA form the Association of Southeast Asian Nations (&ldquo;<B>ASEAN</B>&rdquo;). This region is home to over half a billion
people living in countries with significant diversity, ranging from affluent nations like Singapore (GDP per capita: USD72.8 thousand)
to less developed economies such as Laos (GDP per capita: USD2.5 thousand), Cambodia (GDP per capita: USD1.6 thousand), and Myanmar (GDP
per capita: USD1.2 thousand), according to the World Bank. According to a report about the time spent using the internet in SEA, in 2021
shows that people in SEA tend to spend more time online each day than the global average. For instance, Filipinos indicate that they
spend an average of almost 11 hours online each day, which is almost 60 percent more than the global average. The wide range of geographical
and historical factors has led to significant disparities in health status and healthcare systems both across and within these nations.
As compared to other global regions, the SEA region is undergoing a more rapid epidemiological shift, with the burden of disease transitioning
from infectious to chronic illnesses. While there is an upward trend towards universal healthcare coverage in the SEA region, much more
needs to be accomplished to ensure access to healthcare services for disadvantaged populations. The lack of experts and specialists in
rural areas is a significant concern in certain countries, especially when it comes to diagnosing rare diseases and challenging symptoms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, there exists five principal challenges for SEA, including user inequalities in healthcare, inaccessibility in healthcare, complexities
in obtaining correct healthcare in a timely manner, confusion due to the wide range of healthcare products and services available as
well as the global healthcare burden of obesity and chronic diseases. Although Singapore stands out in the SEA region, ranking 10th in
the 2022 World Index of Healthcare Innovation, and has notable performance in terms of its outstanding research universities and superior
digital healthcare system, the following problems still exist in Singapore:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inequalities
    in healthcare</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
exist significant health inequalities in Singapore, particularly in relation to educational attainment, with men and women of lower education
levels being more likely to develop certain chronic diseases, as compared to those with post-secondary education. According to the Ministry
of Health of Singapore, males with primary education or lower are 1.3 times more likely to have diabetes compared to their counterparts
with post-secondary education. Similarly, females with primary education or below are 3.4 times, 1.9 times, and 1.4 times more likely
to develop diabetes, hypertension, and high cholesterol, respectively, as compared to women with post-secondary education.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inaccessibility
    in healthcare</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Universal
healthcare access requires two conditions to be fulfilled: mandatory payment from those who can afford it and subsidies for those who
are unable to afford it, ensuring responsible use of public funds. In Singapore&rsquo;s public hospitals, at least 65% of the beds are
heavily subsidized. Means testing, which started in 2009, ensures that all Singaporeans have access to high-quality healthcare without
compromising on healthcare standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Complexities
    of getting the right timely healthcare</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long
queues and waiting hours in hospitals, especially in the Accident and Emergency Department, pose a challenge. The complex nature of medical
information can also make it difficult for users to comprehend their healthcare situation. On average, acute care hospital stays last
4.7 days, while the wait period for elective surgeries is typically one week.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Confusions
    in healthcare products and services</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Users
often struggle to find the products and services required for their healthcare, leading to confusion and inefficient outcomes. For instance,
a lack of clear and precise oral and written information from both the doctors and/or pharmacists on the management of prescribed medication
has led to therapeutic failure as a result of users not comprehending instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Healthcare
    burden of obesity and chronic diseases</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the 2019/2020 National Population Health Survey, after a minor drop in 2013 (8.6%) and 2017 (8.6%), the crude
prevalence of obesity among people aged 18 to 74 years in 2019-2020 had reverted to the level reported in 2010 (10.5%). Alarmingly, the
proportion of students who were overweight in schools has also risen. The prevalence of chronic diseases (i.e., diabetes mellitus, hypertension,
and hyperlipidemia) continued to show an increasing trend over the years, with prevalence rates of 9.5%, 35.5%, and 39.1%, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Analysis
of Integrated Smart Health-Tech Service Market Players in Singapore</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smart
health-tech service market players in Singapore can be divided into three types. The first type of players are tech-first doctor-led
healthcare delivery innovators. Generally speaking, the founders or co-founders of the health providers (healthcare companies) are medical
professionals or have medical backgrounds, and technology is at the forefront of their healthcare delivery strategy. The second type
of players are brick &amp; mortar hospitals/clinic chain operators. Most of these players started developing telehealth as an ancillary
service out of necessity due to the COVID-19 pandemic. The third type of players are generally entities or individuals outside the medical
industry. Their founders or co-founders of the healthcare providers (healthcare companies) are typically from other industries who identified
telehealth as a promising trend and started telehealth companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Strengths
and Weaknesses of Each Player</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 22pt; text-align: justify; text-indent: -22pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>a)</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tech-first
    doctor-led healthcare delivery innovators</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
innovators frequently have more specialized resources available to them, such as the assistance of numerous independent clinics and licensed
physicians. These platforms also have more stringent platform management and medical quality standards. These platforms&rsquo; doctors
are also more devoted, which fosters substantial trust among users and the local medical community in Singapore. However, their IT security
may be weak and susceptible to hacking. Additionally, these platforms will be impacted by government interference or negative changes
in regulation and legislation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
for the user interface (&ldquo;<B>UI</B>&rdquo;) and user experience (&ldquo;<B>UX</B>&rdquo;) of tech-first doctor-led healthcare platforms,
they usually have a straightforward user interface as well as a fast, seamless, and convenient process. With knowledge from both doctors
and industry, these apps are easy to use and navigate through and can directly solve problems. Furthermore, the apps for healthcare providers
are also comprehensive, professional, and straightforward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>b)</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Hospital/clinic
    chains operators</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the support of offline services and a parent company that has several hospitals and clinics, these platforms usually have professional
resources and can attract users from their offline hospitals and clinics. However, as part of their suite of ancillary services, they
focus on appointments and pre-clinical calls and are not comprehensive in their range of service through mobile applications. Furthermore,
because they do not have a large ecosystem, their services are limited to their own doctors; for instance, their internal chatrooms cannot
be extended to all doctors. Last but not least, these kinds of platforms usually have barriers to insurance players and innovative payments
and have technology difficulties such as inconsistent online and offline systems; for instance, on occasions they may not fulfil users
request for an online appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
terms of the UI and UX aspects, such platforms target users of certain hospitals and increase accessibility to healthcare. Their teleconsultation
and virtual care services enable users to make appointments for COVID-19 tests, purchase health screening services, and book sessions
with a GP doctor or a specialist of their choice. However, their tilted resources toward hospitals lead to a reduced focus on software
management. Therefore, they usually have many potential problems / vulnerabilities, which cause frequent updates and unnecessary patch
packages. Additionally, some follow-up service is also poor; for instance, delivery and fulfillment information is always missed on their
apps. Last but not least, they are hard to navigate and only offer basic functions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>c)</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Non-medical
    industry operators</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
platforms are usually experienced in marketing, and they can understand and meet users&rsquo; needs in a timely manner. However, they
tend to be unprofessional and have limited expertise. Besides, compared to doctor-led and hospital-led platforms, users and doctors trust
non-medical industry operators&rsquo; platforms less.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
for the UI and UX of non-medical industry operators&rsquo; platforms, they are usually professionals in UI and UX design. Offering a
comprehensive range of services, they are straightforward, user-friendly, and easy to navigate through. Their response time to users
is also quick. However, their drug accessibility is not as good as doctor-led and hospital-led platforms, and their online and offline
fulfillment capabilities are relatively weak. For instance, orders on these platforms are easy to cancel, resulting in complaints from
users. In addition, they also have weaker physician management, and doctors may take a longer time to respond to users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Business
Analysis of Integrated Smart Health-Tech Service Market Players</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrs_19.jpg" ALT="" STYLE="height: 272px; width: 670px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
Size of SEA Smart Health-Tech Service Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Total
Healthcare Expenditure in Singapore (USD Billion), 2020-2027E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore
is an affluent Asian economy with a nominal GDP of USD644 billion in 2022 and a multiethnic population of 5.6 million people. It has
one of the most rapidly aging populations in Asia, resulting in an increasing burden of chronic diseases. In 2020, Singapore&rsquo;s
total healthcare expenditure amounted to USD20.9 billion. With the integration of online and offline medical service models, such as
the digitalization of medical records enabling real-time flow and sharing of user information, the efficiency of medical services is
improving. This integration is driving the expansion of the integrated smart health-tech service market from the digital market to the
offline market. Singapore&rsquo;s healthcare expenditure is forecasted to reach USD26.5 billion by 2022, representing a CAGR of 12.6%
from 2020 to 2022. It is further projected to reach USD43.8 billion by 2027.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
Healthcare Expenditure in Singapore, 2020-2027E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_20.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
WHO- The Global Health Expenditure Database (GHED), Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Total
Healthcare Expenditure in Singapore (Divided by General Government Health Expenditure / Private Health Expenditure, USD Billion), 2020-2027E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aging population and a trend toward earlier identification of chronic diseases, closer monitoring and follow-up, increased government
healthcare spending and local population&rsquo;s use of healthcare services have contributed to the increase in total healthcare expenditure
in Singapore. The multi-tiered healthcare financing approach in Singapore through Medisave, MediShield Life &amp; Integrated Shield Plans,
ElderShield, and Medifund is likely to drive the growth in general government healthcare spending. Increased household income and health
awareness are likely to drive the growth in private healthcare expenditure. Singapore recorded general government healthcare expenditure
and private healthcare expenditure of USD11.0 billion and USD 9.9 billion respectively in 2020. They are forecasted to reach USD14.8
billion and USD11.7 billion by 2022, respectively, representing a CAGR of 16.2% and 8.6% from 2020 to 2022. General government healthcare
expenditure and private healthcare expenditure are anticipated to reach USD26.9 billion, and USD 16.9 billion respectively, by 2027.
To help control rising healthcare expenses and lessen the strain on users&rsquo; families, some nationwide programs emphasizing preventive
healthcare will be introduced. It is expected that there will be changes in the way that healthcare is provided, in order to provide
healthcare treatment that is more user-centric. The digitalization of medical records allows for the real-time flow and sharing of user
information, improving the efficiency of medical services and the integration of online and offline medicine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Breakdown
of Healthcare Expenditure by Government and Private in Singapore, 2020-2027E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrs_21.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
WHO- The Global Health Expenditure Database (GHED), Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Population of Aging People in Singapore (Million), 2020-2027E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Driven
by a rapidly declining total fertility rate and an increasing life expectancy, Singapore has entered an aging society. From 2020 to 2022,
the population was aging rapidly in Singapore with people aged above 65 growing at a CAGR of 4.1%. There were 0.9 million individuals
aged above 65 years old in 2020 and accounted for 15.2% of the resident population. The number of individuals above 65 years old is growing
at a fast pace and is expected to continue its growth momentum into the future. This number of people within this age bracket is expected
to reach 1.2 million by 2027, representing a CAGR of 4.2% from 2022 to 2027 and will account for 19.5% of the resident population. The
aging population in Singapore presents significant challenges for the primary healthcare system. As the population ages, there is a need
to adapt the healthcare system to cater to the specific needs of older individuals. Singapore has recognized the importance of addressing
these challenges proactively. The government has implemented measures to strengthen the healthcare system, focusing on preventive care
and providing high-quality yet affordable care for all, especially seniors. For example, the recently introduced healthcare reform plan,
Healthier SG, aims to shift the healthcare strategy towards preventive care. This initiative recognizes the importance of the primary
healthcare system in addressing the needs of an aging population. By providing accessible and personalized healthcare services, integrated
smart health-tech service market players can play a crucial role in enhancing primary healthcare services for the aging population. According
to &ldquo;White Paper on Healthier SG&rdquo;, the government intends to upgrade IT systems to facilitate seamless data sharing and support
the implementation of Healthier SG. Telehealth technologies enable remote consultations, monitoring, and health education, allowing seniors
to receive care and advice without the need for frequent hospital visits. These digital solutions can bridge the gap between healthcare
providers and users, especially those with limited mobility or living in remote areas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
leveraging on telehealth, Singapore can extend the reach of primary healthcare services to a larger population, including seniors.
It can facilitate early detection and intervention, enhance chronic disease management, and provide continuous monitoring and
support. Telehealth also enables healthcare professionals to access real-time data, improving diagnostics and treatment
decision-making.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Population of Aging People in Singapore, 2020-2027E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><IMG SRC="formdrs_22.jpg" ALT=""></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sources:
</I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Prime Minister&rsquo;s Office Singapore,
Singapore Department of Statistics, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Total
primary care consultations number in Singapore (Million Time), 2020-2027E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rising demand for medical resources from an aging population and increasing chronic disease burden are putting a strain on the healthcare
system and exerting pressure on finite healthcare resources in Singapore. Total primary care consultations number in Singapore was 25.5
million times in 2020, growing by an average of 7.5% annually to reach 29.5 million in 2022. The number is expected to grow at a higher
annual rate of 9.0% to reach 45.3 million times by 2027. The total number of primary care consultations in Singapore consists of both
walk-in primary care consultations and teleconsultations. The COVID-19 pandemic has increased the awareness and importance of health
in the minds of the Singapore population. Services and products related to staying healthy are starting to gain popularity among consumers.
Therefore, telehealth, as an effective method and integrated platform of health services and products, is expected to increase in popularity
in the coming years as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
primary care consultations number in Singapore, 2020-2027E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_23.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
&ldquo;Admissions and Outpatient Attendances&rdquo; from the Ministry of Health in Singapore, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
Number of Teleconsultation in Singapore (Million Time), 2020-2027E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, teleconsultation has gained significant popularity in Singapore, and its usage has been further accelerated by the COVID-19
pandemic. The convenience and safety offered by teleconsultation services have attracted a considerable number of users, and this trend
is expected to continue in the coming years. The use of telemedicine by doctors and patients alike is gradually gaining acceptance in
the healthcare landscape. The number of teleconsultations in Singapore was 2.9 million times in 2020 and accounted for 11.4% as share
of the total consultation numbers. It increased to 4.0 million times in 2022, representing a CAGR of 16.6% from 2020 to 2022, and accounted
for 13.5% as share of total consultation numbers. It will further reach 10.7 million times by 2027 with a CAGR of 21.3% and accounted
for 23.5% of the total consultation numbers. One notable factor contributing to the growth of teleconsultation is the existence of inherent
users within the market. Many individuals who experienced teleconsultation during the pandemic have found it to be a convenient alternative
to traditional in-person consultations. These users have become accustomed to the benefits of teleconsultation and have expressed their
preference for this mode of healthcare delivery. As a result, they are less inclined to return to physical clinics for routine healthcare
needs. Moreover, as users continue to utilize teleconsultation services, they begin to realize the advantages and cost-effectiveness
it offers. This increased awareness and familiarity with teleconsultation prompts users to recommend it to their family members
and friends. The positive word-of-mouth recommendations act as a catalyst for the expansion of the teleconsultation market, attracting
potential users who have yet to try the service. As depicted in the data, the growing number of users and the influence of inherent and
potential users are expected to drive a steady increase in teleconsultation utilization in Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Number of Teleconsultations in Singapore, 2020-2027E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="formdrs_24.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
&ldquo;Admissions and Outpatient Attendances&rdquo; from the Ministry of Health in Singapore, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Market
Size of Teleconsultation Market in Singapore (USD Million), 2020-2027E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore
is one of the countries with the highest penetration rate of mobile Internet in the world. This has established a good ecosystem for
the integrated smart health-tech service market. The wide coverage of the internet and the high popularity of smartphones in Singapore
have contributed to the growth and adoption of telehealth services. The teleconsultation market in Singapore has witnessed significant
growth in recent years, and this trend is expected to continue in the coming years. Within Singapore, those telemedicine players operate
in accordance with the Ministry of Health&rsquo;s clinical and data governance, which ensures that all the practices done in applications
are in accordance with professional and ethical standards. The market size of the teleconsultation market in Singapore was USD96 million
in 2020, and it reached USD147 million by 2022, representing a CAGR of 23.9% from 2020 to 2022, and it is expected to reach USD498 million
by 2027 with a CAGR of 26.7%. One key factor contributing to this expansion is the widening scope of online consultation services. Previously,
teleconsultation primarily served as a platform for basic medical inquiries. However, it has now evolved to include additional services
such as prescription fulfillment and doctor-patient follow-ups, thereby enhancing its value proposition. With the introduction of these
expanded services, the average expenditure per teleconsultation session has increased. Users can now conveniently obtain prescriptions
for their medical needs through teleconsultation, eliminating the need for a separate visit to a physical pharmacy. Additionally, the
inclusion of doctor-patient follow-ups allows for ongoing monitoring of the user&rsquo;s condition, further enhancing the quality of
care provided through teleconsultation. This expanded scope of services has attracted more users to engage in teleconsultation, resulting
in a substantial market size for the teleconsultation market in Singapore. As depicted in the data, the increasing range of services
offered through teleconsultation is expected to drive the market&rsquo;s growth and contribute to the overall revenue generated in the
sector. According to <I>&lsquo;APAC m-Health Market Report&rsquo;</I> from <I>Mordor Intelligence</I>, APAC mobile health market size
is expected to grow from $16.85 billion in 2023 to $49.84 billion by 2028, at a CAGR of 24.22% during this period. The APAC market is
driven by an increasing remotely-located consumer base, growing investments in the digitalization of healthcare institutions, a rising
number of chronic/infectious disease patient populations, including COVID-19, and increasing internet penetration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
Size of the Teleconsultation Market in Singapore, 2020-2027E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrs_25.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
&ldquo;Admissions and Outpatient Attendances&rdquo; from the Ministry of Health in Singapore, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competitive
Landscape in Singapore</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
product &amp; service portfolio of platform</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compared
with integrated smart health-tech services market players who regard telemedicine as their main business in Singapore, MaNaDr has set
up one of the smartest and most comprehensive integrated all-in-one user care-centric platforms in the APAC region to deliver affordable
care to users.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Through the mobile application, MaNaDr
offers users a seamless and hassle-free range of telehealth solutions, which encompasses teleconsultation services, including the issuance
of electronic medical certificates and delivery of medications to users&rsquo; homes, as well as other personalized services such as
weight management programs. As at October 31, 2023, MaNaDr had more than 1,000,000 registered users on the MaNaDr platform. At the
same time, MaNaDr had onboarded more than 700 Singapore clinics and more than 1,500 medical professionals comprising GPs, specialized
and allied health providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
MaNaDr set up one of the smartest 24/7 virtual care ecosystems and support groups to help users navigate the complexities of receiving
correct and timely care. With MaNaChat. the 24/7 user support service, MaNaDr operates Singapore&rsquo;s only in-app live group chat
service and has one of the fastest response time in Singapore and globally to support users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
users with chronic conditions on the platform, MaNaDr is a pioneer in the APAC region, spearheading the
building of a comprehensive weight management ecosystem to target over 60% of users who are overweight. For healthcare providers on the
platform, MaNaDr hosts the region&rsquo;s only in-app drug support and discussion group, where users can organize bulk purchases of drugs,
discuss matters relating to the purchase of drugs, as well as the uses, side effects, and latest news on drugs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><IMG SRC="portfolio_001.jpg" ALT="" STYLE="height: 220px; width: 600px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
Company Website, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Notes:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Self-operated
    Walk-in Clinics: the platform has its own offline clinics operated directly by the company;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Online
    Retail Pharmacy: the platform operates an online retail pharmacy with a curated selection of pharmaceutical products, medical device,
    and wellness products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chronic
    Disease Management Program: the platform offers comprehensive management services including chronic condition consultation, regular
    checkups, risk assessment, integrated intervention and management provided by professional medical staff;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
    Knowledge Forum: the platform offers a health knowledge forum where users and healthcare professionals may discuss various themes,
    offer their thoughts on various concerns, and share evidence-based information in order to proactively manage lifecare;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enterprise
    Telehealth Service: the platform creates effective employee benefits programs for enterprise and provides customizable telehealth
    solutions for employees;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
    &amp; Healthcare Products Wholesale Service: the platform offers pharmaceutical &amp; healthcare product circulation services to
    pharmacies and primary healthcare institutions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    A is a Singapore-based telehealth company that provides on on-demand healthcare solutions to help users lead happier and healthier
    lives;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    B is led by a qualified team of staff doctors and offers a seamless patient-centric experience by providing quality on-demand healthcare
    for individuals and businesses alike;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    C is a digital healthcare platform that provides medical consultation, patient-centric care, and healthcare screening services;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
    D is a patient-centric digital healthcare platform that is simplifying the business of getting well and staying well.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
average number of teleconsultations per day</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr
is the largest telehealth solutions mobile application in Singapore in terms of the number of user consultations per day. It has the
largest number of teleconsultations per day in the six months ending May 2023, and is amongst the fastest-growing telehealth solutions
providers in Singapore. Based on the latest operational data, MaNaDr has recorded more than 120,000 teleconsultation requests
in October 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="tele_001.jpg" ALT="" STYLE="height: 178px; width: 400px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sources:
</I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>DATA.AI. Database. (formerly App Annie),
Company websites, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>User
feedback and rating (As of 14 June 2023)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr&rsquo;s
mobile application has received a 4.8 and 4.9 star rating on the Apple App Store and Google Play Store in Singapore as of 14 June 2023.
On a combined basis, MaNaDr was the most reviewed and highest rated app in Singapore as of 14 June 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="rating_001.jpg" ALT="" STYLE="height: 105px; width: 400px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
play.google.com, apps.apple.com, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Price
Perception based on Cost of Standard Consultation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 31, 2023, MaNaDr offered the most affordable care to nearly 100,000 teleconsultation activities per month through the MaNaDr platform
and strived to deliver quality, timely, and seamless care. As of October 31, 2023, MaNaDr offered the most affordable teleconsultation
solution in terms of starting price when compared to peers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="consult_001.jpg" ALT="" STYLE="height: 178px; width: 400px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Note:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
D is not included because it does not have a fixed rate service and charges are dependent on user&rsquo;s health status &amp; requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrsa_001.jpg" ALT="" STYLE="height: 133px; width: 400px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
Company websites, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Downloads</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr
is a leading telehealth solutions provider in Singapore in terms of downloads in mobile application stores (e.g., Apple App Store and
Google Play Store) in the latest 6 months ended May 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_30.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
DATA.AI. Database. (formerly App Annie), Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
number of countries covered by platform</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr
is a leading telehealth solutions provider in Singapore in terms of the number of countries covered by its platform. Furthermore, the
reach of the MaNaDr platform extends to countries in the APAC region, and it is the only telehealth solutions company based in Singapore
that provides integrated smart health-tech services in the APAC region.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="platform_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Source:
Company Website, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comparison
between traditional primary healthcare and MaNaDr</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compared
with traditional primary healthcare in Singapore and United States, MaNaDr has transformed how healthcare is consumed from the perspective
of patients and has transformed how healthcare is managed from the perspective of healthcare professionals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrsa_002.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes:
(1) US$ equivalent: Based on US$1:S$1.37 (as of October, 3 2023) | (2) Source: https://www.statnews.com/2023/05/02/doctor-appointment-wait-times-solutions/
(accessed October 3, 2023) | (3) ~95% of MaNaDr patients will be attended by a physician in less than 1 minute during normal
working hours of between 8am to 8pm. | (4) Patient can access AI Face-scan to continuously monitor their well-being, and soon, an AI-companion
that reminds, encourages and tracks the patient&rsquo;s healthcare journey | (5) Source: https://pubmed.ncbi.nlm.nih.gov/29982549/ (accessed
October, 3 2023)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sources:
Company websites, Frost &amp; Sullivan analysis</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Growth
Drivers of Smart Health-Tech Service Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Online
and Offline Integrated Fulfillment in One Network</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
integration of online and offline medical service models accelerates the development of the telehealth market. The smart health-tech
service platforms start to integrate medical services across online and offline channels, enabling providers to conduct online consultations,
plan users&rsquo; in-person appointments, synchronize pertinent medical records, and then respond to online inquiries about follow-up
and recovery whenever and wherever they arise. For example, the digitalization of medical records allows for the real-time flow and sharing
of user information, thus improving the efficiency of medical services. This will help the integrated smart health-tech service market
expand from the digital market to the offline market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Increasing
Prevalence of Chronic Disease</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chronic
disease management requires long-term and integrated healthcare services. SEA is facing an epidemic of chronic non-communicable diseases
that is likely to worsen further in the future because of the aging problem. With the help of digital technology as applied in the integrated
smart health-tech service market, physicians can easily monitor and keep track of the electronic records of users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Growing
Population and Service Needs of Aging Population</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
aging population normally has a greater demand for healthcare management due to their health conditions and pursuit of a higher quality
of life. It might be inconvenient for the elderly to physically visit clinics and hospitals. The integrated smart health-tech service
market provides a one-stop comprehensive service portfolio that covers various services, including health monitoring, remote health consultations,
nutrition recommendations and chronic disease management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Growing
Health Awareness</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic has increased the awareness and importance of health in the minds of the SEA population. Services and products to allow
consumers to maintain their health are starting to gain popularity among consumers. Therefore, telehealth, as an effective method and
integrated platform of health services and products, is expected to increase in popularity in the coming years as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Technology
Updates and Service Improvement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
better service model will emerge and rise rapidly, which can promote the transformation of medical care to a personalized model and precisely
meet different needs. Besides, the use of advanced technology can eliminate the information barrier between users and doctors. Last but
not least, the portability of user data is experiencing significant developments. Travelling for medical treatment and receiving medical
care abroad are becoming more common due to an increase in studies and business exchanges between people in different regions.
User data may be easily transferred from one country to another or from one doctor to another thanks to telehealth platforms. The telehealth
market is expanding as a result of technological advancements and better services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Wide
Coverage of the Internet and High Popularity of Smartphones</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore
is one of the countries with the highest penetration rate of mobile Internet in the world. There were 5.81 million internet users in
Singapore in early 2023, when internet penetration stood at 96.9% and 9.22 million cellular mobile connections were active, which were
more than the total population, according to a report on Singapore about digital devices and services. This established a good
ecosystem for the integrated smart health-tech service market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Future
Trends of the Smart Health-Tech Service Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Integration
of online retail pharmacy and healthcare services</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
integration of online retail pharmacy and online consulting services will boost the growth of the integrated smart health-tech service
market, especially in the sales of pharmaceutical products. The purchase of pharmaceutical products and healthcare services are complementary,
and platforms that embody both elements and possess a comprehensive product portfolio are firmly positioned to capture greater demand
as compared to platforms with a more singular business focus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Building
a User-Centered Ecosystem</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
integrated smart health-tech service market has effectively built a user-centered ecological system that coordinates more complex interactions
and transactions between users, providers, payors, and other healthcare stakeholders in an integrated and seamless manner. Firstly, online
medical services led by doctors will eliminate the information gap between users and doctors. Lack of understanding of medical information
by users can lead to adverse health outcomes and decreased satisfaction with the doctor. The information offered through this ecosystem
will be current, precise, thorough, trustworthy, understandable, and useful. Secondly, benefiting from advanced technology, the treatment
of users is well-customized based on users&rsquo; preferences and intentions. Finally, a stable offline supply chain can guarantee effective
delivery and provide a convenient experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Customized
and Intelligent Telehealth solutions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digital
services will help establish a more intelligent and comprehensive health file for users in order for healthcare practitioners and providers
to provide a tailored treatment plan. For instance, when users need to be referred for reasons such as job changes or travel, their medical
records can be quickly, systematically, and comprehensively migrated. This, complemented by an offline delivery and fulfillment system,
will aid telehealth providers in offering a more precise and convenient disease and health management system. Physicians could potentially
expand their user base to include healthy people.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Specialized
Chronic Disease Management</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
integration of the internet, technological tools, and high-quality medical resources and the implementation of chronic disease management
in specialized diseases will be major trends. For example, current market competitors have begun to focus on different types of chronic
diseases, and internet hospitals can deeply cultivate a specialty in chronic disease medical treatment. Chronic disease management requires
long-term and integrated healthcare services. With the help of digital technology applied in the integrated smart health-tech service
market, physicians can easily monitor and keep track of the electronic records of users. This aids in the management of the increasing
prevalence of chronic non-communicable diseases, which is expected to worsen due to the aging population.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Better
user experience empowered by advanced technology</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are some problems, such as perceptions of technology security, that remain to be addressed in order to ensure that the user base is sustainable.
With the upgrading of technology to optimize the content in all aspects of design, production, dissemination, and feedback, telehealth
solutions platforms can attract more users and achieve higher user stickiness, including but not limited to online consulting services,
online drug prescriptions, and online drug purchases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
Success Factors of Smart Health-Tech Service Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Technology-driven
platform</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Safety
and effectiveness of the services and products are key concerns in the integrated smart health-tech service market. Companies that provide
more advanced technology, such as wearable medical devices, AI scans, and telesurgery, would be able to effectively improve user compliance.
Caregivers can examine these aspects separately from hardware and software perspectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>All
services are direct-to-consumer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
should provide access to quality user-centered healthcare services and products at affordable prices and offer those users an omnichannel
healthcare service combining online services and offline access for healthcare facilities to offer various healthcare services directly
to them. This means that higher cost-effectiveness is a key success factor. Healthcare services that are more suitable for the individual
users are introduced, thereby fulfilling consumers&rsquo; varying needs and promoting an efficient utilization of medical resources.
In addition, making healthcare services more affordable can help reduce the financial burden on consumers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Healthcare
ecosystem in an integrated and seamless manner</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COVID-19
has acted as a catalyst for telemedicine and telehealth in the past three years. In the post-COVID-19 era, providers with established
telehealth platforms should consider how to pivot and promote their service. It has been observed that most users enjoy direct interaction
with clinicians. Therefore, providers could capture the telehealth traffic through media such as health knowledge forums to grow their
businesses. Enhanced communications between users and doctors facilitate proactive and ongoing lifecare management. Ultimately, providers
can form an integrated healthcare management ecosystem by connecting multiple stakeholders. In addition, companies could provide care
by going beyond the traditional channels and partnering with other partners and stakeholders in the healthcare industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Special
mobile applications for users with obesity and chronic diseases</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
special applications which are targeted at users with obesity and chronic diseases are one of the strategic differentiators. Obesity
is linked to chronic diseases such as high blood pressure, diabetes, cancer, and orthopedic disorders. Thus, the increasing rate of obesity
fuels the increasing incidence of chronic diseases. As a result, there is a growing need for effective obesity treatment solutions to
reduce the risk of chronic diseases. Companies that identify this huge market space and keep those users highly sticky will do well in
the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>User-friendly
and optimized UI interaction system</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
information or technology in the medical field is sometimes difficult for users to understand, the tendency of users is to opt for platforms
with a user-friendly user interaction system. Companies which provide streamlining medical procedures will enhance the quality of care
by making routine medical processes more efficient.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Replicable
Health-tech&rsquo;s business model to the rest of world</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
mobile applications have been seen to successfully apply in Singapore. Although the types and sizes of medical institutions vary from
country to country, outstanding business models can be imitated. As long as attention is paid to both the purpose and the process of
copying, it is possible to replicate a successful business model in other nations. The player can extend the business internationally
if the technology and business model are highly adaptable and repeatable.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_011"></A>Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a leading
telehealth solutions provider in Singapore in terms of various matrices, such as the number of patient consultations per day and the
ranking of our mobile application, according to Frost &amp; Sullivan. According to Frost &amp; Sullivan, we have the largest number
of teleconsultations per day in the six months ending May 2023, and are amongst the fastest-growing telehealth solutions providers
in Singapore. Our MaNaDr mobile application has received a 4.8 and 4.9 star rating on the Apple App Store and Google Play Store in
Singapore respectively as of June 14, 2023. According to Frost &amp; Sullivan, on a combined basis, MaNaDr was the most reviewed and
highest rated mobile application in Singapore as of June 14, 2023 and has the largest number of teleconsultations per day in the six
months ending May 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> provide our services on our MaNaDr platform,
which is accessible via our mobile application and website. We seek to build a 360-degree holistic healthcare ecosystem supported by
a global community of healthcare providers, with the mission to make healthcare simple and seamless, instantaneous, affordable and available
to the masses. We serve both the community of users, by offering personalized and reliable medical attention to users worldwide, as well
as the community of healthcare providers, by allowing them to have a broader reach to users through virtual clinics without any start-up
costs and the ability to connect to a global network of peer-to-peer support groups and partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr platform is a platform designed and created
by doctors, for doctors and users. We were founded by a team of doctors with the aim of harnessing the power of IT and with a
problem-solving centric approach to address global healthcare concerns and issues such as inequalities and inaccessibility in healthcare,
complexities in obtaining correct healthcare in a timely manner, confusion due to the wide range of healthcare products and services
available, and the global healthcare burden of obesity and chronic diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
diagram below illustrates how we have developed our business with the aim of addressing each of these global healthcare concerns and
issues, and this problem-solving approach is one of our Group&rsquo;s key unique features and competitive strengths:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_10.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<I>Inequalities in healthcare</I>: We have set up one of the smartest integrated all-in-one patient care-centric platforms in the region
to deliver affordable care to users. According to Frost &amp; Sullivan, as at May 31, 2023, MaNaDr offered the most affordable care
to nearly 100,000 teleconsultation activities per month through our MaNaDr platform and strived to deliver quality, timely and seamless
care. We have managed to offer affordable healthcare through the use of technological tools, as we have incorporated AI, smart logic
and algorithms to simplify the entire consultation process, at a price point that does not compromise the quality of care afforded. The
simplification of the teleconsultation process has allowed us to offer instantaneous care to our users round-the-clock. We also have
an Al-driven platform that routes the patients to the relevant pool of healthcare providers and have one of the fastest response times
in Singapore and globally, according to Frost &amp; Sullivan. The quality of care is further bolstered by the fact that our
MaNaDr platform is supported by a trusted network of healthcare professionals both in Singapore and the region, many of whom are part
of the personal network and contacts of our doctor-founders, Dr. Siaw Tung Yeng and Dr. Teoh Pui Pui.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inaccessibility
in healthcare</I>: To alleviate inaccessibility in healthcare encountered, we have capitalized on the ubiquity of mobile technology and
the rise in social platforms to set up MaNaForum, which is a social forum with multimedia capabilities within our MaNaDr mobile
application, to empower our users and providers from all around the world to share and transmit information on medical conditions, interact
with one another freely and ask questions at no charge. MaNaForum is supported by doctors, healthcare professionals and other key players
in the healthcare sector such as dieticians and gym instructors. Furthermore, the reach on our MaNaDr platform extends to countries
in the APAC region and according to Frost &amp; Sullivan, we are the only telehealth solutions company based in Singapore that provides
integrated smart health-tech service in the APAC region.  It has also broadened access to healthcare to many in Singapore and the
region, with many users in our ecosystem being able to post questions freely on various topics ranging from the pandemic, health and
medical conditions and symptoms, fitness and to preventive care such as weight management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<I>Complexities in obtaining correct healthcare in a timely manner</I>: To break down and simplify the complexities in healthcare faced
by users, we seek to provide simplified care. This is achieved by breaking down barriers in time, place, and space with the setting up
 one of the smartest 24/7 virtual care ecosystems and support groups, according to Frost &amp; Sullivan, to help users navigate
the complexities faced in receiving correct and timely care. The platform is centered on providing trusted care to users, with users
being automatically routed to the same doctor to ensure continuity of care and comprehensive healthcare, thereby bridging the gap between
a teleconsultation and physical consultation process. Users also have ready access to a panel of healthcare professionals across various
healthcare disciplines on the platform, which greatly simplifies the delivery of healthcare as users are able to find the right care
timely and with ease. As opposed to waiting weeks or months for a physical appointment or a referral to a specialist doctor, we can provide
our users with the right care within hours whenever or wherever they are in the world, without them having to leave their
homes. The platform enables users to be provided with comprehensive and continuous care from their primary care doctors who act as their
gatekeepers and can help them navigate the increasingly complex healthcare system, and yet have access to a pool of specialist doctors
in the event they require specialist medical attention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<I>Confusion due to the wide range of healthcare products and services available</I>: With the volume of healthcare products and services
available on the market, users often face difficulties in finding the products and services they need, which could result in confusion
and adverse outcomes. To address this, we have set up a web store, MaNaShop/MaNaStore, containing more than 2,000 curated products
and services from reliable suppliers and service providers worldwide, so as to deliver quality trusted products to users at affordable
prices. We offer targeted products which meet our quality standards for our users across different genders and age brackets to address
their specific healthcare and wellness needs. MaNaShop/MaNaStore utilizes smart logic and algorithms to allow users to navigate through
the online store and locate what they require with ease. We have also incorporated a QR code into some of our key products, to allow
users to access further information on any associated health or medical conditions that the product seeks to address, as well as access
to doctors via consultation with just a scan. There is also a 24/7 customer support service to ensure timely delivery of orders placed
and to address any questions that users may pose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<I>Global healthcare burden of obesity and chronic diseases</I>: To alleviate chronic healthcare conditions, we have identified the needs
of users and developed a 360-degree healthcare ecosystem offering holistic, comprehensive, continuing and long-term preventive and pre-emptive
care centered around such needs. The ecosystem is supported by a community of healthcare providers, patient support groups, healthcare
coordinators, pharmaceutical companies and paramedical service providers whom we partner with. We have also incorporated technological
tools like AI, smart diaries for patients to monitor their healthcare journey, smart devices, AI Facescan function in our MaNaDr mobile
application and care pathway, or clinical care pathway, a set of guidelines that outline recommended steps and timeframes for managing
and treating a specific medical condition or procedure to establish a standardized and efficient approach to the delivery of care, as
part of the treatment and care regime. According to Frost &amp; Sullivan, we are a pioneer in the APAC region, spearheading the building
of a comprehensive weight management ecosystem that aims to target over 60% of users on our MaNaDr platform who access the &ldquo;Consult
Weight Management&rdquo; function on our MaNaDr platform and who are overweight. Since the launch of the comprehensive weight management
system in December 2022, most of the participants in our weight management program achieved the weight loss target
set by our doctors as at September  30, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
our founding team and management comprise doctors and other healthcare providers, we believe that we have an in-depth understanding on
the needs of healthcare providers seeking to venture into providing healthcare solutions virtually and are able to readily tap on our
network of doctors in Singapore, Malaysia and the region, to onboard them onto our platform. Since the inception of our MaNaDr platform,
the number of healthcare providers had grown steadily from 22 as at December 31, 2016 to 1,650 as at December 31, 2023.
Our MaNaDr platform facilitates access to a global network of peer-to-peer support groups and partners, which we believe has contributed
greatly to the steady growth in the number of healthcare providers that have been onboarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
platform and services have also been widely adopted in Singapore and was expanded during the COVID-19 pandemic in partnership with Singapore&rsquo;s
Ministry of Health and Ministry of Manpower, and with the support and endorsement from doctors, corporate partners and the public sector
in both Singapore and Malaysia. We worked closely with the Singapore health authorities in the fight against COVID-19. In recognition of our efforts,
our Company was awarded the President&rsquo;s Certificate of Commendation (COVID-19) and our founders, Dr. Siaw Tung Yeng and Dr. Teoh
Pui Pui were awarded the Public Service Medal (Pingat Bakti Masyaraka) (COVID-19) by the President of Singapore in 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
launched our mobile application in October 2016 and the website in January 2019. Our MaNaDr mobile application is streamlined
to provide users with ready access to healthcare and medical providers, and was designed and created by a team of doctors who have an
extensive understanding of users&rsquo; healthcare needs and preferences. Through our mobile application, we offer our users with
a range of seamless and hassle-free telehealth solutions, which encompasses teleconsultation services, including the issuance
of electronic medical certificates and delivery of medications to users&rsquo; homes, as well as other personalized services such as
weight management programs which, according to Frost &amp; Sullivan, are offered at the most affordable price points in Singapore
based on the cost of standard consultation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that we have established a comprehensive ecosystem which connects healthcare needs and services in a single platform. We have
achieved a global reach on our mobile application and website and as at September 2023, we had active users from more than 18 various
jurisdictions across the world, including Singapore, Vietnam, Malaysia, Australia, India and the Philippines. As at October 31, 2023,
we had onboarded more than 700 Singapore clinics and more than 1,500 medical professionals comprising GPs, specialized and allied health
providers. We had also recorded more than 120,000 teleconsultation requests in October 2023 and as at October 31, 2023, we have completed
more than 1,600,000 tele-consultation requests since our inception in 2016. As at October 31, 2023, we had more than 1 million registered
users on our MaNaDr platform, having grown from a handful of registered users since our inception in 2016. The specialists available
through our platform include most major medical and surgical disciplines, such as cardiologists, dermatologists, endocrinologists, gastroenterologists,
internal medicine specialists, obstetricians &amp; gynecologists, otorhinolaryngologists, psychiatrists and urologists.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the month of October 2023, we provided more than 120,000 teleconsultations through our MaNaDr mobile application. Users
can connect with doctors from either our in-house team or one of the clinics in our network of service providers through the mobile application
to chat in real-time via the in-application video call and text messaging function, as well as to send photos or videos to the doctors
as part of the teleconsultation process. During the COVID-19 pandemic, we also provided services for supervised tele-ART tests with a
certified ART supervisor over video calls on our MaNaDr mobile application, as well as for COVID-19 PCR home swab tests by our team of
certified medical professionals comprising doctors and nurses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr
platform also provides users with easy access to a variety of products and services through MaNaShop/MaNaStore, our online
e-commerce platform for B2C sales of medical, pharmaceutical and other health products, such as OTC medications, vitamins and
supplements. Services such as medical screenings and procedures including vaccinations, serology tests and swab tests are also
offered. We also generate revenue by selling healthcare and wellness products under a direct sales model and also from earning
commissions from third-party vendors under an online marketplace model. In addition, we have also set up MaNaPharma in January 2017
to engage in offline B2B sales of pharmaceutical products and medical devices to other clinics and healthcare providers in
Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Group also operates the MaNaDr Clinic, which is a brick-and-mortar GP clinic located in Singapore with an in-house medical team comprising
three doctors and five other medical professionals as of December 31, 2023. It provides consultations and family doctor services,
as well as geriatric care, health check-ups and other services for users who prefer in-person consultations and services, and also specializes
in gender-affirming care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2023, we launched MaNaCare, a one-stop employee flexi-benefits platform offering affordable and accessible healthcare and
wellness solutions for employees of our corporate customers, who will be able to access the full suite of products and services
offered on our MaNaDr platform, ranging from general practitioners, specialist and allied healthcare panel services to
teleconsultations, in-person clinics, on-site health screening, online marketplace and wellness programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also collaborate with other consumer healthcare service providers such as physiotherapy and fitness centers, dieticians, eyecare professionals,
mental health professionals, fertility specialists and aesthetic care. Through the comprehensive suite of products and services, we believe
that we have developed a one-stop platform that connects users with an accessible and affordance range of healthcare and wellness solutions,
and these have enabled us to establish a 360-degree healthcare ecosystem through which users are able to enjoy online and offline healthcare
resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Mission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
be our users&rsquo; trusted companion on their lifelong healthcare journey by providing a seamless healthcare experience from start to
finish, which is affordable, accessible and easy to understand to both users and healthcare providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strengths </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that we are well-positioned to achieve our strategic goals through several key business strengths, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Leading
position in Singapore&rsquo;s rapidly growing telehealth solutions industry</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a leading
telehealth solutions provider in Singapore in terms of various matrices, such as the number of patient consultations per day and the
ranking of our mobile application, according to Frost &amp; Sullivan. According to Frost &amp; Sullivan, we have the largest number
of teleconsultations per day in the six months ending May 2023, and are amongst the fastest-growing telehealth solutions providers
in Singapore. Our MaNaDr mobile application has received a 4.8 and 4.9 star rating on the Apple App Store and Google Play Store in
Singapore respectively as of June 14, 2023. According to Frost &amp; Sullivan, on a combined basis, MaNaDr was the most reviewed and
highest rated mobile application in Singapore as of June 14, 2023 and has the largest number of teleconsultations per day in the six
months ending May 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of developments
in mobile Internet technology and AI, and greater access to such technology in the telehealth solutions industry, Internet healthcare
is expected to further disrupt the traditional healthcare services industry and trigger a shift in how users seek and receive healthcare
services in Singapore and globally. Since the launch of our mobile application and website in 2016 and 2019, respectively, we had recorded
more than 1,000,000 registered users on our mobile application and more than 40,000 registered users on our website as
of December 31, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the back of the rapidly growing telehealth solutions industry, increasing disposable income, rising healthcare awareness and improving
Internet technologies, the Singapore telehealth solutions market is poised for significant growth to meet the demand for efficient and
quality healthcare services. As a leader in Singapore&rsquo;s telehealth solutions industry, we believe that we are well-positioned
to benefit from the rapid growth of this industry by accelerating user acquisition and business expansion. We believe that the comprehensive
ecosystem that we have established, as well as the range and ease of access of the healthcare and wellness solutions that we offer, present
unique value propositions for our users (both individuals and corporate customers) as well as our service providers, and are crucial
to the continual growth of our business, for the following reasons:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; <I>General
Users</I>: Our platform offers a one-stop portal for users to access extensive online and offline healthcare resources in a
cost-effective and convenient manner, and user experience that is remarkably different from the traditional medical experience.
Users can easily access our mobile application for teleconsultation and other telehealth solutions. Additionally, we integrate
offline services and products and offer a variety of services to address the different needs of our users. Our online e-commerce
platform, MaNaShop/MaNaStore, offers a wide range of selected healthcare products with timely delivery of products purchased. A
growing community of users has also developed on MaNaForum, whereby users can also post their questions on various health
topics and issues, which will be answered by our panel of doctors and other healthcare providers at no charge. We also create and
maintain a personalized e-health profile for each user, which allows us to track and manage their health to improve and maintain
their health status.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; <I>Service
Providers</I>: Taking advantage of our growing user base and understanding of our users, we channel our users to hospitals, clinics
and other healthcare institutions in our network based on their needs and create monetization opportunities for pharmacies,
retailers and distributors via our MaNaShop/MaNaStore as they benefit from the user traffic and an additional revenue source through
sales on our platform. We lower the user acquisition costs for such service providers, and also help to increase awareness and
generate publicity for the various services provided at healthcare institutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; <I>Corporate
Customers</I>: We offer health membership plans and consumer healthcare service packages for employers to reduce their healthcare
spending while at the same time offering convenient, affordable and quality healthcare to their employees under MaNaCare. MaNaCare
offers a comprehensive range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel
services, tele-consultation, in-person clinics, on-site health screening, online marketplace and wellness programs. We also
collaborate with insurance companies to provide policyholders with value-added healthcare services complementary to the insurance
products, so as to reduce costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Multi-faceted
business model that offers a one-stop portal connecting our users with both online and offline healthcare resources</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
multi-faceted business model positions us as a one-stop portal to the healthcare ecosystem, connecting users to online and offline healthcare
resources. We offer a comprehensive suite of medical-related and other services including teleconsultations and health check-up services,
vaccinations, skin and aesthetics services and other services on our MaNaDr platform and at the MaNaDr Clinic. In addition, we
engage in B2C sales of medical and other health products on the MaNaShop/MaNaStore online e-commerce platform to our users, B2C sales
of pharmaceutical products and medical devices to other clinics and healthcare providers through MaNaPharma, as well as provide corporate
healthcare and wellness services via MaNaCare to corporate customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize the varying needs of our users &ndash; both when they are in need of medical care and when they want to stay healthy. In response
to users&rsquo; needs, we offer family doctor services, including online consultation services provided primarily by our in-house team,
with a primary focus on common and chronic illnesses, as well as hospital referral and appointment services. Such services can be accessed
both online through the mobile application and website, and offline at the physical brick-and-mortar MaNaDr Clinic. Our MaNaShop/MaNaStore
online e-commerce platform collaborates with third-party delivery couriers via our own platform to provide timely deliveries to our users
in Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the range of online and offline services and product offerings enables us to better serve our users and to bridge the
gap between them and quality healthcare service providers. Our analysis of user behavior and demand also allows us to optimize and
expand service offerings and enhance user engagement on our platform. Users are able to create a personalized e-health profile that
will be continuously updated and improved with new user functions throughout their lifetime, which is intended to form an integral
part of their active health management on our MaNaDr platform. Through in-depth user understanding and a comprehensive
network of healthcare providers across most medical disciplines, our MaNaDr platform is able to optimize the use of medical
resources by matching users with doctors and physicians with the relevant expertise. To enhance user engagement, we have also
created an online social platform, MaNaForum, for our base of global users to post questions anonymously on various health topics
and issues, which will be answered by our panel of doctors and physicians. It also provides a platform for users having similar
healthcare needs or problems to exchange opinions and ideas. According to Frost &amp; Sullivan, we have set up  one of the
smartest 24/7 virtual care ecosystems and support groups to help users navigate the complexities faced in receiving correct and
timely care. According to Frost &amp; Sullivan, we operate Singapore&rsquo;s only in-app live group chat service via MaNaChat, the
24/7 customer support service, and have one of the fastest response times in Singapore and globally to support users, and hosts the
region&rsquo;s only in-app drug support and discussion group via MaNaForum, where users can organize bulk purchases of drugs, discuss
matters relating to the purchase of drugs, as well as the uses, side effects, and latest news on drugs. We believe that our
healthcare ecosystem creates value for both healthcare service providers and users alike, in addition to providing convenient online
and offline access to a wide range of medical services and cost-effective solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Innovative
technological solutions empowered by an experienced in-house medical team </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have digitalized all of our core operations, building a full suite of digital operations systems solutions to ensure end-to-end quality
control from procurement to fulfilment and delivery for the MaNaShop/MaNaStore online e-commerce platform and offline sales, teleconsultation
services, issuance of electronic medical certificates, home delivery of medications, new product reviews to user feedback. For example,
we employ technology for accurate demand forecasting to help us ensure the stability and quality of our product supply while increasing
inventory turnover rates, and the data insights that we can gain also help us with upstream supplier selection and product selection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer 24/7 quality teleconsultation services with minimal waiting time through our self-developed mobile application, which also allows
optimizing of delivery routes by matching the closest clinic from our network of service providers to the user, such that the prescription
submitted by the doctor following the teleconsultation will be quickly fulfilled by the dispatch and home delivery of the medications.
We are also able to improve user engagement, repurchase rates, order size and user lifetime value by creating precise user preference
profiles, optimizing product offerings and categories, and consistently enhancing personalized search functions and recommendations.
One key feature that we have introduced to increase user engagement is the AI Facescan function on the mobile application, which allows
users to know what their estimated vitals are, simply with a basic scan of their face by their phones. This is useful for one to monitor
one&rsquo;s own health condition, as well as for users to describe their condition to their physicians. We work with
a Toronto-based technology firm that holds an award-winning and patented contactless smartphone-based blood pressure measurement technology
known as transdermal optical imaging, which allows for changes in blood flow to be captured using light and the translucency of human
skin, using simply the conventional camera in users&rsquo; mobile devices, to provide the AI Facescan function to our users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as part of the MaNaCare program offered to corporate customers, we provide digital solutions such as automated and real-time
administrative processing and claims management, and cashless payment services which eliminates the need for employees to first make
payment before submitting claims for reimbursement. The digitization of our business enables us to optimize and provide positive user
experience for both our users as well as our suppliers and service providers, which we believe has contributed to the continuous expansion
of our user base and supply chain. As a result, we deeply value and will continue to invest in innovative technological solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
technology infrastructure is supported primarily by our in-house tech and medical team, and supplemented by our network of clinic service
providers. We have adopted stringent hiring and screening procedures, and provide ongoing professional training for our medical staff.
We believe that our dedicated in-house medical team and standardized consultation protocols also enable us to effectively deliver reliable
and high-quality services, which further enhances the user experience. As of December 31, 2023, the medical team comprised more
than 1,500 doctors and allied healthcare professionals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comprehensive
service offerings that maximize user interactions and engagement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our success depends on the ability to serve users both when they are in need of medical care and when they are healthy,
through a comprehensive range of medical-related and other service offerings. By addressing our users&rsquo; full range of healthcare
needs, we maximize our user interaction frequency, which in turn increases user engagement and stickiness throughout our users&rsquo;
lifetimes. We believe that consistently high-quality user experience is critical to increasing traffic on our website and mobile application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer our users a comprehensive range of family doctor services, which includes consultation, treatment, as well as healthcare and wellness
programs. Additionally, we offer a wide spectrum of other types of services such as the sale of products like OTC medications, vitamins
and supplements. We also provide services such as medical screenings, and procedures such as vaccinations, serology tests and swab tests
to users via MaNaShop/MaNaStore, our online e-commerce platform. MaNaShop/MaNaStore offers a wide variety of healthcare and wellness
products and services, and we recommend products of potential interest based on the user&rsquo;s profile, history of interactions, and
other users&rsquo; data. Furthermore, we offer relevant health and wellness information via MaNaForum. We have also implemented interactive
reward plans and customer referral plans that are intended to stimulate constant user engagement with our MaNaDr platform for
purposes of maintaining user loyalty and increase our user base. In the year ended June 30, 2022, an average of 10% of the users
who utilized our family doctor services during a month also used our other services. Through frequent interactions that are of consistent
quality, we believe we can build trust and user loyalty in order to facilitate the adoption and consistent participation in our ecosystem
which, in turn, broaden our user base and strengthen user engagement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Rapidly
growing and diversified monetization channels</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have demonstrated our ability to monetize our large and increasingly diversified user base, and sustain our growth from diverse medical
and wellness segments, through the (i) MaNaDr website and mobile application and the provision of consumer teleconsultations, medicine,
appointments and e-medical certificate services, (ii) MaNaShop/MaNaStore, the e-commerce platform for B2C sales of products and services
to users, (iii) MaNaDr Clinic, which offers a comprehensive list of medical services for users who prefer in-person consultations and
services, (iv) offline B2B sales of pharmaceutical products to other clinics and healthcare providers and provide health check-up services
to our users and (v) MaNaCare, a one-stop employee flexi-benefits platform offering affordable and accessible healthcare and wellness
solutions for employees of corporate customers. With the expansion of the suite of products and services offered on our MaNaDr
platform, our total revenue had also correspondingly increased by approximately 169%, from US$2.6 million in the year
ended June 30, 2021 to US$7.0 million in the year ended June 30, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a balanced mix of medical and wellness offerings that are highly sought after, and those that are designed to meet both the
general and specific healthcare and wellness needs of the public. As user traffic on the website and mobile application increases and
our user base grows, more partners and third-party service providers will be attracted to join our network and create monetization opportunities,
which further enhances our capabilities to serve our users and our competitiveness in the telehealth solutions industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Strong
management team with both technology and medical experiences</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
benefit from the leadership of our management team that combines in-depth understanding of the technology industry in Singapore and the
APAC region with expertise in Singapore&rsquo;s medical and healthcare industry. This integration has enabled us to become a leading
telehealth solutions provider in the Singapore telehealth solutions market with innovative AI-driven mobile solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers have an average of over 25 years of relevant industry experience. Dr. Siaw Tung Yeng, our Co-Founder and CEO,
has a wealth of experience in healthcare and medical informatics. He laid the foundation for the conceptualization, development and commercialization
of MaNaDr. He has been complementing his work as a Senior Consultant Family Physician with knowledge and experience in IT and healthcare
and medical informatics for more than 30 years and had previously worked with the Ministry of Health of Singapore to implement IT systems
and solutions. He also sits on various task forces and advisory committees of the Ministry of Health of Singapore and is actively involved
in the strategic planning of medical informatics programs. He is also a member of the National Telemedicine Advisory Committee (NTAC)
and sits in the Singapore Medical Council (SMC) Disciplinary Tribunal currently. Prior to founding MaNaDr, he was also the Chief Information
Officer of Healthway Medical Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Teoh Pui Pui, our Co-Founder and Executive Director, is a pioneer in the telehealth solutions industry in Singapore. In 2020, she led
a group of doctors, working closely with the Ministry of Health of Singapore and Migrant Workers&rsquo; Centre, to form the frontline
forward triage medical care for foreign migrant workers during the peak of the COVID-19 outbreak in the dormitories in Singapore and
spearheaded an island-wide roll out of tele-monitoring devices to the dormitories as part of the chronic care management and disease
surveillance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
of our founders, Dr. Siaw Tung Yeng and Dr. Teoh Pui Pui, have been awarded the Public Service Medal (<I>Pingat Bakti Masyaraka</I>)
(COVID-19) by the President of Singapore in 2023, in recognition of their contributions to public service during the COVID-19 pandemic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Strategies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Expand
our user base and systematically enhance our user engagement, including through technological tools, to strengthen our market position</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to continue to expand our user base through natural traffic, external marketing and promotional activities. Expansion through natural
traffic will be achieved by word-of-mouth resulting from more comprehensive service offerings and high service quality, changes in user
behavior and improved brand awareness. Expansion through external marketing will be achieved by the acquisition of new users through
mobile application stores, as well as online and offline marketing activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to further enhance our user engagement through further developing data-driven and predictive healthcare services to actively engage
our users in their daily lives and further simplify their healthcare journey, such as by incorporating smart predicative AI into the
mobile application and website to deliver the correct healthcare to our users on a round-the-clock basis, as well as build-in predictive
and pre-emptive care automated by AI to prompt and alert the users round the clock with daily healthcare reminders and alerts. We also
maintain a focus on delivering personalized and customized care to our users by allowing users to adjust and personalize their health
goals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also intend to invest in the development of Internet of Medical Things (IoMT), which refers to a network of medical devices and applications
that can connect to health care IT systems using networking technologies. Users can wear such medical devices, which contain heart rate
monitoring and blood pressure sensors, with the information gathered transmitted to a cloud that can generate health reports to be reviewed
by doctors. Such technology has the effects of enhanced patient care, improved workflow efficiency, better medication management and
increased patient engagement and can also bring about potential cost savings to users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will also scale up MaNaForum into a global social forum beyond APAC to serve the healthcare needs of users across the world. To deepen
user engagement, we intend to leverage on innovative algorithms and incorporate short clips and smart videos based on users&rsquo; interests
and state of health. We also intend to employ AI tools to provide a bridge between individual users and the global community of patients
and providers with similar health issues and health interests as themselves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, with the anticipated growth in our user base, we also plan to implement blockchain technology in the next phase for decentralized
storage of user data, thereby allowing users greater control over their personal information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To strengthen our market
position, we intend to continue expanding on our key strengths in providing telemedicine services and creating a wellness marketplace.
We also intend to develop a next-generation healthcare operating system that will aim to link service providers with patients through
various tools, features and services including AI-forward Triage &amp; Companion, physicians&rsquo; support network, continuous medical education
(CME) programs, clinic management systems, and blockchain patient electronic health records (EHRs).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that these
tools, features and services, together with an AI-enabled tele-monitoring and allocation system, will enable us to develop a healthcare
operating system that can intuitively connect patients with their healthcare services or providers instantly, through faster and smarter
allocations. We aim to develop a system that will achieve a more seamless and instant connection from patients to providers by enhancing
our existing smart virtual clinics with better predictive and preventative healthcare that will be supported by, amongst others, AI face
scans and AI-enabled follow-up care. We believe that such a healthcare operating system will reduce the administrative resources required
and also increase patient compliance with their medical treatment plans.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Expand
our service and product offerings to cover the healthcare value chain</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to increased user engagement, we intend to further improve user stickiness through expanding service offerings to serve differentiated
user needs on our platform and improving the quality of the products and services offered on our MaNaDr platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to offer a broader range of healthcare services and products along the healthcare value chain, help our corporate clients organize
targeted campaigns promoting both products and services, as well as organize workshops and seminars that target medical professionals
so as to increase the brand awareness and stickiness of MaNaDr within the medical community. We will also continue our curation for quality
healthcare products and services across the globe for our users so as to further improve our product offerings available on MaNaShop/MaNaStore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Building
on the personalized care program that we have established for users who are keen to embark on a weight management journey, we intend
to roll out a similar program to manage other chronic diseases such as diabetes as well as mental health conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to improving user stickiness, we believe that by offering a broader range of service and product offerings across the healthcare
value chain will enable us to deepen the connection with healthcare industry stakeholders and integrate them into our ecosystem. The
development of long-term strong business relationships with these industry stakeholders, including healthcare and other service providers,
will correspondingly enable us to attract new users who will utilize our MaNaDr platform to gain access to these stakeholders
on a global level.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Seek
merger and acquisition opportunities and partnerships to add scale and diversify our business through new capabilities and services</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to continue to grow our user base, expand our service offerings and optimize our ecosystem through selected partnerships, investments,
and acquisitions covering our comprehensive medical and wellness service offerings. We also intend to enhance our technological leadership
by building additional features to our platform to improve patient data security and integrity, including adding connectivity with other
payors such as insurers and corporate payors, establishing integration with major accounting and human resource management software,
building clinical information systems, establishing inter-operability with health monitoring devices, as well as introducing AI-enabled
medical companion and medical decision support systems that are built on blockchain databases. Further, we plan to recruit experienced
IT professionals and acquire domestic and overseas companies with advanced technology and service solutions. We are also looking into
establishing partnerships with other pharmacies to diversify our offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we plan to expand our existing reach in certain countries in the APAC region (such as Malaysia, the Philippines, Vietnam and Australia)
and also expand our reach to other countries in the APAC region (including Cambodia, New Zealand, Thailand and Indonesia), through strategic
partnerships, investments, mergers and acquisitions. We believe that we can replicate our business model in these countries to address
their healthcare services industry issues and unmet healthcare demands effectively and efficiently. We plan to collaborate with local
partners to tailor our business model to complement the demographics and healthcare demands of these countries, and in particular, to
increase the reach of our unique healthcare ecosystem including our weight management program and the management of major chronic diseases
to countries beyond Singapore. As at the date of this prospectus, we have not entered into any agreements in relation to the acquisition of any
new business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Main Business Activities </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
diagram below illustrates how our MaNaDr platform is a 360-degree healthcare ecosystem which connects users and service providers
through the range of healthcare services and product offerings that can be accessed through the mobile application and website:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_11.jpg" ALT="" STYLE="height: 308px; width: 550px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr platform is a one-stop healthcare ecosystem
that delivers an integrated and comprehensive suite of products and services as we recognize the needs of our users, both when they are
in need of medical care and when they want to stay healthy. Building upon an integrated technology platform, professional in-house medical
team, network of quality clinic service providers, diversified and evolving range of product and service offerings, sophisticated
consumer engagement strategies and well-established distribution channels, the healthcare solutions offered on our MaNaDr platform
primarily encompass the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<B><I>MaNaDr Mobile Application</I></B>: Our MaNaDr mobile application is an avenue for us to provide timely, personalized and
curated care to our users. It primarily involves the provision of teleconsultation services via online video consultation, which
allows users to chat in real-time with, and send photos or videos to, doctors online, as well as hospital and/or clinic referral and
appointment and inpatient arrangement by our in-house medical team and doctors from our network of clinic service providers. It thereby
offers users a greater measure of convenience and satisfaction. We have also been awarded government contracts for the provision of telehealth
solutions to foreign migrant workers and users under the COVID-19 home recovery program. The following screenshot shows the mobile application
interface of our MaNaDr mobile application:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_12.jpg" ALT="" STYLE="height: 818px; width: 400px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaDr
mobile application contains the following salient features:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consult
                                            a Doctor Online</I>: Doctors from our in-house team and from our network of clinical service
                                            providers provide teleconsultation services to our users.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consult
                                            a Doctor Without Medicine</I>: This is similar to the feature above, but is used in instances
                                            where the user is unwell but only requires a medical certificate and does not require medication.
                                            This forward triage sets us apart from our competitors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consult
Weight Management</I>:</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> We have introduced a weight
management program in view of the rising obesity rates in Singapore and the world, for users to embark on their weight management journey
supported by an ecosystem of healthcare and weight management solutions, well-trained weight management providers and a community of
users. Under this program, the user will be placed under a doctor who will be his adviser in his weight loss journey. The weight management
tools adopted include the use of appetite-control medication and requiring the user to upload a picture of their meals every day for
the doctor&rsquo;s review and supervision. Notifications and personal reminders will be sent to keep users engaged and motivated throughout
their healthcare journey. Apart from weight management, there are also comprehensive and tailored care solutions for users with pre-diabetes
and chronic diseases to ensure that they receive the treatment and support required. According to Frost &amp; Sullivan, we are
the pioneer health and med tech player in the APAC region spearheading the building of a comprehensive weight management
ecosystem that aims to target over 60% of users on our MaNaDr platform who access the &ldquo;Consult Weight Management&rdquo;
function on our MaNaDr platform who are overweight, supported by a community comprising health care providers, patients support groups
and pharmaceutical companies.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                              <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9642;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Pediatric
                                            Consult<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">: This allows
                                            users to access a network of qualified and experienced doctors who are able to provide medical
                                            guidelines and answer users&rsquo; specific questions about their child&rsquo;s health concerns.</FONT></TD></TR>
                                              <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                              <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9642;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Request
                                            Referral Memo<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:
                                            This allows users to consult a GP who will issue a letter to refer users to specialists if
                                            their health condition requires specialist medical attention.</FONT></TD></TR>
                                              </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tele-ART</I>:</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> This involves the provision of real-time remote
supervised self-swab ART.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>MaNaCare</I><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">: This directs users to our MaNaCare
website, a one-stop employee flexi-benefits platform offering affordable and accessible healthcare and wellness solutions for employees
of our corporate customers. </FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>AI Facescan</I>: This is a unique feature of our
mobile application which demonstrates our commitment to technological innovation and automation to enhance the user experience. With a
basic face scan that users can conduct via their mobile phones, this feature allows users to know what their estimated vitals (e.g. heart
rate, breathing rate, systolic blood pressure, diastolic blood pressure, cardiac workload and vascular capacity etc.) are, which are useful
for users to monitor one&rsquo;s own general health and wellness.</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>MaNaForum</I>:
                                            Clicking on the icon in the mobile application will direct users to our MaNaForum, the online
                                            forum platform, which can be accessed globally and allows members of the public to post their
                                            questions anonymously on various health topics and issues, which will be answered by our
                                            panel of doctors and physicians without any fees charged, thereby bridging the inequitable
                                            access to healthcare globally. In addition, it also allows for communities of users with
                                            similar health concerns or interests to interact and share their experience and ideas in
                                            real time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>MaNaChat</I>:
                                            Our MaNaDr mobile application is also supported by a dedicated user care support center
                                            comprising a team of multilingual care coordinators to aid in the resolution of any issues
                                            that our users may have and allows users to enquire about the services that we offer on a
                                            real time basis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Home Service</I><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">: This allows users to arrange
for a medical professional to visit their residence to provide medical services.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9642;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Clinic Visit</I><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">: This allows users to schedule
an appointment with a hospital or clinic on our network of service providers via the mobile application.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">According
to Frost &amp; Sullivan, our MaNaDr mobile application has received a 4.8 and 4.9 star rating on the Apple App Store and Google Play
Store in Singapore respectively as of June 14, 2023, and on a combined basis, MaNaDr was the most reviewed and highest rated mobile application
in Singapore as of June 14, 2023 and has the largest number of teleconsultations per day in the six months ending May 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaDr
                                            Clinic &ndash; Primary healthcare services via our brick-and-mortar clinic</I></B>: We have
                                            one GP clinic in Singapore which offers a comprehensive range of primary healthcare
                                            services, including general medical consultations, treatment and management of acute and
                                            chronic conditions in both adults and children, vaccinations, and health screenings for work
                                            permit applications, as well as pre-employment health screening, children&rsquo;s health
                                            services, geriatric care and minor surgical procedures. We also derive revenue from collecting
                                            transaction fees for appointments, issuing electronic medical certificates, laboratory review
                                            fees and memorandum fees. The clinic also serves as our Innovative Hub where we pioneer various
                                            models of care such as gender-affirming service and aesthetic care.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaPharma
                                            &ndash; B2B sales to clinics and other healthcare service providers</I></B>: We procure pharmaceutical
                                            products and medical devices, as well as engage in the wholesale distribution of pharmaceutical
                                            products to clinics in Singapore.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaShop/MaNaStore
                                            &ndash; B2C sales of products and services to users</I></B>: We offer a diversified
                                            and evolving range of products to users on the MaNaShop/MaNaStore
                                            online e-commerce platform (via both the website and mobile application), including healthcare
                                            products (such as medicines, health supplements, skincare, nutrition products and medical
                                            devices) and wellness products (such as personal care products and health screening packages).
                                            The products offered for sale are curated by our team of medical experts (including doctors)
                                            to ensure that the products meet the relevant quality and safety standards.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify; width: 97%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaCare </I></B>&ndash; <B>Corporate healthcare and wellness services, which is focused on corporate customers</B>: We provide comprehensive corporate healthcare and wellness services, ranging from GP, specialist and allied healthcare panel services to tele-consultation, in-person clinics, on-site health screening, online marketplace and wellness programs. In particular, as part of our services, there are consultants who work with our corporate customers to design a tailored health program to keep their employees healthy and engaged. We also collaborate with insurers in providing value-added services to policyholders that enable the synergistic integration of insurance and healthcare.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Collectively, we believe that our holistic ecosystem enhances the
utilization efficiency of medical and healthcare resources, while providing a positive user experience.</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B><I>MaNaDr Mobile Application</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer teleconsultation services over our MaNaDr mobile application, through online consultations provided by our in-house medical
team and external doctors from our network of clinic service providers. In the year ended June 30, 2022, over one million teleconsultations
had been conducted on our MaNaDr mobile application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
commenced online consultation services to address users&rsquo; needs for cost-effective and convenient evaluation of their health and
other medical conditions. The teleconsultation services comprise medical consultations and wellness consultations. Medical consultations
encompass consultations for a wide range of conditions and cases, with a primary focus on common and chronic illnesses, such as hypertension,
diabetes, allergies and gastroenteritis. For conditions and cases that require further examination, we generally refer the user to hospitals
or specialized clinics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also have an Al-driven platform that routes the patients to the relevant pool of healthcare providers and have one of the fastest response
times in Singapore and globally, according to Frost &amp; Sullivan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-weight: normal; background-color: windowtext"></FONT>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
screenshots below show the user interfaces on our MaNaDr mobile application during a typical online consultation session:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_13.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
teleconsultation session can last up to 30 to 45 minutes, depending on the medical issues faced by the patients. Based on the
customer&rsquo;s response to enquiries on their condition, the doctor provides medical recommendations, issue prescriptions, medical
certificates/memos or advises the customer to schedule examinations or appointments at hospitals or clinics and upload the results to
the MaNaDr system for follow-up consultations. To enhance the efficiency and accuracy of delivery of care and increase the service capacity
of the doctors, we have developed tools and algorithms that simplify the consultation process. We have also adopted a user review system
for users to provide ratings and feedback on his or her teleconsultation experience in order to incentivize the doctors from our in-house
team and from our network of clinic service providers to improve their quality of care. Our mobile platform also allows users to access
past consultation history and communicate with doctors for follow-up consultations or new consultations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, teleconsultations on our MaNaDr mobile application are provided at fees ranging from US$6 to US$15 per session, depending
on the type of services, and length of consultation, and the day on which the consultation is requested. Some of our online consultation services are currently
covered by government medical aid schemes, or commercially by employers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>In-house
Medical Team</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have more than 1,000 members, most of whom are telemedicine locums in our medical team that provide 24/7 teleconsultation support
to our users as at September 2023. They are supported by our 24/7 customer support officers who help to coordinate care and deliveries
of medicine to our users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
adopt stringent onboarding procedures for the doctors and medical assistants, which involve multiple rounds of interviews and in-role
trial evaluations. The locum doctors and medical assistants are recruited through internal referrals and external recruiting. We generally
select doctor candidates with strong professional and teamwork capabilities as well as experience as attending doctors in private clinics.
We require our doctors to maintain relevant professional certifications. For medical assistants, we generally select candidates who possess
medical-related degrees or above, adequate computer skills, strong communication skills, as well as prior working experience in private
clinics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide ongoing training  and professional development programs for our doctors and medical assistants. These programs encompass
general and specialized medical knowledge, case studies, corporate culture, and IT skills, which are designed to enhance their professional
knowledge and management skills and improve their performance. For each medical specialty, we designate a leading medical expert to take
charge of the professional development of our medical team. We also encourage our doctors to attend external symposiums for professional
development purposes and conduct bi-monthly town hall meetings with all our doctors and healthcare providers on any recent mobile application
updates, regulatory compliance as well as sharing of experience and tips in the remote delivery of healthcare.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conduct daily evaluations of our in-house doctors and medical assistants in respect of their quality of service, user feedback, and efficiency.
We also practice quality control with standardized internal protocols for our teleconsulting services performed by our in-house medical
team. Reminders, alerts, or even warnings are being sent out on a daily basis for any lapses in services or complaints received from
users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>External
Network of Service Providers</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
MaNaDr platform features a function which allows external doctors to register with us so as to access our user base. As of December 31,
2023, over 1,500 doctors had registered with us through this function. Users can leave messages for these external doctors
in our network who may respond at their option when they are free. External doctors registered with us are required to agree to our terms
of use, pursuant to which they need to comply with both our specified work scope and quality requirements and applicable rules and regulations.
In particular, external doctors are required to provide evidence of their professional qualifications for verification. We also reserve
the right to modify the relevant terms regarding external doctors&rsquo; scope of service, pricing, and how services are performed in
light of market trends and commercial considerations. Additionally, under our terms of use, these external doctors are obligated to indemnify
us for any losses resulting from violations of their obligations under the contracts with us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaDr
Clinic </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, we had one GP clinic in Singapore, which offers a comprehensive range of primary healthcare services, including
general medical consultations, treatment and management of acute and chronic conditions in both adults and children, vaccinations, and
health screenings for work permit applications as well as pre-employment health screening, children&rsquo;s health services, geriatric
care and minor surgical procedures. Its main function is to serve as our Innovative Hub where we pioneer various models of care such
as gender-affirming service and aesthetic care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaPharma</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
procure pharmaceutical products (including medicines and health supplements) as well as medical devices. We have a retail pharmaceutical
license issued by the Health Sciences Authority of Singapore, which allows us to undertake the wholesale distribution of pharmaceutical
products to clinics in Singapore. We source such pharmaceutical products and medical devices from reputable partners in Singapore and
other regions in the world such as China. Our partners are selected based on our stringent standards for quality, integrity and compliance
with applicable laws, regulations and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
add value to the clinics and other healthcare service providers which are our users by evaluating the pricing, specifications and the
latest requirements in the healthcare and medical industry to assist them in procuring pharmaceutical products and medical devices in
an efficient, timely and cost-effective manner (by conducting bulk purchases on behalf of the clinics).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaShop/MaNaStore</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer a wide spectrum of healthcare and wellness-related products to fulfill the needs of our users through our online e-commerce platform,
MaNaShop/MaNaStore, which can be accessed via our website and mobile application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaShop/MaNaStore
offers curated (i) healthcare products such as medicines, health supplements, skincare, nutrition products and medical devices, (ii)
wellness products such as personal care products and health screening packages and (iii) online services such as medical screenings and
procedures such as vaccinations, serology tests and swab tests to our users. We continuously seek to add more products and services that
we believe will appeal to our users and which also meet the stringent standards of quality, while focusing on establishing a balanced
offering of differentiated pharmaceutical and health-related products that are able to generate high volumes of traffic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
catalogue of products and services available on MaNaShop/MaNaStore is regularly updated in light of market trends as well as changes
in consumer needs and preferences, based on the demand from the market and inputs from healthcare practitioners. Product and service
offerings are carefully chosen across different categories and identify direct sales suppliers and third-party online marketplace vendors
for fulfillment to supply these products and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
screenshot below shows the user interface of MaNaShop/MaNaStore on our mobile application and the website, respectively:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formdrs_14.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="formdrs_15.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are easy site navigation, basic and advanced search functions, comprehensive product information and user reviews and ratings on MaNaShop/MaNaStore.
Such functionalities address our users&rsquo; desire to view, understand and compare products before purchasing. Revenue is also generated
under this segment through omni-channel advertisements placed and published on the website and the mobile application. Users are generally
allowed to modify or cancel an order at any time through the online system or customer service center before the invoice is processed
for the packing of the order. We accept return or exchange requests where the wrong goods are delivered, where the dosage delivered is
incorrect or where the products are defective or damaged. However, once the goods are opened and/or used by the users, they cannot be
returned or exchanged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate MaNaShop/MaNaStore under two business models, namely, the direct sales model (whereby we procure the products from suppliers
and services from service providers, which are then sold directly to users through MaNaShop/MaNaStore) and the online marketplace model
(whereby we facilitate transactions between third party vendors and our users). As of December 31, 2023, there were a total of
14 direct sales suppliers and 4 marketplace vendors who supply products and/or services on MaNaShop/MaNaStore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
require our direct sales suppliers and marketplace vendors to supply authentic products in a timely manner and provide quality delivery
and customer services to our users. Direct sales suppliers and marketplace vendors are selected based on qualification, brand, past experience
with e-commerce, reliability and volume. Background checks are also performed on the suppliers and vendors before we enter into any agreement,
including on the products, the relevant licenses and certifications, compliance with applicable Singapore laws and regulations and brand
recognition. We may also make inquiries about the market acceptance of their products among players in the same industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also put in place stringent rules to ensure that the sales of healthcare and wellness products within MaNaShop/MaNaStore complies
with applicable Singapore laws and regulations. Direct sales suppliers and marketplace vendors may be subject to penalties or termination
of their operations on MaNaShop/MaNaStore if they sell counterfeit products, delay shipment or mishandle user complaints. We have established
a team dedicated to the management of direct sales suppliers and marketplace vendors on MaNaShop/MaNaStore with respect to, among others,
product quality, logistics and after-sales customer services. We perform checks on the products before they are listed on MaNaShop/MaNaStore,
and examine samples of those products with records of complaints or low ratings. Data relating to logistics and customer services on
MaNaShop/MaNaStore is monitored on a daily basis, and regular communication with the sales suppliers and marketplace vendors is maintained
in order to quickly address any issues when they arise. Regular reviews are also conducted on the performance of marketplace vendors,
and we have the right to terminate their operations if they remain for an extended period or have unsatisfactory user reviews.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer competitive pricing to attract and retain users. We seek to optimize our cost structure and create incentives for direct sales
suppliers to provide us with competitive prices. Under the direct sales model, prices are set by us with reference to those on other
major online retailers in Singapore and general market trends and industry dynamics. The direct sales suppliers can suggest pricing changes,
but such pricing changes are subject to our consent. Under the online marketplace model, marketplace vendors have the discretion to set
their own product prices, which they generally undertake to offer the best prices offered to any user. We may also offer special promotions
of selected products on special occasions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>MaNaCare</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MaNaCare
is a one-stop employee flexi-benefits platform offered by us that aims to bring affordable, accessible and automated solutions to organisations.
Under MaNaCare, we offer a comprehensive range of corporate healthcare and wellness services, including GP, specialist and allied healthcare
panel services, tele-consultation, in-person clinics, on-site health screening, online marketplace and forum, as well as tailor-made
wellness programs to our corporate customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our MaNaCare program, the employees of corporate customers are able to connect with our doctors 24/7 via the online platform. We also
have consultants who will work with our corporate customers to design a tailored health program for their company, so as to keep their
employees healthy and engaged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also collaborate with insurance companies to provide policyholders with value-added healthcare services complementary to the insurance
products to reduce costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Technology</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sustainability of our MaNaDr platform depends on the competence and the stability of our technology infrastructure.
We operate and maintain various platforms that connect the respective systems of our service providers, suppliers and marketplace vendors
on MaNaShop/MaNaStore, as well as the network of health check-up centers, hospitals, clinics and other medical institutions, which enable
our users to access the full range of our services and product offerings and our service providers to conduct their operations efficiently
and effectively over our platform. Resulting from the scale and complexity of our businesses, our large-scale, multi-scenario environment
has enabled us to obtain valuable data assets and constantly apply our technology across our business lines, therefore generating knowledge
and innovations that drive further technological development. We have also developed OtterSG, an advanced clinic management system to
centralize user data and streamline medical workflows for healthcare providers, and has the aim of enhancing user care and management,
and ultimately, improving overall user outcomes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, our research and development team comprised 28 engineering and data analysis professionals, with
an average of 8 years of research and development experience in mobile, web, data and AI sectors. They are primarily engaged in building
our technology platform and developing our proprietary technologies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2022, our product development and technology expenditures were approximately US$6.0 million. Our product development
and technology expenditures consist of employee benefit expenses of our product development and technology staff, IT-related equipment
operation expenses, network service charges and cost of additions of IT-related equipment. We expect spending on product development
and technology to increase over time as we add more experienced product development and technology staff, and continue to invest in our
technology platform to enhance user experience and provide value-added services to our ecosystem participants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Data
Protection </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
network configuration is secured at multiple layers to protect our databases from unauthorized access. We use sophisticated security
protocols for communications among our mobile app, website, and plug-ins. To prevent unauthorized access to our system, we utilize a
system of firewalls and maintain a demilitarized zone to separate our external-facing services from our internal systems. For instance,
we employ tools such as SSL certification, Microsoft Azure and AWS cloud services with end-to-end encryption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 89 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conduct frequent reviews of our back-up systems to ensure that they are well-maintained and functional. We have also implemented procedures
such as regular system checks, password policy, user authorization reviews and approval and data back-up, as well as data recovery tests,
to safeguard our information assets and ensure the proper management of our operational data. We have data disaster recovery procedures
in place and are in the process of establishing our active/active data centers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
data protection systems and procedures have led us to become recognized for our data protection practices by the Singapore authorities.
We were the only MedTech company, and one of the six pilot organizations to be awarded the Data Protection Trustmark (DPTM) by the Infocomm
Media Development Authority of Singapore (IMDA), which certifies that we have put in place responsible data protection practices and
that consumers are consequently less likely to experience a data breach. Additionally, we were one of the 11 organizations invited to
join the regulatory sandbox for telemedicine and mobile medicine services under Singapore&rsquo;s Ministry of Health to prepare for licensing
under the Healthcare Services Act (HCSA) in 2020. We have also received a Certificate of Conformance in April 2023 following an independent
assessment conducted where we were found to conform to the requirements of the Cyber Security Agency of Singapore (CSA) Cyber Security
Certification Cyber Essentials mark for the production and development environment for content management system (CMS) vendor providing
software as a service (SaaS) solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Healthcare
Quality and Safety</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
value the quality and safety of the medical services we provide. We have established comprehensive risk management systems and internal
control procedures to minimize medical risks arising from our operations. During the years ended June 30, 2023 and 2022,
we did not receive any written notice or penalty for material non-compliance or violation of healthcare quality and safety laws
or regulations, nor had we received any recommendation for improvement with respect to healthcare quality and safety from any government
authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
skills, competence and attitude of our medical team are essential for the quality of care that our users receive. We continuously monitor
the risk in relation to services provided by our medical team to ensure the risk management policies and procedures have been strictly
followed so as to achieve effective and efficient governance, risk, and control processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted stringent onboarding procedures for doctors and medical assistants, which involve multiple rounds of written tests, interviews,
and in-role trial evaluations. Our in-house medical team receives regular training on relevant safety policies, standards, protocols,
and procedures and is required to strictly comply with them in all aspects of our operations. We conduct monthly evaluations of our in-house
doctors and medical assistants in respect of quality of service, user feedback and efficiency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, we have adopted a quality control system with standardized consultation protocols for our teleconsulting services performed
by our in-house medical team. Such systems have three-tier quality controls:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; <I>Tier
One</I>: All doctors on-duty conduct reviews of and grade consultation cases through the doctor&rsquo;s dashboard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; <I>Tier
Two</I>: Our medical directors will conduct reviews of consultation cases of low grades or those with issues and provide comments on
and select a number of samples for review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; <I>Tier
Three</I>: Our Quality Control Training Department and the expert committee make determinations on the consultation cases with
issues and select a number of samples for review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
any issues arise from any tier as stated above, our quality control personnel will report to the Quality Control Training Department
within 24 hours for it to render intervention or grading for relevant cases. We have set up an expert committee to oversee the three-tiered
quality control system and supervise the quality control process. As of December 31, 2023, the expert committee comprised six
licensed doctors who are highly regarded authorities in their respective fields. During the years ended June 30, 2023 and 2022,
we did not receive any medical malpractice claim against our medical team or ourselves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 90 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
external doctors, we generally require them to strictly adhere to the work scope and quality requirements specified in the agreements
in compliance with applicable legal and regulatory requirements. Additionally, under our terms of use, these external doctors are obligated
to indemnify us for any losses resulting from violations of their obligations under the contracts with us. After an external doctor has
registered with us, we perform detailed checks on credentials and background before he or she is granted access to our user base, and
the profile information of external doctors displayed on our mobile platform needs to be tailored accordingly and subject to internal
review. We regularly analyze cases where a user requests a refund, and sample the consultation records of the external doctors to identify
the reasons for such requests. We also monitor the volume of consultations conducted by external doctors and their response rates. Based
on the foregoing factors, among other things, we have established an evaluation system that imposes penalties, such as reductions in
fee and termination of services, on external doctors providing unsatisfactory service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
healthcare service providers in our network, we consider a variety of factors such as reputation, scale of business, service quality
and capability, as well as their facilities before commencing cooperation with them. We require such healthcare service providers to
maintain appropriate licenses, comply with relevant laws and regulations, and follow our standardized service offering and pricing guidelines.
We also carefully monitor feedback from our users on the services provided by these healthcare service providers, and take that into
consideration when determining our continued cooperation with such healthcare service providers. The healthcare service providers are
responsible for any losses to users resulting from disputes or breach of obligations in relation to the provision of the relevant services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have achieved a strong competitive position in the Singapore telehealth solutions industry. According to Frost &amp; Sullivan,
MaNaDr is a leading telehealth solutions provider in Singapore in terms of the number of countries covered by our platform.
Furthermore, the reach of our MaNaDr platform extends to countries in the APAC region, and we are the only telehealth solutions
company based in Singapore that provides integrated smart health-tech services in the APAC region. However, we face competition
in certain of our business segments, including in terms of our provision of telehealth solutions and our MaNaShop/ MaNaStore
e-commerce business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that the telehealth solutions market will continue to grow in response to rapid technological changes and innovation, evolving
industry standards and shifting user preferences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the primary competitive factors in our industry are user experience, brand recognition and reputation, service and product
quality and selection, medical resources, technological capabilities and pricing. Additionally, new and enhanced technologies may increase
the competition in the telehealth solutions industry. We believe that we are well positioned to effectively compete on the basis of the
foregoing factors. However, some of our current or future competitors may have greater brand recognition, better supplier relationships,
larger user bases or greater financial, technical or marketing resources than we do.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sales
and Marketing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
employ a variety of methods to attract potential users. Generally, we expand our user base through natural traffic, external marketing,
and promotional programs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Natural traffic is achieved by word-of-mouth resulting from free and quality services and products offered on our platform, such as
reward plans, and wellness content;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
We also organize frequent roadshows, events, seminars, webinars and health screenings for the promotion of our platform and services
to healthcare professionals and users alike. These include talks that invite various healthcare professionals, including doctors,
dieticians, counsellors, physiotherapists as keynote speakers. In 2023, we also organized a &ldquo;MaNaDr Health Day&rdquo; in
conjunction with World Obesity Day, for participants to learn more about obesity from the perspective of various professional
healthcare providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Promotional activities include our reward programs which encourage users to share with their friends and family members, and
facilitate the conversion of our active users to paying users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal marketing programs include advertising our company and our solutions through our mobile platform and other media. We also participate
in industry events, trade shows and conferences. Additionally, we have created integrated marketing campaigns, such as innovative reward
plans programs to attract new users. As of December 31, 2023, our business team comprised five key business professionals supported
by sales representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Health,
Safety and Environment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not operate any production facilities. Additionally, for direct sales on MaNaShop/MaNaStore, we engage third parties to ship and deliver
products to our users. Therefore, we are not subject to significant health, safety or environmental risks. During the years ended June
30, 2023 and 2022, we had not been subject to any fines or other penalties due to non-compliance with health, safety or
environmental regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
seek to protect our intellectual property rights through a combination of trademark, copyright and trade secret protection laws in Singapore
and other jurisdictions, as well as through confidentiality agreements and procedures with our employees, partners and others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, we had registered our domain name, manadr.com. As of December 31, 2023, we had 22 trademarks and
2 patents registered in Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, we had 73 employees globally, with 41 employees who are based in Singapore and 32 employees
who are based in Vietnam. The following table sets forth a breakdown of employees categorized by function as of December 31, 2023:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<BR>
 Employees</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Product Development and Technology</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">28</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">38.36</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.74</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Medical Team</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.85</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Sales and Marketing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.11</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Management, Administration, Finance, Human Resource and Pharmacist</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47.95</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Total</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">73</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">100</TD><TD STYLE="font-weight: bold; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at December 31, 2023, we also had 20 part-time staff mainly for our operations division.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed various methods to ensure that our employees are adequately and correctly trained for the functions they perform and are
aware of the legislation affecting our business. Our success depends on our ability to attract, retain, and motivate qualified employees.
We endeavor to offer our employees competitive compensation packages and a positive, dynamic, and creative work environment. We believe
that we maintain a good working relationship with our employees, and we have not experienced any material employment disputes or work
stoppages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
for the fact that the Vietnam representative office of our subsidiary, Mobile Health Pte. Ltd. has entered into a collective bargaining
agreement with its employees, no collective bargaining agreement has been put in place.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 92 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
enter into standard employment contracts with our employees. We also enter into standard confidentiality agreements with all of our employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Insurance
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain public liability
and fire insurance for our clinic and pharmacy, as well as work injury compensation for our staff.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended June 30, 2023 and 2022, we had not made any material insurance claims in relation to our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Facilities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
headquarters are located in Singapore. In Singapore, we leased an aggregate of approximately 1,500 square feet of office space, a commercial
unit used for storage and office purposes of approximately 484 square feet and a clinic of approximately 484 square feet
as of December 31, 2023. In Vietnam, we leased 3,600 square feet of office space as of December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently not a party to any material legal or administrative proceedings. We may from time to time be subject to various legal
or administrative claims and proceedings arising from the ordinary course of business. Any litigation or other legal or
administrative proceedings, regardless of the outcome, is likely to result in substantial costs and diversion of our resources,
including our management&rsquo;s time and attention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Social Responsibility</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
view corporate social responsibility as both a responsibility and a competitive advantage. We recognize that we have an obligation towards
our employees, investors, users and the community as a whole. We believe our reputation, together with the trust and confidence of those
with whom we deal with, is one of our most valuable assets. We seek to maintain our reputation and such trust and confidence, and we
are committed to achieving long-term mutually sustainable relationships with our stakeholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the COVID-19 pandemic in Singapore, we worked with the Singapore Ministry of Manpower and Ministry of Health to curb the rising
infection rates in the community. We had deployed more than 100 customized tele-kiosks to migrant worker dormitories to facilitate
the provision of medical teleconsultation and timely delivery of medication. We also gathered more than 200 medical doctors and
specialists to work together in the provision of timely teleconsultation at the peak of the COVID-19 pandemic. This contributed
to the reduction of the number of visits to hospitals, which freed up resources in hospitals&rsquo; Emergency Department for medical
emergencies to be attended to.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Through the customized mobile
application, the foreign migrant workers were able to easily raise a teleconsultation with our team of medical practitioners with a
few simple clicks. The teleconsultation was also tagged to their identification number such that delivery of medication to their
dormitories could be arranged in a timely manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our panel of medical practitioners also supported the Singapore Ministry of Health&rsquo;s Home Recovery Program for COVID-positive
patients under home recovery and quarantine order by screening patients virtually to confirm that they are suitable for home recovery,
providing teleconsultations, delivering medication and in-person swabbing services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our services rendered to Singapore during the COVID-19 pandemic, including our support towards the provision of medical services to migrant
workers and our assistance in the Singapore Government&rsquo;s Home Recovery Program for COVID-positive patients, we were awarded The
President&rsquo;s Certificate of Commendation (COVID-19) in 2023 as well as a Certificate of Appreciation by the Singapore Ministry of
Manpower in 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 93 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_012"></A>Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Group is subject to the laws and regulations of Singapore, where some of our Group Companies carry on their business and operations.
This section sets forth a summary of the most significant rules and regulations that affect our business activities in Singapore. They
are not exhaustive and are only intended to provide some general information to prospective investors. They are neither designed nor
intended to be a substitute for professional advice. We recommend that prospective investors should consult their own advisers regarding
the implications of such laws and regulations on our Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthcare
Services Act 2020 (&ldquo;HCSA&rdquo;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
HCSA was enacted in 2020 to replace the Private Hospitals and Medical Clinics Act (the &ldquo;<B>PHMC Act</B>&rdquo;). The PHMC Act was
progressively implemented in three phases, which was completed in end-2023 when the PHMC Act was repealed.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
As part of Phase 1 of the implementation of the amendments to the HCSA, healthcare service providers that held PHMC Act licenses
were encouraged to port over their existing license to a HCSA license or obtain a new HCSA license. As part of Phase 2 of the
implementation, healthcare service providers would have had to transit their license under the PHMC Act to the HCSA in order to continue
offering their healthcare services. One of our Group companies, MaNaDr Clinic Pte. Ltd., operates a medical clinic in Singapore. Our
medical clinic in Singapore under the name &ldquo;MaNaDr Clinic&rdquo; located at 371 Beach Road, #02-52 City Gate, Singapore holds a
license issued by the Ministry of Health of Singapore (the &ldquo;<B>MOH</B>&rdquo;), which is subject to the HCSA, the subsidiary
legislation thereunder and any directions or guidelines as may be given or issued from time to time by the Director-General of
Health (the &ldquo;<B>DGH</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
8 of the HCSA </FONT>provides that a person must not provide a licensable healthcare service unless the person is authorized to do so
by a license under the HCSA. Any person who contravenes this provision shall be guilty of an offense and shall be liable on conviction
to a fine not exceeding S$100,000 or to imprisonment for a term not exceeding two years or to both but if the person has any previous
qualifying conviction, to a fine not exceeding S$200,000 or to imprisonment for a term not exceeding two years or to both. Section 9
of the HCSA further provides <I>inter alia</I> that a licensee must not provide a licensable healthcare service at any permanent premises
in Singapore that is not an approved permanent premises for the provision of the licensable healthcare service or using any conveyance
that is not an approved conveyance for the provision of the licensable healthcare service or by any other service delivery mode that
is not approved for the provision of the licensable healthcare service. A licensee that contravenes this shall be guilty of an offense
and shall be liable on conviction in the case of a first offense, to a fine not exceeding S$50,000 or to imprisonment for a term not
exceeding 12 months or to both and if the licensee has a previous qualifying conviction, to a fine not exceeding S$100,000 or to imprisonment
for a term not exceeding 12 months or to both.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the amendments to the HCSA, the regulatory scope under the HCSA is broadened to include healthcare services, nursing and allied
health services. In recognition of new and emerging healthcare services that are not based out of physical locations, such as telemedicine
and mobile medical services, the regulatory basis has been shifted from a &ldquo;premises-based&rdquo; licensing regime to a &ldquo;services-based&rdquo;
licensing regime in which healthcare providers will be licensed based on the types of services they provide, instead of the physical
premises in which the services are provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governance
and oversight over the provision of healthcare services have also been strengthened following the implementation of the
amendments to the HCSA. In this regard, the HCSA introduces: (a) enhanced roles for the principal officer (in respect of a licensed
healthcare service) responsible for overseeing the day-to-day operations of the service and ensuring operational compliance with the
HCSA; (b) the requirement for the appointment of a clinical governance officer for certain selected services responsible for clinical
and technical oversight of more complex services that require specialized expertise; and (c) the requirement that the governing body
of a licensed healthcare service possesses the competence and skills to carry out its role.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amendments to the HCSA will also authorize the MOH to obtain and publish information on non-compliant licensees and unlicensed providers.
Publicity restrictions will also be tightened to prohibit unlicensed persons from advertising healthcare service claims. Additionally,
licensees will be required to contribute to the National Electronic Health Record (the &ldquo;<B>NEHR</B>&rdquo;). NEHR enables a patient&rsquo;s
health record to follow them regardless of where they seek treatment such that a patient&rsquo;s records will not be lost should a provider
cease operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Safeguards
will be put in place to ensure that patients&rsquo; NEHR records are kept confidential. NEHR can be accessed only for purposes of patient
care, and not for other purposes, including assessment for employment and insurance. Measures, including the provision of access logs
to patients and regular audits on NEHR access, will be instituted to protect against illegitimate access. Penalties will be imposed for
unauthorized access. All patients will by default have their specified health data contributed to NEHR. Patients who do not wish for
their records to be accessed via NEHR may opt out. Patients who have opted out will continue to have their information uploaded
to NEHR, but with access blocked (that is, no healthcare providers can access their NEHR record) to allow past information to be unlocked
should the patient choose to opt back in at a later point in time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amendments to the HCSA also aim to update the penalties for offenses to be aligned with comparable offenses under other recently enacted
legislations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 94 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
Registration Act 1997 of Singapore (the &ldquo;Medical Registration Act&rdquo;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
practice of medicine by doctors in Singapore is subject to the Medical Registration Act, which provides for, <I>inter alia</I>, the establishment
of the Singapore Medical Council (the &ldquo;<B>SMC</B>&rdquo;) and the registration of medical practitioners in Singapore. The functions
of the SMC include, <I>inter alia</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;keeping
and maintaining registers of registered medical practitioners;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;approving
or rejecting applications for registration under the Medical Registration Act or approving any such application subject to such restrictions
as it may think fit;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;issuing
practising certificates to registered medical practitioners;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;making
recommendations to the appropriate authorities for the training and education of registered medical practitioners; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;determining
and regulating the conduct and ethics of registered medical practitioners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 13 of the Medical Registration Act, no person shall practice medicine or do any act as a medical practitioner unless he is registered
under the Medical Registration Act and has a valid practising certificate. Under Section 17 of the Medical Registration Act, any person
who is not qualified and <I>inter alia</I>, (a) practises medicine; (b) willfully and falsely pretends to be a duly qualified medical
practitioner; (c) practises medicine or any branch of medicine, under the style or title of physician, surgeon or doctor; or (d) advertises
or holds himself out as a medical practitioner, shall be guilty of an offense and shall be liable on conviction to a fine not exceeding
S$100,000 or to imprisonment for a term not exceeding 12 months or to both. In the case of a second or subsequent conviction, a fine
not exceeding S$200,000 or imprisonment for a term not exceeding two years or to both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nurses
and Midwives Act 1999 of Singapore (the &ldquo;Nurses and Midwives Act&rdquo;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
practice of nursing by nurses is regulated by the Nurses and Midwives Act. Nurses require a valid practising certificate issued by the
Singapore Nursing Board under Section 18 of the Nurses and Midwives Act. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to Section 26 of the Nurses and Midwives Act, any person who is not qualified and <I>inter alia</I>, (a) takes or uses the name or title
of nurse in any language, either alone or in combination with any other words or letters, or any name, title, addition, description,
uniform or badge, implying that the person is a qualified nurse or that the person is qualified to carry out an act of nursing; (b) being
a person whose name is included in any part of the Roll of Nurses (the &ldquo;<B>Roll</B>&rdquo;), takes or uses any name, title, addition
or description or otherwise does any act which falsely implies that the person&rsquo;s name is included in some other part of the Roll,
as the case may be; (d) knowing that some other person is not a qualified nurse and with intent to deceive, makes any statement or does
any act calculated to suggest that that other person is a nurse or qualified nurse, shall be guilty of an offense and shall be liable
on conviction to a fine not exceeding S$10,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 30 of the Nurses and Midwives Act, any person who (a) procures or attempts to procure registration, enrolment, a certificate
of registration, a certificate of enrolment or a practising certificate, by knowingly making or producing or causing to be made or produced
any false or fraudulent declaration, certification, application or representation whether in writing or otherwise; (b) willfully makes
or causes to be made any false entry in the Roll; (c) forges or alters a certificate of registration, a certificate of enrolment or a
practising certificate; (d) fraudulently or dishonestly uses as genuine a certificate of registration, a certificate of enrolment or
a practising certificate which the person knows or has reason to believe is forged or altered; or (e) buys, sells or fraudulently obtains
a certificate of registration, a certificate of enrolment or a practising certificate, shall be guilty of an offense and shall be liable
on conviction to a fine not exceeding S$10,000 and, in the case of a second or subsequent conviction, to a fine not exceeding S$20,000
or to imprisonment for a term not exceeding six months or to both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
28 of the Nurses and Midwives Act provides that there must not be the employment or engagement of a person who is not a qualified nurse
to carry out any act of nursing. An employer who contravenes this by hiring unqualified persons to carry out nursing acts shall be guilty
of an offense and shall be liable on conviction to a fine not exceeding S$10,000 and, in the case of a second or subsequent conviction,
to a fine not exceeding S$20,000 or to imprisonment for a term not exceeding six months or to both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 95 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmacists
Registration Act 2007 of Singapore (the &ldquo;Pharmacists Registration Act&rdquo;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a person did not obtain the required certifications and requirements by the Singapore Pharmacy Council in accordance with Section 22
of the Pharmacists Registration Act, to act validly as a pharmacist, he or she would be deemed as unauthorized to act as a pharmacist.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 28 of the Pharmacists Registration Act, an unauthorized person shall be guilty of an offense if the person (a) practices pharmacy;
(b) willfully and falsely pretends to be a duly qualified pharmacist; (c) practises pharmacy or any branch of pharmacy, under the style
or title of a pharmacist or under any name, title, addition or description implying that the person holds any diploma or degree in pharmacy
or in any branch of pharmacy; (d) takes or uses the name or title of pharmacist, pharmaceutical chemist, druggist, apothecary, or any
other word in any language having the same meaning or with similar intent; (e) takes or uses any name, title, sign, uniform, badge, or
any other addition or description implying, whether in itself or in the circumstances in which it is used, that the person is qualified
to practise as a pharmacist; or (f) advertises or holds himself or herself out as a pharmacist. In addition, Section 29 of the Pharmacists
Registration Act provides that where an offense is committed under Section 28 of the Pharmacists Registration Act by any unauthorized
person acting as an employee, an agent or a partner of another person, that other person shall also be guilty of an offense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
subsidiary, 1Healthservice Pte. Ltd., holds a pharmacy license issued by the Health Sciences Authority (the &ldquo;<B>HSA</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health
Products Act 2007 of Singapore (the &ldquo;Health Products Act&rdquo;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Health Products Act and the regulations thereunder regulate, <I>inter alia</I>, the manufacture, import, supply, presentation and advertisement
of health products, which include therapeutic products, medical devices and cosmetic products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Health Products Act, except in such cases as may be prescribed, a valid importer&rsquo;s license is required to import therapeutic
products and medical devices and a valid wholesaler&rsquo;s license is required to engage in the wholesale supply of therapeutic products
and medical devices. In addition, no person shall supply any therapeutic product or medical device to any other person unless such therapeutic
product or medical device has been registered in accordance with the provisions of the Health Products Act. Any person who contravenes
these provisions is guilty of an offense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
application for an importer&rsquo;s license or a wholesaler&rsquo;s license for a therapeutic product must be made to the HSA in the
prescribed form and manner. The Health Products (Therapeutic Products) Regulations 2016 stipulate certain requirements that must
be satisfied before such license may be issued to an applicant. An applicant of an importer&rsquo;s license or a wholesaler&rsquo;s license
must also be able to provide and maintain, or ensure the provision and maintenance of, such staff, premises, equipment and facilities
for the handling and storage of the therapeutic product as are necessary to prevent the deterioration of the therapeutic product while
it is in the applicant&rsquo;s ownership, possession or control. In addition, an applicant for an importer&rsquo;s license or a wholesaler&rsquo;s
license must be able to comply with the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme Guide
to Good Manufacturing Practice for Medicinal Products in relation to the manufacture of the therapeutic product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
license is required for the manufacture, importation or wholesale supply of cosmetic products in Singapore. However, the Health Products
(Cosmetic Products &ndash; ASEAN Cosmetic Directive) Regulations 2007 provides that prior notification to the HSA in the prescribed form
is required before a cosmetic product may be supplied in Singapore, unless the cosmetic product is supplied solely as a sample in connection
with any advertising, sponsorship or promotional activity, is supplied solely by the transfer of possession as a gift, is supplied
solely for testing or trial use in connection with any research or development of that product or is manufactured by or in accordance
with the specifications of a medical practitioner, and supplied solely by that medical practitioner for the use of patients under his
care. Any person who contravenes this provision is guilty of an offense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Health Products Act imposes various duties on importers, suppliers and registrants of health products. In particular, the Health Products
Act stipulates that where an importer, a supplier or a registrant of a health product becomes aware of any defect in the health product
or any adverse effect that has arisen or can arise from the use of the health product, such person has a duty to inform the HSA of the
defect or adverse effect within the prescribed time. Any person who fails to do so is guilty of an offense and shall be liable
on conviction to a fine not exceeding S$20,000 or to imprisonment for a term not exceeding 12 months or to both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation
4 of the Health Products (Licensing of Retail Pharmacies) Regulations 2016 stipulates that a person must not supply any specified
health product through telepharmacy services unless the person has a valid pharmacy license and has obtained the prior approval of the
HSA to provide telepharmacy services at or from the retail pharmacy specified in the pharmacy license and complies with the conditions
imposed by the HSA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 96 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medicines
Act 1975 of Singapore (the &ldquo;Medicines Act&rdquo;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pharmacy in Singapore holds a pharmacy license issued by the HSA and is subject to the provisions of the Medicines Act and any directions
or guidelines as may be given or issued from time to time by the HSA. The Medicines Act makes provisions with respect to medicinal products
and medical advertisements and matters connected therewith. It applies generally to medicinal products, including Chinese proprietary
medicines, but does not apply to therapeutic products, medical devices and cosmetic products, which are governed under the Health Products
Act. The Medicines Act stipulates, <I>inter alia</I>, that no person shall sell any medicinal product by way of wholesale dealing except
in accordance with a wholesale dealer&rsquo;s license. Any person who contravenes these provisions is guilty of an offense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the provisions of the Medicines Act, in determining whether to issue or refuse to issue a license, the HSA shall have regard to the
safety of medicinal products to which the application relates, the efficacy of medicinal products for the purposes for which it is proposed
to be administered, the quality of medicinal products and the provisions proposed for securing that the products as sold or supplied
will be of that quality and whether the grant of a product license for the medicinal products will be in the public interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Medicines Act, the person selling or supplying any medicinal product must adhere to regulations concerning labelling, marking
and display of distinctive marks on containers and packages of medicinal products. Further, persons who publish any medical advertisement
that refers to any skill or service relating to the treatment of any disease or condition, or directly or indirectly suggest that the
article advertised will prevent, alleviate or cure any disease or condition, shall be guilty of an offense under the Medicines Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Health Products (Licensing of Retail Pharmacies) Regulations 2016 (the &ldquo;<B>Licensing of Retail Pharmacies) Regulations</B>&rdquo;)
provides that a person must not supply by retail sale and specified health product, unless, <I>inter alia</I>, it holds a pharmacy
license and the supply of the specified health product is carried out at or from the retail pharmacy specified in the pharmacy license
by an in-store pharmaceutical officer or in the absence of that office, by a special mode with the prior approval of the HSA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
qualification requirements and application processes for registration of pharmacists and the regulation of the practice of pharmacy in
Singapore are governed by the Pharmacists Registration Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personal
Data Protection Act 2012 (the &ldquo;PDPA&rdquo;)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PDPA generally requires organizations to give notice and obtain consents prior to collection, use or disclosure of personal data (being
data, whether true or not, about an individual who can be identified from that data or other accessible information), and to provide
individuals with the right to access and correct their own personal data. Organizations have mandatory obligations to assess data breaches
that they suffer, and to notify the Personal Data Protection Commission (the &ldquo;<B>PDPC</B>&rdquo;) and the relevant individuals
where the data breach is of a certain severity. The PDPA also imposes various baseline obligations on organizations in connection with
permitted uses of, accountability for, the protection of, the retention of, and overseas transfers of, personal data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PDPA creates various offenses in connection with the improper use of personal data, certain methods of collecting personal data
and certain failures to comply with the requirements under the PDPA. These offenses may be applicable to organizations, their
officers and/or their employees. Offenders are liable on conviction to fines and/or imprisonment. The PDPA empowers the PDPC with significant
regulatory powers to ensure compliance with the PDPA, including powers to investigate, give directions and impose a financial penalty
of (i) 10% of the annual turnover in Singapore of the organization, in the case of a contravention on or after the date of commencement
of Section 24 of the Personal Data Protection (Amendment) Act 2020 by an organization whose annual turnover in Singapore exceeds
S$10 million or (ii) S$1 million in any other case. In addition, the PDPA created a right of private action, pursuant to which the Singapore
courts may grant damages, injunctions and relief by way of declaration, to persons who suffer loss or damages directly as a result of
contraventions of certain requirements under the PDPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<!-- Field: Page; Sequence: 97 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="agh_013"></A>Management</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
and Executive Officers</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding our directors,  executive officers and key personnel
upon the SEC&rsquo;s declaration of effectiveness of our registration statement on Form F-1, of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 52%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position/Title</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><B>Directors and Executive Officers</B></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siaw
    Tung Yeng</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Chief
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Officer/Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Teoh Pui Pui</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Chief
    Executive Officer/Chief Operating Officer/Chairwoman of the Board/Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lai
    Kuan Loong Victor</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
Director </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lun
    Kwok Chan</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
Director </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gabe
    Rijpma</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
Director </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peng Chee Yong</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><B>Key Personnel</B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Rex Chin Chien Howh</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">35</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Financial Controller</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law
Pei Bei</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Business Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Nathan Siaw Seng Taat</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">29</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Medical Officer</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Felicia
Chan Siew Siew</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Technology Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Siaw
Tung Yeng</B>, our co-founder and director, has served as the Co-Chief Executive Officer since our inception in 2016. Dr. Siaw
has more than 30 years of professional experience in healthcare and medical informatics, and has been a senior consultant in family medicine
since 2004. Dr. Siaw has also been complementing his work as a physician with IT knowledge for over 20 years. Prior to founding the Company,
Dr. Siaw served as chief information officer, chairman of medical audit subcommittee and regional medical director of Healthway Medical
Group from 2000 to 2004. Healthway Medical Group has one of the largest networks of clinics and medical centers in Singapore, operating
more than 100 clinics and medical centers. From 2004 to 2020, Dr. Siaw served as a director overseeing the operation of United Vision
Holdings Pte Ltd, which owns several family medicine clinics across Singapore. During the same period, Dr. Siaw also served as a senior
consultant family physician of Healthmark Family Medicine Clinic managed by United Vision Holdings Pte Ltd, where he was in charge of
delivering comprehensive, continuing and holistic care of all patients in the context of family practice. From 2006 to 2021,
Dr. Siaw had been a medical director at Gloco Pte Limited Singapore, which provides health IT services since 2006. Since 2013,
Dr. Siaw has been an examiner for Graduate Diploma in Family Medicine. He was also a clinical lecturer (Family Medicine) for Yong Loo
Lin School of Medicine, National University of Singapore from 2013 to 2020. Dr. Siaw graduated from the National University of Singapore
with a Bachelor of Medicine, Bachelor of Surgery degree in 1991 and a Master of Medicine degree in 1995. He was also awarded fellowship
at the College of Family Physician in 2000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
Dr. Siaw also serves as a member of Singapore Medical Council&rsquo;s Complaints Panel, a member of Singapore Medical Council&rsquo;s
Disciplinary Committee, a senior consultant family physician of HealthLight Family Medicine Clinic, an examiner in Graduate Diploma in
Family Medicine examination, and an advisor of Singapore Family Medicine Continuing Medical Education.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Teoh Pui Pui</B>,
our co-founder, director and Chairwoman of the Board, has been our Co-Chief Executive Officer and Chief Operating Officer since
2019 and is primarily responsible for developing and implementing business strategies, managing relationships with key stakeholders and
overseeing the day-to-day operations of the organization. Dr. Teoh is also our medical doctor in charge of medical diagnosis and treatment.
Dr. Teoh also serves as the director of EC Family Clinic and the director of Punggol Ripples Family Clinic in Singapore. In these roles,
Dr. Teoh is primarily responsible for the management of the clinics, overseeing the clinics&rsquo; strategic objectives, policies
and overall directions. From 2004 to 2007, Dr. Teoh served as an instructor in Advance Trauma Life Support. From 2003 to 2007, Dr.
Teoh served as the surgical resident (general surgery and hand surgery) of National Healthcare Group, which is a leader in public healthcare
in Singapore and recognized for the quality of its medical expertise and facilities. Dr. Teoh was a member of the American Academy of
Family Physicians from 2013 to 2017 and an academy member of International Master Course on Aging Science Asia from 2016 to 2017. She
currently serves as an associate of American Aesthetic Association, a member of American Society for Laser Medicine and Surgery, Inc,
and a member of American Academy of Aesthetic Medicine. Dr. Teoh graduated with a Bachelor of Medicine, Bachelor of Surgery degree from
National University of Singapore in 2002, a Post Graduate Diploma in Practical Dermatology from Cardiff University, UK in 2010, a Post
Graduate Diploma in Family Medicine from National University of Singapore in 2011, and a Post Graduate Diploma in Aesthetic Medicine
from American Academy of Aesthetic Medicine in 2016. She also holds various certificates, including the Certificate of Accreditation
Family Physician awarded by the Ministry of Health of Singapore, the Certificate of Registration Family Physician awarded by the Singapore
Medical Council, as well as Certificate in Aesthetic Medicine and Certificate in Mesotherapy awarded by the American Academy of Aesthetic
Medicine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 98 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lai
Kuan Loong Victor</B> will begin serving as our independent director immediately upon the SEC&rsquo;s declaration of effectiveness of
our registration statement on Form F-1, of which this prospectus forms a part. Mr. Lai will serve as the chairman of the audit committee
and as a member of the compensation and nominations committees. Mr. Lai has over 20 years of professional and management experience with
a focus on corporate advisory in the capital markets sector. He is currently the principal consultant at CitadelCorp Pte Ltd since 2020,
where he advises clients on corporate transactions and governance matters. Mr. Lai started his career at PricewaterhouseCoopers in 2002,
and his last position there was Director in 2014. During his tenure, he covered both audit and advisory engagements. From 2015 to 2019,
he was the Regional Managing Director at Boardroom Limited, where he advised clients on corporate governance, compliance with listing
rules, and various listing and de-listing transactions. At present, he also serves as an independent director and chairman of the board
at Astaka Holdings Limited, a SGX-listed property development and management company, since 2019, and as an independent director at Universal
Terminal(s) Pte Ltd, a company providing fuel storage services, since 2020. Since 2021, he has been an external adviser at Bain &amp;
Company, where he is engaged by Bain&rsquo;s clients to advise on commercial and regulatory due diligence matters, and a member of the
Audit Committee of the Research Entities of Agency for Science, Technology and Research (A*STAR), a statutory board under the Ministry
of Trade and Industry of Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Lai obtained his bachelor of accountancy with honors from Nanyang Technological University and was qualified as a Chartered Accountant
(Practising) by the Institute of Singapore Chartered Accountants in 2002. He obtained his Public Accountant qualification in 2014 from
the Accounting &amp; Corporate Regulatory Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lun
Kwok Chan</B> will begin serving as our independent director immediately upon the SEC&rsquo;s declaration of effectiveness of our registration
statement on Form F-1, of which this prospectus forms a part. Dr. Lun will serve as the chairman of the nominations committee and as
a member of the audit and compensation committees. Dr. Lun has more than 40 years of professional experience in medical science and informatics.
He founded and is currently the chief executive officer of Gateway Consulting Pte Ltd, since 2006 a company specializing in professional
training in the areas of biostatistics and health informatics. He began his career as a lecturer at the Faculty of Science, National
University of Singapore (&ldquo;NUS&rdquo;) in 1974, and left NUS as an associate professor in 2001. From 2007 to 2008, he briefly taught
at Duke-NUS Graduate Medical School. From 2001 to 2010, Dr. Lun held various positions at Nanyang Technology University, including serving
as the adjunct professor and vice dean of the School of Biological Science. He was the professorial fellow at the Department of Information
Systems, NUS when he retired in 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Lun obtained his bachelor of science degree from the University of Singapore in 2017, his Ph.D. degree from the University of Birmingham
in 1971, and his master of science degree from the University of London in 1980. He has been appointed as the course director of 10x10
International Course on Health Informatics, in collaboration with Oregon Health and Science University, USA since 2022, and has been
serving on the editorial board of the Journal of Experimental and Clinical Medicine since 2009.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gabe
Rijpma</B> will begin serving as our independent director immediately upon the SEC&rsquo;s declaration of effectiveness of our registration
statement on Form F-1, of which this prospectus forms a part. Mr. Rijpma will serve as the chairman of the compensation committee and
as a member of the audit and nominations committees. Mr. Rijpma is currently the chief executive officer and director of Aceso Health,
a company delivering platform solutions for the healthcare industry aimed at enhancing the experience of care for both patients and healthcare
providers. From 2006 to 2019, he held various positions at Microsoft across multiple geographies including Australia, the United States,
and Singapore. His most recent role there was the senior director of Health &amp; Social Services for Asia, where he led his team to
scale up an emerging health business rapidly. Mr. Rijpma received his education in Business Computing from the Christchurch Institute
of Technology from 1992 to 1994. He is also a fellow of the Australasian Institute of Digital Health and a founding fellow of Health
Informatics New Zealand.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 99 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Peng
Chee Yong </B>joined our Company in 2022 and is currently our Chief Financial Officer overseeing key financial aspects including
management of a finance team to set up our financial reporting system, supporting senior management in developing plans for
financial growth, financial reporting, forecasting and budgeting, compliance with applicable accounting and legal requirements, as
well as tax matters. Mr. Peng was the assistant manager at KPMG from 2009 to 2013, and audit supervisor at Baker Tilly from 2013 to
2015. From 2015 to 2018, he served as the audit and investment manager at ISOTeam Ltd., a SGX-listed leading facilities maintenance
specialist for the public sector company. From 2018 to 2021, he was the IPO consultant at Pinedex Pte. Ltd., a consultancy company,
where his main duties concentrated on pre-IPO assessments and financial matters such as coordinating internal and external audits,
and preparing profit and working capital forecasts. Immediately prior to joining our Company, Mr. Peng was the chief financial
officer of IAG Holdings Limited, a HKEX-listed company specializing in medical devices manufacturing, where his duties primarily
included overseeing and ensuring compliance with the regulatory requirements of HKEX in financial reporting, accounting, tax, and
internal controls. Mr. Peng earned his Bachelor of Accountancy degree from Northern University of Malaysia and graduated with first
class honors. He has been qualified as a CPA in Australia since 2012, and as a Chartered Accountant in Singapore since
2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rex
Chin Chien Howh</B> has served as our financial controller since 2022 and is primarily responsible for the management of cashflow and
financial statements, including reviewing of all the subsidiaries&rsquo; daily, weekly and monthly financial statements close process
controls to ensure all financial statements presented are in accordance with IFRS and US GAAP. He also supported the senior management
in overseeing the monthly financial performance and setting KPIs for each business unit to ensure their business performance and future
business planning. Prior to joining our Company, since 2021, Mr. Chin was a project cost controller in UEM Sunrise Bhd, a leading property
developer in Malaysia, where he managed tax and financial operations, including the review and approval of payments, the preparation
of revenue analysis and annual budget, as well as the assessment of the company&rsquo;s tax position. From 2018 to 2019, Mr. Chin was
a finance manager in the Johor division of another leading Malaysian property developer, IOI Properties Bhd, overseeing financial reporting,
cash flow forecasts, annual budget as well as daily financial and tax operations. From 2013 to 2017, Mr. Chin worked in Ernst &amp; Yong
in Malaysia and held various positions including audit associate and audit assistant manager, where he engaged in the audits of listed
companies and multinational corporations across various industries. He obtained his Diploma in Accounting from the Southern College University,
Malaysia in 2009, his Bachelor&rsquo;s Degree in Accounting and Finance from the University of Wales, UK in 2012, and became a fellow
member at the Association of Chartered Certified Accountants in 2016.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Law
Pei Bei</B> has served as our Chief Business Officer since 2022. Ms. Law is primarily in charge of the coordination of
departments, supporting senior management in developing plans for business growth, and business development activities. Prior to
assuming her role as our Chief Business Officer, Ms. Law served as the marketing executive of DMG &amp; Partners Securities
Pte Ltd from 2012 to 2014 and the asset management &amp; operations executive of IHC Medical Assets Pte Ltd from 2014 to 2016. From
2017 to 2022, she served as the head of business development &amp; operations of Sano Pain Care Group, a pain care specialist
offering drugless therapies in Malaysia since 2008, where her main duties included managing the healthcare business
chain, expanding business scale, identifying areas of growth, and developing strategic partnerships with key stakeholders. From 2019
to 2022, she was the co-founder and head of business development &amp; operations of Moss Motion, a design studio creating
contents and experiences for brands to help them achieving business goals, primarily responsible for identifying new business
opportunities, overseeing day-to-day operations, and maintaining relationships with clients and partners. She earned her Bachelor of Business Management &amp; Law degree from Aomori Chuo Gakuin University in Japan in 2012,
and earned her MBA degree from University of Cardiff Metropolitan in the UK in 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nathan
Siaw Seng Taat </B>has joined us since 2022 as Deputy Medical Officer and is now serving as our Chief Medical Officer, overseeing the
recruitment and supervision of medical staff, the compliance of medical staff with Company policies and agenda, the development and approval
of medical-related policies and procedures, as well as the training and promotion of subordinate staff under medical directors. Prior
to assuming his role as Chief Medical Officer, he was an ophthalmology medical practitioner with Tan Tock Seng Hospital, Changi General
Hospital, Singapore National Eye Centre and National University Hospital, and a medical officer with Singapore General Hospital and Changi
General Hospital, where he was responsible for the care of patients from the emergency department to the general wards. From 2020 to
2022, Dr. Siaw was also a Singapore Armed Forces Medical Officer, where he was responsible for the daily operations of the medical center,
the training and education of the medics in his camp, as well as patient care. He was also appointed as the medical officer in charge
of the army care facility during the COVID-19 pandemic, and together with the task force, crafted policies and directives related to
the medical care of local and overseas soldiers. He obtained his Bachelor of Medicine, Bachelor of Surgery degree from National University
of Singapore in 2018, and was awarded Singapore Health Quality Service Award by the Singapore National Eye Center and Singapore Health
Services group in 2021.&#8239;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Felicia
Chan Siew Siew </B> has served as our Chief Technology Officer since 2017 and is primarily responsible for leading projects, developing
and delivering computer programs, system software and network solutions to internal and external customers. Before joining Mobile-health,
Ms. Chan worked as the assistant manager and analyst programmer in Gloco Malaysia Sdn Bhd, a leading healthcare IT system provider in
Malaysia since 1997, from 2008 to 2014. From 2014 to 2017, she served as the co-technical lead and senior software developer in Manulife
Technology and Services Sdn Bhd, a company providing software development services to members of Manulife group which is a leading financial
services provider worldwide, where she provided advice and proposed solutions to resolve technical problems, as well as developed or
enhanced new and existing technological features and infrastructures while working closely with business analysts&rsquo; team. Ms. Chan
graduated with first class honors from University Tun Abdul Razak with a Bachelor&rsquo;s Degree in Computer Science/Information
Technology in 2007.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
of Directors</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board will consist of 5 directors upon the SEC&rsquo;s declaration of effectiveness of our registration statement on Form F-1, of which
this prospectus forms a part. A director is not required to hold any shares in our Company to qualify to serve as a director. A director
who is in any way, whether directly or indirectly, interested in a contract or transaction or proposed contract with our Company is required
to declare the nature of his or her interest at a meeting of our directors. A general notice given to the directors by any director to
the effect that he is a shareholder of any specified company or firm and is to be regarded as interested in any contract or transaction
with that company or firm shall be deemed a sufficient declaration of interest with regard to any contract so made or transaction
so consummated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to any separate requirement for audit committee approval under applicable law or the Listing Rules of the Nasdaq Stock Market and disqualification
by the chairman of the relevant board meeting, a director may not vote in respect of any contract or transaction or proposed
contract, that he or she may be interested therein, but he or she may be counted in the quorum at any meeting of
the directors at which any such contract or transaction or proposed contract shall come before the meeting for consideration.
Our Board may exercise all of the powers of our Company to raise or borrow money and to mortgage or charge its
undertaking, property and assets (present and future) and uncalled capital, or any part thereof, and to issue debentures, debenture
stock, bonds and other securities, whether outright or as collateral security for any debt, liability or obligation of
our Company or of any third-party. None of our directors has a service contract with us that provides for benefits upon termination
of service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 100 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a Cayman Islands company listed on the Nasdaq Capital Market, we are a foreign private issuer and are permitted to follow the home country
practice with respect to certain corporate governance matters rather than complying with Nasdaq corporate governance standards. Cayman
Islands law does not require a majority of a publicly traded company&rsquo;s board of directors to be comprised of independent directors.
However, to enhance our corporate governance, we elect to follow Nasdaq corporate governance standards in having a majority
of our board comprised of independent directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committees
of the Board</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the effectiveness</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> of this offering, we intend to
establish an audit committee, a compensation committee and a nominations committee under the Board. We intend to adopt a charter for each of the three committees prior to the completion of this offering. Each committee&rsquo;s members and functions are described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audit
Committee</I></B>. Our audit committee will consist of Lai Kuan Loong Victor, Lun Kwok Chan and Gabe Rijpma, and will be
chaired by Lai Kuan Loong Victor. Our Board has determined that each such member satisfies the &ldquo;independence&rdquo; requirements
of Rule 5605(a)(2) of the Listing Rules of the Nasdaq Stock Market and meet the independence standards under Rule 10A-3 under the Exchange
Act. Our audit committee will consist solely of independent directors that satisfy the Nasdaq Capital Market and SEC requirements within
one year of the completion of this offering. Our Board has also determined that Lai Kuan Loong Victor qualifies as an &ldquo;audit
committee financial expert&rdquo; within the meaning of the SEC rules and possesses financial sophistication within the meaning of the
Listing Rules of the Nasdaq Stock Market. The audit committee will oversee our accounting and financial reporting processes and the audits
of the financial statements of our Company. The audit committee will be responsible for, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">selecting
                                            our independent registered public accounting firm and pre-approving all auditing and non-auditing
                                            services permitted to be performed by our independent registered public accounting firm;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            with our independent registered public accounting firm any audit problems or difficulties
                                            and management&rsquo;s response and approving all proposed related party transactions, as
                                            defined in Item 404 of Regulation S-K;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing
                                            the annual audited financial statements with management and our independent registered public
                                            accounting firm;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">periodically
                                            reviewing and reassessing the adequacy of our audit committee charter;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">meeting
                                            periodically with the management and our internal auditor and our independent registered
                                            public accounting firm;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reporting
                                            regularly to the full Board;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            the adequacy and effectiveness of our accounting and integral control policies and procedures
                                            and any steps taken to monitor and control major financial risk exposure; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            other matters that are specifically delegated to our audit committee by our Board from time
                                            to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 101 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Committee</I></B>. Our compensation committee will consist of Gabe Rijpma, Lai Kuan Loong Victor and Lun Kwok Chan, and will be chaired
by Gabe Rijpma. Our Board has determined that each such member satisfies the &ldquo;independence&rdquo; requirements of Rule 5605(a)(2)
of the Listing Rules of the Nasdaq Stock Market. Our compensation committee will assist the Board in reviewing and approving the compensation
structure, including all forms of compensation, relating to our directors and executive officers. Our chief executive officer may not
be present at any committee meeting during which his compensation is deliberated upon. The compensation committee will be responsible
for, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving to the Board with respect to the total compensation package for our chief executive
                                            officer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            the total compensation package for our employees and recommending any proposed changes to
                                            our management;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and recommending to the Board with respect to the compensation of our directors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            annually and administering all long-term incentive compensation or equity plans, programs
                                            or similar arrangements, annual bonuses, employee pension and welfare benefit plans; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">selecting
and receiving advice from compensation consultants, legal counsel or other advisors after taking into consideration all factors relevant
to that person&rsquo;s independence from management</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nominations
Committee</I></B>. Our nominations committee will consist of Lun Kwok Chan, Lai Kuan Loong Victo and Gabe Rijpma, and will be
chaired by Lun Kwok Chan. Our Board has determined that each such member satisfies the &ldquo;independence&rdquo; requirements
of Rule 5605(a)(2) of the Listing Rules of the Nasdaq Stock Market. The nominations committee will assist the Board in selecting individuals
qualified to become our directors and in determining the composition of the Board and its committees. The nominations committee will
be responsible for, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying
                                            and recommending nominees for election or re-election to our Board or for appointment to
                                            fill any vacancy;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            annually with our Board its current composition in light of the characteristics of independence,
                                            age, skills, experience and availability of service to us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">advising
                                            the Board periodically with respect to significant developments in the law and practice of
                                            corporate governance as well as our compliance with applicable laws and regulations, and
                                            making recommendations to our Board on all matters of corporate governance and on any corrective
                                            action to be taken; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
                                            compliance with our code of business conduct and ethics, including reviewing the adequacy
                                            and effectiveness of our procedures to ensure proper compliance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Advisers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
appointed three advisers in December 2023 to advise our Board and Co-Chief Executive Officers with respect to business strategic and
expansion opportunities. Below presents the information about our three advisers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fan
Min</B> is the co-founder of Ctrip.com International Limited, a Nasdaq-listed travel service provider in China. He has served
as Ctrip&rsquo;s president since 2009 and the vice chairman of its board since 2013. From 2006 to 2013, he was also Ctrip&rsquo;s chief
executive officer. He was awarded the Top 10 Great Leaders Award of the Year on the 2010 APEC China SME Value List, and 2008 EY Entrepreneur
of the Year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ling
Tiung Leng</B> has more than 25 years of developing businesses in various industries, such as the distribution channels, security manpower,
construction, food &amp; beverage, sports, and IT industry. He currently serves as the President of the ASEAN-China Entrepreneurs Association.
In 2012, he was awarded the D.I.M.P., the Knight Companion of the Order of the Crown of Pahang, by the Sultan of Pahang.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gregory
Leong Goh Han</B> currently serves as the executive chairman of Goldplus Universal Pte Ltd, a regional pharmaceutical sales, marketing
and distribution company with offices in Singapore, Myanmar and Brunei. He is also the founding partner of Shenton Family Medical Clinics
in Singapore, and has been involved with the Economic Development Board of Singapore as a SEEDS investor with experience in helping guiding
start-up companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duties
of Directors</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Cayman Islands law, our directors owe fiduciary duties to our Company, including a duty of loyalty, a duty to act honestly, and
a duty to act in what they consider in good faith to be in our best interests. Our directors must also exercise their powers only for
a proper purpose. Our directors also owe to our Company a duty to act with skill and care. It was previously considered that a
director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of
his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard to the required
skill and care and these authorities are likely to be followed in the Cayman Islands. In fulfilling their duty of care to us, our directors
must ensure compliance with our memorandum and articles of association, as amended and restated from time to time. Our Company
has the right to seek damages if a duty owed by our directors is breached. In limited exceptional circumstances, a shareholder may have
the right to seek damages in our name if a duty owed by our directors is breached.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functions and powers of our Board include, among others:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">convening
                                            shareholders&rsquo; annual general meetings and reporting its work to shareholders at such
                                            meetings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">declaring
                                            dividends and distributions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 102 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing
                                            officers and determining the term of office of officers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exercising
                                            the borrowing powers of our Company and mortgaging the property of our Company;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
                                            the transfer of shares of our Company, including the registering of such shares in
                                            our share register.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Terms
of Directors and Executive Officers</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our directors holds office until the expiration of his or her term, as may be provided in a written agreement with our Company,
and his or her successor has been elected and qualified, until his or her resignation or until his or her office is otherwise vacated
in accordance with our articles of association. At each annual general meeting, one-third of the Directors for the time being
shall retire from office by rotation. However, if the number of Directors is not a multiple of three, then the number nearest to but
not less than one-third shall be the number of retiring Directors. A retiring director shall be eligible for re-election. All of our
executive officers are appointed by and serve at the discretion of our Board. Our directors may be appointed or removed from office by
an ordinary resolution of shareholders. A director will be removed from office automatically if, among other things, the director (i)
resigns; (ii) dies; (iii) is declared to be of unsound mind and the Board resolves that his office be vacated; (iv) becomes bankrupt
or has a receiving order made against him or suspends payment or compounds with his creditors generally; (v) is prohibited from being
or ceases to be a director by operation of law;(vi) without special leave, is absent from meetings of the Board for three consecutive
meetings, and the Board resolves that his office is vacated; (vii) has been required by the Nasdaq Capital Market to cease to be a Director;
(viii) or is removed from office by the requisite majority of the Directors or otherwise pursuant to our amended and restated memorandum
and articles of association then in effect. The compensation of our directors is determined by the Board. There is no mandatory retirement
age for directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
Agreements and Indemnification Agreements</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into employment agreements through the Company and MaNaDr Pte. Ltd. with our directors and executive officers.
Each of them is employed for a continuous term, or a specified time period which will be automatically extended, unless either
we or the director and executive officer gives prior notice to terminate such employment. We may terminate the employment for
cause, at any time, without notice or compensation, for certain acts of the director or executive officer, including but not limited
to the commitments of any breach of the provisions of the employment agreements, refusal to perform duties assigned or disobedience of
a lawful and reasonable order, unlawful misconduct such as commission of fraud or embezzlement or a crime involving moral turpitude,
or consistent willful misconduct or negligence. A director or an executive officer may terminate his or her employment at any
time with a one- or three-month prior written notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
director and executive officer has agreed to hold, both during and after the employment agreement expires or is earlier terminated, in
strict confidence and not to use, disclose, divulge to any other person or entity without our written consent, any confidential
information of the Group (including in particular lists or details of customers of the Group) relating to the working of any process,
technology, invention or methods carried on or used by the Group or in respect of which the Group is bound by an obligation of confidence
to a third party, or any financial or trading information or trade secrets relating to the Group, or any information which the director
or executive officer might receive or obtain in relation to the Group&rsquo;s business (including, without limitation, the Group&rsquo;s finances,
customers, clients or suppliers), which for the time being is confidential, proprietary or generally not available to the public.
Each director and executive officer has also agreed that all notes, memoranda, records and writing made by him or her relating to
the business of the Group shall be and remain the property of the Group, and shall be delivered by him or her to the Group upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, all directors and executive officers have agreed to be bound by non-competition and non-solicitation restrictions, according
to which the directors and executive officers shall not, during the term of his or her employment and for a period of one year or
two years thereafter, (i) directly or indirectly engage in any business or activity which is substantially similar to those which
he or she engaged in for the Company, if such activity is in competition with the Company; (ii) directly or indirectly, recruit or seek
to hire any other employee of the Company who are still actively employed by or doing business with the Company; and (iii) directly or
indirectly, solicit, attempt to solicit, or assist others to solicit any of the Company&rsquo;s clients and customers with whom the director
or executive officer had material contact during the term of employment. Each director and executive officer has agreed to devote a reasonable
amount of his or her productive time, ability and attention to our business during the term of the employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 103 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to enter into indemnification agreements with our directors and executive officers, pursuant to which we will agree to indemnify
our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made
by reason of their being such a director or executive officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Governance Practice</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &ldquo;foreign private issuer&rdquo; as defined under the applicable U.S. federal securities laws. The Nasdaq corporate governance
requirements include certain accommodations that allow foreign private issuers to follow &ldquo;home country&rdquo; corporate governance
practices in lieu of the Nasdaq requirements. The application of such exemptions requires that we disclose each Nasdaq corporate governance
rules that we do not follow and describe the Cayman Islands corporate governance practices we do follow. We currently follow Cayman
Islands corporate governance practices in lieu of the Nasdaq corporate governance requirements in respect of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 0.25in; vertical-align: top">&#9679;</TD>
    <TD STYLE="text-align: justify">the requirement under Section 5605(b)(2) of the Nasdaq listing rules that the independent directors have regularly scheduled
    meetings with only the independent directors present.&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to enhance our corporate governance, we elect to
follow Nasdaq corporate governance standards in having a majority of our board comprised of independent directors, and having our nominations and compensation committees to be composed
entirely of independent directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
of Conduct and Code of Ethics</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will adopt a written code of business conduct and ethics that applies to our directors, officers and employees, including our chief executive
officer, chief financial officer, principal accounting officer or controller or persons performing similar functions. We intend to disclose
any amendments to the code of ethics, and any waivers of the code of ethics or the code of conduct for our directors, executive officers
and senior finance executives, on our website to the extent required by applicable U.S. federal securities laws and the corporate governance
rules of the Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
of Directors and Executive Officers</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the year ended June 30, 2022, we had paid an aggregate of S$30,000 (US$22,500) in cash
to our executive directors and S$2,500 (US$1,900) in cash to our non-executive directors. We have not set aside
or accrued any amount to provide pension, retirement or other similar benefits to our directors and executive officers. Our Singapore
subsidiaries are required by law to make contributions equal to certain percentages of each employee&rsquo;s salary for his or her pension
insurance, medical insurance, unemployment insurance and other statutory benefits and a housing provident fund.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as disclosed above, none of our directors has entered into a service agreement with our Company or any of our subsidiaries that
provides for benefits upon termination of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023
Employee Incentive Plan</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2023, we adopted the Employee Incentive Plan, or the Plan, to provide a wealth creation opportunity for the employees, advisors,
consultants and directors in line with value creation for the Company, drive retention of employees, advisors, consultants and directors
for their continued association with the Company, and motivate employees, advisors, consultants and directors by rewarding high performance.
Under the Plan, the maximum aggregate number of Shares which may be issued pursuant to all awards (including incentive share options)
is 10% of the total issued Class A Ordinary Shares of our Company from time to time. On August 1, 2023, we granted options to purchase
a total of 3,738 Class A Ordinary Shares of a nominal or par value of US$0.001 each to our Chief Financial Officer, certain key
personnel and employees at the price of US$1.0 per share. On December 18, 2023, at the same price per share, we further granted options
to purchase a total of 701 Class A Ordinary Shares of a nominal or par value of US$0.001 each to three of our employees. On February 13, 2024, the Company issued 4,439 Class A Ordinary Shares of a nominal or par value of US$0.001 each to the holders of the options, pursuant to the provisions of the Plan.
On February 14, 2024, the issued 4,439 Class A Ordinary Shares of a nominal or par value of US$0.001 each were divided into 1,109,750
Class A Ordinary Shares of a nominal or par value of US$0.000004 each. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following paragraphs summarize the key terms of the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Administration
of the Plan</I>. The Plan will be administered by the Employee Incentive Plan Committee of the Company (the &ldquo;Committee&rdquo;)
in its sole and absolute discretion with such powers and duties as are conferred on it by the Board from time to time. The Committee
shall have the power, from time to time, to make and vary such regulations for the implementation and administration of this Plan as
it in its absolute discretion deems fit. Any matter pertaining or pursuant to the Plan and any dispute as to the interpretation of the
Plan or any rule, regulation, procedure thereunder or as to any rights under the Plan, shall be determined by the Committee and such
decision shall be final and binding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 104 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration
of the Plan</I>. The Plan may be terminated at any time by the Committee or, at the discretion of the Committee, by ordinary resolution
of the Company, and if the Plan is so terminated, no further Options shall be offered hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eligibility</I>.
The Committee shall in its sole and absolute discretion determine if a person is eligible to participate in the Plan, taking into consideration,
among other things, role, seniority, length of service, performance history and potential contribution to the Company and/or any of its
subsidiaries, and such person shall at least be a confirmed employee of the Company and/or any of its subsidiaries, or an advisor,
consultant or director of the Company and/or any of its subsidiaries, and who have attained the age of 21 years (the &ldquo;Participant&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Grant
of Options. </I>An Option may be granted at any time as may be determined by the Committee in its sole and absolute discretion and may
be granted subject to such conditions as may be determined by the Committee in its absolute discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Subscription
Price.</I> The subscription price payable for each Option Share in respect of which an Option is exercisable (the &ldquo;Subscription
Price&rdquo;) shall be determined by the Committee from time to time, provided that in no event shall the subscription price per Option
Share be less than the par value of such Option Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Option
period and vesting schedule.</I> Options shall be exercisable only after vesting. Subject to the occurrence of certain events, the lapsing
or the expiry of options as detailed in the Plan, the Options shall be exercisable in whole or in part, before the expiry of 10 years
from the date of grant of the Option, or such other date as may be determined by the Committee. In the event the following occurs: (i)
an initial public offering and listing of shares of the Company or a direct listing of shares of the Company (a &ldquo;Listing&rdquo;);
or (ii) a change of control in the shares of the Company, (in the case of a Listing, subject to the provisions of the Plan) the Options
granted to such Participants shall immediately vest and the Committee will, as soon as practicable and prior to the completion of such
event, procure the allotment or transfer to each Participant of the relevant number of Option Shares. In the event of a Listing, subject
to applicable law, the Articles of Association of the Company and the rules of the relevant securities exchange: the Participant (a)
shall not, prior to the Listing, transfer any Option Shares without the prior written consent of the Committee; (b) shall not, prior
to the Listing, transfer any Option Shares without first offering such Option Shares to the Company at a price and on terms no less favorable
than those offered to a third party purchaser whose identity shall be disclosed to the Committee; (c) shall agree to be bound by any
applicable lock-up restrictions and/or moratorium requirements under applicable law and the rules of the relevant securities exchange,
or as otherwise requested by the Committee, for the relevant lock-up period; and (d) may, following the Listing, transfer any Option
Shares held by such Participant at any time, subject to compliance with the Company&rsquo;s Articles of Association.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercise
of Options</I>. An Option may be exercised, in whole or in part, by a Participant giving notice in writing to the Company in or substantially
in the form set out in the Plan, subject to modifications as the Committee may from time to time determine, accompanied by (i) a remittance
for the full amount of the aggregate Subscription Price payable in respect of all the Option Shares to be subscribed
for upon exercise of the Option to the bank account of the Company, and (ii) any other documentation which the Committee may require
in connection with an exercise of the Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transfer
Restrictions</I>. An Option shall be personal to the Participant to whom it is granted and, prior to the allotment and/or transfer
to the Participant of the Option Shares to which the Option relates, shall not be transferred (other than to a Participant&rsquo;s personal
representative on the death of that Participant), charged, assigned, pledged or otherwise disposed of, in whole or in part, except with
the prior approval of the Committee. If a Participant shall do, suffer or permit any such act or thing as a result of which he would
or might be deprived of any rights under an Option without the prior approval of the Committee, that Option shall immediately lapse.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as noted above, we did not, and will not, issue any other stock options or Class A Ordinary Share grants prior to this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 105 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A NAME="loi_001"></A><B>Principal
Shareholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning the beneficial ownership of our Ordinary Shares as of the date of this prospectus by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            of our directors, director appointees and executive officers; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            person known to us to beneficially own more than 5% of our Class A or Class B Ordinary Shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined in accordance with the rules and regulations of the SEC. In computing the number of shares beneficially owned
by a person and the percentage ownership of that person, we have included shares that the person has the right to acquire within 60 days,
including through the exercise of any option, warrant, or other right or the conversion of any other security. These shares, however,
are not included in the computation of the percentage ownership of any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares Beneficially Owned As of the Date of this Prospectus</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%
    of Aggregate Voting Power As of the Date of this Prospectus <SUP>&dagger;</SUP></B></FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    B Ordinary Shares</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Executive Officers</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siaw
    Tung Yeng</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">787,625</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,046,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Teoh
Pui Pui</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">3,176,250</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">16.1</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">1,610,000</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">13.7</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Lai Kuan Loong Victor</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Lun Kwok Chan</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Gabe Rijpma</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Peng Chee Yong</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">122,500</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">0.6</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">-</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">0.1</P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Directors and Executive Officers as a Group</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,086,375</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,656,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Shareholders</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siaw
    Tun Mine</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">3,019,500</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ng
    Jet Wei</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,012,500</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculations in the table below are based on 21,921,750 Class A Ordinary Shares and 12,078,250 Class B Ordinary Shares
issued and outstanding immediately after the completion of this offering, assuming the underwriter does not exercise their over-allotment
option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning the beneficial ownership of our Ordinary Shares immediately after the offering by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            of our directors and executive officers; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            person known to us to beneficially own more than 5% of our Class A or Class B Ordinary Shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares Beneficially Owned Immediately After the Offering</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
    of Aggregate Voting Power Immediately After the Offering</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    A Ordinary Shares &nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
    B Ordinary Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
    and Executive Officers</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siaw
    Tung Yeng</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%"><FONT STYLE="font-size: 10pt">787,625</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,046,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 10%"><FONT STYLE="font-size: 10pt">49.9</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Teoh
    Pui Pui</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,176,250</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">1,610,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">13.5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Lai Kuan Loong Victor</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Lun Kwok Chan</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Gabe Rijpma</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Peng Chee Yong</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">122,500</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">0.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">0.1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Directors and Executive Officers as a Group</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;4,086,375</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,656,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Shareholders</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siaw
    Tun Mine</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,019,500</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.0</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Ng Jet Wei</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-size: 10pt">2,012,500</FONT></P>
</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">9.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt">1.4</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, we did not have any Class A Ordinary Shares outstanding that were held by record holders in the United
States. None of our shareholders has informed us that it is affiliated with a registered broker-dealer or is in the business of underwriting
securities. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our Company.
See &ldquo;Description of Share Capital&mdash;History of Securities Issuances&rdquo; for a description of issuances of our securities
that have resulted in significant changes in ownership held by our major shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; font-family: Times New Roman, Times, Serif; width: 30%; margin-bottom: 0pt"><DIV STYLE="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>













<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
  each person included in this column, percentage of aggregate voting power represents voting power based on Class A and Class B Ordinary
  Shares held by such person with respect to all outstanding shares of our Class A and Class B Ordinary Shares as a single class. Each
  holder of our Class A Ordinary Shares is entitled to one vote per share. Each holder of our Class B Ordinary Shares is entitled to
  10 votes per share. Our Class B Ordinary Shares are convertible at any time by the holder into Class A Ordinary Shares on a one-for-one
  basis, while Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances.</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 106 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="loi_002"></A>Related
Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
Agreement</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;Description of Share Capital &mdash; History of Securities Issuances.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
Agreements and Indemnification Agreements</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;Management &mdash; Employment Agreements and Indemnification Agreements.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023
Employee Incentive Plan</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;Management &mdash; 2023 Employee Incentive Plan.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Related Party Transactions</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, we entered into a partnership agreement with five clinics, of which two clinics are jointly owned by our co-founders and
directors Siaw Tung Yeng and Teoh Pui Pui, and one clinic is 50% owned by Teoh Pui Pui (collectively, the &ldquo;Related Party
Clinics&rdquo;). Pursuant to such agreement, we offer our MaNaDr platform, including related IT, administration and accounting
services to the clinics, and the clinics provide teleconsultation, including related medication supply, delivery, and phlebotomists
services to us. For the years ended June 30, 2023, 2022 and 2021, the purchase of goods and services by us from the
Related Party Clinics amounted to US$0.1 million, US$0.9 million and US$0.2 million, and the sales of goods and
services by us to the Related Party Clinics amounted to US$0.4 million, US$0.5 million and US$0.4 million
respectively. See Note 11 to the consolidated financial statements for more details.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
obtain advances from our directors or shareholders for working capital purpose from time to time in the year ended June 30, 2023,
2022 and 2021. The advances are interest-free and repayable on demand. As of June 30, 2023, 2022 and 2021, we
had amount due to: (i) Siaw Tung Yeng of US$1.0 million,  US$1.0 million and US$6.2 million, respectively; and (ii) David
Cheong of US$0.1 million, US$0.1 million and US$0.1 million, respectively. In April 2022, Siaw Tung Yeng converted S$6.5 million (US$4.8
million) of the amount due to him into 11,631 of our Class A Ordinary Shares. See Note 11 to the consolidated financial statements
for more details.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employment of Related Person</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nathan Siaw Seng Taat,
our Chief Medical Officer, is the son of our co-founder and director Siaw Tung Yeng and has been employed by us since September,
2022. He received compensation of S$58,800 (approximately US$43,000) for the year ended June 30,
2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 107 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A NAME="loi_003"></A><B>Description
of Share Capital</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a Cayman Islands exempted company incorporated with limited liability and our affairs are governed by our memorandum and articles
of association, the Companies Act (2022 Revision) of the Cayman Islands, which we refer to as the Companies Act below, and the common
law of the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, our authorized share capital is US$50,000 divided into 12,500,000,000 shares of nominal or par
value of US$0.000004 each, comprising of (i) 6,250,000,000 Class A Ordinary Shares of nominal or par value of US$0.000004
each, (ii) 6,250,000,000 Class B Ordinary Shares of nominal or par value of US$0.000004 each.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,671,750
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Class A Ordinary Shares of nominal or par value
of US$0.000004 each and 12,078,250 Class B Ordinary Shares of nominal or par value of US$0.000004 each have been
issued. All of our issued and outstanding shares are fully paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Post-Offering Memorandum and Articles of Association </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shareholders have adopted an amended and restated memorandum and articles of association (adopted by special resolution dated 14 February
2024), which we refer to below as our post-offering memorandum and articles of association, and this memorandum and articles of association
is effective currently and shall remain in effect after the date of the Company&rsquo;s listing on the Nasdaq Capital Market.
The following are summaries of material provisions of the post-offering memorandum and articles of association and of the Companies Act,
insofar as they relate to the material terms of our Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Objects
of Our Company</I>. Under our post-offering memorandum and articles of association, the objects of our company are unrestricted and we
have the full power and authority to carry out any object not prohibited by the laws of the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Ordinary
Shares</I>. Our Ordinary Shares are divided into Class A Ordinary Shares and Class B Ordinary Shares. Holders of our Class A Ordinary
Shares and Class B Ordinary Shares will have the same rights except for voting and conversion rights. Each Class A Ordinary Share shall
entitle the holder thereof to one vote on all matters subject to vote at our general meetings and each Class B Ordinary Share shall entitle
the holder thereof to 10 votes on all matters subject to vote at our general meetings. Our Class A Ordinary Shares are issued
in registered form and are issued when registered in our register of members. We may not issue shares to bearer. Our shareholders who
are non-residents of the Cayman Islands may freely hold and vote their shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conversion.
</I>Class B Ordinary Shares may be converted into the same number of Class A Ordinary Shares at the option of the holders thereof at
any time, while Class A Ordinary Shares cannot be converted into Class B Ordinary Shares under any circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividends.
</I>The holders of our Class A Ordinary Shares are entitled to such dividends as may be declared by our Board or declared by our shareholders
by ordinary resolution (provided that no dividend may be declared by our shareholders which exceeds the amount recommended by our directors).
Our post-offering memorandum and articles of association provide that dividends may be declared and paid out of our profits, realized
or unrealized, or from any reserve set aside from profits which our Board determines is no longer needed. Under the laws of the
Cayman Islands, our company may pay a dividend out of either profit or share premium account, provided that in no circumstances may a
dividend be paid if this would result in our company being unable to pay its debts as they fall due in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting
Rights. </I>Holders of Class A Ordinary Shares and Class B Ordinary Shares shall, at all times, vote together as one class on all matters
submitted to a vote by the members at any general meeting of the Company. Each Class A Ordinary Share shall be entitled to one vote and
each Class B Ordinary Share shall be entitled to 10 votes on all matters subject to the vote at general meetings of our Company. Voting
at any meeting of shareholders is by show of hands unless a poll (before or on the declaration of the result of the show of hands) is
demanded. A poll may be demanded by the chairperson of such meeting or any one shareholder present in person or by proxy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching
to the Ordinary Shares cast at a meeting, while a special resolution requires the affirmative vote of no less than two-thirds of the
votes cast attaching to the outstanding and issued Ordinary Shares cast at a meeting. A special resolution will be required for important
matters such as a change of name or making changes to our post-offering memorandum and articles of association. Our shareholders may,
among other things, divide or combine their shares by ordinary resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 108 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General
Meetings of Shareholders. </I>As a Cayman Islands exempted company, we are not obliged by the Companies Act to call shareholders&rsquo;
annual general meetings. Our post-offering memorandum and articles of association provide that we may (but are not obliged to) in each
year hold a general meeting as our annual general meeting in which case we shall specify the meeting as such in the notices calling it,
and the annual general meeting shall be held at such time and place as may be determined by our directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders&rsquo;
general meetings may be convened by a majority of our Board. Advance notice of at least seven days is required for the convening of our
annual general shareholders&rsquo; meeting (if any) and any other general meeting of our shareholders. A quorum required for any general
meeting of shareholders consists of at least one shareholder present or by proxy, representing not less than one-third of all votes attaching
to the issued and outstanding shares in our company entitled to vote at the general meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with
any right to put any proposal before a general meeting. However, these rights may be provided in a company&rsquo;s articles of association.
Our post-offering memorandum and articles of association provide that upon the requisition of any one or more of our shareholders who
together hold shares which carry in aggregate not less than one-third of all votes attaching to the issued and outstanding shares of
our company entitled to vote at general meetings, our Board will convene an extraordinary general meeting and put the resolutions so
requisitioned to a vote at such meeting. However, our post-offering memorandum and articles of association do not provide our shareholders
with any right to put any proposals before annual general meetings or extraordinary general meetings not called by such shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transfer
of Ordinary Shares. </I>Subject to the restrictions set out in our post-offering memorandum and articles of association as set out below,
any of our shareholders may transfer all or any of his or her Ordinary Shares by an instrument of transfer in the usual or common form
or any other form approved by our Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which
we have a lien. Our Board may also decline to register any transfer of any ordinary share unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            instrument of transfer is lodged with us, accompanied by the certificate for the Ordinary
                                            Shares to which it relates and such other evidence as our Board may reasonably require to
                                            show the right of the transferor to make the transfer;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            instrument of transfer is in respect of only one class of Ordinary Shares;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            instrument of transfer is properly stamped, if required;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of a transfer to joint holders, the number of joint holders to whom the Ordinary
                                            Share is to be transferred does not exceed four;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ordinary shares transferred is free of any lien in favor of the Company; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            fee of such maximum sum as the Nasdaq Capital Market may determine to be payable or such
                                            lesser sum as our directors may from time to time require is paid to us in respect thereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our directors refuse to register a transfer they shall, within three months after the date on which the instrument of transfer was lodged,
send to each of the transferor and the transferee notice of such refusal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration of transfers may, after compliance with any notice required of Nasdaq Capital Market, be suspended and the register closed
at such times and for such periods as our Board may from time to time determine, provided, however, that the registration of transfers
shall not be suspended nor the register closed for more than 30 days in any year as our Board may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 109 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidation</I>.
On the winding up of our company, if the assets available for distribution amongst our shareholders shall be more than sufficient to
repay the whole of the share capital at the commencement of the winding up, the surplus shall be distributed amongst our shareholders
in proportion to the par value of the shares held by them at the commencement of the winding up, subject to a deduction from those shares
in respect of which there are monies due, of all monies payable to our company for unpaid calls or otherwise. If our assets available
for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by
our shareholders in proportion to the par value of the shares held by them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Calls
on Shares and Forfeiture of Shares</I>. Our Board may from time to time make calls upon shareholders for any amounts unpaid on their
shares in a notice served to such shareholders at least 14 days prior to the specified time and place of payment. The shares that have
been called upon and remain unpaid are subject to forfeiture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Redemption,
Repurchase and Surrender of Shares</I>. We may issue shares on terms that such shares are subject to redemption, at our option or at
the option of the holders of these shares, on such terms and in such manner as may be determined by our Board or by special resolution
of our shareholders. Our company may also repurchase any of our shares on such terms and in such manner as have been approved by our
Board or by an ordinary resolution of our shareholders. Under the Companies Act, the redemption or repurchase of any share may be paid
out of our Company&rsquo;s profits or out of the proceeds of a new issue of shares made for the purpose of such redemption or repurchase,
or out of capital (including share premium account and capital redemption reserve) if our company can, immediately following such payment,
pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act no such share may be redeemed
or repurchased (a) unless it is fully paid up, (b) if such redemption or repurchase would result in there being no shares issued and
outstanding or (c) if the Company has commenced liquidation. In addition, our company may accept the surrender of any fully paid share
for no consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Variations
of Rights of Shares</I>. If at any time, our share capital is divided into different classes of shares, the rights attached to any class
may be materially adversely varied with the consent in writing of the holders of at least two-thirds (2/3) of the issued shares of that
class or with the sanction of a resolution passed by not less than two-thirds of the votes cast at a separate meeting of the holders
of the shares of that class. The rights conferred upon the holders of the shares of any class issued shall not, be deemed to be materially
adversely varied by the creation, allotment or issue of further shares ranking <I>pari passu</I> with or subsequent to them or the redemption
or purchase of any shares of any class by the Company. The rights of the holders of shares shall not be deemed to be materially adversely
varied by the creation or issue of shares with preferred or other rights including, without limitation, the creation of shares with enhanced
or weighted voting rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Issuance
of Additional Shares</I>. Our post-offering memorandum and articles of association authorize our Board to issue additional Ordinary Shares
from time to time as our Board shall determine, to the extent out of available authorized but unissued Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
post-offering memorandum and articles of association also authorize our Board to establish from time to time one or more series of preferred
shares and to determine, with respect to any series of preferred shares, the terms and rights of that series, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
  designation of the series;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
  number of shares of the series;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
  dividend rights, dividend rates, conversion rights, voting rights; and</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
  rights and terms of redemption and liquidation preferences.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board may issue preferred shares without action by our shareholders to the extent out of authorized but unissued preferred shares. Issuance
of these shares may dilute the voting power of holders of Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inspection
of Books and Records</I>. Holders of our Class A Ordinary Shares will have no general right under Cayman Islands law to inspect or obtain copies
of our list of shareholders or our corporate records. However, we will provide our shareholders with annual audited financial statements.
See &ldquo;Where You Can Find Additional Information.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 110 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Anti-Takeover
Provisions</I>. Some provisions of our post-offering memorandum and articles of association may discourage, delay or prevent a change
of control of our company or management that shareholders may consider favorable, including provisions that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorize
                                            our Board to issue preferred shares in one or more series and to designate the price, rights,
                                            preferences, privileges and restrictions of such preferred shares without any further vote
                                            or action by our shareholders; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limit
                                            the ability of shareholders to requisition and convene general meetings of shareholders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our post-offering memorandum and
articles of association for a proper purpose and for what they believe in good faith to be in the best interests of our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exempted
Company</I>. We are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes between ordinary
resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside
of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted company are essentially the
same as for an ordinary company except that an exempted company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not have to file an annual return of its shareholders with the Registrar of Companies of
                                            the Cayman Islands;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
                                            not required to open its register of members for inspection;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">does
                                            not have to hold an annual general meeting;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            obtain an undertaking against the imposition of any future taxation (such undertakings are
                                            usually given for 20 years in the first instance);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            register by way of continuation in another jurisdiction and be deregistered in the Cayman
                                            Islands;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            register as a limited duration company; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            register as a segregated portfolio company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Limited
liability&rdquo; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the
company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper
purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 111 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Differences
in Corporate Law </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Act is derived, to a large extent, from the older Companies Acts of England but does not follow recent English statutory enactments
and accordingly there are significant differences between the Companies Act and the current Companies Act of England. In addition, the
Companies Act differs from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of certain significant
differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated in the United
States and their shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Mergers
and Similar Arrangements</I>. The Companies Act permits mergers and consolidations between Cayman Islands companies and between Cayman
Islands companies and non-Cayman Islands companies. For these purposes, (i) &ldquo;merger&rdquo; means the merging of two or more constituent
companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving company, and (ii)
a &ldquo;consolidation&rdquo; means the combination of two or more constituent companies into a consolidated company and the vesting
of the undertaking, property and liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation,
the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (a)
a special resolution of the shareholders of each constituent company, and (b) such other authorization, if any, as may be specified in
such constituent company&rsquo;s articles of association. The written plan of merger or consolidation must be filed with the Registrar
of Companies of the Cayman Islands together with a declaration as to the solvency of the consolidated or surviving company, a list of
the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will
be given to the members and creditors of each constituent company and that notification of the merger or consolidation will be published
in the Cayman Islands Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these
statutory procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
merger between a Cayman parent company and its Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders
of that Cayman subsidiary if a copy of the plan of merger is given to every member of that Cayman subsidiary to be merged unless that
member agrees otherwise. For this purpose a company is a &ldquo;parent&rdquo; of a subsidiary if it holds issued shares that together
represent at least ninety percent (90%) of the votes at a general meeting of the subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consent of each holder of a fixed or floating security interest over a constituent company is required unless this requirement is waived
by a court in the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Save
in certain limited circumstances, a shareholder of a Cayman constituent company who dissents from the merger or consolidation is entitled
to payment of the fair value of his shares (which, if not agreed between the parties, will be determined by the Cayman Islands court)
upon dissenting to the merger or consolidation, provided that the dissenting shareholder complies strictly with the procedures set out
in the Companies Act. The exercise of dissenter rights will preclude the exercise by the dissenting shareholder of any other rights to
which he or she might otherwise be entitled by virtue of holding shares, save for the right to seek relief on the grounds that the merger
or consolidation is void or unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separate
from the statutory provisions relating to mergers and consolidations, the Companies Act also contains statutory provisions that facilitate
the reconstruction and amalgamation of companies by way of schemes of arrangement, provided that the arrangement is approved by a majority
in number of each class of shareholders and creditors with whom the arrangement is to be made, and who must in addition represent three-fourths
in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy
at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned
by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction
ought not to be approved, the court can be expected to approve the arrangement if it determines that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            statutory provisions as to the required majority vote have been met;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            shareholders have been fairly represented at the meeting in question and the statutory majority
                                            are acting <I>bona fide</I> without coercion of the minority to promote interests adverse
                                            to those of the class;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            arrangement is such that may be reasonably approved by an intelligent and honest man of that
                                            class acting in respect of his interest; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            arrangement is not one that would more properly be sanctioned under some other provision
                                            of the Companies Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 112 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Act also contains a statutory power of compulsory acquisition which may facilitate the &ldquo;squeeze out&rdquo; of dissentient
minority shareholders upon a tender offer. When a tender offer is made and accepted by holders of 90.0% of the shares affected within
four months, the offeror may, within a two-month period commencing on the expiration of such four-month period, require the holders of
the remaining shares to transfer such shares to the offeror on the terms of the offer. An objection can be made to the Grand Court of
the Cayman Islands but this is unlikely to succeed in the case of an offer which has been so approved unless there is evidence of fraud,
bad faith or collusion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an arrangement and reconstruction by way of scheme of arrangement is thus approved and sanctioned, or if a tender offer is made and accepted
in accordance with the foregoing statutory procedures, a dissenting shareholder would have no rights comparable to appraisal rights,
which would otherwise ordinarily be available to dissenting shareholders of Delaware corporations, providing rights to receive payment
in cash for the judicially determined value of the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shareholders&rsquo;
Suits</I>. In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company, and as a general rule a
derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood
be of persuasive authority in the Cayman Islands, the Cayman Islands court can be expected to follow and apply the common law principles
(namely the rule in Foss v. Harbottle and the exceptions thereto) so that a non-controlling shareholder may be permitted to commence
a class action against or derivative actions in the name of the company to challenge actions where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            company acts or proposes to act illegally or ultra vires (and is therefore incapable of ratification
                                            by the shareholder);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            act complained of, although not ultra vires, could only be effected duly if authorized by
                                            more than a simple majority vote that has not been obtained;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            act purports to abridge or abolish the individual rights of a shareholder; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those
                                            who control the company are perpetrating a &ldquo;fraud on the minority.&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of a company (not being a bank) having its share capital divided into shares, the Grand Court may, on the application of members
holding not less than one fifth of the shares of the company in issue, appoint an inspector to examine the affairs of the company and
to report thereon in such manner as the Grand Court shall direct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Indemnification
of Directors and Executive Officers and Limitation of Liability</I>. Cayman Islands law does not limit the extent to which a company&rsquo;s
memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision
may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the
consequences of committing a crime. Our post-offering memorandum and articles of association provide that that we shall indemnify our
officers and directors against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained
by such directors or officer, other than by reason of such person&rsquo;s dishonesty, willful default or fraud, in or about the conduct
of our company&rsquo;s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his
duties, powers, authorities or discretions, including, without prejudice to the generality of the foregoing, any costs, expenses, losses
or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning
our company or its affairs in any court whether in the Cayman Islands or elsewhere. This standard of conduct is generally the same as
permitted under the Delaware General Corporation Law for a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we will enter into indemnification agreements with our directors and executive officers that provide such persons
with additional indemnification beyond that provided in our post-offering memorandum and articles of association.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling
us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 113 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Directors&rsquo;
Fiduciary Duties</I>. Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and
its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act
in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director
must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction.
The duty of loyalty requires that a director acts in a manner he reasonably believes to be in the best interests of the corporation.
He must not use his corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that
the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling
shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed
basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption
may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by
a director, the director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a matter of Cayman Islands law, a director of a Cayman Islands company is in the position of a fiduciary with respect to the company
and therefore it is considered that he owes the following duties to the company &mdash; a duty to act bona fide in the best interests
of the company, a duty not to make a profit based on his position as director (unless the company permits him to do so), a duty not to
put himself in a position where the interests of the company conflict with his personal interest or his duty to a third party, and a
duty to exercise powers for the purpose for which such powers were intended. A director of a Cayman Islands company owes to the company
a duty to act with skill and care. It was previously considered that a director need not exhibit in the performance of his duties a greater
degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts
have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in
the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shareholder
Action by Written Consent</I>. Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act
by written consent by amendment to its certificate of incorporation. Cayman Islands law and our post-offering memorandum and articles
of association provide that our shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf
of each shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shareholder
Proposals</I>. Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting
of shareholders; provided it complies with the notice provisions in the governing documents. A special meeting may be called by the board
of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special
meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with
any right to put any proposal before a general meeting. However, these rights may be provided in a company&rsquo;s articles of association.
Our post-offering memorandum and articles of association allow any one or more of our shareholders holding shares which carry in aggregate
not less than one-third of the total number of votes attaching to all issued and the outstanding shares of our company entitled to vote
at general meetings to requisition an extraordinary general meeting of our shareholders, in which case our Board is obliged to convene
an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than this right to requisition
a shareholders&rsquo; meeting, our post-offering memorandum and articles of association do not provide our shareholders with any other
right to put proposals before annual general meetings or extraordinary general meetings. As a Cayman Islands exempted company, we are
not obliged by law to call shareholders&rsquo; annual general meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cumulative
Voting</I>. Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation&rsquo;s
certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders
on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single
director, which increases the shareholder&rsquo;s voting power with respect to electing such director. There are no prohibitions in relation
to cumulative voting under the laws of the Cayman Islands but our post-offering memorandum and articles of association do not provide
for cumulative voting. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders
of a Delaware corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 114 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Removal
of Directors</I>. Under the Delaware General Corporation Law, a director of a corporation with a classified board may be removed only
for cause with the approval of a majority of the issued and outstanding shares entitled to vote, unless the certificate of incorporation
provides otherwise. Under our post-offering memorandum and articles of association, directors may be removed with or without cause, by
an ordinary resolution of our shareholders. A director will also cease to be a director if he (i) becomes bankrupt or makes any arrangement
or composition with his creditors; (ii) dies or is found to be or becomes of unsound mind; (iii) resigns his office by notice in writing;
(iv) without special leave of absence from our Board, is absent from meetings of our Board for three consecutive meetings and our Board
resolves that his office be vacated; or (v) is removed from office pursuant to any other provision of our articles of association.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transactions
with Interested Shareholders</I>. The Delaware General Corporation Law contains a business combination statute applicable to Delaware
corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate
of incorporation, it is prohibited from engaging in certain business combinations with an &ldquo;interested shareholder&rdquo; for three
years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or a group
who or which owns or owned 15% or more of the target&rsquo;s outstanding voting share within the past three years. This has the effect
of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be treated
equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested shareholder,
the board of directors approves either the business combination or the transaction which resulted in the person becoming an interested
shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms of any acquisition transaction with
the target&rsquo;s board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands law has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business
combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant shareholders,
it does provide that such transactions must be entered into <I>bona fide</I> in the best interests of the company and not with the effect
of constituting a fraud on the minority shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dissolution;
Winding up</I>. Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution
must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the
board of directors may it be approved by a simple majority of the corporation&rsquo;s outstanding shares. Delaware law allows a Delaware
corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated
by either an order of the courts of the Cayman Islands or by the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman Islands or by a special resolution of its
members or, if the company is unable to pay its debts as they fall due, by an ordinary resolution of its members. The court has authority
to order winding up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to
do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Variation
of Rights of Shares</I>. Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the
approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our
post-offering memorandum and articles of association, if our share capital is divided into more than one class of shares, the rights
attached to any such class may, subject to any rights or restrictions for the time being attached to any class, only be materially adversely
varied with the consent in writing of the holders of at least two-thirds (2/3) of the issued shares of that class or with the sanction
of a special resolution passed at a separate meeting of the holders of the shares of that class. The rights conferred upon the holders
of the shares of any class issued with preferred or other rights shall not, subject to any rights or restrictions for the time being
attached to the shares of that class, be deemed to be materially adversely varied by the creation, allotment or issue of further shares
ranking <I>pari passu</I> with or subsequent to them or the redemption or purchase of any shares of any class by our company. The rights
of the holders of shares shall not be deemed to be materially adversely varied by the creation or issue of shares with preferred or other
rights including, without limitation, the creation of shares with enhanced or weighted voting rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amendment
of Governing Documents</I>. Under the Delaware General Corporation Law, a corporation&rsquo;s governing documents may be amended with
the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under
the Companies Act and our post-offering memorandum and articles of association, our memorandum and articles of association may only be
amended by a special resolution of our shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights
of Non-resident or Foreign Shareholders</I>. There are no limitations imposed by our post-offering memorandum and articles of association
on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions
in our post-offering memorandum and articles of association governing the ownership threshold above which shareholder ownership must
be disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>History
of Securities Issuances </B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the past three years, we have issued an aggregate of 15,645,750 Class A Ordinary Shares, as described below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 13, 2024, we have issued an aggregate of 62,583</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Class A Ordinary Shares of a nominal or par value of US$0.001 each, comprising: (i) 16,649 Class A Ordinary Shares of a nominal
or par value of US$0.001 each issued to 5 advisors in February 2024 in consideration for services provided to the Company pursuant to various agreements, (ii) 4,439 Class A Ordinary Shares of a nominal or par value of US$0.001 each issued to 22
employees pursuant to the provisions of the 2023 Employee Incentive Plan in February 2024, (iii) 170 Class A Ordinary Shares of a nominal
or par value of US$0.001 each issued in January 2024 to one investor for a total consideration of S$100,000<B><I>, </I></B>(iv) 2,879
Class A Ordinary Shares of a nominal or par value of US$0.001 each issued in September 2023 and October 2023 to four investors
for a total consideration of S$1,694,843, (v) a total of 935 Class A Ordinary Shares of a nominal or par value of US$0.001
each issued to three investors in July and August 2023 for a total consideration of S$550,000, (vi) 2,225 Class A Ordinary
Shares of a nominal or par value of US$0.001 each issued to two investors on April 18, 2023 for a total consideration of S$1,250,000
pursuant to share subscription agreements, (vii) 11,631 Class A Ordinary Shares of a nominal or par value of US$0.001 each
issued to three persons on May 8, 2022 pursuant to the capitalization of a shareholder loan of S$6,500,000, and (viii) 23,655
Class A Ordinary Shares of a nominal or par value of US$0.001 each issued to four investors on May 8, 2022 for a total consideration
of S$13,220,000 pursuant to a share subscription agreement, among which 16,104 Class A Ordinary Shares of a nominal or par value of US$0.001 each held by one of the investors
were subsequently repurchased by the Company in January 2023 for a consideration of S$9,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that each of the issuances was exempt from registration pursuant to Section 4(2) of the Securities Act, regarding transactions
not involving a public offering, or in reliance on Regulation S under the Securities Act regarding sales by an issuer in offshore transactions.
None of the transactions involved an underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 14, 2024, shareholders&rsquo; resolutions were passed to authorize the sub-division of each of the Company&rsquo;s issued
and unissued shares into 250 Ordinary Shares such that the authorized share capital of the Company was changed from US$50,000
divided into 50,000,000 Ordinary Shares of a nominal or par value of US$0.001 each, comprising 25,000,000 Class A Ordinary Shares of
a nominal or par value of US$0.001 each, and 25,000,000 Class B Ordinary Shares of a nominal or par value of US$0.001 each to
US$50,000 divided into 12,500,000,000 Ordinary Shares of a nominal or par value of US$0.000004 each, comprising 6,250,000,000 Class
A Ordinary Shares of a nominal or par value of US$0.000004 each, and 6,250,000,000 Class B Ordinary Shares of a nominal or par value
of US$0.000004 each. Accordingly, the issued 62,583 Class A Ordinary Shares of a nominal or par value of US$0.001 each were divided into
15,645,750 Class A Ordinary Shares of a nominal or par value of US$0.000004 each.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreements with Shareholders</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with our previous
fund raising, we have entered into a series of agreements with our investors since 2016 and in certain instances, some of our early shareholders
are also parties to such agreements. These agreements provide for certain investors&rsquo; rights, including but not limited to information
rights, rights of first refusal, preemptive rights, rights to appoint directors, co-sale rights, drag-along rights and contain provisions
governing our board of directors and other corporate governance matters. Most of these agreements, along with such rights accorded to
certain shareholders and the corporate governance provisions contained therein, will be terminated on the date of the Company&rsquo;s
listing on the Nasdaq Capital Market, except that we expect four  agreements will survive the completion of this offering.
The investors of these agreements owned approximately 3.5% of the Company&rsquo;s issued and outstanding Class A Ordinary Shares
and approximately 3.3% of the Company&rsquo;s issued and outstanding Class B Ordinary Shares, which in total represented
approximately 3.3% of the aggregate voting power in the Company as of the date of this prospectus. Below is a summary of
key shareholders&rsquo; special rights provided by these agreements which will survive the completion of this offering:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Pre-emption rights</I>. The investors have
the right to participate in any new issues of securities <I>pro rata</I> to their shareholding percentage, and the right to acquire the
Company&rsquo;s shares which are proposed to be transferred, including the right to acquire any excess shares not accepted by other shareholders
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><I>Co-sale rights</I>. If any other shareholders
sell his or her shares, the investors have the right to sell a <I>pro rata</I> proportion of the number of shares being sold by other
shareholders on the same terms and same price.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><I>Drag-along rights</I>.
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the holders of not less than two-thirds of the ordinary
shares (including certain investors) agree to sell their shares, all remaining shareholders and option holders will be required to sell
their shares to the same purchaser at the same price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Grants
of Options</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted options to purchase our Class A Ordinary Shares to certain of our employees of the Company and/or any of its subsidiaries,
including all directors, advisors and consultants of the Company and its subsidiaries, with effect from March 27, 2023. On August
1 and December 18, 2023, we granted options to our employees to purchase a total of 4,439 Class A Ordinary Shares of a nominal or
par value of US$0.001 each. On February 13, 2024, the Company issued 4,439 Class A Ordinary Shares of a nominal or par value of US$0.001
each to the holders of the options, pursuant to the provisions of the Plan. On February 14, 2024, the issued 4,439 Class A Ordinary Shares
of a nominal or par value of US$0.001 each were divided into 1,109,750 Class A Ordinary Shares of a nominal or par value of US$0.000004
each. See &ldquo;Management&mdash;2023 Employee Incentive Plan.&rdquo; </FONT><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 115 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="loi_004"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Shares
Eligible For Future Sale</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
completion of this offering, we will have 21,921,750 Class A Ordinary Shares outstanding, representing approximately 64.5%
of our outstanding Ordinary Shares, assuming the underwriter does not exercise its over-allotment option. All of the Class A Ordinary
Shares sold in this offering will be freely transferable by persons other than by our &ldquo;affiliates&rdquo; without restriction or
further registration under the Securities Act. Sales of substantial amounts of the Class A Ordinary Shares in the public market could
adversely affect prevailing market prices of the Class A Ordinary Shares. Prior to this offering, there has been no public market for
our Class A Ordinary Shares. We have applied to list the Class A Ordinary Shares on the Nasdaq Capital Market, but we cannot assure you
that a regular trading market will develop in the Class A Ordinary Shares. We do not expect that a trading market will develop for our
Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-up
Agreements</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company, on behalf of
itself and any successor entity, agrees that, without the prior written consent of the representative, it will not, for a period of 180
days after the date of this prospectus, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase
any notion or contract to sell, grant any option, right or warrant to purchase, lead, or otherwise transfer or dispose of directly or
indirectly, any share of capital share of the Company or any securities convertible into or exercisable or exchangeable for shares of
capital share of the Company; (ii) file or caused to be filed any registration statement with the SEC relating to the offering of any
shares of capital share of the Company of any securities convertible into or exercisable or exchangeable for shares of capital shares
of the company; (iii) complete any offering of debt securities of the Company, other than entering into a line of credit with a traditional
bank or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of capital share of the Company, whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to be
settled by delivery of shares of capital share of the Company or such other securities, in such or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our directors, executive
officers and shareholders have agreed, subject to limited exceptions, not to offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer
or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or
exchangeable for shares of capital stock of the Company, that transfers, in whole or in part, any of the economic consequences of ownership
of our Class A Ordinary Shares or such other securities for a period of 180 days after the date of this prospectus, without the
prior written consent of the representative. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &ldquo;Underwriting.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than this offering, we are not aware of any plans by any significant shareholders to dispose of significant numbers of the Class A Ordinary
Shares. However, one or more existing shareholders or owners of securities convertible or exchangeable into or exercisable for the Class
A Ordinary Shares may dispose of significant numbers of the Class A Ordinary Shares in the future. We cannot predict what effect, if
any, future sales of the Class A Ordinary Shares, or the availability of Class A Ordinary Shares for future sale, will have on the trading
price of the Class A Ordinary Shares from time to time. Sales of substantial amounts of the Class A Ordinary Shares in the public market,
or the perception that these sales could occur, could adversely affect the trading price of the Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
144</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our Class A Ordinary Shares that will be issued and outstanding upon the completion of this offering, other than those Ordinary Shares sold
in this offering, are &ldquo;restricted securities&rdquo; as that term is defined in Rule 144 under the Securities Act and may be sold
publicly in the United States only if they are subject to an effective registration statement under the Securities Act or pursuant to
an exemption from the registration requirement such as those provided by Rule 144 and Rule 701 promulgated under the Securities Act.
In general, beginning 90 days after the date of this prospectus, a person (or persons whose shares are aggregated) who at the time of
a sale is not, and has not been during the three months preceding the sale, an affiliate of ours and has beneficially owned our restricted
securities for at least six months will be entitled to sell the restricted securities without registration under the Securities Act,
subject only to the availability of current public information about us, and will be entitled to sell restricted securities beneficially
owned for at least one year without restriction. Persons who are our affiliates and have beneficially owned our restricted securities
for at least six months may sell a number of restricted securities within any three-month period that does not exceed the greater of
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1%
                                            of the then issued and outstanding Ordinary Shares of the same class which immediately after
                                            the completion of this offering will equal Class A Ordinary Shares, assuming the underwriter
                                            does not exercise its over-allotment option; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            average weekly trading volume of our Class A Ordinary Shares of the same class during the four calendar
                                            weeks preceding the date on which notice of the sale is filed with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
by our affiliates under Rule 144 are also subject to certain requirements relating to manner of sale, notice and the availability of
current public information about us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
701</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 701 of the Securities Act as currently in effect, each of our employees, consultants or advisors who purchases our
Class A Ordinary Shares from us in connection with a compensatory stock plan or other written agreement executed prior to the completion
of this offering is eligible to resell those Class A Ordinary Shares in reliance on Rule 144, but without compliance with some of the
restrictions, including the holding period, contained in Rule 144. However, the Rule 701 shares would remain subject to lock-up arrangements
and would only become eligible for sale when the lock-up period expires.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 116 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A NAME="loi_005"></A><B>Taxation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of the material Cayman Islands, Singapore and U.S. federal income tax consequences of an investment in the Class A
Ordinary Shares is based upon laws and relevant interpretations thereof in effect as of the date of this registration statement, all
of which are subject to change. This summary does not deal with all possible tax consequences relating to an investment in the Class
A Ordinary Shares, such as the tax consequences under U.S. state and local tax laws or under the tax laws of jurisdictions other than
the Cayman Islands, Singapore and the United States. To the extent that the discussion relates to matters of Cayman Islands tax law,
it represents the opinion of Harney Westwood &amp; Riegels Singapore LLP, our Cayman Islands counsel.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands Taxation</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">The
Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation and there is
no taxation in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to us levied by the government
of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or, after execution, brought within
the jurisdiction of the Cayman Islands. The Cayman Islands is a party to a double tax treaty entered with the United Kingdom in 2010
but is otherwise not party to any double tax treaties that are applicable to any payments made to or by our company. There are no exchange
control regulations or currency restrictions in the Cayman Islands. Pursuant to Section 6 of the Tax Concessions Act (Revised) of the
Cayman Islands, our Company has obtained an undertaking from the Financial Secretary: (a) that no law which is enacted in the Cayman
Islands imposing any tax to be levied on profits, income, gains or appreciations shall apply to our Company or its operations; and (b)
that the aforesaid tax or any tax in the nature of estate duty or inheritance tax shall not be payable on or in respect of the shares,
debentures or other obligations of our Company or by way of withholding in whole or in part of any relevant payment as defined in section
6(3) of the Tax Concessions Act (Revised) of the Cayman Islands. The undertaking for our Company is for a period of 20 years from June
27, 2023.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Payments
of dividends and capital in respect of our Class A Ordinary Shares will not be subject to taxation in the Cayman Islands and no withholding
will be required on the payment of a dividend or capital to any holder of our Class A Ordinary Shares, nor will gains derived from the
disposal of our Class A Ordinary Shares be subject to Cayman Islands income or corporation tax. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">No
stamp duty is payable in the Cayman Islands in respect of the issue of our Class A Ordinary Shares or on an instrument of transfer in
respect of our Class A Ordinary Shares so long as the instrument of transfer is not executed in, brought to, or produced before a court
of the Cayman Islands.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore
Tax Considerations</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends
Distributions </B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Under
the one-tier corporate tax system which currently applies to all Singapore tax resident companies, tax on corporate profits is final,
and dividends paid by a Singapore tax resident company will be income tax exempt in the hands of a shareholder, whether or not the shareholder
is a company or an individual and whether or not the shareholder is a Singapore tax resident.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
company is regarded as tax resident in Singapore if the control and management of the company&rsquo;s business is exercised in Singapore.
Control and management is defined as the making of decisions on strategic matters, such as those concerning the company&rsquo;s policy
and strategy. Generally, the location of the company&rsquo;s board of directors meetings where strategic decisions are made determines
where the control and management is exercised. However, under certain scenarios, holding board meetings in Singapore may not be sufficient
and other factors will be considered to determine if the control and management of the business is indeed exercised in Singapore.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
shareholders are advised to consult their own tax advisers to take into account the tax laws of their respective countries of residence
and the existence of any agreement for the avoidance of double taxation which their country of residence may have with Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gains
upon Disposal of Shares</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Gains arising from the disposal
of the shares may be construed to be of an income nature and subject to Singapore income tax, especially if they arise from activities
which may be regarded as the carrying on of a trade or business in Singapore. Such gains may also be considered income in nature, even
if they do not arise from an activity in the ordinary course of trade or business or an ordinary incident of some other business activity,
if the shares were purchased with the intention or purpose of making a profit by sale rather than holding for long-term investment purposes
in Singapore. Conversely, gains from disposition of the shares in Singapore, if considered as capital gains rather than income by the
Inland Revenue Authority of Singapore (&ldquo;<B>IRAS</B>&rdquo;), are not taxable in Singapore to the extent that they do not fall
within the ambit of the new section 10L of the Income Tax Act 1947 (&ldquo;<B>ITA</B>&rdquo;), which came into effect on January 1, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 117 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no specific laws or regulations which deal with the characterization of whether a gain is income or capital in nature. The characterization
of gains arising from the sale of our shares will depend primarily on the facts and circumstances (commonly referred to as the &ldquo;badges
of trade&rdquo;) of each shareholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to section 10L of the ITA and specified exceptions, Section 13W of the Income Tax Act 1947 of Singapore, or &ldquo;SITA&rdquo;,
provides for certainty on the non-taxability of gains derived by a corporate taxpayer from the disposal of ordinary shares during the
period from June 1, 2012 to December 31, 2027 (both dates inclusive) where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    divesting company had legally and beneficially held a minimum shareholding of 20% of the ordinary shares of the company whose shares
    are being disposed; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    divesting company had maintained the minimum 20% shareholding for a continuous period of at least 24 months immediately prior to
    the disposal.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above-mentioned &ldquo;safe harbor rules&rdquo; prescribed under Section 13W of SITA will not apply to a divesting company under certain
scenarios. These include, but are not limited to, the divesting company that is in the business of trading or holding Singapore immovable
properties (excluding property development), where the shares are not listed on a stock exchange in Singapore or elsewhere, the divesting
company whose gains or profits from the disposal of ordinary shares are included as part of its income, disposal of shares by a partnership,
limited partnership or limited liability partnership where one or more of the partners is a company or are companies, etc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under section 10L of the
ITA, gains received in Singapore by an entity of a relevant group from the sale or disposal of any movable or immovable property outside
Singapore will be treated as income chargeable to tax under section 10(1)(g) of the ITA under certain circumstances. Any registered shares,
equity securities or securities will be deemed to be located outside Singapore if the register or principal register (if there is more
than one register) is located outside Singapore regardless of where the company is incorporated. If our shares are deemed to be foreign
assets, gains from their disposal will be subject to tax if an entity of a relevant group (other than an excluded entity) disposed of
our shares on or after January 1, 2024. An entity is a member of a group of entities if its assets, liabilities, income, expenses and
cash flows are (a) included in the consolidated financial statements of the parent entity of the group; or (b) excluded from the consolidated
financial statements of the parent entity of the group solely on size or materiality grounds or on the grounds that the entity is held
for sale. &nbsp;A group is a relevant group if (a) the entities of the group are not all incorporated, registered or established in Singapore;
or (b) any entity of the group has a place of business outside Singapore. An excluded entity is defined in section 10L of the ITA to
include a pure equity-holding company or any other entity without adequate economic substance in Singapore taking into account factors
enumerated in section 10L of the ITA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investors are advised to consult their own tax advisors on the applicable tax treatment if they
received gains in Singapore from the disposal of our shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Adoption of FRS 39, FRS 109 or SFRS(I) 9
for Singapore Income Tax Purposes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
who apply, or who are required to apply, the Singapore Financial Reporting Standard 39 &ndash;Financial Instruments: Recognition and
Measurement, or FRS 39; the Singapore Financial Reporting Standard 109 &ndash; Financial Instruments, or FRS 109; or the Singapore Financial
Reporting Standard (International) 9 &ndash; Financial Instruments, or SFRS(I) 9, may for the purposes of Singapore income tax be required
to recognize gains or losses in respect of financial instruments (not being gains or losses in the nature of capital) in accordance with
FRS 39, FRS 109 or SFRS(I) 9 (as the case may be) (as modified by the applicable provisions of Singapore income tax law) even where no
sale or disposal of the shares is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
34A of the SITA provides for the tax treatment for financial instruments in accordance with FRS 39 (subject to certain exceptions
and &ldquo;opt-out&rdquo; provisions) for taxpayers who are required to comply with FRS 39 for financial reporting purposes. The IRAS
has also issued a circular entitled &ldquo;Income Tax Implications Arising from the Adoption of FRS 39 &mdash; Financial Instruments:
Recognition and Measurement&rdquo;. FRS 109 or SFRS(I) 9 (as the case may be) is mandatorily effective for annual periods beginning on
or after January 1, 2018, replacing FRS 39. Section 34AA of the SITA requires taxpayers who comply or who are required to comply with
FRS 109 or SFRS(I) 9 (as the case may be) for financial reporting purposes to calculate their profit, loss or expense for Singapore income
tax purposes in respect of financial instruments in accordance with FRS 109 or SFRS(I) 9 (as the case may be), subject to certain exceptions.
The IRAS has also issued a circular entitled &ldquo;Income Tax: Income Tax Treatment Arising from Adoption of FRS 109 &mdash; Financial
Instruments&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
who may be subject to the above-mentioned tax treatments, including under Sections 34A or 34AA of the SITA, should consult their accounting
and tax advisers regarding the Singapore income tax consequences of their acquisition, holding and disposal of the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Income Tax</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Companies
that carry on business in Singapore are subject to a flat rate of 17% of the companies&rsquo; chargeable income. Chargeable income refers
to the companies&rsquo; taxable income (after deducting tax-allowable expenses).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Goods
and Services Tax</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sale of the shares by a GST-registered investor belonging in Singapore for GST purposes to another person belonging in Singapore is an
exempt supply not subject to GST. Any input GST (for example, GST on brokerage) incurred by the GST-registered investor in connection
with the making of an exempt supply is generally not recoverable from the Singapore Comptroller of GST and will become an additional
cost to the investor unless the investor satisfies certain conditions prescribed under the GST legislation or satisfies certain GST concessions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 118 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
the shares are sold by a GST-registered investor in the course of or furtherance of a business carried on by such investor contractually
to and for the direct benefit of a person belonging outside Singapore, the sale should generally, subject to satisfaction of certain
conditions, be considered a taxable supply subject to GST at 0%. Any input GST (for example, GST on brokerage) incurred by the GST-registered
investor in making such a supply in the course of or furtherance of a business may be fully recoverable from the Singapore Comptroller
of GST. Investors should seek their own tax advice on the recoverability of GST incurred on expenses in connection with the purchase
and sale of the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services
consisting of arranging, brokering, underwriting or advising on the issue, allotment or transfer of ownership of the shares rendered
by a GST-registered person to an investor belonging in Singapore for GST purposes in connection with the investor&rsquo;s purchase, sale
or holding of the shares will be subject to GST at the standard rate of 9% with effect from January
1, 2024. Similar services rendered by a GST registered person contractually to an investor belonging outside Singapore and for the direct
benefit of such an investor or a GST registered person belonging in Singapore should generally, subject to the satisfaction of certain
conditions, be subject to GST at 0%.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stamp
Duty</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
our shares evidenced in certificated forms are acquired in Singapore, stamp duty is payable on the instrument of their transfer at the
rate of 0.2% of the consideration or market value of our shares, whichever is higher.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
an instrument of transfer (including electronic documents) is executed outside Singapore, stamp duty may be payable if the instrument
of transfer is executed outside Singapore and is received in Singapore. The stamp duty is borne by the purchaser unless there is an agreement
to the contrary. An electronic instrument that is executed outside Singapore is considered received in Singapore if (a) it is retrieved
or accessed by a person in Singapore; (b) an electronic copy of it is stored on a device (including a computer) and brought into Singapore;
or (c) an electronic copy of it is stored on a computer in Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the basis that any transfer instruments in respect of our shares traded on the NASDAQ are executed outside Singapore through our transfer
agent and share registrar in the United States for registration in our branch share register maintained in the United States, no stamp
duty would be payable in Singapore on such transfers to the extent that the instruments of transfer (including electronic documents)
are not received in Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the relevant deeming provisions under section 60F of the Singapore Stamp Duty Act 1929 of Singapore are quite broad, registered shareholders
of our shares may wish to note that electronic document executed outside Singapore may still be deemed to be received in Singapore if
the branch records is accessed/retried in Singapore. As it may not be practical to anticipate the circumstances where an instrument may
be considered received in Singapore, investors should consult their tax advisors regarding the particular Singapore stamp duty implications
for them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
States Federal Income Tax Considerations</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following discussion
is a summary of U.S. federal income tax considerations generally applicable to U.S. Holders (as defined below) of the ownership and disposition
of Class A Ordinary Shares by U.S. Holders that acquire the Class A Ordinary Shares in this offering and hold the Class A Ordinary Shares
as capital assets within the meaning of Section 1221 of the U.S. Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;).
This summary is based on U.S. federal income tax laws in effect as of the date of this offering circular, including the Code and U.S.
Treasury regulations, as in effect or proposed as of the date of this offering circular, and judicial and administrative interpretations
thereof available on or before such date. All of the foregoing authorities are subject to change, which could apply retroactively and
could affect the tax consequences described below. There can be no assurance that the Internal Revenue Service or a court will not take
a contrary position to this summary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This summary does not
purport to be a comprehensive discussion of all the tax considerations that may be relevant to a particular investor&rsquo;s decision
to purchase, hold or dispose of Class A Ordinary Shares. Moreover, this summary does not address the Medicare tax on net investment income,
alternative minimum tax, non-income tax (such as the gift and estate tax) or any state, local, and non-U.S. tax considerations, relating
to the ownership and disposition of Class A Ordinary Shares. The following summary does not address all aspects of U.S. federal income
taxation that may be important to particular investors in light of their individual circumstances or to persons in special tax situations
such as:</P>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
                                            financial institutions;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
                                            companies;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pension
                                            plans;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cooperatives;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            mutual fund;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
                                            investment companies;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">real
                                            estate investment trusts;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            broker;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dealers
                                            in securities or currencies;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            individual retirement or other tax-deferred account;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders
                                            that elect to use a mark-to-market method of accounting;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
                                            former U.S. citizens or long-term residents;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
                                            entities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">holders
                                            who acquire their Class A Ordinary Shares pursuant to any employee share option or otherwise
                                            as compensation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            accrual method taxpayer subject to special tax accounting rules as a result of its use of
                                            financial statements;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            investor who is a U.S. expatriate, former U.S. citizen or former long term resident of the
                                            United States;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            holding Class A Ordinary Shares as part of a straddle, hedging, conversion or integrated
                                            transaction;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            holding Class A Ordinary Shares in connection with a trade or business outside the United
                                            States;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            subject to special tax accounting rules as a result of their use of financial statements;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            controlled foreign corporation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            passive foreign investment company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
                                            Holders (as defined below) that have a functional currency other than the U.S. dollar;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                            that actually or constructively own 10% or more of (i) the total combined voting power of
                                            all classes of our voting Shares or (ii) the total value of all classes of our Shares; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
                                            or other pass-through entities for U.S. federal income tax purposes, or persons holding the
                                            Class A Ordinary Shares through such entities,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 31.5pt">all of whom may be subject
to tax rules that differ significantly from those discussed below.</P>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 119 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<FONT STYLE="font-style: normal"></FONT></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>General
</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">For
purposes of this discussion, a &ldquo;U.S. Holder&rdquo; is a beneficial owner of the Class A Ordinary Shares that is, for U.S.
federal income tax purposes: </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">an
                                            individual who is a citizen or resident of the United States; </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">a
                                            corporation (or other entity treated as a corporation for U.S. federal income tax purposes)
                                            created in, or organized under the law of, the U.S. or any state thereof or the District
                                            of Columbia; </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">an
                                            estate the income of which is includible in gross income for U.S. federal income tax purposes
                                            regardless of its source; or </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">a
                                            trust (A) the administration of which is subject to the primary supervision of a U.S. court
                                            and which has one or more U.S. persons who have the authority to control all substantial
                                            decisions of the trust or (B) that has otherwise validly elected to be treated as a U.S.
                                            person under the Code.</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">If
a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) is a beneficial owner of the Class A Ordinary
Shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner as a U.S. Holder, as described
above, and the activities of the partnership. Partnerships holding the Class A Ordinary Shares and partners in such partnerships are
urged to consult their tax advisors as to the particular U.S. federal income tax consequences of an investment in the Class A
Ordinary Shares.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 120 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends
</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Any
cash distributions paid on the Class A Ordinary Shares (including the amount of any Singapore tax withheld) out of our current
or accumulated earnings and profits, as determined under U.S. federal income tax principles, will generally be includible in the gross
income of a U.S. Holder as dividend income on the day actually or constructively received by the U.S. Holder, in the case of Class
A Ordinary Shares. Because we do not intend to determine our earnings and profits on the basis of U.S. federal income tax principles,
any distribution we pay will generally be treated as a &ldquo;dividend&rdquo; for U.S. federal income tax purposes. Dividends received
on the Class A Ordinary Shares will not be eligible for the dividends-received deduction allowed to corporations in respect of
dividends received from U.S. corporations.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Individuals
and other non-corporate U.S. Holders will be subject to tax at the lower capital gain tax rate applicable to &ldquo;qualified dividend
income&rdquo;; provided that certain conditions are satisfied, including that (1) the Class A Ordinary Shares on which the dividends
are paid are readily tradable on an established securities market in the U.S., (2) we are neither a PFIC nor treated as such with
respect to a U.S. Holder (as discussed below) for the taxable year in which the dividend is paid and the preceding taxable year, and
(3) certain holding period and other requirements are met. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">For
U.S. foreign tax credit purposes, dividends paid on the Class A Ordinary Shares generally will be treated as income from non-U.S.
sources and generally will constitute passive category income. A U.S. Holder who does not elect to claim a foreign tax credit for
foreign tax withheld may instead claim a deduction for U.S. federal income tax purposes, in respect of such withholding, but only for
a year in which such holder elects to do so for all creditable foreign income taxes. The rules governing the foreign tax credit are complex
and U.S. Holders are urged to consult their tax advisors regarding the availability of the foreign tax credit under their particular
circumstances. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sale
or Other Disposition </B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder will generally recognize capital gain or loss upon a sale or other disposition of Class A Ordinary Shares, in an amount equal
to the difference between the amount realized and the U.S. Holder&rsquo;s adjusted tax basis, determined for federal income tax purposes,
in such Class A Ordinary Shares, each amount determined in U.S. dollars. Any capital gain or loss will be long-term capital gain or loss
if the Class A Ordinary Shares have been held for more than one year and will generally be U.S. source gain or loss for U.S.
foreign tax credit purposes. The deductibility of a capital loss may be subject to limitations, particularly with regard to shareholders
who are individuals. Each U.S. Holder is advised to consult its tax advisor regarding the tax consequences if a foreign tax is imposed
on a disposition of our Class A Ordinary Shares, including the availability of the foreign tax credit under its particular circumstances.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">A
U.S. Holder that receives Singapore dollars or another currency other than U.S. dollars on the disposition of our Class A Ordinary Shares
will realize an amount equal to the U.S. dollar value of the non-U.S. currency received at the spot rate on the date of sale (or, if
the Class A Ordinary Shares are traded on a recognized exchange and in the case of cash basis and electing accrual basis U.S. Holders,
the settlement date). An accrual basis U.S. Holder that does not elect to determine the amount realized using the spot rate on the settlement
date will recognize foreign currency gain or loss equal to the difference between the U.S. dollar value of the amount received based
on the spot market exchange rates in effect on the date of sale or other disposition and the settlement date. A U.S. Holder will have
a tax basis in the currency received equal to the U.S. dollar value of the currency received on the settlement date. Any gain or loss
on a subsequent disposition or conversion of the currency will be United States source ordinary income or loss.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 121 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Passive
Foreign Investment Company Considerations </B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">For
United States federal income tax purposes, a non-United States corporation, such as our Company, will be treated as a &ldquo;passive
foreign investment company,&rdquo; or &ldquo;PFIC&rdquo; if, in the case of any particular taxable year, either (a) 75% or more of our
gross income for such year consists of certain types of &ldquo;passive&rdquo; income or (b) 50% or more of the value of our assets (generally
determined on the basis of a quarterly average) during such year produce or are held for the production of passive income. Based upon
our current and expected income and assets (including goodwill and taking into account the expected proceeds from this offering) and
the expected market price of our Class A Ordinary Shares following this offering, we do not expect to be a PFIC for the current taxable
year or the foreseeable future. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">However,
while we do not expect to be or become a PFIC, no assurance can be given in this regard because the determination of whether we are or
will become a PFIC for any taxable year is a fact-intensive inquiry made annually that depends, in part, upon the composition and classification
of our income and assets. Fluctuations in the market price of our Class A Ordinary Shares may cause us to be or become a PFIC for the
current or subsequent taxable years because the value of our assets for the purpose of the asset test, including the value of our goodwill
and other unbooked intangibles, may be determined by reference to the market price of our Class A Ordinary Shares (which may be volatile).
The composition of our income and assets may also be affected by how, and how quickly, we use our liquid assets and the cash raised in
this offering. It is also possible that the Internal Revenue Service may challenge our classification of certain income or assets for
purposes of the analysis set forth in subparagraphs (a) and (b), above or the valuation of our goodwill and other unbooked intangibles,
which may result in our company being or becoming a PFIC for the current or future taxable years. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder that holds stock in a non-U.S. corporation during any taxable year in which the corporation is treated as a PFIC is subject
to special tax rules with respect to (a) any gain realized on the sale, exchange or other disposition of the stock and (b) any &ldquo;excess
distribution&rdquo; by the corporation to the holder, unless the holder elects to treat the PFIC as a &ldquo;qualified electing fund&rdquo;
(&ldquo;QEF&rdquo;) or makes a &ldquo;mark-to-market&rdquo; election, each as discussed below. An &ldquo;excess distribution&rdquo; is
that portion of a distribution with respect to PFIC stock that exceeds 125% of the average of such distributions over the preceding three-year
period or, if shorter, the U.S. Holder&rsquo;s holding period for its shares. Excess distributions and gains on the sale, exchange or
other disposition of stock of a corporation which was a PFIC at any time during the U.S. Holder&rsquo;s holding period are allocated
ratably to each day of the U.S. Holder&rsquo;s holding period. Amounts allocated to the taxable year in which the disposition occurs
and amounts allocated to any period in the shareholder&rsquo;s holding period before the first day of the first taxable year that the
corporation was a PFIC will be taxed as ordinary income (rather than capital gain) earned in the taxable year of the disposition. Amounts
allocated to each of the other taxable years in the U.S. Holder&rsquo;s holding period are not included in gross income for the year
of the disposition, but are subject to a special tax (equal to the highest ordinary income tax rates in effect for those years, and increased
by an interest charge at the rate applicable to income tax deficiencies) that is added to the tax otherwise due for the taxable year
in which the disposition occurs. The tax liability for amounts allocated to years before the year of disposition or &ldquo;excess distribution&rdquo;
cannot be offset by any net operating losses for such years, and gains (but not losses) realized on the sale of the Class A Ordinary
Shares cannot be treated as capital, even if a U.S. Holder held such Class A Ordinary Shares as capital assets. The preferential U.S.
federal income tax rates for dividends and long-term capital gain of individual U.S. Holders (as well as certain trusts and estates)
would not apply, and special rates would apply for calculating the amount of the foreign tax credit with respect to excess distributions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a corporation is a PFIC for any taxable year during which a U.S. Holder holds shares in the corporation, then the corporation generally
will continue to be treated as a PFIC with respect to the holder&rsquo;s shares, even if the corporation no longer satisfies either the
passive income or passive asset tests described above, unless the U.S. Holder terminates this deemed PFIC status by electing to recognise
gain, which will be taxed under the excess distribution rules as if such shares had been sold on the last day of the last taxable year
for which the corporation was a PFIC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are a PFIC for any taxable year during which a U.S. Holder holds our Class A Ordinary Shares and we own any equity in a non-United
States entity that is also a PFIC, or a lower-tier PFIC, such U.S. Holder would be treated as owning a proportionate amount (by value)
of the shares of the lower-tier PFIC for purposes of the application of these rules. U.S. Holders are advised to consult their tax advisors
regarding the application of the PFIC rules to any of the entities in which we may own equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
excess distribution rules may be avoided if a U.S. Holder makes a QEF election effective beginning with the first taxable year in the
holder&rsquo;s holding period in which the corporation is a PFIC. A U.S. Holder that makes a QEF election is required to include in income
its pro rata share of the PFIC&rsquo;s ordinary earnings and net capital gain as ordinary income and long-term capital gain, respectively,
subject to a separate election to defer payment of taxes, which deferral is subject to an interest charge. A U.S. Holder whose QEF election
is effective after the first taxable year during the holder&rsquo;s holding period in which the corporation is a PFIC will continue to
be subject to the excess distribution rules for years beginning with such first taxable year for which the QEF election is effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a U.S. Holder makes a QEF election by attaching a completed IRS Form 8621 to a timely filed (taking into account any extensions)
U.S. federal income tax return for the year beginning with which the QEF election is to be effective. In certain circumstances, a U.S.
Holder may be able to make a retroactive QEF election. A QEF election can be revoked only with the consent of the IRS. In order for a
U.S. Holder to make a valid QEF election, the corporation must annually provide or make available to the holder certain information.
Our Company does not intend to provide to U.S. Holders the information required to make a valid QEF election and our Company currently
makes no undertaking to provide such information. Accordingly, it is currently anticipated that a U.S. Holder will not be able to avoid
the special tax rules described above by making the QEF election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an alternative to making a QEF election, a U.S. Holder may make a &ldquo;mark-to-market&rdquo; election with respect to its PFIC shares
if the shares meet certain minimum trading requirements. If a U.S. Holder makes a valid mark-to-market election for the first tax year
in which such holder holds (or is deemed to hold) stock in a corporation and for which such corporation is determined to be a PFIC, such
holder generally will not be subject to the PFIC rules described above in respect of its stock. Instead, a U.S. Holder that makes a mark-to-market
election will be required to include in income each year an amount equal to the excess, if any, of the fair market value of the shares
that the holder owns as of the close of the taxable year over the holder&rsquo;s adjusted tax basis in the shares. The U.S. Holder will
be entitled to a deduction for the excess, if any, of the holder&rsquo;s adjusted tax basis in the shares over the fair market value
of the shares as of the close of the taxable year; provided, however, that the deduction will be limited to the extent of any net mark-to-market
gains with respect to the shares included by the U.S. Holder under the election for prior taxable years. The U.S. Holder&rsquo;s basis
in the shares will be adjusted to reflect the amounts included or deducted pursuant to the election. Amounts included in income pursuant
to a mark-to-market election, as well as gain on the sale, exchange or other taxable disposition of the shares, will be treated as ordinary
income. The deductible portion of any mark-to-market loss, as well as loss on a sale, exchange or other disposition of shares to the
extent that the amount of such loss does not exceed net mark-to-market gains previously included in income, will be treated as ordinary
loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mark-to-market election applies to the taxable year for which the election is made and all subsequent taxable years, unless the shares
cease to meet applicable trading requirements (described below) or the IRS consents to its revocation. The excess distribution rules
generally do not apply to a U.S. Holder for tax years for which a mark-to-market election is in effect. However, if a U.S. Holder makes
a mark-to-market election for PFIC stock after the beginning of the holder&rsquo;s holding period for the stock, a coordination rule
applies to ensure that the holder does not avoid the tax and interest charge with respect to amounts attributable to periods before the
election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
mark-to-market election is available only if the shares are considered &ldquo;marketable&rdquo; for these purposes. Shares will be marketable
if they are regularly traded on a national securities exchange that is registered with the Securities and Exchange Commission or on a
non-U.S. exchange or market that the IRS determines has rules sufficient to ensure that the market price represents a legitimate and
sound fair market value. For these purposes, shares will be considered regularly traded during any calendar year during which they are
traded, other than in de minimis quantities, on at least 15 days during each calendar quarter. Any trades that have as their principal
purpose meeting this requirement will be disregarded. Although we have applied for the listing of our Class A Ordinary
Shares on the Nasdaq, we cannot guarantee that our listing will be approved. Furthermore, we cannot guarantee that, once listed, our
Class A Ordinary Shares will continue to be listed and regularly traded on such exchange. Each U.S. Holder should ask its own tax advisor
whether a mark-to-market election is available or desirable, including as to whether the Class A Ordinary Shares are considered marketable
for these purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
a mark-to-market election generally cannot be made for any lower-tier PFICs that a PFIC may own, a U.S. Holder who makes a mark-to-market
election with respect to our Class A Ordinary Shares may continue to be subject to the general PFIC rules with respect to such U.S. Holder&rsquo;s
indirect interest in any of our non-United States subsidiaries if any of them is a PFIC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder of PFIC stock must generally file an IRS Form 8621 annually. A U.S. Holder must also provide such other information as may
be required by the U.S. Treasury Department if the U.S. Holder (i) receives certain direct or indirect distributions from a PFIC, (ii)
recognises gain on a direct or indirect disposition of PFIC stock, or (iii) makes certain elections (including a QEF election or a mark-to-market
election) reportable on IRS Form 8621.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>U.S.
Holders are urged to consult their tax advisors as to our Company&rsquo;s status as a PFIC, and, if our Company is treated as a PFIC,
as to the effect on them of, and the reporting requirements with respect to, the PFIC rules and the desirability of making, and the availability
of, either a QEF election or a mark-to-market election with respect to our Class A Ordinary Shares. Our Company provides no advice on
taxation matters.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Information
with Respect to Foreign Financial Assets</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, certain U.S. Holders may be subject to certain reporting obligations with respect to Class A Ordinary Shares if the aggregate
value of these and certain other &ldquo;specified foreign financial assets&rdquo; exceeds $50,000. If required, this disclosure is made
by filing Form 8938 with the IRS. Significant penalties can apply if U.S. Holders are required to make this disclosure and fail to do
so. In addition, a U.S. Holder should consider the possible obligation for online filing of a FinCEN Report 114&mdash;Foreign Bank and
Financial Accounts Report as a result of holding Class A Ordinary Shares. U.S. Holders are thus encouraged to consult their U.S. tax
advisors with respect to these and other reporting requirements that may apply to their acquisition of Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Information
Reporting and Backup Withholding</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, information reporting requirements will apply to distributions made on our Class A Ordinary Shares within the U.S. to a non-corporate
U.S. Holder and to the proceeds from the sale, exchange, redemption or other disposition of Class A Ordinary Shares by a non-corporate
U.S. Holder to or through a U.S. office of a broker. Payments made (and sales or other dispositions effected at an office) outside the
U.S. will be subject to information reporting in limited circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, backup withholding of U.S. federal income tax may apply to such amounts if the U.S. Holder fails to provide an accurate taxpayer
identification number (or otherwise establishes, in the manner provided by law, an exemption from backup withholding) or to report dividends
required to be shown on the U.S. Holder&rsquo;s U.S. federal income tax returns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional income tax, and the amount of any backup withholding from a payment to a U.S. Holder will be allowed
as credit against the U.S. Holder&rsquo;s U.S. federal income tax liability provided that the appropriate returns are filed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should consult your own tax advisor as to the qualifications for exemption from backup withholding and the procedures for obtaining the
exemption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing does not purport to be a complete analysis of the potential tax considerations relating to the Placement, and is not tax advice.
Prospective investors should consult their own tax advisors as to the particular tax considerations applicable to them relating to the
purchase, ownership and disposition of the Class A Ordinary Shares, including the applicability of the U.S. federal, state and local
tax laws or non-tax laws, non-U.S. tax laws, and any changes in applicable tax laws and any pending or proposed legislation or regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 122 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="loi_006"></A>Underwriting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, we will enter into an underwriting agreement with Network 1 Financial Securities, Inc., as
representative of the underwriters, or the representative, in this offering. The representative may retain other brokers or dealers to
act as sub-agents or selected dealers on their behalf in connection with this offering. The underwriters have agreed to purchase from
us, on a firm commitment basis, the number of Class A Ordinary Shares set forth opposite its name below, at the offering price less the
underwriting discounts set forth on the cover page of this prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of Underwriters</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                            of Class A</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary
    Shares</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 78%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Network 1 Financial Securities, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%; border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 2.25pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 2.25pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are committed to purchase all the Class A Ordinary Shares offered by this prospectus if they purchase any Class A Ordinary
Shares. The underwriters are not obligated to purchase the Class A Ordinary Shares covered by the underwriter&rsquo;s over-allotment
option to purchase Class A Ordinary Shares as described below. The underwriters are offering the Class A Ordinary Shares, subject to
prior sale, when, as, and if issued to and accepted by them, subject to approval of legal matters by their counsel and other conditions
contained in the underwriting agreement, such as the receipt by the underwriters of officer&rsquo;s certificates and legal opinions.
The underwriters reserve the right to withdraw, cancel, or modify offers to the public and to reject orders in whole or in part. The
underwriter is not underwriting the shares registered for the Selling Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
of this Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has been no public market for our Class A Ordinary Shares. The offering price for our Class A Ordinary Shares
will be determined through negotiations between us and the representative. Among the factors to be considered in these negotiations will
be prevailing market conditions, our financial information, market valuations of other companies that we and the representative believe
to be comparable to us, estimate of our business potential and earning prospects, the present state of our development, and other factors
deemed relevant. The offering price of our Class A Ordinary Shares in this offering does not necessarily bear any direct relationship
to the assets, operations, book value, or other established criteria of value of our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 123 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-Allotment
Option</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted to the underwriters a 45-day option to purchase up to an aggregate of additional Class A Ordinary Shares (equal to 15% of
the number of Class A Ordinary Shares sold in the offering) at the offering price per Class A Ordinary Share less underwriting discounts
and commissions. The underwriters may exercise this option for 45 days from the date of closing of this offering solely to cover sales
of Class A Ordinary Shares by the underwriters in excess of the total number of Class A Ordinary Shares set forth in the table above.
If any of the additional Class A Ordinary Shares are purchased, the underwriters will offer the additional Class A Ordinary Shares at
$ per Class A Ordinary Share, the offering price of each Class A Ordinary Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discounts
and Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriting discounts for the shares and the over-allotment shares are equal to 7.5% of the offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the price per share and total offering price, underwriting discounts, and proceeds before expenses to us. The total
amounts are shown assuming both no exercise and full exercise of the over-allotment option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Share</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
                                            Exercise of </B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-allotment
    </B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Full
                                            Exercise of </B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-allotment
    </B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IPO
    price</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discounts to be paid by us<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    to us, before expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Proceeds to the Selling Shareholders, before expenses</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">$</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">$</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">$</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="text-align: justify; font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">This only includes the
    proceeds of the sale of Class A ordinary shares underwritten by the underwriter. We will not receive any proceeds from the sale of
    Class A Ordinary Shares by the Selling Shareholders.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay to the underwriters, by deduction from the gross proceeds of the offering contemplated herein, a non-accountable expense
allowance equal to one percent (1%) of the gross proceeds received by us from the sale of the Class A Ordinary Shares in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay expenses relating to the offering, including: (i)&nbsp;our legal and accounting fees and disbursements; (ii)&nbsp;the
costs of preparing, printing, mailing, and delivering the registration statement, the preliminary and final prospectus contained therein
and amendments thereto, post-effective&nbsp;amendments and supplements thereto, and the underwriting agreement and related documents
(all in such quantities as the representative may reasonably require); (iii)&nbsp;the costs of preparing and printing stock certificates
and warrant certificates; (iv)&nbsp;the costs of any &ldquo;due diligence&rdquo; meetings; (v)&nbsp;all reasonable and documented fees
and expenses for conducting a net road show presentation; (vi)&nbsp;all filing fees and communication expenses relating to the registration
of the shares to be sold in the offering with the SEC and the filing of the offering materials with FINRA; (vii)&nbsp;the reasonable
and documented fees and disbursements of the representative&rsquo;s counsel up to $100,000; (viii)&nbsp;background checks of the Company&rsquo;s
officers and directors up to $15,000; (ix)&nbsp;preparation of bound volumes and mementos in such quantities as the representative may
reasonably request up to $2,500; (x)&nbsp;transfer taxes, if any, payable upon the transfer of securities from us to the representative;
and (xi)&nbsp;the fees and expenses of the transfer agent, clearing firm, and registrar for the shares; provided that the actual accountable
expenses of the representative shall not exceed $150,000. We are required to supply the representative and its counsel, at our cost,
with a reasonable number of bound volumes of the offering materials within a reasonable time after the closing of this offering as well
as commemorative tombstones.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
paid an expense deposit of $75,000 to the representative, upon the execution of a letter of intent between us and the
representative. Upon the closing of this offering, we will pay up to an additional $75,000 to the representative. Any expense
deposits will be returned to us to the extent the representative&rsquo;s out-of-pocket&nbsp;accountable expenses are not actually
incurred in accordance with FINRA Rule&nbsp;5110(g)(4)(A).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">We estimate that
the total expenses of the offering payable by us, excluding the underwriting discounts and non-accountable expense allowance, will be
approximately $0.6 million. In connection with this offering, we made prior payments of $100,000 in total to EF Hutton LLC, the
former representative of the underwriters, in February 2023 and January 2024, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 124 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underwriter
Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to issue warrants to the representative or its designees (the &ldquo;Underwriter Warrants&rdquo;) to purchase a number of
Class A Ordinary Shares equal to seven and one-half percent (7.5%) of the total number of Class A Ordinary Shares sold in this offering,
including Class A Ordinary Shares issued upon exercise of underwriters&rsquo; over-allotment option. Such Underwriter Warrants shall
have an exercise price equal to 140% of the public offering price of the Class A Ordinary Shares sold in this offering. The Underwriter
Warrants are exercisable commencing six (6) months following the date of commencement of sales of the offering and for a period of five
years following the date of commencement of sales of the offering, in whole or in part. The Class A Ordinary Shares underlying the Underwriter
Warrants have resale registration rights including one demand at our expense and one demand at the holders&rsquo; expense and
unlimited &ldquo;piggy-back&rdquo; rights for periods of five and five years, respectively, from the commencement of sales
of this offering. In compliance with FINRA Rule 5110(g)(8), such registration rights are limited to demand and &ldquo;piggy back&rdquo;
rights for periods of five and five years, respectively, from the date of commencement of sales of the offering
of which this prospectus forms a part, and such demand rights may be exercised on only one occasion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter Warrants and the underlying Class A Ordinary Shares are deemed compensation by FINRA and are therefore subject to a lock-up
for a period of 180 days immediately following the commencement of sales of this offering. Pursuant to FINRA 5110(e)(1), these securities
may not be sold, transferred, assigned, pledged or hypothecated, nor may they be the subject of any hedging, short sale, derivative,
put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately
following the commencement of sales of this offering except to any underwriter and selected dealer participating in the offering and
their officers or partners, registered persons of affiliates or as otherwise permitted under FINRA Rule 5110(e)(2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Right
of First Refusal</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted the representative a right of first refusal, for a period of twelve (12) months from the closing of the offering, to co-manage
any public future public and private equity and debt offering, including all equity linked financings (excluding (i) shares issued under
any compensation or stock option plan approved by the Company&rsquo;s shareholders, (ii) shares issued as consideration of an acquisition
or as part of a strategic partnership or transaction and (iii) conventional banking arrangements and commercial debt financing), during
such twelve (12) month period, of the Company, or any successor to or any current or future subsidiary of the Company, with the representative
receiving the right to underwrite or place a number of the securities to be sold therein having an aggregate purchase price therein equal
to a minimum of the aggregate purchase price of the shares sold in this offering (excluding shares issued upon exercise of underwriters&rsquo;
over-allotment option). If the representative fails to accept in writing any such proposal within ten (10) days after receipt of a written
notice from us containing such proposal, the representative will have no claim or right with respect to any such sale contained in any
such notice. If, thereafter, such proposal is modified in any material respect, the Company will adopt the same procedure as with respect
to the original proposed public of private sale, and the representative shall have the right of first refusal with respect to such revised
proposal as set forth above. In accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more
than three years from the commencement of sales of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, on behalf of itself and any successor entity, agrees that, without the prior written consent of the representative, it will
not, for a period of 180 days after the date of this prospectus, (i) offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any notion or contract to sell, grant any option, right or warrant to purchase, lead, or otherwise transfer
or dispose of directly or indirectly, any share of capital share of the Company or any securities convertible into or exercisable or
exchangeable for shares of capital share of the Company; (ii) file or caused to be filed any registration statement with the SEC relating
to the offering of any shares of capital share of the Company of any securities convertible into or exercisable or exchangeable for shares
of capital shares of the company; (iii) complete any offering of debt securities of the Company, other than entering into a line of credit
with a traditional bank or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of capital share of the Company, whether any such transaction described in clause (i), (ii), (iii) or (iv)
above is to be settled by delivery of shares of capital share of the Company or such other securities, in such or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors, executive officers and shareholders have agreed, subject to limited exceptions set forth below, not to offer, pledge, sell,
contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant
to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities
convertible into or exercisable or exchangeable for shares of capital stock of the Company (the &ldquo;Lock-Up Securities&rdquo;), that
transfers, in whole or in part, any of the economic consequences of ownership of our Class A Ordinary Shares or such other securities
for a period of 180 days after the date of this prospectus, without the prior written consent of the representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt">Notwithstanding
the foregoing to the contrary and subject to the conditions below, a holder may transfer Lock-Up Securities without the prior
written consent of the representative in connection with (a) transactions relating to Lock-Up Securities acquired in open market
transactions after the completion of the Public Offering; <U>provided</U> that no filing under Section 16(a) of the Exchange Act, shall be required or shall be voluntarily made in connection with
subsequent sales of Lock-Up Securities acquired in such open market transactions; (b) transfers of Lock-Up Securities (i) as a <I>bona
fide</I> gift, by will or intestacy, (ii) by operation of law, such as pursuant to a qualified domestic order or as required by a
divorce settlement, or (iii) to a family member or trust for the benefit of a family member (for purposes hereof, &ldquo;family
member&rdquo; means any relationship by blood, marriage or adoption, not more remote than first cousin); (c) transfers of Lock-Up
Securities to a charity or educational institution; or (d) if the holder, directly or indirectly, controls a corporation,
partnership, limited liability company or other business entity, any transfers of Lock-Up Securities to any shareholder, partner or
member of, or owner of similar equity interests in, the undersigned, as the case may be; <U>provided</U> that in the case
of any transfer pursuant to the foregoing clauses (b), (c) or (d), (i) any such transfer shall not involve a disposition for value,
(ii) each transferee shall sign and deliver to the representative a lock-up agreement substantially in the form of this lock-up
agreement and (ii) no filing under Section 16(a) of the Exchange Act shall be required or shall be voluntarily made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No
Sales of Similar Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed not to offer; pledge; announce the intention to sell; sell; contract to sell; sell any option or contract to purchase; purchase
any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly,
any Class A Ordinary Shares or any securities convertible into or exercisable or exchangeable for Class A Ordinary Shares or enter into
any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of our Class A Ordinary
Shares, whether any such transaction is to be settled by delivery of Class A Ordinary Shares or such other securities, in cash or otherwise,
without the prior written consent of the representative, for a period of 180 days from the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 125 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign
Regulatory Restrictions on Purchase of our Class A Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not taken any action to permit a public offering of our Class A Ordinary Shares outside the United States or to permit the possession
or distribution of this prospectus outside the United States. People outside the United States who come into possession of this prospectus
must inform themselves about and observe any restrictions relating to this offering of our Class A Ordinary Shares and the distribution
of this prospectus outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the underwriter and its affiliates against liabilities relating to the offering arising under the Securities
Act and the Exchange Act and to contribute to payments that the underwriters may be required to make for these liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
for Nasdaq Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied to list our Class A Ordinary Shares on the Nasdaq Capital Market under the symbol &ldquo;MNDR.&rdquo; We will
not consummate this offering without a listing approval letter from the Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
Offer, Sale, and Distribution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prospectus in electronic format may be made available on websites or through other online services maintained by the underwriters or
selling group members, if any, or by their affiliates, and the underwriters may distribute prospectus electronically. The underwriters
may agree to allocate a number of Class A Ordinary Shares to selling group members for sale to their online brokerage account holders.
The Class A Ordinary Shares to be sold pursuant to Internet distributions will be allocated on the same basis as other allocations. Other
than the prospectus in electronic format, the information on, or that can be accessed through, these websites and any information contained
in any other website maintained by these entities is not part of, and is not incorporated by reference into, this prospectus or the registration
statement of which this prospectus forms a part, has not been approved and/or endorsed by us or the underwriters, and it should not be
relied upon by investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such
as e-mail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Passive
Market Making</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
underwriter who is a qualified market maker on Nasdaq may engage in passive market making transactions on Nasdaq, in accordance with
Rule 103 of Regulation M under the Exchange Act, during a period before the commencement of offers or sales of the shares and extending
through the completion of the distribution. Passive market makers must comply with applicable volume and price limitations and must be
identified as a passive market maker. In general, a passive market maker must display its bid at a price not in excess of the highest
independent bid for such security. If all independent bids are lowered below the passive market maker&rsquo;s bid, however, the passive
market maker&rsquo;s bid must then be lowered when certain purchase limits are exceeded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Potential
Conflicts of Interest</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters and their affiliates may, from time to time, engage in transactions with and perform services for us in the ordinary course
of their business for which they may receive customary fees and reimbursement of expenses. In the ordinary course of their various business
activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities
(or related derivative securities) and financial instruments (including bank loans) for their own accounts and for the accounts of their
customers, and such investment and securities activities may involve securities and/or instruments of our Company. The underwriters and
their affiliates may also make investment recommendations and/or publish or express independent research views in respect to such securities
or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and
instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 126 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
Stabilization, Short Positions, and Penalty Bids</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
the distribution of the Class A Ordinary Shares offered by this prospectus is completed, rules of the SEC may limit the ability of the
underwriters to bid for and to purchase our Class A Ordinary Shares. As an exception to these rules, the underwriters may engage in transactions
effected in accordance with Regulation M under the Exchange Act that are intended to stabilize, maintain, or otherwise affect the price
of our Class A Ordinary Shares. The underwriters may engage in over-allotment sales, syndicate-covering transactions, stabilizing transactions,
and penalty bids in accordance with Regulation M.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stabilizing
    transactions consist of bids or purchases made by the managing underwriter for the purpose of preventing or slowing a decline in
    the market price of our securities while this offering is in progress.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short
    sales and over-allotments occur when the managing underwriter, on behalf of the underwriting syndicate, sells more of our shares
    than they purchase from us in this offering. In order to cover the resulting short position, the managing underwriter may exercise
    the over-allotment option described above and/or may engage in syndicate-covering transactions. There is no contractual limit on
    the size of any syndicate-covering transaction. The underwriters will deliver a prospectus in connection with any such short sales.
    Purchasers of shares sold short by the underwriters are entitled to the same remedies under the federal securities laws as any other
    purchaser of units covered by the registration statement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Syndicate-covering
    transactions are bids for or purchases of our securities on the open market by the managing underwriter on behalf of the underwriters
    in order to reduce a short position incurred by the managing underwriter on behalf of the underwriters. Short sales may be &ldquo;covered
    short sales,&rdquo; which are short positions in an amount not greater than the underwriters&rsquo; option to purchase additional
    shares referred to above, or may be &ldquo;naked short sales,&rdquo; which are short positions in excess of that amount. The underwriters
    may close out any covered short position by either exercising their option, in whole or in part, or by purchasing shares in the open
    market. In making this determination, the underwriters will consider, among other things, the price of shares available for purchase
    in the open market as compared to the price at which they may purchase shares through the over-allotment option. Naked short sales
    are short sales made in excess of the over-allotment option. The underwriters must close out any naked short position by purchasing
    shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be
    downward pressure on the price of our Class A Ordinary Shares in the open market that could adversely affect investors who purchased
    in this offering.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    penalty bid is an arrangement permitting the managing underwriter to reclaim the selling concession that would otherwise accrue to
    an underwriter if the Class A Ordinary Shares originally sold by the underwriter were later repurchased by the managing underwriter
    and therefore were not effectively sold to the public by such underwriter.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 48pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stabilization,
syndicate-covering transactions, and penalty bids may have the effect of raising or maintaining the market price of our Class A Ordinary
Shares or preventing or delaying a decline in the market price of our Class A Ordinary Shares. As a result, the price of our Class A
Ordinary Shares may be higher than the price that might otherwise exist in the open market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the underwriters make any representation or prediction as to the effect that the transactions described above may have on the
prices of our Class A Ordinary Shares. These transactions may occur on Nasdaq or on any trading market. If any of these transactions
are commenced, they may be discontinued without notice at any time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 127 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Offers
Outside of the United States</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the Class A Ordinary
Shares offered by this prospectus in any jurisdiction where action for that purpose is required. The Class A Ordinary Shares offered
by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements
in connection with the offer and sale of any such shares be distributed or published in any jurisdiction, except under circumstances
that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus
comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any Class A Ordinary Shares offered by this
prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Australia</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is not a disclosure document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian
Securities and Investments Commission and does not purport to include the information required of a disclosure document under Chapter
6D of the Australian Corporations Act. Accordingly, (i) the offer of the securities under this prospectus is only made to persons to
whom it is lawful to offer the securities without disclosure under Chapter 6D of the Australian Corporations Act under one or more exemptions
set out in section 708 of the Australian Corporations Act; (ii) this prospectus is made available in Australia only to those persons
as set forth in clause (i) above; and (iii) the offeree must be sent a notice stating in substance that, by accepting this offer, the
offeree represents that the offeree is such a person as set forth in clause (i) above, and, unless permitted under the Australian Corporations
Act, agrees not to sell or offer for sale within Australia any of the securities sold to the offeree within 12 months after its transfer
to the offeree under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Canada</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors,
as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted
clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale
of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements
of applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
(including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by
the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s province or territory. The purchaser
should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s province or territory for particulars
of these rights or consult with a legal advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105), the underwriters are not required to comply with the
disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>China</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document does not constitute a public offer of the securities, whether by way of sale or subscription, in the People&rsquo;s
Republic of China (&ldquo;PRC&rdquo;) (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special
Administrative Region and Taiwan). The securities may not be offered or sold directly or indirectly in the PRC to legal or natural persons
other than directly to &ldquo;qualified domestic institutional investors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 128 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>European
Economic Area &mdash; Belgium, Germany, Luxembourg and Netherlands</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
relation to each Member State of the European Economic Area that has implemented the Prospectus Regulation (each, a &ldquo;Relevant Member
State&rdquo;), an offer to the public of our securities may not be made in that Relevant Member State, except that an offer to the public
in that Relevant Member State of our securities may be made at any time under the following exemptions under the Prospectus Regulation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any legal entity which is a qualified investor as defined in the Prospectus Regulation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            fewer than 150 natural or legal persons (other than qualified investors as defined in the
                                            Prospectus Regulation),</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to obtaining the prior consent of the representative for any such offer; or</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            any other circumstances falling within Article 1(4) of the Prospectus Regulation, provided
                                            that no such offer of</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    securities shall result in a requirement for the publication by us or any underwriter of a prospectus pursuant</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    Article 3 of the Prospectus Regulation.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of this provision, the expression an &ldquo;offer to the public&rdquo; in relation to our securities in any Relevant Member
State means the communication in any form and by any means of sufficient information on the terms of the offer and our securities to
be offered so as to enable an investor to decide to purchase our securities, and the expression &ldquo;Prospectus Regulation&rdquo; means
Regulation (EU) 2017/1129 (as amended).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
European Economic Area selling restriction is in addition to any other applicable selling restrictions set out below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>France</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is not being distributed in the context of a public offering of financial securities (offre au public de titres financiers)
in France within the meaning of Article L.411-1 of the French Monetary and Financial Code (Code Mon&eacute;taire et Financier) and Articles
211-1 et seq. of the General Regulation of the French Autorit&eacute; des March&eacute;s Financiers (&ldquo;AMF&rdquo;). The securities
have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document and any other offering material relating to the securities have not been, and will not be, submitted to the AMF for approval
in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
offers, sales and distributions have been and shall only be made in France to (i) qualified investors (investisseurs qualifi&eacute;s)
acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&deg; and D.411-1 to D.411-3, D. 744-1, D.754-1
and D.764-1 of the French Monetary and Financial Code and any implementing regulation; and/or (ii) a restricted number of non-qualified
investors (cercle restreint d&rsquo;investisseurs) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2
and D.411-4, D.744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Article 211-3 of the General Regulation of the AMF, investors in France are informed that the securities cannot be distributed (directly
or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 to L.621-8-3
of the French Monetary and Financial Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Ireland</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document does not constitute a prospectus under any Irish laws or regulations, and this document has not been filed
with or approved by any Irish regulatory authority, as the information has not been prepared in the context of a public offering of securities
in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations 2005 (the &ldquo;Prospectus Regulations&rdquo;).
The securities have not been offered or sold, and will not be offered, sold or delivered directly or indirectly in Ireland by way of
a public offering, except to (i) qualified investors as defined in Regulation 2(l) of the Prospectus Regulations; and (ii) fewer than
100 natural or legal persons who are not qualified investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 129 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Hong
Kong</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do not constitute an
offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong
Kong) (&ldquo;Companies (Winding Up and Miscellaneous Provisions) Ordinance&rdquo;) or which do not constitute an invitation to the public
within the meaning of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) (&ldquo;Securities and Futures Ordinance&rdquo;);
(ii) to &ldquo;professional investors&rdquo; as defined in the Securities and Futures Ordinance and any rules made thereunder; or (iii)
in other circumstances which do not result in the document being a &ldquo;prospectus&rdquo; as defined in the Companies (Winding Up and
Miscellaneous Provisions) Ordinance, and no advertisement, invitation or document relating to our securities may be issued or may be
in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the
contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws
of Hong Kong) other than with respect to our securities that are or are intended to be disposed of only to persons outside Hong Kong
or only to &ldquo;professional investors&rdquo; in Hong Kong as defined in the Securities and Futures Ordinance and any rules made thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Israel</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities offered by this prospectus have not been approved or disapproved by the Israeli Securities Authority (the ISA), nor have such
securities been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public in Israel,
absent the publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection with the offering or publishing
of the prospectus; nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered an
opinion as to the quality of the securities being offered. Any resale in Israel, directly or indirectly, to the public of the securities
offered by this prospectus is subject to restrictions on transferability and must be effected only in compliance with the Israeli securities
laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Italy</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 12.9pt; text-align: justify; text-indent: 23.1pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission (Commissione
Nazionale per le Societ - $$ - Aga e la Borsa, &ldquo;CONSOB&rdquo;) pursuant to Italian securities legislation, and, accordingly, no
offering material relating to the securities may be distributed in Italy, and such securities may not be offered or sold in Italy in
a public offer within the meaning of Article 1.1(t) of Legislative Decree No. 58 of 24 February 1998 (&ldquo;Decree No. 58&rdquo;), other
than:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 12.9pt; text-align: justify; text-indent: 23.1pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            Italian qualified investors, as defined in Article 100 of Decree no. 58 by reference to Article
                                            34-ter of</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOB
    Regulation no. 11971 of 14 May 1999 (&ldquo;Regulation no. 1197l&rdquo;) as amended (&ldquo;Qualified Investors&rdquo;); and</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                                         other circumstances that are exempt from the rules on public offer pursuant to Article 100 of Decree No. 58 and Article 34-ter of
                                                         Regulation No. 11971 as amended.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
offer, sale or delivery of the securities or distribution of any offer document relating to the securities in Italy (excluding placements
where a Qualified Investor solicits an offer from the issuer) under the paragraphs above must be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">made
by investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with Legislative Decree
No. 385 of 1 September 1993 (as amended), Decree No. 58, CONSOB Regulation No. 16190 of 29 October 2007 and any other applicable laws;
and</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    compliance with all relevant Italian securities, tax and exchange controls and any other applicable laws.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement rules
provided under Decree No. 58 and Regulation No. 11971, as amended, unless an exception from those rules applies. Failure to comply with
such rules may result in the sale of such securities being declared null and void and in the liability of the entity transferring the
securities for any damages suffered by the investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 130 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Japan</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities have not been and will not be registered under the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948, as
amended), or the FIEA. The securities may not be offered or sold, directly or indirectly, in Japan or to or for the benefit of any resident
of Japan (including any person resident in Japan or any corporation or other entity organized under the laws of Japan) or to others for
reoffering or resale, directly or indirectly, in Japan or to or for the benefit of any resident of Japan, except pursuant to an exemption
from the registration requirements of the FIEA and otherwise in compliance with any relevant laws and regulations of Japan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Portugal</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is not being distributed in the context of a public offer of financial securities (oferta p&uacute;blica de valores mobili&aacute;rios)
in Portugal, within the meaning of Article 109 of the Portuguese Securities Code (C&oacute;digo dos Valores Mobili&aacute;rios). The
securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal. This document
and any other offering material relating to the securities have not been, and will not be, submitted to the Portuguese Securities Market
Commission (Comiss&atilde;o do Mercado de Valores Mobili&aacute;rios) for approval in Portugal and, accordingly, may not be distributed
or caused to distributed, directly or indirectly, to the public in Portugal, other than under circumstances that are deemed not to qualify
as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of securities in Portugal are limited to
persons who are &ldquo;qualified investors&rdquo; (as defined in the Portuguese Securities Code). Only such investors may receive this
document, and they may not distribute it or the information contained in it to any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Singapore</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other
document or material in connection with the offer or sale, or invitation for subscription or purchase, of our securities may not be circulated
or distributed, nor may our securities be offered or sold, or be made the subject of an invitation for subscription or purchase, whether
directly or indirectly, to persons in Singapore other than (i) to an institutional investor (as defined under Section 4A of the Securities
and Futures Act, 2001 of Singapore (&ldquo;<B>SFA</B>&rdquo;)) under Section 274 of the SFA; (ii) to a relevant person (as defined in
Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance
with the conditions specified in Section 275 of the SFA and (where applicable) Regulation 3 of the Securities and Futures (Classes of
Investors) Regulations 2018; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision
of the SFA, in each case subject to conditions set forth in the SFA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
our securities are subscribed or purchased under Section 275 of the SFA by a relevant person which is a corporation (which is not an
accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital
of which is owned by one or more individuals, each of whom is an accredited investor, the securities or securities-based derivatives contracts of that corporation shall not be transferable within six months after that corporation has acquired the securities or securities-based derivatives contracts under Section 275
of the SFA except: (1) to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section
275(1A) or Section 276(4)(c)(ii) of the SFA,
(2) where no consideration is or will be given for the transfer, (3) where the transfer is by operation of law, (4) as specified in Section
276(7) of the SFA, or (5) as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives
Contracts) Regulations 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where
our securities are subscribed or purchased under Section 275 of the SFA by a relevant person which is a trust (where the trustee is not
an accredited investor (as defined in Section 4A of the SFA)) whose sole purpose is to hold investments and each beneficiary of the trust
is an accredited investor, the beneficiaries&rsquo; rights and interest (howsoever described) in that trust shall not be transferable
within six months after that trust has acquired the shares under Section 275 of the SFA except: (1) to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section
275(1A) or Section 276(4)(c)(ii) of the SFA, (2) where no consideration is or will be given for the transfer, (3) where the transfer is
by operation of law, (4) as specified in Section 276(7) of the SFA, or (5) as specified in Regulation 37A of the Securities and Futures
(Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 131 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Malaysia</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities have not been and may not be approved by the Securities Commission Malaysia, or SC, and this document has not been and will
not be registered as a prospectus with the SC under the Malaysian capital markets and services act of 2007, or CMSA. Accordingly, no
securities or offer for subscription or purchase of securities or invitation to subscribe for or purchase securities are being made to
any person in or from within Malaysia under this document except to persons falling within any of paragraphs 2(g)(i) to (xi) of schedule
5 of the CMSA and distributed only by a holder of a capital markets services license who carries on the business of dealing in securities
and subject to the issuer having lodged this prospectus with the SC within seven days from the date of the distribution of this prospectus
in Malaysia. The distribution in Malaysia of this document is subject to Malaysian laws. Save as aforementioned, no action has been taken
in Malaysia under its securities laws in respect of this document. This document does not constitute and may not be used for the purpose
of a public offering or an issue, offer for subscription or purchase, invitation to subscribe for or purchase any securities requiring
the approval of the SC or the registration of a prospectus with the SC under the CMSA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sweden</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document has not been, and will not be, registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority).
Accordingly, this document may not be made available, nor may the securities be offered for sale in Sweden, other than under circumstances
that are deemed not to require a prospectus under the Swedish Financial Instruments Trading Act (1991:980) (Sw. lag (1991:980) om handel
med finansiella instrument). Any offering of securities in Sweden is limited to persons who are &ldquo;qualified investors&rdquo; (as
defined in the Financial Instruments Trading Act). Only such investors may receive this document, and they may not distribute it or the
information contained in it to any other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Switzerland</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&ldquo;SIX&rdquo;) or on any
other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards
for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses
under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland.
Neither this document nor any other offering material relating to the securities may be publicly distributed or otherwise made publicly
available in Switzerland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
this document nor any other offering material relating to the securities has been or will be filed with or approved by any Swiss regulatory
authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial
Market Supervisory Authority (FINMA). This document is personal to the recipient only and not for general circulation in Switzerland.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>United
Arab Emirates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.1pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
this document nor the securities have been approved, disapproved or passed on in any way by the Central Bank of the United Arab Emirates
or any other governmental authority in the United Arab Emirates, nor has the Company received authorization or licensing from the Central
Bank of the United Arab Emirates or any other governmental authority in the United Arab Emirates to market or sell the securities within
the United Arab Emirates. This document does not constitute and may not be used for the purpose of an offer or invitation. No services
relating to the securities, including the receipt of applications and/or the allotment or redemption of such shares, may be rendered
within the United Arab Emirates by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
offer or invitation to subscribe for securities is valid or permitted in the Dubai International Financial Centre.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>United
Kingdom</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Services
Authority in the United Kingdom, and no prospectus (within the meaning of section 85 of the Financial Services and Markets Act 2000,
as amended (&ldquo;FSMA&rdquo;)) has been published or is intended to be published in respect of the securities. This document is issued
on a confidential basis to &ldquo;qualified investors&rdquo; (within the meaning of section 86(7) of FSMA) in the United Kingdom, and
the securities may not be offered or sold in the United Kingdom by means of this document, any accompanying letter or any other document,
except in circumstances which do not require the publication of a prospectus pursuant to section 86(1) FSMA. This document should not
be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other person in
the United Kingdom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
address of Network 1 Financial Securities, Inc. is 2 Bridge Avenue, Suite 241 Red Bank, NJ&nbsp;07701.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 132 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="loi_007"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Expenses
Related To This Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is an itemization of the total expenses, excluding underwriting discounts and commissions, which are expected to be incurred
in connection with the offer and sale of the Class A Ordinary Shares by us. With the exception of the SEC registration fee, the Nasdaq
Capital Market listing fee and the Financial Industry Regulatory Authority (&ldquo;FINRA&rdquo;) filing fee, all amounts are estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 78%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">SEC
    registration fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,392</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nasdaq
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">listing fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">FINRA
    filing fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,295</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Printing
    and engraving expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,995</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal
    fees and expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">550,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounting
    fees and expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">320,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Miscellaneous</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,000</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold; font-style: normal; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">US$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt DengXian; margin: 0; text-align: right">1,264,682.00</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Note</I>:
The expenses above are to be completed in amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
expenses will be borne by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 133 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A NAME="loi_008"></A><B>Legal
Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are being represented by Sidley Austin LLP with respect to certain legal matters as to United States federal securities law. The underwriter
is being represented by Loeb &amp; Loeb LLP  with respect to certain legal matters as to United States federal securities law.
The validity of the Class A Ordinary Shares offered in this offering will be passed upon for us by Harney Westwood &amp; Riegels Singapore
LLP. Certain legal matters as to Singapore law will be passed upon for us by Rajah &amp; Tann Singapore LLP. Sidley Austin LLP may rely
upon Harney Westwood &amp; Riegels Singapore LLP with respect to matters governed by Cayman Islands law and Rajah &amp; Tann Singapore
LLP with respect to matters governed by Singapore law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="loi_009"></A>Experts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements as of and for the years ended June 30, 2023 and 2022, and the related financial statement schedule included
in this prospectus have been audited by Simon &amp; Edward, LLP, an independent registered public accounting firm, as stated in their
report appearing herein (which expresses an unqualified opinion on the financial statements and includes an explanatory paragraph referring
to the translation of SGD amounts to United States dollar amounts). Such financial statements and financial statement schedule are included
in reliance upon the report of such firm given upon their authority as experts in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
office of Simon &amp; Edward, LLP is located at 17506 Colima Road Suite #101, Rowland Heights, CA 91748.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 135 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="loi_010"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Where
You Can Find Additional Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed a registration statement, including relevant exhibits and schedules, with the SEC on Form F-1 under the Securities Act with
respect to the Class A Ordinary Shares to be sold in this offering. This prospectus, which constitutes a part of the registration statement
on Form F-1, does not contain all of the information contained in the registration statement. You should read our registration statement
and its exhibits and schedules thereto for further information with respect to us and the Class A Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
upon the effectiveness of the registration statement on Form F-1 of which this prospectus forms a part, we will become subject to periodic
reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we will be
required to file reports, including annual reports on Form 20-F, and other information with the SEC. All information filed with the SEC
can be obtained over the internet at the SEC&rsquo;s website at www.sec.gov or inspected and copied at the public reference facilities
maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. You can request copies of documents, upon payment of a duplicating
fee, by writing to the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 136 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="t_001"></A>MOBILE-HEALTH
NETWORK SOLUTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#F_001">Report of Independent Registered Public Accounting Firm (PCAOB ID: 2485)</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Statements:</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#F_002">Consolidated Balance Sheets as of June 30, 2023 and 2022</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#F_003">Consolidated Statements of Operations and Comprehensive Income for the Years Ended June 30, 2023 and 2022</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#F_004">Consolidated Statements of Changes in Shareholders&rsquo; Equity for the Years Ended June 30, 2023 and 2022</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#F_005">Consolidated Statements of Cash Flows for the Years Ended June 30, 2023 and 2022</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</FONT>7</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif"><A HREF="#sssss_001">Notes to Consolidated Financial Statements</A>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8
    &ndash; F-26</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 137; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="F_001"></A>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
and Board of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mobile-Health
Network Solutions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion
on the Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Mobile-Health Network Solutions and subsidiary (the &ldquo;Company&rdquo;)
as of June 30, 2023 and 2022, the related consolidated statements of operation and comprehensive income (loss), changes in stockholders&rsquo;
equity, and cash flows for each of the two years in the period ended June 30, 2023 and 2022, and the related notes to the consolidated
financial statements. In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position
of the Company as of June 30, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period
ended June 30, 2023 and 2022<B>,</B> in conformity with accounting principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
for Opinion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion
on the Company&rsquo;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting. Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Audit Matter</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that
was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material
to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication
of critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are
not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or
disclosures to which it relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 138; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenue
recognition &ndash; Determination of principal versus agent</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Notes 2 to the consolidated financial statements, revenue is recognized on a gross or net basis based on whether the Company
acts as a principal by controlling the service provided to the consumer, or whether it acts as an agent by arranging for third parties
to provide the service to the consumer. During the years ended June 30, 2023 and 2022, telemedicine service was resulted in deliveries
revenue of $6 million from contractual agreements in which the Company is responsible for arranging telemedicine consultation service
provided to patients by in-house doctors and/or external contractual doctors and the Company is therefore acting as a principal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
identified the determination of principal versus agent for revenue recognition for the telemedicine service arrangements as a critical
audit matter. Specifically, subjective auditor judgment was required to evaluate whether the Company acted as either a principal or an
agent with respect to whether the Company controls the promised service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary procedures we performed to address this critical audit matter included:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&raquo;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtained
                                            understanding the legal requirements and operating environment of medical practice at Singapore.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&raquo;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtained
                                            and understood the service contracts between the Company, Manadr APP users (i.e. patients)
                                            and service provider (i.e. doctors) for telemedine advises subscribed and medical advises
                                            and medicine prescription provided;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&raquo;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performed
                                            testing walkthroughs of sales and purchase transactions to confirm the working flow of the
                                            key business cycles;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&raquo;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtained
                                            revenue recognition memo including analysis of principal versus agent along with the management&rsquo;s
                                            conclusion;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&raquo;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessed
                                            management&rsquo;s determination of revenue recognition for the telemedicine service arrangements
                                            by analyzing whether the Company controls the promised service pursuant to the terms and
                                            conditions with Manadr APP users and service providers.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&raquo;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leveraged
                                            the testing result of substantive testing to further verify the management&rsquo;s conclusion.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Simon &amp; Edward, LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&rsquo;s auditor since 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rowland
Heights, California</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
27, 2023 except Note 14 and 15 on March 6, 2024</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>


<!-- Field: Page; Sequence: 139 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MOBILE-HEALTH
NETWORK SOLUTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="F_002"></A>CONSOLIDATED
BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">2,225,806</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">10,243,088</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,315</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,526</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Inventories, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">146,381</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">71,655</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,410</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,556</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Amount due from related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,897</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,329</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Amount due from officers</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,449</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,717,809</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,541,603</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Non-current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">178,799</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,350</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,783</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,225</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating leases right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">393,198</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,445</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">81,950</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Investment in joint venture</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total non-current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">724,730</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">214,021</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,442,539</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,755,624</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">LIABILITIES AND SHAREHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,358,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">560,730</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accruals and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">826,167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">372,350</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Amount due to officers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">133,586</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">158,344</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Amount due to related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,915</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,303</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating lease liabilities, current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,604</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,163</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Income taxes payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">134,362</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,500,088</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,269,252</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Non-current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Amount due to officers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">994,708</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">958,440</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,763</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">71,849</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Operating lease liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">241,179</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19,954</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total non-current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,309,650</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,050,243</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,809,738</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,319,495</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">COMMITMENTS AND CONTINGENCIES (Note 13)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">SHAREHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Ordinary shares, Class A, $0.000004 par value, 6,250,000,000 shares authorized, 13,403,750
    and 16,873,500 shares issued and outstanding as of June 30, 2023 and 2022, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Ordinary shares, Class B, $0.000004 par value, 6,250,000,000 shares authorized, 12,078,250 shares issued and outstanding
    as of June 30, 2023 and 2022, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,496,710</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,482,926</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,153,001</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,939,641</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive income (loss)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">288,990</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(107,272</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total shareholders&rsquo; (deficit) equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(367,199</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,436,129</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TOTAL LIABILITIES AND SHAREHOLDERS&rsquo; (DEFICIT) EQUITY</B></FONT></P></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,442,539</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,755,624</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 140 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MOBILE-HEALTH
NETWORK SOLUTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="F_003"></A>CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended June 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; font-weight: bold; padding-bottom: 1.5pt">Revenue</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; border-bottom: Black 1.5pt solid; text-align: right">7,874,886</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; border-bottom: Black 1.5pt solid; text-align: right">6,988,849</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">- Third parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,434,789</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,439,164</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">- Related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">440,097</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">549,685</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt">Cost</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(6,779,892</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(5,053,743</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">- Third parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,629,622</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,096,651</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">- Related parties</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(150,270</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(957,092</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,094,994</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,935,106</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Salaries and benefits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,389,892</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,038,877</TD><TD STYLE="text-align: left">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,094</TD><TD STYLE="text-align: left">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,898,986</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">615,473</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,383,694</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,741,444</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Other (loss) income:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Government incentives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,892</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,357</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other income, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">47,448</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">62,453</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total other income, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">75,340</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">64,810</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">(Loss) Income before income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,213,360</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">258,472</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Income tax expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(165,775</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net (loss) income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,213,360</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">92,697</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Other comprehensive income:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Foreign currency translation, net of income tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">396,262</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(114,433</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Comprehensive loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,817,098</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(21,736</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Net (loss) income per share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Basic and diluted</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(29.67</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1.07</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Weighted average number of ordinary shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Basic and diluted</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">108,311</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">86,402</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 141 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MOBILE-HEALTH
NETWORK SOLUTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="F_004"></A>CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS&rsquo; EQUITY (DEFICIT)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><P STYLE="margin-top: 0pt; margin-bottom: 0pt">Ordinary shares,</P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt">Class A</P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><P STYLE="margin-top: 0pt; margin-bottom: 0pt">Ordinary shares,</P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt">Class B</P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">Additional</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">Accumulated other</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-size: 11pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Shares </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Outstanding</B></P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Par value</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Shares </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Outstanding</B></P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Par value</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">paid-in capital</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Accumulated losses</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">comprehensive income (loss)</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">US$</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-size: 11pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 11pt">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">US$</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">US$</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">US$</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">US$</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">US$</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-weight: bold">Balance as of July 1, 2021</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">8,052,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">32</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">12,078,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">49</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">(6,032,338</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">7,161</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">(6,025,096</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Issuance of ordinary shares (Note 10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,821,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,482,926</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,482,961</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net income</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">92,697</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">92,697</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Foreign currency translation adjustment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(114,433</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(114,433</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Balance as of June 30, 2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,873,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,078,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,482,926</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,939,641</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(107,272</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,436,129</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Ordinary shares buy back (Note 10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,026,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,848,257</TD><TD STYLE="text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,848,273</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Issuance of ordinary shares (Note 10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">556,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">862,041</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">862,043</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net loss</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,213,360</TD><TD STYLE="text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,213,360</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Foreign currency translation adjustment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">394,262</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">394,262</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; font-weight: bold">Balance as of June 30, 2023</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">13,403,750</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">53</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">12,078,250</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,496,710</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(9,153,001</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">288,990</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(367,199</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 142 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MOBILE-HEALTH
NETWORK SOLUTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="F_005"></A>CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended June 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left">Net (loss) income</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">(3,213,360</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">92,697</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,094</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Non cash lease expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,076</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,696</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Intangible assets written off</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,887</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,958</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred tax benefit provision</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">549</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Allowance for doubtful debts</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,450</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Provision for stock obsolesces</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,438</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0pt; text-align: left">Change in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(513</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119,360</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(210,622</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,287</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(92,813</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,065</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">748,515</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">298,587</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accruals and other current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">431,812</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">229,844</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Operating lease assets and liabilities, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(105,212</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,353</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-align: left">Income taxes payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(137,100</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">134,362</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Net cash (used in) provided by operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,248,626</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">975,656</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Purchase of property and equipment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(186,001</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(15,211</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(186,001</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(15,211</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Proceeds from issuance of ordinary shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">843,081</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,709,166</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Repurchase of ordinary shares issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,598,240</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Repayment of other payables to related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(45,293</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,889</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Repayment to directors</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(463,381</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Net cash (used in) provided by financial activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(5,800,452</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,233,896</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Effect of exchange rate changes on cash and cash equivalents</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">217,797</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(114,433</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net change in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,017,282</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,079,908</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Cash and cash equivalents - beginning of year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,243,088</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">163,180</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Cash and cash equivalents - end of year</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,225,806</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,243,088</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">SUPPLEMENTAL CASH FLOW INFORMATION:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash paid for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Cash paid for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">217,228</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Cash refund from income taxes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">27,844</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Shares issued via the capitalization of amount due to director</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,773,795</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes form an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 143; Options: NewSection; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B><A NAME="sssss_001"></A>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Organization and business overview </B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mobile-Health
Network Solutions. is an investment holding company incorporated on 28 July 2016 under the laws of the Cayman Islands. The Company through
its subsidiaries provides telehealth solutions through our MaNaDr platform, which is accessible via our mobile application and website
to offer users with a range of seamless and hassle-free telehealth solutions. The platform seeks to offer users the ability to teleconsult
with doctors and be prescribed and delivered with the medication at their doorsteps. We also sell prescription drugs, non-prescription
drugs and healthcare products directly on our platform and indirectly through the Company&rsquo;s retail pharmacy network. Mobile-Health
Network Solutions and its subsidiaries are collectively referred to as the &ldquo;Company&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is headquartered in Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements of the Company include the following entities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 16%"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date of</B></FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation</B></FONT></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage
    of direct or indirect interests</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 12%"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Place of</B></FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation</B></FONT></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
    activities</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mobile-Health
                                            Network Solutions</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28
    July 2016</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
    Islands</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    holding</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manadr
    Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28
    September 2016</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70%
    <SUP>(1)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Providing
    healthcare services through mobile application and web portals </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mobile
    Health Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
    July 2009</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
    IT systems on mobile phone </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Songline
    Analytics Pvt Ltd. </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
    August 2015</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.99%<SUP>(3)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">India</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposed
    on December 2022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    Healthservice Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28
    September 2016</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmacies,
    drug stores and other health services</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manahome
    care Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    23, 2017</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Struck
    off in January 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manacollege
    Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    11, 2017</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Struck
    off in September 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mana
    Aesthetics Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    11, 2017</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beauty
    and other personal care services</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managourmet
    Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    28, 2017</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Struck
    off in April 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nano
    Mana Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    2, 2018</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%<SUP>(2)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Struck
    off in September 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manaheart
    Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    29, 2019</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Struck
    off in April 2023</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manapharma
    Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    17, 2019</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Struck
    off in December 2022</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 144; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1&nbsp;</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Organization and business overview (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 16%"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date of</B></FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 24%"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage of direct</B></FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>or indirect interests</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 12%"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Place of</B></FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incorporation</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
    activities</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manadr
    Clinic Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    6, 2023</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%<SUP>(4)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinics
    and other general medical services</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manadr
    Vietnam Pte. Ltd.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    29, 2023</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%<SUP>(5)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vietnam</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
    IT systems on mobile phone and web portals</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company entered into a trust deed with Teoh Pui Pui to hold 30% legal ownership of Manadr Pte. Ltd. on behalf of the Company with
    effective from April 8, 2021 in connection with the restructuring exercise to rationalize the Group structure. The Company had 100%
    beneficial ownership of Manadr Pte. Ltd. pursuant to the trust deed. On March 31, 2023, the 30% ownership was transferred back from
    Teoh Pui Pui to the Company in the same consideration to streamline the capital structure of the Company prior to the Nasdaq listing
    application. Manadr Pte. Ltd is consolidated in the accompanying consolidated financial statements as a wholly owned subsidiary during
    the period. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has a 50% interest in Nano Mana Pte. Ltd., a dormant joint venture company. The joint venture company was struck off in September
    2023. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    December 2022, the Company completed the disposal of the subsidiary, Songline Analytics Pvt Ltd. to an independent third party, for
    a consideration of approximately $8,000. The disposal of Songline Analytics Pvt Ltd. did not represent a strategic shift that has
    a major effect on the Company&rsquo;s operations and financial results. Therefore, the disposal of the subsidiary is not reported
    in discontinued operations.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    March 6, 2023, Manadr Clinic Pte. Ltd had been incorporated and the capital injection was $75,358 (S$100,000)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    June 29, 2023, Manadr Vietnam Pte. Ltd had been incorporated and the capital injection was $50,000.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary of significant accounting policies </B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary of significant accounting policies is presented to assist in understanding the Company&rsquo;s consolidated financial statements
and has been consistently applied in the preparation of the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Basis
of presentation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&ldquo;US GAAP&rdquo;) and pursuant to the rules and regulations of the Securities and Exchange Commission
(&ldquo;SEC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consolidation</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. Significant inter-company balances,
inter-company transactions, investment and capital, if any, have been eliminated upon consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-controlling
interest represents the portion of the net assets of a subsidiary attributable to interests that are not owned by the Company. The non-controlling
interest is presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling
interest&rsquo;s operating result is presented on the face of the consolidated statements of income and comprehensive income/(loss) as
an allocation of the total income/(loss) for the year between non-controlling shareholders and the shareholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 145; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary of significant accounting policies (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Use
of estimates </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with US GAAP requires management to make judgements, estimates and assumptions
that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated
assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances,
the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent
from other sources. Significant accounting estimates reflected in the Company&rsquo;s consolidated financial statements include, but
are not limited to, inventory valuation, impairment of long-lived assets, estimated useful life of property and equipment and intangible
assets, and allowance for credit losses on receivables, and realisation of deferred tax assets. Actual results may differ from these
estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Foreign
currency and translation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
functional currency of Mobile-Health Network Solutions and its Singapore subsidiaries is the Singapore dollar (&ldquo;S$&rdquo;) The
functional currency of the Company&rsquo;s Indian subsidiary is the Indian Rupee (INR). The reporting currency of the Company is the
United States dollar (the &ldquo;US$&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of the Company is translated from the functional currency to the reporting currency, the US$. Transactions denominated
in foreign currencies are re-measured into the functional currency at the exchange rates prevailing on the transaction dates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monetary
assets and liabilities denominated in foreign currencies are re-measured at the exchange rates prevailing at the balance sheet date.
Non-monetary items that are measured in terms of historical costs in foreign currency. Exchange gains and losses are included in the
consolidated statements of income and comprehensive income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the average exchange rate for the year and the exchange rate at the balance sheet date to translate the operating results
and financial position, respectively. Equity accounts other than earnings generated in current year are translated into US$ at the appropriate
historical rates. Translation differences are recorded in accumulated other comprehensive income, a component of shareholders&rsquo;
equity (deficit).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
and cash equivalents </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents primarily consist of bank deposits with original maturities of three months or less, which are unrestricted as to
withdrawal and use. The Company maintains most of its bank accounts in Singapore. Cash and cash equivalents represent cash in bank and
are unrestricted as to withdrawal or use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Accounts
receivable, net</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable mainly represent amounts due from customers that meet the revenue recognition criteria. These accounts receivables are recorded
net of any allowance for credit losses and specific customer credit allowances. The Company maintains an allowance for estimated credit
losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses
adjusted to take into account current market conditions and the Company&rsquo;s customers&rsquo; financial condition, the receivable
amount in dispute, and the current receivables aging and current payment patterns, over the contractual life of the receivable. The Company
writes off the receivable when it is determined to be uncollectible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
current assets </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
current assets, including deposits, other receivables (from staff), income tax receivable and prepayments, are classified based on the
terms of the respective agreements. These advances are unsecured and are reviewed periodically to determine whether their carrying value
has become impaired. As of June 30, 2023 and 2022, management believes that the Company&rsquo;s prepayments and deposits are not impaired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 146; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary of significant accounting policies (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inventory,
net</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are measured at the lower of cost or net realizable value. The cost of inventories is based on the first-in, first-out principle, and
includes expenditure incurred in acquiring the inventories and other costs incurred in bringing them to their existing location and condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review inventory quarterly for salability and obsolescence based on expiration dates. A statistical allowance is provided for inventory
considered unlikely to be sold. The statistical allowance is based on an analysis of the expiration dates, historical disposal activity,
historical customer shipments, as well as estimated future sales. We write off inventory in the period in which disposal occurs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Property
and equipment, net </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost less accumulated depreciation and impairment if applicable. The Company computes depreciation using
the straight-line method over the estimated useful lives of the assets as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Categories</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 65%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Useful
    life</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    and software</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; fittings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    years</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    equipment</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    years</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvement</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter
    of the remaining lease term or 3 years</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is
included in the consolidated statement of operations and comprehensive income. Expenditures for maintenance and repairs are charged to
expense as incurred, while additions renewals and betterments, which are expected to extend the useful life of assets, are capitalized.
The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates
of useful lives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Intangible
assets, net </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets represent the Manadr platform, patents and trademarks. These intangible assets arise primarily from the determination of their
respective fair market values at the date of acquisition. The useful life of the intangible assets is assessed to be finite and amortization
is computed using the straight-line method over the estimated useful lives or 3 to 10 years based upon the future cash flows attributable
to the asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Impairment
of long-lived assets </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the recoverability of its long-lived assets (asset groups), including property and equipment, definite-lived intangible
assets and operating lease right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying
amount of its asset (asset group) may not be fully recoverable. When these events occur, the Company measures impairment by comparing
the carrying amount of the assets to the estimated undiscounted future cash flows expected to result from the use of the asset (asset
group) and their eventual disposition. If the sum of the expected undiscounted cash flows is less than the carrying amount of the asset
(asset group), the Company recognizes an impairment loss based on the excess of the carrying amount of the asset (asset group) over their
fair value. Fair value is generally determined by discounting the cash flows expected to be generated by the asset (asset group), when
the market prices are not readily available. The adjusted carrying amount of the asset is the new cost basis and is depreciated over
the asset&rsquo;s remaining useful life. Long-lived assets are grouped with other assets and liabilities at the lowest level for which
identifiable cash flows are largely independent of the cash flows of other assets and liabilities. For the years ended June 30, 2023
and 2022, no impairment of long-lived assets was recognized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 147; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary of significant accounting policies (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Leases</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a lessee of non-cancellable operating leases for its corporate office premise. The Company determines if an arrangement is
a lease at inception. Lease assets and liabilities are recognized at the present value of the future lease payments at the lease commencement
date. The interest rate used to determine the present value of the future lease payments is the Company&rsquo;s incremental borrowing
rate based on the information available at the lease commencement date. The Company generally uses the base, non-cancellable lease term
in calculating the right-of-use assets and liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less.
The Company recognizes the lease payments associated with its short-term leases as an expense on a straight-line basis over the lease
term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the impairment of its right-of-use assets consistent with the approach applied for its other long-lived assets. The
assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future
pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of finance and operating lease liabilities
in any tested asset group and include the associated lease payments in the undiscounted future pre-tax cash flows. For the years ended
June 30, 2023 and 2022, the Company did not have any impairment loss against its operating lease right-of-use assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fair
value measurements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal
or most advantageous market. ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair
value as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in; margin-right: 0pt">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    other inputs that are directly or indirectly observable in the marketplace. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-
    unobservable inputs which are supported by little or no market activity. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of cash and cash equivalents, accounts receivable, other current assets, accounts payable, and accruals and other payables
approximate their fair values because of their generally short maturities. Other non-current liabilities are stated at amortized cost,
which approximates fair value. The carrying amounts of operating lease liabilities and the amount due to officers approximate their fair
values since they bear an interest rate which approximates market interest rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenue
recognition </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the revenue requirements of Accounting Standards Update (&ldquo;ASU&rdquo;) No. 2014-09, Revenue from Contracts with
Customers (Topic 606) (&ldquo;Accounting Standards Codification (&ldquo;ASC&rdquo;) 606&rdquo;). The core principle underlying the revenue
recognition of this ASC allows the Company to recognize revenue that represents the transfer of goods and services to customers in an
amount that reflects the consideration to which the Company expect to be entitled in such exchange. This will require the Company to
identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based
on when control of goods and services transfers to a customer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
achieve that core principle, the Company applies five-step model to recognize revenue from customer contracts. The five-step model requires
that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine
the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not
occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when
(or as) the Company satisfies the performance obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives revenue from two main segments: (1) telemedicine and other services; and (2) sale of medicine and medical devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 148; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary of significant accounting policies (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenue
recognition (continued)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Telemedicine
and other services</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telemedicine
services are provided to both private sector and public sector. The Company earns telemedicine services revenue from private sector by
providing teleconsultation services to patients who have subscribed to Manadr APP by contractual service providers and sale of prescribed
medicine. Telemedicine revenue derived from public sector represents revenue generated from contracts with the relevant authorities and
departments of the Singapore government by providing teleconsultation services to patients identified by the authorities and departments
of the Singapore government. Telemedicine services with prescribed medicine are two distinct performance obligations with standalone
prices that are fixed and paid post rendering of teleconsultation service with patients. Prescribed medicine will be delivered to the
customer on the same day. The amount paid by the patient is then allocated to each performance obligation in a contract based on its
relative standalone selling price (&ldquo;SSP&rdquo;). The SSP is the observable price at which we sell the product or service separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from teleconsultation services and sale of prescribed medicine are recognized at a point in time when the services are rendered and the
products are delivered to the customers respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers the following indicators amongst others when determining whether it is acting as a principal in the contract where
revenue would be recorded on a gross basis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company is primarily responsible for fulfilling the promise to provide the specified products or services; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company has control over services provided in which the prescription issued by our service providers is under the clinic name of
    the Company; and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Company has discretion in establishing the price for the specified products or services. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
services are rendered by the Company&rsquo;s in-house doctors and external service providers who are registered and credentialed to deliver
care on MaNaDr platform. The company contracts with the external service providers who are paid based on the consultation fee set by
the Company. Patient contracts with the Company and make payment on the MaNadr platform. In these arrangements, as the Company assumes
a principal role in the transaction, revenue is recognized gross. The Company has the right to determine the service price to patients
and is responsible for the holding and fulfilment of prescribed medicine to the patients, the Company assumes the credit risk and rewards
of ownership of the inventory. Accordingly, the Company accounts for the telemedicine service contracts on a gross basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also provided the medical consultation services for the physical walk-in patients in our own clinics. The services are rendered
by the Company&rsquo;s in-house doctors who are registered and credentialed to deliver care for the physical walk-in patients, as well
as sale of prescribed medicines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Sale
of medicine and medical devices</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sells prescription drugs, non-prescription drugs and healthcare products to clinics and end customers offline and online. The
online transactions are performed through MaNaShop/MaNaStore. These products are purchased by the Company as inventory for onward sale
to customers. Revenue from sale of these products under direct sales model is recognized on a gross basis upon delivery of the medicines
or products to the customers. For products that are not purchased by the Company as inventory for onward sale to customers through online
marketplace model, the Company facilitates setting product prices with vendors. The Company is not responsible for fulfilling the contracts
being provided to the customers nor does the Company have inventory risk related to the contracts. Revenue from sale of these products
is recognized on a net basis upon delivery of the medicines or products to the customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Deferred
revenue</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue includes amounts collected or billed in excess of revenue recognized. Deferred revenue is recognized as revenue as the related
performance obligations are satisfied. Deferred revenue balances are generally expected to be recognized within 12 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cost
of revenue</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue primarily consists of fees paid to the service providers, medicine costs and delivery fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 149; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary of significant accounting policies (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Related
party transactions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also
considered to be related if they are subject to common control or common significant influence, such as a family member or relative,
shareholder, or a related corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Segment
Reporting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 280, Segment Reporting, operating segments are defined as components of an enterprise about which separate financial
information is available that is evaluated regularly by the chief operating decision maker (&ldquo;CODM&rdquo;), or decision making group,
in deciding how to allocate resources and in assessing performance. The Company uses the &ldquo;management approach&rdquo; in determining
reportable operating segments. The management approach considers the internal organization and reporting used by the Company&rsquo;s
CODM for making operating decisions and assessing performance as the source for determining the Company&rsquo;s reportable segments.
Management, including the CODM maker, reviews operation results by the revenue of different services. Based on management&rsquo;s assessment,
the Company has determined that it has two operating segments as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Telemedicine and other services</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Sale of medicine and medical devices</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Concentrations
and credit risk</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash with banks in Singapore (&ldquo;SGN&rdquo;). Should any bank holding cash become insolvent, or if the Company
is otherwise unable to withdraw funds, the Company would lose the cash with that bank; however, the Company has not experienced any losses
in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts. In Singapore, a depositor has
up to S$75,000 insured by Singapore Deposit Insurance Corporation (&ldquo;SDIC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023 and 2022, $1,921,497 and $13,915,831 of the company&rsquo;s cash held by financial institutions were uninsured respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially expose the Company to concentration of credit risk consist primarily of cash and cash equivalent and accounts
receivable. The Company has designed its credit policies with an objective to minimize their exposure to credit risk. The Company&rsquo;s
accounts receivable are short term in nature and the associated risk is minimal. The Company conducts credit evaluations on its clients
and generally does not require collateral or other security. The Company periodically evaluates the creditworthiness of the existing
clients in determining the allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the
credit risk of specific clients. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended June 30, 2023, none of the customers accounted more than 10% of the Company&rsquo;s total sales. For the year ended June
30, 2022, customer A accounted for 66.0% of the Company&rsquo;s total sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, customer B accounted 21.1% of the account receivables. None of the customers consisted of more than 10% of account
receivables as of June 30, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended June 30, 2023, none of the suppliers accounted more than 10% of the Company&rsquo;s total purchases. For the year ended
June 30, 2022, supplier F, accounted for 19.3% of the Company&rsquo;s total purchases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, none of the suppliers accounted more than 10% of the account payable. As of June 30, 2022, supplier A and B, accounted
for 14.2% and 15.8% of the account payable respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 150; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary of significant accounting policies (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employee
benefits</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
benefits are recognized as an expense, unless the cost qualifies to be capitalized as an asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>i)</I></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defined contribution plans</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>Defined <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">contribution
  plans are post-employment benefit plans under which the Company pays fixed contributions into separate entities such as the Central
  Provident Fund on a mandatory, contractual or voluntary basis. The Company has no further payment obligations once the contributions
  have been paid.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>ii)</I></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term compensated absences</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"></TD>
  <TD STYLE="text-align: justify">Employee <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">entitlements
  to annual leave are recognized when they accrue to employees. A provision is made for the estimated liability for annual leave as a
  result of services rendered by employees up to the balance sheet date.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Share-Based
Compensation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock options and other equity-based compensation issued in accordance with ASC 718 &ldquo;Stock Compensation&rdquo;,
which requires the measurement and recognition of compensation expenses related to the fair value of equity-based compensation awards
that are ultimately expected to vest. Stock-based compensation expense recognized includes the compensation cost for all share-based
compensation payments granted to employees and non-employees, net of estimated forfeitures, over the employees&rsquo; requisite service
period or the non-employee performance period based on the grant date&rsquo;s fair value estimated in accordance with the provisions
of ASC 718. ASC 718 is also applied to award modified repurchased or cancelled during the periods reported.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
determination of each option award&rsquo;s fair value is conducted at the grant date, utilizing the Black-Scholes option pricing model.
This model depends on subjective factors such as the fair value of common stock, the expected lifespan of the option, the projected volatility
of stock price, prevailing risk-free interest rates, and the anticipated dividend yield. These factors, guided by management&rsquo;s
estimates, inherently involve uncertainties and the need for sound managerial judgment. In assessing the valuation of common stock, the
Company employed a comprehensive approach that combines both market and income methodologies to determine the enterprise value, or fair
value of the business. The market approach involves estimating value by comparing the Company to similar publicly traded entities within
the same business sector, as well as examining secondary transactions involving our capital stock. The income approach calculates the
fair value by considering the present value of the Company&rsquo;s anticipated future cash flows and the residual value beyond the forecast
period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
vesting of options upon the effectiveness of an IPO triggers an accounting recognition event. Any previously unrecognized option-based
compensation expenses related to these vested options will be recognized on income statement. This expense represents the cumulative
compensation cost associated with the options that have now become fully vested.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Income
taxes</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under FASB ASC 740. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their
respective tax bases. Deferred tax assets are also provided for net operating loss carryforwards that can be utilized to offset future
taxable income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period including the enactment date. A valuation allowance is established, when necessary, to reduce net deferred tax
assets to the amount expected to be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing
authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of FASB ASC 740-10-25, &ldquo;Accounting for Uncertainty in Income Taxes,&rdquo; prescribe a more-likely-than-not threshold
for consolidated financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. This
interpretation also provides guidance on the recognition of income tax assets and liabilities, classification of current and deferred
income tax assets and liabilities, accounting for interest and penalties associated with tax positions, and related disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not accrue any liability, interest or penalties related to uncertain tax positions in its provision for income taxes for
the years ended June 30, 2023 and 2022. The Company does not expect that its assessment regarding unrecognized tax positions will materially
change over the next 12 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Comprehensive
Income (Loss)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comprehensive
income (loss) is comprised of net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) consists of
foreign currency translation that have been excluded from the determination of net income (loss).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Earnings
(loss) per share</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share is computed by dividing net earnings (loss) attributable to ordinary shareholders by the weighted average number
of ordinary shares outstanding during the year. Diluted earnings per share is computed in the same manner as basic EPS, except the number
of shares include additional ordinary shares that would have been outstanding if potential ordinary shares with a dilutive effect had
been issued. When the Company has a loss, diluted shares are not included as their effect would be anti-dilutive. The Company has no
dilutive securities or debt for each of the years end June 30, 2023 and 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 151; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary of significant accounting policies (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recent
Accounting Pronouncements </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &ldquo; emerging growth company &ldquo; (&ldquo;EGC &ldquo;) as defined in the Jumpstart Our Business Startups Act of 2012
(the &ldquo; JOBS Act &ldquo;). Under the JOBS Act, EGC can delay adopting new or revised accounting standards issued subsequent to the
enactment of the JOBS Act until such time as those standards apply to private companies. The Company made the election to delay the adoption
of new or revised accounting standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2020, the FASB issued ASU 2020-10, &ldquo;Codification Improvements to Subtopic 205-10, presentation of financial statements&rdquo;.
The amendments in this Update improve the codification by ensuring that all guidance that requires or provides an option for an entity
to provide information in the notes to financial statements is codified in the disclosure section of the codification that reduce the
likelihood that the disclosure requirements would be missed. The amendments also clarify guidance so that an entity can apply the guidance
more consistently. Early application of the amendments is permitted for any annual or interim period which financial statements are available
to be issued. The amendments in this Update should be applied retrospectively. An entity should apply the amendments at the beginning
of the period that includes the adoption date. The adoption of this standard is not expected to have a significant impact on the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as mentioned above, the Company does not believe other recently issued but not yet effective accounting standards, if currently adopted,
would have a material effect on the Company&rsquo;s consolidated balance sheets, statements of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounts receivable, net</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Accounts receivable</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">196,345</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">127,066</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Less: allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(122,030</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(14,540</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Total accounts receivable</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">74,315</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">112,526</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements
of allowance for doubtful accounts are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Allowance for doubtful accounts, beginning balance</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">14,540</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">9,944</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Addition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,450</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,044</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Exchange difference</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,040</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(448</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Allowance for doubtful accounts, ending balance</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">122,030</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">14,540</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended June 30, 2023 and 2022, the Company recognized $106,450 and $5,044 respectively of bad debts expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant amount of addition allowance for doubtful accounts during the financial year resulted from one of the major customers is
in undergoing liquidation. The recoverability is uncertain therefore the receivable amount due from the customer was fully reserved for
allowance for doubtful debts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 152; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inventories, net</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%">Medicines</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">168,559</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">73,426</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,153</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,898</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Finished goods</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">170,712</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">75,324</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Less: Allowance for stock obsolesces</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(24,331</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,669</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Total inventories, net</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">146,381</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">71,655</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Movements
of allowance for stock obsolesces are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Allowance for stock obsolesces, beginning balance</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">3,669</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">1,750</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Addition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,438</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,022</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Exchange difference</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">224</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(103</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Allowance for stock obsolesces ending balance</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">24,331</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,669</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no inventories pledged as security for liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other assets</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><U>Current</U></TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%">Deposits</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">47,170</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">21,229</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Prepayments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,758</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,333</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Other receivables</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">78,482</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,994</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Other current assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">164,410</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">33,556</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline">Non-current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Other receivable</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">81,950</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 153; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Property and equipment, net</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Computer and software</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">65,725</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">34,789</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Furniture &amp; fittings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,109</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,742</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Office equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,621</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,152</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Leasehold improvement</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">231,820</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">96,317</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">356,275</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">174,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Less: accumulated depreciation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(177,476</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(139,650</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Net book value</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">178,799</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">34,350</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2in 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expenses for the years ended June 30, 2023 and 2022 were $43,339 and $34,704 respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intangible assets, net</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%">Patent</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">15,613</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">15,209</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">MaNadr APP Software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">603,177</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">587,532</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Trademarks</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">65,209</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">66,346</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">683,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">669,087</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: accumulated amortization</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(613,216</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(546,862</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Net book value</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">70,783</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">122,225</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expenses for the years ended June 30, 2023 and 2022 were $51,477 and $52,390 respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the carrying value of definite-lived intangible assets as of June 30, 2023, the Company estimates its amortization expense for following
years will be as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 65%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; margin-bottom: 0pt">Amortization</P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt">expense</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Years Ended June 30,</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; text-align: left">2024</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; text-align: right">52,082</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2026</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,079</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total amortization expense</FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">70,783</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 154; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lease</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if a contract contains a lease at inception. US GAAP requires that the Company&rsquo;s leases be evaluated and classified
as operating or finance leases for financial reporting purposes. The classification evaluation begins at the commencement date and the
lease term used in the evaluation includes the non-cancellable period for which the Company has the right to use the underlying asset,
together with renewal option periods when the exercise of the renewal option is reasonably certain and failure to exercise such option
which results in an economic penalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered five lease agreements, including three for office premises, one for clinic premise and one for pharmacy premise,
with lease terms ranging from 1 to 3 years. The Company&rsquo;s lease agreements do not contain any material residual value guarantees
or material restrictive covenants. Upon adoption of ASU 2016-02, no right-of-use (&ldquo;ROU&rdquo;) assets nor lease liability was recorded
for the lease with a lease term with one year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incremental
rate applied to ROU and lease liabilities calculation refer to the central bank of Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2022, the Company subsisted of the following non-cancellable lease contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse; margin-left: 0.25in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
    of lease</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lease
    term</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    premises, Vision exchange #07-06/07</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    premises, Vision exchange #07-04</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    premises, Icon 4 Tower #243A</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">City
    Gate, Clinic #02-52</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
    years</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmacy
    retail unit, Block 356 Hougang Ave 7 #01-799</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    year</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Amount recognized in the consolidated balance sheet:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; width: 60%; text-align: left">Right-of-use assets</TD><TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 16%; text-align: right">393,198</TD><TD STYLE="padding-bottom: 2.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 16%; text-align: right">57,445</TD><TD STYLE="padding-bottom: 2.5pt; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,604</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,163</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Non-current</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">241,179</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19,954</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">395,783</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">59,117</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
A summary of lease cost recognized in the Company&rsquo;s consolidated statements of operations is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Operating lease cost</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">112,202</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">53,952</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 155; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lease (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
information related to leases in as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; width: 60%; text-align: left">Weighted average remaining lease term (in years)</TD><TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 16%; text-align: right">2.40</TD><TD STYLE="padding-bottom: 2.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 16%; text-align: right">1.08</TD><TD STYLE="padding-bottom: 2.5pt; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average discount rate</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5.25</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5.25</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023, the maturities of the Company&rsquo;s operating lease liabilities (excluding short-term leases) are as following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Years ending June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: left">2024</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">164,038</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,038</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">2026</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">82,942</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total future minimum lease payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">411,018</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Less imputed interest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(15,235</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Present value of operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">395,783</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Less: current portion</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(154,604</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Long-term portion</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">241,179</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accrual and other payables </B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Accruals</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 60%; text-align: left">Staff salaries</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">95,480</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">50,070</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,258</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,555</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Professional and consultancy fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">503,286</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">143,595</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Others</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,761</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,956</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 0pt; text-align: left">GST payables</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">171,382</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">139,174</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">826,167</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">372,350</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accruals of professional and consultancy fee represent unpaid IPO related professional and consultancy fees, such as audit fee, Singapore
and US legal counsel review fee, market research fee and other IPO professional consultancy related expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 156; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accrual and other payables (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GST
payable represents goods and services tax imposed by the Singapore authorities, collected from customers and patient, to be remitted
to the local tax authorities. The Company&rsquo;s policy is to record the GST collected as a liability on the books and then remove the
liability when the sales tax is remitted. There is no impact on the statement of operations as revenue is recorded net of GST.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2023 and 2022, the accruals of director refers to the directors&rsquo; fee payable amounted $7,376 and $7,185 each to 3 company&rsquo;s
directors named Nam Min Fern, Teo Kian Huat and Tsang Bih Shiou respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10&nbsp;</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was incorporated under the laws of the Cayman Islands on 28 July 2016. The authorized share capital of the Company is US$50,000
divided into 6,250,000,000 Class A Ordinary Shares and 6,250,000,000 Class B Ordinary Shares. Holders of Class A Ordinary
Shares and Class B Ordinary Shares have the same rights except for voting and conversion rights. Each holder of our Class A Ordinary
Share is entitled to one vote per share. Each holder of our Class B Ordinary Share is entitled to 10 votes per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with our fund raising, the Company entered into a series of agreements with investors since 2016. The Company issued 13,403,750
Class A Ordinary Shares and 12,078,250 Class B Ordinary Shares as of 30 June 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
8 May 2022, the Company issue an aggregate of 8,821,500 Class A Ordinary Shares, comprising (i) 2,907,750 Class A Ordinary
Shares issued to three persons pursuant to the capitalization of a shareholder loan of S$6,500,000, and (ii) 5,913,750 Class A
Ordinary Shares issued to four investors for a total consideration of S$13,200,000 pursuant to a share subscription agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2023, the Company purchased 4,026,000 Class A Ordinary Shares at $1.70 (S$2.24) per share price at an
aggregate purchase price of $6,848,273 (S$9,000,000) from an investor (the &ldquo;Ex-investor&rdquo;) which have been subsequently cancelled
and are available for re-issue. The purchase price was agreed mutually between the Company and the Ex-investor on the same date the legal
settlement entered, which is considered at its fair value given the share issuance price of the new Class A Ordinary Shares issued subsequently
on April 18, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 18, 2023, the Company had issued 556,250 Class A Ordinary Shares at S$2.25 per share to two investors for a total
consideration of $937,031 ($1,250,000). The Company incurred the incremental cost in connection to such Ordinary Shares issuance cost
amounted $74,988, which was deducted from the funds received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Employee
Incentive Plan</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2023, the Board of Directors of the Company approved the Employee Incentive Plan, (the &ldquo;Incentive Plan&rdquo;), to provide
a wealth creation opportunity for the employees, advisors, consultants and directors in line with value creation for the Company, drive
retention and increase motivation by rewarding high performance. Under the Plan, the maximum aggregate number of Shares under the Incentive
Plan, including incentive share options is 10% of the total issued Class A Ordinary Shares of the Company from time to time. As of June
30, 2023, the maximum aggregate number of Shares under the Incentive Plan was 1,340,250 shares of Class A Ordinary Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan will be administered by the Employee Incentive Plan Committee of the Company (the &ldquo;Committee&rdquo;) in its sole and absolute
discretion with such powers and duties as are conferred on it by the Board from time to time. The subscription price payable or not
for each Option Share in respect of which an Option is exercisable (the &ldquo;Subscription Price&rdquo;) shall be determined by the Committee
from time to time, provided that in no event shall the subscription price be less than the par value of an Option Share. Options
shall be exercisable only after vesting. Subject to the occurrence of certain events, the lapsing or the expiry of options as detailed
in the Plan, the Options shall be exercisable in whole or in part, before the expiry of 10 years from the date of grant of the Option,
or such other date as may be determined by the Committee. In the event of (i) an initial public offering and listing of shares of
the Company or a direct listing of shares of the Company (a &ldquo;Listing&rdquo;); or (ii) a change of control in the shares of the
Company, the Options granted to such Participants shall immediately vest. In the event of post-listing,  any Options (if unvested) granted
to participants under the Plan shall vest on the third anniversary of the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 157; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related party transactions and balances</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the major related parties and their relationships with the Company as of June 30, 2023 and 2022:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of related parties</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Relationship
    with the Company</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manadr
    Medical Holdings Pte. Ltd. (dba. Healthlight Family Medicine Clinic)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    company under common control of directors, Dr. Siaw Tung Yeng and Dr. Rachel Teoh Pui Pui</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kim
    JL Healthcare Pte. Ltd. (dba. Punggol Ripples Family Clinic)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related
    company under common control of the same directors, Dr. Siaw Tung Yeng and Dr. Rachel Teoh Pui Pui</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EC
    Family Clinic Pte. Ltd.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%
    owned by Dr. Rachel Teoh Pui Pui</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manadr
    Malaysia Sdn. Bhd.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76%
    owned by Dr. Siaw Tung Yeng</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rachel
    Teoh Pui Pui</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siaw
    Tung Yeng</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nam
    Min Fern</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Teo
    Kian Huat</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tsang
    Bih Shiou</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provided services to Manadr Medical Holdings Pte. Ltd. amounting to $401,253 and $544,594 for the year ended June 30, 2023 and
2022, respectively. At the same time, the Company received goods and services from Manadr Medical Holdings Pte. Ltd. amounting to $99,817
and $913,140 for the years ended June 30, 2023 and 2022, respectively. The receivables balance due from Manadr Medical Holdings
Pte. Ltd. were $53,853 and $53,168 as of June 30, 2023 and 2022, respectively. The payable balance due to Manadr Medical Holdings Pte.
Ltd. were $6,315 and $23,964 as of June 30, 2023 and 2022, respectively. The credit term is 30 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provided services to Kim JL Healthcare Pte. Ltd. amounting to $31,077 and $3,332 for the years ended June 30, 2023 and
2022, respectively. At the same time, the Company received goods and services from Kim JL Healthcare Pte. Ltd. amounting to $46 and $1,695
for the years ended June 30, 2023 and 2022, respectively. The receivables balance due from Kim JL Healthcare Pte. Ltd. were $12,471
and $9,006 as of June 30, 2023 and 2022, respectively. The payable balance due to Kim JL Healthcare Pte. Ltd. were $nil and $210 as of
June 30, 2023 and 2022, respectively. The credit term is 30 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provided services to EC Family Clinic Pte. Ltd. amounting to $2,589 and $1,759 for the years ended June 30, 2023 and 2022,
respectively. At the same time, the Company received goods and services from Kim JL Healthcare Pte. Ltd. amounting to $7 and $15 for
the years ended June 30, 2023 and 2022, respectively. The receivables balance due from EC Family Clinic Pte. Ltd. were $2,410
and $1,508 as of June 30, 2023 and 2022, respectively. The credit term is 30 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
receivables balance due from Manadr Malaysia Sdn. Bhd. were $38,161 and $37,051 as of June 30, 2023 and 2022, respectively. Such balance
is interest free, unsecured, and due on demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received goods and services from Rachel Teoh Pui Pui amounting to $2,798 and $14,455 for the year ended June 30, 2023 and 2022,
respectively. The payable balance to Rachel Teoh Pui Pui were $nil and $13,618 as of June 30, 2023 and 2022, respectively. Such balance
is interest free, unsecured, and due on demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received goods and services from Siaw Tung Yeng amounting to $28,564 and $27,787 for the year ended June 30, 2023 and 2022, respectively.
The payable balance to Siaw Tung Yeng were $994,708 and $963,543 as of June 30, 2023 and 2022, respectively. Such balance is interest
free, unsecured, and due on demand. As of the date the financial statements were available to be issued, the Company did not make any
payment. On 21 April 2022, the payable balance to Siaw Tung Yeng amounted $4,773,795 being capitalized into ordinary shares capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accrued the annual directors&rsquo; fee payable to Nam Min Fern, Teo Kian Huat and Tsang Bih Shiou amounted $7,376 each.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 158; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Segment Reporting</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on management&rsquo;s assessment, the Company has determined that it has two operating segments as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)
Telemedicine and other services</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)
Sale of medicine and medical devices</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June, 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Telemedicine and other services</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">6,898,166</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">6,125,438</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Sale of medicine and medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">976,720</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">863,411</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Total revenue</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,874,886</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,988,849</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Telemedicine and other services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,948,232</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,283,480</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Sale of medicine and medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">831,660</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">770,263</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Total cost of revenue</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,779,892</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,053,743</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present summary information by segment for the years ended June 30, 2023 and 2022, respectively:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended June 30, 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Telemedicine and other services</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Sale of medicine and medical devices</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Consolidated totals</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">6,898,166</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">976,720</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">7,874,886</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">949,934</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">145,060</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,094,994</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss before income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,965,165</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(248,195</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,213,360</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,965,165</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(248,195</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,213,360</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Total reportable assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,121,643</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">320,896</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,442,539</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended June 30, 2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Telemedicine services</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Sale of medicine and medical devices</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Consolidated totals</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">US$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">6,125,438</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">863,411</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">6,988,849</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,841,958</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">93,148</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,935,106</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income (Loss) before income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">329,827</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(71,355</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">258,472</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Net income (loss)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">164,052</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(71,355</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">92,697</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Total reportable assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,529,651</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">225,973</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,755,624</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sells at one geographical location which is Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 159; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxes</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Income
Taxes </U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Caymans</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is domiciled in the Cayman Island. The locality currently enjoys permanent income tax holidays; accordingly, the Company does
not accrue for income taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Singapore</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Singapore subsidiaries are incorporated in Singapore and are subject to Singapore Corporate Tax on the taxable income as reported in
its statutory financial statements adjusted in accordance with relevant Singapore tax laws. The applicable tax rate is 17% in Singapore,
with 75% of the first S$10,000 taxable income and 50% of the next S$190,000 taxable income exempted from income tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
components of the provision for income taxes are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Income tax expense is comprised of the following:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%">Current</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">165,226</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Deferred</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">549</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Total income tax expense</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">165,775</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation between the Company&rsquo;s actual provision for income tax and the provision at the Singapore statutory rate was as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Years Ended June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; width: 60%; text-align: left">(Loss) Income before tax</TD><TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(3,213,360</TD><TD STYLE="padding-bottom: 2.5pt; width: 1%; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 16%; text-align: right">258,472</TD><TD STYLE="padding-bottom: 2.5pt; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">(Loss) Income tax expense computed at statutory rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17.0</TD><TD STYLE="text-align: left">%)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Reconciling items:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Non-deductible expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22.8</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Income not subject to tax</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.3</TD><TD STYLE="text-align: left">%)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6.5</TD><TD STYLE="text-align: left">%)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Underprovision in respect of prior years</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.8</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Utilization of previously unrecognized tax losses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17.5</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Deferred tax assets not recognised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Effective tax rate</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64.1</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 160; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxes (continued)</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Deferred
tax assets</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-indent: -14.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
components of deferred tax were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Years Ended June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">US$</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Deferred tax assets, gross:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left">Net operating loss carried forward</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">406,251</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">549</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Valuation allowance</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(406,251</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(549</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">Deferred tax assets, net of valuation allowance</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the realizability of deferred tax assets, the Company only consider to the extent that it is probable that future taxable profits
will be available against which the Company can utilize the benefits. After consideration of all the information available, the Company
has recorded a full valuation allowance against its deferred tax assets as of June 30, 2023 and 2022, respectively, because the Company
has determined that is it more likely than not that these assets will not be fully realized due to continuous net operating losses incurred
in those geographic areas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contingencies and commitment</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Operating
lease:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company entered into lease agreements to rent the office premises for its own use. The office lease agreements included Vision exchange
office unit #07-04, #07-06 and #07-07 in Singapore and Icon 4 Tower office #234A in Vietnam. The company also entered into lease agreements
to rent one clinic and pharmacy each for business operation purpose. The monthly lease fee for all these premises are approximately equivalent
to $14,300, and the tenancy periods range about 1 -3 years. The company accounted for the lease arrangements under operating leases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lease commitments are disclosed in note 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Legal
settlement:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2022, a shareholder filed a claim against the Company in the High Court of the Republic of Singapore, in connection with
a dispute arising from a subscription agreement entered into by the Company and the Ex-investor on April 21, 2022. As of June 30, 2022,
no liability has been accrued for this claim as the suit was settled on January 18, 2023 with the Company purchasing 4,026,000
Class A Ordinary Shares back from the Ex-investor at an aggregate purchase price of $6,848,273 (S$9,000,000) as detailed in &ldquo;Shares
buyback&rdquo; section in note 10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Contingencies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company might be a party to various legal actions arising in the ordinary course of business. The Company accrues costs
associated with these matters when they become probable and the amount can be reasonably estimated. Legal costs incurred in connection
with loss contingencies are expensed as incurred. The Company&rsquo;s management does not expect any liability from the disposition of
such claims and litigation individually or in the aggregate to have a material adverse impact on the Company&rsquo;s consolidated financial
position, results of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Validity
of certain issuances and transfers of shares</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have in the past encountered corporate secretarial irregularities, which may conflict with or affect the validity of corporate actions
we have taken. These past corporate secretarial irregularities include records of waivers or approvals of shareholders of their rights
of pre-emption and rights of first refusal under the memorandum and articles of association of our Company effective at the relevant
time and/or under the shareholder agreement, subscription agreement or investment agreement entered into with such shareholders not having
been obtained prior to issuances and transfers of shares of our Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event such legal proceedings or claims are commenced against our Company, we may incur cost and resources to defending such proceedings,
and further, in the event a claimant successfully challenges the validity of a transfer or allotment, certain corporate actions may be
considered void or we may be required to issue or transfer certain shares to the claimant. In the opinion of management, the likelihood
of loss to be incurred in respect of the Company&rsquo;s corporate secretarial irregularities is remote based on current facts and circumstances.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 161; Value: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><B>MOBILE-HEALTH NETWORK SOLUTIONS</B></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</B></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsequent events</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has assessed all events of transactions that occurred after June 30, 2023 through the date that these consolidated financial
statements are available to be issued and other than the following, there are no further material subsequent events that require disclosure
in these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2023 and December 18, 2023, the Company granted options with exercise price of $0.004 per Option Share to employees
to purchase a total of 1,109,750 Class A Ordinary Shares of a nominal or par value of US$0.000004 each under the Incentive
Plan. The fair value per Option Share was approximately $1.74 which gives aggregate fair value of the 1,109,750 Option
Shares of approximately $1.9 million on the grant date. The $1.9 million share-based compensation expense will be amortized and recognized
under salaries and benefits expense over the three-year vesting term starting from the grant date. The effectiveness of the IPO will
trigger the immediately recognition of the remaining unamortized share-based compensation expense of the grant on income statement. The
details of the Incentive Plan are disclosed in note 10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 14, 2023, the Company had issued 233,750 Class A Ordinary Shares of a nominal or par value of US$0.000004 each at
S$2.35 per share to three investors for a total consideration of $407,317 (S$550,000). The Company had received the consideration
in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2023, the Company had issued 82,750 Class A Ordinary Shares of a nominal or par value of US$0.000004 each
at S$2.35 per share to three investors for a total consideration of $142,763 (S$194,843). The Company had received the cash subscription
in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 5, 2023, the Company had issued 637,000 Class A Ordinary Shares of a nominal or par value of US$0.000004 each at
S$2.35 per share to three investors for a total consideration of $1,095,610 (S$1,500,000). The Company had received the cash subscription
in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 15, 2023, the Company entered into a service agreement with Network 1 Financial Securities Inc. who is acting as an underwriter
of the Company. The Company agreed to issue warrants to the underwriter to purchase a number of Class A Ordinary Shares equal to 7.5%
of the total number of Class A Ordinary Shares sold in the IPO, including Class A Ordinary Shares issued upon exercise of underwriters&rsquo;
over-allotment option at an exercise price equal to 125% of the public offering price of the Class A Ordinary Shares sold in the IPO.
The warrants are exercisable commencing six months following the date of commencement of sales of the offering and for a period of five
years thereafter, in whole or in part.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 5, 2024, the Company had issued 42,500 Class A Ordinary Shares of a nominal or par value of US$0.000004 each at S$2.35 per share
to an investor for a consideration of $75,239 (S$100,000). The Company had received the cash subscription in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2024, the Company issued an aggregate of 5,272,000 Class A Ordinary Shares of a nominal or par value of US$0.000004 each, comprising
(i) 4,162,250 Class A Ordinary Shares of a nominal or par value of US$0.000004 each issued to 5 advisors of the Company in consideration
for services provided to the Company pursuant to various agreements; and (ii) 1,109,750 Class A Ordinary Shares of a nominal or par value
of US$0.000004 each issued to certain employees of the Company pursuant to the Incentive Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 19, 2024, the Company completed the sub-division of the issued Class A and Class B Ordinary Shares of a nominal or par value
of $0.001 each in the capital of the Company into 250 ordinary shares of a nominal or par value of $0.000004 each. Before the subdivision,
the Company&rsquo;s ordinary shares issued and outstanding was 78,687 Class A Ordinary Shares and 48,313 Class B Ordinary Shares. After
the subdivision, the Company&rsquo;s ordinary shares issued and outstanding was 19,671,750 Class A Ordinary Shares and 12,078,250 Class
B Ordinary Shares.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 162 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024, all dealers that effect transactions
in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the
dealers&rsquo; obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,250,000
Class A Ordinary Shares Offered by Mobile-health Network Solutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mobile-health
Network Solutions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus
dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 163 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this preliminary prospectus is not complete and may be changed. The securities may not be sold until the registration
statement filed with the U.S. Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these
securities and it is not soliciting any offer to buy these securities in any jurisdiction where such offer or sale is not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBJECT
TO COMPLETION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRELIMINARY
PROSPECTUS DATED &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mobile-health
Network Solutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>2,574,750
</I></B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Class A Ordinary Shares to be sold
by the Selling Shareholders</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the resale of 2,574,750 Class A Ordinary Shares by the Selling Shareholders named in this prospectus. We
will not receive any of the proceeds from the sale of the Class A Ordinary Shares by the Selling Shareholders named in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have reserved the symbol &ldquo;MNDR&rdquo; for purposes of listing our Class A Ordinary Shares on the NASDAQ Capital Market (&ldquo;NASDAQ&rdquo;)
and have applied to list our Class A Ordinary Shares on the Nasdaq Capital Market. The closing of this resale offering is conditioned
upon NASDAQ&rsquo;s final approval of our listing application. We cannot assure you that our listing application will be approved&#894;
if it is not approved by NASDAQ, we will not proceed with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
sales of the Class A Ordinary Shares covered by this prospectus shall occur until after the closing of our initial public offering (the
&ldquo;IPO&rdquo;). Any sales will occur from time to time at prevailing market prices or in privately negotiated prices. The distribution
of securities offered hereby may be effected in one or more transactions that may take place in ordinary brokers&rsquo; transactions,
privately negotiated transactions or through sales to one or more dealers for resale of such securities as principals. Usual and customary
or specifically negotiated brokerage fees or commissions may be paid by the Selling Shareholders. The date of effectiveness of the registration
statement for our IPO is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024. The IPO price of the Class A Ordinary
Shares is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. On &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024,
the last reported sale price of our Class A Ordinary Shares on NASDAQ was &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our Class A Ordinary Shares is highly speculative and involves a high degree of risk. Before buying any shares, you should carefully
read the discussion of material risks of investing in our Class A Ordinary Shares in &ldquo;Risk Factors&rdquo; section of the Public
Offering Prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are both an &ldquo;emerging growth company&rdquo; and a &ldquo;foreign private issuer&rdquo; as defined under the applicable U.S. federal
securities laws and, as such, may elect to comply with certain reduced public company reporting requirements for this and future filings.
See &ldquo;Prospectus Summary&mdash;Corporate Information.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the U.S. Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon
the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 164 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="la_001"></A>THE
OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
A Ordinary Shares offered by the Selling Shareholders: 2,574,750 Class A Ordinary Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
A Ordinary Shares outstanding before the offering: 19,671,750 Class A Ordinary Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
A Ordinary Shares to be outstanding after our initial public offering pursuant to the Public Offering Prospectus: 21,921,750 Class A
Ordinary Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
of proceeds: We will not receive any of the proceeds from the sale of the Class A Ordinary Shares by the Selling Shareholders named in
this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 165; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A NAME="la_002"></A><B>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not receive any of the proceeds from the sale of Class A Ordinary Shares by the Selling Shareholders. In addition, the underwriter
will not receive any compensation from the sale of the Class A Ordinary Shares by the Selling Shareholders. The Selling Shareholders
will receive all of the net proceeds from the sales of Class A Ordinary Shares offered by the Selling Shareholders under this prospectus.
We have agreed to pay all of the expenses of this registration, and the Selling Shareholders will not contribute to the costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><A NAME="la_003"></A><B>SELLING
SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the Selling Shareholders Shares. The Selling Shareholders are offering an aggregate of 2,574,750 Class A Ordinary
Shares. See &ldquo;Plan of Distribution for Stock Registered for Selling Shareholders.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the Selling Shareholders. The second column lists the number of Class A Ordinary Shares beneficially owned by each
of the Selling Shareholders, prior to and immediately after this Offering. Prior to this Offering, 19,671,750 Class A Ordinary Shares
were issued and outstanding. The third column lists the number of Class A Ordinary Shares being offered by this prospectus by the Selling
Shareholders. None of the Selling Shareholders are officers, directors, or 5% or more shareholders of us. We have agreed to pay all of
the expenses of this registration, and the Selling Shareholders will not contribute to the costs. The underwriter is not underwriting
the shares of the Selling Shareholders. Any sales will occur from time to time at prevailing market prices or in privately negotiated
prices. The distribution of securities offered hereby may be effected in one or more transactions that may take place in ordinary brokers&rsquo;
transactions, privately negotiated transactions or through sales to one or more dealers for resale of such securities as principals.
Usual and customary or specifically negotiated brokerage fees or commissions may be paid by the Selling Shareholders. Neither we nor
the underwriter will receive any proceeds from the sales of any of the Class A Ordinary Shares being offered by the Selling Shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Number
                                            of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Class
                                            A Ordinary Shares</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Owned</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Prior
                                            to</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Offering</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Maximum</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Number
                                            of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Class
                                            A Ordinary Shares to be</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Sold</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>to
                                            this</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Prospectus*</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Number
                                            of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Class
                                            A Ordinary Shares</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Owned
                                            After</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Offering</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(if
                                            Sold)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>%
                                            of Class A Ordinary Shares</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Owned
                                            After</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Offering</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Excluding</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Over-</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Allotment)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>%
                                            of</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Class
                                            A Ordinary Shares</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Owned
                                            After</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Offering</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Including</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Over-</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Allotment</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>of
                                            337,500</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Shares)</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; width: 35%"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"> Lau Chun </P></TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">850,000</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">850,000</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">-</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">-</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right; width: 9%">-</TD><TD STYLE="font-size: 10pt; text-align: left; width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"> Wong Alfred Lut Yiu </P></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">800,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">800,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"> Xie Guifen </P></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">924,750</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">924,750</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold">Total</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"> 2,574,750 </TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"> 2,574,750 </TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"> - </TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"> - </P></TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right"> - </TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Assumes all shares registered for the Selling Shareholders are sold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Shareholders named above acquired their shares in offerings that was exempt from registration under Section 4(a)(2) of the Securities
Act. There was no placement agent for that offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 166 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><A NAME="la_004"></A>SELLING
SHAREHOLDERS PLAN OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering 2,574,750 Class A Ordinary Shares for Selling Shareholders. We are required to pay all fees and expenses incidental
to the registration of the shares of our securities to be offered and sold pursuant to this prospectus, including the shares of the Selling
Shareholders. The Class A Ordinary Shares beneficially owned by the Selling Shareholders covered by this prospectus may be offered and
sold from time to time by the Selling Shareholders, but only after our Class A Ordinary Shares have begun trading on the NASDAQ Capital
Market. We anticipate receiving conditional approval to list our Class A Ordinary Shares on the NASDAQ Capital Market under the symbol
&ldquo;MNDR,&rdquo; provided we have satisfied the initial listing requirements of NASDAQ. No assurance can be given that we will meet
those requirements. If Class A Ordinary Shares are not approved for listing on NASDAQ, we will not consummate this offering. There can
be no assurance that the Selling Shareholders will sell any or all of the shares offered under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &ldquo;Selling Shareholders&rdquo; includes donees, pledgees, transferees or other successors in interest selling securities received
after the date of this prospectus from a Selling Shareholder as a gift, pledge, partnership distribution or other transfer. The Selling
Shareholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may
be made on one or more exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or at prices
related to the then-current market price or in negotiated transactions. The Selling Shareholders may dispose of their securities by one
or more of, or a combination of, the following methods once our Class A Ordinary Shares have commenced trading on the NASDAQ Capital
Market:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">distributions
    to members, partners, shareholders or other equity holders of the Selling Shareholders&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker solicits purchasers&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer so engaged will attempt to sell the securities as agent but may position and resell a portion of
    the block as principal to facilitate the transaction&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    over-the-counter distribution in accordance with the rules of the NASDAQ&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    trading plans entered into by a Selling Shareholder pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time
    of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their
    securities on the basis of parameters described in such trading plans&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    or through underwriters or broker-dealers&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    &ldquo;at the market&rdquo; offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing
    at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities
    exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    privately negotiated transactions&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    options transactions&#894;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    a combination of any of the above methods of sale&#894; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any securities that qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to this prospectus,
<FONT STYLE="background-color: white">provided that the Selling Shareholders meet the criteria and conform to the requirements of that
rule, or pursuant to other available exemptions from the registration requirements of the Securities Act.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
effecting sales, broker-dealers or agents engaged by the Selling Shareholders may arrange for other broker-dealers to participate. Broker-dealers
or agents may receive commissions, discounts or concessions from the Selling Shareholders in amounts to be negotiated immediately prior
to the sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
offering the securities covered by this prospectus, the Selling Shareholders and any broker-dealers who execute sales for the Selling
Shareholders may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities Act in connection with such sales. Any
profits realized by the Selling Shareholders and the compensation of any broker-dealer may be deemed to be underwriting discounts and
commissions. In order to comply with the securities laws of certain states, if applicable, the securities must be sold in such jurisdictions
only through registered or licensed brokers or dealers. In addition, in certain states the securities may not be sold unless they have
been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available
and is complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have advised the Selling Shareholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of securities
in the market and to the activities of the Selling Shareholders and their affiliates. In addition, we will make copies of this prospectus
available to the Selling Shareholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The Selling
Shareholders may indemnify any broker-dealer that participates in transactions involving the sale of the securities against certain liabilities,
including liabilities arising under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time a particular offer of securities is made, if required, a prospectus supplement will be distributed that will set forth the number
of securities being offered and the terms of the offering, including the name of any underwriter, dealer or agent, the purchase price
paid by any underwriter, any discount, commission and other item constituting compensation, any discount, commission or concession allowed
or reallowed or paid to any dealer, and the proposed selling price to the public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="la_005"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>LEGAL
MATTERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the Class A Ordinary Shares offered in this offering and certain other legal matters as to Cayman Islands law will be passed
upon for the Selling Shareholders by Harney Westwood &amp; Riegels Singapore LLP, our counsel as to Cayman Islands law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 167 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mobile-health
Network Solutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2,574,750
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class A Ordinary Shares</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to
be sold by the Selling Shareholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RESALE
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>,
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this Resale Prospectus. No dealer, salesperson or other person is authorized to give
information that is not contained in this Resale Prospectus. This Resale Prospectus is not an offer to sell nor is it seeking an offer
to buy these securities in any jurisdiction where the offer or sale is not permitted. The information contained in this Resale Prospectus
is correct only as of the date of this prospectus, regardless of the time of the delivery of this prospectus or the sale of these securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024, all dealers that effect transactions
in these securities, whether or not participating in this offering, may be required to deliver a prospectus when acting as underwriters
and with respect to their unsold allotments or subscriptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 168 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
II</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
Not Required In Prospectus</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands law does not limit the extent to which a company&rsquo;s articles of association may provide for indemnification of officers
and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such
as to provide indemnification against civil fraud or the consequences of committing a crime. Under our post-offering memorandum
and articles of association, which will become effective immediately prior to the completion of this offering, to the fullest extent
permissible under Cayman Islands law every director and officer of our company shall be indemnified against all actions, proceedings,
costs, charges, expenses, losses, damages or liabilities incurred or sustained by him, other than by reason of such person&rsquo;s own
dishonesty, willful default or fraud, in connection with the execution or discharge of his duties, powers, authorities or discretions
as a director or officer of our company, including without prejudice to the generality of the foregoing, any costs, expenses, losses
or liabilities incurred by him in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs
in any court whether in the Cayman Islands or elsewhere.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the form of indemnification agreements to be filed as Exhibit 10.2 to this Registration Statement, we will agree to indemnify
our directors and officers against certain liabilities and expenses that they incur in connection with claims made by reason of their
being a director or officer of our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriting Agreement, the form of which is filed as Exhibit 1.1 to this Registration Statement, will also provide for indemnification
of the underwriter and its affiliates against liabilities relating to the offering arising under the Securities Act and the Exchange
Act and to contribute to payments that the underwriters may be required to make for these liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act of 1933, as amended, may be permitted to directors, officers or persons
controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
7. RECENT SALES OF UNREGISTERED SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the past three years, we have issued an aggregate of 15,645,750 Class A Ordinary Shares, as described below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 13, 2024, we have issued an aggregate of 62,583</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Class A Ordinary Shares of a nominal or par value of US$0.001 each, comprising: (i) 16,649 Class A Ordinary Shares of a nominal
or par value of US$0.001 each issued to 5 advisors in February 2024 in consideration for services provided to the Company pursuant to various agreements, (ii) 4,439 Class A Ordinary Shares of a nominal or par value of US$0.001 each issued to 22
employees pursuant to the provisions of the 2023 Employee Incentive Plan in February 2024, iii) 170 Class A Ordinary Shares of a nominal
or par value of US$0.001 each issued in January 2024 to one investor for a total consideration of S$100,000; (iv) 2,879 Class A Ordinary
Shares of a nominal or par value of US$0.001 each issued in September 2023 and October 2023 to four investors for a total consideration
of S$1,694,843; (v) a total of 935 Class A Ordinary Shares of a nominal or par value of US$0.001 each issued to three investors
on 14 August 2023 for a total consideration of S$550,000; (vi) 2,225 Class A Ordinary Shares of a nominal or par value of US$0.001
each issued to two investors on April 18, 2023 for a total consideration of S$1,250,000 pursuant to share subscription agreements,
(vii) 11,631 Class A Ordinary Shares of a nominal or par value of US$0.001 each issued to three persons on May 8, 2022
pursuant to the capitalization of a shareholder loan of S$6,500,000, and (viii) 23,655 Class A Ordinary Shares of a nominal
or par value of US$0.001 each issued to four investors on May 8, 2022 for a total consideration of S$13,220,000 pursuant to a share
subscription agreement, among which 16,104 Class A Ordinary Shares of a nominal or par value of US$0.001 each held by one of the investors were subsequently repurchased
by the Company in January 2023 for a consideration of S$9,000,000.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that each of the issuances was exempt from registration pursuant to Section 4(2) of the Securities Act, regarding transactions
not involving a public offering, or in reliance on Regulation S under the Securities Act regarding sales by an issuer in offshore transactions.
None of the transactions involved an underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 14, 2024,
shareholders&rsquo; resolutions were passed to authorize the sub-division of each of the Company&rsquo;s issued and unissued shares into
250 Ordinary Shares such that the authorized share capital of the Company was changed from US$50,000 divided into 50,000,000 Ordinary
Shares of a nominal or par value of US$0.001 each, comprising 25,000,000 Class A Ordinary Shares of a nominal or par value of US$0.001
each, and 25,000,000 Class B Ordinary Shares of a nominal or par value of US$0.001 each to US$50,000 divided into 12,500,000,000 Ordinary
Shares of a nominal or par value of US$0.000004 each, comprising 6,250,000,000 Class A Ordinary Shares of a nominal or par value of US$0.000004
each, and 6,250,000,000 Class B Ordinary Shares of a nominal or par value of US$0.000004 each. Accordingly, the issued 62,583 Class A
Ordinary Shares of a nominal or par value of US$0.001 each were divided into 15,645,750 Class A Ordinary Shares of a nominal or par value
of US$0.000004 each.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 169; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
8. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Exhibits</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Exhibit Index beginning on page II-3 of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Financial Statement Schedules</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
have been omitted because the information required to be set forth therein is not applicable or is shown in the Combined and Consolidated
Financial Statements or the Notes thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
9. UNDERTAKINGS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreements, certificates
in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the provisions described in Item 6, or otherwise, the registrant has been advised that in the opinion of the
SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that
a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant under Rule 424(b)(1)
or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 170 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Mobile-health
Network Solutions<BR>
Exhibit Index</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
                                            Number</B></FONT></P></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
                                            of Document</B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex1-1.htm" STYLE="-sec-extract: exhibit">Form of Underwriting Agreement</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex3-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Memorandum and Articles of Association of the Registrant, as currently in effect</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1&dagger;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224008984/ex4-1.htm" STYLE="-sec-extract: exhibit">Registrant&rsquo;s Specimen Certificate for Class A Ordinary Shares</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> 4.2&dagger; </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224008984/ex4-2.htm" STYLE="-sec-extract: exhibit">Form of Underwriter Warrant</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">4.3&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex4-3.htm" STYLE="-sec-extract: exhibit">Form of Subscription Agreement between the Registrant and its investors</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">4.4&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex4-4.htm" STYLE="-sec-extract: exhibit">Form of Share Transfer and Shareholders&rsquo; Agreement</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1&dagger;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224008984/ex5-1.htm" STYLE="-sec-extract: exhibit">Opinion of Harney Westwood &amp; Riegels Singapore LLP regarding the validity of the Class A Ordinary Shares being registered</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1&dagger;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224008984/ex5-1.htm" STYLE="-sec-extract: exhibit">Opinion of Harney Westwood &amp; Riegels Singapore LLP regarding certain Cayman Islands tax matters (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex10-1.htm" STYLE="-sec-extract: exhibit">2023 Employee Incentive Plan</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Indemnification Agreement between the Registrant and its directors and executive officers&dagger;</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex10-3.htm" STYLE="-sec-extract: exhibit">Form of Employment Agreement between the Registrant and its Chief Executive Officer and Chief Operating Officer</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">10.4#&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex10-4.htm" STYLE="-sec-extract: exhibit">Employment Agreement <FONT STYLE="font-size: 10pt">wit<FONT STYLE="font-family: Times New Roman, Times, Serif">h </FONT></FONT>Chief Financial Officer</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">10.5&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex10-5.htm" STYLE="-sec-extract: exhibit">Form of Independent Director Agreement</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">10.6&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex10-6.htm" STYLE="-sec-extract: exhibit">Partnership Agreement between Manadr Pte Ltd and five other clinics</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">10.7#&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex10-7.htm" STYLE="-sec-extract: exhibit">Medical Service Agreement, dated April 5, 2023</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">14.1&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex14-1.htm" STYLE="-sec-extract: exhibit">Code of Business Conduct and Ethics of the Registrant</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">19.1&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex19-1.htm" STYLE="-sec-extract: exhibit">Insider Trading and Confidentiality Policy of the Registrant</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">21.1&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex21-1.htm" STYLE="-sec-extract: exhibit">List of Subsidiaries of Mobile-health Network Solutions</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex23-1.htm">Consent of Simon &amp; Edward, LLP, Independent Registered Public Accounting Firm</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2&dagger;</FONT> </TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224008984/ex5-1.htm" STYLE="-sec-extract: exhibit">Consent of Harney Westwood &amp; Riegels Singapore LLP (included in Exhibit 5.1)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex23-3.htm" STYLE="-sec-extract: exhibit">Consent of Rajah &amp; Tann Singapore LLP</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">23.4&dagger;</TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex23-4.htm" STYLE="-sec-extract: exhibit">Consent of Frost &amp; Sullivan</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#loi_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included on signature page)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex99-1.htm" STYLE="-sec-extract: exhibit">Consent of Lai Kuan Loong Victor to Act as Independent Director</A></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex99-2.htm" STYLE="-sec-extract: exhibit">Consent of Lun Kwok Chan to Act as Independent Director</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">99.3&dagger;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex99-3.htm" STYLE="-sec-extract: exhibit">Consent of Gabe Rijpma to Act as Independent Director</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107&dagger;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex107.htm" STYLE="-sec-extract: exhibit">Filing Fee Table</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="text-align: justify; margin-top: 0pt; font-family: Times New Roman, Times, Serif; width: 30%; margin-bottom: 0pt"><DIV STYLE="border-top: Black 1.5pt solid; text-align: justify; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin: 0">Submitted
                                            herewith.</P></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&dagger;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Previously
                                            filed</TD></TR>
                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">#</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Portions
                                            of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K on the
                                            basis that the Company customarily and actually treats that information as private or confidential
                                            and the omitted information is not material.</TD></TR>
                                                                                   </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 171 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Singapore, on March 20, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mobile-health
    Network Solutions</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Siaw Tung Yeng</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siaw
    Tung Yeng</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Co-Chief
    </I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Executive Officer and Director</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 172 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="loi_012"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Power
of Attorney</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Siaw Tung Yeng
and Peng Chee Yong as an attorney-in-fact with full power of substitution, for him or her in any and all capacities, to do any
and all acts and all things and to execute any and all instruments which said attorney and agent may deem necessary or desirable to enable
the registrant to comply with the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and any rules, regulations and
requirements of the Securities and Exchange Commission thereunder, in connection with the registration under the Securities Act of Class
A Ordinary Shares of the registrant (the &ldquo;Shares&rdquo;), including, without limitation, the power and authority to sign the name
of each of the undersigned in the capacities indicated below to the Registration Statement on Form F-1 (the &ldquo;Registration Statement&rdquo;)
to be filed with the Securities and Exchange Commission with respect to such Shares, to any and all amendments or supplements to such
Registration Statement, whether such amendments or supplements are filed before or after the effective date of such Registration Statement,
to any related Registration Statement filed pursuant to Rule 462(b) under the Securities Act, and to any and all instruments or documents
filed as part of or in connection with such Registration Statement or any and all amendments thereto, whether such amendments are filed
before or after the effective date of such Registration Statement; and each of the undersigned hereby ratifies and confirms all that
such attorney and agent shall do or cause to be done by virtue hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and
on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Siaw Tung Yeng</I></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Chief
    Executive Officer and Director</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    20, 2024</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Siaw Tung Yeng</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal
    executive officer)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Peng Chee Yong</I></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    20, 2024</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Peng Chee Yong</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal
    financial and principal accounting officer)</FONT></TD>
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 173 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: justify; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Signature
of Authorized Representative in the United States</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Mobile-health
Network Solutions, has signed this registration statement or amendment thereto in New York, New York, United States on March 20,
2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cogency
                                            Global Inc.</FONT></P>
                                                                                <P STYLE="margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized U.S. Representative</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Colleen A. De Vries</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colleen
    A. De Vries</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sr.
    Vice President on behalf of Cogency Global Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 174; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="ex23-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mobile-health
Network Solutions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference in this Registration Statement on Form F-1 Amendment No.2, of our report dated
October 27, 2023, relating to the consolidated financial statements of Mobile-health Network Solutions, which is included in this
Registration Statement on the Form F-1 Amendment No.2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the reference to us under the caption &ldquo;Experts&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_002.jpg" ALT="" STYLE="height: 27.35pt; width: 173.5pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rowland
Heights, California</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">March 20, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">(p. 1 of 1)</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo_001.jpg
<TEXT>
begin 644 logo_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #% E(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 4444 %%%% !1110 4444 >3_$367N]6_LY'/D0 ;@&X+<_T(KC "2  22<
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MXW598OW3?F3G+?MTO+]3N_ 'AJUU))=0OHUE1& CC905ZG.0>O05Z&-'TL#
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M*5G!(1<X&UJ\J>WGC.'@E4^A6NG+FO8)>IQYLG]9;MT1+IO_ "%['_KYC_\
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M%'4UO##TX/F2//KYGB:\/9SEHQ.3P!DGH!WKUCPM8FPT&WC<8=@7.1@\G/\
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M #H /I2T4"L@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>netw1_001.jpg
<TEXT>
begin 644 netw1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" <P# 2(  A$! Q$!_\0
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M==\6Q?$:#PU!=Z(+:YM'O$FDL)6=%5L;"!. QZ<\?2A:NP=+G>T4#.!GK10
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M8#+[\UV\LB0Q/+(P5$4LS$\ #J:S],T*PT>\U"XL8A$;^83SJOW3)C!8#MG
MS[TSQ!HA\0::UB=3OK")S^\:S,8:1?[I+HW'TQ^5-^0)=SAO$-OJGB3P?JUF
M?"NL&ZOF-Q!<++:*JLI!A.#.&  5,_*#UXS77>"-?_X2;P=IVIN")WCV7"D8
M*RK\KC'^\#6O#;2Q:>+9KVXEE";?M+A/,)_O8"A,_P# <>U<_P"%O \'A.ZN
MYK36M5N8[N5IIH+IHC&TC')<!8U(/T('M36EUT_K]!/5)]?Z_4U?$O\ R*NK
M_P#7E-_Z :XCQIX9U&U^Q>-O"J[=<L8%%Q /NWL  RA'<@=._P"(%=QKND'7
M-+EL/[1O+&.4%9'M/+WNI!!7+HV!SU&#[U/I=A)INGQVDE_=7QC&!-<A-^.P
M.Q5''TS4Z[K<JZM8Y7X;^([;Q9::OK5I&\<=Q>+F.0<HP@B##\"#S67\;H)Y
M/!=I.N\VMMJ4$UV%'_+($@D^P)%=OI&@V&AO?FPB$*WMR;F1%^Z'*@$@=L[<
M_4FK]Q;PW=M);W$22PRJ4>-URK*>H([BJD]4UTM^%A+K?K?\=!89(YH4EB97
MC=0RLIR"#T(IP922 02#@@'I7.V'A%=)V0Z9K>K6E@G"V*R1R1*.> 9$9U'/
M0,,8XK?@@CMHA'&"%'/)))/J2>2?>AV$CBOBI_R+FF_]ABS_ /1HKN:YKQ3X
M.C\6"&.ZUG5+6WAD258+0PJOF(<JY+1LV?;...E;UE;R6MI'#->3WDBCF><(
M'?Z[%5?R I+9^OZ(;W7I^IC>)[N=1:6%MIUSJ#32>9/!;-&&\E""?]8RK@MM
M7&<X)QTKCX;^ZT?XN6]]<:/?:98^(8!:2BZ:!@US&"4(\J1\97*\XKM+3P[)
M:^(I]8.NZI.TR[&M9?)\D*,E5 $88 ;CT;)[DU6\7>#+;QC%:0WFIZC:16LH
MGC6R:-/W@^ZV61CD<]"!0M&G_78'K=?UW_,Z6N OO^2ZZ3_V!)O_ $8*[BRM
MY+2SB@ENYKMT&#/.%WO[G:JC/T KF;KP)]I\3CQ"/$NM17ZQ-#&4%L4CC8YV
M!6A(Q[G)]Z%I)/U_)H/LM?UNO\CJI9HX=GF.%WL$7W)[4^L&U\,RQ:M;:A>Z
M_JNHM;!O*BN?(6-688+8BB3)P2!G/4UO4 %%%% !1110 5S_ (V\3_\ "'>$
M+[7_ +']L^R^7^X\WR]VZ14^]@XQNST[5T%>?_&W_DD.N_\ ;O\ ^E$= 'G_
M /PTU_U*/_E2_P#M5'_#37_4H_\ E2_^U5X!10![_P#\--?]2C_Y4O\ [51_
MPTU_U*/_ )4O_M5> 44 >_\ _#37_4H_^5+_ .U4?\--?]2C_P"5+_[57@%%
M 'O_ /PTU_U*/_E2_P#M5'_#37_4H_\ E2_^U5X!7??#SPG::_I7B'4'L&U:
M]TZ!&MM+65D\XL3ECM(8A0.BD$]/2CHWV#JD>@_\--?]2C_Y4O\ [51_PTU_
MU*/_ )4O_M5>4:V= G\.13VFE_V7K*7AANK43NRA0O55<EEYX.2<$=:Y>@#W
M_P#X::_ZE'_RI?\ VJC_ (::_P"I1_\ *E_]JKB/#=AH5Q\+M>UR[\.6-S?Z
M5+!'&[SW*B4.V"7"R@9YXVXKG-6N--G\,P2CPS#I=Y-<;K>YM99FCEB4$."L
MLCG(8KR/?TY'I^'X@M5?U_ ]:_X::_ZE'_RI?_:J/^&FO^I1_P#*E_\ :J\
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MK^E>,-1C\(6$<6DVWVBR4W5V2W)QYG[[G@#IBCI<.MCJ?^&FO^I1_P#*E_\
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MVGD8Z?=%>(ZSHFI^']0>PU:RFL[I1GRY5QD>H/0C@\CBO4?^&<?&'_02T/\
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MQ;J"X4K8VRWJ,)YU&]R[;CNXR!DCG(^IZS_AG'QA_P!!+0_^_P#-_P#&J/\
MAG'QA_T$M#_[_P W_P :IRU;?I^"L"T27J>/UZQX?A\:^#[72;_P=]HU.SU"
MV26[L% N%60Y!#QKRBD8PW'UJQ_PSCXP_P"@EH?_ '_F_P#C5'_#./C#_H):
M'_W_ )O_ (U0G835SF?BS%H\7C!#I5M!:2R6L<E]:V[!HX;@Y+J"...,X[US
M<?AC69O#4OB*.Q9M)BE\F2X#KA7XX*YW=QSC'->E?\,X^,/^@EH?_?\ F_\
MC578O@'XUM],GL8;[P]&MP1YTHFGWR*""$),> N0#P!D@9S@5*5E_7<IN[1P
MWPIL+R\^)&BR6MI//';W223-%&6$29^\Q'0>YJO\2["\LOB%K;7=I/;B>\EE
MA,L93S$+G#+GJ/<5VG_#./C#_H):'_W_ )O_ (U1_P ,X^,/^@EH?_?^;_XU
M3>MO*_X_\,):7\[?A?\ S,"#2->M/A-#J5OI^H1>3K O$N$A<;8Q#Q*#C[N?
MXNE=-=Z]I/C'X=^(-?<);^)H[&.UU"-!@7*^=&5F ]?EP?\ ]50?\,X^,/\
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M#_H):'_W_F_^-4!U/'Z*]@_X9Q\8?]!+0_\ O_-_\:H_X9Q\8?\ 02T/_O\
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4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>formdrs_1.jpg
<TEXT>
begin 644 formdrs_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %)!$P# 2(  A$! Q$!_\0
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M&3@X R?H?Z5PU?HS^$&%G*-3(,-=*VN:XB-NOVK?\'>QT4_&7Q'K-VS*4?\
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M]$[PLEOZV/PF'C=Q^HU'5SBM0E[9M4Z4)3B]7UA3E9>=[>>J/Z-/^(@9.O\
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M+.5IY.H727-S35M5M>:N^GST['YP_&_CV2<?[:E=]K:6L][:;=6G^!_1J_\
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M*F.2 <?VC=''3.<+U&?_ *^:_G*5FP?NDC((V+G@9X&01GH <9Z4V$N)B3@
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MI3,=S!21PI(P"<DY['N*</\ @O\ 1@!O^%3 #''_ !,+C@=/^>8^G?CZY/\
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MC&ARK2/OQM9;?@)@9''WN_X9/Y]_Q'3&)(6RIZ_ZK'H,G''IT&?ITQ3%ZX]
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M !/\<[/2+VXBTYH+H(8R=@0GD] Q4#T ;. 3TSTY<_M"SD"0VK*WH AZG!'
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MFN:&UM[N2O9-[^MSX*DB5=CM"PPP/)'IT_#@'I]>E0GRR6D23+$\1@AL8/0
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M)M42 DC *$ \=2.G!YST^F/#FE3:#I\6GQ7:RQ6<8M7)1<[VCV*%*98 ;AG
M!QUXS7Y?Q;F.29RZ$\NJJ4Z:;E&G)W:523=1WC!:/W;;Z.RUN?H'#V$K82"E
MBXRBI6<N=6LW';1RU=[[6U.;^*41N/ ^I>=&JRQ%Q@XP1Y;?=]0,Y).,CH*_
M-_R9GE>/RLGD\D# SC[PSC .,8 R>/2OT_\ $6DG6=*N+*>9E2>5D!*ED7>
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MESN(')6-0P[ DXQ]..23VP>Q'@?[,:X\(ZB<C][=7"*/^!CN,#'7.#TQBOH
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M917K37EYCRHTC'EDLR_ZR4C:K?+W/(+9(.*]2=T=I8KEHXFM$)N&CV;/F78
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M;_?/_H"UY6.GX-_Z*->J? __ )*=HW^^?_0%KAX4_P"1Z_\ %#_TJ)T<7_\
M(@Q__8/B/_39^DFIG&I:J3VNDZ?]>\%400V2,\XZ\'[JU=U7C4M5'K<H<_\
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MZW^7D*>5/T/\J <-GG ;G')^YC^9I.6!Y!#9.<'OR._H?3CT-+@Y.".>>1[
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MY*_3^>3_ #%-?C)^IY]]J_UR/?BOZ1JJ]2+Z1HRA+RDTM//9ZK0_C76*H/\
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MO^"YOVU;WX5PW-W=>&E\2+IUK:Q@+;W5OKDT!*!0X0[8U=0JG"YQQFOSC/\
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MY.7#GC-Q?E\LJPRP:S'%RI2=>=.24*\H5IT_W+<E%N4U&/O7BDK7YK\O5FG
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M$UW9MX\9G'*\OP^4X.E+%3HXWZS.5:W+4I5Z4*23DES1<7-N25](V6MD\O\
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M:^,UTM[()D@9;B_FN+JXMX&Q#:B0--M1&W[ F\KM!.0I!R5S7Y^765U"_P"
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MDG;^5L+0P*B7#><SMN<2 M(<-GRXI!DQKMY((.2#DYK[1^ *B*WU.YE\\)%
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MK:-Y%PJRI-*H7:=IR!A@WS'X32**...W4%K8B1G61R[B21E9F5R<J0=RY"\
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MC2K46K.562F^>7+%-*2E:4I.[;N=.<\;X[#5'0G.<E%M64-G=76Z\K['Z)>
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MYK/1WLE9;OOHM+'QK^T5$TK6!+$CS'7#')P<9YXZ'@8P<'.!S7GOP2^*.J?
MSXA6/Q%T>V6]O=,A$*6Y7<6RR2_P21,R$J <.#@MSGD>B?M#QG%DYF$;HV?L
M_5BQ"C /MGDXSR>" :^:&)*;4P)F19&+$Y1=I!)!*@]SM/0GOG ^[X=PN6XO
M(\1@,SP]'%4:^%JTJM&3YIM5(N"M&RYKN5I7>D6WKL?,YYFKPV8QJT^95*,N
M9.*=TW>.FJ[]_P CW_P]^T)XGT7]H_6?VCK+35EUWQ)J<OG6(C+O%'=7)E?*
M+.)04! 9O/V[RY"A2%'T+X;M+CQ%XYUCXOWUNMKX@U&]DU?34";72[>7SAYA
M4$A 2 0L@DR"/,R1CY+^#?AU/$FOM*ZO(EK*4#E,0RR1$IB-2. 2"1C.1CKC
M%?H-8P6UO!#IL0^QS!%22&4 B-2H!=3A2 WMT!]@#^:\095@,OF\%@*5/!U:
MF C@JJA9QEAX2G*C3<[+E4?:2M%+=V2T9]=D$<7B8T:SKSC>7UG1M_%9R<NS
M:6F[;ZV/M]OVX[^QLM)-_P"!K*]\4Z5:PP1ZQ):(61(T6-6$GVD,'C4<;2%^
M]\I& /A;Q_\ M_WVB_&'4?&$OAVT\27MU"+/6]%NK5)T>VD"Q%88_.0.?)RF
MTR,"3CT6O)OB[XT_X1W0KQ(9774X$17"R9(5@1N*@;AMZDCMTR>*^$+N[.J3
MMJUY)]IFF$LD5Y'N0SN<E8I"^& B)&3G+?PXKY[A;P@R64GB,;E<:E.NY6FW
M*]JDI2GRKE7+!S;D^5Q2>J2:371GG&6;X1UZ.%Q=2,6XQCS::TTXOJ[[V3Z^
M6B/LCX^_MO>)_C7I.G^%_"'AVV^'7@+PY?66I1::UNMC++J]B7FC*1PS-"\3
M7+!MKPE^%970AB.^\4?MG:Q\>? '@WX>ZOX"TV/Q[X/BL(M'\<"QV2QV=K&%
M@C@O/M4DR;I<$J  TNW@)G=^?EMNU0VB2;1=33(QMA$67AUC4;<'#,.K'<6S
MTZ5]K_![X=0Z5''JL]F\5X\#XCN5*F-#*"K(KJJXP<KC( &!TKZ;-^"N <MJ
M8"G#!.EBL&JCPU2EB)4U[>JITZD*BYKRIN#NYRYG)MQ<7RIGG</9WG.,QBGB
MYU*L-W*=[=[*]T[;_,_2OP-^UG;Q^"/#>A_$3X7Z7XUUK0;.TM&UR;1X+F=!
M:@+DW%Q,26.5;(0$]@,<_//CG]J'Q-\-/%R_&7P-8:;H+([02Z 8_)2_MD9Q
M]F-JDH+DH60[9%& ,8  /)74MK90W%_(9DAMQYLP21D1C'R3L& 1CEC]!C!K
MXE^,GQ#M]?OI-/M2T]O;,/L"1,OEQRLYWO(227(Y&2 >1R<\?GN4>'.2U,=F
M*IQJ5<-C/K-%T:TO:TU5JS3E&$I3E'V=YV]VG%)-WC*Y];GW&.8X;#QI8>C4
M48M+G<&E=JS2:?2RMKU/LFZ_X*D:AI&J:C>> ?AAH_@^\\3V4EIXHU*/38[=
MKQ[NSGM9&+1W(>3S#-,S&1FVLX)(WL*_.BQU26Y\;WOB"VAB%UK=\UY?0+"$
M2*29V9B1$P.2&RI+,3TYW8'$NYBN+RUFDA)N5B-R6'FE6#%XEB8;A&<J1G@<
M]">G2>'YY(M6MG2$I(TB+*)!O,@. K1[20 J@@YY#''6OV[*> ^'^$,)]:R[
M THXRO@:=.OB$^:7-3HN$4Y--M4U*2A=^ZFTDKM'YSB^(\9C:]%8AU&N9<VC
M<>E[:]K7TW7S/TD\)H@T&V:V.^9X4,H).0Q52<GC&!@ 'C@#J#GR_P"-NP:-
M$" 28@#@?-DJ#],D#GD<\XXQ7IWA")Y-$LVTQ//40*U^^[:+48#2.RG#/\FT
MX QTY))KROXVS02Z-.;5_M300LPB56C,@ ^9@7 'RD=<\CCO7QN74\1+B"DD
MTY1JN<ZC;C#XKZRY6DTK=.B^7N8^O"KEE.4%?EE&]X^]IVWOOM?:Q\*%E2>3
M" @E@,YR!EL@]L8.,GT'7%)G .!P. 3[<8//./8 $YP!3Y7BAF2.7Y)YD$BI
MPP4N VUBHQD@\$^O?!J 2'SVC=2F5! ;'5CZYXS[XR:_<:%.-:4%.K%^[&]I
M7OHMG;6_2W0_-,97G];FE%*\Y.-]-.=M7>NMK7Z>1+G! R.@X ]>X_3CTYJ2
M$88CK\AY_P"^JA;*(S AV215VCC[V,\<^I'7 ['K4T/#XZC8P'U'(^O!XQ]3
MZ5AF34:6*[*-ONA;\;7/4P/)]>P<8M*7,GY:RBWKZWZ=3\R/B1_R/GB3_K[N
M*XD'"Y]U_DM=M\2/^1\\2?\ 7W<5Q(&00?;_ -!6OXGXD_Y'N-_Z^+_TH_TX
MX(_Y)K*O^O2_0:V=K9Z\?F6.#].01UZ>HKU;X($_\+-T8>LGY853^HZ_7'U\
MID^X22<@]AV5^?RXQGI^=>J_ [_DIFB]CO.1TY( X[=.??ZXK@X<26=4Y1NY
M?6(<RBO>^*UHKKO=:ZG3Q;'GR/-%+5K 8JZ]*2V\O\['Z2:J/^)CJA$S0,)8
M]K+C<Q-I;(4PP*\Y/4<8SC R/?/V?-#_ &>9GOM?_:1O-4MM#T.VDO(-,T5[
M47>H"W+2*ABNU:.3>BX*B6,EG4AE&X'P/565=0U9G"X$RDEAD BT@.X8'!!'
MO@9KT+X->--+^''B0^./%/@R/X@^'+:$6T^G7FG)J-DK%DD+RV\\,L$B1@!6
M5@,@D$XK^M.(,-7_ -2*LL/7KT:DLNFX?5\5]3Q//RQ<53K:^SF[)*WQ7</M
M'^:N!HPK<3UXU.5IYK524G9-)U/+U?6^B/T%^/G[-'[./C']FMOVFO@-'JN@
M6EO//82Z'KK6D-U<0VZ121L(K8;55A)!@>>Y8M*5(P,<+\$_V</@EX(^#EA^
MT5^UMK5XFCZXTUGH'@O2)1_:-W;P2 ;H[2[A\J0F!VD\S[6I 8CRR@3=]9>-
M_&_@S]N3]AKQ7XJ\"^#KKX/:9\-KF[EGT6T@ATFRUG^SY(X"Z6MK%!$\=R5\
MQ8V!^15"MA2:Z?\ :#^/WPX^!?[)7[.>K>*_A9!\1+ [+'RGTZTU*WC>*STZ
MSN6DMYHIT$\IE!61E'1L'/7^0\%Q5Q#_ &=ALAEF68RK8O,\10QE&IC.3&X2
MA'VM6FGC;N,5*,8\M2,W5DJL4X1<9./[)2X>R^ICZLWA:55>Q@VG9Q<N5:WM
MTU>NFEMK(^0O#]E^SK\0OB7X-T?]E6+Q%IL.IR26MQ8ZC+ EQ&ERZ(TIALHD
M0>7%)NR6?E3NST/ZCS?!K]E?P;K6A? [QU=ZA>?$76+56AUI);8BTU&X5/*@
MFGDC#*2TZEU90WF [6"J /./ _@'X0WOB[]GW]H;X?\ @^V^'*^,$NQ=Z"MO
M!9 R2+#"C+;PI#&HW%V4!01\I^G$_M :!K$W[:CZ7;6%[')JWB+0[_1+NYC:
M61K&W6WE>2"X,8$89UB)P2)%R?E+8'B<19[C\ZJ97E<,?F&6X*A@,;.C6Q6(
M>)Q=;$9;7I1G"MC/:.3C*7-R4M8U;<S<5%)_09'E&$H+$..6T6G5<=+:)QD[
MOW59:;]+]+GC>F_ KX=?"K]ICQKX8^(;6>JZK;Z5J6H^$(O$SQRZ;/8QD"VD
MVRC+DLV#Y<J %0 1P1\4_MKV'PQTSXBZ%)\-I+!M5OH(;CQ'8Z.(ETVVNIFE
M>[38B9 24 8$@4%B555*!?;O^"M%^R?M!>%WT[5[BQUO2_![V5S<VEP8YQ<B
MX1S#,4."A92&C*C((!((Q7YFRS33W3/<S37%Y<1DO=R.7G=P!N;S""=K$$E>
MYSP,BOZ2\),@S'&X#*>(J^-QM=8K RQ$J-"LZ<5*#]AK"4DN1NG[2"3NG.\G
M)61^*<=8O"4*^+PD*4*3>)2M&ST<[6W73KKMLM6?H%_P3V_9_P#A?\?-<^)%
MS\78OM&@^"M+CU,C2TB/^LN5A956Y !958G:"#D?>(X'V=JFC?L7^'_#MY;_
M  UT;7;/Q-8S7=O97FH1V422S)))" '@1TV$A6&" 3DGY?EKF/\ @D'%;Z)!
M\7?%&HZ3%J=G:Z'#)?Z8UNDZ7T0O@!&(75MS9 )X.<\BN_\ B5\</AW\3;A?
M"F@?#_2/"]XGB:"">>#2K>SE6!M442DR1V\8(96(!X%?BO&.>Y['CS/:*Q6:
M^PP3C.G0CF"]E%.-1RA4H*5ZCFE&33:BURQ3BT[_ *CPWPWE$^'L!C:GLU5J
M4>:7,ES*R5K>EWV?J>9>%_@G\9_'OAR7Q)H'A9Y['3WGDMYH[5F%V Q:%(<S
M(9&9<<J1ERN.M?#GC"+XV>/O'-]\*/"O@[4M0\5P78BU32O)9WTR3Y(_.G10
MHCC#'."S83J2P+C]&?\ @IC\<_B5^SU:_!3P9\&Y-2TGPY=>'KV>YN-)-P'O
M[ZT>TDLC*UHF&B8/*DN[_6$YR,"L#X3>/?&%E^QQ\7/V@[/2H7^-=[<7=KJ&
MJ+:[KZSM+G37DDNHF5/M2M&R(4P69)&!Y[>MP_QIG^ RNCF4GEM6.8XJ.%RN
MDZ$/;8/%2<J=/&YG)MKV<>6SIM2BU;FM*]O.QF2X#$SJ89*?+>4O:_"H\JU@
MFI;[.W_#'Y7_ !6_9V^._P &8?[8^+/@S7]*TTAK=;M;1XM/G6,X9RP>X'S,
M5.\O'P20G3'I'[/G[*WQO^)UWIOC#0?".H3^%;!S=0WYM#,\T/E'<+:<R11,
MRQOE5,$A""0D[@#7W+^Q%\0?'W[5/[*_QNT'XYW4_BRPTZRU6\\/Z_J4=R9K
M>58T-K LVI*'W1A&!$84,^&P#P?MWX(>*?#_ ,0?A1X:^#7A76Y?A=\0/#X:
MTT=?]*ABUZ."UD^SJXM8U262Y19"[.0I&0<94'7/?&3B3+<NQ.68KZGB,PHX
MJ,<9F.$@H8"M'$QBX5:/LVN5\L.6=&,4J<O?3E!M'+E7!&68RNYRI3_<MQ2F
MVN9P:?-'>Z;>CW=FK'PQJ/PT\9Z#X<74K[17M/"^GRM ]WY+1OYJ2>7/YP+,
M%"R$J3GALKCJ:^?_ (S>'/'EYX2M?&FA:+->^$[(?V?<RQ6[E9+K4+A;"U"R
M;V49EC4*"CY#RX_A*_K=\-[+Q'XN\#?%S]F_X@"!_'5FRS>'YU4;[HWET999
M%#$R.I&<=-I(P>.?CO\ :J\?7'[-G@+X&_!]-'_M;6;S4Y]>\6^'XT#WL\6A
M:[!>V^]<<*;;S7:.53N#;E/+ >#D_B-FM>K6RVG253,*,_;TDG=5(5(JO[2Z
MN^574?A:OUM8^@S;A?!4<MH5'&<(2J5*3C'IRU.1::*SWOV_'\R]1_9)_:4L
M/#"?$#4O %T/"-W;37>D3BT9+L.%Q']J82NI0D$DI;P';C'(W'[K\"_\$Z_B
MC;_L]^'OC(EF;SQ=JTUMJ*Z=8JWV>ST:6UCG'VK<$DW1R1W V"0LH.YY'R%3
MUGXQ:GJW[7O@+Q1XY_9V^)E]HNH>$O"M_?\ B3X3--J,/]F/IVG23/!;VV(+
M.!]J*QPQ)&<#G-;(^+_Q7TO_ ()U^$M0@\2ZG8ZS9:O9>']5GCENI9;>T2QS
M+!,8=Y=@[.#G"@'ONR/8S_Q/XZQ^283ZOC,MI8BCF>%P>,PRH1JU*="NZJA1
M4W).56T'*=1I4KIQ@FM3R\IX4R*&<1PM2#E[;!SK\^G*YVO>3OOLK6OLSS?P
M-\,/B#\0+I[#P5X:EU!=,LTM=?E2*5E2[MV5KU8@JJ@\LD[,.Q)P7W9POR7^
MT3\//'?@WQ%<^%=8\,WUKJ>K!+:PCU"W:.XGDDD"J; &0 L6)4[@3@C 7BOW
MJ\$:MX(^'O[)?@[7;B[O-#D\2V\=SK7B.PDDAOKBYO+6*6>666W5I5C=ESA@
M<=3RU?!O[97QJ^$?Q0TWX5^'O!IN;OQII_B6T>3Q5<2R-+=1_;+4Q0(TJ"<Y
M(8/N;."!@#KXO#OB5Q5#/,?2PN5NOA\-6J8.-51A2E+$4J<YRK.G[5J%%N$H
M+EYG&HXQLXMR7T.=<,94LCI2?*K<NS3NNR[Z=78_*[2_V/OVG]8BN!8?##7H
M])TNW6[NWGTN[^TS17$;W \AMI0@6@C9<I+B1OO.A%9OAG]E']IOQ-IFJWGA
MCX::O;Z;I1?[;;:U8-]I61 7S L;6WR%8Y-RM&6W%0&&-I_6+]JC]J+XM^"?
MVS/@KX \%SII'@V;3]"BUS2UAD:/5HY-.TY)#<@,HE+Y898' )Z\FM#XP?M)
M_$_2?^"@?@;P-X::#2/ NMVUO!J_AZV5X;:\25K99GD@! ,F&95D*Y4$@"OL
M\'XI^(V-E42R^E&FLJGFU"]=.,:-)KVE-J#YI59)R<'"T$[*;LSX:7#&4QP\
MIIQYN9I+W;]?)V2ZK=ZV/P:O[?4M)U"ZTO7+%])US2+PZ;J=DR/!Y,D)_>$Q
MR-*^0< ;FQ\PR,Y)X?XF_P#)./%#*,Q&WN")0,,SEU*KSQM8X4@+GJ<]"?NO
M]O+2+'0/VM_&\&DP0V=EJ4^HZC+:.JC;OEYRV,!^ 5XZ<''%?#'Q,P?AEXH=
M 0K1W(VYXXDC (!_NYS]3TS7[[#-*N?>'=/-:\7"<L+'$N$K<ZA5I.48M;.2
M<U&5G:R;3::/D,CPE+!<;90J;:7]J3Z;_O*:?EK^!^9$:@1$9/S33@9]F_#I
MR/P]227JT@&%4$ D$G.<YR>_O[_6F1'=%G_IXG'ZGZ]A]>G/K;BC5TR<YW,.
MO;<3_6OY&Q$5B,RQRF^51JMKMNUW7_ Z'^EN7)3IT9/1_4,%\3LO@]?NU^\I
M0\W<0_Z>H_\ T**OU(\) ?\ ")^&SW-AR?HF!^@%?ES JF[CR!Q>6H'L&QN'
MT.!GZ#T%?J/X0Y\)>&<][ 9_[Y]J_;_!-<^:9I%:.HKJ_2W?_@'\N?21_P"1
M/3_QK\6CIXP,8Q]Y!N]^H_#CTIHV_,6]%&?J3G^0]_2DR00 <=.GT;_ 4A!&
M!DG)YR>N <9X[?U.>M?T9B9-U4X[PA*.O\W*[-6OI?YG\<1C%SPRG\+IPYO\
M-KO?39VU[!,0T? !(RPYZ 9Y/J0,#!SD8_#T/X>7,2>(-+A./FG7.2<#YL _
M,>N,Y!XST7O7G>0>^#GD>O/3!Y.?3C)Z@$UJ>';C^S]<L;R65E2"9&ZX5CN!
MP>!WRWL.,X&:\[-(RJY75HSMS\LI6UNTW%V76Z?7;2VYUX*^$QE.=)^XZEU=
MNRWWZ-6T5K_F?J5#&$BMF&TC[.&')8Y !&&'/<C'(Q_#7RW^T1ILAL+:?,B1
MFY!R$+'YN3CKZ'T[XR#7T#X6U:#Q#H]G<V<J.ZQ(&0. 2 #E6SQ@E<]^@./6
MWXC\.V?BFR>WU""-HD0B($J3YX'R$#.<@ =?0@\U^*X6K/+<TE.4W"*J2:>J
MLWM?YGZ5.<LQP2BH)VA9Z7O9:-6Z:?<?EL=ODLRL\K!@ "/X]Q&3P.=H&1RO
M0XSS7U7\#M)AB9M0N%\EV2,Q2 '*N%/!.X!MS'@-E0/E48&*LWO[/]](\[V@
M6$22;E48.?FSGO@G/(XP0,XKVCPCX4E\-Z.MBT<<UTLD!,657*I,HD?D9!5<
M[CG !ZCM]=Q1Q1A:&0UJM*I2JUO9KG@VN:<O95+<J3^*^USP^'\HJ4<WI<]-
M651R;L[/WXZ-V6KOI?1I.[V9^A?PS^!/@+2/AX/CS\==0:Q\,+'+%#I*F6U>
M^2W)@9\Q-F02HL;@QQAQN R#DGX!_:RU3]DGQGX>_M/X+ZY=:?XI6=(=/T)Y
MM3O#+()#^XB^U 00++RN<9/(W$&OU _:OTK4O%/[,GPDO?"UL=2\):?9W<6N
M)8.TQMYDBB242PP9R5N8I%.\';M&,]3^3/ACX+IXA\2Z/<Q:!>S3ZIJ%I!9/
M=64MG;:=--<((KD/)$(9UBSD!SEN<C/7^7>!LX4,=CN)<=G%6GC*&/QD:67Q
MK.,(T:=2JH1G3G[CE>*=TTTVE%\MK_K>>9!4QV&5"A3A[W)4OMI.*CK:W5[+
M3=OR\4\._L8?M+>,=%T[Q=H_P_NTTF]2._6!;ZU$EVG#*RQE-VUU93MZ'(+A
MR"Q]C^#_ .S)XJU'5]3MI/"UX?%VDB4GP\9FS'.I50 G38!D[RI]"S @5^[O
MPVTFQ^"WBKX>?#_QE\2-;U'Q+K%C;OI?ANV\*R3Z:+:21(1%]NB4P"/<NT$G
MG&[&"!6/X%GLO#7[8WQ2N+6Q5=0MO!-Q<QZ?) JQB9=6:-9I#MVA_* 0$C(3
MCJ#58GQTX@Q57-L+@XT:T5"56ARSY>?V=2<(J3=TEK%\\;Q2;[QYEA?#3 T(
M4L1F4E0?)%J2N^=VO*W^%-/7>^G8_-[Q+\(?B1X,M=/7Q%X7N+6YU=8K>UT^
M%USN6/Y2T<*JZ$MM+9&&^ZX894^??'+X7?&?P1X1B\06?A61_"R6SW%];VLD
M<EXEO<0!E:8A'NEV<GYI!EL@G&#7W7^S+\;KSXU?M9_$7PU\0]6M=7C\(R74
M^E:7)'$D4.)KH)%:9;$S0+&@,03+A0I.6K&\+_M/?!R?QM\5+3Q)XT\5^+H;
MB34]$C\*ZCX*NK.SLI+2:ZLUCBDDBV>3 P"I*5 D4!@3P*X<'XCY_A\PIPQ^
M#53$>SP^*JQBOXL:KTITW4Y7S12E=S2CHN[:[<9PIE57!5887$*;C&23N[Q2
MC>VFNN^BZ??_ #K-*VL7-Y)%9S)"ERK1_:+HNR3;RS1$2$RC$P4EE.\%0N?+
MW!F*DADF>Y^25"!(A)?@%=H7!QC"D?3KDCC[*\1?L^MK/B76M6T>*&;1+O4;
MR\M$\];:>!)YW:)# 2ARBM]T#*@'I61_PSS?J3B>$C.&"E<J!G(.>IS@9X.0
M<"O[%X?XORW%Y#AZK<*56=%2E'EBG%\D6XNWVEO=:--6ZV_ \PX2<,RG:I5Y
M5JTG*S?-.[U7565GT6Y\T>%HYM1\1VR"-R@D6-2%+$ NA[@D@D9RV3R,<'G]
M'O"]D;#1HXV##,<8())/4=<]2<_D..]>;^%?@]9^'YXKRY56DC8$D -O8.".
MV> #P<9ZXQS7M;C*+#;Q#R @W.WRJN!R > ><_CCG-?#9_FU/,*E&%%RG:LT
M]N]NCOZ>I]'E.62P4JDW=QC!>]*[;LKV^71'D'QD:,6M@CL%3RY<$\8(B4A0
M1UW$<YR<C'3(/P%=D>;<X)P9V...S =>A&TCDX]QR17UI^T!XJMB8+*"0>9:
ME2=C@DG,:N1@]1TZ #/4$\_)3 S/)G'SN6#9Y P" /7_ /6<D"OT#A7"?N^9
M^Z^2]W=)V6MOEIZGSF>XZ]2:2O:5K+EWLM/\^XG41C/2(C/'3*XZ=NWY\]Z5
M>W^ZO]:.,K@8"Y48Z$8))'J"<<^W'J6Y(QC_ &OTS@?A7V-).,Y:Z3@X)=;M
M/5['S=:?M,-!V:;K1>MM+R2Z>A(O*2_[LWZ1@5^6WB__ )&_Q!_U^R_^CI:_
M4G_EE+_USN/_ $ _YXK\M/&!/_"7^(/^ORX_2>3%?@OC.G]1P\.M)I2?1[[=
M>O4_J/Z-Z_X5,>_YX**\G:UWY:&$>LO^]'_Z%12'AG Z$ _B)  ?P'3M2#^#
MW9<^^>M?S7B4TJ$NE5Z=U>SU^_H?VFU^Z2\U^*L>K?!?CQUI'_72'_TI%?HS
M<@><I[B1<?BB@_H3_D"OSG^#&!X^TD<!1L..PQ)&0?P))K]&+@?Z0,]-PQ]=
MB_XBOZJ\)7?+HQV:2;;VVMTUZ'\,_21@WQ#E^JM"FI/?:+YG;SM%K7\BH@ C
M8#.#<.I )Z;6_'C&>.N*?D9R>V>P&0IZ \')[]<Y-(F-C''_ "V8@$]]O7GH
M<_S[\&G$ \<'KG(( [$G'0 ]2<\9&:_854G2J.5)S3M)SE35I/27PMI).^_,
MTK7=UI?^:\1#FC&5-I2;3U76ZOM?I=7Z_>R.20 >7"FZY=A]F!Z-)_ K=RI.
MW@'GIRIY_<+]E+]FCX:_#?X)V7QW_:#U.2UM_$J1RV/AOS983<0SK)$SK;1L
MKLK2I&P*JH7?P0" /Q%L39V_B+P]<7QQ;0ZOI\A9F"J569'D5RQ"'=&I4!NI
M/3M7[P?M@7^K1?![]G+QC96EUK'@:?PSIVGK::7"US;V]W=7$DEN]S';!H_W
M2@ES(!C8ISRPK^:O&W-LQQDN'<GAB?JE+&XK$0Q>)DY1KJE0HU,0HPDDU%S]
MG&$FVI*+ERW9^L\!8+#U.:K-0TC'D@[<T9-6FWLG=.5O-ZB?%^+]G_6/#L5_
M\&;X:;J<@"1:/+#=W,T[%<"&WDNVF,+OG& "=QW!A@9_-+Q)^R!^TCJT]WXN
ML_AOJ=SX<N);B]DCEN8C=3(R[E=8RHN-NU5.T-S\W48Q^A/[-'AO3O%GQL\
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M#>8$1@-C';M5G W\$DD_,/U(\3_&3Q_;?L9>$/%L&HQS>-I+@11^)18V7VE
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M58$ 9,6,C\1G QUX [#L:8XP&.3DJ0>@Z D= .A _*G8_>(!Z$''4#*_G^/
MZ]J_14E04J<(4HW5FVG;KY7Z6V['XPZ?-*/,U[--76M[7T[+336_3L>E?"J9
M/^$IT>,D(1=1CG.>6(8#/49ZDC R<#DY_4#P;I%CXH\<>"_"NI7<=IH&JZO%
M;ZK/D1NL#("&$RD,H,F.=Z^GW1MK\E?"-W]D\26-RTGD):RB5220& ;YL'H/
MNA>2,ENF<U^RO[)'@O3OCOX^TRSN[H:?:Z/':ZA,L4RA]1V2$&W1E.Y7PJLW
M'"MR>:_#?%F^5Y;B,PKU*>#@J;G&K&-3VEU&JDHM1:YIMI*_N^[KH?I_ _U6
MIF"I57>\TK-KIRZ:_P!7W/MOQWX3^$H^(EO\"-4^ ^[P;=>'H)+CXG/<);6Z
M(;*:0W;S8,RM*Z;PZ7*9W87: <_S3_%[1?#'ACXP>-/!?@B]-SX;L-4D6RG9
MII(G5)9))X8YI,^80FZ,$.3A=V0Q+'^IGQ7\2;#]J30_&/[,'ABVO_ GQ+\,
M(=&L]5?3I!_:-G97#V4,*:G)''M!MXB3(DA4AN/XL_EC^U[^Q=X:^$OA?X>>
M%--AD'Q)$^HW'B75"CM$Y=0Z23W14JY/G!E/F$ NP)QT_GCP8\1:F19A7R_'
MYCB%B<=)4*>#K5O;Q]G2Q-1_6E>5J:J*<(M*R4FHN/,KO]<XUX4P^*P=&MA*
M,%&U-\W+U]G*37NIII>MWZ7/!_V,/A';_$_X@:!H*R&TLKZ'SKN4'RV9$==T
M2'<K;C'D QLCG.[.[!'Z7_%KPW^R%\.#XE\#:E;ZGIGC'18)X)[^>]UC,LUK
M$>8W-P4(F8JS[R[J2/GR23\(?".W\3?"O4M&U#PC;R3:OX;:)S+:K)(]RT>&
MDC\N'+#S,;-QR"H!)ZX_2'1-8^&7[<&C>,/!7BSP)=>$OBWI?A74Y[W6FLKM
M4N;F"TB@DGN;HPQQI(9$(VA\*%ZD\UZWBQFF+AQ7A<ZQ/-7RVC3A-4Z.(=.I
M2J^ZW6FHMJI2G3:I2A%.2;<FK:QX.$<OBLMQ%"%!.M%>SDFEMS-7775[/K]R
M?X1_&?P5\0;NPO?B)::+=S?#+3[J:TL=2$P=)0@RKF1D+MM !RTA.#C@Y XC
M0O@?\3M9\+VWQ T_PQ>2^ \H+:\$^$DG.8YE5@/O%R"W/!X7:#@_NOXA^%D?
MAC]B#Q+X"U+3QK]MH^N:A8C['!]HDD6VBSS+&KL"57+;CNY))SFKVA>'V\-?
ML%>%[2WTYM*MQK]R8DEM%\UXC-"P\[S5'.X[AD@9S["O6P?CQ6P624,/A\MP
MKA4QE/#T7/$U'.=)1DYS2C[T91:@I1DE=R34FE*WE8G@%8S'QJXB@U"<I2;<
M6T]4[*R>B6__  #\\_@Q^Q)\47L[#4;#PCJ%UJ6JI]M#W=P&B\@(+E<+.#&S
M)#]Q=F!C.,\UZI)\._%&D^(F\''P_=:=J\L16+3IY61I9E!62&V,Q=3B0@*R
M#(W+@@8!^_?VG?BS\3OAIX$^#L/@7=HD5U#8"ZU;3[6&\ENS(EA$MO(D0_<J
MZ2O$7!R%D8@$G(C^,_BNS?XB_LLZ_KVG16WCC7;62ZU2T$2Q2M,;ZV'F26<?
M[UF("\$$X;D>OQM7Q5XAS+,,35>!IT\+7HXQT*5.M.I:>$4I2J5'4?+%2BDE
MRZJ3:=[IGT?^HW#^%A3;J3IRC3LX1TE)MKWEII;;76W8_-SXE? O]I$^'=5'
MASX?W7V+3[:3^T[.2>)[Z:U2#SII8VF22<G(V*8V5S]U&5BI7\OM(\+^+?%O
MB5_".D:-?ZMXDM[QK$^'Q"_VJQO8Y=DCW4KJ6 #[DS(2%#97;@U^Z7B3XW?M
M.ZQ_P4>N_"5G?:A:?#ZRU6WTT>'#H<9T[4-$D:-[BZ+; Y5%9D+A2I& Y -?
M2GA_X(>'_!OQ+_:2^*?@S1-.E^($V@ZY<Z5IBK9O,VI;UDBD@M&4B)MZ,595
M#98@')&?H\D\7\UR'#UI5X82I6GE-+$T_8R<_9U9SA%TIN4;^ZZL6JL4HM1=
MTFTSQ,RX'P^,IR>'KUG1NUKS)Z*[5N]G&^ZNUKH?SU>/_P!E/]H;X7Z"OB'Q
MQ\.]1@L&22];4;:\6\M;:TFW-;QR06@V1O''EG>6,MM4J[$FM+X,? ;XL_$J
M^TGQ#X%\+2ZKX/N9FBU#4HE7R[1H8]KK)-+&\FXS,P8"4%2F,8.#^R'[%6K_
M !K^)FN?&;P;\;]7G\4>"[S2;UYH]3TJ.WM?#DDMR^ZTAGE7#-9D?9U&0H7Y
ML]*](^'*7WP&_8[\=_\ "!B"R\SQ-XC%I="WMI'2(>(9(4 DD'[M6A9=NPC(
M(Z8!KOQ7CGQ6J<<H5+!_7)RI3=:$VN>CB^6I%N2C-J=.DY6I^\Y.-KP4_=XL
M!X896H2QU2I5I^ROS<SU<H[<NJ5K]7:W6]M>"_9]_8M^(GC/P_JEIXGABT^V
MT.RD:SA0Q(]Q>*DCH97MQ'(V2$7+N5 X YY_/']HSPSXA\ :A>>&_%T:6FK(
MSK9/^[^:QMWD)9=@53O+.&+!F&T%6&:_6W]D#XM?$'5= ^*>IWGB*2ZN+?39
M98HXXX7:UEBLYG#QPAB9 ) "0JDYXX-?B!^T[\4]?\?>)$N?$MY/J6LI=W-N
MK7< M)1;/<3QRE5.TA"B#(89)7T %/PYSCB7-O$/%4\SQL)X64J#I4:4:JJT
M^?#T7-3<ER^\W>-K*SNM&T:\49;EV6Y!!T,34YE"479WNW*=NVEGZ_<?)=U&
M8[JZ&_S"TK$OGJI(*YQ@@@8PV >I..HAP1SGI@=.W' _   '.2.3R:<Y1IKG
M8XD59=JL.@R5#*#WVY*YSSC/6C:,8ZCZFO[+EA%1<.2<^=12DY/>22N]&]V_
M736Y^ 2Y?:U.=NI'GE9]6K[ZV_K?L-V@\9/3N".F/7C'3CK[TZ/)F';Y0<9'
M42#/(Z_KSU XIF>P&.>#G'? QGJ,8'?CCTI\(!G8$9 4^YX"G []23]<<UM3
MYE)<[YE==7??SM\RYU725\.DW:]NVGDM_P K=4?'?[4@!O=$XX,+G'U!/\Z^
M5$)_<?\  #^.]:^J?VHS_INAG/6V8X^K[<_@./05\MA5"Q$ 9#(!]-R<5_&/
MB2G_ *PXJ73FBK?]O<O^7W'^C/@Z[\+Y7+^[+3KHE^H-]YOHO_HLTWO#_P!?
M%L/SDB'^1WZ4YOO-]%_]%FFG/[K R1/;D#KR'C(Z>G7ZU\CA?^1CAO5?^G(G
MZ=C_ /D79A_UXQ'_ *:JGZB?#UO^*+T0]Q;1C/7JISD'C'KZ#IBNE3*^00 Q
MS(0&SAB&+KNZ CV/4G&*YGX>,&\':(@49^RJ>.F0F!R3WSD=NOO72C),*#^+
M>,$XR2S@+Z+D@<D@<8]J_MW)I^RX5RBO!_OFJ,:MK\WL_P!VG==M=GIU9_EC
MQ>KY]5FU[CQ6-@UM)?[1/7M;IU]"S#'?W>K:=I]G +G4=<NX;"VTZ( I/>W+
M>5;DQ*-C$NR_(05!4G;@D']2V_9K_9?_ &9? GAGQ3^U1J-UJGC[QK:VMW9^
M$[:]U*VETVROXPT0\FP<0QQQNAWRR1(VY@NYPH,?YQ_!R^TVR^-?PONM3S:)
M9>,]#+F=0ULGEWBR&?>^(2P56+;F "DD\9K[X_X*V:+K5M\8_A]XVN+#5+_P
MKJO@72[/2]6L+*;4M.=Y96N[>)D@$L$09'(5AD@*>1SG\9\3LVQ];CG*<BH8
MNO@\!C:-2=6>'FH59.C1C548S;481YFI5FI1J.$;1:N[_5<,9?A?9UL2Z2G.
M=*2A=1:3Y)-N71[.UNMMSD/%?A7X!:IXU\"K^S!?3ZMK6O:A%&WA=I;V:9&:
M+S?+>>]7>/+VL,J&)P-\A' ^A)_!OB=?$=EX1?3;BV\:M KPZ*[&9YB8%>0F
M3)2)4!_=HJ@Y4[\K@#XJ_8>M-8TW]KOX,7;:)?:3IU]K<3"ZU2S>TMYA)I]Q
M(1$]PJ([N'^5$[-P"<U^R<3:GJO[>$0TW3;^YC@C@:YENM.EBMX8?L[H986:
M,).C*.#&3P,GUK\KXRXBQ?">:4\#A\5/$4Z>&5:6)KU?>J3YW%4W4DW'WDM9
M-\S:LHMIM_<<-9//'4ZSGAY*/MG%64;<OE;HS\JOC7\$?B=XG\1S>'?#?A"[
MU/Q3IY+2V22F0PB1$D#2HP90"K@_,K$ \8P!7@>H_LO?'W2+_3-(U3P).=:U
M4QM';1W<$:Q^80O[PJ$RHP,J?E^]D<XK^CCP4SVO[3O[0%[IEC%=7^F:'FU2
M>)52WG_L&XE+QQLO[P^;!$P3C;L4 $*<_ WPF\!?M%_M'?%W6=3O/B(VE:/X
M>^UW6HSPZ?:-+IEG:RN[PQ6Y(D>18TRJC.=PQVS>2^-6:4Z->O4AA:.%P6&C
M6<O:TYUISDW%PER^[&$='S3EJVE9/?3-_#7#8W$4Y>SE%SFKRCV6NMNE[[=C
MYM\"_LR_&KX6PQZQX]\(-96K(O\ 9\]E/ T:E0I5IC;(D3$J%W>>K-D9;))8
M_HC9?L@^,M?^ LGQ0M2EWXN;[8]C9EH5B:".,-;JY 6!B@QD-&V22&+=#]4>
M#KCPUK_P)^,GAC1?%FK?$+4_"<.L;M<U_06T1=/GLK.%'AM3,&6X\B=7V2QL
M5?)9<@C/BDOQ ^(-A_P3]\2:OINNW46HZ=J>L:=8WEA'%=7$ 5T14,,3-(%5
M<J-R\\YZU^99WXM9]Q#C<-B:%>C1<<R7UB;3Y*N&7+*-."4G*,Y<LHQYGHXM
MJ\7K]KEW 67X'#-1K2YGAU324G>,E??RU]>C5S\2?$WPD^-GQH\?ZWH_@/PG
M=2S:;'#;:EJ$CQ&R-Q JK*L+7$+VK>9<*W C^4MM4A<*/'/$GP&^*_A/7_[!
M\;^%;K0M4BE@#19;[+=,KCR9+?"B#$YVB7[.J%@V3T&?Z6/#EGX!^$_[,G@7
M7]=US4/#TOB1C>:MXETG0CJVK7=Y,JW$B2VL(\V';<$C#D<L01Q@>4_&#XG_
M  L^+O\ PJCPQIJSZGKVDZE;I>>)-3TC^Q[B_@&HV?D^;'-&I8^4VQP2Q"'(
M7YLU^E9+X_Y__:-+*<)AJ<\,L'B:"=6KAX2A4HTFU5:E).<9R@XKE;DKQ;ZI
M?+9KX:8&6&^L5<1)R]LKM.7VY)]>B7XZ)L_/;X%?L8_$^]U'PCXIOO!+3Z9J
M=[82.)E@C)MQ*H.$E3 5E.X$)DD#&&P:^POVPO!NC>"/&'@S1=&LDTLP^&8[
MG4[*.,)(SK<K&QD9"&V*G#%6  &?O<U[K^T/\7/BUX"^/WPC^'O@J*ZT/0&;
M2REE9:2UW8ZA;K-;HJM=1(T4:NA*@D_*6RQ'!/R%_P %3_BT=&^)_AA;FVDT
MKQ+>^$8EOKA$+JT+R.9;;R$X#[02TIP#T!)%?-</<4<1\><999"M7HJA/#XN
MJZ5/%17+*.)G&/M8)J,FX--27PNRZW/0S3)\BX<R"%3#3C+$PC!SORN<FURO
ME:O976J?74N_!SX2>#OBAX.\<_$WX@3SS_#_ ,!V5[->V&DW,]O=LVG/B?<E
MDKW$["-E7RY$8R#++(I'/YY_'JT_9+\?VME=_LRW%]:^++K5?[-U+0]3O-4,
MTQ654*>3JP"PMYA!\R(JQ(Q@;@1UW[)/QV^+GPKUCQ#KVE:7?>+OA=J9N(_%
M/AN6SE:WU*.60"X5B4EC21\1[CMS@'%?;?QV_9*^#_Q<^$$'[3_P4T-OAIXH
MAU*.XU#2'MI[6U%^EQ%]I2-[A(8F)<AW:(9+*#P,BO>QV<YOP7QE;-,??!8I
MSA@88?$0>'IU^22MB:<IN3DZD4W44>7X4G??QLOPM#/\M2=*/NRG.4I)7<6X
MV4;7:DDG>^FJMIM\L?&/_@G)\0OAK\&/ 'Q%\-:8]]=:W97^H>,+"XNT;[-!
M;0)<6\Z37+RL%5)Y#LMWB \G*J3(X/RK\"_V??C3\8-2-_X \-7$^DZ2Y@U#
M5941()+H%21 UU&Z/Y95TP@VDG/7FOV<_:^O?C'JO[-/[//A[3O%&I++?R2V
MVMWEM9@V]_:":RMIK62Y!^54M_,12O568-T!'1_&Z[\7_ #X%?!K2/@Y;GPU
MI^H6EM/X@U72M/6_EN+YKE=QN %W$L69=RL5&[DY&#STO''BJCE>)P>.GA\3
MB*^.QD,-B:3_ -GAA:>*Q'LU*[=24HT(PA[B]Z2;;2.FCP!@J]6%Z<8QCRMM
MW;;?+V7X_F?&]M\-/&_AG4-,\$ZIHMYH_C*5XI3 P/V?4[5Y-CPHQ!B*E&@Q
ML"MNW8(W-GC/V@O@A\7+'P9K7BS7?#KZ/X9TBQDA>W5;>*\O!$2&\LO"9B9$
M!/[ME;N!TQ^R-E+-XV\)_ GQCXX@@@\;+<: ELQMX%N=8A>3<T<RA%>W:5XE
M:2&0$@)&<@G _,[]OOX_>._%G[5/@#X23:_:Z5X)G\2V6GZQH9-G!;RV32)'
M(TJDK(Y*Y1BPV')5<5R<.^)G%./S>M+#T,/*CAL'4Q6-J)SDY*G=<M!1A=N:
M2]ZHX1@_==Y'9GO#61Y9@L/0=6$:U2<4H-.[;=[/S]-T^EF?F7X(_9A^/OC_
M $23QCX,^'\\OAL+NA^WW,<=S(BH6W(;E'N&"HI.48%\9.=V:\@UC1M:T'6;
M[3/$=A)I^J6$B1/;2JT>T!6#JQ8+O"R#ED]MN._]('[2OQ<^#_P!\7_#/1M7
M\8^)O 5E9^'-#OX/#7AWP;<:UI?B:,V,1D6XOK1/)M3<0XD^;)PP]Z_&W]MS
MXK?"_P"-'Q?7Q3\)=+EL?#QL[1;LWMJ^FW,MQ%8'[1,MI*D;%)9W\ULC);G!
MXK]=\,_$K.N*,^H82GA6Z%2A5K>TFXN.'5"7+[#$.,Y-U9V:INFG#W6I-63?
MYYQ#PM@,-1>)O3AO)=&T[M-:*UUTNFKZ'R#D%E? 'F*6 !^4N,X(!).!_=^[
MMP2,@"IH#AQG^Z2>?15[>N1WQWJLGR(J,&$L1*(K#Y)&8K@M)P%' SV^;'3%
M6[?[^?5&X[CE./4\Y.?>OZ'S-MT,1?1N$6UV;BFU\FW]Q^;8&E!9KA(J[]]Z
MIZ:3TZ]4OZZ_F-\2/^1\\2?]?=Q7$C[I^G_LHKMOB1_R/GB3_K[N*XI>1^7_
M *"O^37\5<1NV>XUO5*HFTMVE*[MYV3L?Z=\$?\ )-Y3_P!>U^:&/]T^QS^<
MG]-M>J_ _!^)NC>[\=?[BD?Y_IFO+  1STXS[Y .#GW)_,^M>I_!#CXFZ-CL
MV/R4$_I_*O.X3YGQ'&,G[KKTI)J]TE+[KI_+5:G7Q9ID>:2>T\%B8)=FZ>[\
MM-=W8_23561=1U7?.8 9QSL#M*/LL!:%05;EP#@\8"\,#@U](_L^?M1S?L_-
M)8:QX&T?Q=X6UB"26?3+RPLKNYG20%0JW5U;RRQ-C!(DDV@?=P17SCJ4C0ZG
MJKC!S<(CY"GY&MK?/!!Y' &,'!(!Y-9L3K&90R^8IW*JN-ZH@!( W A1U4 '
MUQGFO[)J\/X3/<FH9?C*U:6'JT(1K152=-.#Y&G&5.491E&24X[+F2OHV?Y?
M8W$3PN?XNM3ER^RS&M*3VO9U-O6ZWMN?=OQ]_;LUSXH^#;CX6?#;P?8_##X?
MWT(GUBTL;6S62Y-QL,RM<VL45T060L56X 0D"-8U+*7? 7]NS7_A9X$'PV^(
MO@*P^*?A/3QYOAPZG;:?++;W$A0O*GV^"Y)WH@7YW9EP"A#*IKX,4,0D)(9
MS>9%@*70DC!; P 1D@G(!Z#%(QD\N.)@K>5.94!Q^[X4*O.!N 7/4@YZCH?
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MOE=^9)WB_*_O=.A\7?M3>)?%7CSXGZCXK\8$W6J7C2W1F4'RV5Y68%?*5$&
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MH+!I'?'RAP@ K#^#O[6?QG\/>/O$7B67PEI^J?##Q==2)>?#I]-L5M[>.X#
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MN\M%R_"^9N]_G_P#ZW+<ZEAZ2@IW235K]UY[6^\_41-;LS&EY%=+Y2 $QJ5
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M@C.1G!&<8Z\9^)S?P]R[*Z-6G' :2HX?#S5E&].BZCU;333<DTGMR[O1+Z7
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MF6FI7VJ1M<^3"5-O<36JD,55GWNJ# [KDY %?C9>^(M3U0_Z7-N)!4 %N"5
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M("-U/M@=<]\#M73 @-&&)*?/O4<EP&1MH!)'+X8@#H#ZFN:^'@QX-T5B.MJ
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M94\QB003_P L\XR>>,YX/7&2,C&0];F)+69C@RR.^"1GDK@MD9^91\P#9*X
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M,RXAQ6;3CAG[24.9.Z4M[WM;EMKO?='?0R?"X6M&M5I*C&*;OI?1WO9VT3W
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M2LMN[2O=^FA]S_LR_P#(I77_ %\W%?0+E=RD8P&8Y'3&UO3W(^O%?/7[,?\
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MVUN9^;['R#^U&?\ 3]#_ .N##]2?Y5\IQ<)!GC$L>?;_ %?6OJG]J3B\T')
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M3G!TZD79W:C-RT\[VLKVUU]#[N^"FKQ3:!IUG"X4^5$F W/^K4#&#W"\9X
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MH2<XSV'3!P1@<D\YY(,#J>2.<X_7\^_:C@<!@!^?IZG^0/3KVI",\%QZ]O\
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MK'3M'FV8;;.P*L& *JH4#H/O;L8Y*]N*X<GH5,7CH5YR]USO:44K6=WH[?\
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MWW=M3\RX?^/?Z74Q/L-[<U)@=QU)_A)[GOBHK8 VY)QGSIL#/+$-TQZ =1[
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M$N)<DKV53'Y?32T=L3#FMW?[VUGK;3N-Y#C(1]_*\7S6_P"?<UITUY5Z?GU
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M+26VU_+^KI'JOP;P/'FEA3\S)@C@<^<O7L,CWQQP<CC]&;L@R \$&+C!&!N
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MV/+GD\ CD],#.,\]1@_AQVI9,'<H;EH6QDGO]>.0>Y'TIHQ@9Z9';@ GOUY
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MP)A)/XD\\=.*TCG_  U!W_M/!2Z6>)IV7_E17,HY+B4W?+:\M+6C3JM^NM]
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MGUZX/3HS[/K;9(\-Z\P&!DZ9-QP.@,/&>20!CDFD^SZWC_D6=<^O]F3XZ_\
M7/\ K^G%>E5XCX<I)0AF6"47IKB*5X^G[Q[>=SGCDF-E%2EE>+E??FIS[O>T
M%^@W&[!!!&/7/^/ZDTT@ X+(#Z%L&G>1K)Y_X1S7/QTNYS_X[$!^G]:/(UD<
M?\(WKO\ X*Y\<\\9A)_/H<C&,5FL]X=_Z&6!?F\33O\ /]ZE?T2!Y#C&W;*L
M7UT]G*WRO$<'0  NO3L0?Y4NX8)ST .<$\'&#QZY'UJ,Q:S_ -"UKO7J-*G'
M;OF+!Z]AVZ ]'I%K&YL^'-> P!_R#;SL1D<1@#&,;0-O.0,=5_;^0RBU3S3
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MVOA_0/&^BZSJ4B221V]A/YKMY:2.  !]X^66&2  #7M44@F2&3!(F&'.X9R
M"!QV'/!R#VYK"IQ-QGAY*GB<^SFE-I3Y?[0Q2:BVTG_%O?W6K6Z:H7^J^0)W
M_LS#777V</R5/]3YO_X8\_9W !_X5=X5YPN/L?(X)&Y<<8P>1DXY&149_8\_
M9Y+$?\*N\*,!CG[)G@CMA0.Q'ID8)!Z_3NU%)3!..<CD#G!Y.,'(QD8P!D')
M)IH*.&4*[*N-S@XSR<#.03M]S@<=*Q_UNXD4W"7$.=724FWC\5+25VM?:^3[
M"EPMP_+?*\+M;2G!;?\ ;A\R']CK]GC.!\+/"AZ<BR)!SD\>N .3_P#7PO\
MPQU^SQDC_A5GA0X&X_Z&, =^<]L D<G##UKZ8<;0KHLA4;?W8PS-DCWQP.2.
MI' Z8JA'JVFQZA_9PO(6NY0Q-KYJB:,\@;DW9&0,*,9Z\#O4.*>)ZLU[#/\
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M*)?"CY0S&:RW9Z*O]K6G(]/7TS@^H/\ IM^(-2M=&T?4M5O#MMM.ADO9F7(
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M4WF7'W)=8WB1U%]AXW'>]YJSO;37\P_U7R.6L\KR^ZVMAZ*W\E$R#^R!^SX
M"WPU\.;3Q_QZ*<=AP5_R,TS_ (9 _9]*G'PR\.,N!ULUVD<=<#GKQ@^_2MM?
MVH_@02Q_X67X9*>]^@Y'0'D\@_B<9Z@54N/VK?@##DGXF>'FP5!9+U-HW,%P
M<C( +#.3CVS4/.>.*</WV9Y_3>[4L=BX\O35RDDM@?"N1O;+<$EVC1II;]4H
M/\3.'['_ .SSU;X7>&>!_P ^8.?0 ' '/(YXQ3V_8^_9X. OPP\+[B?N_80.
M,]3CCT_!@3U!KTOP3\6? ?Q)-Q'X.\1VFM+#G,MJ^^-BN/N$ ;@"P)(..F>P
MKT=\- A=SE'(\Q#M(P"1D'D\CH,]!QU(XJG$_$]+7^WLXC4O:TLPQ+LNCTJ*
M^SZZ6#_5G(XIQ>68-M[MT:>SV^QT^9\U?\,>_L\XR_PN\+D9(!%EP,'!S@9
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MZ7U\@_U3X>_Z%>%_\%0_^5GS'_PQY^SP.OPM\+G)^\+,D$]>H'YXR>#Q3O\
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M8N<G[V><&OMO"SP,KY95S7#\7X:C2G752C0]HVHQ@[\LHRBXZ34N=J^C=NR
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M]&]+Z:[._P"7DOZ_K^OP/Z_O^#60[?#'Q;4'@7MYG:!T>^))!Y&>-OISDD<
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MVA_0/^QM_P %)_#_ .U1\5?&OP\M+*/3TT.[D&C73A4&H6BW+QQ2*=D3.75
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M ,7]=_: T+X_>(=?OEG37HVL],69A;1:8UY&JQK;*VP8A0!F900<D]\?VE?
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M528G3]V& !.X$#((&:]!_8+_ ."AFE>-].M/A9\6KZ.Q\5:0D>G17LV5%Q)
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MK'PA^,7A#XR>%-.\6>$=0M;U;I(FO+99U$UM(S1M*K199L@CKP ,@8K\BO\
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MH!\8=9^"OA7X303M9VMGHT6G:[?O("9K93Y,H:XD8M,QCW$*0S+GY]YR3D?
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M ?P9X@^ 7P \0V'B_P"+FM6EUI6JZEI]Y'+:Z6)>)%%S:&0K. Q*N67 P&(
M)/\ "_>ZGK?B/6M5\4^)M4GU;Q'KUY=ZAJ,T\C2M'-(7DGB$S9+F)G8C!PQ
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MX"GCGT(.?3!!S[XZXI%,:!GE7,$X\K8NXLI?(\TX(/R\G'0=,=<KU_SR"/\
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MB!P@)P]M"V\^@R_(R"#GWK^%@V-E]W[&2/94"D>P)R,]@>1W%*NGZ:Q DLP
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M%(!%SCDY]_7TZ?D?<&EP!T'^>O\ ,D_C113N^[^]_P"8$9,F3A5QGCGM2[0
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M3^5-W'_GF_\ WT?\:DP/?\"1_(T8'O\ F?\ &AW:MS->C?Y70$>X_P#/-_\
MOH_XT;C_ ,\W_P"^C_C4F![_ )G_ !HP/?\ ,_XTE&U]6[][_P"; 103C:=G
M!P3Q@9 (_$\T_>W/[Q.AZ @_GV^O:FX'3'Y\TM*4;VUM:_X_- -W$'(;GZ@D
M_AM&?ID9I6=P"PP2/]D _GGZFC ]!^0I:N#Y$T[RN[_A;K<!"Q. V <]B<Y
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M@$/3\C^1S^M+128'H/RK*K152UW^?Z-#%HHHK804444 %%%% !1110 4444
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M;"Z6Z6.,F"VB3RV)DVH@8-P,UQU,\P,)1BZE.+DK14JL$Y;_  IRN]%TOU[
M?FTIR-VTJ ?GR""K^C#^$\L?FQD<C(Z+D$J%()?[HZER!_ !RW YVYQC/8Y]
M)\+?!+XW^-[&[UCP'\+_ !AXET+3)'EUG7--T6>YMX5P1+;R7%O$Z H[*2"1
MM8+SC->:S6+6-S/::E%>:=J%I</$;>>-EN;2<2F.190V#&  ZD$=5/?)KHHX
M[#8J/+>-DWHY1W5O-?\ !#81V$8W,C$ @8VMDLQX;IVP<D],^_$BH=KNKJAC
MQD.P1I0RYV1!B"[87HH;&X BO1?"?P1^-?Q CGU;P5\./'GB[0X[<FTU70]'
MFU#2Y2@D\]'F6!X]C%%#$'(*$D;CQR5WX)\8V'B+_A#==\&:MHGCJU=XU\,W
MVG>1J E#A42""11+)([%.-GWF4"JGF6&HMPDDE&VKDDFM^K2V?<#!4-E5,<T
M9ESM\Z-XQ&0"#DNJA3WVL00,=B"9&4QJ79&)5B!L!((X#., @ALYSG!SP37J
M-K\!_P!H&^T[4]43X-_$N\LM*1WU"2^\+SQV=N@522DBVX!0#G<23@GU)/GF
MBZ-KNO:O'H&DZ'JE[XCN(UL(_#&F:?'<ZA]JD)C1#9HK3K('4J=R_>' !Z71
MS;!5*5:47'FA>[YHV=DMGS-=5<#,EDA1T1YH27SM;S$ #%2VW)/4$G<HRPZ$
M<4\ K(X/5 F[G.WY6Y)[#D<GU%?JQ^PA^PS>?$FU^/2?M$_#3Q%\/[/P/X&M
M=<\)W&MZ*]A=ZKJ,TAC_ '/VM(PX*_/A.?+(.0,U^6VJQP6OB3Q5IMNI,%CJ
MVH6-KN 5C#:W<T$>0,*"$124 P!@8X%<>7YK2QM:I334N6<HKE:>TFOLM_=^
M.YJD_9R=K?\ #,I -L60],+@YP2<8^7MD$8"CN<<9Y=TI@7<8D+;5#NY' PN
M1@\#HHR#GI@CTIPZ?U]?<=.#U%>N]]FM7N9"T444@"BBB@ HHHH ***#Q0 4
M4FX?KC\?3TI P.2.<$@^Q'4'W'MF@!U%'6CI0 44?@01U!ZCO_(TF1@$<YX'
MN>F!3L^S^Y@+12!@<'LV=I[-CKCZ=Z,C^7Z]#^/]1FD M%(3C^9]@.I/^<T9
M&<>G!]B1D#\1DT?UNO\ ,!:*0D#D\#_'BC('Y9_"C;?3U 6BD!S[?Y([9[@C
M\* 0<8Z'H>W3./RYH6NVOIK^5P%HI"0#@]3T_P _XT9[8.2<#IR>N.O4T?YV
M^?;U\M_(!:*.M)GT!YZ#N<C(_,<__7XH 6BCK10 4444 %%%% !1110 444A
M.,#N>GOW/Z4KKNOO 6BFALG&.P/X'."?K@_IZ\*>O7'ITY/XY]NG?-#DH+F:
MNET2;W\EJ M%-'(!#'! /;O^%&3SWQ^9X'08YZ]OQZ$U"Q%*3Y;6>_5?G?\
MS'\QU%(#D9Z=?T_PZ'T.?K1GTR1ZCD#MU_S[XK1.,OAB_N_X A:*;N'MCZ_J
M!W [G/&#Z4ZG9]G]P!129'7(QZYHR/\ /Y?CSQ]>*5T M%%)GG']>?J1V'H<
M]QZT77<!:**,XH **,YHI\T4M5ZN[7Z %%(#G^7_ .KV]*6E=/5;/8 HHHH
M**** "BBB@ HHHH ***,YHN@"BBD&2<  X]3CT_Q'^>JYHQUEMYW6KVZ +13
M=V02,8&<DDCIUQQR/>C+?W?_ !X?YXH=:BMW%>LG_P#(@.HIN3Z?AGGZX],]
M_P <4N#W)'Y?X&I>(HKJGZ-R_16 6BD/'<_I_A^=)NY(XRO7)P/J#@Y'O]*2
MKTI[-1MWNK_> ZBD!S_G_/'I2UHFGL 444A..Q/TYIV>]G8!:*3)/( Y]_\
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MM&"Q);GC.!BOED?\%0?'.C_MO:S^V1H/A6Q.F^++$Z/XH\#PV=NL4^G3:/\
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M5\[W_P"&M=;!SFTQ[6?Y3+C:G<$,R@;1R,C!)QMY/(Z4U K'RRRJRH"P.00
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MN[MK;8#BFCAD*+;QN$@A'E1F0.JMN<[3$V =O5N^#M!(Q30OF0LLR*7)RHB
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MK\*_"O\ P5T_9OFT3PSIKZ3XP\,1^(O&VCPP6T5A?W":Q:)<3+!Y"VJK+!N
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MX?S/VZE+$U*D>2*LWRI2YI-N^LGHU&VD5:ZU;0'Z$_LU_%/QE\._^"S?QQ\
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M?AT]Z^Z7NP47NU_EN,6BBBH **** "BBB@ HHHIJ]]%=]G_P0&D$]#QWQU_
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MGO?VSM0UC]NN3]L_5].:]M(=6CNK;PH5\XV5A]KCFN(TM7=F"O$@;:'"ALL
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M)=1MM)TVU6*69EGO)$@214A#.2C2@L1C:A8[A@"OV=M_^"0GP8^'\/AKP?\
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MI([=.>,8XY/4T 8&/\\\_P">_J2:6B@ HHHH **** "C_/\ G&.G4>A -%%
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M[8[@X&/7MCD]NO/3.:BK))J2IQ:YU'97OH[I:Z:VW[^H?UZ?U_P1& 8!0%3
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M\*?@K\0(O#?PD\8_\)]X>N=*TB]DU*TL]0LVAU*^B9[JVAM[XF9MCC9N164
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MV=6EBJ+2G']WIS734O?]5]SU73HB,E%N_;]3]4_%C?LN_"+_ (*=>$;WXO\
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M/.>,?7BDZ*<<# !''('4'OD#(Z^WK3CS28Q^OZ\G]:>NJ^S*+BUYOKVM;Y@
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M_MR?#+XU? []D_X9^'/#TFGZO\"]3L[[Q=?/'>QW=^ENMI'+Y<*R!!&QMMS
M,>0,8[\/^W=^VKX5_:'_ &DOA#\</A9IEQ92?"FV\/HUO/;7<,-V-,T_2HKA
M+F8R!U2233V",=Q3>6&"3GG_ +*K2JTZTZ4I5*:G&,G>Z4W%R2U^URQ;]-;
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MQGD!B?ESTV;1]#T[X'KCFKA!0CRQ25FFFDKI=5?<!9&:>[FO+B-6N)5C21R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>formdrs_2.jpg
<TEXT>
begin 644 formdrs_2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %1 EH# 2(  A$! Q$!_\0
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M?]P_RKQ3PPP_X1W2N_\ HT>?^^16=6K*G#F7<NG352=GV-@ZA?!<G0/#./\
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M#O .K#4R^<?>WCR_]WGK0!Z/#\2OA%<2:PD>O^$W?1XVFU!1-;YM45S&S/\
MW0'!4^_'6G6GQ$^$M]91W=OKGA66UDCAE6598-I66;R(SG_:E_=C_:XZUX;X
M5_8<N=7TF6Y\7>)I[35[>[OIM(@T^W@:+3S+JOVY)&.W-P28XB5DX W#WK5\
M4?L ^&O&4.GOJGBC5FU%9]2O-3N[>**(:C<7<@F5V0#""&=4EC5>Z\YR:0'L
M(\>?"MM6M=,&K^%SJ%U+-!#;!X-[R1.R2(!ZJR.N/52.U5+#XI?![5%TYK/Q
M%X2NEU&Y:TM&AF@83S*54HI'4@LH^K =:\TT+]A'POX?\1>&]8BU:2^N=+TZ
MWLKEM2L8KA[J:%Y9!=*QQY4S23.Q9<\XQCK4@_86\*1S?#^1;];C_A%=(@T9
MX[[389H[V**83"0KP(YBX)WC/7ID TP.[\,_%3X=^-/BUJ'@+0;72M8O=/TQ
MM1N[RR6"6&%EN/(:!MO(D##/3'![USWPK_:0^$WQ:U#[%8Z<FCW$@@-J-9LH
M(1=B9Y4B$15F!=FAD_=MA_ESMQS5_P""O[+]I\&/%QUFW\37VL00:2^B6%E<
MVT,8MK4W37(!= &D<,[#<W4>^<^0ZM^P"/"_PO\ %.G^%=>DOO%%QIT%GH\X
MMX=/6VFBNS<1W4K1C][.C,P\UOFV94=: /JK0;7PGXHTFWU32+;2=3TZX!,-
MU:Q1R1R88J=K 8/((_"K_P#PBVB_] BP_P# 9/\ "JO@/PC9_#_P3H7AK3U"
MV6DV4-E%QU6- N3[G&3]:WJ ,O\ X1;1?^@18?\ @,G^%'_"+:+_ - BP_\
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MA &MDW7B0B1I/)7.<@(HW'@EL#I5RX7P4)2B\2[K^Y_P2(Y_B9)25!:_WO\
M@'WFWB[0STUS3,?]?L7_ ,50/%VAX_Y#FF?^!L7_ ,57YR:QX1LHM#FU6Q2\
MBBB>W#0:A"$?9,K[6!'WANB89P,@CWKF?(C_ .>:_E7?3X*H55>.(?\ X#_P
M3FGQ/5@[.BOO_P" ?J WBW0^O]N:8?;[;%_\53/^$NT/@'7-,S[7D7_Q5?F%
M]GC_ .>:_E1Y$?\ SS7\JU_U%I?]!#_\!7^9'^M53_GROO\ ^ ?IXWBO0_\
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M74\<O_"4Z]"ZK&#Y.H;-^SNWR\D]ZZ+2[.+2[>RM#?3Z@L$90W5Y)OED]W;
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MQ26FBN-)C18E$C1D9V<MD#Y1G.>,U/\ K'C^U/\ \ _X(_['P?\ ?_\  O\
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MK'X;CG>8;MT0FVJNQFR29/5=N!R"1FNA<35$E^XA]QE_8<'_ ,O)'DDGPO\
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M>NLXJ9E%RG&SCV\SR:F61PE6*C*Z?Z'UI\+8Q#\/="0=%MP/R)KJJYCX9_\
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MY8V(KK_CVE_W#_*O+OAJ<ZYX=_[%Z3_T9!7J-S_Q[R_[A_E7E'POD$GB#P^
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MB.!M^4K4EW-XUEAN?*^)?A6.5O+6(>=%M'+>8Q[\C;M7MSR:7]J9A_T$S_\
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M&,'\*I6K-YUKL^^45<?@*]$M555ME;D ;F;J,]J\[^W<T_Z")?>>E'*< _\
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MJ!7YIEO"F58+%_VA1HVGJUJ[*_9=/TZ'U>+S3$U:2P\IZ=?,V/ \>WQYH/\
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M(;*QNK&6SBAF87#(P9)02N"C'GCD&M?Q1XB\.+.VGZEK5G97,>-\$TBY(<<
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M/@P*#_PMF^^;O_PBO7]:8WQQ\&2=?BSJ!_[E;_Z]?%*3=,U:CDKT(^'^6/\
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M,,2!G.!R,XR37)5WT<IP4X*53#J+[;G+4S#%1E:-9M'N?_#8?C;_ )\M'_\
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MP1]NEX_\>H_X33Q'_P!##JW_ ('2_P#Q5=?^HM;_ *"%_P" O_,P_P!:J?\
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MVOT]=C]>Q&2>QP[JQE=I79ZEJW_(:\/?]?C_ /HEZZFN6U;_ )#7AW_K\?\
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M2?\ F:+(J%:Z=6;^:_R/@;_AF?XH_P#0F7__ 'U'_P#%4G_#-'Q1_P"A,O\
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M89 9>>#C^9KH+/P;I-EJ<6HI;EK^/=BX=V9_F!SG)YSN-?*/_#PH_P#0D_\
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M9+]M:O/.0@X4"9MH_&O6RZZYFO+]3S\:D^6_G^A%X9T&/PC;O?7D?F7I&V"
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M%JK&=Y%B"-IL2X9ON@DIQGWI?ZK9BD_WD-/-_P"0_P"WL%_)/[O^"?6_]O\
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M\[1&W'^W7V5J7_"3>,/%OBE;*_T/3K/2M1_LV)+K1A=2NHMX)2S.7'>4C&.
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M%V$J!HV3RSMB^3A&:,LP.3EC^/Z$+I\5OPVEV4@]K:,'^53(VE*0)=*LT/\
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MAX9T>^O)<&2XN;"*21\# RS*2> !^%=#161H<K_PJ?P1_P!"=X?_ /!7!_\
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M]*]+"Q4^:WD<-:7)8^L?AK_R(NCX_P">/_LQKIJY#X1W'VKX:^'9ATDM%?\
M/)KKZ^8K?Q)>K/>I?PX^B"BBBLC4**** "BBB@ HHHH **** "BBB@ HHHH
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M[L/>[?U]P[SD_OK_ -]"CSD_OK_WT*;_ ,(?H?\ T";/_ORO^%'_  A^A_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>formdrs_16.jpg
<TEXT>
begin 644 formdrs_16.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $+ G # 2(  A$! Q$!_\0
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M_P"!S?\ Q%'_  WW?_\ 0FV__@<W_P 17H_ZNYE_S[_%?YGD_P"MV3_\_?\
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M-]W_ /T)MO\ ^!S?_$4?\-]W_P#T)MO_ .!S?_$4?ZNYE_S[_%?YA_K=D_\
MS]_\EE_D?9-%?&W_  WW?_\ 0FV__@<W_P 11_PWW?\ _0FV_P#X'-_\11_J
M[F7_ #[_ !7^8?ZW9/\ \_?_ "67^1]DT5RGPK\;/\1OA]HOB22T6Q?4(3*;
M=7WA,,5QG STKJZ^>J4Y4IRISW3L_D?64:L*].-6F[QDDUZ/4****S-0HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3DM[BZCM(6F:&U3?*X49(49&3^(JH\TY*,5J_)":25V-^R:G_P!!&'_P%_\
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M.5&;]DU/_H(P_P#@+_\ 9T?9-3_Z",/_ ("__9UQWQ$^(]YX)UAX(QIT\/\
M8EYJ$=M)(1<O-"8\#&?]60YS@$_*>F*XM?CAXBGU&ZTZU70KRZM;F*UBD7>B
M:J996C$EO\YVK'@%^7'!Y7K7M4,KQ>(IJK!+E?IWM^?^>R;7-*O3A+E=[GLO
MV34_^@C#_P" O_V=1227]C=68ENHKB*:;RF40;#]UCD'<?[M</\ "CXHWGC+
M5;O2]5B2WOK>W61%BC^6=0W,P8,1M8,F ,@X)!(Z=[JW_'QI?_7U_P"TWKBQ
M&'JX6JZ-9*__  .AI"4:D>:)I4445YYN%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %%M<TU&*MJ%JK X(,RY!_.D_M[3/^@C:?\
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M2,@8D,;N,D]OD(_$5FLGI3O:KMY&53CO&T7%3P:]Z[7OIWMJ]D?I?_;VF?\
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MDHI1<KIOHTOU/3Z***^>/T\**** "BBB@ KG)OB/X5MYGBD\1:9'(C%65KI
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M^ J<E>HP<]*C^R\(MZK^XU7&&=2U6"B]OM=]5U_K;<_5W_A9GA+_ *&72_\
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M.*S/,XY?7H1C?FO9MV:3?Z'T11117S1^KA1110 4444 %%%% !1110 4444
M%%%% 'YU^)?^1DU?_K\F_P#1C5B7^I6NEQH]W.ENCL55G.!D*6/Y*K$GT%;?
MB7_D9-7_ .OR;_T8U<7XQ\.3^(EL4A=55?M,,I8_=2:VDBW@=RI8''?FOUB[
M5-.*UT/XQ<82Q$E4=E=_J="KK)&'5E9" P8'C!Z&N;U3X;>&-8OIKV^TB"XN
MI#,SRN3G,T:QR=^-R(H_#BL5OA2L;B6*]B:0N7ECGA+17'[T.JR*&&5 !4?6
MI;7X7HNK+=7-\D\*W(G:(0D&<>8TF)3N.XKD*O'"C%92YIZ2A<ZJ:HT;SI8A
MI^2:?Y]327X7^%4F@G71K=)X96D$ZY$C.TBR'>P.7^=5;#9Z#%5_^%2^"X5O
M"=!LA]H+O(SY)0L_FNR$G]V=WS97'0=A7.Z?\(;Q],076H6\%PZE9+=86>(9
M$@\T_/S,-^0_3Y1Q6G=?"G[1-IY74]D,%S)<7&Z',ER7?.&;/]T[2.G\JS4;
MJ_LE^!U2J*,K+&2_\F]>_<T=*^%?A"V7SK/2H9EFD2Y61IWF'$OG*4W,0J>9
M\V%PI/7-7-$T?PW%%H;Z=#%LT\W$.FX9CY625E5<^F".>F.*Y:W^#9MQD:F@
M9;2&UC5(W6-1&$7;L#X,;A/F'7+-BM7_ (5J&\,:=HYOE2.U:X+^3$51Q*^X
MJ%W< <@<TXJ2VII?=W_ID59TY_%BI2N^M]N5IO?7MZ-]"UX@\(>%&:.34D6T
MDN-1^WQS)=R02/=M'Y9=61@<E!@@<8JW=^"]!\0:7:6\L,DUK;W37UN\=S*C
MI-ELNKA@PY9AUQSBJ=WX$9]%L;"TO$M)+.[EN+>Z5&\RV5Y&8+$0PQA6V8.5
M(X(K!UOX57/]DWLEA>>?JS)LB=OD+)M=3'DG !W[N>"5'UIR35W[-,FG*,N5
M/$M-/3?3HGY:>?<Z#4/A;X5U:&WBN=,66&"2XF1%N)%!,[!IMVUAN5R!E3D&
MNBTW2[7287AM(_*BDD:8IO)&6QG&3P.G X':O*U^$NKOI,4BSP6EPEJULNFC
M!3YI 27<'YL_>VYP,E0< &MAOA'(S$?VLJJRMS' RM#GS?W<1W_+%^]Y7D_*
M.?11<D[JE;[BZT*<H\D\6Y)-Z6;_ %MKWZ]V=]>7UOI\'G7$JQ1;E3>>@+,%
M7/U) JQTX/6O.;WX5&&35I;*X#F^CCMXXV9E%NFZ+=CYMI4",L!C.37H[MN=
MB.YKIA*3;YE8\NM3I0C%TI\U]]+=%_F_N/I?]CK_ (\?%/\ UU@_]!>OHVOG
M+]CK_CQ\4_\ 76#_ -!>OHVOSS-O]]J?+\D?TWP;_P B+#_]O?\ I4@HHHKR
M3[4**** "BBB@ HHHH **** "BBB@#\Y=8YUK4/^OF7_ -#-<-#H/@OQ)-+=
MBPT^[FD#L\DBE7(G(+$Y(^_Y:GWVBNWUR,2ZIJ<;$@//,I(ZC+,*\TMOA1%=
M6%JNHW"M/':):F,1"1%9(6B612>^"&]C7ZI*[44HW/XXHN$95)2J.#OI;Y]C
M8D^'/@Z2XU-WT33O.U'=%>9.#(68.RXS\I9@&.W!)&:8_P ,?!<D*6IT/3]J
ME%5%<A]R,SKR&W%@SNV<Y^8YK-N/A/'<0+"VH1E \W[QK%6E996#,S/NYE4C
M"R]0.,&F7/PI2;5K5DN(X;.-'>2=8%^T/*UUY^5?.4.,+OY) Q6?*_\ GTOP
M.J-5:?[7+_R;IMU]#>L_ _A;3['4[6WTVSBL]39A>0^:3',Q)9@06P#DDG&.
MO-0WW@WP=K&J2W%S8V$^H*QO))!.5D!D54,A*L.&$:CT.T5E6?PE@M(\_P!H
M*;A87BBD2R15C)B6(2["2#)A<LW\1)Z54_X4G:_V:+0ZBK_*@=VM<&0I+)(%
M.UPVS]Z1LS_"ISQBBTK6]FOP",Z2DY?6I7[VE?7?KV2]?D;.H>"/!%QJ5C87
M.C6)O$@#V\<:LC)'!]TY0C&WS#@GD[CUK0@\*^&;FV4Q:=9M"T5QQR#Y=S\T
M^03D"3JV:SM#^&\&AZ\=2BNPRB"6!(_LX#@2+&I!D+%F5?*&U3TR>34WAWX>
MVOAR_BO(KCS;A8WC>1H5#2*T<2 ,<\@>5G'JQJHQ=]8+\#*I5CRV6(D[+3??
M73RTLNNYH:/<^'[B[74M->W,YM%M5ND#*#;HV53<<#:"V1ZYR,U6F\$^%?.L
M7?3K*.73P[6Q$I0PB1][D88<,W)SD$UD6WPHMEFB:ZOOM-O'*L@L?LX%LJAU
M?8B,S;5)7)&2,DX Z5SMO\&[\ZEJ4+W<$=E-;K;Q7[1K+-Y:K$-FPG@-Y?//
M&!M/)J6YV5Z:9M".'YI.&)<;>OIY=&^FU['?7?@OPU=_V;]HT^U<Z1$4M-TA
M!MHS@$<-]T[1][(XJ"3P!X2:]T^\DTC3S<:?#'#:R.>(8D/[L %L84GY20<$
M\5S=K\(6\^>2?4(AY<H-N?LJN9E58 //RW[Q28?]6< ;CS5BX^#.GW&FFU:[
MWN9(7+R0\,J(Z^60KJ=G[PD*&&TA>N*+2?\ RZ7X"YJ4;+ZW+Y*77?KYL[/1
M?L$-B;/356.VL7:T\E01Y3+U7GGN/SK[F_9M_P"2/Z-_O3?^C6KX/\-Z+)HW
M]IF0K_I-UYD:J20L:QI&G7N0F3]:^\/V;?\ DC^C?[TW_HUJ\?.K_5(W77]&
M?<< V_MFIRN_[MZ_.-ST^BBBOAS^A0HHHH **** "OSM\4''BC6,?\_LW_HQ
MJ_1*OSL\4?\ (T:S_P!?LW_HQJ^LR#XJGR_4_&?$G^#A?67Y(X6X^'GA&WM9
MY)M"L8X5A42OM(Q''O9<D'.%WN?^!&FV/AOP?JLAN;;3-.>0Q+:,!'L.PQ8$
M93CGRY,8QG#5MZ_IIUG0=2T]7\MKJVDA#^A92 ?S-<J_PQ@U"9KR[N-EY*%D
MPD8;[/)^X),;=1_J, ]<,:^HE'E?NP3/R"E6<XMUJ\D_5OM_7R+Z_#GP:VFK
MIPT+3#:;_EA 'WEC\K .<\1_+C/3M1:_#GP=#9BP@T33OLY65?*!W%@ZA9,D
MDDY55!R> HZ8K-C^%<:FP#7\(6U5(\QV*HY5)%D5@V[Y9"5PT@^\#T%49/@[
M'-<+ +N.TL(;*"VCEM[=5N&=(Y59MV?D!,F6'.[UK/E?_/I?@=*J1:=\7+O]
MKT[[G9WFAZ'?7^GZG=6UG/>6,4D5I=2,"T4;KMD"MGH0,&LFQ\#>#+>>_6TT
MW3XY)+==/NXXY3@Q&,*L3KNQR@ '&<=ZSU^%,*PWA%]%'=W$31"2*Q18H=TB
M.WEQDD*"$VD ]R<U2/P3LC9V]NU\LL<31.PDMB/.*1>4=Y1U+<8(Y^4YZYIO
MG;O[-?@33E1BFOK4DMM%+:]^^UV_GKZ[VJ>'?!^I7D]G?Z;9W-Q:QQZA(C(S
M&,(AA1\CH0H*@#G':EU'P3X+^SW%W>:/IBP0VGD3.4 5(!&R;6 [>6[KR,X)
MJMIOPUBTV37&6_W#4[.2RW"W59%5I))-[OG,C R$9..%%7M#\!V.BW5Y*")U
MO(98;E#$%\T/*SDL1U(#%1GM5*+>\$9RK0@O<KR=K=_*_I^/0=;Z-X6C^TZ5
M#:62+'+%>3VZ@A$DC$?E.3T!4+%CGH!4VK:'X<\33:DFH6]C?RSQ)8WHD?YF
MC#>8D;X/'S'<.^37-3?!^"XT>"REU:>>6/<9)Y8_]>?,C91(%8$J%B1, C(&
M<U+)\(=-D66,R0K R_*@M02K_9Q#NW%B3@ ,,\@]^]3[^WLU8J^'3YEB)77D
M^EM?G;3M97V-[_A#_#8TB_TQK&U;3KQ%MKNWDE++(JC"HQ+9X^N:I3>"O!]T
MC:+)I5K*EU'%<&'<Y\Q;=ML;;]V28RW'.1FLB3X.V]Y-J,E]JC7OVQF8K):H
M I,<J XS@LHE^]@'Y!]:V-#\$#0=<MIK>1?L$*W,BH%";7F\E=@4?P@1%L]R
MU/E;WIK\!.<()N&)DWOU6MM.N]TE\C9T?PWI7AY2NF6$-@OE)!M@&T;$W;5Q
M[;F]SDYKZP_8[_Y OB?_ *^H?_0#7S#7T]^QW_R!?$__ %]0_P#H!K@S9*."
MDEY?F?2<%3E4SZC*;N[2W_PL^B****_/#^G0HHHH **** "BBB@ HHHH ***
M* "BBB@#\Z_$O_(R:O\ ]?DW_HQJS:^LM0_9,T'4-0NKIM:U)6GE>4J!'@%F
M)QT]Z@_X9!\/_P#0<U+\H_\ XFOT".<8112YG]S/YHJ\#YW*I*2IK5O[2/E2
MBOJO_AD'P_\ ]!S4ORC_ ,*/^&0?#_\ T'-2_*/_  JO[9P?\S^YF?\ J+GG
M_/M?^!(^5**^J_\ AD'P_P#]!S4ORC_PH_X9!\/_ /0<U+\H_P#"C^V<'_,_
MN8?ZBYY_S[7_ ($CY4HKZK_X9!\/_P#0<U+\H_\ "C_AD'P__P!!S4ORC_PH
M_MG!_P S^YA_J+GG_/M?^!(^5**^HF_9+T%=1BMO[;U+#1-(3MC[%1Z>]6?^
M&0?#_P#T'-2_*/\ PI_VQA/YG]S%_J+G?_/M?^!(^5**^J_^&0?#_P#T'-2_
M*/\ PH_X9!\/_P#0<U+\H_\ "E_;.#_F?W,?^HN>?\^U_P"!(^5**^J_^&0?
M#_\ T'-2_*/_  H_X9!\/_\ 0<U+\H_\*/[9P?\ ,_N8?ZBYY_S[7_@2,W]C
MK_CQ\4_]=8/_ $%Z^C:X3X6_"2P^%4.HQV-[<WHO61G-QM^7:"!C ]Z[NOC<
M?6AB,3.I3V=OR1^[<-X&OEN54<+B%:<;WZ[R;_4****\\^E"BBB@ HHHH **
M** "BBB@ HHHH _.76?^0SJ'_7S+_P"AFJ=?8]Q^RWX)NKB:=_[2WRNTC8NN
M,DY/\/O4?_#*?@?_ *B?_@7_ /8U]['.L*DEK]W_  3^<)\ YQ*3:Y/_  )_
MY'QY17V'_P ,I^!_^HG_ .!?_P!C1_PRGX'_ .HG_P"!?_V-/^V\)Y_=_P $
MC_4#.?[G_@3_ ,CX\HK[#_X93\#_ /43_P# O_[&C_AE/P/_ -1/_P "_P#[
M&C^V\)Y_=_P0_P"(?YS_ '/_  )_Y'QY17US>_LN^"K>>R1?[2Q--L;-UVV,
M?3U JU_PRGX'_P"HG_X%_P#V-/\ MK"^?W?\$/\ 4#.?[G_@3_R/CRBOL/\
MX93\#_\ 43_\"_\ [&C_ (93\#_]1/\ \"__ +&E_;>$\_N_X(?Z@9S_ '/_
M  )_Y'QY17V'_P ,I^!_^HG_ .!?_P!C1_PRGX'_ .HG_P"!?_V-']MX3S^[
M_@A_J!G/]S_P)_Y'QY7VO^S;_P D?T;_ 'IO_1K5E_\ #*?@?_J)_P#@7_\
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M^"'_ !#_ #G^Y_X$_P#(^/**^P_^&4_ _P#U$_\ P+_^QH_X93\#_P#43_\
M O\ ^QH_MO">?W?\$/\ B'^<_P!S_P "?^1\>45]A_\ #*?@?_J)_P#@7_\
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M -%O6C6=JG_'WI?_ %\G_P!%O6C5RV0EU"BBBH&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%5-7N7L])O;B+ DB@>1<C(R%)%?'L?[4GCQHU)N+#) /_'H/\:]'"8"KC$W3
MMIW/E\YXBP612IQQ:E[][65]K>:[GV;17QA_PU9XUVEOMVE[0_EEOLZXWYQM
M^]USVZTO_#5?C8L%^VZ827\H#[.N=_\ =^]][VZUW_V)BNZ^_P#X!\[_ ,1
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MK8/"U5&$;6NE_*F]6GYL^S/^&Q-*_P"A:O\ _O\ QT?\-B:5_P!"U?\ _?\
MCKX%AO/&-GI.FS:E?:C%+=6TTT<5K")Y5G$,?EQRXCQAI"Y"D<#@MQ6_X2U+
M7[KQ,D5\UVP-Q<K?6\L.+>WC 7R3$^T9);(X)R,GM75'+L%)I>S?WO\ S/'J
M<49_3BY_68M*^T8]/^W?+[[=T?;?_#8FE?\ 0M7_ /W_ (Z/^&Q-*_Z%J_\
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M2%23SA%E6"_,NXYZ#CWJKH?Q2M=>U VL4*E_[16R#).&W1LDA6;V!:)QM//
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M9]!?;K?_ )[Q?]]BC[=;_P#/>+_OL5'_ &38_P#/E;_]^E_PH_LFQ_Y\K?\
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M1N"K6:$'ZC=3O^&.[+_H:KO_ ,!$_P#BJ^B:*/[5QG_/S\%_D'^IN1?] _\
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M(8M]?;BOU"_X1O2/^@59?^ Z?X4?\(WI'_0*LO\ P'3_  JO[:I?\^OQ_P"
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ME*[_ .0A8?5__0:NU2N_^0A8?5__ $&KM4]D)=0HHHJ1A1110 4444 %%%%
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M[7%X-0=\QHHCCA\B02;64_<8F/ ;!R*_0K_AE?P'_P \-0_\#6H_X97\"?\
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M7 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>formdrs_17.jpg
<TEXT>
begin 644 formdrs_17.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $+ G # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **S
MO$6JG0O#^J:DL?G&SM9;@1DXW;$+8SVSBOD9/V_;]D5O^$,M^1G_ (_F_P#B
M*]3!Y9BL>I2P\;VWU2_,\3,,YP65RC'%SY7+;1O;T1]E45\;?\-]W_\ T)MO
M_P"!S?\ Q%'_  WW?_\ 0FV__@<W_P 17H_ZNYE_S[_%?YGD_P"MV3_\_?\
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M-]W_ /T)MO\ ^!S?_$4?\-]W_P#T)MO_ .!S?_$4?ZNYE_S[_%?YA_K=D_\
MS]_\EE_D?9-%?&W_  WW?_\ 0FV__@<W_P 11_PWW?\ _0FV_P#X'-_\11_J
M[F7_ #[_ !7^8?ZW9/\ \_?_ "67^1]DT5RGPK\;/\1OA]HOB22T6Q?4(3*;
M=7WA,,5QG STKJZ^>J4Y4IRISW3L_D?64:L*].-6F[QDDUZ/4****S-0HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3DM[BZCM(6F:&U3?*X49(49&3^(JH\TY*,5J_)":25V-^R:G_P!!&'_P%_\
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M.5&;]DU/_H(P_P#@+_\ 9T?9-3_Z",/_ ("__9UQWQ$^(]YX)UAX(QIT\/\
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M444 %%%% !1110 4444 %%%% %%M<TU&*MJ%JK X(,RY!_.D_M[3/^@C:?\
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M2,@8D,;N,D]OD(_$5FLGI3O:KMY&53CO&T7%3P:]Z[7OIWMJ]D?I?_;VF?\
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MDHI1<KIOHTOU/3Z***^>/T\**** "BBB@ KG)OB/X5MYGBD\1:9'(C%65KI
M00<$'FNCK\[/$T:MXIU@8'_'[-V_Z:-7LY;@8XYR4I6M8^%XJXBJ\/PHRI4U
M+G;WOTMV]3[M_P"%F>$O^ADTO_P+3_&C_A9GA+_H9=+_ / M/\:_*G1/V@=)
MUJYT>U72;B"[OM0>RFA>5#]DC&-EPYQRCY& .>OI3--_:(T/5--M+^'3YFMI
M=2DL)G2:-_L\8C\Q;AL?P,I4XZKDYZ&O1_LO"?\ /Y_=_7<^6?&&=1NG@EIY
M^OGY.W?INC]49/'7@>>Z2YDUK1)+E%VK,T\1=1SD!LY Y/YTV+QMX%A\CR]8
MT./[."L.V:(>6#U"^@/M7Y92?M#:'#-'"UA)Y[Z$VM>3]HCWAA$91;XZ[BBE
MMW3M5;7/VA[?PV8K>_\ #%Q%J1F6*6T6\C;:&B26,HX&'++(,+P<C!J_[.PR
M7\9V01XNSJ4E%8*-WK\7X[[>?IW1^K<?Q"\&0R;TU_1T?:$W+<Q@[1T&<]!Z
M56U/XC^%9)].*^(],8)<[FQ=)P-CC/7W%?FWXB^(UMX<U^31IM,FDOF6V>T0
M.H^TK*SJY'''E[&+=>,>M<M9_'K^U+/6;FP\+37$6E:;'J4V^]6,E&A64J#L
M*Y"MZY)'3O3EE>&A+WJKOZ&-/C3-JT.>&$C;1_%;>UMWY_?IT9^K?_"S/"7_
M $,NE_\ @6G^-'_"S/"7_0R:7_X%I_C7Y90?&RWCUZVTC4=!GTZ[N)+*-&^T
MI)&3<!2<, .8U=&([@G'0UGV?[1^@7NGVE[%I\CVTNK'39I$N(V%O%L#K=-C
M^ J<E>HP<]*C^R\(MZK^XU7&&=2U6"B]OM=]5U_K;<_5W_A9GA+_ *&72_\
MP+3_ !H_X69X2_Z&32__  +3_&ORQ_X7A82>!];\31Z-.;;3M3734BEF5#<!
MVC"3!L':A$@;!!./K5*Z^.T]E87=]/X,NX+6WTJ'5CYM[&LACDE\I%\O9D'>
M#^&#WQ0\JPB_Y>OOL$>,,YE=+!QWM\5M=--7YK[S]6_^%F>$O^ADTO\ \"T_
MQH_X69X2_P"AETO_ ,"T_P :_-G5/&2:/\/I?%-UISA8K9;E[)'^;!8+M#%1
MZ@\@?2N?UCXJ:AI.O:KI7_"(O/+9WMG8QR+J4:B>2Z;$)P5^48!)STQBKED^
M'AO4?W?UV9S4N.<SK7Y,+#1M?%;9I/=]Y+[S]1O^%F>$O^AETO\ \"T_QK5T
M;Q'I7B*.5]+U&UU!(B%D:VE60*3R <'BOS0\(>(X?%^@0ZG%:R69:66"6WF*
MLT4L4C1R+N'#893R.#7UQ^QR -%\48&/]*A_] -<V,RJGA\.Z\)M[?B>MD?&
M.*S/,XY?7H1C?FO9MV:3?Z'T11117S1^KA1110 4444 %%%% !1110 4444
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M?3U JU_PRGX'_P"HG_X%_P#V-/\ MK"^?W?\$/\ 4#.?[G_@3_R/CRBOL/\
MX93\#_\ 43_\"_\ [&C_ (93\#_]1/\ \"__ +&E_;>$\_N_X(?Z@9S_ '/_
M  )_Y'QY17V'_P ,I^!_^HG_ .!?_P!C1_PRGX'_ .HG_P"!?_V-']MX3S^[
M_@A_J!G/]S_P)_Y'QY7VO^S;_P D?T;_ 'IO_1K5E_\ #*?@?_J)_P#@7_\
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M^"'_ !#_ #G^Y_X$_P#(^/**^P_^&4_ _P#U$_\ P+_^QH_X93\#_P#43_\
M O\ ^QH_MO">?W?\$/\ B'^<_P!S_P "?^1\>45]A_\ #*?@?_J)_P#@7_\
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M -%O6C6=JG_'WI?_ %\G_P!%O6C5RV0EU"BBBH&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%5-7N7L])O;B+ DB@>1<C(R%)%?'L?[4GCQHU)N+#) /_'H/\:]'"8"KC$W3
MMIW/E\YXBP612IQQ:E[][65]K>:[GV;17QA_PU9XUVEOMVE[0_EEOLZXWYQM
M^]USVZTO_#5?C8L%^VZ827\H#[.N=_\ =^]][VZUW_V)BNZ^_P#X!\[_ ,1
MRC^6?_@*_P S[.HKXQ7]JKQM(RJM[IC,R[U"VRDE<XR/FZ>]-F_:P\9VZ2--
MJ&E1+%CS&D@50F>F<MQGWH_L3%=U]_\ P _XB!E&W+/_ ,!7^9]H45\4R_M=
M>+(5S)JVBQ@!22\:#@]#RW?MZU+_ ,-8^,O)\W^T=)\K!/F>0NW@9/.[L.?I
M2_L7$]U]_P#P!_Z_93_+/_P%?YGVC17Q0O[7WBF1E5=8T1F8;E4)&21ZCYNE
M2R?M9^,86D$FI:3&8\>8&A0%,],_-QGWH_L7$]U]_P#P _U^RK^2I_X"O\S[
M2HKXNF_:R\8VT@CFU'289"I<)) JMM'5L%NGO44/[7?BNX:-8M6T65I"1&L<
M:,7QUQAN?PH_L7$]U]__   _U^REJ_+4_P# 5_F?:U%?%]Q^U?XSLU+W%_I<
M"J,EI8%4 $XSRWK3+?\ :V\7W4BQP:GI$TC+O"1PHQ*^H ;I[T?V+B=KK[_^
M +_7_*;7Y9V_PK_,^TZ*^-/^&H_'?_/Q8?\ @(/\:]V\'_%#5[WP5X)U2^M;
M>[DUJ\:TNYE?RO*_UA4HF#N)V 8R*QJY3B:*5[._GY-]?0]G*>*L!G-:5##*
M2:5]5;2Z7=]SU6BO$!^T)?M"N-&L?,?3O[;7-\=GV,1&3RR=G$^!C'W><YK=
M\&?&"[USQ?\ V!J^G)I%T7D"*P=B_P H>- 1E=^W>6R0.!CKQ53)L;2A*<H:
M)7W3T771GT\<32DTDST&3_D/V_\ U[2?^A)6C6=)_P A^W_Z]I/_ $)*T:\>
M70Z%U"BBBH*"BBB@ HHHH **** /._BS\9+3X3OIBW6F7&HF^$A7R'5=FS;G
M.?7=^E>??\-B:5_T+5__ -_XZS?VQO\ CX\*?[MS_P"TZ^1?$]UKEOKUG:Z?
MYS6>H(J&:.,,+-HVWR,3CC?'E1G^("OL<#E^%JX6%6I&[?F^Y^&\0<39M@\X
MK8/"U5&$;6NE_*F]6GYL^S/^&Q-*_P"A:O\ _O\ QT?\-B:5_P!"U?\ _?\
MCKX%AO/&-GI.FS:E?:C%+=6TTT<5K")Y5G$,?EQRXCQAI"Y"D<#@MQ6_X2U+
M7[KQ,D5\UVP-Q<K?6\L.+>WC 7R3$^T9);(X)R,GM75'+L%)I>S?WO\ S/'J
M<49_3BY_68M*^T8]/^W?+[[=T?;?_#8FE?\ 0M7_ /W_ (Z/^&Q-*_Z%J_\
M^_\ '7P-9ZWX]:TLH/(N)+FWE>>2XE@4+=K(CF&$\<;&!#'CHG/-1:WKGBF'
M3]VEW6J3PD19N+NV,4BW!AE+Q@"(DH'$7&W&3MW8-3]0P-K^S?WO_,U7$G$'
M-R_68?='_P"1Z[K_ #N??W_#8FE?]"U?_P#?^.C_ (;$TK_H6K__ +_QU\)2
M>)?$D46M+.E[%<2:?</8)]E)(G4@H. 0"!G@G'UK8_M#75T/PV^G$W]S++(+
MIKEG12HAD/S,8]PPX7'R]<"K678%_8?WO_,YY<4\002;Q$=?[L>U][?+U/M7
M_AL32O\ H6K_ /[_ ,='_#8FE?\ 0M7_ /W_ (Z^!],U[Q8UGJ(G^W2:K):V
ML-K;B$C9))%%YDN"H3Y6:0Y+=5P15B37O$=YHM_;S?VEI^L1Z;$T"Q0<O<QO
M*DIW!2IW!4;&<<C%3_9^!_Y]O[W_ )FSXEX@B_\ >(]/LQZVU^';75^3/O#_
M (;$TK_H6K__ +_QT?\ #8FE?]"U?_\ ?^.OBFTNO$D/BR*S97FT1=2:$W,C
M$RM"+4,-PV8V^9GYMW7C%9:V_B^YL-0NYM0O;9&U!8[>&$J9?+^UE&;&SY4\
MDC .>F[-5_9N"_Y]OKU?3YF*XKSW2^)BKV^S'K\OO['W5_PV)I7_ $+5_P#]
M_P".O2OA/\5[7XK6&H75MI\^GBSE6)EG=6+97.1BOSJ\%W6HS:EK\6H7-Q+Y
M-Y)';QS*PVPAB$(RH4Y&.03GOBOLW]CW_D7_ !'_ -?<?_HNN''X##4<+*K2
MC9^K[GT'#G$F:XW.*>"Q=52@T[VBE]FZU23/H.BBBOD3]M,[5/\ C[TO_KY/
M_HMZT:SM4_X^]+_Z^3_Z+>M&KELA+J%%%%0,**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S_$7
M_(OZG_UZR_\ H!K\YX/]5'_NBOT8\1?\B_J?_7K+_P"@&OSFA_U,?^Z/Y5]E
MD'PU/E^I^%>)/\;"^D_SB>=3?"V_.I3S1WMO]B?4?[7%JRM@W8G#*Y/IY7!_
MV@#45K\)=1C5([C5X9A]L753/'$4DBO1%(IE7DYRS1GGJ%(/6MKQ/JFJV_B8
M06+2GR[>UD6&,9#JUR5F8CV4*,]@:IVOBKQ6KP1WFFQAFB\T20VDI620Q(ZV
M_P!X[#N9QO/'R]*]MPHJ5FF?G\:V-E3O&<=5Y7V]"/PO\.]9T75M$U.ZU.TD
MFL;:.PDAAA(5[<1XD"L3D9E.\#'\*\U5U3X8ZS>W.IW7]H6LSZG<1W%Q;[6B
MP8IU>(+)SG$8*9(]*F;QMXHATN[O9+&%+>UM9KDS2V<L?FLJ1$1A"V1AWD7/
M\7E\4Z/QKXJ,B@:1YJY;RC]CE3[6FYP7Y/[K:%4[6Y;=QUI?N;<MG_6A=\=S
M^UYHWVZ='>VW?7OU>SM)J'PZN]177HP+&VM]2@0&%B9LSAXSYF2H*_*A4@$@
MD@X'-1>)/A;=ZQ_:YM]1\M;R>]ECM6;$$:S6XB7 "Y# CDY(QT%0ZEXL\8K.
MMG%9>45M89Y[Z/3W9$<F)G5%+'<-KNOJ"AJ+5/&'C*?2=84:4MDQ>:"%X;::
M66+"2[/E&-Q<K'AE. 7Y[4I>Q=TTQTUC8\LHSC]_=)7[[)>?WJ^UJ7@&74[;
MF.TM[@Z/<Z;\Q\TAY'1E;?M!( 0YX!YJI>?#V_DTF>R2+37N$NI+JVU-F99]
M[.S*T@V$-MW8*G(8#M5[6-4\265Q;1:=;^9NLH6>2XC:1 XCF9Q@$?,2B+U_
MBJOXHU;7H;ZQELHKR1;C3\O8VT;+Y$I5F+L^TA@#A=NX,#@C.36DE3U;3.:G
M/$^[%35MU^?^>[_0U+CP/'J7C"TUK4)EGCM;:W18$10'FC:0EFR"0O[S[H./
M7-9&@_#^\\.ZAH=Q"MG-]@TPV3A7,2F3S&</@*=P^8#L1CO69XF^(GB;P[9A
MYK.TA-S*R02S0.%B"F;[_P WS?+&C$C& QX/%.N?B/XBCFG1=-$<3S^59SO8
MRN9P(I7PJ*V2"8TPV>DF34N=&^SN:QHX[DLI)Q:MOT6G3U?_  QTGB+PQ?ZU
M?7$BI9O#>:0^G3+,Q/EN6+!U&T[@">^#6?\ \(#?0ZTMS;IIR11/:7$<V&64
M/! 8S&,+\J.3R<_=)X)IMKXJ\6WM^EN=)CLS)/'%)YEO(5M 90I);($N4R^5
MP%QS4>@^)O$6IZAI#:K:)ILLFH/!]CC#@F+R)&</N&&V%4(9<CFJ;IR:T9E&
M.*I0:4HV2[W\_P!-]NNSN_05SM&[ ;'..F:^T/@7X?TW7/A'X3DU"P@O)+-I
M)K=IHPQB<2MAEST/N*^,*^T?V?=%L;CX1Z#++;*\C+(68D\GS&KS<ZDX4(R3
ML[]/1GV/AYKFE33_ )=O_P!*B=Q_P@OASR?*_L'3?*^T?:MGV5,>=_?QC[WO
M5Y=!TU;R&[%A;"ZA:1HYO*7>A<Y<@XX+'KZTW_A'=._Y]$_6C_A'=._Y]$_6
MOBW6G+>;_KYG]"\MMD@D_P"0_;_]>TG_ *$E:-8D>G6UAXBM3;PK$6MI0VW/
M.&CK;K*5M+%1ZW"BBBLR@HHHH **** "BBB@#YH_;&_X^/"G^[<_^TZ^<:^C
MOVQO^/CPI_NW/_M.OG"OT?*?]RA\_P V?RSQG_R/L1_V[_Z1$7<>>:,GIFJ&
ML:U:Z%:I/=%PCR")1&A9BQ!/0>@!/X57C\5Z3-/Y27B']RMP9&^6-8V3>I+'
M@97FO4YHIV;/CXT:DES*+L6=>U3^Q-#U#42AF%I;R3^7G&[:I.,]LXKFM3\=
M:GI^HWENNFVLB11V;1.;E@S_ &F38@8;>,8).,]L5KW'B?PY>Q7MI<:KITD*
MQJMS'+<)LV2*2H))P0PS5::T\)6]E=6DS:7';1K''<1R3J-@!+1AB6R,$DKD
M_2L9MR^&7]:_U\CMHQA35JU)M^CVT\UT_,@N/&E__8<-[:Z?";C^T?[,G@FN
M2%23SA%E6"_,NXYZ#CWJKH?Q2M=>U VL4*E_[16R#).&W1LDA6;V!:)QM//
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M9]!?;K?_ )[Q?]]BC[=;_P#/>+_OL5'_ &38_P#/E;_]^E_PH_LFQ_Y\K?\
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M1N"K6:$'ZC=3O^&.[+_H:KO_ ,!$_P#BJ^B:*/[5QG_/S\%_D'^IN1?] _\
MY-+_ .2/G;_ACNR_Z&J[_P# 1/\ XJC_ (8[LO\ H:KO_P !$_\ BJ^B:*/[
M5QO_ #\_!?Y"_P!3<B_Z!O\ R:7_ ,D?.O\ PQU9?]#3=?\ @(G_ ,52_P##
M'=E_T-5W_P" B?\ Q5?1-%']JXS_ )^?@O\ (/\ 4W(O^@;_ ,FE_P#)'SA=
M?L7:5?1B.Y\0RW,8(8)/81NH(Z'!/6I&_8WL&9"?$]R2G*DV:97C''S<<5]%
MT4O[5QG\_P""_P A_P"IV16M]7_\FG_\D?.W_#'=E_T-5W_X")_\536_8WL&
M96/B>Y++G:QLT)&>N#NXKZ+HI_VKC/\ GY^"_P @_P!3<B_Z!_\ R:?_ ,D?
M.O\ PQS8_P#0TW7_ (")_P#%5[1\/_!Z> O"-AH4=TUZEH& G= I;+%N@^M=
M%17/7QN(Q,>2K*Z^1Z>7Y!EN5576P=+EDU:]Y/31]6^P4445PGT!FW'_ ",5
ME_U[3?\ H4=:59MQ_P C%9?]>TW_ *%'6E5RV1*W84445!04444 %%%% !11
M10!\S_MC,!<>%,G'RW/_ +3KYPWK_>'YU^CUYIMGJ&S[5:07.S[OG1A\?3(J
MM_PC>D?] JR_\!T_PKZ;!YQ'"T(T7"]O/S]#\GSO@BIF^85,;'$**G;3EOLD
MM[^1^;&M::=2DTN6.5$DL;V.Z ?HR@,K+^*L:YJ7X2Z)-I']G-<7)A$LLJLS
MJ6&\KM7D8*H(T50>RX.:_4S_ (1O2/\ H%67_@.G^%'_  C>D?\ 0*LO_ =/
M\*WEG=*7Q4OQ_P" >;3X QE%)4\8E;^[_P#;>;/R]@^&^E6X1%F80*$/D)'$
MD>]8Y$W !>,B0\#C(!]:KV_PKTN&_>ZDO[RY8A%1)F1E14SM XZ<FOU*_P"$
M;TC_ *!5E_X#I_A1_P (WI'_ $"K+_P'3_"E_;-'_GS^/_ +_P!0\=K_ +:M
M?[O_  3\PH?A[H\.B2Z22\ME*]J[QOMPWD+&JJ1C&"(ES]3TK%N_@[IBV]T;
M*Z9;J6&.".6YCC<Q!"H!5MN1A%"XZ' SWK]5_P#A&](_Z!5E_P" Z?X4?\(W
MI'_0*LO_  '3_"D\YHRWH_C_ , <.!<?3=XXW_R7T\_)'YD1^#8+:UL5M=2N
M;:]LYY[B.^58RY>8MYN4*[,'<> .,#%5(_AMI$-MY$<UPL>TK]Y2>8&A)R1U
M(8M]?;BOU"_X1O2/^@59?^ Z?X4?\(WI'_0*LO\ P'3_  JO[:I?\^OQ_P"
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ME*[_ .0A8?5__0:NU2N_^0A8?5__ $&KM4]D)=0HHHJ1A1110 4444 %%%%
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M[7%X-0=\QHHCCA\B02;64_<8F/ ;!R*_0K_AE?P'_P \-0_\#6H_X97\"?\
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M7 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>formdrs_18.jpg
<TEXT>
begin 644 formdrs_18.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #M 7H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHILDBQ1L[L$11EF8X  [F@!U<QX?TC2==LI-8DM
MS?MJB-N;4$61A"Q_U('("  #:.#C)R237DOQ6_;5\!?#HSV>G3MXJU>/*^1I
MS#R$;T:;[O\ WSNKU+X1>((_%7PO\+ZS%91Z='J&GPW(M(W+K%O4-M!/) S7
MHSPN(P]!5JD7%2=ET_X)PPQ-"O6]E"2DTM>O_ -*+P'X9@L9[*+P[I,=G.RM
M+;K8Q".0K]TLNW!([9Z42> _#,MA%8OX=TE[*%VDCMFL8C&C'JP7;@$]S7)?
M'[XC:]\+? L6O:%H%UXA\J^A34(K"W-U<6UD<^=<1VX96F*  [%.<$GG&*\Z
MTG]M;PFEKH44XO/$LNJ6EE>QZIX>L_\ 1'CO+Z2RMOEED$B/YR!'0C*$G/ K
MC]K4_F?WG5[.'\J/<KOP)X:OUMEN?#VE7*VT8A@$UE$PB0'(5<K\H&>@XJ63
MP?H,NK#5'T337U-6#B]:TC,P8# ._&[( '.>U>2:7^V!X+U9?!3QV6LPIXLN
MUT^R:>U"A+DSSV_EL=W)$EO(&*[@H*$\,*H:+^U_IOBR3X<OH?A#7I;'QIJ\
MFEV=Y?I%;H!%#/)-*H\PE@OD,O09ZC/&5[2?\S'[.'8]GMO!/AVSNIKFWT#2
MX+F9766:.SC5W#?>#$+D@]\]:;;^ _#-I:W-K!X=TF&VN@HGACL8E24*<J'
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MV5X@EO;34].TIK&.R4SM-?/,EL I<8)>!U*G!7Y21@T>UJ?S,7LX?RH]BN_
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M[A.%< E;AFEW'DLQ))KLKI/$QCM_LTVDA_+_ 'WFQ2D%\_PX;@8QUJ61=?\
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M<?30FIA95I7<^;[V_P O/8^A?^%,^!O^A6T[_OV?\:/^%,^!O^A6T[_OV?\
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M-/-<2-+*S_:SO9C(2<;?663_ +Z-<E62B]6EZG=0@Y1NHR?H>H2>)OAAJ-O
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M@</C5KVH0W-^^FZ7IT:O/)"H,KLQ(55SP/NDD^U?0/\ PPGX2_Z#^M?G%_\
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MO\SXI^%O[07A3]D?Q]J_@SQ;9?$$:EJ$EJ+I_$E[;7@L%*DJZB)CP1("<9/
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M,:)PW)9 Y!&. .>2='5/A_\ %B^NK:\/BC3I+F"=YHUW,@@W 1L8_DQS&\N
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M9:3)^Z!6+KGP]^+.DZ3(UOXIEUR9;?[-%%:W4D4NYI$=G9F&#@+(@;[WSKT
M)K7NOA;\1[Z.#_BO;BV=;A6>19V#M;J%"(55=HDP9-[#(9@ISC@39-<O(RN:
M2?/[1?=_P"5O@3KRQ310^-KB.("0VL>R7%NSS,SCB0;U,1$7S<@*,>M3:3\#
M=7T^^T]KGQ?<W6GQ-;&ZL_WJ_:1#$%4A_,W+EU#E<[2<^M9TGPI^)UQI*V\G
MQ":.]3RT6ZBFE ,8B.05V\N96W;R22H XZ5Z9\/O#=[X5\+PV.I7K:EJ3337
M%S=&1W\QY)6?@OR  54#H-O%7&$9/6+7S,YU)1CI-/Y?\ Z,G))HHHKK.$*\
M[^(GPC_X6%K4EQ<:JT%A<:2^CSVICW-'$\RR2O"<X6215$98@D+TYKT2H;QK
ME;.<V8C-WY;>3YQ(3?CY=Q )QG&<"IE%25I%PE*#O'<\.7]G74[J0/+XY.H)
M]H,^V>-Y0KY0LJ_O/E! D7 _ADQVKHOA_P#!?5/!^N65WJ'B^^UZRM2\J6MP
MT@/GE GF$[R&&T'Y2, G(%<II?[-^M^&1X9N] U^'3-8L;8'4+G=(R7-U@!F
M50 !&<$$$9(=L]JV(_A)\1IM&F23QU.FHA0(98+F;RP6G9Y&;(R3Y8CC4=!E
MSZ5QQC9WY-?4[Y3YE;VBMZ$1_9[U63Q5KNO2>)XA<ZU=F:Z\FWDC98&E!>"-
MPX*!XDA1B.28%/ )%06O[..LVBM$OC1C;,C+Y)MI,%GF264G]YAMVUQSS\_7
M@5-!\+?BE:>0L?Q!CG\DR2))<O*S&0PE$W ##+N",0> =V <UV7P]\.:]INM
M:Q=ZK?WSV#>7#965U=--L8*!,^3U1G7*$\X)R!G%.-.+>L&B959Q5U-/Y?\
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M V\#)/%?2=%>I.G&II-7/D:.(K8=MT9.+?8^5O\ AV?\#_\ GPUW_P &I_\
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M1QP)"=K$#C@XZ5]A5UX67-3O>ZN_S.#'0Y*W*XV=E>W>VH4445UG >M_!_\
MY M[_P!?'_LBUWM<%\'_ /D"WO\ U\?^R+7>U\1CO]YF?I66?[G3] HHHKA/
M3"BBB@ HHHH **** *&O?\@/4/\ KWD_]!->'3?ZZ3_>/\Z]QU[_ ) >H?\
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M7B<.%(\QAM.-K8ZBO$C2K6E*4;2O==?EN?23KX9RC&$[PLDT[K5==CS[X4_
M.Q\3>"/$_BR6-- U2S58?#7B#05FM;D+90&-;P.^#+'<;5=D8;6(;KD&OI/X
M/^*KSQU\)O!OB/4?+_M#5=(M;RY\I=JF1XU+$#L"<\5Q=UX&^,_B:TFLM7^(
M_AS1;*XC:*7_ (1_PZS3;&!4JKSRLJ\'KM.*])\$^$[/P'X.T/PUISS26&D6
M45C ]PP:1DC4*"Q &3@>E=]"GR/165OO9Y6)J^T6LKN^F^BMYI>1M4445V'
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FH10J@*H&  , 4M%%> >T%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>formdrs_19.jpg
<TEXT>
begin 644 formdrs_19.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #F BH# 2(  A$! Q$!_\0
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M_>JR[=Q*^@WBE'*LMEM^82S3,8[_ )'TE_PV!X;_ .@/J7_CG^-'_#8'AO\
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M_P :^3**/["P7\K^\/[:QG\R^X^L_P#AL#PW_P! ?4O_ !S_ !H_X; \-_\
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MI:_)-%&L+&4,<<<CG.<GFL:/P[X$^W6B-K$WE27*1SYE4"!=B%CDCYEW%UW
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M*OE2,0,'GIEEY[Y%8RDHRY95+/Y?Y&L8N4>:-.Z^?^9!_P (OI7_ $-.G?\
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MF*_Q$%U"@\9.3G&*_-#P3_P4N^/WA+Q<FLWGC6X\1VK2!I])U1%>VD7/*
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MSKD/[?T#_H4XO_!C-_A1_;^@?]"G%_X,9O\ "E]6C_)+[U_\D/ZQ+^>/W/\
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M.!7Y4>"?V8?BI\0/%D7AS2/ FN-J;2B*07-E)!'!S@M*[@!%'<DU^]?QX_:
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MA\+:!IOBCP?;&Z@U&VN;EDU%Y)U\G:)BO4$;1M&<G'6N>_X1*PZ_\)/I.?\
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M_,/7UI-@5W^\WUIM3M NX_ODZ^])]G7_ )[)^M%P(:*F^SK_ ,]D_6C[.O\
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M4A^'>OQQR23V)MHDMFNS),P53&H4D@]S\Z\>]'M%_P _5^ >S?\ S[?XC?\
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M[$_X9)\$?\]M6_\  I?_ (BC_ADKP1_SVU;_ ,"E_P#B*ZJ6<X&BFH\WW?\
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K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>formdrs_20.jpg
<TEXT>
begin 644 formdrs_20.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "; BH# 2(  A$! Q$!_\0
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M')=:MC!)K,<9UOS,/IMW*^_.U 7B96PRMAPIXP >S_\ "Z$_Z$CQI_X)6_\
MBJ/^%T)_T)'C3_P2M_\ %5XG\/? /Q,TCX^6_B35+)K+PG)-");.UU]9S$QT
MR.)V+/)F:W6=9,J560N4E&>17U7]NMO^?B+_ +[% ' ?\+H3_H2/&G_@E;_X
MJNA\(^-QXNDN5&A:YH_D!3NU>Q-N),Y^YDG.,<_45O?;K;_GXB_[[%/CN(IL
M^7(DF.NU@: )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH S=?\-Z7XJT\V&L:?;ZG9,P<V
M]U&'0L.0<'N*YAO@CX 521X-T8D#./LB#^E=S574M0L]+L9KK4+F"SLXQF6:
MYD5(U!X^9FX ^M 'STLG@1-8CTN?X::!%<N[1K-OB:W8'SO+D639RG^CR;SC
MY..""#5CPRWPWUK6ETS4/AUI.D7#1$ 20QR?OPL)*'"\*1<)M?H<-TQ7K?\
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M2,X!QR*G_P"%(?#_ /Z$[1O_  #3_"NHT74=,U+3XWTBYM+JR0!$:RD5XU
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M_P!>Z?R%:E?(5/CEZGZ/1_A1]$%5-6_Y!=Y_UQ?_ -!-6ZJ:M_R"[S_KB_\
MZ":F/Q(N?PL\)7[H^E+2+]T?2EK[$_- HHHH&=C\+?\ D.7?_7M_[,*]/KS#
MX6_\AR[_ .O;_P!F%>GU\YCOXS^1]ME7^[+U84445YYZYY;\3O\ D8(?^N _
MF:Y&NN^)W_(P0_\ 7 ?S-<C7U6&_@Q]#X#'?[S4]0HHHKI.$:_W6^E>]:?\
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M/&M**270RO"EGJ6G^%]'M=8FM[G5X;.*.\FM(_+A>8( [(O\*DYP*]2^%/\
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M;FT(T\KKPBK)0?Y'N\.U)UL^PM2H[MU(W^\^Z:***_G4_LX*\Y^*G_'YI_\
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M5AOX,?0^ QW^\U/4****Z3A&O]UOI7O6G_\ (/MO^N2_R%>"O]UOI7O6G_\
M(/MO^N2_R%>/F.T?F?29+\53Y?J6****\0^I,?Q=_P BSJ/_ %Q->+U[1XN_
MY%G4?^N)KQ>O>R_^&_4^1SG^-'T_4****]4\ *[WX4_ZS4_I'_[-7!5WOPI_
MUFI_2/\ ]FKBQG\"7]=3TLM_WJ'S_)GH=%%%?,GW85XYXZ_Y&J_^J_\ H"U[
M'7CGCK_D:K_ZK_Z M>GE_P#%?I_D>#G'\"/K^C,*BBBOH#Y *=#_ *Z+_?7^
M=-IT/^NB_P!]?YTAK<]^HHHKXT_3 KEOB1_R*\G_ %UC_G74URWQ(_Y%>3_K
MK'_.NC#_ ,:/J<>,_P!VJ>C/*****^K/SX**** /3?A=_P @2X_Z[G^0KLZX
MSX7?\@2X_P"NY_D*[.OEL5_&D??8#_=H>@4445RG>>(^)O\ D8]3_P"OA_YU
MFUI>)O\ D8]3_P"OA_YUFU]?3^"/HC\WK?Q)>K_,****T,C4\*_\C)IG_7=:
M]LKQ/PK_ ,C)IG_7=:]LKP<P^./H?69-_"GZ_H%%%%>4?0A116#<>$(+BXDE
M.I:LA=BQ6/4)549[  \#VH V+O\ X]9O]QOY5^7MY_Q]S_\ 71OYFOTF;P3;
MLI!U36<$8/\ Q,IO_BJ\Y;]D+X:.S,VG:D68Y)_MBZ_^.5]EP[G5#)_:^VBW
MS6M:W2_=KN?FG&?#&+XC]A]5G&/)S7YK];;63['PS17W+_PR!\,_^@=J7_@X
MNO\ XY1_PR!\,_\ H':E_P"#BZ_^.5]G_KI@?^?<_N7^9^9?\0QS7_G]3^^7
M_P B?#5>R_LE?\EGLO\ KSN/_017T!_PR!\,_P#H':E_X.+K_P".5K>&/V:O
M!'@W5DU/1H=4L;Y49%F75KDD*PP1@N17!F'%F#Q>$JT(0DG)-:VZ_,]C)_#W
M,LOS"ABZM6#C"2;LY7T?3W3U.BN=_P"$*M_^@IK/_@RF_P#BJ/\ A"K?_H*:
MS_X,IO\ XJORD_H Z*O.?BI_Q^:?_P!<V_F*Z3_A"K?_ *"FL_\ @RF_^*JC
MJ/POTK5F1KN]UB8H"%SJDXQGZ-73AZBHU%.1Q8RA+$473CN['E]%>B?\*8\/
M_P#/?6/_  :W'_Q='_"F/#__ #WUC_P:W'_Q=>M_:%/LSYW^QZ_\R_'_ "/.
MZ*]$_P"%,>'_ /GOK'_@UN/_ (NC_A3'A_\ Y[ZQ_P"#6X_^+H_M"GV8?V/7
M_F7X_P"1U'A?_D6],_Z]T_D*U*YJW\!VEK!'#%J6LK'&H55_M.8X Z#[U/\
M^$*M_P#H*:S_ .#*;_XJO"D^:39]73BX047T1T55-6_Y!=Y_UQ?_ -!-9'_"
M%6__ $%-9_\ !E-_\539/ UM-&R/J>LE6!4C^TINA_X%2B[-,J2NFCR)?NCZ
M4M>B?\*7\/\ _/?6/_!K<?\ Q='_  ICP_\ \]]8_P#!K<?_ !=>]_:%/LSY
M'^QZ_P#,OQ_R/.Z*]$_X4QX?_P">^L?^#6X_^+H_X4QX?_Y[ZQ_X-;C_ .+H
M_M"GV8_['K_S+\?\C,^%O_(<N_\ KV_]F%>GUQVG_"O2=)F:6UO-8B=EVDC5
M)SQU[M5__A"K?_H*:S_X,IO_ (JO*Q%55JG/$^AP5"6&HJG)ZG145SO_  A5
MO_T%-9_\&4W_ ,51_P (5;_]!36?_!E-_P#%5RG<<?\ $[_D8(?^N _F:Y&O
M3M0^%>D:K,LMU>:Q+(J[03JDXX_!JJ_\*8\/_P#/?6/_  :W'_Q=>U1QM.G3
M46GH?,8C*ZU:M*I%JS]?\CSNBO1/^%,>'_\ GOK'_@UN/_BZ/^%,>'_^>^L?
M^#6X_P#BZU_M"GV9S_V/7_F7X_Y'G+_=;Z5[UI__ "#[;_KDO\A7%_\ "E_#
MY_Y;ZQ_X-;C_ .+K93P/;1JJKJ>LA5&!_P 3*;_XJN'%8B-=)16QZV7X*IA'
M)S:=[;'1T5SO_"%6_P#T%-9_\&4W_P 51_PA5O\ ]!36?_!E-_\ %5YQ[):\
M7?\ (LZC_P!<37B]>M7/@&SO+>2&;4M9>*0;67^TYAD?]]5D_P#"F/#_ /SW
MUC_P:W'_ ,77I87%0H1<9(\/'X&IBJBE!I674\[HKT3_ (4QX?\ ^>^L?^#6
MX_\ BZ/^%,>'_P#GOK'_ (-;C_XNNW^T*?9GF?V/7_F7X_Y'G==[\*?]9J?T
MC_\ 9JG_ .%,>'_^>^L?^#6X_P#BZNZ;\,-+TGS#:7NL0^9C=C5)SG&<=6]S
M6%?&0JTW!)ZG7A,LJX>M&I)JR_R]#KZ*YW_A"K?_ *"FL_\ @RF_^*H_X0JW
M_P"@IK/_ (,IO_BJ\<^D.BKQSQU_R-5_]5_] 6O0?^$*M_\ H*:S_P"#*;_X
MJLR\^$FBZA<O<7%UK$DSXW,=5G&<#'][VKLPM:-";E+L>;C\-/%4U"#M9WU/
M-**]$_X4QX?_ .>^L?\ @UN/_BZ/^%,>'_\ GOK'_@UN/_BZ]/\ M"GV9X7]
MCU_YE^/^1YW3H?\ 71?[Z_SKT+_A3'A__GOK'_@UN/\ XNE7X,Z K BXU@$'
M(_XFMQ_\71_:%/LP63U_YE^/^1W=%<[_ ,(5;_\ 04UG_P &4W_Q5'_"%6__
M $%-9_\ !E-_\57@'UYT5<M\2/\ D5Y/^NL?\ZG_ .$*M_\ H*:S_P"#*;_X
MJJ]]\.[#4K<P7.H:S+$2"5_M.8=.G1JUI25.<9/H<^(INK2E36[1Y317HG_"
MF/#_ /SWUC_P:W'_ ,71_P *8\/_ //?6/\ P:W'_P 77M?VA3[,^8_L>O\
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M*** "BBB@#R'X\>&=2\3:QX!&F:-KE[-9:U%>/J6CZ@EL+%$92?,5Y4$B/\
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M+*4J:U^&/Q2A\*_"_3[#3=0M?#^F/JCZMI.J:L);U?.MKQ8HV*NZRQH\L2Q
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F33'\Q74S0VK1SW!D:3>@!)RN#YA8$YVU]044 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>formdrs_21.jpg
<TEXT>
begin 644 formdrs_21.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "T BH# 2(  A$! Q$!_\0
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M /(]<#XTN#X3\96'A6+QMXQOM9NM,N=997O[*W@@M(&C1Y'E># )>5% ^I.
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M@G>Z3XADUN#X=6/]I/?W&H^8WBR0A99X(H)=J_9=JJ5@A. .&C##!YK(\/\
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MTW^PQU/@_P "Z]X%U@ZII'P[TN&];3;32WDD\4/(7AMD,<).ZU/SA#M+#&X
M9S@5[C10!P7_  DGQ$_Z$?1__"C;_P"1:/\ A)/B)_T(^C_^%&W_ ,BUWM%
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M&HO^%]_#O_H<=)_\"!7Y^?$'_D?/$7_80G_]#-8%?N%'@'!5*<9NM+5)]/\
M(_+ZG%F*A-Q5..C\_P#,_2+_ (7W\._^AQTG_P "!1_POOX=_P#0XZ3_ .!
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M=FTS7#6\*1&9A@N54#<?<XS5NB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\;V$7C87&B^+1>0W\-U#(\C+<M,7N!\X5;A5>.)2!L*1#(SC'S9_PT5\2?\
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M_P!%FOT(K\.X^_Y&=/\ P+\Y'Z?PG_N4_P#$_P D%%%%?FA]L%%%% !1110
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M=F\.W45K)>7$L<QE@67*J@( W=.37SO_ ,-<?$S_ *"UI_X 1?X5ZS^W9_R
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MMP5\X_ML:=<ZEX.\/K;1>:RWS$C<!@;#ZFOHZOA3_@K,H;X7^",C/_$XD_\
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MT\BNO^/6;_<;^5?E9J7_ "$KW_KO)_Z&:_5.Z_X]9O\ <;^5?E9J7_(2O?\
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M_P##3^?Z'.4445^CGQP5]2_\$U?^3JM)_P"P9>_^BZ^6J^I?^":O_)U6D_\
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M54:<4K)/O_,S\ISC!TZF/J3DW=V_)'VK_P (GKG_ $![[_P';_"C_A$]<_Z
M]]_X#M_A7Q5]LN/^?B;_ +^-_C1]LN/^?B;_ +^-_C7T?]JU_P"5?B>-_9]+
MN_P/M.3PEKGEM_Q)[[I_S[M_A7Z7> 8G@\"^'(Y$:.1-.MU96&""(ER"*_G\
MDO+CRV_TB;I_ST;_ !K][?@BQ;X,> B223H%ADG_ *]TK\YXTQ=3%4:*FDK-
M[>B/LN&\-"A5J.+>J1VM%%%?E!]Z07K;+.=@,XC8\_2OQ*UC]I76X]8OU'AO
MPV0MS(.;6;^^?^FU?MIJ'_'A<_\ 7)OY&OY[M;_Y#6H_]?4O_H9K]#X1<E[?
ME;7P[-KOV/D.(%%^RND]]U?L>I?\-,:Y_P!"WX:_\!9O_CU'_#3&N?\ 0M^&
MO_ 6;_X]7D4<;S-MC1G;&=J@D\=:=)!+$L;/$Z+(-R,RD!QG&1ZC/I7Z)SS_
M )W_ .!/_,^/Y(?RK[E_D>M_\-,:Y_T+?AK_ ,!9O_CU?6G_  3>^+VH_$#X
MM>)+"\TG2+".+13,)-/AD1R1/&,$L[#'/IV%?G=)&\,C1R(T<BG#(X((/H0>
ME?:__!*/_DN'BK_L7V_]*(J\7.I3>7UKR;T[O_,]/+8Q6+IVBM^R/U-HHHK\
M2/TP*_/;_@K=_P @GX;_ /7Q>?\ H$=?H37Y[?\ !6[_ )!/PW_Z^+S_ - C
MKZ#(/^1E2^?Y,\G-?]SG\OS1^<5%%=/I/PYUO7+CPY!8QP7$NOB5K,+,!_JV
M*OO)^Y@@]>V*_8Y3C!7D['YU&,I:11S%%;UIX*U6]\*7GB.*./\ LJUE,$DC
M2 '>-F0!Z_O%XZGG&=IQ@T*2E>SV%9JUS]Q?V/\ _DV/X;_]@B+^M>PUX]^Q
M_P#\FQ_#?_L$1?UKV&OPC&?[S5_Q/\S]3PW\"'HOR"F3?ZF3_=/\J?3)O]3)
M_NG^5<9TG\]WB;_D9M8_Z_9__1C5FUI>)O\ D9M8_P"OV?\ ]&-6C\/?#MKX
ML\766DWCS107"S$O;D;P5B=QU!XRHS[5_0/,H0YGT1^2\KE.R.<HKT6X^%D5
MK:>#W-U)<G5Y[6&]:U&Y[=KB-)41(R!O/EN#N#$%LK@8&</XE>%+;P7XNN-,
MLY_M=F(HIH;E9!(DRN@;>C@#<AR<$@'CD U$:T)RY8E2I2BKL^A/^"9O_)T5
MG_V";S_T%:_7FOR&_P""9O\ R=%9_P#8)O/_ $%:_7FOR_B?_?E_A7ZGW&2?
M[K\W^@4445\B?0'P!_P5N_Y%7X;_ /7_ 'G_ **CK\V*_2?_ (*W?\BK\-_^
MO^\_]%1U^;%?L7#W_(MI_/\ -GYWG'^^2^7Y!N'K1FO8/!?BCP[I.D^#_P"T
M;BT+PV]['=R1*IN+0&YCD0[2A$C,BN@4_P ,C<BJMKX@\)0^!?$ENT5K#<WD
MEW/#9HI>0>;Y)LU5L<>3MFW<\9[[J]CV\KVY'O\ J>?[%6OS'E-?MW^Q;_R:
MS\-_^P6O_H;5^(E?MW^Q;_R:S\-_^P6O_H;5\KQ5_NM/_%^C/=R'^//T_5'M
M=%%%?EY]N%?S^?$C_DHOBK_L+7?_ *.>OZ Z_G\^)'_)1?%7_86N_P#T<]??
M<)_'6]%^I\GG_P -/Y_H4O"_ANZ\6ZU;Z79S6D%S.0D;7MPL$98D!5W-QDD@
M >IHUGPOJ&@V.GW=Y&B17S3)$$D#,&BD\N16 Z$-^=/\(Z];^&=;BU"XTR/5
MA$K>7#+,\01R.) R$'<O4>]7KGQNT^FZ/:#3H8_[):XDMI/,9B'EE$FY@2=V
MW& #USSDU^@2=3GT6G_#_P# /E(J'+J]?^&,SQ)X;U#PEJSZ9JD(M[U(XI6C
M#AL+)&LB\COM8<=NE?2/_!-7_DZK2?\ L&7O_HNOG7QAXKN?&FMG5+N&&"<V
M\%N5MU*J1%$L8/U(4$^YKZ*_X)J_\G5:3_V#+W_T77!F/-_9]7GWY7^1U8.W
MURGR[<R/V!HHHK\0/TT*^%?^"LG_ "2_P3_V&)/_ $2:^ZJ^%?\ @K)_R2_P
M3_V&)/\ T2:]S(_^1C2]?T9Y>:?[G4_KJC\PZ]7\'_#_ $K7-%\(R:KH]WI:
MZAJT<+:FUPRQWUL3M=06&Q7WX5-IS@.3G ->44]II&14,C%%Z*6.!]!7[)4A
M*:M%V/SJG)1=VKGJND_#719=#\57-\98IK.YO([=_-PL$,4,KQ2?[8DD01YZ
M<'')KR>G;VQC<<8QU_&FT4X2BWS2O<)R4K65C]I?V"?^33_ ?_7";_T?)7T#
M7S]^P3_R:?X#_P"N$W_H^2OH&OP_,/\ ?*W^*7YL_3\)_N]/T7Y!1117GG4?
M@3\9/^2N>-?^PU>?^CFK&\)WFE6.O6MQK4=Y+IT9W21V.WS'(Y4?,0"NX#([
MBMGXR?\ )7/&O_8:O/\ T<U<?7[]37-1BO)?D?D\WRU&_,]0\3?%VV\1:796
M[P7GVVSN!<0:A*(FE1UDFD$@X^]*TJF0=,Q@C/;F/B%XW/CC5+6=+2.RMK6
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MYK\AO^"9O_)T5G_V";S_ -!6OUYK\IXG_P!^7^%?J?>9)_NOS?Z!1117R)]
M? '_  5N_P"15^&__7_>?^BHZ_-BOTG_ ."MW_(J_#?_ *_[S_T5'7YL5^Q<
M/?\ (MI_/\V?G><?[Y+Y?D%%%%?1GC!7[=_L6_\ )K/PW_[!:_\ H;5^(E?M
MW^Q;_P FL_#?_L%K_P"AM7Q7%7^ZT_\ %^C/ILA_CS]/U1[71117Y>?;A7\_
MGQ(_Y*+XJ_["UW_Z.>OZ Z_G\^)'_)1?%7_86N__ $<]??<)_'6]%^I\GG_P
MT_G^ASE%%%?HY\<%?4O_  35_P"3JM)_[!E[_P"BZ^6J^I?^":O_ "=5I/\
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M36G_ ,31_P (/XW_ .BE7'_@FM/_ (FO0:*XCI//U\$>-P>?B3<'V_L:U_\
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M2LJTOO.!X#"MW=-?<<-_PZ7\"_\ 0]^*/^^+3_XS1_PZ7\"_]#WXH_[XM/\
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MQC<32ZA)<DK$XA\I !@F$QDDQL1N ?##)&!0!W=%%% !1110 4G6O#K[X?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
=44 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>formdrs_22.jpg
<TEXT>
begin 644 formdrs_22.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "X FP# 2(  A$! Q$!_\0
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MD[\[3MP#FNP;X.W\FFPZ:?AYX/-C;Z;)HT5L-=O-D=D\B2- !Y'";HT(';:
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MG !QUKMZXOQ+\1%\/_$#PQX<-O\ NM5%PTUW*KJL0CB9UPVW:<[3G)&..N:
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M=A#X>LDRQZDX7K4\7P[\=P1K''\4)XXU&%5=!LP /0#;7I=% 'FW_" ^/_\
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M **** "BBB@ HHHH ***\X^(OQ>_X5WX\\)Z-=:>LFE:Q::G=W.HB8[[9;.
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MBBB@#Q[7/C!XEFUSXFZ)H6C:1%?>#X["XCN]7OI%MIX9XGED=_+B+(46,@*
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MQ,_Y#D?_ %S%<A7U6'_@Q]#\_P ;_O,_4****Z3B)+;_ %R_C_*O?*\#MO\
M7+^/\J]\KQ<Q^Q\_T/I\EVJ?+]0HHHKQCZ8YGXA?\BZW_70?R->2UZU\0O\
MD76_ZZ#^1KR6OHL!_!^9\9F_^\_)?J%%%%>B>*%>I_#3_D R_P#7<_\ H"UY
M97J?PT_Y ,O_ %W/_H"UY^._@GL93_O*]&=;1117SA]J%%%% !1110 4444
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MSK:***^</M0HHHH **** "BBB@ HHHH **** "BBB@#\R/%W_(T:M_U]2?\
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M1)\/?]@ZW_\ 12U\#QO_  :'K+\D?KGA;_O.+_PQ_-FY1117Y*?T.<-\</\
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MWQ-_Y \/^_\ X5UX7^-$\[,/]UG_ %U/,****^H/@PHHHH ]G\'_ /(NVG_
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M@5FY)"''KG[,?C#QYXKBU\^-(+B,0QV3HUQ!Y12\>-C>0+P,K&X0#TR>:?\
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M;O!V,:M&G67+45T>-?\ "F_&/_0X:-_X()/_ )*H_P"%-^,?^APT;_P02?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>formdrs_23.jpg
<TEXT>
begin 644 formdrs_23.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "? BH# 2(  A$! Q$!_\0
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MCKFNPKQB_P#C)K%GK6K6MK)HNN0VUZT$/]GE_,#*%S:R#<<2DDD-P"$;Y>*
M&3?!;5BT,<BZ7JB_;8YC=W4\J3P;'=Q<QD*?WY+A3R/EB W<G%@_"37[?P;J
M>D&;2=9AO(UB;1]01A:.P2*,S&0*S!B(VD*A<;WZ\9,2?&'53I9N(;_0M97[
M;>0_:-*RR+!' SI*Z&0L-L@",02,$-\N[B:'XPWC?#E]4EO=.L=2:U6X&H7D
M)?3H7(CQ%))')C>6? 7<#CDCB@"AJ'P0U::WGA:'2=5AF:.,V]]=3+M02;_,
M$@1F\V, 1HW7 SD'BN_^&OA6Z\*V>K_:].TO2YKZ_>[,.DRR/"<JJ[B&5=K$
M(-V!R<G))->?W7QMUM+R"$OH.F.\\4>+YWV2-Y@0PHX(^9TW2HV#\N/E.:T6
M^(7B;2/'UKHNJ7^CR6=RTSQR0P>0^Q)H8]N))<L<R.,KR2F0.U 'L%%%% !1
M110!Y_K7PML+S3O%-E!I5C]F\1';?)#*]HTB[0 2\:Y+DER3[@>M8]O\']7\
M.WEO>>']?\BY>XM9+TWB;TF6.+RY"J 85F'0#@9(R!@!(_BMK:V^O?:]/M[-
M[6\AM89V.Z% TQ25]P;]XL4>R5B"N-Y4@%34&D_&37;1[6;Q+X>:PL;^YMH;
M5[-6F<>:A(#C/!)&><$ D8/!(![!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !16!-XXTB&1D>=PR]?W3?X4S_
M (3[1O\ GO)_WZ;_  K?V%7^5_<<GUO#_P#/Q?>CHJ*YW_A/M&_Y[R?]^F_P
MH_X3[1O^>\G_ 'Z;_"CV%7^5_<'UO#_\_%]Z.BHK%L?%^F:E=);P2NTK= 8V
M'\Q6U6<H2@[25C>G4A55X._H%%%%0:!1110!P>H>"?&%U?7,UO\ $:]L[>21
MGCMUTJS<1*3PH9H\G XR>:JK\/?&:YV_$N]7)R<:-8]?7_5UV?B3Q+IGA#1K
MC5M9O(]/TVWV^;<RYV)N8*"<#@9(Y[5F7WQ(\-Z;>:A:W&J1K/I\D45VJH[>
M2\@4HK8!Y(=#_P "&: .>7X=^,5&!\2KP#!'&C6/?K_RSH'PY\8K'Y8^)5X(
M\YV_V+8X_+RZ[#1?%FD^(+**[L+V.:VEQY<C H'R,X&X YP#QU&*KZ[X\T+P
MVVGKJ%^(O[0D\FU,<3RB5_[H**1GKU]#Z4 <PWP]\9MC/Q+O3@Y&=&L>OK_J
MZ&^'GC*1U=OB7>LR_=8Z-8DCZ?NZ[FTUJQOEC,-U$QD&50L Q_X">:M0S1W$
M:R1.LD;#(9#D'Z&@#S__ (0+QM_T4Z__ /!/9?\ QNC_ (0+QM_T4Z__ /!/
M9?\ QNO0Z* ///\ A O&W_13K_\ \$]E_P#&Z/\ A O&W_13K_\ \$]E_P#&
MZ]#HH \Z_P"%?^--N/\ A9E]CGC^Q['OU_Y9T[_A ?&W_13K_P#\$]E_\;KT
M.B@#SS_A O&W_13K_P#\$]E_\;H_X0+QM_T4Z_\ _!/9?_&Z]#HH \\/@+QM
M_P!%/OQ_W![+_P"-UWUK')#;11RRFXE5 KRLH4N0.6P.!GKQ4M% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 445 ;ZV'!N(@?]\4[-[";2W)Z*K_VA:_\ /S#_ -]BC^T+7_GYA_[[%/E?
M87-'N6**K_VA:_\ /S#_ -]BG1W<$S;4FC=O16!-*S[!S1[DU%%%(H*@NKZW
ML5#7$\<"MT,C 9J>N*^)S%;&V()!^;I]5K:C356HH/J<N*K/#T95$KV.E_X2
M#3/^@A;?]_5_QH_X2#3/^@A;?]_5_P :\1\Z3^^WYT>=)_?;\Z]?^SX?S'SW
M]M5/Y$>W?\)!IG_00MO^_J_XT?\ "0:9_P!!"V_[^K_C7B/G2?WV_.CSI/[[
M?G1_9\/Y@_MJI_(CWFWN8KJ,20R++&>C(<BI:YWP$Q;PW 2<G<W7ZUT5>-4C
MR3<5T/I:-1U:4:CZJX4445F;'A6K?\A&;ZC^0JI5O5O^0C-]1_(54K[&.R/S
M.6["BBBJ$;W@?_D9+7Z_U%>Q5X[X'_Y&2U^O]17L5>!F'\1>A]=DW\&7K^B"
MBBBO+/?"BBB@#+\3>'X/%.AW6E73%;:Y 24;5;>FX$J0P((8#!]B:\X7]G/2
M8V0QZYJV%V_-*8I';"1)EG*9)(B7)/\ A7K=% 'D*_LUZ&RRB;5M2G\Q0C;O
M)'0)AAA.&S&IW#G!*_=)%=%X?^$=EX=T31=+M]2O&@TO4O[2B++&"S;67RR
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M!_Z%Z_\ ^_J?X5\@45^K?ZJY5_S[?_@3_P S^?O^(@<0?\_E_P" Q_R/K_\
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MZ$M?6\*_\C:EZ2_])9^=^('_ "3U?UA_Z7$^8J***_>#^2PHHHH _0WX ?\
M)'O#/_7!O_1CUZ#7GWP _P"2/>&?^N#?^C'KT&OYKS+_ 'ZO_CE^;/[>R/\
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M-BTC,Y5NAV\CD>MT5O[.)R>WG:W]=@KVGPG_ ,B_:?\  O\ T,UXM7M/A/\
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M_KP_]J/7SC7T=^VM_P CAH/_ %X?^U'KYQK^@^'O^150]/U9_'7&7_(_Q?\
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MRK\5O^@!I7_@Y7_XU7WW^L65?\_U]S_R/R'_ %-X@_Z!)??'_,\IKV_]C_\
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MKX<_\A]/Q_\ 06KU:O%/#MOX^\/WPNO^$%AGQ_"NNQ9Z$=XQZUU'_":>/_\
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MM?K_ %%>Q5X?H>G^/=%U*.[/@:&;R_X%UV+)_..NM_X33Q__ -$W7_P?0?\
MQ->/C:D*DTX.^A])E=&I0I2C45G?]$>AT5R/AGQ)XKU35!!K'@X:)9;&8W8U
M2*XPPQA=BJ#SSS[5UU>>>R%%%% !69XEN[RP\/ZC<Z>UFE[# [Q/J,C1VZL!
MG=(R@D(.IQV%:=9^O:!IOBG1KS2-8L8-2TN\C,-Q9W2!XI4/564\$'TH ^>-
M)_:F\27E[X>TF^\+6.F:UJ%K8K<I-=.8(;F[AO98WW!<^2JV)9LC<!*!P5.9
M_"G[4NN7VO>#='UWPM!I]]JWV**]6VG:14DNWO1#)$2!^[VV0<AAN F ."IS
M[ OP?\#KH\6E#PEHXTV*U>QCM191^6MN^[?$!C[IW/D?[3>IJWH?PU\)^&8]
M,32?#>EZ<NEHT=B+:U1/LRL69@F!\H)9CQ_>/J: .EHHHH **** "BBB@#R+
MXR?%_7_A7KMI-!HMCK'AQ=*U#4+X)=,E]!]FMWE5PNW:8V=4BZ[MTH(&%-<_
MX(^/_BGQAXJT"QBT#2VL)=5O=(U1UNG6>)H8%E6YB4KM,67CB()W;I!CI7K.
MI?#?PKK/BNV\3W_AW3;WQ#;0-;0ZG<6R//'$0P**Y&0I#N,?[1]:IQ_![P/#
MK.F:M'X2T=-3TQ&CLKQ;-!+;JQ)8(V,KDLV<>M %3X'_ !&N?BU\,=(\4W>G
MQZ5<WKW*/9PRF58S%<20\.0,Y\O/0=:[NLKPQX4T;P7H\6DZ#IEKH^F1,[I:
M640BB5F8LQ"C@98DGW)K5H **** "BBB@"KJDUQ!IMU):" W2Q,T7VIRD6['
M&]@"0N>I Z5\XZ5^U1XD-UX6TS5?"]A;ZKJ7V>.<P73M QN;RXM;::(E=PC(
M@68AAN"2 =1D_1NK:39Z[I=WIVHVT5[87<303VTRADEC8896!Z@@D$5S=C\(
M/ ^FZ3::7:>$M'M].M(I8;>UCLHU2))<^8JC' ;<V?J: /./#/QF\?:G'\/I
M;SPWH136]5N]/U);/4)"RP1F7R[ZW#*,PE4C8J^&_?H!U&?=JX72_@7\/-#N
M-%N-/\%:'9S:*S/ILD-C&ILRS;F,6!\I)Y.*[J@ HHHH **** "OFKQA^U!X
MG^'_ /PD*:QX:TN?[#J5XEG=6%X[PW-K;6!NY5.5!$RE3"?X=^2/ND5]*UQN
ME_!OP)HMO=06/A#1;6&ZNQ?3QQV48$MQS^]88Y;YFY/J?6@#RWQ)\??&WAWP
M?\1M:?PUI5U_PC4\,UD+6XEE%Y:E%DG5E"[EDA5CO8 J,'@[2*Z'X*_&/6OB
MEXE\86UQ:V5KIF@ZW=Z2DL=O,AN53:8I$D9BK,5W;T RORG/-=1!\"?AU:W3
MW,7@C0DN'O?[1>5;"/<US\V92<<L=[9/?<?6M;1?AMX5\-ZM-J>E^']/T_4)
MIY;F6XM[=4=Y9<>;(2!RS8&6ZG% '2T444 %%%% !7 _&+QEXD\#Z)I=]X;T
MS3M8N)M3MK6:ROKEH))8Y)51A"0"/,"LS_-@!8VS[=]7/>+OA[X9\?+8+XDT
M'3]<6PF^TVHO[=91!+TWIN'#>] '@_\ PU-XGUQ=7'AOPQIUY<6=Q#)#:WEV
M\3W-N^H7-EY2D*0)R;9I!G"A2<_=)K.\8?MM6\/CS5_#_A2VL=8ATK6='TF>
M:,27,TGVQ[E)F2%-IW1- H"Y^;=VXKWC7O@WX$\4*RZOX0T745:Z^VL+FRC?
M,X!'F'(^]\S<_P"T?4U:USX7^$?$VH&_U7PUI>H7IE@F^T7%JC2>9#N\E]Q&
M<IYC[3_#N.,9H V=#FN[C2;62_-NUZ4_?&U#"/=WVAN1]#TJ_5/2=)LM!T^"
MPTZUBL[.$;8X(5VJHSDX'U)/XU<H **** "BBB@#YN\9?M->*/ ,_B.'5?#>
MES)9:G<0V%W97CO#/;P:?)>S*^5!$J^5Y1Q\NYO]DBI?$'Q^^(&FZ'XLO;3P
MC87:Z==VGV.YLVENPMK)"9IS- NV1I(5"AA%NY<8!VD5ZWIWP;\"Z3'?1V?A
M#1K=+ZZ%[=+'91@3S@D^8_'+?,W)_O'U-1V?P5\ Z=>7%W:^#]%M[JXO1J,T
MT=E&'>Y&[$Q.,[_WC\_[1]: .*^!_P :M;^*WB3Q3:SV]A%INB:K+IRW-O;3
M(MVGE1R121R,Q4L0[;H\94;3GG%>U5S6C_#7PIX>U:;5-,\/:=I^HS3R74ES
M;VZH[S2 +)(2!RS  $]2!BNEH **** "BBB@#@?C-XR\1^!?#-GJ/AG3-.UB
M\:_M[>2QO[EH&G2214*0D CS,,6^;Y0$8FO([O\ :H\3:I_;T?AOPQIU[=V$
MGFVUM>73Q&ZA749[$P@A2!,[6Y=<X4!N?NDGWGQA\/?#/Q"@LX?$V@Z?KT-G
M,+BVCU"W698I0,!U##AL$\^]9_B#X-^!?%<<J:SX0T74TEN1>2+<V4;AI@"!
M(<CE@&;G_:/J: /#_&7[8LNGWU]%HFG02&V\16VBI:SVTTUQ=6[7;6<UY$$*
MJP69'18P2QV@G;N%?2'AZYO+S1;2;4# ;QDS+]F5E3.>P8D@^H)X.16'J7PC
M\$ZQ<2SWOA31[F:6YCO7DDLHRS3H<I)G'WE))!Z@G/6NATG1[+0=/BL-.M8K
M*SBSLAA7:JY))X]R2?QH N4444 %%%% !7@'C;]H+Q1X'\1^(M.N] TNYM(K
M^VL]+U"UNG9"7M[F>6.X4@$2(ENI^7Y?WZ#.0<^_UQ]O\'_ ]I<ZS<0^$]'C
MGUJ59]2D%FFZ[D#%@\AQ\Q!8G)]30!Y5I_QU\>>*-#\0ZII6C>'-/L;?1=/U
MZQNM1N9W6..>%I9K:X1%#&=$$;#9\O[U0>>NG\(OC/XM\<?$GQ3X5US3-.TZ
M3PY+:1WDEO!-L<S6,-P565FVB19)PFPC)52W'2O1]-^%'@S1]0U>^L?"VDVE
MYJY4ZA-#:(K76TY7S"!\V"!U]!4]I\-O"MCXBN=>MO#^GP:U<W'VN>^CMU$L
:LWE^7YC-C);9\N3SCB@#I**** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>formdrs_24.jpg
<TEXT>
begin 644 formdrs_24.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "C BH# 2(  A$! Q$!_\0
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M .WT <-<6NER?$S5/!FG#Q)<7FEZ;:ZG=W%WXNO[="D\LD:+$/,/F$>2Y8\
M909RW'(VOQ&\):EX@&A67_"5/JC>(9]" G\6WR0A([-KM;IG65L))$IV* 2S
M C^$X]0UKPOK\=Y8S:KXNT%KJ>3[':R7/AQ6=F8$^6I,_<*3CVK'_P"$7;[
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MUA1^-]!F\+:/I4OQ!\/6]S:WWVF2^37XY'$8G=]G/+9C(7J""?0'(!ZCX?\
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M:+&O7"C I]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3;.65E>62%'=HU*JS%020#R!GH#S7N?[(O\ R5Z#_KSG_P#017EO_"$^*?\
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M_A"?%'_0H^)O_!'=_P#QNOTBIB,NJSYY5XWT^VNGS/Q*C@\ZP]/V4,).VO\
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MF<.O!!C/\7'M%<?X=^$?A#PK<:7<:;HD,-SID7DVEQ)(\TL:_/CYW8LQ ED
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MJK+(2$0GEL#)P/I4M>"Z+\!O%VBW"SQ>*TDG=PUS))+<,;E%CV+"_P PRI4
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A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>formdrs_25.jpg
<TEXT>
begin 644 formdrs_25.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "9 BD# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$9H \^\.?"W4=(ALTV6FGPP:*VD-9V-W(4978,S([1AD*8(4\@@@87;63:_
M34=*L9KS3]>:+Q&\$D:S.?\ 1URZ,L80*!M 4Y;'+$MMYQ5_P+\7-4\1:U9Z
M;?P6*":P5TU"Q8O;3W#!3N&6W+$=X5>N65UW97F*?XC>,_"<+W>N6-CJFCQV
MTTS:AIL#QOE9@@/E,[$+M(.<X.0<CF@#UC3H[F'3[6.\E6>[6)5FE1=JNX W
M,!V!.3BK%5]/ODU/3[:\B5UBN(EE59%VL P! (['GI5B@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH XF^\!ZY=7D\T7C_7;2.21G6WB@LBD8)R%4M 3@=.23[U
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^AKU*O+?AI_R''_W/Z&O4J^=Q_\ &^1]EE'^[_-_H%%%%><>V%%%% !1110
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M*\]^*7^LM/I_C7H5>>_%+_66GT_QKNP7\='DYI_NLOE^9P-%%%?2GQ 4444
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M%22J2O9&G1117DGT1#>?\>D_^XW\J\(G_P!<_P#O&O=[S_CTG_W&_E7A$_\
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MOM?]2*W_ #_7W/\ S/R__B*6&_Z!9?\ @2_R/TOHK\T/^%@>)_\ H8M6_P#
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M)!'0=\CA_%G[0&M^'-!\1ZI'X52X@T+Q!?:/=2+,[HJ6\2/&Q(4$/,SB->"
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M^+?&OCKQ#X6\17BVMC#J6G0VCW"PQ<LJK%G?(1RI\TJ,=U)(Y%=9X-UIM?\
M#\%Y(SO*7DCD9XP@9D<JQ4 D%,@[3DY&.:[Z>49-4JRHJ@N9>O\ F>16XBXE
MH4(XF6+;C*UK<KWZ/30^IQ^VKXE) _L/2ORE_P#BZ^I/ ?B";Q7X,T76;B*.
M&>^M([AXX\[5+*"0,\XK\T%^\/K7Z-_!O_DE/A/_ +!L/_H KY/BO+,'@</3
MGAJ:BV]=^Q^A>'^>9EFV,KT\;6<U&*:O;>_DCLJ***_,S]R,OQ4Q7POK#*2K
M"SF((."/D-?FY-XHU<32#^TKK[Q_Y:MZ_6OTB\6?\BMK/_7E-_Z :_,J?_72
M?[Q_G7ZMP3&,J=>ZZQ_4_GWQ1G*-?"<KMI/\XFA_PE&L?]!.Z_[^M_C2_P#"
M3ZQ_T$KO_OZU<+XXCU!UT%M.^UEH]6MWN5M2<&W!/F;P.JXQQ7&ZYI_BZXC\
M0I8MJ!0ZQ.]MND(8PFSVPE#G[@GYQ[9Z5][6K1I-I4K^B\C\EPV%GB(J3KJ-
M^[\['M?_  E&K_\ 03NO^_K?XU[C^R'K%]J'Q-N4N;R>=!ITI"R2$C.^/G%?
M.MHLJV=N+@AK@1*)6'0OM&X_GFO?OV-_^2H77_8.E_\ 0XZX,\A'^S*[2^R>
MKPK4G_;N%BY7]]=3[5HHHK^>S^QPKY#_ &U_^1J\/_\ 7D?_ $8U?7E?(?[:
M_P#R-7A__KR/_HQJ^PX3_P"1K#TE^3/S?Q"_Y)^KZP_]*1\W5S5Q\0-'M='U
M+4Y7G2VT^\-A,&A(?S@RK@+W&6'/3'-=+7$:M\(-!\0:;?66I&ZO$NKY]0\Q
MI CQ2N5+;-H P=BC!!K]KQ#KJ/[A)O7?OT/Y?P:PCE_M;:C=;:NU]?ZO]^QO
M:1XD_M;6-1TYM,O["2RVDR7<:JDJEF 9,,3@[2>0.*V:JVNGQ6ES=SIN,ETZ
MLY8YQM4*JCV 'ZGUJU6U-24??=WK_P #\#EK2IRE>FK*R^^VOXGZ,?!;_DD_
MA3_L'Q?^@UVM<5\%O^23^%/^P?%_Z#7:U_-F._WNK_BE^;/[=RG_ )%^'_P1
M_P#24%5-6_Y!5[_UQ?\ ]!-6ZJ:M_P @J]_ZXO\ ^@FN./Q(]*I\#/#KC_CX
ME_WC_.N ^*FBZMJ]UX(FTB"ZG.G^([6]O!;SF-1:J'$F\;@''*_*<].!7?W'
M_'Q+_O'^=1U]>US*Q^;1ERNY\R:K\%?&:>'/%.E6\FI:BFJW$*Z7//<Q>;:/
M"\DHN[G,@_UC.(B8SO"1J< \5]-*7*)YFWS-HW;,[=V.<9[9I:*F,%'8TJ5)
M5-_Z_JQUWPS_ .0\_P#UQ;^8KU*O+?AG_P AY_\ KBW\Q7J5>#COXWR/KLI_
MW;YL****\X]H\W^*/_(0MO\ KD/YM7#UW'Q1_P"0A;?]<A_-JX>OJ,+_  8G
MP.8?[U/U,^W\/Z39[1;Z3I]N%D\Y?)M(TQ)C&\87AL=^M7(X(H6D:.*.-I&W
MR,B!2[=,MCJ?<U)174<%Q5^\/K7MGAG_ )%W3?\ K@G\J\37[P^M>V>&?^1=
MTW_K@G\J\K,/@CZGT&3?Q9^AIT445X1]:0WG_'I/_N-_*O")_P#7/_O&O=[S
M_CTG_P!QOY5X1/\ ZY_]XU[>7;2^1\MG7Q4_G^@RBBBO8/FPKK_AG_R''_ZX
MM_-:Y"NO^&?_ "''_P"N+?S6N;$_P9>AVX'_ 'F'J>HT445\J?H 5Y[\4O\
M66GT_P :]"KSWXI?ZRT^G^-=V"_CH\G-/]UE\OS.!HHHKZ4^("BBB@#VSPS_
M ,@*S_W?ZFM2LOPS_P @*S_W?ZFM2OD:O\27JS]%P_\ !AZ+\@JOJ'_'A<_]
M<F_D:L57U#_CPN?^N3?R-1'=&TOA9X9=?\?4W^^W\ZBJ6Z_X^IO]]OYU%7V!
M^9A1113&==\-/^0X_P#N?T->I5Y;\-/^0X_^Y_0UZE7SN/\ XWR/LLH_W?YO
M] HHHKSCVSG_ !9X\T+P-';2:W??8DN698CY,DFX@9/W%..O>N<_X: \!?\
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M/(6WO;1X9+>??.@@F5N4D+6EP .1^[//(SW?Z[8K_GS'\?\ ,\K_ (A?E_\
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M8O!+;,K0+YDBMTC)N[;##.?-'HV/4_M"?\J/G_[&I?SO\#SO_A/M _Y_9O\
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MF.X\?Z UQ*1?3$%B1_H%SZ_]<ZC_ .$^T#_G]F_\ +G_ .-U]/DX!)KR2/\
M:C\"K>7=G>3:EI5]97SV-W:ZC82026^WR/WSAA_JB+JW(89_UJ\=<>I_:$_Y
M4?/_ -C4OYW^!YW_ ,)]H'_/[-_X 7/_ ,;H_P"$^T#_ )_9O_ "Y_\ C=>A
M7O[37AZSDU*)/#_BNZGTO5%TF_AAT:3=:.RQM'*^XC]U(LJ%6&<YZ5TGP]^,
M&C_$R^U6VTBTU!1IE[=Z==37$2*D=Q;3>3+&=KD@[L[20 P4D$XH_M"?\J'_
M &-2_G?X'GG@CXJ>%M&U-Y[S5)((]N-S6-R.Q_Z9UW7_  T!X"_Z#W_DG<?_
M !NO0Z*X:U9UI<S1ZN%P\<+3]G%W.9\)_$CP[XXN+B#1-1^VRVZAY5\B2/:"
M< _.HST[5TU%%8'6%%%% !5#7M.GUC1+^QM=0N-)N+F%XH[^U"&6W9@0'0."
MNX=1D$9'2K]% 'B6D_LKZ)I4NGWO]OZO/K5E#&L6I.MNK^=%%<Q6]P46()OB
M2[E &W:3M9@Q&38\+?LO^'_#^K:!JMWJVJ:WJ6DM#()[OR8_M$D N! [K%&H
MR@NIN@&XL"V2,U[+10 4444 %%%% !1110!YA\2O@7:_%37GNM9\0ZI_8TFG
M2:<^API +<ASN,H<QF17W+&>' /EJ"",@T]+_9[M]#US3[_3O%.K6L%JM\\E
MCY-J\5Q<WDCRW%PQ:(L'9WZ*P "!<8R#ZW10!S'PS\"V_P ,? &@^$[2\N-0
MM-'M$LX;B[""5T087=L55SC'0"NGHHH **** "BBB@#-\2:7<:YH&H:?:ZG<
MZ-<74#0IJ%F$,UN6&-Z;U9=P[9!&:\ETO]E?1=)FL[Z/7]6;6[6!%BU3;;JZ
MW$=O/;0W(18@@>.&XD4 +M)"L02,GVRB@#RGP;\"[CPCK?AF^;QQK>IV^A6<
MEG%8W-O9K%*')+.Q2!6#'Y,E2N=@SG)SZM110 4444 %%%% ","RD [21P?2
MO$8_V4]#OF27Q#X@UCQ-=_:)99;B\6WC::*2X@N6A<11*"OG6T3;OO8&W.W
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(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>portfolio_001.jpg
<TEXT>
begin 644 portfolio_001.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $H R8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z\^!OP=A^
M('PKT'Q%K'C3QS)J6H))+.T7B:Z1,^:XX4-@# '%=W_PS7H__0X>//\ PJ;O
M_P"*J7]E?_D@/A#_ *X2_P#HZ2O5Z /(_P#AFO1_^AP\>?\ A4W?_P 51_PS
M7H__ $.'CS_PJ;O_ .*KURB@#R/_ (9KT?\ Z'#QY_X5-W_\51_PS7H__0X>
M//\ PJ;O_P"*KURB@#R/_AFO1_\ H</'G_A4W?\ \51_PS7H_P#T.'CS_P *
MF[_^*KURB@#R/_AFO1_^AP\>?^%3=_\ Q5'_  S7H_\ T.'CS_PJ;O\ ^*KU
MRB@#R/\ X9KT?_H</'G_ (5-W_\ %5Y_XF^"\&G?&KP+X?@\;>/%TS4]-U6X
MN8O^$GN\N\)M?+.=W&/-?\Z^G*\G\:?\G)?##_L#:[_Z%8T 1_\ #->C_P#0
MX>//_"IN_P#XJC_AFO1_^AP\>?\ A4W?_P 57KE% 'D?_#->C_\ 0X>//_"I
MN_\ XJC_ (9KT?\ Z'#QY_X5-W_\57KE% 'D?_#->C_]#AX\_P#"IN__ (JC
M_AFO1_\ H</'G_A4W?\ \57KE% 'D?\ PS7H_P#T.'CS_P *F[_^*H_X9KT?
M_H</'G_A4W?_ ,57KE% 'D?_  S7H_\ T.'CS_PJ;O\ ^*H_X9KT?_H</'G_
M (5-W_\ %5ZY10!\X_%+X&Z9X:T72YX?'WQ!L&GU:SM3)%XBNYBRO*%*$;^
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M*O9N] &3_P ,UZ/_ -#AX\_\*F[_ /BJ/^&:]'_Z'#QY_P"%3=__ !5>N44
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MSV, [$ @2.,_[5%=#^U!_P C]X&_[!FJ_P#HVPHH [?]E?\ Y(#X0_ZX2_\
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MRF62WD8[$D'RLD9 Y+  @5[;\./#=[X9\/&+4[71;/4KB9KBYA\/VOD6@<@
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M7&IVQ.N6"EM+!,C S#*OR/W9_B]J] H *\R^)WQ6UCP-X\\!^&],\/VFK_\
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MOM;;D\9P:\/\$_M/7_BG5?A1!>^&;'2K/QY:W;";^US))97ELI:2T,?D+O8
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M8PA=MJ?>(R&;Y01P2".HJ*P^*G@W5+RRM;/Q3I%U<WDTEO;PPWL;-+*GWT4
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MS'Y2H48P#WK)\1? =?$FK^.+RXU^:&+Q&E@8(K>V56T^:S(:&16S\_SA6*D
M<8H T]2^.'AI/#M]>65[*^H0R3VJZ?)8SFZ6XCB\PJ]OM$@ 4JY. -I!S@YK
MG? ?[2V@:OX&TO4_$-PUCJSV^FO?16MA<&&)[UQ';E3M;Y&<A=V2%)^8BI+S
M]GG[1XB7Q-%XBDM_$\DTSWE\MFIBN8Y+<0&,Q;L+A5!# Y!SU!Q6!'^RE+;^
M&TTF'QE,I-EI=I-.VG1DR-878N87"[N,X",O<<T =?XS_:+\*^$;"^F07^JS
MVKJ@ALK*9A-F<0,T;[=KJLC!6*DX/%=CH/C[1?$VJ7FGZ=<2SW%HS)-FWD5
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M_I(]>OT %<9XV^)UEX/\3>&?#GE"ZUSQ$UP+"WDF6%'$"*\N7;OAUPH!)SZ
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MX2_Y\O$O_A/7G_QN@#U>BO*/^&EO"7_/EXE_\)Z\_P#C='_#2WA+_GR\2_\
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M\K^X/;4_YE]Y[K17A7_#:WPG_P"@QJ/_ ()KO_XU1_PVM\)_^@QJ/_@FN_\
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MIMI>7%M<3VL,\]JQ:"62,,T3$8)4D94D<<=JLUX5_P -K?"?_H,:C_X)KO\
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M[_\ C5'L:O\ *_N#VU/^9?>>ZT5X5_PVM\)_^@QJ/_@FN_\ XU1_PVM\)_\
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MN_\ XU1_PVM\)_\ H,:C_P"":[_^-4>QJ_RO[A>VI_S+[SW6BO"O^&UOA/\
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M+I^CVAM/&.C3D12Z>]VD;27T)W"*>)9'D+\APKDCY2!ZP?VUOA.>#K&HD?\
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MEM-6P,[+>59"#)CG:^TT >T45S/@OQQ'XN\+V>M7.G77AY+IF5+75)(1+PQ
M/[MW7G' SFO/O%'[3=AX;^,UQ\,T\(>(M5\0QZ0=<1K(6IAFM0Q4LA:=3N#
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M;^\?SHWM_>/YTVB@!V]O[Q_.N2A8_P#"V;CD_P#(%7_T=75UR</_ "5BX_[
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MWLO"_CK0_P!K+PWX^G\%:WJ.FZ?\/(="N)XQ&QDU'=YA3)?E><&3IG-?9E%
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M]M+R^Y?Y'F7C;POXG?3+(/XIDO1]OMR$CTZ-"IW\.3OY ZX[UT3>&O%6X_\
M%:9Y_P"@5'_\75GQS")M+L@;>:YQJ%LVV!MI&'^\?8=ZZ1OO'ZUE&C'GEOTZ
MO_,T=:7(MNO1?Y'(_P#"->*O^AT_\I4?_P 71_PC7BK_ *'3_P I4?\ \776
M45K[&/G][_S,_;2\ON7^1R?_  C7BK_H=/\ RE1__%T?\(UXJ_Z'3_RE1_\
MQ==911[&/G][_P P]M+R^Y?Y')_\(UXJ_P"AT_\ *5'_ /%T?\(UXJ_Z'3_R
ME1__ !==911[&/G][_S#VTO+[E_D<G_PC7BK_H=/_*5'_P#%T?\ "->*O^AT
M_P#*5'_\77644>QCY_>_\P]M+R^Y?Y')_P#"->*O^AT_\I4?_P 77+_%#P_X
MEA^'FO/-XM^T0K "T7]FHFX;UXSOXKU2N2^+7_),_$7_ %[#_P!&)6-:C'V4
M]]GU?;U-:-67M8[;KHN_H)'X:\5>5'_Q6>/E'_,*C]/]^G?\(UXJ_P"AT_\
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M'%?_  5Q_P#Q=']C^+/^AQ7_ ,%<?_Q==-11]6I^?WO_ ##ZS5\ON7^1S/\
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M ,I4?_Q==911[&/G][_S#VTO+[E_D<G_ ,(UXJ_Z'3_RE1__ !='_"->*O\
MH=/_ "E1_P#Q==911[&/G][_ ,P]M+R^Y?Y')_\ "->*O^AT_P#*5'_\71_P
MC7BK_H=/_*5'_P#%UUE%'L8^?WO_ ##VTO+[E_D<G_PC7BK_ *'3_P I4?\
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M\$T'_P 57UA11_:.+_Y^O[P_L_"?\^U]Q\G_ /##.I?]%1O/_!-!_P#%4?\
M##.I?]%1O/\ P30?_%5]844?VCB_^?K^\/[/PG_/M?<?"?B_X"WOP9^)'AN:
M3Q?-X@-]I.I(%FL(X/*VS61R-K'.<_I17KW[4'_(_>!O^P9JO_HVPHKCJ5)U
MI<]1W9UTZ<*4>2FK([?]E?\ Y(#X0_ZX2_\ HZ2N/_:\^-GB#X9R?#7PMX7F
MCTW5_'7B*'1?[9EB$@L(>#*Z*WRF4J<)N!&<\&NP_97_ .2 ^$/^N$O_ *.D
MKI?BG\)/#/QD\.PZ/XFLFN8;:ZCOK2XAD,4]I<QG='-%(.4=3T-9&AR?Q'UK
M_A0FA7GQ U?Q5JMWX2T+2Y3J.E7 CFDNI<KY<J-M#"0G*[<A/F!P,5P_BK]M
M_0_".B>(;B[\-:C+JV@WVD6E[I<,T9?9J(4V\J.3M8 MM8<8(/L:];\1?!W1
M?&?A?5O#WB6YU#Q#I6J6+:?<0WUQD>6<98;0,/D*=W7*BN(US]CGX?\ B+0]
M8TZ^.KRR:O>Z??WNH"](NIGLE5;52^WA$V@X Y.30!RUM^W!I_\ PD$>E7_@
M;6=.>/QM#X%O9FN;>1+6^F4-$WRN2Z$'DKTI/#?[<&GZQXHLM/OO!6K:7I-U
MXQNO RZTUS!)$-2ASP4#;Q&V.&QU(KIKK]C?P+>:I=:A+=Z\;BY\60>-9-NH
M8!U.%=L;XV_<QQLZ<"N)^ G[)]SIMYKE]\1+)O/MOB#J7C'0[6UU 26V;CB*
M210H_>*"W!.,D&@#:TW]MS0=0\4>)_#Y\,ZM9ZIHGAW4/$C6]UL1FBLY6BEB
M89.R0E05Z@AADBLOPM^W7;>,-%URYT_X>:\VHZ?X3MO&<.F^? TEYI\K$'85
M8@.NUCM/) XKH/#7[#'PW\)W%U-ITVOI)<:/J.A.9-39_P#1+V5I9TY7KO8D
M'J/>GZ9^S/8_ ^&;Q)\-M.N/$?BJV\/VWABUTW7]5*6LMA%(&6-FV'# %L-@
MYZ=Z /0O@_\ %ZT^,NA6NO:-;*=!N["VO+>]6=7#M*FYHB!T9/NM[YKRC]I'
M]HC6/@[\6OADT-Q9+X$EUI='\3%I%,T<EU$1;-CJJ1G:S'OO05Z_\%?A;I/P
M<^'>G>&-&L(M-M86EN'MX3N59)9&D< ]\%B/H!7,>./V6?!'Q(\#ZWX8\21W
M>JPZO=&ZN-3F=/[05O,$BJDX3<JJ0 H[  =* /8*^0_VXO\ DH'PK_Z]=8_]
MLZ^J_#VC+X=T*PTM+JZO4LX$@6XO9/,GD"C 9VQ\S<<GO7RI^W%_R4#X5_\
M7KK'_MG7I9;_ +Y2]4>=F/\ NE3T/#:***_63\M"BBB@ HHHH **** "BBB@
M#G?'-N;C2[)5MI+HKJ%LVV)]A&'^\3CD#N.]=(WWC]:YKQY"+C2K)3;-=8U&
MV;:K[-N'^]GOCT[UTK?>;ZUE'XY?+]367P1^8VBBBM3(**** "BBB@ HHHH
M*Y+XM?\ ),_$7_7L/_1B5UM<E\6O^29^(O\ KV'_ *,2L*_\*?H_R-Z'\6'J
MOS.KC_U4?^Z/Y4ZFQ_ZJ/_='\J=6RV,0HHHIB"BBB@ HHHH **** *FL*9-'
MOU"-(6MY!L4X+?*> >QK!\'Q&#PCH<1A>W*6%NIAD;<T>(U&TGN1TS[5O:PO
MF:/?KL,FZWD&P'!;Y3QGM6!X-C\GP?H,8A:W":?;KY+-N,>(U&TGN1TS[55+
M^+\B*W\/YFQ1117<< 4444 %%%% !1110 4E+24 <I\+?^1)L_\ KK/_ .CG
MKK*Y/X6_\B39_P#76?\ ]'/765SX?^##T7Y&]?\ BS]6%%%%=!@%%%% !111
M0 4444 %?6/["'_))=>_[&?4?_0UKY.KZQ_80_Y)+KW_ &,^H_\ H:U\;Q/_
M +M#_%^C/K^&?]YG_A_5'T?1117YL?HP4444 %%%% !1110 4444 ? G[0'_
M "<EX_\ ^O?2O_2=ZXRNS_: _P"3DO'_ /U[Z5_Z3O7&5^J93_N-/T_5GYCF
MO^^U/7]$%%%%>N>4%%%% !1110 4444 %>N_L;_\ER\4?]B]!_Z4&O(J]=_8
MW_Y+EXH_[%Z#_P!*#7@9Y_N4O5?F>[DO^^1]'^1]HT445^9GZ,%%%% !1110
M 4444 %%%% 'SC^U!_R/W@;_ +!FJ_\ HVPHH_:@_P"1^\#?]@S5?_1MA10!
M5_9S_:#^&WAKX+^&=+U3QKH]CJ%K'+'/;37(5XV\Z3@CUKTC_AI_X3_]% T+
M_P "UJI^RS;Q-\ O"!,2$^1+R5'_ #VDKU;[+#_SQC_[Y% 'FG_#3_PG_P"B
M@:%_X%K1_P -/_"?_HH&A?\ @6M>E_98?^>,?_?(H^RP_P#/&/\ [Y% 'FG_
M  T_\)_^B@:%_P"!:T?\-/\ PG_Z*!H7_@6M>E_98?\ GC'_ -\BC[+#_P \
M8_\ OD4 >:?\-/\ PG_Z*!H7_@6M'_#3_P )_P#HH&A?^!:UZ7]EA_YXQ_\
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M:?\ A/\ ]% T+_P+6O2_LL/_ #QC_P"^11]EA_YXQ_\ ?(H \T_X:?\ A/\
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M% !1110 4444 ?./[4'_ "/W@;_L&:K_ .C;"BC]J#_D?O W_8,U7_T;844
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M_!1+_P#':/\ ABWXB?\ 0\^'O_!1+_\ ':?]NX+^9_<P_L3&=E]YX]17L/\
MPQ;\1/\ H>?#W_@HE_\ CM'_  Q;\1/^AY\/?^"B7_X[1_;N"_F?W,/[$QG9
M?>>/45[#_P ,6_$3_H>?#W_@HE_^.T?\,6_$3_H>?#W_ (*)?_CM']NX+^9_
M<P_L3&=E]YX]17L/_#%OQ$_Z'GP]_P""B7_X[1_PQ;\1/^AY\/?^"B7_ ..T
M?V[@OYG]S#^Q,9V7WGBNJ+OTN]78),P2#:S;0?E/!/;ZU^@WP;A^S_"'P-%Y
M"6OEZ%8KY$<GF+'BW0;0^3N Z9R<XS7RMKG[&?Q"M]#U&5O&OAV94MI6,?\
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M "/N"DKX@_X:R^+G_//PA_X!W/\ \=H_X:R^+G_//PA_X!W/_P =H_L?'?\
M/O\ %?YA_:^"_P"?GX/_ "/HW]F7_DC>D?\ 7S>_^E<U>IU\L?LQQ_%K6O@C
MX=O].UOPG;6ET;F9(9]-N'=-UQ*2"1* ><]NF*]2_LGXT?\ 0Q>#?_!5<_\
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MQ7$HPOH#F@#ZDHKRK^R?C1_T,7@W_P %5S_\>H_LGXT?]#%X-_\ !5<__'J
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MO5]H_P"5_A_F>7[-?S+^OD=917)_9?'7_03T'_P"E_\ BZ/LOCK_ *">@_\
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MXR3GC \0?MC>#O#-@\M[IVL?;;7Q);>%=0TV&&.2XL;ZX4-"K@/AE8$89"U
M'O-%> >'_P!M+P5XAUK1=+32]?L[K4]<NO#7^E601+?4H 6-O(V[&Y@,@C(Y
M&2*B^'G[;'@OX@:YH>G+I'B#15UJ\O=-L+S4K-5@GO+7)FMU9';YP%)'&&Q@
M'- 'T)17SU9_MP> -0TSQI>6UMJ\C>%M&3Q!<VYMU66:Q9B/,12XPP*MF-]K
M#'3FJ<G[=G@K_A#?%GB*+0/$T\/ABSL-2U"S%DBSK9W<0DBN%4N 4 /S<Y&,
MXQS0!](T5RO@?X@0>/!=366GW4-A''!)#?2-&T-TLL0D'EE'.=H8 Y P:\?^
M&OQB\1_'WXR?%'0M(U+_ (1?PKX#U&/1?-MH(Y;S4+S#&9F,JLJ1*1M "Y;K
MN'2@#Z*KX_\ VY?^2A?"G_KVUC^5I7U#X)@\0VNA"+Q1=6M]JR32 W-G%Y4<
MD>X^60F3@[<9YZYKY>_;E_Y*%\*?^O;6/Y6E>EEO^^4O5'G9C_NE7T/$:***
M_63\M"BBB@ HHHH **** "BBB@#G?'48FTNR!MH[K&H6QVRR; N'^\#GDCT[
MUTC?>/UKF_'47G:79 PPSXU"V;;/)L P_4'(R1V'>ND;[S?6LH_'+Y&LO@C\
MQM%%%:F04444 %%%% !1110 5SGQ%_Y$G4_K#_Z/CKHZYSXB_P#(DZG]8?\
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M$I_C1_PDVC_]!:Q_\"4_QHYX]PY9=C1HK._X2;1_^@M8_P#@2G^-'_"3:/\
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MB4?83UZ/\C?#QE[:&G5?F?JW:?\ 'K#_ +B_RJ:N9M?B)X46UA!\3:/G8O\
MR_Q>G^]4G_"Q?"G_ $,^C_\ @?%_\57X^?K)T5%<[_PL7PI_T,^C_P#@?%_\
M51_PL7PI_P!#/H__ ('Q?_%4 =%17._\+%\*?]#/H_\ X'Q?_%4?\+%\*?\
M0SZ/_P"!\7_Q5 '145SO_"Q?"G_0SZ/_ .!\7_Q5'_"Q?"G_ $,^C_\ @?%_
M\50!T5%<[_PL7PI_T,^C_P#@?%_\51_PL7PI_P!#/H__ ('Q?_%4 6_%R[_"
M>M+L23-E,-DAPK?NVX)["OS2\(Q^3X2T-/*AM]MA ODV[[XTQ&ORHW=1T![B
MOT.\5?$#PK-X7UB-?$6ASLUG,HBDU&(*^4/!.[@&OSC\*ZYI5OX6T6)KW2[1
MH[*!#;V]VCQ18C4;$;<<J.@.3D <FOL.'&E.K?LOU/DN($W"G;N_T.DHK/\
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M&?1__ ^+_P"*H_X6+X4_Z&?1_P#P/B_^*H Z*BN=_P"%B^%/^AGT?_P/B_\
MBJ/^%B^%/^AGT?\ \#XO_BJ .BHKG?\ A8OA3_H9]'_\#XO_ (JC_A8OA3_H
M9]'_ / ^+_XJ@#HJ\C_9X^[\2/\ L==4_P#0UKNO^%B^%/\ H9]'_P# ^+_X
MJO*_V?\ QOX<ME^(OF^(-+BW^,M3==]Y&-REUP1EN0?6@#W:BL#_ (6!X7_Z
M&32/_ ^+_P"*H_X6!X7_ .ADTC_P/B_^*H WZ*P/^%@>%_\ H9-(_P# ^+_X
MJC_A8'A?_H9-(_\  ^+_ .*H WZ*P/\ A8'A?_H9-(_\#XO_ (JC_A8'A?\
MZ&32/_ ^+_XJ@#?HK _X6!X7_P"ADTC_ ,#XO_BJ/^%@>%_^ADTC_P #XO\
MXJ@#?HK _P"%@>%_^ADTC_P/B_\ BJ/^%@>%_P#H9-(_\#XO_BJ /B/]H#_D
MY+Q__P!>^E?^D[UQE=!\>O%.BS?M&>/)H]8L'B>WTO;(MRA5L0/G!SS7'?\
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M7/A+_H5M%_\ !?%_\370T5^J>RI_RK[C\Q]K4_F9SW_"N?"7_0K:+_X+XO\
MXFC_ (5SX2_Z%;1?_!?%_P#$UT-%'LJ?\J^X/:U/YF<]_P *Y\)?]"MHO_@O
MB_\ B:/^%<^$O^A6T7_P7Q?_ !-=#11[*G_*ON#VM3^9G/?\*Y\)?]"MHO\
MX+XO_B:/^%<^$O\ H5M%_P#!?%_\370T4>RI_P J^X/:U/YF<]_PKGPE_P!"
MMHO_ (+XO_B:/^%<^$O^A6T7_P %\7_Q-=#11[*G_*ON#VM3^9GG_C/X>^%X
M=-LS#X7T!6-];@^=9QH-I?G! &3Z#O70-\./"6X_\4MHO7_H'Q?_ !-,\=KN
MTNQ&RWD_XF-L<7#84?/U'^UZ5TK?>/UK*-*GSR]U=.AHZD^1>\^ISG_"N?"7
M_0K:+_X+XO\ XFC_ (5SX2_Z%;1?_!?%_P#$UT-%:^RI_P J^XS]K4_F9SW_
M  KGPE_T*VB_^"^+_P")H_X5SX2_Z%;1?_!?%_\ $UT-%'LJ?\J^X/:U/YF<
M]_PKGPE_T*VB_P#@OB_^)H_X5SX2_P"A6T7_ ,%\7_Q-=#11[*G_ "K[@]K4
M_F9SW_"N?"7_ $*VB_\ @OB_^)H_X5SX2_Z%;1?_  7Q?_$UT-%'LJ?\J^X/
M:U/YF<]_PKGPE_T*VB_^"^+_ .)KG_'_ ,/_  M;^#]1DA\-:/%(IAPZ6$0(
MS-&#SM]":]!KG/B+_P B3J?UA_\ 1\=<^(IP]C/W5L^GD;X>I/VT/>>Z_,_0
M^U^ /PP:UA)^&_A$DH/^8%:^G_7.I/\ AG_X7_\ 1-_"/_@BM?\ XW7<6G_'
MK#_N+_*IJ_(3]7.!_P"&?_A?_P!$W\(_^"*U_P#C='_#/_PO_P"B;^$?_!%:
M_P#QNN^HH X'_AG_ .%__1-_"/\ X(K7_P"-T?\ #/\ \+_^B;^$?_!%:_\
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M  N_Z)MX1_\ !%:__&Z[ZB@#@?\ AG_X7?\ 1-O"/_@BM?\ XW1_PS_\+_\
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M_'2[M+LN+8_\3"V_X^ON_?[?[7I[UTC?>;ZUE'XY?(UE\"^8VBBBM3(****
M"BBB@ HHHH *YSXB_P#(DZG]8?\ T?'71USGQ%_Y$G4_K#_Z/CKFQ/\  GZ/
M\CHP_P#&AZK\S]2[3_CUA_W%_E4U0VG_ !ZP_P"XO\JFK\=/UL**** "BBB@
M HHHH **** ,OQ5_R+&K_+$_^AS?+.<1GY#PQST]?:L;X1_\DI\%XCM(1_8E
ME^[T]]]NO[A.(FR<H/X3D\8Y-;'BKGPOK _=_P#'G-_KON?</WO;UK'^$:[?
MA1X+7%H,:)9#%A_Q[_ZA/]5_L?W?;% '6T444 %%%% !1110 4444 %)2TE
M'EO[,O\ R1O2/^OF]_\ 2N:O4Z\L_9E_Y(WI'_7S>_\ I7-7J= !1110 444
M4 %%%% !1110 5^;7BC_ )*M\3O^QHO/_9:_26OS:\4?\E6^)W_8T7G_ ++7
MTO#_ /OC]'^A\[GO^Z?-?J5J***_1C\^"BBB@ HHHH **** "BBB@#D/"_\
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MPO=M;RSR&8>(95SYDSR=/LQZ;\=>U=7_ ,)-\8O^A%\+_P#A1R__ "+7JE%
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M\'4W_P CT?\ #+OQB_Z!7A7_ ,'4W_R/7W511_;6._G_  7^0?V/@OY/Q?\
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M'W=\'_BNOQ7TS4+M=._LW[+,L6SSO,W9&<YVC%>@5\]_L=_\BSX@_P"OM/\
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M!]*T5P'PK^*7_"REOF%DEO%%!:W<,L,PD5HYU9EC;^[*FPAU[$BN_H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KY0_:6\&:_KWQ%^TZ;HFH7]O\ 9HU\VVM9)%R!TRH(
MHHKV<IK2HXCFCV/(S2E&M0Y9=SR;_A6/B_\ Z%?6/_ ";_XFC_A6/B__ *%?
M6/\ P F_^)HHK['^T*O9?C_F?(_4*7=_U\@_X5CXO_Z%?6/_   F_P#B:/\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tele_001.jpg
<TEXT>
begin 644 tele_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #- <T# 2(  A$! Q$!_\0
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MAM^T1K7@/XF>(]#UN&76M#U3QKKMC!<M=O+/9"UM1<^7&A_Y9X5@!GJU>Y?
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MYSS7!?"/]L#4_AI\%_#I\7V4WB)F\'3>(X-2CN6DGE\N\%N8YRP."6D0AAT
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M8]U_T%KK_OE/_B:U:* ,K^Q[K_H+77_?*?\ Q-']CW7_ $%KK_OE/_B:U:*
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M*C.]UY'ZAT5^7G_#Q/XM>NA_^ )_^*H_X>)_%KUT/_P!/_Q5=G^I^9?W?O\
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M/U#HK\O/^'B?Q:]=#_\  $__ !5'_#Q/XM>NA_\ @"?_ (JC_4_,O[OW_P#
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M&)C524NEF?+XK/J>%K2HR@VT?M)17XM_\+[^)7_0^^(O_!E+_C1_POOXE?\
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M/OB+_P &4O\ C1_J3B/^?T?N8?ZS4?\ GV_O1^TE%?BW_P +[^)7_0^^(O\
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MH#*& /YUYQV%NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX.^'/!GQ"\4>,])BN+75O$B6Z:C$LQ%M(85*QN(@,*P4D%AR>]=O10 4444
M?,_[37[(LO[17C+3]6C\2KH@T^T^RF)K7S=^6+;L[ACKBO'_ /AU_<_]% C_
M /!;_P#9U]WP?\?ES_P'^56:^BPW$&8X2E&A1J6C';1?Y'D5LIP>(J.K4A=O
MS?\ F? __#K^Y_Z*!'_X+?\ [.C_ (=?W/\ T4"/_P %O_V=??%%=/\ K1FW
M_/W_ ,EC_D8?V'@/^??XO_,^!_\ AU_<_P#10(__  6__9T?\.O[G_HH$?\
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MO_DL?\@_L/ ?\^_Q?^9\#_\ #K^Y_P"B@1_^"W_[.C_AU_<_]% C_P#!;_\
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M#F*>!UMBV[+ 89)0R^^WWKSO]BOXI>)O%'C_ %O0O$/B.]UN)O"6@ZU;12W
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M_P"$JT3_ *#%A_X%)_C5RRU*TU)&>TNH;I%.&:&0. ?0X-?A)]GB_P">:?\
M?(K]%O\ @F*BI\-_&&U0O_$V3H,?\L5KQLWX7CE>$EB56YK6TM;=^K/1R_/)
M8[$*@Z=KWUO?]#[.HKC/B9KFH:"OA=K"Y^S_ &K7K2SN!L#>9#(2&7GIVY'/
M%,^(WB*\T>3PJ=-O%B6ZU^VL;I557WQL'W(<]#P.G/%? GU9VU%%% !1110
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MW\,/^B?^&_\ P5P__$UT_A;P7H'@>RDL_#VC6.B6DC^:\-A;K"C/C&XA0.<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH KP_\ 'W<_\!_E5BFA%5F8##-U/K3J "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
:**** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>rating_001.jpg
<TEXT>
begin 644 rating_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ". A\# 2(  A$! Q$!_\0
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MW]YOS-'^K<?^?OX?\$/]87_SZ_'_ (!^C_\ ;6G_ //];?\ ?Y?\:/[:T_\
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MX-[?WF_,T;V_O-^9H_U;C_S]_#_@A_K"_P#GU^/_  #]'_[:T_\ Y_K;_O\
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M%-Q<V?S0+%#")!_RT*1*A?\ $J:YVNVG)R@I25FSCFE&347=!1116AF%%%%
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M[0\,_P#0#U#_ ,&B_P#QFCGE_(_P_P PY(_S+\?\CGZ*Z#^T/#/_ $ ]0_\
M!HO_ ,9H_M#PS_T ]0_\&B__ !FCGE_(_P /\PY(_P R_'_(Y^N@C_Y)_/\
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M_P#QFCGE_(_P_P PY(_S+\?\CGZ*Z#^T/#/_ $ ]0_\ !HO_ ,9H_M#PS_T
M]0_\&B__ !FCGE_(_P /\PY(_P R_'_(Y^BN@_M#PS_T ]0_\&B__&:/[0\,
M_P#0#U#_ ,&B_P#QFCGE_(_P_P PY(_S+\?\CGZ*Z#^T/#/_ $ ]0_\ !HO_
M ,9H_M#PS_T ]0_\&B__ !FCGE_(_P /\PY(_P R_'_(K^#?^1PT/_K^A_\
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MC8JP]"#@TRIKR2.:ZFDAC,,+NS)&S;BJD\ GOCUJ&O26VIYSW"BBBF(****
M.@T/_D5_$O\ N6__ *-%<_G')Z5T&A_\BOXE_P!RW_\ 1HKGZQI_%/U_1&T_
MACZ?JSO-:^%YL;"VU#3KYM5L+I1$DJ1!3'=[E5K>4;OE/S @\Y%9J_"_Q,UP
MT']FE9%0R-NE0 *)/*))SV?Y:HV_C35;07JP3+##>2Q3S0HN(S)&P*,%[$$5
MMW7QB\175U+.38HTD;1E5M1C:9A,>_7>,_I7);%QT33]?^ =5\++5IKT_P""
M/T_X1ZO,NJ+?@:=/:V<EU K,K),R2K$T9;=A<$]?:LU?AEXF,@C.E2+*;C[*
M(V8!O,W;/7INXSTS5V3XN:]<><LXLIHYHY8Y(S; *RR2B5QP>[J#[4R;XL>(
M;BXLKF>6WN+NSNVO()Y8<LK,VXJ1G!7=R >E)?7-;\HW]4Z7,B/P;JTFK2Z:
ML"-=0Q>=+ME5DC3@99@<#D@?4XK1UCP./#OA6VU'4IYH-1N+R6U6Q$8.SRF
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M!'92&2-8SRGS'[QVXR1QGIQ6E3^L5_\ GY+[W_F'U:A_S[C]R.8_X5'\/O\
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MR*5X+L_0 XSGWH^IYE]6^M7ER^KVM>^^WF/VV ]M["T;^BW[>IUG_"HOA_\
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M?6:__/R7WO\ S#ZM0_Y]Q^Y'5?\ "H_A]_T*-I_WV_\ C1_PJ/X??]"C:?\
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M6_A)X)OOAW8ZKHMR8[BT^T_:+2\C !E1A@JXZA@1^M>@M<)&K,T<:JHR6)(
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MK+L_%FJ:?KT^LV]T4U.9I&>X(!),F=_7U!(_&HM2UZ^UZ\M9+^Y:X,"I!$I
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MXRCC:E*FJ$O>W=[+;7[[]-CKM+\6:YJGA>35U\+3038WPZ?-<JLTJ=STP#Z
M\FO$]0^/UT/B=9ZJVCW4%O:6SV$FENX\UF8Y/X[@OY5]&Z3'=V^DVD=ZR37L
M4*I*Z'Y7<#!(^N,_C7E5Q^SO::C:WE_=ZI-_PE-Q<F\%_'GRHI-VX*$[KG'/
M6EEN(RZG.K]:@DGHK<ST>CZ[6Z[]O(QU'&3A3^KR=UJ[VZ?KY;=SME\5:\_A
M4ZO_ ,(K.+G[XTPW*_:#'C[WIG_9ZUXC;_'ZZ_X6?-JPT>ZDMIK1=/72U?\
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M_P DSMO^PA%_Z"]?-S>'=.T7P)HVOWL,FH2ZI>30K%',8U@CBVYY Y=MW?@
M5]WDOLU@X\RNW)K]3XC..=XM\KLDDS/_ .$SG_Z!.B_^ "_XT?\ "9S_ /0)
MT7_P 7_&MVS^$.JZLUF]K+;01WIA>..=VW11S!VA+D#G(C/3..*F7X)ZM+]D
M\G4+"474MO$C9D 'G(SQDY7I\C ]Q7L.KA5HVCQU2Q3V3.<_X3.?_H$Z+_X
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M38=R7[1_TSC_ .^:/M'_ $SC_P"^:BK*\5R:E#X<U&72'*:C'"SPE;;[2Q8
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MOG'[,3L3[_\ =]JJU-_RZG_?_I2: 3[1WV1X_P!VF6^H1W4$<T/DRPR#<CJ
M0P]17EOQ@^('B/P+I]R\&BPW&EW"&&/4HYCNA=@0-ZXZ^G8URWP%^('B/5M)
ML_#]GHT-U9Z<-DVIW$Y58T))5<8Y.,X'M7NPR>M/!O&)KE3[K;KUWO96WU/*
MEF-..)6&:=_1_P!=]=CWV2[$<;.ZQJB@LS%> !U-)%>+/$DL8B>-U#*RJ""#
MT(KQOXW?$#Q'X2TF^LCHT)TW4(VMH=5AF)VEAR&7'#8S[5!\#/B!XC\3:38:
M7%HT+Z=IL:V\^JS3$<#HH7NVW'%']CUOJ7UVZY;]UM]^]]+;^0O[1I_6?JUG
M?T>_]:WV/:IKY+:%YI?)CBC4LSL  H'<T];K<H8)&589!V]17A'QX\?>(]#T
M>^T.YT:&&PU)3##JD$Q8,N067:1PV.WO6Y\&?B!XC\:Z;:1R:-#%IEG&MO-J
MDLQS*R@ A5QR>F>PHED]:."6-;7+?NMOOWO=6W\@CF-.6)>&L[^CW_KKL>LR
M7BPQL[B)$49+,  !3OM!_P"><?\ WS7A'Q\^(6O:'I%UH<VC+:6]_A8-4AN-
MZNJD,1MP"&X&17>?"OQQJ/CWPRFHW.F?854^4DKR;A<%5 +CC@;LUE4RNM2P
MD<9*W*W;=>5NOKINK:FE/'TZF(>&5[I=G_7;UN=V;G&,I&,G ^6C[1_TSC_[
MYJEM:XQNVJR<X'9O7\JDBD>0Y(79C@CO_P#6KR>5'H<Q9^T?],X_^^:/M'_3
M./\ [YJ*BE8HE^T?],X_^^:/M'_3./\ [YJ*N)M?%&KP_&1O#5XZ-I-WI3WU
MGBR=#YB2HK(LV2LAVOE@<$$KC(SA: =W]H_Z9Q_]\T?:/^F<?_?->6?#;XHZ
MAXP\<:_HE_!%:K8B5X&5?W=TBW#1B6VD'^MC 4*^<%9,KC%>G4: 6KJ8K<2#
M8AY_NU%]H_Z9Q_\ ?-+=?\?,G^]4-"6@$OVC_IG'_P!\T?:/^F<?_?-144[
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MO4$':V.XYK]$M4T>PURW%OJ-G!?0!MPCN(PZY'?![UD_\*Z\+?\ 0N:7_P"
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MMIX#U+5&TF5H]+ORLGV%R2(91P2A_ND=CTQ7JOV6'_GDG_?(H^RP_P#/)/\
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L6'_GDG_?(H]IY!R'-6__ !\1_P"\/YUU51"UA4Y$2 _[HJ6LY2YBHJQ__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>consult_001.jpg
<TEXT>
begin 644 consult_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #$ ;@# 2(  A$! Q$!_\0
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M$"6)/"]?>LY1P\8NTKLM2K.2NM"?X;_&35OB?X0T;Q=I7A20>'-8ND2T\V[
MNOLK2;/M3Q[<*,?-LW$[><]JZAOBSX+6SU*[/BK2!:Z;C[;,;Q-EOER@+G.
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MT^[2,D1O/.=VT]>/+.,X&1FJDNB/-(\DF@Z:[N268W!R<KL/_+/^[\OTXZ4
M9TGQ*5;R>)-.8Q0HS/+),J! (T<%O0-Y@4'N5-4O^%M-M61='>2%%#SLMPNY
M%,YA.U<98@C...#ZU-#X!9-6N+V73;*X68Y^SR3# ^4+M+>5EE  PIR!@>E7
M(/"<EMKHU.+2-/C*P"%;=9@(U.\OO&(OO9- %+_A:GG-9+::4UR]\(WMLSA
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MOFY'7D5H6OAU;.-$@\-Z3"B-O54EP <8S_JO2K4FGW,I8OHFFL6D\TDSGE\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^U:'PS\(:EX?O]7O]11+8W=O8VJ6L;[POV>'8SY''S$_DHKOJ*^(/I@HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %8/BWQUHG@>&Q?6;]+5[^X6SLK< O-=3L"1'$B@L[$ G '09/
M%;U>,?&;X6>(/$'Q<^%/Q#\/^3J$O@V>_2YT:YF\H7$-W;B%I(W((62/ //!
M!(R* /4_#_B73_%%K-<:=,TJ03/;3*\;(\4J_>1E8 @C/-:E?./Q@^%OQ/\
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MT5XSKG[06E_"GQ%%X5\87LVI:MOMYIKZQM0D5K;7=X;:R:8%L[F<;3L!Y!.
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MM)Q>Z;9<,#A:<E.%-)KR04445Y9W!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>formdrsa_001.jpg
<TEXT>
begin 644 formdrsa_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $L X<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MOG+XM?M%7>G?M%>&/@[H^K6/A:YU*Q>_NM?U&)9=I^;RK>!&(4NVTG+9] ,U
MT^F:S\3O"OQ<T+0-?OM*UWP7?V=U/_;D-F;:Z2:-5(AE4,4 ()8,H&=I! QS
MT_5Y**;=KJ_R,/;1;:71V/9J*\5^&O[4GA?XL?&3Q5X,\.7EK?:?H%K"7U59
MALN;IW8-'#S\RH  6'5B<<#)]@N-4LK.9(9[N"&9_NQR2JK'Z FLYTYTWRS5
MF:1G&:O%EJBJ]WJ%KIZJUU<PVRL<*9G"@GVS45UK>G6-NT]Q?VL$*Q&<R23*
MJB,#)?)/W0._2L[,HNT5XK\%?VG_  Y\=-=\=0Z!<VC:/X?NTL[2_DF"B^/E
M;Y)5!_Y9@\!NX!--_9U\5?%/4K'Q;-\6X_#]@L&I%=)DTNZB<&U.<&0H[ #[
MNW<0QYR!Q6\J$X<W-HU;3KJ9JK&5N76_Z'ME%4UUBP:.-UO;<I(VQ&$JX9O0
M'/)JQ/<16L+2S2)%$O+/(P51]2:P-22BJ%OKVF74B1PZC:3.YPJQSJQ/T -8
MWQ+36?\ A"M4GT'6/[#U*VA>XCNC:I< [%+;2C<8.!SUIJ-VD]!-Z7.HHK\]
M?V<?VEOC=\>/@[\1_&"^+-(L-5\*+YMO8MHL9M[I5A:5E=MVY2=N 0>,]#7T
M+^QM^U-_PTG\)9O$>LV=MH6JZ=?'3;T))B"20(L@>/<<@%7'!Z$&NVM@JM%2
M;L^5V=NESFIXF%1I+KL?0M%5?[4LML;?;+?;(I9&\U<,!U(YY%>._ 'Q)\6]
M<\6>.X_B+;:!#H4-[_Q3\FDW,<LDD&YN6",WRXV\OM;.>,5RQIN47*^W]:&[
MDDTNY[9159=2LVNS:BZ@-R.L(D&__OG.:6[O[;3U5KJXAME8X5IG"@GT&:SU
M++%%(&# $'(/0U\Q_MN_M5ZA^SCHWA:Q\/V]I<:_XBO3;+-='>EG$I3?(4R,
ML?,&,\<&M:-&=>:IPW9G4J1IQ<Y;'T[17F/PA/Q$TBSU]_B3KWAW5K$7A.C:
MEI2F%I+7G!G! 0/TX3(Z\UZ0EY!);?:$GC>WQN\U7!3'KGIBHG'E=KW*C+F5
MR:BJ<>LZ?)"\R7UL\*$!I%F4JN>F3GBL3XF7FOV/P]\0W'A.-)O$J6,ITU'C
M\Q6N-I\O*]QNQGVI*+;2&W97.GHKX+_;#^//QI_97\/^!YH_&VF:[JFMO+%>
MB30HHX(V14/[H!MV,L?O$]!7T;X?MOBGI/C[P=/>>)X?$W@S4[68ZE&VD1V\
MUI-Y6^)A)&<;"<CD=<<G-=<L+*,%4<E9WMOT^1SQKJ4G"SNK?B>ST52^UQ:I
M:W*6%]%YH4IYT++)Y3$<$CID>A]*^2OV/?VB?B#\4/CE\4?!/C'4[#5++PN3
M%:SVM@ML[LL[1[FP3U Z5E"A*I"<U]G<TE4C&48OJ?85%5UU"U>[:U6YA:Z4
M9,(D&\#UVYS5BN<U"BOFG]I;]K:Y^%_COPY\,? VD6_B/XE>(7C2""[D*6MD
MCMA9)BOS'@,V!V4D^A[>3PQ\9-'\,RWL'CC1=>\21Q&0:==:,+>PE<#/EAT?
MS5!Z;B3USBNGZO)1C*;2YMKF/M4Y.,5>VYZ_17&_"?Q/JWB/X8Z#K?B>"+3-
M:N+427]OC8EO+DATY/ 4C')[5U=O?6UY;^?!<13P?\](W#+QUY'%82BXMI]#
M124DF3T52CUS3IH9)4O[5XH\%W692JYZ9.>*LM<1+!YYE00[=WF%AMQZY]*6
MI1)159-3LY+?[0EW T&W=YJR*5QZYSC%1?V[IOD^;_:%KY6[;O\ /7;GKC.>
MM%F*Z+U%?,G[=_QF\:? _P"#]GXW\"ZW96[)?QV<UM=627,4ZR!\,&R"I!7M
MP<FI/%?[8>D_#+X,?#W5M=NK._\ '/BJTL#!I4;!-SS!/,F=0<I$NXG/<X ]
MNN.%J3A&<->9V^XPE7A&3C+2VI]+T5674K1K/[6+J$VN,^>)!L_[ZSBD&JV3
M64EX+RW-I&"SW E7RU &22V< "N2S.@M45XK\&_VH_"_QM\=>/=*T&[M9-&\
M,O:V\.IM, +Z5Q*96C!/,:[% ;O\QZ8I/V=?$7Q;UW4_&B_$VVT&WLH=0(T-
MM'N8Y6>WRV"VQVXQMP6PW7(%;RH3AS<^C5M'OJ8JK&5N76_Z'M=%5H]2M)+I
MK5+J%[E?O0K("X^JYS22ZK907(MY+RWCN#C$+2J'.>G&<\UA9FQ:HJ&"\M[I
MI%AGCF:,[7$;ABI]#CI4U( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3\2WCQR7LLAS@CY!&H4L2%";?4&M7BJ7L>3KRV^=[\W]:F:H3]IS>=_E;8^
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MH?LZ^#_BIH_ARRO+>;2+CPU/'<Z)J&DN(;C3I$V[3&<%<?*ORL".!Q4/@/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6!1<]\;B/IB@#TG4-;T[27B2^O[6S>4XC6XF6,O],GFKFX!=Q(QC.:\@^/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVN-T<<BN!&"BD,2H&3T!-=%_PF6H?]";KW_?5G_\D4?\)EJ'_0FZ]_WU9_\
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MU9__ "11_P )EJ'_ $)NO?\ ?5G_ /)% '445R__  F6H?\ 0FZ]_P!]6?\
M\D4?\)EJ'_0FZ]_WU9__ "10!U%%<O\ \)EJ'_0FZ]_WU9__ "11_P )EJ'_
M $)NO?\ ?5G_ /)% '445R__  F6H?\ 0FZ]_P!]6?\ \D4?\)EJ'_0FZ]_W
MU9__ "10!U%%<O\ \)EJ'_0FZ]_WU9__ "11_P )EJ'_ $)NO?\ ?5G_ /)%
M '445R__  F6H?\ 0FZ]_P!]6?\ \D4?\)EJ'_0FZ]_WU9__ "10!U%%<O\
M\)EJ'_0FZ]_WU9__ "11_P )EJ'_ $)NO?\ ?5G_ /)% '445R__  F6H?\
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M'_0FZ]_WU9__ "10!U%%<O\ \)EJ'_0FZ]_WU9__ "11_P )EJ'_ $)NO?\
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MU9__ "11_P )EJ'_ $)NO?\ ?5G_ /)% '445R__  F6H?\ 0FZ]_P!]6?\
M\D4?\)EJ'_0FZ]_WU9__ "10!U%%<O\ \)EJ'_0FZ]_WU9__ "11_P )EJ'_
M $)NO?\ ?5G_ /)% '445R__  F6H?\ 0FZ]_P!]6?\ \D4?\)EJ'_0FZ]_W
MU9__ "10!U%%<O\ \)EJ'_0FZ]_WU9__ "11_P )EJ'_ $)NO?\ ?5G_ /)%
M '445R__  F6H?\ 0FZ]_P!]6?\ \D4?\)EJ'_0FZ]_WU9__ "10!U%%<O\
M\)EJ'_0FZ]_WU9__ "16IHNL7&K+*9]'OM)V$ "],)WY]/+D?I[XH U****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "J>DZA_:EA'<^7Y>XL-N<]&(Z_A5RLCPG_R
MH/\ >D_]#:@#7HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "LCPG_P @*#_>D_\ 0VK7K(\)_P#("@_WI/\ T-J ->BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ***S/%&N)X9\-ZKJ\J[X["UEN67U"(6Q^E5&+DU%
M;LF4E"+E+9&A)-'" 9)%C'^T0*C%];,<"XB)_P!\5\%>#_!_CO\ :HUS6=7F
M\0K:Q6SC/GR.(T+9*I&B] !WKJKK]BCQI:VTLT'BNSFFC4LD8:5=Q R!GM7U
M4\GPM"7LL1BE&?56;M\SX:GQ#CL5#VV$P,I4WL^9*]O*Q]I45\N_L<?%+7-;
MNM9\'Z]=27KZ='YMO).VZ1 K;'C+=P"1C\:^HJ\+'8.>!KRH3=[=>Z/I\LS"
MGFF%CB::LGT?1K=!1117 >H%%%% !1110 5\T>)_VVO 'PAUV[\)ZW::[+J>
MGL/.:SM(WB/F 2+M8R GY7';KFOI>OR _:\_Y.'\6_[UM_Z315]5PYEM#-,7
M*CB+V46]--;I?J>%G&,JX'#QJ4=V[:^C/M3_ (>2?"K_ )\/$W_@!%_\>H_X
M>2?"K_GP\3?^ $7_ ,>K\RJ*_1O]4,L[2^__ (!\=_K!C?+[C]-?^'DGPJ_Y
M\/$W_@!%_P#'J/\ AY)\*O\ GP\3?^ $7_QZOS*HH_U0RSM+[_\ @!_K!C?+
M[C]-?^'DGPJ_Y\/$W_@!%_\ 'J/^'DGPJ_Y\/$W_ ( 1?_'J_,JBC_5#+.TO
MO_X ?ZP8WR^X_37_ (>2?"K_ )\/$W_@!%_\>H_X>2?"K_GP\3?^ $7_ ,>K
M\RJ*/]4,L[2^_P#X ?ZP8WR^X_37_AY)\*O^?#Q-_P" $7_QZC_AY)\*O^?#
MQ-_X 1?_ !ZOS*HH_P!4,L[2^_\ X ?ZP8WR^X_37_AY)\*O^?#Q-_X 1?\
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MJ\_DE>=F7"^7X7!U:]-2YHQ;6IV8//,77Q%.E.UFTMC]3****_(#]""BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .3^*WB^Y\
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MR;$9Q2HYEF=><DI<T8/;1^Z_Z_(^7?VFO 'B/Q)X[M[[2M'NK^T6Q2,RP)N
M8,Y(_45P2^"?BEXDTNTT*2PU9],@PL5M.=D*8Z9R<<5]OT5S4<XJ4:4:?(GR
M[-GJ8W@C#XW&5<6\1./M'[R5M?+;;UN>3? ?X+M\,;&YO-1DCFUJ\4*XCY2%
M!SM![G/4UX?J'PM\6R?%R6^30+PV9U?SA/L&W9YN=V<],5]DT5A2S.M3J3JR
M2;DK'I8OA+ XC"X?!TVX0HNZM;5];W[GR_\ M'?!G5M2\6)KGA_3);]+U/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %9'A/_D!0?[TG_H;5KUD>$_^0%!_O2?^AM0!
MKT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M61X3_P"0%!_O2?\ H;5KUD>$_P#D!0?[TG_H;4 :]%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5D>$_^0%!_O2?^AM6O7S7
MXE_;7^'OPCUR[\)ZY#K3ZII[#SFM+-9(OG D7#%QGY7';KFNO#82OC)NGAX.
M32O9=C"MB*6'CSU9<J\SZ4HKY8_X>/\ PG_Y]O$?_@O3_P".4?\ #Q_X3_\
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M.4?\/'_A/_S[>(__  7I_P#'*/["S/\ Z!Y?<']J8+_GZOO/J>BOEC_AX_\
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MSZGHKY8_X>/_  G_ .?;Q'_X+T_^.4?\/'_A/_S[>(__  7I_P#'*/["S/\
MZ!Y?<']J8+_GZOO/J>BOEC_AX_\ "?\ Y]O$?_@O3_XY1_P\?^$__/MXC_\
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M/'_A/_S[>(__  7I_P#'*/["S/\ Z!Y?<']J8+_GZOO/J>BOEC_AX_\ "?\
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M=!\&7/B*\FT<:S9R1W\4*7,6[;@9SM[]>3@<<T >NU!-?6ULZI-<11.W17<
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MVSE-.BE8JN>_SEAGN(U]!7N-5-*TJTT/3;;3["WCM+*VC$4,$0PJ*!@ "K=
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M?\,,?!+_ *$O_P JM[_\>H_X88^"7_0E_P#E5O?_ (]7O-%']K9A_P!!$_\
MP*7^8?4,)_SYC_X"O\CP;_AACX)?]"7_ .56]_\ CU'_  PQ\$O^A+_\JM[_
M /'J]YHH_M;,/^@B?_@4O\P^H83_ )\Q_P# 5_D>#?\ ##'P2_Z$O_RJWO\
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MYA]0PG_/F/\ X"O\CP;_ (88^"7_ $)?_E5O?_CU'_##'P2_Z$O_ ,JM[_\
M'J]YHH_M;,/^@B?_ (%+_,/J&$_Y\Q_\!7^1X-_PPQ\$O^A+_P#*K>__ !ZC
M_AACX)?]"7_Y5;W_ ./5[S11_:V8?]!$_P#P*7^8?4,)_P ^8_\ @*_R/!O^
M&&/@E_T)?_E5O?\ X]1_PPQ\$O\ H2__ "JWO_QZO>:*/[6S#_H(G_X%+_,/
MJ&$_Y\Q_\!7^1X-_PPQ\$O\ H2__ "JWO_QZC_AACX)?]"7_ .56]_\ CU>\
MT4?VMF'_ $$3_P# I?YA]0PG_/F/_@*_R/!O^&&/@E_T)?\ Y5;W_P"/4?\
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MA/\ Y 4'^])_Z&U &O1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %5=-L$TRS2WC9G52Q!;KR2?ZU:HH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
4* "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>formdrs_30.jpg
<TEXT>
begin 644 formdrs_30.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #" ;D# 2(  A$! Q$!_\0
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M<#\ZXKQ+\7]#\,^.]+\'R0ZAJ&O7\"W7V?3[4S>1;M*(A-+C[J;S@D9Q@DX
MS7!_$3P5K'CSP;\+KOPJMS=Z%ITL-[>:+?2?9IKVV:T98Q)OP-Z,Z,4;N#W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>M1;KM6&$,(VRQ9BPQR68Y)[U+I&GV^CJ0DGB"X!E$N+C>_())'3H2>?7B@
M_P"$KU:\T#5KRSM;);BPO;FW(N)'$;)$Q / SN; X]^]:&N>)+K2?"UMJOV-
M5GD>V62VE8_)YLJ(PR!U&_\ 2LF?0["2SDMHEUZU62]>_9K<,K&1CD\X^[GG
M%6;RQL]0T][*YBUJ:%GA<EE<MNB964@_503ZT ;[ZU:-+/;P75O)>Q_+Y!E
M.X] 1UZUQ\OC[5K&2:SN;"U>_C>X*R0R-Y$L<42R,5)&<Y;9[$$UT5Y>6M[$
M5?3[Y7PP25+4AXR1@E3C@^XK!B\-Z6MC':S0ZY>"/<$DN [.JLNUD!Q]UAG/
MUH O67BC5-0U.R6&SMFT_4+)KJ!][>9"0JE?-&,88L1QSQ4F@>*[O6/"=UJ2
MVB75];O-%]FM"?WCHQ  #[2I.!PV.M4X])M;>]N;B%_$$ F39Y,>X1Q@*%78
MN., <=N35@6=I';M%#%K5L7WL\L*,KN[E<N3CEOE'/UH M>']?O=:\*?;P+?
M[>/,5X_+D18W5B&5E(W9!!! [CBJ&D^.+C4;'PM<&"W/]K320S>6[8C*JY^7
M(!ZI@AL$=.HJQY%LD BA36K;Y6!:%&#,S,&9SQRQ(Z^Y]:;]BT[=II6PU-#8
M3/<1;86&Z1]V]F]22S'ZF@#K**R_[>3_ )\;[_P&:C^WD_Y\;[_P&:@#4HK+
M_MY/^?&^_P# 9J/[>3_GQOO_  &:@#4HK+_MY/\ GQOO_ 9J/[>3_GQOO_ 9
MJ -2BLO^WD_Y\;[_ ,!FH_MY/^?&^_\  9J -2BLO^WD_P"?&^_\!FH_MY/^
M?&^_\!FH U**R_[>3_GQOO\ P&:C^WD_Y\;[_P !FH U**R_[>3_ )\;[_P&
M:C^WD_Y\;[_P&:@#4HK+_MY/^?&^_P# 9J/[>3_GQOO_  &:@#4HK+_MY/\
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M'_P&3_"C_A%]&_Z!%C_X#)_A6I11[2?<.6/8R_\ A%]&_P"@18_^ R?X4?\
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M\X\8?]"=HO\ X$2UYE_PPG\:?^A5A_\ !E;_ /Q='_#"?QI_Z%6'_P &5O\
M_%T?4^&N]/\ \#_^V#ZQG7:?_@/_  #TW_AYQXP_Z$[1?_ B6C_AYQXP_P"A
M.T7_ ,"):\R_X83^-/\ T*L/_@RM_P#XNC_AA/XT_P#0JP_^#*W_ /BZ/J?#
M7>G_ .!__;!]8SKM/_P'_@'IO_#SCQA_T)VB_P#@1+1_P\X\8?\ 0G:+_P"!
M$M>9?\,)_&G_ *%6'_P96_\ \71_PPG\:?\ H58?_!E;_P#Q='U/AKO3_P#
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M_P# ?^ >F_\ #SCQA_T)VB_^!$M'_#SCQA_T)VB_^!$M>9?\,)_&G_H58?\
MP96__P 71_PPG\:?^A5A_P#!E;__ !='U/AKO3_\#_\ M@^L9UVG_P" _P#
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M:,^*/_0_:]_X&-1_PT9\4?\ H?M>_P# QJ^O?^'8&C?]#]J'_@OC_P#BZ/\
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M,4/S,<?='4UWE<S_ ,*[T5KJ*YEBFN)E$0=IYW?SO*<O$9,GYRC,2I/2NFH
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MSZ<USFQKT4R&:.XA26)UEBD4,CH<JP(R"#W%/H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KQ_P#:4^$6K_%?0?"4V@W-O'J_A?Q)8^(H
M+.\<I;WOV=R6A=@#M)5CM;!VL <5[!10!\_?M!?#/XB?%C2])?19+;1FM8]0
MBETUM091))-:-';7)D5/O02G>%QWR#D"O+/$7[*?Q5U;Q3J%\^N6VH133S#S
MI=8N(C+$VB_9,F,(57-WB8J.._)%?:E% 'PCX-^$_P 3]5^*DFCR:E<0ZOX9
M_P"$5GN]8FU&?R)%@LI4OXH?E_>^<VQ6; Z@GD"M/1?V8_C')9&#4[ZQ@@FU
M[2=5FLX-=N&00PVTT5W$&\O<V]FB)+??P2W(K[;HH ^3O@S\(?%OA_QOX!T_
M6-<N+J]T+PK!IWBZWD:XFM;F>)Q)9SV\SJ%=\[U<]2JJ#TJ?XU?LY>./B!\6
M/B7JVDKHR:)XP\!Q^#4N+R[<2VKF:5I)S$(SN"K+\H# DKVKZJHH P_ OA=/
M _@GP]X<CN)+R/1].M]/6XE^_*(HEC#M[G;D_6MRBB@ KXV^ '@GQ#I?[;GQ
M/UV\T/4+31+R"Z6WU&:V98)B9H" KD8.0K=/0U]DU5TW_CS7_>;_ -"->CA<
M9+"PJP2O[2/+Z:I_H<=?#JO*G)NW([F5XVN-4M]%)T;2_P"U+YW$:KYB)Y2G
MAI 7X) Z#O7-W&@WK?#Y?"]KH-QIEC]ACL83:WT?FP*8V4\D8^7"@GG.XXZ5
MZ'17G'89OANQN=+\.Z797DL<]Y;VL4,TL2!$=U0!F51T!(.!VK2HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "D50HP!@>U%% "T444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>platform_001.jpg
<TEXT>
begin 644 platform_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #0 =T# 2(  A$! Q$!_\0
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M:_$_9K_AI#X6?]%"\.?^#&+_ !H_X:0^%G_10O#G_@QB_P :_&6BC_4G"_\
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MKPK($#(K08RH&"=X/5L$8->E5Y1WA1110 4444 %%%% !1110 4444 %%%%
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MOIFBC^VLR_Z")?>P_LW!?\^H_<?,W_#O'X1?\^VL?^!Y_P#B:/\ AWC\(O\
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M;4?%NH0C6;>6*[U:PDU:U$<F8(+=9O*$++_#(N5R3G)+<C&!^4'WIZS1110
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M!(%4<&-"(R0>6#9KY/L_AYXC;X^3:O8>&=2U)XOB[+JJ::=*DM ;-K98VO\
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M365G';RS%F=U')RVXC)Z#)S@<9K3HKP3U0HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "LB#Q=H=UJCZ;#K%C+J"-L:
MU6X0R!L9V[<YS[57^(%EK&I>!/$5IX>N%M->GT^XBL)V.!'<&-A&WX-BOF[X
M%QOH/[*OA_0[;PA<_P#"TO#>F7-Q%I>IV#^9'K212YE>5@%<NY^^'.X2#GT
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M$*ZG'Q \4@3R@?VM=\!S_P ]G]ZY_P"V7'_/Q-_W\/\ C7ZA3X*YX*7UC?\
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=%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>formdrsa_002.jpg
<TEXT>
begin 644 formdrsa_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #O BH# 2(  A$! Q$!_\0
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M / IJ/\ A;GC?_H;-7_\"FKDJ*/J]'^1?<@^L5OYW][.M_X6YXW_ .ALU?\
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M_&>C"IERI^[A[_)%1YFO>KV^;.%_X6YXW_Z&S5__  *:C_A;GC?_ *&S5_\
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M)?\ ^(H]M3[A]7K?RLZ&BN>_X6=X"_Z'WP]_X$O_ /$4?\+.\!?]#[X>_P#
ME_\ XBCVU/N'U>M_*SH:*Y[_ (6=X"_Z'WP]_P"!+_\ Q%'_  L[P%_T/OA[
M_P "7_\ B*/;4^X?5ZW\K.AHKGO^%G> O^A]\/?^!+__ !%'_"SO 7_0^^'O
M_ E__B*/;4^X?5ZW\K.AHKGO^%G> O\ H??#W_@2_P#\11_PL[P%_P!#[X>_
M\"7_ /B*/;4^X?5ZW\K.Z\2_=T7_ +!<'_LU8U9^M?%SX>WRZ9Y7C[P^?(L8
MH'S<.,.N[(^Y[UG?\+.\!?\ 0^^'O_ E_P#XBLZ=6"BDV7/#U7+X6=#17/?\
M+.\!?]#[X>_\"7_^(H_X6=X"_P"A]\/?^!+_ /Q%:>VI]R/J];^5G0T5SW_"
MSO 7_0^^'O\ P)?_ .(H_P"%G> O^A]\/?\ @2__ ,11[:GW#ZO6_E9VGABV
MLKWQ)I5OJ,GE:?+=1I</G&$+ 'GMQWKT2RC\)S6T,.HFTTN_A69)8U5&1VV3
M;>HS&P;8I!RIRI4@BO!O^%G> O\ H??#W_@2_P#\12GXH> SR?'OA\G_ *^7
M_P#B*Y:O)5?QV.FE&K27\.Y] P_#?P=JDDYT>]O-46"U\QX8+N,L)-V!RP'7
MT]CS5:T\ ^#+JSN[J/5I9[6SM()+J>*X&V"1Y2C9^3GY=I [G(KP@?%#P(N<
M>/O#XSUQ=./_ &2@?%'P(JD#Q]X? /4"Z?!_\<K#D?\ S^?]?U_PYM[W_/@]
MCGT#P';V<TR:O<7CI:JZ1K*(V9RZ#.-O7:TAV?[ YYJIXIT7P[8:+J9TJZ^U
MI;WD$=G=%@3<!E<R]AP (S@_=+$=Z\F_X6=X"_Z'WP]_X$O_ /$4?\+/\!\#
M_A/?#^/^OE__ (BM8J,6G[5O^OZ^\RE&I)->RM\CH:*Y[_A9W@+_ *'WP]_X
M$O\ _$4?\+/\!?\ 0^^'_P#P)?\ ^(KK]M3[G+]7K?RLZ&BN>_X6=X"_Z'WP
M]_X$O_\ $4?\+.\!?]#[X>_\"7_^(I^VI]P^KUOY6=#17/?\+.\!?]#[X>_\
M"7_^(H_X6=X"_P"A]\/?^!+_ /Q%'MJ?</J];^5G=>)/]3HG_8-C_P#0Y*QJ
MS]9^+GP]O(],$7C[P^3!9)"^;AQA@SDC[GN*SO\ A9_@+_H??#__ ($O_P#$
M5G3JP4=67/#U7+X6=#6SX-U6#0O%VBZE=;OLUI>13R[!EMJL"<#N<5PO_"SO
M 7_0^^'O_ E__B*/^%G> O\ H??#W_@2_P#\13E4I3BXM[BC0K1DI*+T/I#Q
M!\8/#VI6?Q2BA-T6\1B$6.Z @'9&%._GY>:V6^/'A7_A,M.U#R[WR(]"_LPW
MJ6Z^=:3;L[T5NO'>OE;_ (6=X"_Z'WP]_P"!+_\ Q%'_  L[P%_T/OA[_P "
M7_\ B*\SZEA&K<S^_P DOR2/2^LXV]^7\/-O\V?5S_'CPQ'XN\%WC7VJZG;Z
M-;W45U?W5L!+,TB!5;:.IR.>!7+VGQ:\/VG@N+39;6:^GC\3-J[6LD6(Y+<R
MEL$GC.#T]:^>?^%G> O^A]\/?^!+_P#Q%'_"SO 7_0^^'O\ P)?_ .(HC@\)
M%)*3T_S;[>;"6)QLFVX[^7DE^B/J;QY\<O#FL^#/$>GV.I:OJ-UJDL4MM:WE
MLL<5F%=6\M2/X?E]S6WH^N>$/%EGX]\86NH:O:7=Y96T%_';VNZ>S5L*PA(^
M]NVXSVQFOC[_ (6=X"_Z'WP]_P"!+_\ Q%:_ACX_>&_!E^UYHGQ-T33KAUV.
MT5RV'7KA@4P?QK"6!H1I\M&=G_\ LZ;?W5T^\VCBL3*IS5H77H_/7?S?7[CZ
M*5O#6L^#[+4)VU+PGX-\-ZE'':6*VWF3WLQ <RR$_P 1P1QD#)J'3?B[X.U[
M3?'MAXB.HV-IXBU#[0BVD.]Q$ @ )Y ;Y/UKP?Q7^TIHWCB.&/7/BGHM_%"=
MT<37!5 WKA8P,^]<Y_PL[P%_T/OA[_P)?_XBKAA:4H_O9ZWTL]M4]VKMMJ[;
M(G7KQE^ZIZ=;K?2VU]%9V21]21_M :!<>,M2O'M[JTTB/0FTFP!CWR.VX'<X
M!X!Q^E</\6/B#I/Q \/^$WMC/;:KIUK]ENK$1;;=>!\T9''4?ECTKQ/_ (6=
MX"_Z'WP]_P"!+_\ Q%'_  L[P%_T/OA[_P "7_\ B*WI87"T9QJ0>J_RL8U*
MV,JP<)QT?EYW.AHKGO\ A9W@+_H??#W_ ($O_P#$4?\ "SO 7_0^^'O_  )?
M_P"(KTO;4^YYWU>M_*SNO#O_ ![ZY_V#G_\ 1D=8U9^C_%SX>V<.J++X^\/@
MW%FT,>+ASEBZ$#[GH#6=_P +.\!?]#[X>_\  E__ (BHC6AS/4TEAZO+'W6=
M#17/?\+.\!?]#[X>_P# E_\ XBC_ (6=X"_Z'WP]_P"!+_\ Q%:>VI]S/ZO6
M_E9T-+QD9.T=SZ>]<[_PL[P%_P!#[X>_\"7_ /B*/^%G> O^A]\/?^!+_P#Q
M%'MJ?</J];^5GMVM6?AS2;*X@AMM/:YL=4(_?'][/9FWRC\GYPS\\=R*N6_@
MWP+9M"SZ]!<Q2Q0^?')<QEHV,L&_81T^5Y>V?W9KP9OBCX$;&?'WA\X&!FY?
M@>GW*3_A9W@+_H??#W_@2_\ \17!R1LDJK.[]Y=MT3W;2O"G@>'Q!837&M03
MVWF&>6VDG3R&43A3$6SD80ELG[P'!K)T>S\,266MQWKVMO(+N8VMQO5P8APL
M>W.X9!RKKGD?,,5X_P#\+.\!?]#[X>_\"7_^(H_X6=X"_P"A]\/?^!+_ /Q%
M-1CK>JR;5-+43W@^#/ R:D]P=:MS;&^DC2T6^0@PXD\MBV,CE8^?]NLF3PGX
M8MU+6FL#4+Q+>":*%G0Q7,C%=T0"G<&&2-I ^[UY%>.?\+/\!?\ 0^^'_P#P
M)?\ ^(IR_%'P)&P9?'WA]6'0BZ<$?^.4**7_ "^8VIO_ )<G:>*+&UTSQ)JE
MI8R^=9P7,D<,F<Y4,0.>_P!:RZY[_A9W@+_H??#W_@2__P 11_PL[P%_T/OA
M[_P)?_XBNR-6"23E<XY8>JVVH,Z&BN>_X6=X"_Z'WP]_X$O_ /$4?\+.\!?]
M#[X>_P# E_\ XBJ]M3[B^KUOY6;\G^K;Z&OT4\"_\B3X>_[!UO\ ^BEK\R9/
MB?X"\M_^*]\/=#_R\O\ _$5^F?P_N(;KP%X:GMYDN+>33+9XYHSE74Q*0P/H
M1S7R/$,XSIT^5]6?49#2G3J5'-6T1^%?[7'_ "=%\5?^QBN__0S7DE?;O[1'
M[)\/BSX\>/\ 66\:Q61OM:N+@VYTIW,>YL[=PD&<>N*\\_X8O@_Z'^'_ ,$\
MG_QVO<P]_8PT>RZ/L<E:I#VDO>6_<^9:*^FO^&+X/^A_A_\ !/)_\=H_X8O@
M_P"A_A_\$\G_ ,=K?7L_N9C[2'\R^\^9:*^FO^&+X/\ H?X?_!/)_P#':/\
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MXD7;_P 7)T7D9_Y!LW_Q5,_X=(^(_P#HI&B_^"V;_P"*I_6\.]JWYD^PJ_\
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M3\2?]%)T;_P6S_\ Q5']HX7^?\'_ )!]2K_RGP117WO_ ,.D_$G_ $4G1O\
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M:'I<XL[*YDL$N;C4K21$VS(C[H&.<!G;9RV ,>YKA_M/AX?\PW4A_P!OT?\
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M:A#-J#365S?1R02>2PSY?D.?W80_*-N%8 -CK7;;HO[K_P#?0_PI-T7]QO\
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M_P#OF3_XNJ5#33F^_P#X)/M]=>7[A(/$\MJLD<%G9K;M,T\<;0YV,1A2#G/
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MJ?\ T$[W_P "7_QH_MS4_P#H)WO_ ($O_C1_8K_Y^?A_P0_M./\ )^)_0O\
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M/;TOYOS_ ,CXXHK[)/[)OP[50Q?Q0%/1C>P8_/R*(_V2_AW*2$?Q3(1R0M[
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M=C@D=16FWQ5CT70](UGQ':QZ=INL16\EF]F[7#*TV"$E&!C 9,N,@EB .*-
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M?+_>/J*9YD?_ #R_\>-$/W9?]S^HJ*@1+YD?_/+_ ,>-'F1_\\O_ !XU%13
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M*-J]VRW/^NW29\SY=OS>OR\5)%JD<UQ+!'X;TUYH@Q>,>=E0OWB?WG;!J/\
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MN21DJW?TK;2RMXY5E2WB2546-75 &"*"%4'T )P.V34D420QK'&BQQJ,*JC
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MGVDJML*RZ8@PV <=.N"#^(K>M/BO!;Z=):R:']K9K>>W\^XN=SD2ECN)V<L
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M @QW^89(I#/4_//]R/\ [Y%'GG^Y'_WR*KP><((A<.DMQL DDC38K-CDA<G
M)SQDX]:?3$2^>?[D?_?(H\\_W$_[Y%144 2^>?[D?_?(H\\_W(_^^145% $O
MGG^Y'_WR*///]R/_ +Y%144 699B/+^1/N_W1[U'YY_N1_\ ?(HFZ1_[@J*D
M,E\\_P!R/_OD4>>?[D?_ 'R*BHIB)?//]R/_ +Y%'GG^Y'_WR*BHH E\\_W(
M_P#OD51USQ'8>&='O=6U6>"QTRRB:>YNI4.R*-1EF. 3@"K-!"LI5T61&!5D
M895@>"".X- %33/$VG:U-<0V%U;W4ENL;2K&A^42()$.2,'*$-QV(S5\7&X
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M2'2\-O+G_1.&R9"P(ST/G2?G[5PWG%Z*#^[Y';:#W<E_6I@Z._BC5[?5)?\
MA()K1M,C,MU%<2R!XU#JF< '^)@,=>M,T\>-M1UJ/21=ZE!?21/,D,S,K,BJ
M22J]6. < <DC%,TV/Q7I8U?R=)F9M4B\JX:2$D[=X?Y>>#N Y]JM:I?>,]:U
M>'4KW3)9KB*)XD_T?:%WLSLPP00Q9F;<#D$\8K1[NW+;Y=O\S-;*_-?Y]_\
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M1A@@[VZUU_V>3^XWY5^98GE]O4MW?YGZ5AK^PIW[+\A?M,O_ #T;\Z/M,O\
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M;T/S#(_/Z$&L+>W]YOSKVW4OV<_B=K (OKJVNPTAE/G7Q;+D8+'CKCC-4/\
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3]]5N0J4A13U"@&LJC3V+BC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>formdrs_10.jpg
<TEXT>
begin 644 formdrs_10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "T EH# 2(  A$! Q$!_\0
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MO_ F>V?\-E?%G_H8+7_P6P?_ !-'_#97Q9_Z&"U_\%L'_P 37B=%:_V/EO\
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M8[U[J>.(1EE++@L<,& .""0>/6O2-(^!J:!X8U?5]3M! ;.RCN8F\]#(&>1
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M (^9O^NC?S-1U)<?\?,W_71OYFHZ_,9;L_=8?"CW2U_X]8/^N:_R%25':_\
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M6<P3>#K)?RO\CU"BND_X5KXO_P"A5UK_ , )?_B:/^%:^+_^A5UK_P  )?\
MXFOT;ZQ1_G7WH_%O8U/Y7]QS=%=)_P *U\7_ /0JZU_X 2__ !-'_"M?%_\
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M_P")H_X5KXO_ .A5UK_P E_^)K3ZQ1_G7WHGV-3^5_<<?K7_ "!K_P#ZX/\
MRKQ-?NBOHCQ3X%\2Z7X;U2[O?#VJ6=K%;NTD\]G(B(,=2Q& *^=U^Z*^2SJI
M"I.#@[Z/8_0^%XRC2J\RMJOR-+PW_P C!IO_ %W3^=>SM]XUXUX6C>;Q-I4<
M:-)(]S&J(HR68G  '<DU]$-\-?%^X_\ %*ZU_P" $O\ \36^25(4XU.>26V_
MS.3BB$I3H\JOH_T.;HKI/^%:^+_^A5UK_P  )?\ XFC_ (5KXO\ ^A5UK_P
ME_\ B:^F^L4?YU]Z/A_8U/Y7]PGPXFTJW^(/AJ770IT9-0@:[\P97RPXSN]O
M7VS7T%;VNO?8O'<WBY=>MKVW26[35OM(_LN[B,BB*-.,,"#D!3C '%?/W_"M
M?%__ $*NM?\ @!+_ /$U*WP_\;-"L+>'/$#0K]V,VDQ4?08Q7D8RC1Q4U)54
MMO/K?35;]=[Z=CT,-5J8=-.FW_PUM=/N[:]SZ=E\.Z%J?B::PA\+:3>7%GHL
M=[:0-!N>\N3"A.[G+C#%@@_NU!/\.M'U",H_A6PM/$=SH$UP^F6]L%*S+*-C
MK'_"[1Y.W\<<U\T?\*_\;!PX\.:^''1OL<V1^.*=_P (#XX\WS?^$>\0>;G/
MF?9)MWYXS7D_V8HVY<4M/Z_FV>_ZGH_7KWOA_P"M/[OR/J"P\&6F@QWT,'AF
MUN=5M?#5O>"P:+),YFPS%0?F;;_#WQC%<U=>';36O&\MFOA.)=6N=-T\R>98
M&]L])NI2QD2:$,#&KJ%)8?ZOGBO&-'T3X@:'I^M6EOX9UIDU:W2UGDDL9BZJ
MLBR H<<'<H_6LI? /C>.21U\.^(%>3AV6TF!?ZG'/XT4\OY93E+$*[V=_3^]
MM>^GWZ70IXR\8J-%_P!?+?S_ %U.?U*W-KJ5Y QB+13.A\DYCR&(^4]U]/:J
MU=)_PK7Q?_T*NM?^ $O_ ,31_P *U\7_ /0JZU_X 2__ !-?5K$44K.:^]'@
M.E4;NH/[CFZ5>M='_P *U\7_ /0JZU_X 2__ !-(WPY\6Q*SOX7UE$4$LS6$
MH  [GY:KZQ1_G7WH7L:G\K^X^:+C_CYF_P"NC?S-1U)<<W$Q'(WM_,U&>E?F
M$MV?NT/A1[I:_P#'K!_US7^0J2MVQ^'7BR>QM9(_#&L21O"C*ZV,A# J,$';
MTJ?_ (5KXO\ ^A5UK_P E_\ B:_38XBC9>^OO1^%RHU.9^Z_N.;HKI/^%:^+
M_P#H5=:_\ )?_B:/^%:^+_\ H5=:_P# "7_XFJ^L4?YU]Z)]C4_E?W%3POKI
MT/4%=ANA;AA^F:]/AFL=<MU8+'<QGG#+D#\Z\[_X5KXO_P"A5UK_ , )?_B:
M</ASXR7IX8UP?2QE']*X*\</6?,JB3]4=5*56FN5P;7H>A?V'IW_ #X6W_?H
M4JZ?86&95MH(,?QJ@!KSS_A7?C/_ *%G7?\ P"F_PH_X5WXS_P"A8UT_]N4W
M^%<OL*?6NOO_ .";^UGTI/\ KY&CXV\5174)LK5MZG_6.#P?:N(KI/\ A6OB
M_P#Z%76O_ "7_P")H_X5KXO_ .A5UK_P E_^)KTJ,\/1CRQFOO1Q5(UJDN9Q
M?W'-T5TG_"M?%_\ T*NM?^ $O_Q-'_"M?%__ $*NM?\ @!+_ /$UO]8H_P Z
M^]&?L:G\K^XYRO'?%W_(S:E_UV/\A7T+_P *U\7_ /0JZU_X 2__ !-?/WC6
M"6U\7:M#-&T,T=PR/'("&5A@$$=B#7SV=5:=2C%0DGKT?DS['AB$XXFHY*WN
M_JC$KV?PS_R+.D_]>R_S->,5]!>"? _B35O!VBW=CX?U2]M9+52D]O9R.C<D
M<,!@UYN33C3Q#<W;3]4>SQ-&4L)!15_>_1E6BND_X5KXO_Z%76O_   E_P#B
M:/\ A6OB_P#Z%76O_ "7_P")K[/ZQ1_G7WH_-?8U/Y7]QS=6]+U!]-O8KA.2
MIY'J/2MG_A6OB_\ Z%76O_ "7_XFC_A6OB__ *%76O\ P E_^)J77H25G-?>
MAJE53NHO[CO=+UJR\06HP5=F'SQ-SCVJ?^P]._Y\+;_OT*\\7X<>,5^[X7UM
M?I8RC_V6E_X5WXS_ .A9UW_P"F_PKR70HW]RLDO7_@G>JM2WO4V_E_P#T-='
MT^%@ZV5NA7D,(P,5A^*?%EO8V<EO;.'N&&!M_A^M<Q_PKOQG_P!"SKO_ (!3
M?X4T_#?Q@W)\+:T3_P!>$O\ \35PHT%)2G53^:_S%*I5:M&FU\CG"=Q)I*Z3
M_A6OB_\ Z%76O_ "7_XFC_A6OB__ *%76O\ P E_^)KU/K%'^=?>C@]C4_E?
MW'-T5TG_  K7Q?\ ]"KK7_@!+_\ $T?\*U\7_P#0JZU_X 2__$T_K%'^=?>@
M]C4_E?W'AGQ(_P"1D_[=X_ZURU=E\6=,O-'\8/:7]I/8W4=O'O@N(RCKG)&5
M/(XKC:_/,<U+$U&MKG[)E::P-%/^5'V-_P $NR?^%Y>(_P#L /\ ^CXJ_2ZQ
M\16&I:QJ>EV\ZO?::8_M,/=/,7<A_$?RK\R/^"8>H0VOQ]U>WD<++=:%*L2G
M^(K+$Q _#)_"O8K[]H%O /[3'C#Q BRWVE3.^GS6L3 >;Y2A(VR?1U_(FOCZ
MV6U,QQ554]XQ37F[K3YJ_P SU#[C:YB2=(&E19G!98RPW,!C) [@9'YU)7YQ
MV'[07B6?XPZ=XYU.\\UH)?+:SC)$4=JQ >)%/MSZD@&O7?CM^U_<?VA!I7@"
M<?9[>1);G5"N1-@AO*0'^$]&;OR!ZUG5X9QD*M.E"SYE=OHGU7Y>H'U_7-W/
MQ(\*V=P]O<>(M,M[B,X>&:Z1'4^X)R*XS6OVC?#&@?"G3/&=Q.LQU& -;:?"
MP\V6;&'C /3:V02>F/I3OA7XF\.?'KX?VNO:KHNEW%Z"T5[;S0)*()%/(RP)
MP1@@^AKQ8X&I3INOB(-03Y;KO\P.N_X6=X1_Z&;2?_ R/_&E_P"%G>$?^AFT
MG_P,C_QKA/".B_"#XB:OK=AHN@:+>3Z1*L-PT5J@1B1G<A'WESD9Z9!K'\&^
M OA]I'PRN_$&N>'--DALY[UI9I+<,Q5+B1549ZG "@?2NEX7"QNI*:E=*UE?
MWDV@/46^*/@]>OBC2!];V/\ QK?T_4+;5;2.ZLYTN;:0926,Y5AZ@]ZXOP?H
M'P[U#0H?$&A:)HJV+1F47,5G&"F!D@\94CN*YOX5_M%:+\0-?O=%DB72[@3,
M-/W$!;F('"@>C_[/?M7-+!NI&<L/"7N?%>VGR ]AIDDT<.SS'5-[;5W$#)/0
M#WKY;\7?M.ZAH/Q@NS8@WWABS_T*:S_YZ%6.^5#_ 'LY SP0*P?VC?C-#XVO
MM#M/#MZZZ?:*M\;B-RC>>P^4>Q0?J37I4>'\54J4XS5HS5[]O)^8'UWJFIVN
MBZ=<WU[,MO:6Z&265S@*HZFOEO\ X*42K-^S&9$.4?6+%@?4$L:XOQM^T)JW
MC;X8P^&=04"\,H^UW\9P+B)>5!'9B>O8XJ3]MOQ-%KG[$WA:Y:99)KV]T]00
M<[F17W_^@FM?[(K8"=&I5W<[?+H_GJ!^:]>\_L+_ /)U/@?_ *Z7/_I/)7@U
M>X_L2WT.G_M2> GG<(LES+"I/]YX)%4?B2!^-?08K^!4]'^0'[!MXBL%\1)H
M;7"C4WM3>+ >IB#!"P_$BKTEQ%"T8DD2,R-L0,P&YL$X'J< _E7QK^T!\79?
M!O[3VDZG:.[IH-M%;W,41'[V.0EY8_\ OEA^.*\O^(W[0GB;Q[X\L?$,5R=/
MM]*N!-IEA&Y"PX/WF_O.PX)]#@<5XV'X:KXJ-.I%VC*-[OOT7ST _1ZBOEGX
ML?MC647@RQA\''S=>U*V5YYF7*Z=D<K_ +4@.<=AU/I7=?"#]H#2M6^":>)?
M$FHK!<Z2OV347DP'DF494J/XF<8('<YKQZF3XVE05><-W:W7[OP ]/U;QUX=
MT&\-KJ6MV&GW(&?*N;A8VQZX)JK_ ,+.\(?]#-I/_@9'_C7GOP:^,&@_M#Q:
M[!J&AVJS6$^8K6[B64M;-]QSN!^;(.<<#BK*Z7\(-4^(<O@R/0-$FUZ*W:YD
MBBLT"K@C*$@??P<[>PH>"A1G*CB(34XJ[M9V7?T [K_A9WA'_H9M)_\  R/_
M !IK?%#P>O)\3Z2![WD?^-<!X3^$O@B;Q-XV2Z\-:8UM9WT2Q"2$;8D^S1L<
M9Z#))_&M?X<Z3\+_ !I8R7_AWP_HKF"5HI%-E%YD; D D8/!QD'N**F'PD$Y
M1YVE:[LK:JZ ]!T?7M.\0VQN-,OH+^W!V^;;N'3/U'%7Z\9T_P#:*\/VGQ-O
M_",\4-AIL,@MK;4$($1F'#JV. ,\ ^W-<M\>OC]J?@SQ]I>F^'Y8Y$T]?.OH
MR=R3EQQ$V.F%YXYR113RC%5JZHQA;F7,K]O7\/4#Z+FGCMXFDED6*->6=R !
M]2:>S!%+,0JJ,DG@"OE+XZ_'ZP\<?#G3-.T1FBDU-B]_#(V)+=4(_=G'7<V#
MGN!7(6'[1VNV_P ,]1\+7C-=W4L7V>VU,L?,CB/#JW]X[> ??FN^CP[BZM&-
M39MV:?1;7_/Y;"/<?VJM6M=<_91^(%_8S+/:3Z-*\<J]&7(Y%?C+7ZB>)/$<
M-W_P3_\ &BO,K?8[&XL!R."9%V+^3K7Y=UZF7T/JSK4?Y9-?<,ZOX2_\E6\%
M?]ANR_\ 1Z5^Y.I>(M/TC4=,L;NX6&YU*5H;5&_Y:.J%R/R!K\+_ (:WL.F_
M$CPE=W#B."#5[.21CT51,A)_*OTN_;7\=3Z'XE\"P:;<&#4=/=]526,\J<A4
M_ X:HQ6">88NEAUI=2_!7_,#ZPGN(K6,R32)%&, O(P4#)P.3[U)7YX?'+]H
M[6?B]-;VEH7T;0K?9(MJKX>68 '?(1UPP^4=NO6O8KG]LJWTWX/Z5);(+[QQ
M-";>6)QF.%T^4SOZANH ZD^@K@J<-XVG3IR2O*3LU_+VN_OOV ^K:QM:\8Z%
MX=F2'5=7L]-D<;E6ZG6/</;)YKQK]FOX\1>*OAKJ,_BO5534M!8F^O+HA0T+
M$E'/ZK]0/6KGPK^/WA[X[>+=>\/S:1#]EMU$VGB]B5VN81P[,IR <D''H:\V
M>5XBC4JJI!N-/XFOPM?[_0#TL?$_P@>GB?23_P!OD?\ C2_\+.\(_P#0S:3_
M .!D?^-<1XHL/A'HOC+1O#.HZ#H@UO5WVP01V4>5X)!? ^4,1@>IJM#\(/!3
M?%BZL#X8TW[$NBQ3B'R!MWF>0%L>N !^%4L/A.7FGSK2ZT6JO;0#OS\4/""]
M?$^DC_M\C_QK2T7Q5HWB0R#2=4M-2\O[YM95D"_4@UY]X3T7X4Z]X@U;2-+\
M/Z(VIZ5*8IHFLXBQP!EDR#N4$X)[$5G^+?CQH'PQ^(5GX6-A#!I?D@W=Q:J%
M%M(Q^3Y5[ <GN,BI^HJK-TL/"3G:^MEI_6P'LU(S!5))P!R2:\(_:.^-5QX0
MTW1+3PS?1_;[UEO#<0D.! I! ]PYX^@-<[XL_:=MO$/P>NUM4%EXGNB+&:VW
M8\L,IWRH?[N,@=P35T<FQ=:G3JQC[LW;T\WY ?2\4J3QK)&ZR1L-RLIR"#T(
M-8>J:Q::OX9U]K.=9Q;1W%O(R'A9%0[E_#-?'WPO_:%UGX<Z#>:/*#J=EY+"
MQ#L=UK(1\O/=,\[?RKT#]FGQ2LGPQ^($%U=>8UH);V1F89 >%BS'ZE":[,5D
M5;!TZE6;NHM6\TW^'0#\F>Y^I_G3)O\ 4O\ 0TY6W+N]>:;-_J7^AKZT#]U_
M#OB*P\,_#/PO>:G<+;6[V5C )&Z;Y$1%'XDBNPDD6-&=V"(HR68X 'J:^4/V
MC/&%K_PS'X$@M9]W]KQ6,D,D;<[8X5<L/H=OYUY=\1/VIO$'C;P#I7AFVD>P
M(M5BU6\W8DO' P0".B,.3W))[5\KA<AK8ZE"M3=DY-._1+K^: ^_XI4GC22-
MUDC<!E=3D,#T(/<4^OD#X/\ [55AX)^";V>L%K_7]);[+86:];B(C,9+=E7D
M$^@%=)^RW^T/J?C[7M?TCQ7>P_;)"U_9,0(U6,?ZR)?]E0 P]MQKEKY%C*$:
MU1Q]VF_O\UY=6!]$ZUXDTKPY$DNJZA;Z=$YPLES((U)],GBLH?%#P>W3Q/I)
M^EY'_C7EVE_M/>&_&?Q>C\%6\$%WHDR/"NI3@%)[D<A4!X*$;@">IQCBM[XC
M6OPF\#S:</$6A:'#<ZE<I;PQBRBWDLV-Y  P@[MVKG6 =*4:6(IR4I*Z2MMZ
M =I_PLWPC_T,VE?^!D?^-)_PL[P@/^9GTG_P,C_QKS[Q%\(?!5O\1/!UI#X9
MTU+6ZCOC-$L VR;8T*Y'?!)Q]:OV.@_"8>.+GPI%X?T1=;MXUE\F2SC(;(SM
M4D<L!@D>]/ZOA'%2ASO2^RT5VM?N [[1_&WA_P 071MM+UJQU&<#<8[6=9"!
MZG!XK;KQ_P")OQ:T+X&ZEHFFV>C6X2[8R745G$L9B@'&X  9;=T!]#47QM^-
M%IHOPMAU'P[J DO-:_=6-S;L"8^[O[%1QCL36<<MK5I4O90:C4T3?XWM]_H!
M[+3(IHYE+1NLB@E25.1D'!'YU\X>&/VK(I_AWJC:M&L7BFRM\0*/E2[8_*K#
MT(R"P]CBO)?A)\<M8^&>K3M<2/JFDW<C2W5FSY;S#R9$)Z,3U[&O2I\.XR<:
MMU:4=E_-Z,#[@M]7M+O4KRPAF62[LPC3QJ>4W@E<_4 U^(?Q^Y^.GQ!)_P"@
M]>?^C6K](?V7_'D_B/XL>+)+V8&YU> WACSP"C@  >@5@/PK\U_CC>1ZA\:/
M'EQ"VZ*37;PJWJ/.85Z&#P4L!BZE&3O[L7]^_P"-P.(K]C/V/M6MM"_9"\#Z
MC>R>3:6FE23S28SM19)"3^0K\<Z_3WX9^,;33?\ @G3I4B2AG;3I-+P#R)6N
M'0CZ@$G\*TS*B\1[*DOM32^\#[#L[R'4+."ZMW$MO/&LL;KT96&0?R-.AN(K
MF/S(9%E3)&Y&!&0<$9'N*_/[3OVI/$&C?!VS\&Z?))!J<): ZLY^=+;^!4]&
M'*Y/0 8KL?V6_P!H33?A_P"&-<T7Q1>NMI;;KVP;EV<G[\*_[1;##/JU<-?A
MG%T:-2JM6G9);M7M?\M/4#[4JKJ6J6FCV;W=]<QVELGWIIFVJOU/:OD_X3_M
M7:KXN^-ZV^L_Z#X=U9?L5C9*,BWDW9C9F[LW*D].1Z5Z+\3OVJ/#O@GQUIGA
MB*--31KE8M6N5(:.T0Y&!_><'!([ 'O7GU,DQE*NJ#A=M<VG;KKWZ>H'IJ_%
M'P>WW?%&D'Z7L?\ C3O^%G>$?^AFTG_P,C_QKG?B-IOPU\)^'KGQ#XFT/11:
M1KN\QK*)I)F(X5.,LQ[5ROBKX<^ -1\-^%=6T?PYI@M=2U33RLD4 'F0R2+E
M3CL0<$5E2P^%J*,FII-VO96N!Z7_ ,+.\(_]#-I/_@9'_C4UC\1/"^IW<=K9
M^(--N[F0X2&"Y1W8^P!S7"ZYX;^$O@_Q)I&C:CX>T6UO=3#F#S;5"@VXQN)^
M[DG ]2#5KXG^*M"^!/A6/4=+T+3XKV>=88+:WA2'?SESE1GA<_B12^JTJDH0
MHQFY3^&]DF!ZC17F-]\=M"F^%-]XPTZ=9&ACV+9R,!(EP>%C8>N3^(!(KS'X
M-?M0%;*;3/&<I:>*-Y;?42,>;@%O+?\ VNRGOP**>4XNK2G5C#X'9KKY_<!]
M,I-'))(BR*SQD!U4@E<C(R.W%5I-8M(]6BTQIU%]+"UPL.?F,:E5+?3+"OA;
M0_CAXAT+XB:AXKAF#'4)_,NK!V)BDC_A3V*K@ ]L5W/P_P#BY)XT_:6L-8E)
MM;>^C?3[>V=A\D>PE5/ON&>.YKUJO#E>BI3D[Q46_FEM_P $1\B?\%"O^3J/
M$G_7I9?^B%KYPKZ'_;^O8[S]JGQ8(FW>3#9PM_O"W0D?K7SQ7MX/_=J?HOR&
M=G\&_B9>_!SXG>'_ !A8QF>33+C?+;AMOG0L"LD>?=2?QQ7ZR:3\+O@]^T%X
M7M?%FDZ5:75KJ@,WVW3W:"0.3\ZN%(PX.001UK\:*[[X2_';QQ\#]2EO/!^N
M2Z<L^//M)%$MM-CINC;C/N,'WK'%8>K4:J8>;A-=FU=>=@/TSU[]A7PE>(QT
MG6M4TN3MYI2X3\B ?UKS?6/V%/%EFCOIFOZ7?X/RQRJ\+$?7!%>;Z3_P52\5
MP6:)J7@?2+RY PTUO=R0JWOM(;'YU=_X>L:W_P!$]L/_  9/_P#$5STL9GM'
M3FYEYV?_  0(=<_9O^*6CXCG\-7=]##D)]DE2X4 G)V@'(R>>E<W;>)?&/P[
MT;6O#ZI?Z%:ZJ4%Y#)"\+-LR, D<9!P<=1Q75?\ #UC6_P#HGMA_X,G_ /B*
MAN/^"IFJ7B[9_AOIDR^DE^S#]8Z]B&;8^2Y<3AHR7D[>?6_4#FOAGXSU7P/J
M&H7V@WTEA/+:-;2-& 24)!X]"".#VK>M/B=KNJ>$[G1)M3N3HTL_G26\S C?
MN+$@GL6.2/6N-\5_MP:'XNAF^T_![1;2[D4@7EC>M#*I]<K&,_CFN<\)?M8:
M)X;:1[[X9V7B&1B"O]H:BQC3'H@3!/US7I_7J51.K4H>_I_*WIMK?H(]4T+X
MBZCH.FZII&E:C*MIJD?DW-K#E]_N .C8XR.Q(K1T'X<>.M;\FXTCPCK#)N#1
M7#0_9P".A#.1BLO3?^"FLVC1)'8?"K1+*-/NK;W1C ^F(ZT?^'K&M_\ 1/;#
M_P &3_\ Q%>94S/%IMT,,DWNW):_=;\P.]T7]E'XC:YB2^;2]#5N3]JN#/)^
M(08_6NXT']B4':^O^+IY?6'3+=8A_P!]MD_I7A7_  ]8UO\ Z)[8?^#)_P#X
MBFR?\%5]>V'9\/M/#]BVHN1_Z!7DU<=G=32-HKRM^MV,^L='_9)^&^BMYUU8
M76K%!DG4KQW0>^ 0*^!_VZOCKHGC[Q)I7@7P5Y">"_"I=5-HH$,]T<AF3'55
M!*@]R6/>N6^,O[;7Q.^,UE<Z7=ZC#H&@W VR:;HZF,2+Z/(278'N,@>U>!@8
M&!P*>&P^)E-5<94<FME>Z0!5[0=;O/#6N:=J^GRF&_T^XCNK>0$C;(C!E/YB
MJ-%>MOHP/V!^&?\ PJK]KSP/!XM?0[&76)46+4XXV,=S:7 4 HQ4@G_98YR,
M5!K?[#?@B^C;^S=1U;2Y#]W]ZLRC\&&?UK\K/AY\3/%'PH\0)K?A/6;C1M14
M;6>$Y21?[KH?E<>Q%?5WAG_@J3XVT[3XX-;\)Z/K-RBX-U!-);%_<K\PS],"
MO!E2S+"R_P!CK/EZ*^WR>@'K^K?L&Z] TC:7XHL+E!]Q;J!XF/U*D@5Y_KO[
M+_Q4T%'MQHKZE:;@_P#H%RLL;, 0&V$@YP3V[U#_ ,/6-;_Z)[8?^#)__B*/
M^'K&M_\ 1/;#_P &3_\ Q%>A2S/.X?Q(QEZV_1H#G-+NO'?P8UFXNX;'4O#E
M_) ]L\DULZ HW7DC&>A![$9K(\$^)-0T'QA::SIU[+;ZK!(TPN"V]F8@[MV>
MN<G.>M=O+_P52UB="DGPZTZ1/[K:@Y'_ *!7*>(_V_-)\6!CJ?P:T":4C'GI
M=M'*/<.L8/ZUZU/-*TK^WPJ]Y6;36J]'_F!U.G_&+Q3)<:_"-8O"-31H[XRL
M&$N0%)]FP, CMQ57PG\1+WP#JWVW1-1-M=%#$ZJ=XD4@C#*.O7(]#7D>@_M1
MZ+I.J2W5W\/8M8MSGR[.ZU1Q&N?[VU 6_&O4=%_X*11>';=8=+^$6@6$2]%M
M[C9^>(^:TQ&,I03A1P_,GO\ "D_S_(1I:-X)\6^*E:32?"VK:@C'F;[*R(2>
M<EGQ7>Z-^S#\3?$DGFW=I9Z,K'F34KOS).G7:F?U-<3_ ,/5];_Z)[8?^#%_
M_B*7_AZQK?\ T3VP_P#!D_\ \17E5<TS27\*C&/SN_S2_ 9[9H?[$][))NUS
MQ>JQY_U>F6F"1_O.>/RKO-'_ &._A[I\B/>1:EK#*<E;V\;8WU5-HKY6_P"'
MK&N=OA[8?^#%_P#XBO+_ (K?\%"OBC\2+*;3M.EM/!VFS(8Y%TH,9W4\']\W
M*\?W0*\J53.L1*TZG*O)I?\ I.H'I/[?'QB\+^'-!B^#?@"*UM+1+D7>N_80
M/+5UP4@+ \OD!F]-JCVKX9I69I'9W9G=B69F.22>I)[FDKUJ%'V$.6]WU;W;
M[@!Y'7'N*_5+]F'QQX!_:R^&VG6?BO2[&_\ &V@VJ65]%.2)WC4;4G5@0Q5N
MIYX;/J*_*VM3PSXHU?P9KEIK.A:E<Z3JMJV^&ZM9"CJ?ZCV/!K/%4)5HKV<G
M&2V: _6_6/V(_ %^KFRFU72W/3RKD2*/P<'^=><:U^P7JD<S'1_%EK-%C*K?
M6S(WTRI->$>!_P#@IU\0] T]+7Q#H>D^)W08%WEK65O][;E3^ %=3_P]8UO_
M *)[8?\ @R?_ .(KSZ>)SW#NT:G,O.S_ #U NZY^RK\4_#JRPP::NJ6L@&_^
MS[M65\'(RC$$X//2N/L]/\=_!WQ%:ZQ_8^I:'J-MDQS36C!,$$$$XVD$'I71
M_P##UC6_^B>V'_@R?_XBFR?\%5-9E4J_P[T]U/56U%R/_0*]BGFV9-.&(P\9
M)[ZVO^+7X >>OXAU'6/%":O=ZA<2ZS)<+.UZ\F9/,!!#9[8Q7I*_'3QBGC9]
M4&M77]J-'Y;2G'EF/DA-G3:"2?KS7+:]_P %$+'Q1'LU7X.>'[WT:2Y.\?1A
M'D?@:\V3]J#1E\0&_/@!7L=V_P#LTZL_E_[N_9NV^V?QKU(XZEB(_P"T8>UE
M9+W7\E_5@/5=+\83>%]<@U6QU%K74X9/,697^8DG)! Z@]P>M:BV/BKXD:S>
MZG9:!JFLWEY*T\TUO9ML+,>?F/ %8'A__@HA8^%8O+TGX.>'[$=VBN3N/U;R
M\G\370K_ ,%5-:C4*OP[T]5'0#47 _\ 0*XJN9UU+FHX;7:[DMOE_F(ZW1OV
M</B?XB*"31X=)A50JR:G>+\J^@5-Q[GCBNXT?]BG6YI@=8\76MO%W73[0LWT
MRY'YXKQS_AZQK?\ T3VP_P#!D_\ \11_P]8UO_HGMA_X,G_^(KR:N89U/X(Q
MCZ6_5L9]/Z7^QGX$M-K7]QJ^K,.HGO-B-_P% *\:_;0^)7@S]GGX;ZC\/_ M
MG9Z;XI\2PB&\6SYDM[0Y#-(Q.06!*J#ZDUX?\0_^"EGQ+\6636F@6.F>$(V&
M&N+<&XN,>S/\J_4+FOE'5-4O-;U*YU#4;N:_O[ES)-<W,A>21CU+,>2:YZ-#
M'5Y*6-JMI?9OI\^@%4<# HHHKVP/T1_87^*7@WXO_#VR^%'CFRL[[6=#WG25
MON3<VQ)8B,]0R=" ?N[<=#7ONM?L7_#G5'D>VAU#2F8Y M;LE5^BN&K\=[.\
MN-/NX;JTGEM;J%Q)%/"Y1T8<@@CD&OJGX;_\%(OB?X,LTL]=AT_QE;H JS7R
MF&Y 'K(G#'W92:\6M0QM&;G@JKBGTO97_(#Z8\0?L%3"7=H?BQ3'_<U"UY'_
M  )#S^0KS_7?V0_B;X;=GL(;;5H\%=^GW>QRI&""K[3@CC'-8W_#UC6_^B>V
M'_@R?_XBC_AZQK?_ $3VP_\ !D__ ,1711S'/*>DTI+SM^E@.7U+X<^.? -W
M;7U[X:U33I;>59HKC[,Q564Y!#+D<$5C^,O&6J^/?$%QJVOW<EUJ$YP68X"+
MV5%_A4>@KOS_ ,%5M;(P?A[8$?\ 81?_ .(K$UK_ (*/0>([=H=4^$.@7\;=
MI[C=^1,>17L4<WQ7,IU\,N9:74EM\_\ ,#:O/C3XN_MO1)9-9NS=Z?"L-I)&
M0%C4*%/R]#D*-V>M96J^+;BZUZ;6KO4&75I9_M#7"R;7$F<Y&.F.U>5:M^U%
MHVHZTEY;_#^/3;3(+V%OJK^6?928R5!]J] \/?\ !0#2O"O.E_!GP_:R=Y?M
M3/(?J[1EOUKIGC*-&*="A=V_NKY7_P KB.JU#5?%/Q8UY]073M2\1:C(BH9+
M6T=EVJ,  XVC_P"N:Z71_@!\4/$"QPKX>;3K8$LIU*[2-$SC)V DY.!T':N9
MB_X*I:Q"@2/X=:=&@Z*NH.!_Z!3_ /AZQK?_ $3VP_\ !D__ ,17DSS+,(Q4
M,/AXQ2VN[V_% >MZ5^Q;XFNI(SJGBG3K.,_?6SMGE=?8%B!7>:3^Q;X.MU4Z
MEJ>LZK)_%FX$*'\$'3\:^:/^'K&M_P#1/;#_ ,&3_P#Q%<YXS_X*@>/]:TY[
M;P_X>TCPY,XQ]L9GNI%_W0V%_,&O*J8C/*SLY\J\K+\M1GTS\>O%'P[_ &.O
MA[>:CX>TNSM/&NHV[VFDH"9+AW88,K%B2$7@D]"0!WK\GIII+F:2::1I9I&+
MR2-U9B<DGZDUK^,?&FN_$'Q!<ZYXCU6YUC5K@YDN;E]QQV4#HJCL!@"L6N_"
MT)44W5DY3>[8!7V=^P'\:/#,,5_\)/'<-K/HNKW0N]+:_ :(71 5H3G[I; *
MGCG([U\8TO(P02#U!'!K:O15>#@W;LUT?<#]E]>_8[^&NLR-)#IUUI+MVL;I
ME4?\!;(KSGQ%^P7;.6?0O%4T0[1:A;AP/^!*1_*OC_X1_M]?%'X5V-OIEQ<V
MWBW2+=!'%;ZP&,L:CH%F4AC@<#=FO6U_X*KZY@9^'NGY[XU%_P#XBO(A4SO#
M2M3JN2\VG_Z4!T^N?L8_$3P^PGTJXL-7,9#*;6X,,@(.00'QR/K7G'B+X+_$
M'P^LL^J>$]4\O),DRP^<"3U)9,YSZUT/_#UC6_\ HGMA_P"#)_\ XBC_ (>L
M:W_T3VP_\&3_ /Q%>O1S;-X?Q:49?@_P?Z <1XP\>>(?%T6F6GB&]N+B/2X%
MM;:";*"-0,9(/5L8!8\\"NAA^*/B/2O!VB:0NKWATVQD\VUAB;;Y;;MRG(Y.
MT]/2I-3_ ."F<NM0O%J'PIT.^C?[RW%T9 ?SCKRWQ9^U;HOB*>*:Q^&]IX?9
M?OQV&HMY;\_W"F%/TKU:.80J*-.MAN5+7=-)_@!ZIXL\;7WB[4$U/7[\W-X(
M4A$DA"G:HX_'U]35O4?&'B+XD)I-DRW_ (A?3HC;VRV]N\S[2<_,0.3T&3V
MKB/"_P"W+H7A-8FL_@WHDUS&H'VN\O6FF8CON:,X/TQ7;V__  5-U6U7;!\-
M],A7TCOV4?I'7-5S"<+*AAK\NUVE;T2O^8C>T?X&_$W6OW5OX4N[.*0@L;Z=
M+=..A92<\9/;-=QI?[&OC*]5'U'7])TX$_-'#').RCZG ->7?\/6-;_Z)[8?
M^#)__B*/^'K&M_\ 1/;#_P &3_\ Q%>75S+.9_PX1CZ6?YMC/H[1_P!BGPU
MBG5]?UC5)._DNMLA_!03^M7?&?AWX1_LJ^$)_&E[I,$=U8@FTDN)#-=7$^#L
MCCW'[Q/<=!DU\H>(/^"IOC*\T^2+1_!NCZ9=,"%N+BXDN-GN%PH)^M?*OQ.^
M+GB_XQZ\-7\7ZW/J]VB[8E;"0PKZ1QK\JCZ#)[UP1IYGBG;%UFH]4GO\EH!E
M^.?&6H_$/QEK7B;5Y/,U+5;I[J8CHI8\*/8# 'L*PZ**]U)15D 4444P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*16#="#]*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M03RE9E4E03['!-=&O[2=OX?\4+<Q>&--\3-H>NZEJ&@ZI=S31-%%<S,[912
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M8P\"/LD,>XA2>H W9HE]8^S^FUO\]_P!>?\ 7](T_P#AFV^_MWPCH0\2Z?\
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M@? ^7QUINA:;X6FT_59M0UZ\L8M;"7$4DD4-LDKEHF!PB@L0 -Y(([BK=_\
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M1(S%EC4DA 3D*,^G2F445U@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
E44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>formdrs_11.jpg
<TEXT>
begin 644 formdrs_11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )H!$P# 2(  A$! Q$!_\0
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M<6E'FJTJC9*N1\P(. >3TW8Z]0.N>F!1YB1 )*ID+XD4H=P5EX3ID?-R5'3
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M4?F/45#D_P!UO^^FIZ]/SZ_4_P JY:DHJ*O)?$NM^C[#NMDT_1IL6D+!1DG
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M' 'T%!O%-7NFO7J+4I92#@]0<?E45(.@^F/RJ)[+U_0<DW:R;L^GR_R%IK$
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MTUR#C&"2<EAC&.A!Y.<X[=P":@W] PXW9)'(P1C)SZ8&?;)'2G[?F!!(Z+@
M8P6'..>>?;\JZ(2C&DTV[W72_8RY)+IY[K^NA+'(58+GCH,'!X!QWP#G !'/
M&#]XDVP0XYP<@$@X)R1STZ#KCTY X JHZ_*J@9Z8X&1CJ0.,Y[Y/K3[4$N5W
M<D +NS@#YCD^_  '7G';%4FFDUU^7E^9C-[+MK]Y;^G<@?F<?UIF[G&/O#/K
MCCT[]*<2%8AW5 @WEB"0^WG$>.IR,<]>.F>*TDJJ\<7SM<2;!#;JFZ>Y+/M\
MJVBR&>51R03@]%&>*F<XTUS2:2OK_GZ>9*HU*ONPBY-J_P EY_C9]"]D(JDG
M[HP,'[W .1V()&,'.0<]*G23>H8L"V, >@ZD8SR1R3W./?)ZN/X6_%TZ>-6/
MPD^(;Z8T/VA+Y?#=Z;1[=<M)<B98V01",AE;E6#,0S <<3N):5%CE6XB=EN+
M66)HI[(QX#-<QMAX0?N!V 7S 01P,W1Q%"JG&E5A4E"RE&$E)IRU5TM?733J
M3/"5Z=^:&VKM*,M]?LN7XV_ROG(ST8C'3OD \?@?QH!R >F0#CZU"DBGYMQR
MP)$*8:1CCY=@Y'8!L]3D@ 8)F;Y4C.Y?,<;C%AM\2@9+2C'R@=\=#QDX(/=\
M,9-M/V<(SG9IVBTK6MN_):KJ8==>XHX(QD?,HX.!@D<8Z8]?6I^5QM/)R.>1
MT)P<Y]![U !DN"0"%5HPP_U^XX(B'<=ANZGZT%&7<=AW0LIEC4#>@(^\QSMV
MC(/7D9]14JI![2B_22?W),S2J^ZW>S:5[1_^1T_ T8Y!C);@@%<\GOD9[[??
MI4RN<'8PQGGC/. /4=@*HQG?=6]A:++J5[=SI#:6NG(9I[J212RI#$'#$OMV
M+UQ)G=@8!ZW5/A_\2="L!JVO?#7QYH>ELI8:EJ6@W,&GG*H44W3,(][[RH&1
MRASQP(EB:-.4(RJ1C.;M&+UE?;6.Z]7IUV.CV-1Q<U&\5N[K]6F_DGJ8#,3M
M(4Y!8YR,9+ C /., 9!QSFGB4CHIP3C!((SG'3Z^A X':H5#H2LH%NB*2\UP
M=J(_++$Q5G'F."I7!(PPX'0&08]Y)CWC,2R8!G#'(\KC!RI##)&1G%==Y1:4
M_M)<O*KWYGIJFUJF<LH22<W%\MWTUW?3T+I,G\*L!@#!"G/KG\,"K$6XX)!Q
MMZ'D!L]B><\G/Y'IQGH[# \Q2?W>54D,N_L^05'7@COD8(%3B9D;8X:(F58O
MWH*YW='P"/EQ]YAQGD@'-;JE/VG):TE:3NTE;?1]7Y(YN5O5+1W:OIU?<O\
M.?;_ /5C\N<^N1Z<+59BR,P\P&, DS9Q",<G+=AM((+=1G&36GHNBZ_XFU2Q
MT+PMI&I^*->U1BNF:)H%I<ZCJ=\^\(4M[:"&5I&#,N2#SN'RCJ;4DXU):J-)
MVFVFN7Y/=>:!0FW90D_-)V^_;U[=2F2<G"YQ[@=L_P!:-T@&!D 8 &5. .WW
M<]/\FNF\7>!?'GPYU-M"^)'@KQ1\/=>9=\&B^,])N=$U&Y0L566*"[CCD:%]
MIV.$PPVE20<GF,L,#!#L R1N0&D4\@H0,<*0S9Z#)Z=-L/5I5W"%*4).7NIW
M:3:WU;M;1V=K/IN1.FHM\T9)]5=O7KM=:.][-VV)$X8 AN2<<Y'3.?7/'7MD
MU8#8PI.!R023D#T/()Y(QSVYZ54#.'D&T-Y!4LZDM'M93R#QSC/M].M2I)OQ
MM!<%%<.F/+.[&!DDD,/NLIR<\CISU^T5.IRR7OJ/M+6=N7UV>ZTW(Y823LGM
MU;2OTU>GJ78G7YOG7^'DYQ_%ZMU_'\*F4Y)96'!QD=.G7'()Y .<\#C!JE&6
M,BJ 2KY#2*I9(MO*^81TWY(';Y3]"YI$! 5C(Q).V,,Q"#/SX!X7(QDD\AAV
MQ70JMY<C@KZ:>NWW_@8RI].6WFE=:>>VOKZ%T/MR#S[[L-W/.3DXS@=>!]*G
M'(&>>.?RJI&%:Y2S5HVE9&?(.X ; X!/=B#C Z' ZYP+EE8[<;"5.X#JIVY&
M.H..Y[\9P:)22J>S<5&:5[+K>R6JT_X>YSU(VLEJ[Z^[;IY7+G)ZLQ'IG_
MT E3E<9Z?-E@.AR >XQQ]357@Y& &YX]^WH??(J=2"O4[P0.?]T9![<G.<9)
MP"..:#)IK=%I)V^ZQ8]\97DCKC@'G)]#C.:D!C!"@#!&0>V3QCZX&?I5,C/X
M?3^H_44 $'(8_0G(([@_6@TC**BKO7M9]W\C41@%&< 9.TY^]DD\>PR!GIZ=
MJ4NI!&X9/'IS_3WJA$Y9BI("A2""?4G 4=QCDC/&X@4Z*=94D*C8L>1\XP"
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MC'?'3%=^$C03C[:2C:[>E]5T^_YG/6YG%\BNW):;:79SBS1;5)&5P/+?L<9
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MC\Q3&*@D* 2!CC "GG!/8X/4>U5_-5?F"LN.^W'7Y>V3GG(X/2F&=1@J&]P
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MG)!4G)(P#QC@9SR>HJNY'*] ."2>,$ X'<98@^_3..*B:8,6&>!@<!AGC/.
M3P>V1@@]>:C>2,X4G&#]W'4GIQC/?^[R?;!KGG-*35^OZ(V5)\J?*GIW7F2[
MT'&X<<?E5<OMY.68\D=__K =NW84>8G]X=_7\,\#G'7WJ$DGD]21GVR>GX \
M?RZU+J1L_1]'V>NYJJ<=%KTZOLK_ "W&\]USZDD<GU.??/YFE&>> O3WSU],
M>E+@^I_3_"DY!]<COQT^@]ZYI3BXM+=^4EU5]W;:X_9Q>BO=[>\_UT[B\^H_
M(_XT 8_7]3FHVE"$ANO4 9.5[$X!([@\=13&D5TSR,$G&#@@$CG(QCN<X/'
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MB0RH':V*!271F!X^7'&,[L]A7*Z<]H+_ $V*_#QV;W'F7,<;8 #RJI5A@J
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M '0\"V0ZD@ED;K@@ X/(R,9_QQQZU$JQF.2 X*R'YNK;=K;E"$\@;3V^Z?P
M4 @YRS'!7!X&T?=QQC. !U[G@#@?3NOS5'&%_9QIP44U9*SMIZI)/T/->KE)
MZN3NW=ZN[?XMM^NNY*9&_NJ?H3GGCV]:3>QZID?[Q_QHHI^T?9??+]&A-1>\
M5^/^9*LIP!NVYX 89/ICKSVP1P?KG$JN5!!+#G/R#C&!ST//;\*J8Y!YX(Z8
M]0>_IC-/\QCT /'4Y'/MUS]>GM6L*K:::6GF^MS)P;;:2MIU2Z>C\RZLI*D#
M!ZCG(;GH".G? _/VIP9>Z$<X)STYP>^<"J(E*DD@8( P 6Z9X/3/7(.!CD'M
M4H=R. H4CWS@^_K[XZUU1ERZ63N][OT$J<NR7S2_0NKMR"H]>IX/4'H3C!/Y
MU(K@-R HQUR2,\<<]^_^>**2-G&0#@G@$@\^G7O^?.3C E#OD\CZ%<=ASC(/
M;'IU]JUO;6]O,BHK7BM;V6OF7E96SM(..N/?_&D+8)&0/P))]_3V[]*KQN^6
MY .%Y /^UZDT_>^2,CM_#ZY]_:E[1QUC)W]6]'ONC!PLM8I>EB8$$<E/QR#U
MZXVD<]>M1JCY4DCJ">>>N3_".?Q_&DW/_>'_ 'S_ /7H#/D988+*#\O8D#UI
M0G-N3YNVZOW[@2G@9)9O88R?Y?7K3-_( 5\CD@GG'TW'V_Q!Q3VX&1V/?WX_
MK35 SO(&2,$CIU_'TX.?;TSLJDE%Q:3N[WU36VEEI;_,F2G=25G%*S5W>^O3
M9JVO<L&Y8=A]6!P?IMZ_7OP>.E"W)+?-@#T&<<=>HX)SQSCC!Q46!Z8^G'\L
M48'O^9_QJ.9]W\M/R'SP[27_  -/QW[=M"V9$)X4L/[P (/XY[=*/,3^[_Z!
M_P#%53Q]1U[GUZ]1UZTF/]@_FG]%'\Q]11=_S2^]D\\;_:_\!?XZ?E<N^8G]
MQO\ OE1_,THD7/&Y.HS@ 'GID9S_ /6JG\O]U_\ OL4X,P  P  >#ENISG.1
MT]/KUXPKOO+[V/GCW_!ESS1_SU/YC_"G!BPR'8CIU'^%4M[_ .S_ -\G_P"*
MII+$YW8_W1C\3G//^%%WWE][#GCW_!FAEO[[?F/\*AWS_P"U^7_V55<M_?;\
MQ_A3_-E_OC_OD?XT[ON_O8<\>_X,L!Y<C<6 YR<8QP<<Y/? Z5)N/_/0_F/\
M*I&20C!?@^B@'\Z;EO[[?F/\*+ON_O9+<'JV_E_P476RV/WA&,]QWQ_A3=I/
M_+7'U.#^BD?3GI53+?WV_,?X49;^^WYC_"B[[O[V*U/O+\/\BT1LRQ9F]-H!
M)R>"!C)QQG( [CM1YB=T;T^Z,9_/^M5 ,'.6/4X+'D^_M[#'6CY?[KX_WNWT
M!_2B[[O[V7S1[_@_\BWYJ#@J1GM\GUZ;O:D,J @XQUZ[?;N">?P]:I&-6).7
MQVYQD8'4?7/IGJ<TJH%.03TQR<TFWW?WMB<E9V>MNS+1F3ML_'_ZPH\],8^4
M'VR1U[#')]/>H**5GW_#_@F0F">I(/<#&!].*"6'\1/(ZX(ZCM@4M-?[K'N
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M627GG+#)( P  ,X/KG'/T([U78[!G;@D@#/ .3[>W-+\IRS*><GALEB2"!@
M<>F<D?05$%D8X<84'C!'H>V.W09SP3GGFHE44>SWZ_AIUOIY&E/K\A"6?@KD
M YXYYQTYQV.:50=RDJ1@G)( _A(ZY]<5,JJ!MYW<[>PSU&3W+8Y)]2!BD=5*
MX8?,>2=W !X';!'&<<'/0C-<TJCE?1*]MF^AH-,BJ05Y;@8'7!Z9SU SGVSG
MIFHG;(R 3CG:>=S\CD=..I([9[CAJE0Q49S][DY[[>H  Z#C''KSPX]N^#GM
MZ$=_J*4'KK*RZW>C\G=VU^_LRXR:LK;OSO9_\,0JIQ)D$%AW Y)W<X!Z<_YQ
M3"Q0G.!DKDXX./F'?((!.>HX_"GRN5!(X.. <9)Y '7IDC)'/':JQ+-]XC@Y
MP,]>><G)[GCITJY36B2B]'JG??3IZ^AT*%U>]M]+>=NXKMO]3@]3C! #8VCT
MR<BH) ,KP.C?^RTKN<[5X(/)(R,8S_4>],)).6.<9Q@8ZXS_ "%8FD596]?Q
M"BBB@8C' )] 3^0J!G8C!"@9!)&2>"#Z4I9CN&1C+#&.<9(Z_3VI./XAD=QU
M^GZUS]"DM4O/I_6_WC=R^OZ'_#VI&? RH+=<X[8]?\\]N^%)"@GL"=N1@X/1
M<<]^!] :K.S =R6]3\O'/(] 3TZGH3B@UC3BVM_P[7Z(';KC*D@#J">IR?J<
MX'T]@#" !T_S]?6ER2<L<GIP, #)./PR>:*#H22V ^_U_+FG9&TC(W$\#OCC
M_#]*;1Z =3TR<#H3U_"LY[KT_4&D][Z=K=[A_@2?8#J?I_C4$LBKC&"W8?7;
MW],$'@'ISQU620*!U)...>X.,@=>F2.X[U5)+')Z<X_O'.,EO?CICC..U1?M
M_7_!_(VIP22>NE[7[_K^B&YSDG+$C)[X&23GL,$Y(Y(R,\]#'4*O)&. .N/P
M]:7/)X/*L@QW8[?TY'/J:GC0?Q9R>N.<G R..V<CCTY[T/W5?KRJ5GWN:2=E
MS>FEW_6EA(D*N&[88'T!)&T#CK@@$= 0>>M668@$X/;&<=20!T)]::YVJ N!
MG@>@&"<CUX''OS4#E@I^8GD=<$<D#.,#IU'OUR*YC-3;:T6K\[D;,68]!AB?
M<GGK[ '@>A&>E)1_4DGZDY-%!84444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% '04AR1QU]_K51"6!/<-TRQ!Q@\Y]<X/%3J%(!*\\]-Q'!(Z_A7H'
MF>SL_BV?;_@D\>0V,DC:2 3G&"H&.^ .U355&%.0/;!#8/Z9'X?3O4BR$E5P
M .1W'0;LD''XG'';@TT[-.U[7_%6%*&E[W^5B:CK29'J/S%+5JIW37IK^B,Q
MRN1A3GJ &_'@'OGMGZ$GK4H+ Y+$CN,=?\_GZ57/'/H0?R.?Z5,&W*"<@YSP
M"?NM].^.<UI&>CY7;76Z6]O/R$X<SO9Z=M?T9<C.1\I)^4$#/..1C)R!CI@=
M\TV0 EN<X^]@],* !G^]QD^@//(!J ,1D D=^F",@CC/KUZ=>:E7YE)]<@_A
ME<_4@"J<Y-6;T7DD]?-:F4J;YFU'MT2>WR)06B&,D@_+P<8.2>K9R3USG(R,
M'FIHGW<%N<# +'ALG*GH>O3.20..!48RZ]<9)_ JV!CV^7)SW/%1!)!RN,$$
M<XY';/7V/J.@Q5P;=TWM:W]6\C%P=WM>[Z^?W%QU/##&0""/4#D#C@'KSTY]
M*1<*=S$ $$ =2"<'DC(Z+_3FF+,Q<*R$<C^8QGGIG\?;O4TA+*/W8)!'&!Z'
M/0_Y/XUIWVU]+KT[?(GEEV8PL7/[LD$=0<9.0,94].*F0LO)Z\>G4'(/';/4
M9[=:K ..0K GJ!UQVR<Y/?&?<>AIXD*\,K<]R1^0SUY'J._''*3:=TW^'^1E
M)2NU9?<K^E_\S123S.@QUZ\XP0"#@]>0>O2G8)SU/)'4 <$CIG./7OZ&J4<C
M#+*!SQSGL2.F ?\ ]0J19"V?F88R2!CUP2,XZ<]>O4'KC:$Y/1O1;=.OEN3R
MR[+\/Q[EHY QU&.<G!_E^M(&.>2 .V/F/TP""?<TJDLH)QG/3J/E;^N*>2#P
M57\O_KUM&:6KWM;:^G^?Z HR_EC]R_2PP$YX;GC</4=0"">,\_7)QP:L(Q/(
MR,'!&>#QZ=.,]QU%0 8Y[GO[#.,_3-.#,N< ')SSGT [?2GS1WN]'=;[B?/?
MMY*,;?D[_/8N"8@ %E'USGJ>3D'.?6ITD#;!U+=^V?\ (Z=NAYK.$G'*G/?&
M,=?<@]/:E63#J=O0\9(QSSC SCDDDC/(!/'(TYF^N_DKZZ[[K[S)-N<DW>U^
MB6TK=$:6-P&<'//T_6FLK'&&P1C!QR<=CR<CO_/WC$_(!4@'OQZ''\1ZG YX
MYZU,&##*GN!^H]?4'\C51FU*-W=<RNK+9OT'-)INRO9CD8IC<20-IXZ#!)/
MYP3TZD8]!BI_/&X+D$'Y@,KDL<KD$8'08QS^9%0?2F187+.&W[O3/\(_J217
M3S0[?>K_ )W_ ,D8.*?1?+3\BX@Y+!3@\8W8QC ZYZC!Y]"15E9,*HVDX4#.
M1Z>]4#(0,(3WR#D;3]/?)./ITR*E25B%R!R0IQT'S;3U.?T_*FI1Z:?*WY$2
MAMRI^9;\P_W#^8_QJ0$,,CH?PZ<']:JHQ90V.N>F.Q([D>E()3&QR."/8 ],
M'EAR!D'!XZ<C!JN:/=?U\B>67\K_  _S+9!/0X_#-&.,>V*KBX!.,=P.W<X[
M,>>WU(S@9(E\P>C'UX P?3DCMCID=P<' %-+:2U_KL+5:6MZI7_7\P._)P<X
M]@.V?ZT#S!CEL<?Q=OP-"L68CD @GMGC:.>H_P _A3\'U/Z?X"NI8BZ5VMEM
M#R5]5\[#YG_=^<5_D.#D=06]P0#U)]N><<<8_*E#D'(##C'4$]<]3G^GU]6<
M^H_(_P"-&#Z_D/\ '-5[>GW>W9_Y&<H)INRYMUJ]U;IML3I*QW??S\O\0!_B
M]."/Y?C4GF-_TT_[['^-55)7.#UQUQVS[>]+O?.!CH#S@=<^Q]*%6@W97OZ6
M_.QFZ<GHTN_Q)%L2$C_6;>HPQ&1R>ISS_ABG;QD?O >1P6&.H].?\*H[F]%_
M3_XFGAQD?)@Y!'3U'IDCGKQC'?/%:*HEL[>J7_!)]CY?^3(T>1U8#'<,V1VX
MY/K@_6D+D8P[G+!1\QXSW/Y'I[55#D')08_V>3^&<4\2J2.&&"#RIQP0<<9-
M:*IIT>N]TO\ (3I-/X7\GS+_ "O^A8R_0.Q/4C+#^>,T]6<<-D\]2Q.,X]#G
M'\N:@\X-T"G']X$=?3(]J0G=Z #/W2><XZXQT_K0YOI^C_&Y+@[[17K&SV[6
M+>\CC!..X(Q^&X9_^O3@P/1CD8)4X'?GL/SSW'J*I8'O^9_QI02OH1Q][G;S
MR1U]<G/I2YY7W_!$NF_[OI9+]"]N'^2O_P 51N'^2O\ \550,A.!L_/_ .QI
M25'7 '^R QS]"!QC.?PK7FC_ #+[_P#@$>R_N_\ DS_S+6X?Y*__ !5*&'KC
MZD?X^]5 4/3GUW@+UZ8P#GH<_A3AQT&>>Q'_ -;^73%',NZ^_P#X I4VEI#6
MZ^UZWWO^19R/4?F*,CU'YBJ^3Z']/\:,GT/Z?XTN9=U][_R,N2?\C_\  E_\
MB6-P]0?H1]*3</\ )7_XJJYR>,>G7&.#GL3_ "HQ_LK_ )_X#34EW7W_ .:-
M(4VUK#6_\W2R[6\RQN'^2O\ \51N'^2O_P 555BJ_>"C/U/\E--\V/U0>Q(!
MX]< C]:.:/\ ,OO_ . 5[)?R_P#DS_S+)DY(VDX)&<CL<4>8?[A_,?XU6\P8
MPI4GCU QCG'&,9Z>WYD\Q_1?S/\ A1S1_F7W_P# #V2_E_%_YEGS#_</YC_&
MCS.N5Q@$\D=L#MGGD8]:K"1L\@8]CS^&<#]:4OGHO_?6,?H3S^'X^J<DD[-7
MZ=1^R_NV^;_S)7=FQ@,N,YPP&<X_ES3,OZO_ -]U$<GKQZ!20!^6,D^_TI,#
MW_,_XU'/+^D/V*[+[Y?YDF\CJY_[^BE9P%;$A/!X+@CUQ^.,8[\^]0B4#C9G
M'&<+R1P3RWM36F&TC8>00. >OON)HYW9M^5M/Z^2'&BF]MK;-O[[DF^3_*K_
M /%4A9SP2P_W<*?SW=/:H/-;&=H_7KG'2F22O@8!7Y@. 23P3[>E9^U>N^CM
M]GRWUWU+]B^TON+(W?WG'_ O\*:6"D_-DG&03EOJ3VP#GD=!Q5/S93T;\P0<
M_F?;\Z0EV^]@YZ\D9^O!S@8XZ?F:3KM-J\?1M)_,J-)K5+7S:3^Y[%C=SPY
M[#*X [#I_/KWIIVX.,9P<8QDG'3\:@ _V5[_ ,_]WM1C'. ,<Y!Y&.<CCK4>
MU3>\=>TG?7MMKKH;>SC:UNEG[S[6?XMB$LI.68 ?[6T#DCC.,CL", ]J3=_T
MU(X&?G[GTY''OWS[4[&3G.1WSSN/KGTS^!YXP>5P/0?D*QJ54FTG;U;=O+6]
MWU>C2O\ <U%1T2[;MO;;<8&'>12?4G)^GWJ<,D9!4CU R/\ T*EP/0?D*C<$
M8(8@$XP, #@GC\1^M9.L_P":_I%?JD._I]PXL%4GKS@CN6S@\?KCT]JCWO\
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M*OA'XBL<#X;?$8$<Y_X0CQ&PP.H^72N^>N>,8ZFO]A]?BG^QVQ '@OPGD_\
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MC\1]12_XB!7_ .A77_'_ #'_ &#A.F*C?IK):^>G<_QV3X-^(0!/_"M?B0<
MX_XHGQ'C/;)&D\<^_/N,BJK>#?B.QS_PKCXC8QP/^$(\1?B?^03WX[GG.,#B
MO]C ?$K]CM>?^$.\'_\ A,:0?;_GB?7^70BD_P"%I?L>#@>#O".>A_XI?1P.
M/^W<U+X^KO3^RJS?>Z]=+LG^P<$OXF,C"W9RMVO:VO3\S_'/'@_XCJV/^%;_
M !'(.#_R)'B(^Q_YA.1@ >O7I4C>#OB(5R?AK\1N.5)\$^(P,],?\@GISR<\
M5_L4M\4_V.\_-X.\(YQ_T+&D=/J+:E'Q0_8\ER!X.\)G;@Y'AC2#Z],V_O\
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MOB,/^Y*\2C_W%TG_  A/Q$_Z)K\1_P#PB_$G_P K*_V2X_BE^QH^5'A7P4H
M.2?#6B9^7&>?(R3TYS@]N])_PM3]C/)V^%O!3$$@C_A&]%[<'AH<=O3KSUYI
MOCJL_CRJLEY2CO\ \-</[#PW\\O_  8__D3_ !M#X*^(P)/_  K?XB =<'P3
MXD. 3P#_ ,2HGVS^M0/X-^(QP!\-/B,<'.3X(\2#IE3G_B5#IGG &"1@=A_L
MIGXJ?L8M@'PMX&ST(_L#00<]\C P1] 1SP.E,;XJ?L8*"C^%O ZJPVL6\.:(
M0![DPYYSU_+H*SEQQ5?PY?4AWYG%W]+M;=?4:R;#1^U)W_ORZ>D?.Y_C3MX*
M^(V0Q^&GQ& .2Y_X0GQ+@@8 P?[+./3.1@@YXQ@/@KXC@ CX:?$7)]/!/B8X
M'&WKI?KGG))_"O\ 9;_X6C^QD8\?\(KX&\@'=Y@\-Z%L! Z$^3GIG@YZ<\@4
MV/XH_L7N,Q^&? CKT++X;T+''0'%N#QD]N.?6L9<;5V_]RGLND?\W^9:R?#O
M6\O_  9/_P"1/\:0^!OB,A&/AE\1<@$@#P5XH([K_P! PX[^@'44I\%?$?&1
M\,OB,IYR#X)\3'Z $Z6?Z5_LM?\ "T_V-"_EQ>%O!TLI((2+PWHKGDD9!,)Z
M;3P<COU-6#\2OV/L[)/!GA-'7JK>%]'##(W+G;#W4A@!U!&1QQ/^NM?_ * 9
M_P#DH_[%P_>7_@R?_P A_7<_QF_^$+^(HZ_#?XBGV'@GQ)Q]?^)3^'7.:@/@
M7XCGK\-?B*#C _XHCQ)D#_P4D5_LTM\2/V.EQCP/X2<CG(\+Z."2/?R <?4\
MG)Y/)/\ A9_['K$'_A!_"6.A_P"*7T<<'&.!"!U/?G]*'QE6_P"A;5?K)?AJ
M"R_+Z+M5KPBWHKRD][))WC_7WG^,PO@GXC)D?\*V^(N, 8'@CQ'V]<Z4.GI[
MU _@KXC@_P#)-_B'P. ?!/B,8&0#TTL'J/PP< XK_9OE^)G['40!?P-X0&X8
M&?"VC<Y(P.8#C\,XSWZB,_$S]C=& _X0?P>"_3/A71LMTQS]GR<9YZXSUI?Z
MY5WHLMJ1?=M-+\;&GU/+%K'$POTU^_[-]C_&,_X0OXC'AOAS\02<\8\%>(N>
MW'_$L!S^&.>E(? WQ(R<_#?XB!CDA1X*\1X;Y1C_ )AI/Y'\2*_V<W^)/[&R
M$>9X'\'HQY0'PMHV6&2-P/V;(YR 0>HQFG'XG_L;[?,E\$>$$*DA WA;1BS#
M/&TF D>F 0 ?;!$OB[%M66 DWOJHO3;^8J.%P5WRUX7MUD[6T[Q[G^,0? OQ
M&(Y^&WQ$W#)Q_P (5XDR!G!_YAV,<9Y[C!..*3_A!/B+V^&WQ%)]#X+\2$?D
M-/!_7ZYK_9T_X6=^QN5:9O _A)0,8SX6T4]<8X\@?CDGC(R>*>OQ,_8[*[T\
M#^$&!_ZE71>03VS!CIZ8XZU#XLQG_0"UI_+'])%/"85VM54O\$W'[_=U\GV/
M\8C_ (0/XCYY^&_Q$7COX)\2#J><$Z;(<<8P1VZYSE?^$#^(W7_A7'Q$./\
MJ2_$G]-) _.O]G7_ (69^QRKX/@?P?O*YY\*:,>"1_TPXZ8_/O2O\3?V.H<!
MO!/A %QP/^$5T<YVXR>8./O#..#WXI?ZUXO_ * G]R_^20G@,-)W4F_^WY/;
MI=1/\87_ (0'XB=OAM\0Q_W)GB;]/^);P,?7ZT'P!\1>WPX^(G_A%^)?_E::
M_P!G@?$G]CES_P B/X1P!DG_ (1;1\=#P?W&??C/)SV&%'Q-_8X)V?\ "#^#
MP0<9'A71ESWZ"#I^ )ZD'!-)<68V3<5@&VG;1)/_ -*U".!P=VG4DFM_?EOU
MWA^.I_C OX!^(Y! ^&_Q"7((.?!?B/!)Z<'3F&#SQWR<8(&(C\/OB5CGX<_$
M CT'@SQ#SS_V#?Q."/I7^T!+\5/V*8\)+X4\"(_'#>'= W ]<8*DA@>,8R#V
M[4X?%#]BZ0@?\(MX&7DX)\.:'@X!SD&WP> < YYY'(!K5\48R*;J996A9735
MK:*]W:6W5KM<T6%PNBIU:<]DO>=[[63Y79].NJ^9_B]'X??$?O\ #?X@#Z^#
M?$>/_'=.!S^G7/:C_A7WQ(_A^&WQ 8=R/!OB0X^N[3S[XQCWSV_V@G^*7[$\
M3;9/#?@)2./G\.Z$@)XXW-&N3CG .<<D8Y _Q9_8A"<Z+\.8AD9_XD.@*20<
M#)$;G /KM!SW!Q6+XNKM6>#DD^J23W_Q6_$OZ@E]F_\ W$;7_I!_B^GX>_$D
M\+\-_B%DY QX+\0G&.^#IO.<X(Y[=,YIK?#_ .))R!\-_'XZ@AO!GB/(]CC3
M^O7T[5_M"6_Q4_8@FN[2V73/AI#/=3Q06@FT;0HA--*ZHL:8M^KEE!!P&.,Y
MY-?45K\$_@O=0QW4/PS\#2Q7$<<\4T?AS1G62.50Z,I2UV[64@@X&<G&>:YZ
MO%U2FD_JTU=VZ=O\1I# 0DVI1LDM^9Z_^2G^&J_P^^);YS\-_'Y."/\ D3/$
M/H<8'V >ISD\YZ@56/PZ^)8/'PX^(./;P7XA Z=@=/)_,FO]SP? WX.@Y_X5
MCX)XY_Y%C2?_ )&H/P.^#9Z?#'P1GM_Q3&CY_2T!_(UDN,ZW2C%?XXQ?W7E]
MYO'+Z44]]_YF_P!#_#"/P[^)0Y/PX\?CMEO!?B''/TT\'/'KC]*F@^'WQ)W8
M_P"%<>/W!ZA/!?B(XY)Y_P")>3C)SZ8R#VK_ '-O^%&?!W_HF/@G_P )C2?_
M )&H_P"%%_!S(/\ PK'P1D9P?^$7TC(SUP?LW? S]*3XPKR=_90[:0A;3_MX
M;P%-]_O:_0_PT)? /Q*P!_PKCX@C'//@OQ$#R"!_S#1C\?R/:J?A]\1F&&^'
M/C_G&1_PAGB$<CZ:?7^YR?@9\&]I#?##P20?^I9TA>O'4VPQ^)QS5=?@3\%9
M"0OPQ\"D#J!X<T<N),YV.#;G!]5Z$>V:C_7"JGI3A%]?<5[_ "D2LOIKK+UY
MG?\ (_PSO^%=_$@-S\-_'X;:1M_X0SQ(3Z@X-@#CV].0>U!^'OQ(QG_A6_CX
M98*#_P (;XC/.>>38 $G@!>H]^@_W-Q\"_@Z6:1OA9X&W;<*/^$;T<^P'%O@
M'CMTSP35;_A2'P8&[S/A=X''D,!C_A'-'PTC,&1BJV^22<$G[W?N0'_KABO^
M?-+_ ,%Q\O[P_P"SZ?=_^!/_ "/\-+_A7GQ&!(;X<>/P1U'_  AGB/DG&#S8
MY7C.!T.>O0E#\//B0N-WPX\?*3C!/@OQ(,YY "FQP<X)SG) (&.M?[F8^"'P
M<=@9/A9X',D@S@>&M(R(QGE@UN.!D'D9R1CBF2_ [X-,J%_A;X)N-K_N0WAO
M22RR+GY>(,@#' /0# P.*;XPQ-M*%.__ %[A_P#)?J@_L^GW?_@3_P OZ^2/
M\- _#OXD#@_#?Q^..0?!?B3(.?7[",C''3/?-)_PKOXD]OAOX_Q_V)GB/I]?
M[//ZD\U_N:'X&_!Q_FD^%G@C>RKN"^&]'"J-I(SF G.,Y/?KG X8OP0^#I0@
M?"WP0JI\J$^'M'7<%/&2+?G(P<D_, ?4BDN+\2]Z-->E./\ \D"R^GW?W_\
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MCQ\=Q^7_ (HWQ(%?(ZJ18Y)!Z $CIP:4?#SXCY('PX\?$CM_PAGB0D<9.?\
M0<GU' .!SZU_N73? OX-I&F?A9X&$5NC&!X?#>D;T;;^[,:?9U#-NQY:]"<
M@C@B_ _X,KEH_A?X"5G7*,_AW2/,=\#<LBBV8\#C@' P"*?^M^(_Y\0_\%PT
M_$?]GT^[_P# G_D?X:)^'GQ'/3X;^/QP0/\ BC/$?WNV?] YXSQ^/--_X5Y\
M2?\ HG'C[/\ V)GB/_Y7_P"';CJ3_N9#X'?!P2,C_"_P0 A5XC_PC>D*KL5
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M344 0^3_ +;4>3_MM4U% $8C7'(W'U/4^GY#BI ,# Z#@444 %%%% !1110
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MS%CMQM=2!DKZ%3[YST(XX'7I6W]H3[?E_D3]1IWMS*][;O?;MWTW^9AQ>%/
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MSXY6"-&&F9I"Q&?+3=DD"A:Z+?U7^87O_P ,_P#(_#?_ ();?M)_#32/V?\
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M[@J%W<*%=PAP<JH,94$# W#!&>L\1"IR.2QR1WZ<DYP3SSC SGCU0WIO^O\
MD3T4S>/0_I_C3@<C/KZTKK35:[:[BNG_ $_\D+13"X!QSUV].,FGT.23LVD_
M,=@HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !5<G_6^Q3_T(FK%5B"3(.,,V#ZC:3C'KG\,4FKII[-6
M8+1I]O\ @$%R/]$N >A$F<#/5."!GUQZGGCD5^07P4F-MX1\03N2L0\>>+T9
M<[2O_$ZG&=WHP.[ 7W)!Y'Z_71 M+C.<8<G')P(L\9XSQQFOR%^!,[S>'/$!
M"1W$,WC?QDD\#A8Q%$NL7/[S,K$95?F8<DX.W # \.<RJ0R/&RIIM0E2C*W\
MM5J$;+K>6CMLM7T.O*(QGG>%C/9Q<EO;FO+?MMI?\SVJ(%BSQLYAC"L)2I$;
MAAP5&>0 ,'&21QWQ1/+%&BOA26P,J,]=P !&?3MTX['%<X_BWPA9JUHOB#3V
MFBS'Y/VM<+'R"S#;C,9R&(8KPN ,$&*?QEX1:)/^*DTHJ>C+.@ .&X!!]<\X
M/3'88_.Y82O!+EA-:1NHIV3Y5S6LN[T=M3[^EB:5:4E*=.ZJ5(OGER_!.4.N
M]K6]#::Y1W4'(/.'89YSD9(&<CCZ<YP>!9FFC%L4\Q=PRN<<$ ,ON>O)/7GK
MS7)/XK\),BY\2:7VQF>,-T/7Y^OOW[YHM_%7@\N0_B72R!D &=>@QQ][VZCK
MSR<'&'U?$-[U=7M:=M?D=-Z"T]OA^UKQ?RO?\=NIOVLBF18]ZLV"QPS9!Q@9
MZ]<D$YZ;<X K722./(9ER%4<$') R",9/(/7&!TS7%6_BCP>MU-CQ+I0!7*X
MFC!&#S@G/08R2#P>F<$+)XP\*_:!CQ)I709'GQGOCGYE'H!S^'7&\<+7BM95
M-NS_ .!I\]SGE.A%/6EHNDHOMY6-J1%>_$NY5'3G^':!R#T)..!CTQD$$ZC.
M(V0(R_,Q)8'<#QR.F>F#C&,$'L17+S^+O"2E)!XDTH-GD&>$*>F3U)) ]ZO7
M/BSP;]FC<>(]*+8.=LZ$Y.,@89<#&!CGC/)XQ<:->_Q5/E%]O+I_6YE[>@NM
M/Y-/\.QUJL, F1"6 +''7V/7@=!CK^5#*6Q^]3@D_?4DGL>#G=UYY.3Z\URU
MMXV\(BWCSXCTK<1@@RQ=F*\_,>_&22,\#UII\7^$Y,X\2Z4%')S*F<8)YPW7
M /3IC'I6L:&(?VJO3[,NM^W_  2%.A)NTJ-WK\4;_-=.VN^W0ZF&Z1@8\ERP
MR0!G!4@@$X.0>2> "<DXR<Z7DB!"[@+G)P< D$'DXYZ#!.,Y;'()K@-/\5>#
MX9CL\2Z<"."6G0@Y)(/;.<X!SQSD$UOWOC'PC)$=OB;2_,$?RC[0J@G@8);D
MC&"0 /7UJHT*OM$I2J/1.S3MOW??[C.>(PU._-.GH[-*4;W\E?\ '_(T;>5)
MKAR';;@[CC'13CMAB2#[ ]>PK+OM]XX@M5,S[_N*,M@@EL\#&[G'.<9 '&:S
MD\6^%(X-C^(]'$S@<?:X^A/H.3QTY[G.,U)!XB\&(C22>)=.26-?.C:.ZC4[
MXCD*7SN*G/(.>V&4 UTQI5_:."DHQ5E%<O-T3WMW;\S*.,P[J<KC!J5E%Z.]
M[:O6R[?(HZR\44#VK2I',%!*%@&&T?=8@=?0?B#SBO!/CSX1UCQ_^SU\9?!?
MA^)7\0:_X"\4V6EVC$&XO)[C1M0AMT@C',PEED5(P6!).,'(%>NZKXG\)WLU
MO;Q^)=*-U=7:ON::!R(60KM*AM[?O @QP &P>>39MPL7G2,PFCB\DW4EO\K
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MNAVDZP211RA68;L#)QR%')9LXX''7K@@] E_!:(B&01R*@)7[.W4?PD;L\G
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M>VBJ)V]7?5+3?74PJ9_GE+:K3_\ !#VZ_?;J>BG]K?X,6[1&;Q'$LH4@*LB
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MHH'Z5^51C)P@[7E9\VJWYG;5[Z6Z_<?HK5I25V[6^6@M%%%;B"BBB@ HHHH
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M#DR?#/1EEC ,L?\ ;NNDQXXVG.K%R&9E''S9Z< BN+UK]DB7Q!\./#_A2_\
MB-XBE\9>%K^_U#1O&D>I3/JP:^ #I<WQA:9L0(JA8F"EG''!(XFT_8V^)NE>
M.?"'B>V^.OBS4=*TX2#Q5H.KZQ?2KK9\U7#01-$(F81Q$(9LC:S<$'(S>#P3
MTLNUN5?Y?U\C*5:M!I4ZLYQ>C:E)?@V^WZ][^PP_LC?LG7F_[-X \/S,)! R
MP^(M;<1SKN+0MC5]P9< L'&[GC&":M1_L?\ [+]RWDCX6Z:Q4\^1J_B"XC4;
MBN?,&JL"&VDX).!TQFO'-8_8;NSXK\2:UX>^,_CK1++Q!JEUJ]OHW]NSQVMI
M<7) $,,$492.--I.$5 %)4 AF"^Z_LU_"'QS\&_!MYX:\:^.+OQO??VI>W$.
ML:G<W%]/)97%R98(C+< 2 Q1YB((^Z%4DJJA9^IX.-Y*,;I/>"_X/]=A>WQ#
MT<IV?]Y_UMT(1^Q;^S%M /PJTP=\?VMXE[\YXU4#)')QP.G2I!^QA^S*H)'P
MLTM<@9(U?Q%D8!&<?VN3QD]C[YKZ;4HP!3#+U#+T8>F#SC(P <  9! Q3-G?
M<V1@XSP3T R">,\>U..&PSCS*,8VW]U?Y+3UO]XXU&G?VTHOJKMM]K:_?===
M?/Y6O_V,OV<'CW6GPQLA("0 FL>((UXYY+:BQY SG'!Q7%W?[)7P1MB6?X/:
M?/%&P.?[?\0;V7!/1;\;L9SP 1]TYR:^V[B2.-"TLPC52"0Q'(+ 9. ,#.,\
M\9&2.M</K/C'2;-FC^:YEVD!44$MP >2!W7)^IS[GU3#35N2,7;2=M+>2LK[
M_G8\/-,0H6D\9[.3^&_/*[Z1:4KW[/\ #<^1H?V7?V9Y;E9-0^%1MGY&U-6\
M0.G8<YOLC  "_-\P(STR>ZNOV0OV9Y+*.]C^%MI(@*;D&K>(%/DL0'W8U#(Q
MD$[0" .N1S[MHVJOK3INT@"-B-SR1*0HYY)V]-J'KTX/?GLIK.);>2VC 3S(
MV0(JE5!(^4 =,8& 0><CKWQI8*BZDOAEKOR[[+=]ONT(P6(QWL74<W*R;C\5
MVM=FW^'HS\V?VI_V9/@CX'^#NM>*O W@*UT;5[-(YK?5+?4]<FFM1YD1 CCG
MOIHB >SH1G@\' \<U[Q+JGAWX+OXDTME&N:5X52\L#*0$$L5@]P9)B0?ORQ@
MY8%HLYCV$ CZ7_;FUF]T[X!RZ5 1F_UXZ1,-W2W6'[22>?50"#GICL*^2?'T
MD/\ PSUK\:#=,/!:>4N.&QI$F0<C@9[=N.WWMLJRS!XSBS)<)B(*I0K9CA,)
M5@M%RU:^%]HW?>+ISJ0:7O7E=/1'T$Z^.J\/9O6IUZM*M0PE6HI.5TI1PM>:
MLHVDE&4(NSU:C9.]C\)E_P""IW[4L,T4ER; RJ9W+HMB(C-%/+#%(P%H(U<X
M1@BE%X4E2,@V&_X*R?M5J)Q+?Z0ES< A#"]G++(C$9^U 6C-%&, 94KARJ\
MXK\]=#3S_$&BVEU<%X;OQ#%97%B&P9EGO9 47<RJKX(YR,$<$D ']H;_ /9X
M^%,6J:?X6\4>"])\'_#[4?A_H>MW/CZ[MK2&YN-=U)&!M(+E?-F1HY0I8,H#
MJ'&<D9_U:SG@#P4X:PN3X67!6!Q$\5EV'Q->NXSYVL+AJ-6IRWC*3G.-6T7K
M:TN9-21_GQEGB%XA9JLU:SK$*C#,:\:=13GS0ITJ]?#VCSRY;N5)25UR\LK/
MWD?,R?\ !4W]J:-4CLGTF+!$DT$DL#QSDY+RM+(BR(%&2H# ,7QM"\#3M_\
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M!Y4@MAEA@G (! &0<&F?\/?/VLHY(X3=:+'*[M&/->SA4NN-H)\EB Q/)W8
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M5CR0.!LQR2!U)5+:(\%) ,#@%\+@= ,],C@Y^@ K?,,:36RRK:VT;H[C[0R
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M8C2!<.P).><$<XX/<  Y!(/;@>LT;L!Q\V<CN!D@$'GD]_3KVX%5HS(J?O6
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M#O!HB/BCQ'H>ASRCB'4-2M+>4$[L'$TJ$AE!8# VCY1G&:X^']H+X2RS%?\
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MIRE2Q6$G.@J\9TU[_)%59N2YE*S?W+<OF7IAU^Z!GD9QGTJ9&(5BY PW7/;
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M=:?>BR9%R%# %3P. 1E@6(SWQR..![\5+$Q,C$L"", >XZ\8Z#/!S@ @=35
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M 7DLDE@1ISQO"HMRX.T@@A3G'&/L8_\ !*?X%P9+?M*Z%/##'Y85==TD%&W
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M8? 8>I&[IQ;5.S3O=KXM]VC]-/C!9IJ&F>&O%MBK7-G?V*17K!60$DIMRR\
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M<^;+K4_B%9:C)H-QJ_BQ-=#!CHJOJ8NP"6YMU\\2S(=KDE8RO#-RN,7+._\
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MW(4D$8(R#UJ>S^)7Q=U:9;/2?B+XXNKV&%I+F.+6M9EDD8?+Y<4,-WNSC W
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M8"AF']W'Q/\ \$N9)3^W%-#M3[-_:?C5#/M*2,IO+L-$T9&[83V#+CU('/\
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M3^'?V6K;]H#Q#^T=?^+O$FIVMM>ZEX):[@N+&:]O899%@+_VU.T84';*/LO
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M[,^WOV."Y_9M^#SXR1H-YO.2<YU24@ <#C:,^V,5Y?\ MC^,M9^ ?PZD\4^
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MH^"/VVO%>D? #38/'OAGX>Z-K_BGQ)=QZ=JE[/I<-W>307JM'.3,=TP#+M)
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M:(^(;^#M4T36?AYX=T75+7Q9X3\31?;':2ZT'RXK6RO8G@@4)=N"7BF=T?S
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MMSD[> 5 ')P,#)Q7YZ_#FZO9-1OO(D!EBY &<EBJMM.6.1G(]22,8/%?5?\
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MH*Y?%2G1Q>4X:,Z2Y(24FY7=I\UTTWJKOI>RU,>%:]; NNXN7/*3:2O?S?\
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MJT_'<J%%+9Y"A1P2/;'/8=2<#C/K4ARK9QG*G# 9! ]!QC!.3G(/TZ*\+LI
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MI&A8%@2'Z9]1T YZ<@''8#MD'<;?XHXUWGHW7@Y)' 7G.<\XY-.2&16))SD
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M 8YYQ@#CDDBL/8R:C"I/FM&]]=[O3\.G?74['6A3LZ*:YU>:5E:6J=[>5O\
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M<E*M+EE&#:>[T>FR3[+YGR<?VG/VH? /Q]\9>)M(N=>\5:=!JEYHQ\#FS?\
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M1^*]U\,O#OP;TV&.]O!_PC.MO>:B([JURB/'K<C6ACL7+.8P.<##'H0>T/\
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MDTG3M.1#(+4W&[[7)IL<X2,ZBR 2H3US7:Z7_P % O'>@L[>'/\ @G!^T1I
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M]Z*RD*6!&5Q@Y';)P>*YN:.UUOW7^?<]MQDH6<7?FVL^_I_P#M]4O T]M8Q
M,OW7*\E@W!.,CGVYQFK?C&]BT+PQ*T) B@M//<D[?N+N;/3!/(!X.3C'-8&A
MO!JVM"6*52(I1A!N+85SQG;C/!YSGG)[UX=^T_XIU71+#_A'=-F+7>NM%!;Q
M D.B.<RDH<$*(R?NAB!C.,Y$U9<M.3T;5K:K5MI);]6_T,8TY2E)<KU_SO\
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M69FQCG=E1C) ^E;V:5VM._0WNOZ3_P CYLN-3GM]4U'3-.23S9[E$8@$DJ$
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MGW%_W5_D*_D2G\$?\*/Z7CO+U_0=1115E!1110 4444 %%%% !1110 4444
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MV?O\W_!4_P#9/EN96N-8OI)]0F"WMPUA=HJ6['!CC&]\#:<##J"1D#!I)O\
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M[UW'Q!^#7B_X<>,O!WP_UR"-_%OCFTAGTBQC=M\4D]Q%;)'?*,/&09 #L&0
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MN8F:=DB+?=^8*S-D@+GO7'_%"Z;3K/PAX!TFX2S'V=([MXVVLT3-&"?*(QN
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M^TUX@_:Q^"'[0NC?#"\\=Z9:Z1K>FZOX?AU) VFZ0=%1V-S/'$PE8F51Y:X
M\O:<"5NGA^$7[=MR 3^VUX(R0,_\4%I8/(!(P)\#DGT'OTKYMU#X?>*OVG/^
M"A7Q<^"FI?&_X@_#;X<_#K0M&OM)T'P8NFM;W=UJ&@-?RM="^MY5B,4\>Z)T
M9-X.UE+_ ##Z:B_X)QV* ;?VL_CXP_O&#P[N.,CC99!..@*DY R#FO<K_5J5
M>=*C"=U%2DHT6^6+ORQYDFG9:6OI;I>[\BG*K."E!KDMUFHO;^5W^5_S)O\
MA2O[=*KO?]MGP2%&",> ],49QUW&X/3@=OJ,<>7:_I7[<NCW,EJW[:_@N[FC
M8I%(/ VE#RMN2.?M6%( 89+KDE@">_J$O_!.2UNHC;']K7X^[6!!4P>'MOS)
ML(&+)2021_%D],C-<<W_  2H\'SO))-^U/\ 'F2=GVRG[/H!'FEPH!!LV<*&
M8<!\@\[MH*G7#5\%#_>*52?3E>'FW;[24E=JZT;T^>QRU/K+NXS46E=-R5DU
M?5^2?<Y*PTK]OJ_'/[9O@J21<,)3X*T908\J/)!^VMR68'\#7>Z7\,_V^+[;
M/<?ME>#HH=JL /!>DOD'O\ET./3VQTQ5C3_^"5_AP%8M/_:>^/\ *(W(9(H-
M 8I,"06+&S ,87@*<$MM^?\ A;7M_P#@FY;6I?/[6_[05F5>2%+6:#P]"NY
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M5'Q\,KC<J&UT!5 . =Y-H=N>A(/ Y[#-7_AUGX2ED 3]J#X_M(D@2=A:: T
M8@L=C&R&(\#:26;!/7M6[Q>3.3:P=9*ZM>A46GE[RT_!OY&*AC$DWB:3YM5:
MVWS6_P#3/-(4_;WNB))?VN/!Q=@N''A/1E51M.5)6Y'1B.",,1VX-=+8^'?V
M_KQX;67]L7P24D96*KX0T3* Y(X^T[F([X!![=:ZV;_@E7X:M[:%'_:@^/\
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M_"C]E*?X(>&]>T7Q-XKL_'?B+6M?G\1:GK]I91V<4ES-'MD C0N&,C!F#AV
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M2.#D>35^E?#O_M]+]6']O8?:5"M%]M'_ .VGZR45^4R_&W]L!S@:/X8([?\
M$[T__P",_7]/Q7_A=G[7T>]GTCPN0/N_\3O3L'./^F)//?T//L4\GKI7=?#=
MOX@_[>PRWI55?1:;O_P$_5BBOR/O?VA_VM;.(LVB>&7*G+DZYIV  .P\GC)R
M!^><=..N_P!J_P#:QMV(_P"$<\,OV 77;'KV.%A8G\L=.W-4\FJI)O%8-75[
M>T=UTU_X!JLWA+58:NUT>BO_ .2G[0T5^&NI?MJ?M;:6C.W@_P -R(N6+-KU
MJ"0,= ML,Y]?;IU->:R_\%&OVJTO9;4^!?#C[CL4C7[<;23@$_Z.#P03QW/H
M<"7D]91E+ZQA6HK=5/B[I:]/.Q%3.J=.,I2P>-:2O>%%SB_22LM.NFCT/Z%*
M*_$#PS^V1^USXAC4#PCX:@WE"LC:];G .T_*#;?PX((/4Y/0Y'JZ?'[]K.6W
M$QTCPT'POR+K>GXY )X,.X^@[^N">=%D=3DHS>.RY*M:T98J*E!M)VFK:-7L
MTF[/N3+/L+'"1QGLZWLY2<)1<>64)+1QE=-73T:[GZT45^27_"_/VNP3MT?P
MQCL3K>G\=?\ I@>.O.<>]4;G]HC]KJ!)GAT3PS(88Y)&7^VK%VPG4;8[<L3@
M$X [=>FZ:V35*,W36-R^M-7]VCB8SD[=(QM=MZV6C=GU1-//\-.,9>QK14G9
M.5DM?/EL?KW17RC^R;\7O%WQH^$^G^*?%UG:Z?KYU#4+*\2VN!-$QLKR:W)R
M@55P8B1@ ,&!QP<?4J.)),J3PVUAR &"9. >J\K@XZFO+JTI49N$K<R[?UU_
M(]>A7CB(*<59.VC=]_DBS4)^]+_VS_E4U5)3@OSCAN_^P,?KT_2N>KK3GZ?J
MC9]N]_P5RM>\V5T.G[B8GO@[6X./J>>G!ZBOR\^%S9^!?Q4'&!KWC<XX/+:A
M=$GH?[S=\<GVK]0;XXL[L^D,Y_)17Y?_  N(_P"%%?%(\ GQ!X[[\X&HWV!]
M!@8],#'2NZC'_A(QKO\ \NX_E?\ X!P5*DHYM@(Z./+7AR_WJL.12]([VM?L
MSZG_ &2K?[5^S+\+D8X_XD\S X&,KJ=\!P!VZ>W?J*]C\2^ - \9Z1=>'/%N
MC:;KWA^]AVSVFH6L%W'(S;U8LEPK)]TC!V@G/WB, >5_L?@']FWX7# (_L.;
MCCJ=3O1T]<<]*^D1&$##/[LY9W8D'@=!G&!\H/)&>GTY*%>KA50KX=RC7BZ<
MX58OWZ348ZTFK.$KJ]]N;6S.FM0H5DJ6(H4J].+<>6I&Z5GRMV\WKY:'QCX;
M_P""?_[)OA7Q!!XIT+X+^ ;76[25Y4NX_#6C)*&D)8Y:*S1\'C"ER 06 YKZ
MDBT+R/+@LX=.L;2VB6&T@M[>."&WC0G:B11*B!1U"A2!T' (J6;Q?HL%Q+;E
M[J9DX?R;4R*,#!.]&.>.I. ,D9P":L67B+2[Z86MNSJ[P^=$+E6@SSMQAPQ)
M] 0-W*Y()KUL?FV>9I.GB<QQ^88N5*"C3=?%UYQC'ETBXOW9)*RM9*RML<%+
M+\#2KM8:E'#PUO"A[EVM/DO+_,A&BSR';'>0!\?.8UV[N03D#@Y?DDC)R,'D
MBK T*8J$2Z4 $$A<GH"">&]QZ< "MQ(A&.@S(=Y&3QDC@$<'EN@[+GN,2'/\
M.<X/XCC()SWXYZ\5Y?UJK47-4Y8M:MZ1BO5_/7HM.YZ4*5.FK1C96L[ZO\%\
MSG?[&G4Q/]N \HY7J0&.,$#=CH&Z@@YSC(I/[&N]C1K=0,)F).]6))P2V.<\
M@J1@XYZ8K1N[V"P1[F\N8+>VA1GGEFD2&&")%R999I"H1$ &6&5[G Z\#_PM
M_P"&C(DK?$#PD1)<-;1K!X@L9VEEW^6D2HKJXG,A"&/! ( !)R*Z:5'&8A*>
M'H8C%0O9RPM"MB+-WM_#IR5M&VW)))7UNC*M7P-%J-?%86E>WQU80:;Z<LFI
M7Z;;G8#2+A9%GEDBG91M1<!HP"I!"HP*CH2#C<"3@YX+?[)N\,SSQQK,5Q&F
M0.<8) QDC/./<UL6MS'/'&\<BS1.H>.96#"1&&]75EX_BXQGG&,Y%6MJ@ .2
M'P2,'A0>."#@9'H>^/:N>=:<%)R4ERMIQDG":<;W3BW>-K:WUW6Z*A[*HFX6
ME'>,EK&2>THNUFF<^VBW+*$%S'_L@H>HYY/!/ .<DD]Z8=%N-BI]IB/7.W.3
MA@PYR>%(4CH1P!QG/2%G52IP=PV(0><D$9)]!U'?'OQ7!_$+XA>'/ACX4O?%
MOC'4)--T?35+7=W!";AV55D)58LJP^5"<Y !"\GJ:I2K5YTZ=*+G4J2Y8PCJ
M_7?7M:ZUZE2C3@G*22C%7;^_R\C6_L:=<+YRYY.X$J1DDG+8R>K'DD=NF*!H
MDC'$DF0>Q.X \Y//?.,D\#J<$\>5?"#]H3X;?'NPO]3^&>LSZW!IAC687=L;
M,@N_E8"F1]WW7;MM*KG@@GWA"&V#*<. 0A! *ML8=R?N[B3CL,<9J\3]:PE1
MT:]&=.I&W-&3M)<RYHWC9M7336KT9AAE2G.I7I[3=D]/LKE=K+O&VQ\B_MEV
MRVG[.WC.$.7_ -&8#!P.9(C@8/(''(/?'08K\I_CM+''^R9XD0AEN!H.EK;C
MG:S-9KM8C@%5?)/4!03VX_6C]M50_P"S_P"-@ !BU !P,Y\R$$C\,'_]5?F9
M\4O!>L^-_P!FN_\ #7ARRAU#6M3T"PCLK66X\MF"V0W!2JY<C(X ( /.%-='
M"^,R[!\<\.5<VQM/"8>684,14K3C)QI0HSH1DI-->]*,9.,M%%:M.S3TSC#U
MZ_"W$6'P>&EBL5B<)4C3H4VE.<I8;$0NKIWUFM$K]%9NY_+'\+_$L/@;XE?#
M[Q;?01W=AX;\8:=JNJI+L9'M[6]E>5 7&UM\:A,'C'!#$D'[Q^)?PD\#>._B
MI=_'ZY^-5MH'PXU2S@O[V*#4;I?$-O-*[3C1M-OH"/L@&'7[,J"(1(Q(.SCQ
M./\ 83_:@5)(8_ <5S#<RS21W$U]+$+?YPR[2MNV[(RH# \.^".<0Q?L*?M1
MP^;*/ LK1RQM#+$VLWDEK*H=68K;R0BW"G8,@)SCIU(_UKQ'%?AMG=#*L;3X
M\RFA4IY)#+Y1K8^G=X9>S:48N<;5&X1]^VFK/\[<)PCQKE$<U<N$\PKSECI5
M(_[)*Z=[6:ES-O5[6_ ^\M%\8^ ]0M_AWKW@KQ/X3L?@MHNA^*+#Q]X>U2V$
MNN7M\^^#3&N[F3;)<W%]-!-/%))&[,9")#_#6SH'Q?T;QG^T/\/_  /\-KCP
M>GP^C^&$<UO8/I:&UTC55OR87U%,B*::.,EV#;<!>3SFOS<O_P!B_P#:)TS,
MMYX3>RB#;GB36;B. L&##?"BB%\-G;N0D$J05J?PI\$/VB_ VJ3ZSX4T4:;J
M\MO+837D=RUPS6TH9)(4W1_(,,<%< ,2P(QFOEL1A_#C%8;%37'^72Q%7FI4
MI_VG%TJ:J-^^Z:JIR4>562=VM&TFV>G2I<<P@H3X0QM&.CYJF"Y%=;1YO9O5
M]K:V>Q^D>C>-_A]X'A?PK\=O$O@3Q+\4[SQ5XR_X0WQ?9Z;"VEZ!!=O.VE17
M$3?:) D:FVA?9/&J[5QA\DY'A/XC^%_AYX67_A9OB+P+XJ^,VF^$_%,^A:MI
MEE&FFEFNKR?2WDMI%D=98ECMU3]X' 7Y-KD&OS9G_9;^/%]<7%W<^%Y[FYO)
MWN[B2YU&:5FGN#OFDBW!S"S/SA"G.,^@FC_9&^/L\D,D?A>>>:( 12RZI<RR
M+&K%RFYE=]NXD[!P2,A<]=HX;PU3PE^/,NJ1I4X*K!YKHYPC!2E#][:G"IRZ
MP3>O,VVY-CG3XUTMPUB%;>U#_*EJ?IE^S!X_\ Z_H,?BOX@^)O#-U=7?BG5)
M_$UD%@MD2.>V>?RYX)'5Y;2.<0KN108W92A0JI';V/QB^$^J>)/"<OB[Q%X8
M\0^&-,E\<6N@VCVR,NEW5PQBL',<V4C =H3 0"&505R>3^5:_L5?M*7);RO!
M=Q&DNXS);ZI?00R*S*V3'%"B.795\S<I+@#=T!74_P"&#_VFKE(@G@F<QQLD
MD:C4KX>7(&5T?(@&?F"@X S\I).,UPYAE/AOCZ]3$+C[+Z7-.*C3CFBM&,=;
M^[57O/FE'FLKK39&U*7&4*$Z;X6KSJ2E)IN@M$XQ2WI;)IZ::L]._;G\8^"=
M9T/X:V6B2:!=>)M-M('UC6=*MXQ*=/$YW0"2-#-'=E7C578A=R@C&!CV8>'O
M WQ1\5? 'XYV/Q)T73-$^&.EPP^*-#U21I-8E%AHK6[K!*THV%)_+##8QYPO
M7;7RS%^P?^U69;B?_A WN9[DJ96FO+FXX4?+&IGA)2->H12%R<K@\B$_L"?M
M6F42)X"NHCSNCCU6^A@?=Q\UM'$86X')*DGG<<DU]%C)^&<L#E6'H<>9?&I@
MJ;A5<LQC4<FZDY7353W=)+>]K*_8\N.$XYC5Y_\ 5>K9.ZC]6=_O]E;S/T?\
M*_&'X2>/] \3ZIJNK^'5\'3VVJPW^J6ZI9W_ )UJMPD$&JR.$N+^2X55-DS1
MR1J.",,PJY)\1_V=AX"T^YTNX\.2> M-^&T>E3Z8D5L'O]>BD+&^N(_+032F
MW#1LS1#<N23O.^OS8'_!/;]K>4L8_ -RJGEX[?4[Z& G!SOBCMU1SU.60EL\
M\$YMC_@G=^UHB!!\/+A8^C0IJU^(@/NG;$+<)D G:-HQP3WQY&+R?PMQG-B9
M^(N'I59U*;Y(YHU"'+.#E[L:JO:SM;165CTE5XQ4;2X-Q$IV:Y_[-E;;?G<-
MKZN>BM>;5M#[6NOV@O"VH_M">'M%TO5?AXOPRM?#.E/;0SZ1#*+6ZGT[]\]C
M-&HAL[M7.99(MKLFY#@$BODK]J_5/!+_ +0_PAU?PUK-CK%E=W]E<>(F@;>]
M@B:DNYFN.8UA\@LXC9\J",@!1C!/_!/+]KDQ*1\.Y552 I_M&\$F!T&];8.H
M  VCICY<$8-,/_!//]K61@!\.G=RI0/)J-VTB@K@[&D@W;MH(5E.5XQ@#-?1
MY1B?#3*\14G1\1L%R/"3PZ4LP@[WB[2;J3E&RU:CI=OWN;2WG5X<=5&U#A"\
MGHO9X92GNK\L535W:_72S/OCP7XAT_P]\6_C/;RW^C-#XS^"]A9> _\ A((X
M[W3;Z[.I17,",LQ$$MN8(?FC$FU5!VH!FN'^)FD>"OC/<_!SP%\0/B?X9\%Z
MIX7;Q#>:\O@YV\.:-+9RR120V%U:6I$%Q+>1;XW7.R0.SL"=K+\U>)_V)?VW
M/&UEI%EXA\(RW$7AVWM;+2Q;ZC<V4T5C:+Y5K:O/;P"23RUX=F8ALDX.YJY=
M_P#@GM^U\9V,OPZN()C'\MVVNZC*^R, ; [6Y<;AP<D#'&../F:>6^&\\5BL
MP?B'EWMZE634_KN%G&,I<T8R49NS<5;1JS=[JV_H^TXTI1IT)\)8]4)17/36
M";DYZ6LU'1?%Z:'WOX#\4IX2^)NL>'+SQ)X.TKX;Z9\--2\*?"G298('TC5#
M+,)+*+5K19#;7SS7,A2<7"*7A?>6P%VXOBCQ.=7F^#WA2YU'PGIOQ'TSQAKM
M[;Z7X(M+;2M$MM)?39&BNKK3K%W@B,MH&C9IBP=22VYOGKX9_P"'?'[6DD;3
MS^"96,G6V/B74/-3/&$<P%HP H4*A"A5 & ,5TOA+]B?]MGP-J=SKGA[PC';
MZM+:^1'=7>L27\UM9S1M B@W,<AB9T/ENT; ^42O*\%K >&]+&/,*?B%D<L3
MIS>VQM.$4XW:Y514N:\FW-3ZVY+)R,ZU3C.4%A/]4\TAAFI))8&5US))N4N3
M7I:UNO4^</CG?V4_QB\>WFD1PS:-]NLHHOLZDI+)'"PO&C 9@V9022,DL.O:
MO+0@#M(LF])L/&A;/DH>!&5YV$, 2 .^>>M?8W_# ?[7#SO<2?#W3WGE>=Y)
MYM8:621I2SRK(#"_[PLS%'YV_<!  !:?^"?W[6-NC,/A]IJK)^\);5V9MQ'3
M)ML@9/KP!G@D _L&6^)'A_A<MI8.MQOP_4G3A&"J4\?%PM&UKJ2C*^^G337M
M\#C.!^,,1BWB*7#N;.G)IN+P-5>]=MI7:MNNECX[XQVZ$<^A(VY/KCD<\8]J
M#U]..!G'KSZ9R3SVYXR17V&G[ /[6DB%D^'NF,0.VKO\O7'2WP/7L<]:@D_8
M&_:T@56E\ 6 48)":J6X7!.2+8\D>O0YSWQZ4_%+PX:@WQED:LDFGCJ5]%:Z
M][1;?+YWQQ' ?&.(E"_#^/IQC\4)TI1F]E9I0?*^NK>COUT^0\G'\7;D#&/I
MCKG/'3M1P1R&)]2,?U]#G)_E@5]4WW[$/[4-H 9/ MG'GGG4V.1Z@>1C!/0
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M(245@=FTXR2H8 \<GO/AYX&OO#IU#QEXNNHYM5N09+7S5):#.7"",Y4,"F<
M8W9[\C_#OAK),]XDSO+,CR[ 8BM6^NT:DJOL*D'.*FH.-W&]U=N_-;RUT_N[
M&8O"8/!U'#%RY:.$>'A!5(N=1\SJ.I&S^%Z)1LVKW;/FO]OJ(?\ "G?%D88.
M8=.94D7[XF$C;PY'.<8&&)P!\N!BOP"^#=[!IGQ@^'NI7UXUC;:;XDTS4KB]
M$AACAEL;^"X@9Y59-FR5!)N!5<Q_-E<@_OO^UQ9ZIXM^$'BRQTFUGU'5-06<
M0I!$\TKEIDV!(D!<C;DG . <D8S7X,6OP*^+DD,D8\%:HMN!.9KLQ7<=Y%(K
MLHD"",D?[)7IR<@9K_LV_9]?ZG<$> M#A3B/-<'EN88W)84,1#%54JO/5PBH
MSC&+FIK6LVE?1QEHKH_QD^E7E>?9SQQ_;G#^3XW'5Z.,C4<)4Y3?+3<DE=0<
M7K&Z=NMMTS]I]<_:/^#NL?$63XQQ^)M.C^)FF>.(/A_;:A-*);W^Q)+:&^GU
M:WF4&2.W6;RAYZ.H5HG3D&0-5\.?%'X&ZSIUS>:9J6C/J4'B[Q5?^-9;B6$W
M&NPW4I#,)75&D,C,[KO$A+.3DY!K\9E_9\^,TB(T?@K7YXRH*SM;WNYSDDS$
MB-<RDD@R,?,*J!G VT]OV??C-$\#MX+\2HT+&1?(AU")77:%)EV;?,;(Y\P$
MY.1T%?TI2X8\*L#]6HT/$'#866&Y4HK$P4X4E[_U3FY9-85RG*:I.<K.H[):
M)?@RQGB!B(J>)X3Q,JDE>:>%N[I<N_LK-VBKNVNQ^LGA+XB>"]4\0^'?$OP<
M\:^"O GP[TFTU*+QKI>IV?\ Q-4O)9F=)/M$30AO,6.4)L&_#%BW (TO$7Q+
M^#.LW7B&S\+>)/ P^(>K6TO_  B7B"_M+>>-M;E<E;EWVABS(,*-P#_?Y;##
M\AQ^SQ\9WA'D>!_$4-N[;MD(O[<2NH(W31QQHK$!B!O4D L!G.*27X _&7<I
MD\$^(%:+_5R1B_61,95=CK'O5E! !4C&>!R<=%3*?#"6*^L1\1<G6B2@LVE[
M2ZVLDE[UTK0WYER[ZDNIQLTT^$<4D[I_[)LFK/:ET77?2Y^IOPZU+P];:EJV
ME_$;XE?#S4/B(+K1Y[Z?1M,-I=#3]\3&%;IF*H6BCDWK)-+&X. B@(!D?MF^
M/OA1??"+XE^'OA_K>@KJEYX_T:_M='M@K">TCM%CEO9$3_CY,6XDNAD49Y&#
M7Y>O\%/BG"KP?\(IXE4R?+-,XU'[0P (PUP0)2$R=BER!D@#DT1_!KXK%X9H
M_".M%X(3"C7 U!U:-L[MVY&W84# .>.@&,5Z%#">',,[H9I_Q$##SIT:^#KK
M"O&.:E+#*/M+QF_8MU%&2@VO<4M>9HYHT>,(T:E./"N*<IRE)-826ET[+6E>
MZO\ .Q[?^S!XH\(>&OAK^T;8>*-7L+=-;\!^%[.UT[:(9-8N[?7?-O4M0<&4
M")W9H@"%$A)4)M5?TGN?B=\!5^'&@:E8R>%9O#C:19Q0Z'=6]K<PV&HPPBW=
M[JS$>)-UU%+.VU-P\[YCOR3^-+?!GXH@Q.WA>]MC"[RILCNU1V<+N:9%B"R1
MD*H$<@8!DW$<\9K_  J\?)*]O)H>KR/.=_D@WY@!/4I#CRTPP(7:HVCH1TKL
MS[#^&F;YC5S"''6%P*J8G#8A4XXJG2LZ&"6$E&<L,TIN<HNJDX\JN[OFU?%@
M\)QYAZ=>_#.);DVU?!U+6YKVLZ;U>FQ^UD_Q8^%]EI'PN\52^+/"&A:SHGBC
M3WTY-.M_LVFFV6"01J+2$9C9"Y.Z6,!C@?=( @\)^./"5]9^.+#QUXL\)7<.
MJ7VNZO>ZU;1QV]_:6-^99M+2[NVD$ES%EMR1HS>3GRY%'"C\:XO@=\5+N!5M
MO"^MW,+%=L;_ &]@K(OR/&&#>60/NX((SCCK5Y?V??C.HBD3P9XCVB,!6674
M\$#'#KC#J!GY&R"#@]>/)H9+X9T<7B,;#Q#H^WK1IQ4HXZ4N3DGSKXZL.MVD
MKJ[NUH>E)\;UL)"C4X3Q%W?7ZG)6V3NO8WN_ZV/HO]E>Z\$1?'SQSJ-[XIT*
MUT^WGOX/#VIWL/\ R$D;*1'378*T,RR&,++N(]<YQ7W/\<_C)\+O _A7Q_K'
MPWU?PI;_ !*E^&FGVL5W?6\%_<MK$>H6J7+>9"OG/-)')(?EDW1J3TW$'\BY
M?@5\8T""3P7K$!C8,ODV][ =PR2QD1%(()Z'DYX.<507X)_%6WDED/A36'6;
M/G?:VOY3(6(RI\Q&+@,!][<"0C#)45V9G'PYQV94L7B_$/"RA3<'##RQ]2*]
MV,8KFY95(RNX7^)>G?GI9;QG'#RC'AC%4W*HY.?U9I:.+MRNDI=-[VV[-GZB
MQ?$KPKXTL]3B\">(O VA?&C7;'X?7<FMW%C'':R+IJQS^(2741R(XC%PH66=
MFW$_*#L-?,7[:7BKP]K_ .T;\*-4C\665[)X;TNPT_Q1XHT1VM3I$T5[%-=:
ME#<QLTL:VZP&22-'#*AW #(KY-N/A+\2U*A_#.JP2#Y?.@DOHIL'C DC16"$
M'!!8?*3D>M5_AGX]M83:S^'M4WR.UR9IDNIY'5B5=?.D0O()/F#J3R"0X(%>
MGE-'PRH9C6QCX^PO+4HSHTJ<,10<*2J*%W"=67M.2T$W&R<I-MWM$Y\RPW&T
MX6I9#BHNRU>'D]DEJE3]?.Q^N>H^)_!U]X:\2:C\3O&7@3Q9X ;PEX=AT7Q;
MHEC%:^/-5NK:^6232;SQ'/OO[F*&W(EGA.?,.2_!K(/BKP_>^)O#_B31OB#\
M.M#^!-O<:,-*\%WVD%K]I;;REN)YR"MN7FE&YY7C&YBQ9NE?DZWP[\9W 53I
M&KL$=S%!=O?V]JK'(E*1-NBR0" 0N6 4G':%_ OC*$2"XT?4(8(HRD,0GO1$
M@;()2/:8DR>!L4?,<^U<=/*_#^'UC_C8.#M5G-QC@\33@FI2G92BH64I)I2<
M7&UY)-(VHXCC2C0I4WPQ6Q+IQ:<J^%<MTOA7LFU:[M=O9=3]B_"'Q^^&OBOX
MT_%[PUXA_P"$>>+_ (1+5-+^&-]I=O!86UIJGV@)83VY?,+,BMN\R-P"%"LK
M!F4]QIGQ2_9WNO&/B/P[#-H,'Q&LM T*)-5G2*0230L1>JMX?D>1HQ(6'VAP
M1(3M&Q&'XC6OPW\<7FGVHM="U+,4@,<\,MZMP6;<=YDC5)<C@DA\;C@9-6K?
MX0?$>XADM[;PWJ[A6WRS(;Y;I\@ER;G:)B%VX7YR=H.< 5Y4N'>"%.I.GQ[9
MRY5"+QT[044HV7^TV5X[V^)V;;U-5CN,[<W^J*TZ+!.[N^_L;=>WEJ?K9\2/
MCS\/?!^B^.I_AYJ'@RR\7#QYX?LY;F[T^*:>ZL);.+[;)#(@$C10E8HY&)D1
M ,B0%WK7T?XG?!=M:^'NNWD_A"YUJ#4WU#7&6RM_LCWC:5=IF6)5 P;V0,A#
MYRJG@8 _'RS^$_Q"U&Y,%KH&KO/ LEL%D2\<L' YG9E8R.I;EW+D*%PP"\6$
M^#7Q(NY&M[?0=8EN;$;G ^VY41C+?-L^\7#$'[Q[$=*]&AD'AO\ 57#%\<1J
M592?-_M[CHXM.W^T:._6]M?N;Q/&M:2E_JHZ:2W6"DV]-FU2_JVW4_53X5_%
M_P $_$'PM-;>.F\):U\0-+U;QG;^$OLFG0B;1A>W=XFDW3Q$&>1(4AMG=8,?
M+&2IW?,/9K>ZUOX>_#KX<7/Q@UOX;>)?%>I:]8VMOJ<NA)#/<Z9/+,WV=&NR
M)8+D!HT\\!>GW\$U^07@KX3?M#>%M8T[QCX3\'ZM:7\8>*PO!;W=P$VY$AEM
MVA,3$C/SDG[Q^8Y8'N_B9X:_:T^+T5A%XYT/Q!J\.EIBQCALKJQ6W=1E7A$$
M:'<K8(9=K @-D8&?#QW#?#M2U'*^,<'' S4HU98G,)1JJ+:Y52?M^JNY33TM
MRV=[JJ6=<482KRUN%ZC:6G^RI1:U35G1>NO<ZG]O*[\&7GQ(T35/"6HV.I73
M(#JJZ:L0CLB8)@]G*804,D#%0S*0KXRH^7(^(-D3LL8)V;#<1M@D%U8DIGAO
ME++D9[C<.>?5C^S[\9K&1RW@;7&D>%4D,]M?3NP'#$R2(Q+L<88$G&[)P:1O
M@=\74C _X0?5T2,2%,V-W\I8C=G,8X.U3CG&/R_:N&^)^%LFR[ 9;6XIP4_J
MM"%#GIXJ%53A'2,IS4U>=F^;JK1NV[W_ #_-LFSW-\QQ.-J9%6C3J*+]FJ,E
MRRBI7V@DM7O9'E)+[K:9\[!*)'4GC8#LP#U!P 2<CU'/-?8?[$>JV]A\7X3-
M+'$UW<6WV<,P505FW?*,A>5P. =W)QDDUX<?@G\7S&$_X0G4)"_]ZWNT(4\8
MV"(],?>QW/)ZGL? 7PT^-/@?QAI'B.R\%:KNM+F%F,<-R551(@EZ1Y8",G;D
M\'G.!BOPGZ7^6<->+/@+XE\"8#B/*ZF(SC(JD\)"6+C";JX.#<H<JFI.=3FM
M'E?NNSDG?3]"\$ZF<<&^)7#&=3RG$QP&$S#"4\2G#E25:I_$O.FXJ,==&G=;
M-'] 'QKCN(?$&@:D&M,OIJS07*Q#8V-O!E&#D$<C<"3N/0'&7H_C_P 074EE
M!'H%CJ8W1P279LDD?:,(2DOS%0J!L@'&!@Y&#70>$-0LOB_\.-,TO5C/I7B_
M3;.*.S2_MVMRV59G4.Y+M\Z[<]6.,@<4[3G\>^%=,N?#<OAY)+Q<IIVIVZ+)
MN#.%$F-AW'83DDY&<CGK_P )O%/".9\)\6<197C,#BZ.,P>8XC#JE7H5E[6&
M%G7?M83<&N24:::^)V:DVTS_ *$\ES[+LTRS"3E6I-TZ=.?.JD(Q2E"G/5;K
ME4K/77E>W2D-#M%^+NCKIF&%Q&;N[MX@#':R+"6D!"91$&64AL$;@00!Q;^(
M-M>:WXZU'&Z2VC8F-D)*1@_*.!V&T]<YYR,@$>C^!/!C^"8+GQ3XKNEGU_4X
M76,$!G@\Y-V-K<KPN&*X]#E2:AL=/'G7,\R>;+=2-+YI&24)E*#)YP-^",8!
MXQU-?ZC_ +.#PQS#!9AQ!Q]F>%AAL#F&7QP&!DXU%.K5C)3J./-&":Y&TU9-
M?%>Q_+_TB^*L)BHX;*\'6IUI0BX3E"4);OLKR5NJOW7F>6Z[H8L;'PDP0 C7
M+7/&"3]IMCG/!()).1GD<9K^A+0L_P!B:/D8/]EZ;Q_V[Q>Y_G7X5^.(%6U\
M/\ +#K%BPX/):\M0<  \8&!TX89R,U^[.AH6T?2@<#_B66/( XQ;1;5'N!WZ
M#MU!K_5GB^2FLN4=(0B[+T@D^UKG\S<,^]5S"H[\U3V,=[V]E'D?KS/5=EHV
MR^QX;UR#_P"@U,K!QL8@^G^T!@]1W'<=^N,5&!^\$><@$-D@<@#.,_7J/QX'
M D( E7 QP/Y25\7;5/LI+_P)I_A:Q]:E9)=O\DOT$=0 0HQP3]!AB>#GN /Q
MK\6OBGK TW]JWXB!8)0B^"=(:1AN 8&]E)/)  4#HN-HX&.A_:)\[SC/WAZX
MP%!/MV-?DOXPT.SU[]IOXHPW*+(X\&Z7']JR!Y8:]8"->!T; R<#:>P-?>^'
M,8PQ^9*3;MA8O2ZOSNRTUV3U[GQ7&T;X7!):<U>73;EUOYWV37;4^._V7M:L
MM8_X*G_M.S0._F1>'O"Q8!B  /"DIP0&P<9(&<X/(()R?V$^8G)96.[)+D,Y
MY_B9R6)[<G/3FOP;L_$7C3]D[_@H1\:?B^GPQN_&?@/XBZ+HMOI]S:/<EX7M
M-$-E-L9$*LQF884[C@@<#FO==?\ ^"LFA>%(U?Q%\!?%%@@ 7F/4V8;0 <E5
MVDXYSD@CJ00:^GKX7%QQM5T,+.K"<4HS3CWD[V:NK76[U?71GSF%JP]C)3KT
MZ7+HE*2ULE;JMV]MU\S];)-Q51\@(.2R[2VT=3P,$@8*YYSTXZ/"1,9/**Q.
M5,ZEL+ND56VG)Y)+8P!\I8@,,$BOQ?3_ (+4_#(LOD?!?Q%(< $F+5.R\]00
M<$#/.",\9-:Z?\%B_ =[&K1_!'Q$[KB*,QQZFI;=\V< #( SDDGDX^N<L-CI
MIWRW$]5S+ELM-VN5-K?;;HS18[!J?++&8=):M-IW5[-64KN^NF[]6>\?M?\
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M3E:FV_Y7?KT=S^?'XH^'=1U[]HCX[2D7HA1/#@9(B0"8D58T)4\J3@<C&3G
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MYYL\URB$847CL*Z$9.<H>VHR3D]6Y-R;>MW>]WUZD>,1E/*3)! )+9[+V'X
MC/)X'4U@26<J7*7*R) (4N)'0!\S,+>4A<$G@#/;DXSQUO7GC/P-'.RR>+M
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M86)=D*DQ^4F&R"#M^9N ,G'0]AD\Y(%5X(X((8H+=8(X4C*I'"$6-F ^4A4
M!)(9LX();/4U81ALVQ\8 W$@[LX.0 0-PR#PI.><=:_+LUQJS;,,?F'LX4/K
MV)JXATJ:452=64I.,4DDH^]=65[MW/LL'AE@\+A\,JBJ1H484D^ON*W-)]9-
M;M.W9"LRA8\*7V ,47DY+*,C/'7=GVR!CBOF3]HZZ\/:]I$?P\UZP@O['6E\
MV[^TKYD-G;$/'-/<#(*(@F"$L<CS ,'.5^E!.OF%#/"9'QL@=A#,S1DCA)"'
M^4[<D _F<UY!XE^'0UO6&U:TU&S-]N6:[L+M([S,6?FC968@0, &:)AY998W
M()4$8X.<:&(I5755/V4N9/[5VW?RLC6OK2G&UVT]-[_+^O+4^=_V>+'P1\*+
MRV\*^$?#^C:9IVLW4RW6I6,11+C 'E,)-V&Y51DC!,@]Z^[K>-4)\M(UC(#+
MM5@?G+$DY)R2<Y(XXXKPZT^&.GR7=[=V6HZ=#I=PMO"8X+>/=;7T#;YC;R+M
M6)79D4)$!C!# X!KVR%HOEA,V'A$491W <-L"J",[B'V[E'0EGK;-<7#$XGV
M\*LZSJ<O/)\K7NPC!6LD[)12N]=-[:/' T72H6::5Y.W:\Y/[G?Y'RI^VP6_
MX9]\:LA88MSDCGCS(\?@22!CITSVK\D?VC/BGXZ^#W[+MEXT^'T.DOXP-SX.
MT/2;C63<>1;/KFHV^E/*I@*%08I8I,]E(X8KBOUQ_;5.W]GGQQOX5;,<X(R1
M+$ 1QGG'X]20#FOQ+_;,OQ-^R+HJ)(RC_A*OA>N2C2;6'B+33D$9"D'E2?NG
M!RM?-XA4L3C\'1K8-SBZD>6OK[2%IP7NOX>7JU).Z33WU^GRV4H8/%5J;2G1
MA4=Y;-.G4WMK:/1JST3UW/6H/V;O^"@5YIMD[_%/X<;]4^RWTUM!<:H7M%F4
M2K%C9@1I&0K]3N/ (Z6IOV:O^"@+1-$/BM\.4:)FC$:W6I@E ,HQ+(03Q['&
M3@ 5^IMBR?V5HTBPR/*^F6)$T$A0D+:P@%PA)<Y +#D$9R1GB:2616(<EW<Y
M+@",?]<R7&'//)!!R.^3C]3JY!0Q<L+)5)05*@H1Y'&%XJUG92M^"3UTV/RB
M6/G%8V<\5S?O_:-N=1N_,M$KVZ]?2^MS\<]=_8S_ &\/$2-#>?%GX=QHX)+B
M]U$$9QD#;'U./?H.:XN'_@GM^VO$1M^+_@@C/WDOM1*Y.<G+1$GL?3(Z#)S^
MX D)S\I.,?\ +6,<\XS@G\3V].:0G)R4.1SQ,#QDXZ,.>OO75#*Z-!>RYKI*
M[;E[SMW]]+K853.)5'"$*U*ZC_R\BY1LK:N,U:_9[K6Q^*\?[!'[;T0^7XN>
M"2%7.1>ZAR!WSY7/? Z_C6Q:?L0?MUV3>8GQ9^&V,-RUYJ.1M^4DG9P5(^8M
MM .3G'3]E(,M/"A2<J\\"EMTI3RV.&Y"E<<^X(Q@GK7XK_&[]MOXZ_"_]I[]
MI[X.*LDFAZ)+;3_!R[319KJ.QFD\+6=XJ7,T2&/44.L3[F@R?.3=$Q4NPJ)X
M2C%\B?(W'FYDY:I-1M?GWNT[6V*6,Q$K<M;!O76]&'E:UH[O70[BV_9,_;ZM
M@BQ_%WX9C87"JU[J(R -C<%<X4$$G;@$9Z9KH(_V;/\ @H'9Q_+\6/AF0N%Y
MN]3P!U!^YTXSUP0>IZU\^:]_P4I^-EW\-I/A_P"$]"6Z^,@^'^BZB_B=]+1;
M6+Q))?117=O)82Q!TC$+,KH5W;6(;"C!TK+_ (*;_%#PQXQ\9>'O%7A*[;6_
M!6A^ ;C5=#EL#;>==ZYI\;7MS:W<D+VS"ZGBE801%S;HZA00S;6J%..THNRM
MJY:VZM\^C^^WF:?6J\6KUL'>RU5&'_R#\_RV/H&'X!_\%#8TS%\4?AF1NV[A
M=:G@9Y'/<Y]"<#GU%-'P,_X*((Q<_%3X8G;@M_I>J9Y;:.J\_-\N1QGGI7'_
M  Z_:K\=_&;4/%'Q,\0?%+3OA%X?\+^+[?1=$^%]_P"%KN]U?7=&>.*>;4([
MJU4>;&"6B>;R"JR%\\)\]71_^"G?C;Q5XIC\$^&?AK=:_K$VNZQI;R6UO]GW
MZ3I4$KP74:2PAHO,6$/E59\,"P!P*(T:<;I3B[[MMW6VUWKUU_-WL/&XAZ^W
MPFO_ $YAZ?RKMV/3H?@[_P %#D#(GQ3^&(.<L1<ZH,Y;!.,<D\!@.5/) &:D
M7X0_\%%=X7_A:GPP!R.MSJ9Z^G'\OIUKLOV2/VT/$'[2GC[Q+X2UOP1=^&+#
M31=)I4LZJ&@EL(6BO8[J0(K)YEPK;3,/F7#1@FOO:))05CD&;F1FC:3?$L0P
M2NZ-58A<*QVL,X<9X-:0PT*ETZC6CVLUK>SU?DV]-//2^$L<XW4X1E>^L7*S
MUM=1U5FW=*UK.VB9^;+?"3_@HOD_\73^&!5>6'VC4NWU7L1GG],4W_A4W_!1
M3@K\4_A@,D ,MSJ8())Y!V^QX ]>>Q_2H^9PI5B5.T,TD()&,GH>FW(YP.@(
MR  NV0?=3(QG!D@ZY !X.,8.,]>>/2M7EU.247--+Y7]7S?E8S6.BE_"CZJG
M&,NFTHQ33]/0_--O@_\ \%$&6Z=OBC\.':2'"N+G4R%<,#N/R@Y !'OSU[^;
M_&*R_P""A7P5^'6H_$2_^(7PWUJPT.]TU+ZWBGU1IS9W,P6>.$%0&D=00@.,
M' .!FOUU'G;9$ER5*\#S8NISDC#+G(XSR1]#@_)_[<1=/V5O'RI'(%%WHWSB
M0-]VZ+-G:Q7&,@#)_,&N;$993I4).,VES+:75\VOQ_YZV+HXJ$ZU->S;DY+6
M3F]/3[OS-_X4^,];\>?"SP%XWO(K:+4_%/AD:C) %8#S/M4L#L XR%/SD DM
MP00#7H$<]QY*W$]S&TC!;>6'=G+1\CI%VQS@\\X(P!7C'[-P\S]G7X)29*/_
M ,(<J#D?=.HW#'E<CDJ1QP>QP:]6FLV\MT&1EE=>2<$@;SWZ<X.2,@9P:^)J
M2JT*]7DJ5VD[.-*M.%[-I<W++WNMGI;7T/N*='#SI)NCJU%WUNM.EUUTW\C1
M%XYS@*,<!@&X/;&4([CL?;GFF2-+(,.YVYSC Z@^OEX]1DY/3(ZJ:_G+&(T7
M:67;NSM!)!!QQR3D=.O'&.,I,6E 8_*,@$C(4C&1C!Y/ /RCG  [ PL;:]Y5
MT[WM4G*I+Y2D[\O9;+5]0=&@[?[/=)6NG);#GU)=/BP"I9C@<]<C&?EA)/7'
M/ Y]":(;J:2W>5VBVNW"L"6P?F8Y$:\9Z_ATYJJ$MB09 LA![L/?WZY).>O)
MYIT\Y\H0Q(-K$9VC(P?EP,')P!_0GI6<\8Y-KVE1+;KMV^+:X>QI?] T+>=.
M$G\Y.',_F_T*FLV5I=6A=HK9CC&[8A .#P05R2N>IYZ@^E9'A:'[%=7R0M%#
M$\4K$L<+\BDOT3G"@D@#![ G@=$UF[V;;@.N &3GD _FP &3U]A7(W-C='3=
M1C6Y$+A)%M,#YG+(0W(Y*_=Z$@YP17+B*\HT^=5:O6ZZ6L_.][7M_D?497+
M\B4Z5/G2BN5T:-EHE_S[OT[W\NI\6_M0Z[9>(]6\.^#$O5E&HWT4$T<1##,D
MBHX970 =",GH>?8=GH-K_P (]/IVA6GG*EI9V\/(12/+C"_PI@YXQQ@ #%?,
M'Q$\/:OHGBBZU_6)6:[AGEDL ZLS(4?*,@8#8<8(8#J..E?07@S7)]=AT/4Y
MB7F-NJ2LY^<R&,*Q=^K 8)P>0>#@U\UB,QQE2O2A1Q-2'O))3DU%Z._,E+U[
M:V/:IX3#4I>U^JX>I3G)-\U"FU9-.R7):S:5[WLM>Q[S:>(;NTM@L4TJ2Q.
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MA."><;N@/ R>2,5_2Y-*3!H4P2665_#6@9>*;RC(O]D6H_> 9RN3N"\X.2<
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MECG&),YQT]>#QS7[3YE'3<?<W"Y/N?WG4]33\,<Y,F &8A90Q.Q2P 56+$Y
MX4$^U/\ L3#KWOK6-T][3&UKZ:Z.][^=[WUO<:XDS!NWU*AJ[?[O3>__ &YY
MGX@7/[,G_!2V=CN'[-*EAN5BGB!-Q(+ @M)C) ) '/7N #E3_LH_\%,)\*M]
M^S7&K *__(?4J""P_CW<J6.<$< <'K]V>$OVQK6P\#_&?Q7X_EB9?AGJC6]M
MHZ$I?W-L+^YAA8*%:0 0(-Y"%@"-@;%?)/A?_@K78>(?&NEZHO@[4;?X:7OA
MO4[V9Y%E>ZAG@N'AA0*8#<R-M3"1I$Q.0%R"2,EE])\R^LYC-Q^S]?Q,D_\
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MX&>.@Y!/!Z^_^"=2O3<7\#B*1#:NX9P%PP60J ?+//; SC'8=?D3PAJ1#V$
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M>OW*T3_D#:4.XTZR!]C]FB./UK\/OB#A-/T,$8;^U].7.WG(O;7/U X//&2
M17[?Z%_R!M*/][3K$Y]?]%A'/N,8_#/>N3BRR>!25DZ3=ELGRKY_\,>KPO\
M%C/.3_"1H?\ +7_@7_M.G$'S%.#C'7MT?_$4W_EK_P "_P#:=35\7*34HI6L
M]_OMH?7D4O1?]\>OHQ[=.!WXK\L-6M7N/VG_ (G1H&C(\)Z8YB4?/(K7SDG.
M<$,%/OG@Y%?J;*W*J,Y#\\<'*,<?F0?;OQ7YLPVWG?M/_%.9@',?@W301WP+
MZ<'CG/ XQ@G]*^XX)J_5\5F52^KP/.K[-TYJ*6FMGS:]>Q\=QE%2P^ NVK5J
MCTM_=75>?0Q/%VDRB/<D-E<RXB6""X4,\8**&=<QL 8\Y(+#D<8S7Q_\</ J
M>)?#]V)[2WN;F&&8*T:+E005('[H'C&">QYXXK[%\2Z@D^I/%PIB"X.<?*JC
MY2%[D$X_+KU\Z\4+;?\ "/:U<3"-(TAF EPJY)&<ACP3@GG&.ISBOVO+827+
M+EC/FC&7O+;FBI:6];?T[_EF90IR35Y1=VFX2:;V6NMNG1>>Q^"Q\.W6GZKJ
M=F++ M[AEC4H<LO&3_JB#TSR0, C' %>G^'-/NE>'=:Q)]T9V$\G:>\1[X'X
M]Z];G\*?VKXAO[F%59;BZ*Q[$)#@%22 ,YR,XQGD9[5[IX1^%(-NEQ)&I9ES
MM="=N%&,A@0/8'!Z8[5]O1GRT>:IADG9_8A;;_#?_@?A\C5PE-UFX8EW712E
M=M:V3N];Z/N^AQOA&.6V:"0^3&2 K%8USMW1M@EHCE> >.>GM7OMKKB8C3=$
M6"!2?+7CCG_EGU!Z#OVQR#EMX-ET_+Q1(R_<QY8( QG/ )R"H[ 'J2<5EWFC
M3B-GC!5P#DQ?*>!D @<\@9Z*#Q@5C4C&JFU0A%=^6GRJ_P KZ['HP6)I02C.
M;B]W)N_X.WEK^+/8?!7B233]81I741.0"JB%0Y8 #)\IB,<G@]>F!R/HZVUL
M/*EVLBLC*N558""V =O^HSQQWY)Y(QS^<W]J:AI\A!,JO&2VYB02%/..>@YR
M".<XX)%>K^$_B-*ODVMU<D'*Y\QR2".PRQ/;' ZD<8YKP<5@*M25XTZ;C?I%
M+1^FGR?;H>EA<74C*TYM62ZO5W7?HEY?+9'W38ZI<2\;5*@9X6'! .3QY7<9
M& ,G QS736]SM0287>0>0D()+94#/V?((X(ZYSCIR?G#1_&<+A#]I58=I(?>
M!QV/WL8]^F.HX-;5Y\2M.T]%'VH.57<3YJD$]0#\PSDD*/4_4"O!EE:=2:=%
M)IV?NNS_ .'VOZ?+VUCI)1M6W7VFOPVT_73R/7-=UJVT339[R4J9&0MN98<Y
M"],&'N0.N[MQW'A.F:O<:YJ37IE_T=[C&"D(!^8Y(_<'<,#KCK@YS\U>2>*?
MB%<:_,RF6401OM"AR$92V 3AASCCV&2>G'8_#VY638H#"*1BISRJ_,26^]\I
M! P0/<=":ZZ> I8>E+FI)NS;]W37;=7VTM?=>9+Q-6K*T9Q:LK6;OI>_6R^[
MS9[J9X;=&VQ#@$ [8F(/ )_U." 2.?8<X)K/BO\ 4I)DC@8+ELY>.+&" 00?
M)_ #'0]R.+R10&41^9OSP.<D@ '+9X#<8P3U_"MDZ?%;V^Z/ DX 88R.0 0W
M?KG/0@UY%:IAXW2H[:74>S_X?U.W#PJO1S[=?^'?YC(]'M-1FCEN5A>8 [L+
M&1T[CR<GCC /X@DFO#_B%\*= \17K"X,68P9$0JB!I22"H(A)&%SZ#CO7N/F
M_8@MR5",H)VDG (Z9!*CG)SGDKT[URM^K:K-'<J5$DC-&410K*%SAC@G . .
M,$@XP 16E"OAX3YI4KTHV?P*^CWO9ZNUET_ SJTJDVH\]KZ:.R3>G5O4_/GQ
MM\+)_"[O=VT4\XA218HHBA*K(7 7_5'@<$ $ 8(/7 ^9]?E\70M]FNI[G[*J
M[(TGR#'&3A4!554J.#GD \^@K]E_$'@NUU30)XI%4SA<EL8;/3(; )&0,G)P
M3D@<8\#O?A)8:[I5[;O';F2")P'>(-)E-P&&.6 #=!]#D'@?4X'-,,ZBG&/+
M"247&UEI;E=K7O?OH>#BLNKQE.7.Y)W>KVOVL?E[_P (X]UMN8[AQ-G<?G)^
M;/ _'CMD$XP,"OU _P""4T5U#XX^+,%TY)M]0MQR#@M]AMEW9R1R.3GL1T-?
M&6K^ M2TK5;BTCMG7RKG:I52JN 1V / Z]><'C<<U]^_\$UM(NM(\?\ Q0%S
M&R/=7D<A#+C@65MCDX.0&P<9]_6O.\0JBJ<,8V4)*S@G9/;W5_PW_#G1PHI0
MS_"0E'X9W3[WM'_@H_94,I#$'/[]V_X"5(!^F2*MI]Q?]U?Y"J:JRQMG'WNQ
M[Y QT]C5Q/N+_NK_ "%?RQ'X5Z?GJOP/Z$DK3E%:I<OXQU_$:C,Q/ &",]3U
MZX]\ =?7TZLF7Y20!G! [8R""??U]>M)SC&<#.[(SG/N<X('88[#\6N2(W8E
MFVY&#C'W0>>/4U25I<RTD[*_S73;JS.:7))-:*+TU[/MKU/P/\=:U/8_M$_'
MF*)78*GAY@$'"Y7)&<8 SGD#D=N,5\ _M_ZYJK_!S3PEY>:>DFO6+F:!Y(W!
M5I3AWC>,A67@_/M!SQTK]-]4T"'6?V@/CW<;,^2GAI2. I+1@D,<$GMSD$$<
M'/-?!O\ P4S\-1:3^S];7"((S)KVGID $!6DD./N\'(( R!CMZ?L?A716(\5
MN#,#6H0JX:>88-2A4A&I!\_(Y*49IWONKWY7\-G<^"\0%"CX=<3XNE5='$PP
M%><)PE*$XRCS<LDTU:U]MGUNK'X*+KNMF-G_ +>U<DN=I^USGY-_!!,F?NCY
M23C&2.,8M65UXSUB\6TTG4_$.H74F%%K8RW,LV1R/D67H4(D/8;BO!YK"B.(
M$"G(%LC!L<C:2H!!R,8X/'N,#I[#\$I/'UCXUDU'X>Z+)KFJV=K=-<P*B.T6
MG_9U-Y=6R-(F;FVMMOV9FWH+A2SQ2IB,?Z[9QE.49;EU?'K)<IKSASMP>!PD
M+>SBN7544F[)1U]7J[G^<N!S'-\9B:>'CG6.@DJ>OUJLFE.[EK[2[7-=V;TZ
M66AR=UI'Q1LKY-&N;;Q>-4F(:+3;B"_6]DC/#.EN6\]P'.P8C&3R,9X9)X7^
M)O\ :D>@S:!XO74YU5H+&XL]0CNY2<N/)B$KRRHR#?OV  * 5/##]W_#ND>#
MM<\*:5\3M5MKAM4TGX5/'-IUS)&_C:[U!;@S^=9W9W)]J,2?(\JC]Z48RJ,B
MN%UBW-UX*\:_$WPUI^I_\)S-H>EVW@G1=;>"X\36E]9*OVF96CPI6:*94*A1
MEDDY(PH_#J?B'2CC98:'!N7*TW'FC@Z,8M7MJHT;-7MKK9;M6:7Z#_JQF$\/
M[6IQ+BVFN91EBZMT[)[^TOI]WD?B-J-KXJT"Z?3]337=$OE&1;7XO;:[*#()
M$,K[@%^;=AN,Y)[56TZX\3:E<2VNEW^NZI>1Q/*]M83W-U*B*R+O:-904B_>
M$LPR%9" &)-?HW\6?A'>_&#PA\%]:\;^+O#'P_\ BI!X7UUO&5MJ:R6QN)/[
M0=U-RL0:0W#VH18-TX =LX(( ]R^$/PG^%OPT\41>$=*\#:YKU[J'PKTSQ/J
M?Q!B>RDT.&>]N1!<()]J3+:AF5@I995(P7;!+?28GCSAS"86G7Q?#"IU7S*I
M1HX"G.FG&3BG&<J/,^9+F>JW5KH\K!Y'FM>M4I4\]Q,H0=HWQM:+7>]JO>Z6
MGS9^- U[6O-=#K^I*T3M%*IU"=622/*,CH9U975U*D%<9'!8$$R'Q'JVXQ_\
M)'JD<H8+M.HS\[N1UGX _B&,J1SZG]H=1_8C^ T6AW6C7.HRP:CK][)J<?B0
M7D @L3>73SOYTB1 F/,@2) ^0 N78  \?HW[-GP0O?%7B#X-)X*\3S7WA/PS
MJ6J0?$F:YM'T;7FLXX]K13HFX^9YD1W;#N!<Y!8%,,+XG>'M1.5;A^G1JZVI
MRRK#.4]_?;E0NV]&]6WYEU^&N*'4Y,/F]113M?Z]6;DD_BUJO5[]C\D!XDUH
MEF3Q+J16(['8:E=#$AD*A.9 /N@R ENA [;J<?$VOH&8^)M6&WY7)O[DHC.1
ML#2+(P^<@X^7L#S7[!VW[.'[.?B'XJGX;:7H&HZ5?^!_ /A_QIKHO)[,Q>*)
MM8,EK]DTUHU&^>*2%9-D@W*C'<S'##:TW]A[]GZ^\1R^*H=3NYMD$[ZEX"N[
MV$LIM251H[98T &%#X+.Q8_(RC(JH>)G TI4XRX8=.4Z=[2R3"Q]][7_ -FT
M[Z-JUMMD2X7XD2<O[?E*RNE]?J:^G[WS/QDCU[7YOW@\1ZJX9A&,ZA=YW,.%
MQOX;!^;)Z;6')P"+7]?8E8O$VILZL1(J:E<Y3!()8>9N!SD8"[<#)<'('U_^
MTK\$_ /@SXN_"[PKX1U Z7X?^)-[866L_;9(V?0IKV617NV$'E""&!46,^8K
MG!R6.<#[2\:?L,_ F32Y_"R:C?Z'<Z3I'AK4K?QA9WL%O:ZW<WS,+B":7RT,
MZ2M&0D4)C,89?,DE.<^KB>.N"</0PDI<-4W4Q$:DU_PCX?6,.6[_ -WY5R\T
M7O=WV:3:X%DO$2E*,\UJ22=N=8^L[;V5O:];/II:_4_&N/Q)XB=R7\2ZIM7>
MF#J<F<JV,<W ZX)QG/.#T(J(:YJY>0/XAU3(7<^[4I2R*1@OM6=B2&)&.O.>
M^*_3"_\ @-\)_$7Q$U#X66WPV\>:-9>#M5TVVG\;37FGKI>N1M;07,GE/Y:>
M?)+YIC#QI&/,5P5<Y8]CHG[-WP-\=7-YJT_@[QAX0L?A[X[U#P[J4-Y=65L?
M%&GV 6W2>U8*6GCN9)8Y8F"D%5;=D[C653Q!X&H85XB7#E)N/V%E&%5_+^!?
M3<TIY%GLY)?VM7^6-K>E_P")_770_)R'6]7"Q[/$.HG<752=1EQ(4V@[/WQ+
M*."2!\F<<YR)6\1:PA ?Q#?!B0%$FI3A23D@\2'LK$Y  P>>M?K'XX_9!^%V
MI^/=-\#>%]+UC3;WX@6KW/@"6ZN;=(X(M%MHYM;#B,;RUP+B  *H8D' YP-+
MP/\ LM_ '4IO$7@"\T_5KGXD^&'N/#6KRSW-J^E1ZO) Q2&"&16GCNUAD1TF
MD=XPV6VA#LKFJ^(WA_*C1K0X?HSJ.'MJM".4X7FC3<G&S2HII<R=Y='I=HZ*
M>0<2*HX?VUB8QNFG]=K66RM_$O\ ?T^1^1,VM:V%6>]U;4UM'S%'/)<S^0TR
MX)C20G!+9X)8GC& 2,1'6-0C9C'KM_$C?=<7<D9&3R?EG4G<A!7N^2N[C)_9
MK3?@7\+?',7P]^$6J>#Y-&^Q^,_$5KK&O.;%(;B+2M/FGCCCG!D N&E@12TJ
M,A\S"Q;FW"Q)^Q]^S_G3?%5U::K_ &5I^B>)[K4-#CN;.&XOIM!$T5O/:H8E
MV;!;EG\P2F7<NQD!Q7GT_$O@U^T2X5C&KK)4_P"R</=0=W3?\#52CJMF^JUU
MWK<-\0-:Y]B-4K?[;5\KZ^T[O16^9^,B^)M70&-/$FI*!C(_M2?*\Y7>//.,
M\GDD+G:,@5:77?$>"YU[5BAX0?;[K:ZG.#O$I!RHSG#9R.?3]7H/@S^S!K^D
M^#K?2_!_B73;_P"(UM!!9W-[=V!^PW%U%.4GD:.,>7Q%O)<-C>,YSBOR>UW3
MWT77_$.B)YBVN@:[JVE0.Y5C)#879MH=I'#$*O.#G:!\S,"Q^YX;S+A'BK"U
M*>&R"AA\;%J2IXC+:%+FC=ZQM12:O%J[5]?,\+,L+G.44&Y9I7K.3U_VVL]7
MH_\ E[IOT[#$UG7H;C3Y8?$6L))!?0L^+RX*LFX?)S/EAZ@$<9ZYR?Z,OA]\
M3BO@3P&$GS*?!NF)/(S,S/*MCMD9LY)+$EB=Q/'OFOYO( 9+JR4\%KR, #IE
MF7..OW@Q)Y/3(Q@U^\W@#2F?P/X)=58;O".GN0" AW6#%N"I(]L'@<^M?R;]
M-3!8?!X#A26 R["X-.I#VTJ&%HP?):5]8TURVTLXM/70_I+Z+M+&YEB,^H8^
MI4E#"8:=2%2IBJ]12<7':,JC4KWV::M?>Q^V?_!-/5CJ_P"STMUNWJ_B#7MK
MYR&QJ5T&(..^,XR<<#W/Z(H<[B1C)SCKCY5']*_-/_@E9 (?V9-/C'1?$GB,
M;20<?\32Y^N<YZD\@>U?I< !G'<Y/UP!_0&O\_9O7Y)_@?UFZ:I2E!/FL[)K
M;3^NY&X8L" ,*<_>QGE3Z<=,=_6HYLX+X['(ST((!&<>@R/7GCU<Q;<V&( (
MX&/[H/I[T-S""2<\'ZDG'/YY^M9R2DG%JZ>C7_#"LFTGYK[[)_@5;OYK:=<<
MF)CCKC@?G_\ 6K\A_AY?Y^"?Q2A<$-_PD?CE0,YR!J-\#V[YX[8/4\U^OMX!
M]EE<=1"XR.>"N1T'KW]_R_&+P3JEK:?"#XHB1D6:'Q/XU)7(&1+J=XBY&=Q!
MSGM\P!SCY:ZY35+)<SE_++"TX^2J5%"2^<7:[U6ZU..-+VN<Y=32WCBIRWU=
M.BYP_P# 9*[V3ZGZ ?L@1)>?LP?#"!FDB$_AVYA+I@/'OO[X%U).,KN##@^F
M/3P36?V4_C_)XHUW4M"^/FMV^@7%]/?:7H<L5J((U<+MA,H>1T3*@'(.#U49
MS7O_ .QJX?\ 9G^%3G"E]"N-N>@SJ-X, 9P<@ \Y //M7TVN<  LH4D?P?,O
MN0HX/MCWZ9K@E5ITXN#<E9)64;^ZDK6;UT37GOU1UO=M[W;>NC;;N^B/SF\*
M_LW_ +2-WJ-SJWC7XU7EI"MQ L&D:<MM/!+:0,JR-)(5A,<FU-^-K9;'/I1\
M4?LV?M(Q:_>:GX&^.5]-IVIW?V40:@+: VU@RAFCC5 VX[PQ)^1SC&!G<?T%
MUC6-*TB$R:K?6UA;(P+/-*D*M]Y6.^1Q]YBNX=<< ?,"*6C^(= UOS3I-_8W
M\<0)9;.42R1.N5=L(6PV2H4E<#KDCIVT,/B'AG7IX3&SP^G^T>PD\(NRG7Y.
M6,MM.=:W5M4<[S#+(5/J\L136*;M["ZYFUIWYM]VMM5:S5OGKX3?!7XI>#_%
MQ\3>*_BWJ_B6RFTRSL9=!N+6S-I;7=O&4EEAFB*R,LY.074% 1EGP5;ZBU&"
M:\@NH5?[.9K2ZMH;I/WDD$DRX24*5('ED;AE3DX!;'6Y;Q(#A0Q9T$A9VR<$
MJ0",8] 25SC(R.,6C$ /E/)/S%B<8P<@@$9&?7U-<--VE57*H3DK*=M%=[VV
M3T:VZF\&TFY+FDU;M=^FVNOX'YN:Q^RG^T5+J^IW6C?M$Z_:6&KWTC26OV2Q
M/V73W=&"0*S$EE(3K("PY 7;@V;;]E[]H&'5Y[27XZ:KJWA18H&M5N8[2*Y-
MW&'\]F"1LVUILX)<\9X!SG]%9HE8H59@0V?W>T9&,!6SG*@D,.F"HR2.#GIJ
M-C<7C6-O>12W5K\TUO"Z,R;B01*HY#;E9FV[2,CVJE1ARR7).;?O-JK6CMK=
MJ,U%+7M8+1;NZ:5^KT_7K\CX<T?X _M!V7B30M4N?C%J+Z/IVKV<U_HVRT99
MK"*0;T1@H:4,FW!8\$G(91FONPXE4(0TGEY5I)CL)SA2V!@#;G<#T+#& *L[
MH\!]NXD-E@<GDG@'J?8<E1@9XII!R2<LI..0O4'*\@#N &R#U/(.:J$;1V:U
M=K[Z=&WJ_G^95X[127H?)/[07P-^*/Q*\2>%O$7PY^*&H>!I=&MM0AO[.WCM
MC%<O=*OV=AYB'>\(# LQ._<7^7;M;P-/V3OVG+0W-]IW[2.OC4]1LVL-1:6T
MT\1I')(LLDD$G.YAY2@ *G!8;L'!_2]E&0'=E=L*%3(WD?WERP)P1C:%.#CG
MBJ5YJMEI\D4-W?V=HTQ^2&=AO<L& 0?.#AL%@3EAC&2,BK5]E",D]=8Q;_%-
MV_"[)E%-ZR2\F?$C?LY?&W1[/2;'P_\ &C5KA;6UBEO7O8+./[3J#*OVB;.)
M 0TD:G[IZ $_,,=Q\+?A!\9/#GC&'Q1X\^*-[XELEMKFVET*2.!;1WF!$=R'
MA4,LD0 "_NVXYW#)(^GX-6TN^G:&SO[:XE1?+>))5+*4^;[H;.6!SD$ X.01
MC%\2#S&)$D9S@'<-O'7 VG@C&3UR#R >);C1<93@ES[1M:VMM$K+S]2X3<HS
MI0>JTNDNJO\ K_6I\H_MM\?LZ>-E)/%B<D!B05EC/<Y)SQDGO^!_"']M37;3
M1OV.K"_N)-0:UT_Q-\-KN_MM)M?MMZ]G;>(+&2><V^5\N..")I9&+.%0$D$#
MG]W/VVW<?LZ>/60C=]A;!YQE9(^<$D]/<Y]<<5^5+1Z1%\*TU3Q7HMCXA\/V
M&@)<WVE7]NMS;70M;)95BEA?Y9%8*X*2,P)<Y^0[:Y'1KU<QRRCAH2K5<975
M.A!-Z5'5A%1TZ2E.,6GLF[*YZ."JQA@,P^LR]CAH4IN==Z)<M.IS;I)Z1D]>
MUK'OMG_P4H_8F>PTS3H_BAK NK73;:.Y1=*M2%:*")9%;==(>&5E+!" XQSD
ML%?_ (*3?L/H0/\ A:&KHW.=VGV0R_&>6N8P,X) R>G /;\3+7]LG]D-8XH;
MK]F+P#!=0"2T5X_#=D)IO+=O-D9VD<LLSJV1@'<<@KTI;_\ ;$_8UOHH[)?V
M6_!<5S<,8HIET"Q4"4*S$MM(;! /WB1GKT%?OF'\)?&.O"G4P_#-5P=/VM*:
MG4:J4FTN6*=.UDI73LW:.Y^)XCC'P]H1DWGE&HYXOZO7C:G^[GJW)^]IK&UM
MM=M#]J_^'FG["R,$/Q7U%3@DJ;2P! !^8C_33T)Z>XYX.)D_X*9_L,[<K\5M
M08'D'[+8'/&03B\&"1C@COZ]/Y\-9_:)_98O;K?;_LZ>"+>16=78Z%:@)&I&
M1CS.LAYR2>F0 :IP?M#?LOQ^2Z?L]>!\23+"8VT*VX9@22/WP/;Z=SQU]A>"
M/C%/EG3X>E4E[-SJ.56I%1BK<T;\GQ:V2M=VZ=/.Q''WAK'$SH?VS3;@ERJ"
MBY+1=5*[5WK?RN?T0I_P4L_8@(64?%'4]A=MK+8V#;I$ (49O03[$'!YP,UQ
M6H?MO_\ !-W7]4EU;4]=EU/7+F:.[GU6XTFS:0W%N@6&/[3]I+N6\N-<$8&
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ME=I89/L/F[VCRR .-P.=P'/*C."21SD>F!Q7XWP_\%A/A0P%M'X U33=.C8
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MKX T31M/TGP'HOQ"U[QSXAN=#T3PWX@TW^UM,>\38[//:%TR7+[0RGA  -K
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M'1!R1_:]A[D$WMJ,^^3C:.O4GD&OW%T+_D":1_V#+'_TFBK\*_B/(6M-"7.
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M23_JYS>TA*5JF,P\?9IJT:JM+JV[2T[+RW['H$ >8(JQL-Q& !EO[V2,C@G
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MJUDW=*VMN^FK.[".LZ--UE:HZ<>;_%KO\OZV)&+-C V;>$<A2V&XRH)'(';
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M_?!RQT#Q#?\ P^^+UMXQ\5>&;U;"XT*;3?[+$LQA5KB&P>9PVH@S;XXWMHY
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M>Q>5IQ(QUBW&^,,6)(!P=K<#) Z5_/G\.;N,^"?#;*@Q)91;SCYAD0+GUW8
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M&]1P7-IJWK?UW]-.R1\WF6+>,J<LES4XR:C%:\J73R_X/F36EMOVMG(!4\<
M;1D'IGOGOS@5KQQA0% .5 ^<G('!Z 8^\1MQW'N>88$V8VXY&6^G _$YY!/4
M9'H*NQ]6/T'XC)_]F'ZUT2?/9OI;UZ?\-8Y5T[:?E_D0ON0'# 9QG&>0>>G.
M"1R#W!/<<<W++E\  <D?4LKE><\CG'Y<BMV\?:<9.,#&.<$ L 1UQP,>G(&
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MH/J#$2B6R,AE0C>1MX!/7Z@_X4+_ ,$K5.X:QX^CF!PL;^"O$I4@#GK(IYZ
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M#@@&IKO_ (*D?LA:O:C3;SX):W>Z-;S;IM.O/!FJW5I!<$@.]E#+H[1PRLP
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MWM2[OT[W\_,U]I"W\.FM/)M?.VZ[]T=I<$I!'=2.R.H&U2_RAEP06;"Y'?!
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MK:37TUM96L9ENYI1$JJI9BIPK9 Y."2,@\ =SBOT*^%WA*T\"^%X(A"BW5Y
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M*\4I7UMKRNS[:.S!)R:4=W**7_@2T^>QR7C* O;>'(T5F9=9MR\8YY%S#DY
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MMOI6/P._;0Q_R<&^?0W.E\X_[=/\D5]TR&,?NDAEC;!D8NR&/YLJ=W&<#.6
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M=:Z?9V7]?\$^^L#<W&<;R!S@$MM!&/R/; _&G98=/_0C_A2?Q3_7_P!D)_F
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M-?3=WV[/JC\$?B3\?_CMXLCF_L#_ ()^^&[1\,T8.FZ8%3 )!!?1\#&/;/(
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MP3I4L<4FFW.L:I=?V=922M!B0Q172B)_+4E=GW'.35"/]LA? %GIUA\?VL_
M?C^XU*;0-6L=-4+:":UMS)//#)=(LAAF9'\O$1<D[2I!WFO[.G)V]M12LV[R
MDGT6BY;VNVN;TTU=ICF%>UOJ]V]&^5>[;56U2N]G]WF?ES\-_'WBGX<^'8=#
M\,_\$\=$^T1);B^NKU+:1KB6!?WQ8W.DN6#YYYVDGUXKMY?VA/B-*\EQ:_\
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M;E97>NUO4_G'^&>M?%#P=-:F?_@G]HUZ\+"#3W:*RE.Y229)(CIC(SN25&\
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MWO\ /=7OL>]Z-XMM+G;;S-$"X( 8#@C [@$'KU YR3GJ>K$D>P-$492W&#D
M$<$]<8&WCH.W:OFU["[ \V$.ORG!VR<\9&,*>F0,G X   P:V-+\7WVGLEO<
M13%%*JSLK8QD*2,MG;@;@".!T KJE4A%+W;[;K_AM?(\J>#DGS*=KOFLVKJ[
MNT[6V^1ZOK_AVVU>UD\Q5\Y5+!@/GP"!M#<D'/!/=1CH*\4LGN]&U)K&6,I
MSDK(QX." H).>"N.O!'&2<@>R:5XLM;O"'!W !OE.1@J1Z#!Q@<=#SCD5!XF
MT>SUJWS:A4GC.XLH8-E0V=NU3G)(/..1[DUSSA*I[R4[+M_PWY>O>^\9<JLV
MIOHKIM];*_7SM_F8\$C2A3(% RJ C^)3SDD#H"J<#G!SQFMFT898N/F;;GUR
M PQC@<?*<CDD@#J!7G]K<WUG*MG/',3 VQ7VYRHR <D@Y.!VR<=37<V&;E@0
MS#( X#]LGG SP3CH.<$9ZURU%-:.\5W:D]>BT[]RN=O14I>ON]#J$=F48YB
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M Q'L+/1HP4=1($&Q0O(;@_P\ @Y)R!GH<DD5GSQ:SJCI)$RP:<0JS%MJON)
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M12OS.,C _?,?7H/P_3'>LJYT7;R02.<Y8MV[ D=CG/7D<BO>KFPC?[D3,,=
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M2_4YPP[9#O&5Y.#C@],\G  VX /3..15!X_-GDM8@3*RC+(K-\I7 R0" .0
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M2OYDV"7V;B03D*< D,"<': " 3_=YQW:$,B>8@9UZ!M\9'')!&\D\9Z+CGG
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MP,Y!^^A[=B6&>@R.,DGKS35"[AP .<EG3'W3P<.2<G'&.OIUI.,G_P O)?\
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M  #]'Q:LI?\ ;GZ%FH9^%W>@8?FI.?\ QW]:FJ&?[@'JX4_1@0?T-90_B_\
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ML;6NIM>:1XE@M[2)?^)8C>*]);[%J9'R:K$3MQ)$2P$ZA2Q.7R" )[3]@?\
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M= [<$#)(W!1\Q.T%J#(X<IY\N]6*E!=3%HV7 (DVR?(<D JP4Y(!&3BOR_\
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M.!_Q+K1B"23Q_I0R0<YY Z>F1^YR7VHW+.S7=S%OP<><[ [B3G<<EAURY.2
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M]ZNQ+<LH_P!*F'!.!(1P&(SUQC)_7ZUD\NHIM:2MUUU.J&=XR;O)2N]TDO\
MY'RW/YZE_9I_X*4,@7_A /#6W P&TRT)YSR?],7!X'3(SGVJ)OV7O^"DC!A_
MP@'AC)!'_()LQ@GN/]..,=NN*_HB2.8Y_>S-CJ?,;)R3D]6ZXS@#D\^U6P)
MP/FRG!S_ *XY/Y8.?H?QK&65TK-J:O9Z6ZZZ?%W.M9U6T3A*^BV5U>RU]VWG
MJ?SC#]D+_@I!*&;_ (0KPPCG<>-/M%'.>!F] [@\8Y!X'2LZ;]B__@I#-N/_
M  B?AI"<?>L+(_AD7K?G\OZ\?TH;9&.(WFR,Y83S*1ZC=N([CC&??I4JF>,[
MWEN!@' ^TS') R<X9>P]#U[5BLL2:?-_7S;1UT\RKRZMOS44]KVT7_#'\RMQ
M^PU_P4=N$.?#OA13MP%_LJTXZG&?M8W<DG)'/3'0UAM^P'_P4>E8EO#_ (3
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M;+*3QQYC@]>S*RG(R>_Z9!3SS$M-6U::5EY>FXUEF'NDE;97=_O>OX'X2Q>
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M;DNB:LNUUJ=\NFG2_P!Y_+4GQG_X.7RR[_A/^S\5WKG=X$M\;>2W3Q(",J"
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MHZ=M_+\3]N_^'U/AL !OA!K><GKJ5H3CCOMY&>G']0&'_@M5X:+9_P"%0:T
M,<?VE9=1UP2O'3(SSQSDCG\ V,;Y&$;82-Z["K[6ZC&, C@KDGO@<9-B8^XF
M#G^$$#' /3GH3GOGIS7JQ^C?P$I1DJ$JE*3YE/VF-UB^GNXE+SNOO/$I^,/&
M+J.G6E4=F[75%W_\I+6US]]F_P""U'AKH?A#K0Z'/]HVWKCG]WD#GJ >_P"*
M#_@M3X;4Y_X5%K/?KJ=KW!'\40'?C)Z_E7X%>7'R-B X." P(ST));(_ECKU
M%/$:9^['QD_?!Z ]O\XZ]JTG]'/P]YI?NI6>R53&62MMKB7?[S5^,'%$924I
MRC9JVE#M_P!>T]['[X#_ (+2^&B?^22ZY_X-K/\ HAH_X?2^&E(/_"I=;/7K
MJMG[>J#\>N>.E?@> G_/-3P.@7CZ@C ]OQI2J'^ +C_93G\EI?\ $NOA]_)+
M_P &8S_Y>->+_%+5U5E]U']*;/WS_P"'U'AH\_\ "I-7'M_:ME_532_\/J/#
M/_1(]6_\&ME_\37X$%5S]T'_ ("OY<(?\FC:/[H_[Y'_ ,;%+_B7/P]_Y]S_
M /!F,_\ FDU7BWQ<TFI4FFDTY>RYFNC?N+7N?O[_ ,/I_"[@_P#%HM:X[?VA
MIO)],B $ \#(&1U!["J?^"T7A>$22_\ "H]6!)&%-_9ONW?+@_(3UQT3C@]J
M_ \*!T .<<%5_P ./<TH&U@Y*H45ARB8+%6 .,#C) P#CDD9&"'#Z.?AUS14
MZ4N1R7.O:X[6-[O_ )B;[=K,S_XC#Q/9WC.W72DM.MG[.Z]58_>#4/\ @M'X
M6@AEFD^%FJKY>V01B\L_EDX(8'R<DH<Y 4$GCMBOU8^"?Q/M_C/\*_#7Q4M=
M,GTB/Q3ID&J+9W$T=PZ_:$W_ 'XUC55S\OW <GIM )_BZOG)L=0:41M+)#*-
MC1KQ^[8 J3RN!R,'.[N:_KA_80C<?LB_"/\ ?;]WA33 5;)V#R0N%)SU^]D$
M\D''!K\-\=O#;A+@S*LNGDM%TYUZR523EB9*48-RB^:K6J6:<8NR<4^M]C].
M\+^/<UXAQ^)H5XMQ49*UXMKW==%'KW>JZ:'UM;!) DKDD,,X[@@?RR. .@Z'
MKGH/V>V(^,GC#.#A2>"<'=:6YZ$<?K7+X*"&,$ !3GKQD9ZYX!P!D'/0=S71
M_L[N)/C%XP8?W#T]K*W(_#MGO[5_)W$-Y91BY-?N_JONM?S*5F[K?W?,_HC)
M8R6)P\IZ3^M2M?=+EC966FEWTU^X^^$/+C&2Q9<^G;IC_9SVZ^V:4L5.#SGG
M/3V_I2  $$9^;YB.V20./3[QI'ZCZ?U-?BE*4E"+OJ^:^VZDUV/TK%+17UNE
M?Y/3[O(NU#/]S/H21]0K$'\" :/,;(!"\D#@GN?I44S;2YSR.WML].G>E!?O
MEZ__ ""[#JZ4JG^"7_I+/SA^%LVSXO?M!=1SX;''^_*IR<=Q[]3CGG/T)#>%
M!*RDDEG! _WWYR<9XP?SQD?=^<?A@C-\7/VA9 ,?\BWSSC_72Y/I_#^AX.*]
MU>26VCG8 .Y9B%. H 9^1[G!&!CCUXKZ7&56HT7&W-R[VL[)6WW5NQX.'A&<
MZD9;-O\ !Z>?]>1T D5PI;C<L3<XSS*N/4# !V@=1]*_.C6I=_\ P4^\+0I*
M[C_A$-=N1&0&ADDMM#CV%@P(+(RJ0.5W %A7W7_:9^15/F-MA,B="A\P=![\
M'VPW3J/SXNKVQD_X*=Z#YM_:6A3PAKGERWM_!:1Y;0D4PQ-,\8<3L3N*EMK'
M:>N!G@JSE73J<C5MW).VZU^7G^-B\3AXQIW@VFKW^)/;3MU/TMDU;4VNHKJ=
MT$SE8FCB (3?@''R\A<G'UY-,&J7V7"W0F0ROAI-I(^3++C&"JG &1U'?M3,
MNG6K6\J:[X<2XE0.T,VO:/<@$#H'$Z@'C[V.#C'>D>;2"Q4:_P"'"3RQ&N:.
M &)&=O[PKUX'?&>3GC[*-;!14;>S:Y5NHO9VLKQT2\G:]]-+OY6I*?/*]*=1
M7^+F:<?+5WUWTO\ >7CJ5\/XHOKM7K[Y4#\AV]*<-7U'&!.H XQD8]>@!'4^
MWK@5F-+IP&1K_A[DXR=>T; [_P#/0>A[]N^:>)K%@ NN^', 8P==T9CZGGS>
M1T].E4\1@^JI?.,?_D?U(C4E&7N8:3BNLGKKONT]'IZ&DFI7DC*C7"*';8YR
M!@G&"?W9'3!&.O.1FOCOQU^W9X!^''Q7\>_!CQ!I^MOXF\!?#GQ'\2HI88[,
M0ZSH7AI(?M-KICO(K27\[[DA5E4%&!.#D#ZVCN=/AD5GUOPZ=CJP']N:/AB
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M_P#!7AS6M-\.Z7#:1SZE>ZQI5MJ#-"EQ-%,H/GC=F.1RB;ERN^OP\_X)1?\
M!''X;_M4?%#]L+QY^V/9_%30-'T[]H.74M"^'NE^(M7\+>$O&.G0V\I635-
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MT*H29>B@D8.2Q!S^(;TZ\<YP,<F99&P$D&2A.0#DKDD].,YR"?J<] *L89>
M !Z,,G/Z\?\ UZ@<-O)V9^[DJ=H/ XXZ<?XU%UW7WK_,"3/3Y,\#DCD\=^#_
M #/L32@Y(^7;SUQZ<XZ#KC%5]DAY!."<XP.A.<9VD].,Y/J*?YG(!3&.GS<G
MTSG@XZ#&./6AVV;2OYI;]KM?>*]'^>TO.77YM)ZZ$Y /X8[ ].AY!Y&3R*3
MSD\YQU&?Y# [?K2*^XXP$ST+$8SZ<'J>U2&-_4?A_7/]*CV<=[I/O[2%]=]>
M9/7U^\/:*.O.K=N96?RYM1H'?N<9_#MT'J?SI 0O V@#U./TQ_\ KSQ3F5U.
M,K^1/<]]P_SWYXC(;^\N?0[A_)ZU511ARQY'KJFXVZ^;3?D[>H<JD[\R[7YD
MO_;OQ%/()R3@9'! X_G^)/MBE&WL><<<\]R>OZYI/FX^9>G0$<G'OZGMG/;K
MS1\QR#@<>QYSZ9S].>HS[5S\TFY.2@HK?X/\UZ[;[W*44K^_'RO)/\4]-12
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M&(3XGU]E0DC=:VF<=MQW\Y_PR, TS_B'P_9@MG\^Z\5:O%;H,9N+2S2,MA<
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MH):WM\JSQMP>A3;P!DDJ ,CK[\^AP*ES%869-W<R)ID!4$74\BQKMQ@??(4
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MD[7QN%U2WM^Y;_"_97-H^.?A]549/&XE<UVG]3IJ[6_17L_3;J]3^DDH.H+
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M80S7%PIFFDGW2W<KS2$F3/(:0@D$YXW'M7JT>"&Z'YL$#L=J\'_#G@U6)99
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M]L03U(5]S9;&, GGC'K7H'AKQEX&UNR.J^"KNTU73Y)##)>:*R7$6\X(W8)
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MG&5)^F-2_;?^!>C^'="L=&UV]L=:TJU\71:3J%E]F>9I-5BV6$DLA#% I2/
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MXZ=E;1W[CMH_YY_^/D?R(%("G_/,'W,D@_\ 9P*3)_Z:?]\-_C1GV<_\ ?\
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M!;Q&<>8'\SE).%)(%?E9\0-0T#7_ !QXFU?0Q/!HT][/)86Z1JB11//,T;*
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MT/W;^*\RK-X:\"V4SV]L+&-I3M$,4FW&00"%!*G )+\ D@D\5M4\0W?@Y8-
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M%YIK6?4[::X)_CGEAOHVG)(SND+'/S$Y()<?^"?W[(PZ_!O2>G_03UO^FIT
M:Q_;N_9-88'QH\.*?7[/J^?R_L[--_X;L_9/_P"BV>'/_ ?4_P"NFY_/GUYK
M*_X=_P#[(O\ T1S2?_!IK?\ \LZ7_A@#]D;_ *([I7_@TUS_ .6= &I_PW9^
MR?\ ]%L\.?\ @/J7_P K:/\ ANS]D_\ Z+9X<_\  ?4O_E;67_PP!^R/_P!$
M=TK_ ,&FN?\ RSH_X8 _9'_Z([I7_@TUS_Y9T :G_#=G[)__ $6SPY_X#ZE_
M\K:/^&[/V3_^BV>'/_ ?4O\ Y6UE_P## '[(_P#T1W2O_!IKG_RSH_X8 _9'
M_P"B.Z5_X--<_P#EG0!J?\-V?LG_ /1;/#G_ (#ZE_\ *VC_ (;L_9/_ .BV
M>'/_  'U+_Y6UE_\, ?LC_\ 1'=*_P#!IKG_ ,LZ/^& /V1_^B.Z5_X--<_^
M6= &I_PW9^RA_P!%L\-_C!J0^O\ S#3SZ>IXXZTR3]NW]DT*96^-GAKRXLM(
M#;ZHP*J"",+IX((/\1.T8.1SD9W_  P!^R-_T1S2O_!IKG_RSIK?\$__ -D3
MRY WP;TAE:.164ZIKF2"C'"XU/[V0,>_4$9! /H7X<_%CX?_ !<T<^(?AOXK
MTSQ9HR-Y;W.GNY16R0%9)(HY$)VMC<#G;_#@FO1( $9T7=M#$_-W)6)@0.P
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M.<]^%'_!#;]J4$G_ (3#P[D]<:;/CV^]+@?\!_''%?UMBXE\I9))&&]AM].
MW'. 2V1@=^G.*<78?\M&_P"^G_\ B_R]>U9?\3<^,"BTL9@FG;58!]U_>UN_
MN.O_ (ETX W]CB/_  I_X'H?R0M_P0V_:F*G'C'P]GK_ ,@V7GGIQ+Z4P?\
M!#;]J3 _XJWP\??[!..G'3SQ7];^]V.-[8_WVY]\$D^_X=12Y?\ O,??)_\
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MLDY1WDH*$6G+56<8[W=_>>Y\(_LZ? C5(M9BUG4W%Y?-*);V:99&!#,I.TL
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M,M?_ $EBK^GZ[3P])IW7,K/O[F_X?B?G-)?[7-]J5O\ R>+N;?\ RT_[:?\
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M]H?PXICB*HO]E:UA2I7:PVR$Y'0 <<G)YJ+_ (AZ/B>8O^3DO#XFXX.DZVI
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MY(93D<<X).,#]-5BRJ,"=ZHH#GDXP>.N1UYZ Y[Y(K\S/V0#_P 9;_MB#W\
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M3<I/39QG/B_QO\;7_@#P%XI^(WA.PF\0ZIIL+)ING11+,(FN=\<DTD2Q@K%
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MXUDU^;Q5)///IUYX6UN?1+6UN71GLTT^YM)+==K*C)*(UPP!X(!'5P_M _\
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M]^]OO3/LQGS(G,F#CDY7IA3PI.[@]@>"3CK574&?_A'?&"GS0!X5\0%=CG+
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M2>BX.&?\-D644$UI%^R9K$>FW,PO)[%$B$4MPY#F1A_8X3=NVDJT<AR.),@
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MH_\ "O+_  J^'B !5;PGI04XP7QI]B",<%22?XL=0,\8/XE?M(_'SQ]^T/\
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M5SRY'JY_]!J2/JWT7^;5Y\FTKJW3?7]4=LGK%?W+_=;_ #&R,#M5>2'^8#C
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M;6?>Y_03)_P4J_8>9]MQ^T'X/C%J/..-1N>8G^Y*P$!QN)(QG> #E0*?;_\
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M'/&&A:GX?OH2,LMOJUE/922(9%*F2-)V*L>5;& 2 *_,[X)_\$^-5^";>'/
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MB5K)*Q]/E.&QF#R[#4\?7A7Q+48SK5)7E4DE[TI/3FG*3;<G=MMMNYI":,G
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M^/M8373J'@6])7PEH[7#2R:79_94R9(792,S X8(H4N5P#N-?K=$-Q921F(
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M<)+E<4UVV_%6?XE)[*S;[]O'P>#L_#DX_P#K=.:SKKPYIMU\SV\*,P*[E/\
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MRP5NN\D]L=N<@\+>$M.T6>+QAK$H\1WD(N5+32LT9D"E=H;)P7; X[@CBO\
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MH?!B\#@\5%JUK5Z49M73:;;ET;/Y+G2E0G5H5-:E&M.#?I.4=?\ (<)2ZC&
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MS)$=IZ9ZY/4G('T^1/B3XAGL?V:?$^CZHYMK]OAI<-;6X!!FC'A^Y; V$/\
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M*0-WS$:R"IX)Y(& "<YJT?\ AC9,,G_!)7X@-G!##P#XF*D9SG/]MD=0.AP
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M%Y$LL_[HR8^SGYY&PH<MAAQC],?!&<PA"2S2E"O24E+V==^\I:I_QEK;DO\
M$M+-MJY^<?V]A*LFJV25-[75)QO96V]C&VB2V7?8_17X>_"3X+?%00:[X*T
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MQY/RMFN-UWX*?L[>(KBS\">'_"<OA>\\2?"W2/'VFZ^^H75P-)EU>X$7]E-
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MX^C)XGY1DE>"S'%Y7B\7AE"M'VC6&51NG&-*JZC=?E494XQ;K*T7&JK(_;/
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M5Z!HEQXDU6P\1Q7\>BQF827EQ;Z7.R6R&".613(7*\(><C((S5?PG^V1\?\
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M5/>UVK6V[7\]6UYGL9U"_P C_3IDP.$:>=R<\9RLC 8X/7T)ZTTW]^PP=0F
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MD=OJ?\G%*Z]UW_O1?1VT?RN_7L%Y)/E5VUJMM+]4VGNO)@6V#G ''8G&2W'
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M=GJ]$K,_'(_'/_@GR521OV3=<8R?O O]B0DI_"02-(VDE@6ZG&<9]7/\=O\
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MDY4<# ]N>:_8LV^D$8_L;1!Z?\2+3SC\/LX%)]ET?OHVAGZ^'].XY]H!V_\
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MV#H5Q\P.,$XP 5SWQZG !K7ENRTC!"F.@VJPQC&1P#U/)ZG .1TKY;E_:^^
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MD$5:\-_L*^(M7L;8^(?B#X3\.ZSJ]_;Z;HFGW=S+;O?3738M2J!!YLDBD%F
MY;<>O3P*'X[3S>"?!?@FYTI63PIXL\1^)(DCN88PTFNZB^J#<_RQG9*ZH <
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M!D]2,8S-2_X)E>&=*D:)O&_Q780L09/[17+@%L_<54 (') /..3FOT\@TO\
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M;WE9>=D[Z.Z6E_GN9Y#CJM2C-U<+&5:";4>5.[T5E=:Z-OX;Z'P _P#P2_\
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M4$?-M!R>!DXQU''3K^=20DD#[PR1\OJV2#DG')P#C@=..,TR7)4D D%CABN
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MZO\ AW+^TJ>/^&V[C=TQ_P (M? $\\ _VIG\AGBD/_!.+]I+^+]MNYR<Y/\
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M=DF>GA,IS7$UYYAA\'5JTN1I0Y)\BLOBMR-=+WM;7H]%W!FN5'E2B)F49&T
MG;TSG'0YSD<=^ .(1YDK;5R"S 9'?A@2#CW'/3OFI;>:SN(#<VLJW(V[B8Y
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M2+BDO)QN.IDG^KD_W&_]!-/IDG^KD_W&_P#035C/S'_8_P#^3N/VQ/I\/_\
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MHKFTU*WECE125+[]C#:",*0>3QUX&:\5O&2ZOQYG"ZMN.#25O/ZO9?/YF;X
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MYP?F_P")@,Y//.<'BF_\.D_V 1D#]H[2<$GIK/AOC/<_Z>"/S./7I7V%;_\
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M'S?(!M)SD>9%QW/'KV!R?6O+M!T/?\*-+OYM_P!@?PO%<7,40WL?LVG%VVY
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M</C/P1KWANVU"-S;WEZ#Y5QY84^63;N'P <E2JL,XV\',%S\#/BZD>J:K8^
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M^J_*<5_.G^QYX2GOOCK#I7B*PDM;G39/+N+.[B99[>4F,!6)9\KC!W\*P/'
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MDF^U92Y[ -CW!]ACWK\H7_8Q^/+7V@Z9IVBKJD/B.%[Q=0M(7-J1& "S&24
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MGXR^)%.;A/B'%QE'>+5-33O;6+A=>O<_?Y/^"_OCWI_PI;PM[#[;JN<YP.W
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M#;XN:Y=:[\1H/&5UXO\ #OACPSI/@.32XOLVCZEIUW"+F[6<R,L,DI^\^%8
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M:Z.^CEOB13PN-PV(X5Q4YUX*%.2A%V]^#E]EW]R,K66CL]M^"^'GQ<\)Z_\
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MEV#1E.K;MQ&W-?HF/^"$?[1BR!AXU\/Q#@NR7N%\Q>%$2&T;"8SG<?2J4_\
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MO9<E^23@0@8/ /0C&3[;/A[_ ((@_M,>'O$&F:Y8^-?#T4]E.LA*ZA,"-NT
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MG!Q2<5+1[7OUW6JVU _38HP;<#L/; "EB1SN.1O)]/Y]:6,D[LLSX/HN /4
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M5-'_  DG_!4K_HD?P._\.B?_ )4T[ON_O?\ F*R[+[E_D?IOF3^[_P".+_\
M%4?O.I7)[G8/P_B-?F1_PDG_  5*_P"B1_ [_P .B?\ Y4T?\))_P5*_Z)'\
M#O\ PZ)_^5-(9^F_[S^[_P".+_\ %4?O/[O_ (XO_P 57YD?\))_P5*_Z)'\
M#O\ PZ)_^5-'_"2?\%2O^B1_ [_PZ)_^5-.[[O[W_F*R[+[E_D?IQF7T/_?
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M'I^7O:P=M$TU9K7?1&L<PQS@TJE35/JM/P_4_2L_L0>+R4CN/VL?'=A+<H!
MUQX\\0Q7<_ECJ/,U&*=F(.W<5P50G)[H_P"Q#XT5WAE_:F^)*%BD;.GCCQ3)
M*X$:A9#(EZ00RX8%CA?E4$A0:_/70]%_:Z_;#\0W.M:TVK>$Y;'3X)+76-4E
MN=$GAC0S207*V92*!I93OB>)5_=C:0PS7H^@?%K]L'X$^ ;VR\13>)/&DNN0
M:G#:ZA;:/->7&@MHGFV=FL1%N1<0ZA]F0F0G*L[E<@Y+A@Z3YDX15XV2G0I)
M7;6SY$^[L^Q-+'XR*E[2I4:;:2;M=[K9+H?8#_L.^-TQ(G[3WQ*D^S+)"/\
MBLO$NZ5,KY4H)N2QR01N((W9.[)-/7]A[QO<LL"_M.?$X/*HD,8\;>*E\\#E
MS\UWY9"\AQ@\X'.!7QUX%_:!_;K^(7AO1]=%OJ?AN5((M#DL9K!@)S*YD&I,
MTMJ'5HR-GED9/\7W:V->_:-_;!^'W@379O$=EXEU[6]0F>+0YM.T26X?2WT^
M7;,Y^SVZ_+=QLGR\KDE^3UZHY?0]BH<E&^K;]E#Y7]WI\M_)&BQ]5J3]C/UY
MIWEW;][I?73\SZN/[$OBM?E?]IOXF6\]N<"U;Q?XG#LN"#@K=+D$@-QD<[L=
M,5U_8@\7&0N_[4/Q)#NH9D'C'Q2=A)("Y-Z#E<C(.,;O;CW_ /9I\<^,_B1\
M"O OC7X@:==Z;XOOK1I-4AU"U-K<I(D\D>Z1)(P1O15(0@=,YQQ7NTC!)'):
M/YV\Q3&$E!R!UX 4]\?4=N:CEE'V<5*-+XWM3AMII\*;^?F<TLQQ"E>,9+1+
M>3[]TSX.;]B3Q<[@?\-0?$GI@!O%WB=AP22<M=L>1C !P<<?,32G]B'QD%>
M?M/?$=I)%W1N_BKQ$2D>%W!"USP"020H)R3W&*^[!(F<A\9XR(DR#W_0\\GZ
M<\CL5\K)\^0M^ZD5 /LZY.XMA0,$EFP?7MWT_L6@JD*J5.*ZKV<+=.\6K+?_
M #"GFN+=11:FXWVO^35G^)^27[3WP'^*GP$^$Z?%/P;^TG\0=8U?P[J^FPS6
M&H^,/$UQ"\$M_:6LH$%Q=K&05E(P00/N_=)%?M]X#U/5-4^'7@S5KB6XFOM1
M\-:5/=2M>2,T]S-8V<LTQ)E^9G=FZY/)8FOS7_X**,K_ +,&OV\TCR?\3;2-
MFQ=@D5M6MF&64@LV8U.>HZ$<D5^C/PP1!\*_AEM'R+X4TH$%L=;"P)+'))(
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MK*E?^%I_#SYL@JOBG2BV#Z!;@%<D ;LX!P#3XOB7\+R)$7XI?#\0S(T,R_\
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M)Q7X_?L!:MI\VB?'.:RDAU2WO_C+JDMO<VEPD\%S'*J[)XIXV?Y< ,.<E>G
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MT_'%[;'GUP0?R!KZ4\,_\@'0O?3;8GZ_9H^:^;OVDVQ\(]27'_+WIY&,Y/\
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MB*]KAEI[2*MT<977K:!G&%645+VMKZVN]-7V7EW'AG(X<EAU ]>AP?8U."<
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MXT?[-_S_ (_?_P  /FOO7^84493_ )Y?J/\ &C*?\\OU'^-'^S?\_P"/W_\
M #YK[U_F%%&4_P">7ZC_ !HRG_/+]1_C1_LW_/\ C]__   ^:^]?YA11E/\
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M=).4Z\5RZR;A"-E;2\6D[>BU77J4N)*+7*Z,;=[JVKUMKT_J]S]ZOA_^Q?\
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M:***Z1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7IR0"3UKT[PW\=?#'AV'3='N=;B-A86MO:V=QO11(8"L9#A9-R,X4MR ,]\
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MM8N-]RRQNS+$1M+*> &!WYX.,X[#C+ "OIOX76?@M+B'4]8N[.>XBVO!]J*
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MERQ?_N8V_P!1:T$U[7W>O[QZ]M.3OZ>A^..M>,/#$MT775;:2'RW\P;XO1L
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#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>formdrs_12.jpg
<TEXT>
begin 644 formdrs_12.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 9R R<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**2@!A
M.:8S!>M#G;5=FS0 Z1_[M1!Q_%28,GW*FCLRWWJ (3-2&;WJU]A3UI#8I0!2
M^T&C[0:N?V>E']GI0!3\X>M'G#UJY_9\5']GQ4 5?-/]W]:/-/\ =_6K7]GI
M_>H_L]/[U %7S3_=_6CS3_=_6K7]GI_>H_L]/[U %7S3_=_6CS3_ '?UJU_9
MZ?WJ/[/3^]0!5\T_W?UH\T_W?UJU_9Z?WJ/[/3^]0!5\T_W?UH\T_P!W]:M?
MV>G]ZC^ST_O4 5?-/]W]:/-/]W]:M?V>G]ZC^ST_O4 5?-/]W]:/-/\ =_6K
M7]GI_>H_L]/[U %7S3_=_6CS3_=_6K7]GI_>H_L]/[U %7S3_=_6CS3_ '?U
MJU_9Z?WJ/[/3^]0!5\T_W?UI#-@?=Q^-6_[/3^]1_9Z?WLT 4_."]^M9,[>7
MJD)[$UT3:?&WX5%-H\4S*_=: (5F#+UI/,#@J3P:N)IL:T?V?&W%(#C)K-'N
MG#GZ55DT^>'=M&Y*[6;0[>X8$<$5,-/BV@#^'VK%TR.4\_\ (E'_ "R-'DRG
M@QD5Z#_9L7^12'2XL=*S]F3R'!K8SR=!BK4.BW#=3Q7:KI\07[M(+%/7 JU3
ML-1L<U;^'T7#2'FM2W5+=0J#-:+:>A'6@6"CVK1&A3\X^E+YQ_NU;^PK_>H^
MPK_>K0"KYI_N_K1YI_N_K5K^ST_O4?V>G]Z@"KYI_N_K1YI_N_K5K^ST_O4?
MV>G]Z@"KYI_N_K1YI_N_K5K^ST_O4?V>G]Z@"KYI_N_K1YI_N_K5K^ST_O4?
MV>G]Z@"KYI_N_K1YI_N_K5K^ST_O4?V>G]Z@"KYI_N_K1YQ],5:_L]/[U L$
M]<T 5?.-'G>M6_L"T?8%H I"XVM6/KEH)H_,'K72M8*5]Z;_ &>C1E7&164E
M<EJYYLTWEL5H6Z,>&!YS7<2>$[69BQJ-?"-FO3^5<[I]3/DZF9I/B $".=L5
MNK,'4,K93M5;_A$;3<":T8=)CMT"J?EKIIJQHB'SC36G*\U>^P)3?L* \\UM
MU+,K4%-U;FN.FS%*\;=*]&_L]!QV-4+CPS;W$A)XKEJ0NS-Q.:T+61;S>03\
MIKJ1<+_"<BJZ>$;53D'YJT8=-BC4(.H[UK!61216^T4OGYJW_9Z4?8%JQE3S
MC2-.1BKGV!:/L*=Z!&%K5N+JU8@\U!X?N_W#P-_#70G34964]#4-KH<-JS,.
M]9N(CBM9D6'4F7UK2\+R*IDQ6Y=>&K>[N#*PYJ2QT.WM4)6H4=0L<?KEX);Y
MCG[M+H1$UX'6NGE\)VTTC.3RU26/AVWL6&S\:7+J9N&I)YPSUI/.]*MK81L3
M2C3T[5NM$:I6*BS4GG^]75T]*%L(QD&J;NAG,^(KR-8=I-<SYZ*N17>WGAN"
M\;+=*A/A"T90N*XY4[LSE&ZL<5Y^[!!KH?#]KMS*3S6I_P (C:\"M"WTF*"/
M8AJHPY28PL5VN"TE+YV2<&K@TY!]:1=/5<\UT(V*OG&E6<U:^P+2_8$I@5A+
MN[TY9!ZU,=/7L:CDL_+Z4 .5]M3(^:HC*GFK$9Q0!:4T^H4:I5H 6BBB@ J)
MC4AJ)Z (I6JN[=JDD:JLS8(H NV<>.:MU%;\0@U(K?+0 ZBBB@ HI** %HI,
MT9H 6BF[J-U #J*3-&: %HI,T9H 6BBDH 6BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **3/M10 C'M24K#O0* $I5'>C=2[O:@!:*;NI=U%@%H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!-M(:7/M0* $ I
MU%%( I*6D-, :DW4ZF4 /HIISBE6D M%%%, HHHH **** "FM3J0C- " T+2
M4^D,;_%11WI5H$"TM%%, I&I:;]ZD E*M.HI@%%%% !1110 4AI:0G% %&\C
M.<TQ&SBK-X1Y=4HFW4 7%:IA52-OFJRO:@"6BD6B@ :HI*E:HI>] T5F/)JE
M,?WF:MR?<S5*8]#0#-BS_P!0M2_QU%9_ZA:E_CH$.HHHH 9110:GX588TX&,
M4-POS';5>^OXM/@,CL,XZ9K@=:\9373M' 2!TXKIHX>=5W..MB(4$=K>:Y;6
M*_O) :Q;CQY;QMB,;JX.61YN99&:H^/X17MT\N6\CPYYB^AW+?$"('E*GA\>
MVLF-PP*X'KC*TC*/3%;2R^%M#)9A,]9LM;M=10>5,%-:"M\O(S[UXO!,T#;H
MW9).WI72Z)XTN;=ECN_F3.,UY53 U*:UU/1P^84Y_&>B@YYS2YJE9WD5_$'B
M8$5<!/%>8X\A[$)1J:HDHINZC=06.HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DH K:A_Q[FLZ'H*T
M-1_X]C69">!0!>C[5;C^[5./M5N+[M $BT4JT4 -;O4$E3MWJ"2@:*\OW35"
M;[WXU?E^Z:H3?>_&@&;5K_J(_I4J]345K_J(_I4J]30(=112&@"/=U![56O;
MQ+*W>9VQ@<5.[5Y_XWUA[B7[%"V&![5T4*?M96./$U_8QL8^N:Y-JMV2SE(Q
MT45G!2I#?,H/'2N"^*WQFT'X2V EU-UDO6&1&#D_E7SH_P#P4"MK?5SY]JIL
M<\<GI7T\90P\;'S<J-2L^9GV1AGWQ+@=^31CY!GAAZ5XUX._:X\ >,K6)VNU
MM)\<A^,U@:O^U!::M\3M+\-Z"4GADQOD!XQG%:1K:;F*PK2NT?0<F=\3-\J8
M[4V6>.VW22.#%W+G&*AU.Z73=/ENVS(47(3'M7SAXT^*&K>(+B:W5C:6ZMM^
M0]17JX'!SQ<K(^>QN-6%N>YW_P 1=#L9'1KQ3L[=JS/^%P:&<9FP"<<CBOGG
M0]/@UK6K:WOYC';,X!D)Z\]Z^B?&WPI\(6_@.*6)HHI(XPZ2AN6.*]#%82AA
M*L:-2[N>;1QU2O3=6.ECK_!?Q3TQ)UBCNU:.0_<)KV6SO%O(XYD8!&&1MYS7
MYJQR2V=PPMYW1@^%85[C\"?VAKU?%5KX4ORUV7 57/.WG%>5F^0.G3]O2V/>
MR?/Y5*GL9'V,GWB:?MYS4<?S1T]>G-?GA^E+:XZBBB@8444E "T4F:6@ HI,
MCUHW#UH 6BBDH 6BDHS0 M%%)0 M%)2T %%%% !124M !129HH 6BDS10 M%
M)FC(H 6BDS2T %%)FC- "T4E+0 44E+0 44E% "T444 %%%)0 M%)GMWI: "
MBDHH 6BDHH 6BDW#UHH 6BBDH 6BDHH 6BDHS0 M%)2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 5-2_P"/8UE6_:M74O\ CV-95OVH
M OKVJU']T557M5J/[HH F6BA:* $;[IJ"3[M3M]TU!)]V@"M)]RJ,W2KTGW*
MHS=* -FU_P!1']*E7J:BM?\ 41_2I5ZF@!U%%% %+4YA;V,K],"O'[Z[\QKR
M\8X,:LP_ 5Z;XNN/(TU\?Q5Y5>1-<:;>Q+P[1,%]SBO=P$5&+F?/YA4O-1/S
M _:/\;:OXS^(NIQ0Q37LT<IBC"@G ->0O\-/%\C?O-&F:,^J&OT?^ _P'72_
M&7B36_$VG+,MQ<%K?S!G@CM7O3>$]%*J/[,@"J,'Y:^.Q^;2IUW$^SR_ *=!
M2/QD3X9^+HW=AH]Q&Z [& ;I7:_LY_VC:?'#0K2]66"48W*X/)W>]?K!-X1T
MB3;$--@P1W':OGKXH? :&'XP>'M?T"R6!8BOG[!C^+)IY?FCKU%&09AE\:5)
MRB?2EW;K<QK$WW67:U?*WQ@M=/\ !?B27S)UCMY"6 STYKZKDN%MK6:>3D0Q
MF4_0#I7Y@?M)>/M0^(GQ0NK"P\QUDD,<4* D\GCBOT^CF?\ 9\>='Y9/*5F-
M5Q9T?B3X^>'M%=X$+3RAL!E%5+G]L1-1LX-.O8Y'LH<!5YQQ6;!^P?XSF\+#
M6WN#Y[Q^8+5F&>G3%>'^(O 'B3PC/+;:MI<T/EMG<B$YKS*W%4L1-+L>K2X3
MC27+8^F-%^.?A_6+=P'%LR_,$KW;]DOP[!X@\07'B[S%812&-<'/O7YF[E4,
MSYMV8X^;AA^%?8__  3S^(5Y:Z]>^&FG::V?=*"YX]*]:7$,L;0]@>6N'8X*
MM[0_6?3;D75HDGJ,U;]ZQ/"[[M-1?05L[N<>E?"5(VJ,^WHRO30\_=I.U'\-
M(^ O/2L>IT=!K,>6/"K^M<OX^^)7A[X8:.^K>(=1CL+0#.UV )_ UU#,H7+?
M<49K\B/VCO$?B#]L+]K:T^'MO>RVOANUN!;31Q'@X8@DBM(*^X'TOKG_  5<
M^&>DZ_\ 8(;2^N[?S-ANX[9F0#/7(XKZ6^$/[07@SXW:6EQX;UB.>7&XPLP#
MCVQFN,\&_L1?"KPG\/QX9D\-6EZ&BV2W<B'S"Q'4<U\7S?LL^.OV8?VKM-O_
M (>VLUSX/GD26=%SL4$Y(K2,8L#]24.[< /W8X/J33MI900N<\'/I7D?QV_:
M3\.?L]^ 8_$'B28+=20AH[)>7=\9P!UKXSD_X*A^*O,;5H_ ]T^@D[A,8),A
M/7&/2H4+@?I2N48?,2/3TI6PK+DDDFO&/V>_VGO#7[0W@2?7=#?%U:H3<V;C
M#*1[=>M?.=M_P4\TJU\;:[HNHZ2Q^Q.T4442LQ=E8CI1[-L#[S7.WYA@YXQ2
M-M5CR<]Q7YNS?\%4-3\.^)4DU_PI<V6AR2;8Y)(7'&>O(K[J\+_%[0O$WPUA
M\<)<+%HTD/FO(QQM &<4O9V [<<<Y8J?X<4YL[2!\S>]?GKXF_X*6ZWXD\17
M]G\/?"<VLV-FY1[A8W(.#@\@>U>H?LR_M\:?\9O$W_"(Z[HMWHOB%>"LD+*I
M/U-'(P/KSC@$?X4Q=W(8#';FODCXG?MQ#X>_M":7\.FTU9%O9 @FYSTS7TAX
M]\7?\(;X#U#Q"(A+]FM_/"'Z9J>4#:UO5/['TB\OY 0EO&7V^N!FOG7]G/\
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MLW7<EQ_P3]\3;^4CL)%49]A7G/\ P39^;]FSXG'&!YMU_P"A5Z!^S3:7,?\
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M1O!^A^'HYH]+TRWLEDYD$:[=V:71_"&A:)=3W>G:7;V=S.<R21I@M]:V64L
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MD)8R7)L?L>4PG'#1YR7U-%)_#1TKQ;'N#J***8!1110 4444 %%%% !1110
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MUM8#2=Z=28H&+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%)FEH **** "BBDS0 M%)FEH **** "BBDH 6BDI: "B
MBB@ HHHH **2EH **** "BBB@ HHI* *NI?\>YK-MQP*T=0/^CX/6J,"GB@"
MRHZ5;CJLJ\U:CI 24444P$:HV6IJ810!4D6JDRYJ_*M5W7B@!+&X\OAC6AQU
M4YK$:%NH.*6.]>'CK0!M9/J*7<?5:Q_[8E_YYK3?[:E_YYK0!M<]L4O-8?\
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M_P"W6GGVHS[4 9G]C_[=']C_ .W6GGVHS0!F?V/_ +=']C_[=:>ZC<* ,O\
ML7_;H_L7_;K4W4F\4 9O]C_[=']C_P"W6GNHS[4 9G]C_P"W1_8_^W6GGVHS
M[4 9G]C_ .W1_8_^W6GGVHS[4 9G]C_[=']C_P"W6GGVHS[4 9G]C_[=']C_
M .W6GGVHS[4 9G]C_P"W1_8_^W6GGVHS[4 9G]C_ .W1_8_^W6GGVHS[4 9G
M]C_[=']C_P"W6GGVHS[4 9G]C_[=']C_ .W6GGVHS[4 9G]C_P"W1_8_^W6G
MGVHS[4 9G]C_ .W1_8_^W6GGVHS[4 9G]C_[=']C_P"W6GGVHS[4 9G]C_[=
M']C_ .W6GGVHS[4 9G]C_P"W1_8_^W6GGVHS[4 9G]C_ .W1_8_^W6GGVHS[
M4 9G]C_[=']C_P"W6GGVHS[4 9G]C_[=']C_ .W6GGVHS[4 9G]C_P"W1_8_
M^W6GGVHS[4 9G]C_ .W1_8_^W6GGVHS[4 9G]C_[=']C_P"W6GGVHS[4 9G]
MC_[=']C_ .W6GGVHS[4 9G]C_P"W1_8_^W6GGVHS[4 9G]C_ .W1_8_^W6GG
MVHS[4 9G]C_[=']C_P"W6GGVHS[4 9G]C_[=']C_ .W6GGVHS[4 9G]C_P"W
M1_8_^W6GGVHS[4 9G]C_ .W1_8_^W6GGVHS[4 9G]C_[=(='/]_-:F?:B@#,
M_L?Y<%JKR>'5D.=U;=)W[U+C<5C#_P"$:7^]3XO#XA;(;]:V?SH_.A1L%C)F
MT/SA@M5<^&1V;I6_TI",=*7+J,R5T/\ =[2U8]QX)6:1COQFNN I-OM4RC<E
MJYR^G^$?L,F[?6L=&$D;J7ZUI$9 H K115BM+'+V_@T0WAE#]ZUAH_\ M9_&
MM,_C0HIH$K&;_8_O1_8_^UBM/'O1TH S/['_ -ND;1S_ 'ZU,^U&?:@#*DT7
M?$4WUB2>!0TC,'QFNOV_6CEO45G*-P.7T_P>+.7=OK6_LGK\U:1'XTH&*J*L
M*QF?V2?[U']D_+][FM.CK30SG]3\.O>Q "3'XUA3>&+FQFB927Y!KO-M,9>G
M&>:B2U)9FPS!8U7;\^.:L)]T'O3;R/R9-X'6DC8[02>M:]"T6XVJ9>E5XS4Z
M=*.@AU%%%( J)C4AJ&0T 0.W%59&YJP^?2J<A.Z@#6@ ^SK4N!4-O_Q[K4WI
M0 M%%% !1110 4E&X>M&X=.] $?.=V<"FO* ,CFN1^(GQ>\'_"FUCG\4:Y:Z
M1'*<)]ID"YS6/)^T-\.H_#+Z\/$]@^GJF_>LHYXZ"C3J-./4]%.>&.2>RK3L
M8^8D YK\UOB=_P %:H-$^("V?AO3/M>A0R[)I60,63/)!^E?='P0^,6B?'#P
M/:>)M%?-O,H,D;$$HQ&<5',1S+[)Z+WIU1[AQSUZ4^FBA:2EI,TP%HHHI@%%
M%% !129%% !NHW49&<=Z,C..](!:*2EI@%%%% !1110 4444 %%%)0 M%)FC
M<.N:0"T4FX<C/2BF M%%% !1129H 6BFLVT9/ I030 M%)N'/-&:0"T444P"
MBBDH 6BDW#.,\TM !129%% "T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS[K7M-L;1+JXOH8K=SA9&< $U:M[B*\A66"198V&0RG(-(">BFK3J "BBB@
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKC& >*^8/C!JFO?"_P =7MA!-FQG+/$7!( ]J^I-4U[2M4NM(ED^>:,*N$Z
MYKRO]L_P^E[H-AJ42JLL>T;L<XS75A84YUDIHNK6J0IV@[,I?!'XTZ/=:;'+
MXFO?(GMI!#&2^-S=JZS]IK]FKPO^TG\.KF1[*-=6:!I;.ZB4*S-@[<GJ>:\
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MA?I_ANYF6Y>V4 ,H]!BO457YL\]*,_P]2:53M.TUFV ZBBBA %%%%, HHHH
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M ^G!12!OEYX-*IS4@+1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6_X2*+^X?SH_X2*+^X?SK)\LT>6: -;_ (2*+^X?SH_X2*+^X?SK)\LT>6:
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M'I4_]F7']S]:/[,N/[GZT 0<>E''I4_]F7']S]:/[,N/[GZT 0<>E''I4_\
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MT>E% &* $W=J7WQS1^%% !SZ4?A1SZT4K 'X4S!]*?S2<T6 %'M1SV%+S12
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M@"6BHVD*XS2++N8CTH EHIF[Y<]L9H#94-GB@!]%1^9\N>V<=*>,T +1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"DI:2@"MJ'_'J:RH*U=0XM3FLJWH&7XZLIVJK'VJU&:!LF6BA:*"1&^Z:@E^
M[4[?=-02_=H K/TJC-]ZKTGW<U1FZYH V;7_ %$?TJ5>IJ*U_P!1']*E7J:
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M[48*X[ <9%.&.I %(S;LX)&*KF0"_,O?=36?&"QXZ;13F8+ZY]J.,Y. 1WH
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MAQ2%AVH =13>:49I@+1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)J"V8\4PAV;:KEUVY^N:YS]K3X%6?QPT?2'U_P 7?\(YX>6-9+I//5-X*@D
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M/]?_ &E/AW/XBF\8WMKY<WEG9*,YQFOT._;E;R_V=_$I'SMY#@*W?Y#7BO\
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M1QCJ#[5^F/PE^$>@?!?PO%H'AVW\BPC.0N,5+20'<?>IU,7Y:<.M9@+1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %3
M4O\ CV-9=MVK4U+_ (]C67;=J!HOKVJ>.H%[5/'0,G7[M%"]**"0:H)>@J=J
M@EZ"@"M)]RJ,W2K\GW*SYN>* -JU_P!1']*E7J:BM?\ 41_2I5ZF@!U)2T4
M0GG(]:^:/VQ[&>U\.VE_;Q9BCD57P/4U]+MGL!7(?%3P>GCCP;?Z445GDC.S
M=_>P<5Z.78CV&)C/H>3FF'6(P[B]S\N?'FE2RW4=_"OF6[CJO-<FL4C(T9$B
MX/'%>A^(+76OA?K$_A_Q!8R/"DA\N782N ?6JLWBS0GD"M;IGU %?T=A<91Q
M%"*4M3\%Q6'JX>HXN.AQ4=M)<S10!& SR<5ZIH>DP:19QE5W2,*PE\4:+&RL
ML:;A]*M#Q]IO8C%=3K1?4\^I&H_LG3LS_>X(]*R?$&F1:I92MLVLJ$]*SO\
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M.0>N:\>@_95\#VOQ17Q]'9XU]6WB3:.N<UI!\H'Q5^WA8ZA^R]\?-)^,FD1
MZ=?;+::)?[XR22/QKTG_ ()Q_#>2\\.>+OBSJG.K>)))]C-_!$3N7'YU]8?&
M#X*>%_CEX=CT;Q39K=V<;^8JLH.&K5\$_#W2OA_X5A\-Z1 MMI,,>Q%48/3%
M7[1VL!^;7_!.^\D@^/7QQFT_;<:A&;AD4GYL^:>E>4?!'5O"'C[X\>-5^/>N
MW-FT%W+]BM[M@(^)#@?-VQ7ZE?"K]F3P9\&_%FM^(_#UKY.IZL6-R^T#=DY/
MZUROQ4_85^%'Q<UQM7UC0X4OG.YY(HQEC[T_: ?G!^V[KWP9CG\+67PRL[>W
ME2Z N+Z-0 Z\?Q U]4_M3.C?\$XY2LBLIL$&X'K]VO:[O]@'X/W?A^RTIO#U
MN([5_,681#>3[UZ/XK^ ?A7QA\,/^$!OK;/A\1B/RE Z#V_"ES@>2?\ !-5U
MD_9/\-.K;B7D!QSV%?'/[64UO_PWCX9C>9 6G088X[5^G?PK^%^B?![P=;>&
MO#\7E:=;DE%QCK7">-?V2? /CSXA6?C/5+/S=9M7#QR;1P14\RO<#X3_ ."D
MGBS5X?C+X#TK5-0O-+\#-'$+IX3B-EV#.>U;_C>;]EKP?\'[TZ##;Z[KDUH#
M"\:K(XDQSG!K[O\ BM\ ?!WQM\/Q:7XKTBWO8X5V1NR E0!@8KS+P;_P3]^#
M_@FWN8K?0HKCS1@--&"4^E5&:0'QU_P31T%?B!\*?B+I-NR"2Y1A#"QZ?,V!
MBN1_95^/UU^Q-\2/%'A3QCHEVEA-.6%PD)(P6)X-?I1\*_V=O"7[/>GZI-X0
MT_9-,&D9=@R>IQQ7R-XN_:Z^'7B#XB:AHGQ5^%YM)+5RHOFL3B0>NX]:TY_:
M,=SR3]OK]K!/V@/AW!I^@:-<Q:%'*K/=S1%0<L._3M7O6M?#&]^+'_!/73+/
M3@S7EI;%TA3^+!!-> ?M4?&SP7\8O!FF?#CX1>$)X?M,P#3V]K@## \D5^D7
M[,_@2\\!_!'0-#U>-?M20?O(S[CI1)\JT"Y^=_[&?B7X$V_@A]!^*>EV-AXH
MM79&_M!0F<,?4^E>R:/\4OV;[CXIZ;X7\'>#[?5;J20?Z99VPDC4C!!W U[K
M\2_V!_A'\4->EUC4M"BAO)#EFAC R:Z3X._LA?#3X(3?:/#^AP+=@Y%P\8WB
MH]H(^#?^"B4\5G^TQX)A\U(E\U/+AW8VCY>,5^@GQ VQ_L]WNYAM&F\LI_V*
MI_$[]E7P+\6_&%EXEU^R\_4K1MT;E <$?_JKTO4/"NGZGX:DT&:+-A)%Y)7'
M\.,5FY7 _/S_ ()-W"3S^.?*:)XOM0Z-ENIKB?\ @JS<1P_%SX?*943_ $N/
MY2V#_K%K] /@U^SGX/\ @2M__P (O:"W:]?S)6V@$G\*H_&+]EGP-\<M;TW5
M?$MB+B\T]P\#[02""#W^E-2UN!\8_P#!33X=W^O?#GX9^*;&UDNM.TF&,7,<
M:EAM)4G]*W/ACXX_9/UOX=Z=?:M8Z7I^J00#[5;SA4D+CM@FOO74O ^C:UX6
M_P"$>U"SCO-+\L1^3*N1@# KYOU;_@FC\&=8U26]ET<*\C;V14&W-5[0#$_9
M<^(WPE\??$Z:W^'G@I;&.S5@=66UVJ>,\-TYKYX^'TZK_P %9/%4:R1B7=,,
M*>GRC(K]&/A7\&?"OP9T-=,\+Z7#8P\!G1 &;ZURVE?LK^!]'^,EY\3+>SV^
M)[K<9)]HYR,'FCG X+_@HM,D'[,^MEFV_O$Y8X'0UY?_ ,$S/]-_9?\ $*0N
MLKMN4>6<\F-J^OOB=\,]$^+?A6;P[X@B^T:=,073&<D50^#OP2\-? WPW+HO
MABU6WL9&WLN ,GI4\VE@/RP_9A^*FA? G]L3Q5-XWD_LJVDDF599,*"QZ=:_
M73PAXNTSQOH-KK6D7'VO3[E0\4BD$$&O'/BE^Q'\+OB]JDFI:YH<)OI'\QY4
MC&2:];\ ^!-,^&_A6Q\/Z/'Y.GV40BB3&.!42=P/'_V[&6/]G3Q(Y(5A X!_
MX":^0/\ @F[^U%\-?A#\'+S3/$GB"*TU.:Z$FR1U'RXQW-?HU\0/ 6E?$CPO
M<Z!K,?G6-PI60$9ZC%?-P_X)A_!/JVC!OK&M5&2M9@>/_M;_ /!1OPUJ_@^]
M\)?#M+C7-3U*)H//MTWA=PQU!K4_84_9PU_P[^SYXIO]=MC;:QK]O*4A<$,V
M].I]Z^A_AY^Q#\)?AK>176E^&[5IH^09(AU]:]UAMX[6..*)%CAC&$51@*/0
M>U/VBCH@/R6_8M^-&D?LM_&CQAX>\>B31HIKB417$Z[$;D8.37;?\%#OVKO"
M/Q=\#V/@GP-??V[J&H3+&WV4A\!@1V-?:'QB_9"^&GQPN!<>(M"MY+GJ9EC&
MXGUKG?A?^P3\)?A3K2:II>@03W2'*M<1@[3ZBGS)OF ^=/&W[..N1_\ !/.Q
MT..W9M5M8EO#" =Q41XQBHOV"?VU?!/@OX4Q^#O&]]_PCVL::WE^7<XC&T #
MC)ZU^BC6-O):M:R0H]L5V>21\NWTQ7SA\0_^">OPA^).N2ZMJ&B1PW4C;F\F
M, &FY\VX'GUE_P %%M.\<?&JR\%>!],FUNR=U62_2,NB\X)W#BO(_P#@KUI>
MH/:^$-86TE>VMYHWF:)2=F <YK[6^#G[*_P\^!CF7PSHEO;7!&/.\L!OSKM/
MB!\-] ^*&AS:3XBT^*]M9 1^\7)'TJ$TG<#YC^ ?QF\%?&S]G6;P/X>U:.?7
MO['$3VCNN[=M Q@>]?*?[#GQLTW]E#XK>,?!_CYGT6WN+J5HI91M3)?U/TK[
M\^#_ .QM\./@?XFGU[PQIJVVH2C!;8!WS5CXP?L=_#/XWW7VOQ%H<$EWNW&=
M8QN)^M7SH#XN_P""B'[5/A+XU>"['P'X&N1K]]=3<M:X?&1CL:Z_XK>$;GX<
M_P#!._3],U-1!<K!YC+)P>4%?1/PM_8-^$WPGUI-4TK089+M#E7FC&17J?Q.
M^$^@_%KPF_A[7[99-.;@1JN0!THYUL@/FG_@ES-'-^SZC1RB0>>_R@Y]*^R8
MQQU-</\ "+X-^'/@MX>&B^&K86UEDMM"@<UW:KMXK&3 ,4H&*6BE< HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"IJ
M7_'L:R[?M6IJ7_'N:RH<KB@#07M4\=5T/2K$= $Z_=HI5Z44 (U02]!4[5!)
MS0!7E^[5"5?FJ_)5.9<$4 :UK_J(_I4J]345H<PK[5*IZT .I#2T4 1-TZ4P
MK\O/X5-MI&7-"TT1/*I.[.,\:?"WPYX\A"ZOIT,\AZR; 37G-Y^Q[X$FR$L%
MC8^B"O=_+;\*4(<<\UW4<9B*"]R;1P5<#0KR]^!\S7G['?A6#[ED&_X"*S)/
MV5?"T.0VG?7Y!7U;Y?XTUK:-_O(I/TKTXYYBTM9'FRR3#-['R?\ \,O^$1P-
M,_\ (8J:/]E3PM-C;IV/^ "OJ?[#!_SR7\J<MK&OW4 _"K_MW%?S"_L/#KH?
M-%G^QWX4G8>;9 #_ '!70V?['O@2%1OL%8C_ &!7O"QXIVWBN.IG&,J:<[2.
MFGE.&@^;E./\'_"_P[X#MPFDZ=% W]X( :ZV-1UQS2K&5SSN^M."_A7E2G.H
M^:;N>O"G"FK15@XHXI=M&VH-!::W6E.:3!H -M&VG44M0(]M&VI**8$>VC;4
ME%+4!E&*=11J S;1MJ2BER@,%(WKQGWI]#+D=*=@(3PHY.?5>E<)X\^!G@CX
MF+G7M M+J7O*\0+'\:[]8PJ;>U+M/UHNT] /,_ O[.?P_P#AU+YNB^'+."=3
MD2>4,BO2< X.,]ACH*DY_&D"XZ<"J;; ;MI=M/HI ,\NC93Z* (]M*%I]% #
M=M&VG44 -VTAXI])2 3:*0'M3J-M4 FVD8<4ZD-(!/+HV\XI=U&: #;2;<]J
M,T9J>6^XP"XI<<49I.:+6$&VDQZ4_=2#K1J W;ZTN!Z4[\*3%.X">72[:6BB
MP";:0K3Z*+ ,48-/HI,TP%HI-U'7I0 M%,S3A0 M%%% !1110 44F:-U "T4
MF:6@ HHHH **** "BBDS0 M%)NI: "BBFM0 N:6F4H- #J*3-% %74O^/<UF
M1C[OTK4U#FW-9L*YQ0!;C7I5F.H(^U68U/6@"6B@44 #5"XJ8TQEH J.M5)E
MYJ^\=59HRU %FPD!CVDU948:L42M#)D<"M"'4$;&>M %VBH?M<7]\4GVR+^^
M/SH GHJO]LB_YZ#\Z7[5%_ST'YT 3T5!]LA_OBC[9#_?% $]%5OMD7_/0?G1
M]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-
M%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1
M]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-
M%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1
M]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-
M%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1
M]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G1]LB_YZ#\Z +-
M%5OMD7_/0?G1]LB_YZ#\Z +-%5OMD7_/0?G0;V+_ )Z _C0!9I/PJO\ ;(O^
M>@_.E6\B_OC\Z ):7%5I-2MH_O3*/QJ/^V;/_GX3\ZGF0N8N[:-M4O[:M/\
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M.X_SK"4NPFT<O,KBX;]XV,^M;5DOF6WWB?QK+N@?/;IBM72AYT>P<&L;RN0
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MT; HH!]ZWIFD2["H\E=H[5/&I[TQ054>E2QY[UTHU)XQ4J]*CCJ5:L!:***
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M1110 4444 %%%% !1110 4AI:* &Y/I2C-+10 4A&:6B@!*6DI: "D Q110
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M5<_E7YU_$;_@G+X^\6:QX4\1W6M'5]=CE2;4)2#MW!@> 3QQ7Z1>#='D\/\
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MH^N79#&'+X#<U+96DU])MA0MV!K6\#^$SJ6A65Q>@HY0$H:]!T[1[;3DVQ(
M?6OQ_$8Z--M4]3]DPN!=:*E-'-Z'\/["SN8K^YMUFO\ &-Y'2NP\OY@@&%'.
M:""  IP<\T[:68'/'I7SM2K.M+FFSZ:C0CAX^XA^VEVT;:6LSI"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT4F11D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T4F11D4
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MQGS"*Z;PQ+]Y,]ZP9$\NZ=3ZUH^'Y#'>$9ZUC'W9:DJRD=<%QGM10IS178=
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ML%&P4O.[!&!VH+!<9[T )L%&P4H/X4BMN8X' [T &P4;!3AG<<].U(N6_K0
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M;M_8%_92^:EQ:IDGVKY=_P""@UYJ/P^\*^"/ \NH3:A9B0)+*W#2+M'&!]*
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M+0LH...M8VD7#K=30N<@-P:SVD!OYYIU-X7BG5KN A-)]ZE(I.U,#&\0Q;H
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M%% !1110 4444 %%%% !129I-U"U =129I-QH =129/M10 M%-W4M "T4A-
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M*N-.4GH8SJQ@;6X]\"F-,BYRX'XUY[J'CR>1ML"KCUK'FUR^G;<9BOL#7?#
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MCL>SAL=%M0DSMP:>*B5@^-O/?/:I%;UKR.MCW%JKH=13=U+0 M%%% !1110
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M\)T1V,+Q)'MVN/I15K78_.C4'UHI6$:]%%%;%A1110 4444 %%%% !1125+
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M8Y5.3CFOQ;-L$\+5:1^UY-COK5-7+JTY::O"T]<GFO$6J/H7N+1110 4444
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MX9S_ !$^(EK=FW8:;I[!W9EX;!KSKP/X!U7X@:C%:64$@B9_GD(XK].?@?\
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M9[XJTC9QZU\[/XCZFF_<0^BBBD6%%%% !1110 4444 %%%% #6IK_=Q3FIK
M]J3$]45[J86\)9CP*\C\<>*FU"X>VC.8X^]>@^-KXV>CS%3AB.*\6;$F\DDL
MQYK\*X_SR>%M1INS9]/E6%53WFA&4#:<9)JKJ%O'=:?/%*=J,,'%6U8=STK*
MU+40F44 GT/2OP##XBO"LJJF[GW2H1J)0Y3Y#^,'P;F\-ZA-?:8AEM9&W,P&
M<5@>$?"!F;[3<*0J] :^M]2LH=2TR\@N%WHRYQ7AD\0AN'50J*K$!5Z5_?\
MX0YW_:6&]G45Y(_G;Q)PLL)57([(8JI'&H080=J[SX.^#;3QSXICL+HXB;I^
M5<*JY;/'T[5Z]^S#_P E"3@'@_AQ7] 9S7J4L%4G3=FC\6R>E#$XN,:FJ.^U
MCX+_  [\-R/;ZEK$=K=?W'D -6=$^!/@3Q,SPZ3JD=XR\GRY V*^6_VX+Z:/
MXP2I'>36RG^$-@=*[C_@GQ=3W'B+5$EN9IFV]9&RO0U^,?VIC$G^\9^V0R/
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MH^GE&->#A-73.*\3?"_3M>G6>V'E.QRV*Z/0] MO#UDMM;Q#>!RP'6M)?O$
MA0:3Y1\H;)KZ;%\49EC<-]7JU'RKS/"P^0X.A5]K&.HG.<N":I:Y!'>:>\4H
M#JPZ&KDT@A0L[<USNH7GVA^'PJ]O6O!RW%U\+66(HO5'T,L!3QRY*BT/$?B5
MH[>&6^W1PDVX.2 *\Y_X6+:L=_E,0W85]+^)/#+^--%DTF/:LT@PK,,XKR/_
M (8Q\41,P.J6O)R!L/%?Z)>%_%SS#+[8O==6?R]QMPW##XIO#K0X3_A8EJ?^
M6+_G3?\ A85M_P \7%=__P ,:^*1_P Q2T'_   TJ_L6^+;I@D>IVKM_LH>*
M_:WG6!CK*1^<1R;$2T43@/\ A8-N%_U3_G7O_P"QQK4'B?QA=*$*F//#?2N7
MA_8%\930@_VQ:(WO&:]V_9?_ &8-2^"^LW>H:I?PWDDO3R@0!QWKY//,\P>(
MPDZ=*5Y,^IR?)*]'$QE*-D?2JHL<:JO %2YST[5$K+AG/W2>*ESZ$5^.:\US
M]?6B20AI:/QHX[4"7F%4]4M_M%FZ#KUJY367=GZ8I,+&)X=NMH:%CRM;N>@K
ME5;[!K1'1&-=.K[ER.G:LUN"8R\&ZWE'L:XQAM<CWKM;A<PM[BN,F&V=P.QK
M"LC*:ZD6<;OK78Z6VZQB^E<>RC;GN:ZO0W+V2CTXHHA TJ*6BNTV"BBB@ HH
MHH **** "BBB@ HHHH *8:?2$4 1/AE('\0KQ[QMX%O#JCW5JF_?UP*]C*AL
M4UH5?)(S]:X\10]JK'3AZ_L971\O>*OAWJOB30;NQ2S8RD' V^U?(OBKP#K?
M@ZZE@U"PF@5&X8+@5^K"VL:]$7ZXJEJ/AC2=87%[I]O<>\D8-7@Z;PVQKBL1
M]86I^*_BV>YO;PQK;R% ?[IK#^SW3 )]FD 7_9-?M:WPG\).VXZ!8D_]<%_P
MIK?"7P@W_,OV'_?A?\*]/VQY]C\7K*ZO]-):-) #VVFI9M:U2^5D*2!>XVGF
MOV8/P=\',V3X?L?^_"_X4O\ PI_P=NS_ ,(_8@_]<%_PH]L%C\6%M[G=G[-)
M_P!\FC[/<Y)^S28_W37[4_\ "I?!Z\?\(_8_]^%_PI5^$OA#/_(OV'_?A?\
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MA2U10K<\-M\S#WK#K8\.,?.85A3W,XZ,Z1>IHI5HKO.@6BBBF 4444 %%%%
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MEQ:9:NR' _O8H [[X7?%?3?BEI5]>Z>P5;6=X7.<XVG!K?\ #7C+2/%C7/\
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M\C^%;HO[57Q$E4@A<,4QZ1UO?!/XV+XW\6>/+&+1HK0Z+N;SXD52Y"DCI]*
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M>E?'7[7VEMX/^*W@WQK,C/IL<A2>0=$R0!7V-P">*Y?XB_#W2?B;X7N=#U>
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MVXYI:",T 1K[<,>2*1L<<X J:DVC.: (@'4$D[\GCCH*4J%^4#.>HJ3'6C%
M$9_=J!G:O2C''/?@&I,48H C9>0NW(]:5<X.1CFG[>"*,=!0 FVG444 %%%%
M !1110 4C8XS2TAYH :"0W/'I3&0Y+!>14NT#BC;B@"-5(QSSU-&!R=N*D50
MO2C:#F@"/8%Y52<^]+SN/.1_=I^*,#K0!%QO7/&>@IVTXZY:G[0:6@"(*&7
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MHH **** "BBB@ HHHH **** "BBB@ HIOXTN10 M%)NHR* %HI*.: %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHI* %HIN:44 +124@S0 ZBDI/O4 .HIG2E!]\T .HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***2@"*;YD85QEV-MVX]Z[&ZS'"Y'I7&7#>9,[9
MYS7'4,9C?6DSM7/O2*WK2LPV],\US&2>IUVD2>99K[45FZ!>@JT9. **[(RT
M-TU8Z*BBBNDT"BBB@ HHHH **** "BBB@ HHHH **** "D/-+32U "44?7BC
MBC4-1=M I,TFXU-QZCN:6F\T;CS1S"L/HIH;U%+FGJ M%%)3 6BFY-+0 M%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(W2C=2,W% "9%+
MGTIHH8G;Q1ZBNN@OX44C$KC S1GGVJ?F4.W>U&ZFDXYHW[>2,"C7N(=@4*M-
M\P'O3EIZBT'4444QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !112+0 M(<]J6D) ZT )S1S2[A1GTI:@)S2C/>EI,TP%HHHH *8[;6%/
MJ&;[N>] $M+4<;^9'P>:>.E "T444 %%%% !24M-;K0 V1/,C93]*Y+4M.>W
MG)"Y!YKK^F3VQ66=1ADF>*7!YXKGDA25SE=VW@KS3E;MCO74MI-K-\RXIHT6
M$,">U9N)CRF3H]N_G.0**T[BZATWB/ )ZT4]!FU11176;!1110 4444 %%%%
M !1110 4444 %%)_*D9L<4@ FDIK':.6K%U?Q/!IHQD,WM6D8N6QE.I&&YLL
MRIR352;6+2W^_*!BOF/XT?M;1_#K4EL7M=S.,YR:\MF_;:TN9U::S+$CGD]:
M[(X9_:9RRKR:]T^W;KQA8P#*ONK/;XB6JG&PG\*^+_\ AM/1Q_RX?J:=_P -
MK:2.FG\?4UUK#THKWCAE7Q#>A]K6_CFSF^\=M:$/B"QF(Q*,FOA@_MJ:.W_,
M-'_?1H7]M72$Y73N1T^8U,\-"UXEPJU;ZGWQ%,EQRCAOI4H.W&:_-[4O^"FE
MCX/U 1-8%U_NY-?9'P;^/%G\5O"=GK(A^RK,H;;UZC-<,J$NAW1K17Q'KF11
MFJT-TLT8>-@ZGWJ8'(!'/]*Y97CN=49*2NA:=3.<TX]:2U&M1U%%%,84444
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MLTG_  [LTOT6L?:.VYNU!/8^"O\ A--&_OR?]\&C_A--''(>0?\  #7WJ?\
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M4IC)=3-)NYY-0#:JYRV?3)K["GP]&<4YRU/CZF?3ISM%:'U5_P +$\.CI?\
MZ4I^(GATXS?@^O%?*GEKW=@3T&::4'(9FRO;/6M9</1B[<Q$L^FW=(^KHOB1
MX?M9 \.HX/TKJM#^//A^W8176H]?NG'2OB?:8>HV[NF&S3F3;\I)Y[YKFK<+
MX>I&UW<Z:?$]>AK8^]I?CQX.LX]\NJ#!]JVO#GQ.\.^*E)T[5(I<'&TD _E7
MYV36<4T>R3<P/;<:P]4_M3PJ(]1T"\EM)X3NVH2=U>35X,BJ;E"3N>_A>,)U
M&E4CH?J9<DNH/5?458@DWQC':OF/]EW]HX?$K3TT35Y-NK0C:9#U;%?2ELQ1
MF3/?@^M?F6(PD\#5=.H?H^"Q<<?!3B7J?3%R*5:Y>MST.MAU%%%,!I^\*=24
MM "-5>[3S+=P?2K!IC+N4BIEL(X>9<7#+[TAJUJD(AOC@8!JK@^8?2O.EN8/
M<MZ6V+H_[M%0VDACF8@XXQ13N3<[BBBBO2.H**** "BBB@ HHHH ;M-*!BEH
MH *8>0:5L\8Z4R1MBLV< "A:B;LC#\4:L--L6"G]X17F!D>XD::3D]16UXKU
M%KS4G7=F,'@5BXW#&<"OI\%14(IL^3QU;G=HBE69D*C<S]J[GP[X1B6-)YN2
M1G::\\U76E\-63Z@4^T"'G!KC%_;! D:--*7:G&=QKHJX7$XC2A&YPTL;A\+
MK7/J2*-85V#A<5(&4<=:^6?^&R1_T"5/_ C1_P -E#;_ ,@E?^^C7!_8>8-_
MPV>FN(,"E\1]3YH_E7RM_P -D!>NE <9')Q3S^V5M4 Z2G(S]\T2R+,/^?;)
MAQ%@'O(^I?XO:HY[=+I"K@$5\NG]LM1A6TI03_M&D_X;*&X@Z2H '!W&C^P\
M>O\ EVRO]8<#OS'O^I:1]C8SHG ]*Q;B%+R/YQ@D^E>'ZO\ MG?9]-FD.CHP
M"DX+&O/O^&\ YV_V#&<?[1KNP^2X^.\")9]@JBT9])ZEIXMVRG2J2JS8KR'X
M8_M2#XK:Z^E#24M649W!CZU[ RC?][&.U=DJ-2B^2JK,\VI6A6?/2V.G\$ZV
MT%P;:4\$\5Z*F& KQ:&4V\JR@X8'@UZKH.H?;K&)BVYL<U\WCZ'*^9'T67XC
MF7*S6VBC%-HKR3VQ]%(*6@ HHHH **** "BBB@ I&Z4M(>E #:,[>:&Z4UB>
MU*]E<%O8=@+]:R]:U:/2[5W)^?L*O32>4,EL^]?,7[5/QQ'P_P!%86YW7<P(
M0@]*ZJ-/G:;V.:I+[*W.\U+5A?WCM/>PQ#/"O(!54WEINQ_:%L3Z>:N*^"-%
ML_BC\7W>]LGN);7)*RY(#5JK\$_C(ORLDY4_[9KVHXF-/2)Y#P4Z\K-GW&+F
MV_Y_K7_O\M-:XM65@;ZU48//G+7P^/@G\8LXV3_]]FDD^"/QA_N3_P#?9JHX
MSF>IB\M;BX)G=?$50WBZ_.Y98V?@J<U@VTQL;JVN8AM,#!]PY/!S1HOPS\=:
M#93S>(;)MJG_ %S$DU'O5LF/. <-QWK]@RNO1QF&Y;WTL?BF;82I@<5S(]]/
M[4 G\+-9_9 ;PQ^66/TQFO/OA?\ %>?X?^(KC4)D\V"X)+Q^Y[UPDBA,%L#/
M3;S1('3&1D]C6:R'"TZ,X1^T$LWK.<*CWB>F?%WXR?\ "R/+AAMA';Q'/)[U
MTW@?]I%/"_A6/3;JVWS1)LC89KPSY=A4G!)S1Y8VG.,@9!;C\*TED6&G1C0:
MT15/-JT:CJ7U9H^)->D\3:W>:C<C#32[U]A7F%TW]N>/+*UB^=?-"DCZUK>*
MO%4=C#Y4+@3E<$+T%=!^SI\/;GQ-XC.KSH1:1-NWN,9;J#7@<6YO1X?RB;;L
MTM#VN'\OK9CCDXK=GW1X!\=1:7X9TO2YH_+-M"L6?I7IEAJ,6H0K+%)N3':O
M )&!GVGE5&,UM>&?$MSHMXB^8WV9CC9VK^&\#QY*KC7"L]),_IVKE#IT8J*U
M1[CNXIZU4L+I+RUCE4@AAFK:U^[4:L*].-2+W/F)1<9.X^BBBN@04444 %%%
M% !1110 4444 %-;M3J0C-(!M(>V*6F,Q'(HET0M%[S,_7M472[-I"<-BO+K
MJ^?4;B260Y!^[6UXRU<W5Z8@V8UZK7.JHV@9V@=*^GP6'4(J4CY;&XCG;408
M\8HQ\N!U-"YD8(!N/:M.T\-WUTP(CV+V-=M2O&*W/.IT93E<Q;IA':SD'YU6
MODWQ9-)?>*[MY&W MP#7V]>^ S'8W$CS')0DK^%?$'BJ'R/$EZG=7(!_&OJ>
M&ZM.M6;6Z/D>)*-2C3]3,),F6/1:7C!('(IOW5P. >HI=NY?6OTR3<7<_.'V
M9-8Z=<ZE=I:P)YES(<*!7J]G^SC=0Z;'?ZSJ?]G(1R#BN)^&6OV?AOQ=!?7R
MYC0]QTKN_CW\6+3QQ86UAI,S>5C,A^[C%?$YIB<=+$1I459=SZW+Z&#]ESU7
MJ/F_9ENKC3VOM)U7^T(\9 XKR36-(NO#]_):7L!AF0XY[U]/_LFSW%QX8N%=
MWEA4@*'Z#Z5R_P"UEI-I;WUG<PJJSD'.!7DY=FV)CC_JE5W/:QV54/JGUB&Q
M\^;O,ZBDF7S89$VY7:?Y4^-MV#CC%-52J,V<DJ:_3KZGYU#?1F'\!=0GT+XV
MZ:EJ_$S'>N<=Z_4.-QYR,.X&?RK\LOA" /CKI3#J7Q^HK]36&Q8@. %%?AW&
M4(QQ"Y>I^W<*SDZ-[FFK;NE/'M4%NP:,8ZU.M?")W2L??I=Q:***H84444 )
M3>]/IK< 8]:6X',^(D/VA2*R6;)S6_XDCY5A^-<^,'-<-2.ISR0Y&V\T4E%9
MD'?4445Z9UA1110 4444 %%%% !1112 ;V:LO7KS[)I<CY[8K4/&:Y;QO*5T
M[8#@'M6]&/-)(YJ\K19YT\K7$K2-2X&T'/>C.U<=#1A=H&:^R4;)'Q,V[Z&#
MXXX\+WQ(R,'^5?)S;?,EQE3N]*^L?'&?^$7O, $ '^5?*$S_ .D2YX&ZOO.'
MU&TKGP&>RUW$55HVKD<9'I3MPZ@TL:/<S)$BYD=MJ*O.37V<Y1IQYWL?(04I
MOD3U&?>7#/MVMQ'VQ7J'P^_9^U3QUIKWSM]BA/,>W^(5H^%_V8]=\06,-Y/(
ML 8 A=W.*^K? OAA_#'AFTTZ5MS0H%S^%?F6<\0>SERX62NC]$R;A^56/-B%
MH?!WC/P?=>!-<DTZ_7=Q\CFL)<M"0W9NOM7U]\;O@3?_ !(UJWOK.411Q1A2
MI(&3GK7SAX_^%NK?#J8?:T+6[G&\<BO:R;/*6*BH5I+G/-S;)*N#?.O@. \0
M8_LBX Z;#VKR55Q(V#Q7K?B!MVD7!'38:\D!^9L=:^ZBH26A\U1<KZ;'L/[+
M'S?$249P/+ S^-?:^-L>TC)W9S7Q/^RYSX^D';RQ_.OMH\$#M7YCGRC]97+V
M/T#*N:=/48_S?+WKM?A_?;M\).<5Q@YY[UM^#7,.JJJG 8\U\7C*?[IW/K<'
M4Y)I'J%%)_#[TOI7R9]DAR]*6D6EH&%%%% !1110 4444 %)2TAZ4GL T]J1
MN!TI^*:W%)ZI(6VIS_BG4AI]DX!^=^%K\_/VV&D:YL%W9)#5]P>/;HM=)&#]
MWH*^(/VUCMN;$#@X->Y2I\M*Z/%]IS5K'T_^Q+9P6_P)T1#&K2;"7DP,GYC7
MOR[6=B5'MP*\(_8I4?\ "B-$_P!P_P S7L_B378/#FBW&HW&?+A7/RC.3V%>
M5JYVZL]6_*G)[(TL)N^Z/RI&V+SL!_X"*^>(_P!K;3_L\[361CN%;"( =I_&
MO8/AWXTC\=>'8-46/RS(,E1T%=%3 XC#KVE5:,XZ./H8B3A2>IY_^TAXXT;P
MYX+NX+VZB%P_W8\C-? %Q\1K>&]"Q)^X=L''4\U]N_&K]F2'XLZ\;^?47CCS
M_J\\5SGA#]B;P_X=U2&YU)EU&)"&6.3&,]J^[R/-L-E=!N;U9\7G&35L=5YD
M?,</B*P95#&2T8C/[Y=N?IFGC7K&8$K=YV]0<5]O^+OV=/!GC2U\F72;=)(Q
MMCEZ%:\$^)'['6G^&M/^VQ7S",MM^3!/->Q+C3!TZ,JM;1(^?_U.Q-5J*ZGA
ME]XWT^UC.TAV'>N4O/&UWK3-#90M*>R(,G\J]QTK]EW3+ZU!^VR,0<L<=:]O
M^&_PF\ ^![1+AM(AN=3C7 FD7GZU\-B_%W*J*DH2U1[6'X!Q7M(QFM#Y/^%G
MP$U_XCZHDMU;26]L6W,'!!_(U]=:5X+3P)8VVE00B+: N5'WO>NJT#78-+UB
M6=(UCC?. !VIWB/Q!%J6J0RQH"D?4>]?S-QCQD^)UK5M&Y^P9'D/]BM*,;F;
M<:)>0VYE,1"=<U0;...R\?6NUU+QA!<Z3Y"K\Q&#7%*P*MGCO7XIC\/0HSA.
MA+4^]PM2K44O:H]2^&>I27>G^5(W*]*[M#VZUYO\+8SMED(XZ UZ0@%?U1PC
M4E4RV+GN? 9ARK$22)****^U/-"BBB@ HHHH **** "BBB@ I#FEI#0 GUJA
MK%X+"QEE/\(J_P#Q5S7C>8QZ2Z]FXQ6U./--)G/6ERP9YS<S&XFDD/)<\4ZT
MM9;ZZ2*--P/!/I4<4+S-'$OWB>*]*\-:$FG6P=T_>N.37T-:LJ--)'S6'HNM
M-M[$.B^#[>PQ)+B1^N*Z+RMJX0 "G*FTY( H;.XKZ]&KYNI4G/4^GIT81*FL
M(/[.N,_\\S_*OSO\:+M\5:A_UT/\Z_0_6F;^S[@ #[ASS[5^=_C9P?%FH8S_
M *P_SK]"X.NZTC\TXR]VG%Q,9J,=#VI6-)DE2/SK]C;LTF?D$[R6HWDJ<X(^
MM=I\)?AF?B/KGV)F^S6R',KKR?6N+VKN(/ %>H? 7QY9>#=8N9+L3$2*=K1H
M6[5\]GMX8>4Z7Q'OY/"'MX^TU1]&?VYX5^"?AO[(L\:F)<;(R"S'W':OE3XF
M?$:[^(VO-<2#R[92?+0'@"LGQWK)\0>*]5NR\AMYI 4WY!_*L56"\(>!7C9/
MDOL?]IF^:;/5S;-O;1^K05HH%8J^ /EH;Y5?TVFD]NU.9?W;GL%-?><KLK[G
MQ:W]TY?X0-N^.FD^F_\ J*_4V?.V/_=K\L?A%(J_'#27Z#S/ZBOU2;#0QL/[
MM?BG&:_VF/H?MO"?^[C["3;\IJ^O>LB!]LG)K4C;/2OSJ#V/T0DHHHK80444
M4 %(>:6D- &1XB&+,MWKEXQA0?7FNPUJ,2V;@C.!FN17[H'I7'6W,)[A1117
M+J9G?4445ZQUA1110 4444 %%%% !24+14@,)S7&^/Y"MFF.N:[/'RUR/CZ,
M?858CO770=IHX<2FXLX'[V2]$:O*V(X]]7=(T6;5I0%SM[M7HND>&[6QB4&-
M6<=37OU,7&G%)ZL^?HX2=26AY=KG@?4_$6@7$$,2Q-(,#)QVKQ8_LL^)Q)(1
MY;;N0"]?:7EJHP%XI-@;FLL/GF)PU_9&F*R##XI?O#X(\1? ?Q=X;A:66QCE
MB7DB-BQKB+5I]'U2WEEMGM9() ^V12,X^M?I5-;QW$;!D5OPKSKX@_!?0_&N
MGR!K6."[(^695Y!KZ'"\4SJ1]GB5HSYG%\*1H_O<.]4>?>%?VG_#UIIMM!>B
M1+@*%(5,C->Y^&]?@\2:3#?0']U(H9:^"?B5\,=1^'.H_9[E&DM6/[NX'/TK
MW#X4_M":+H?AFWTN^9HYH4"@X^]@=:YLPRFG5@J^#5[FV6YK+#-T<7I8]5^(
M?QJT7X=7R6FI%Q-(NY0JYR*^=/C=\:+7XAZ?%8Z<G[I7WLS#!^E<Q\;/'UO\
M1O$R74*_N[==H?V!Z5P/RL@>->,XKZ?(\@A34:U9>^?+YYGCQ$G1@_=,_7EV
MZ+.#_<->2J-K/7K?B+_D$7''\!KR1<LS"OTZG!1BK'R%!M-J.Q[!^RW_ ,E
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M8)%9@V<_[*\T;2WS]/3UK]J34_>1^)U(R3Y6#.&5\CH>:^A_V>(?"=QI<YU
M6WVCC'GL!^5?/*YP1GKU]Z2-GM\"-S&/]DUXN;8-XZBZ496/8P.*A@IJ;5SU
M#X^PZ%:^(HDT3RR_.X1\K^=>7E?F)/WCUQ05<N92_FD]V- 8;N.<]?:NO+\/
M+!453E*[.3&8A8JK[1*R"GG_ %<@_P!D_P JCVDMMW8-9WB36$T?3Y9'95.,
M#!Y->EU3FSDIIROR+0P?A?D_&32RO:7^M?JS:Y?38">NP?RK\U_V7_ %]XJ\
M=V^LRP%;17R)&&.]?I?#'LLP@Z* !^5?BG%U:%7$+EZ'[=PK2E&AJ4R-O-:-
MJVZ,&L\YZ'GFKEFV..U?F\'J??+74NT445U#"BBB@ I#2T4 5-0_X]9?H:XS
M;M8_6NVNE#0.",\5Q4WRS./>N.KW,9(2BBBN;0R.^HHHKU3K"BBB@ HHHH *
M*** $Z4G6E[4VDT C?=P.M8_B'2SJEFL8YYYK9['UIK#Y0 >:J+:(G'F1G:/
MI,>FVJHJX;'6M!5V#/<T]?:@\42DY"C!0V$;Y1QS45Q=+;Q[GI;BX6VA+,?P
MKG;V^:X;)/RYR!50A<TNNIL6VIV\S84D,>QJTV3V!%86EZ>TUQYY''O6_P!#
M4SBF[)C]U1T.+^)G@2T\;>';JTEB5Y2I,3$<JV.*^!_$&A3>&=8NK"\C'FQ2
M% V>=HK]*]N[*D?C7G7B3X&>'?$VI/>W5NK3L<LVT9-?6Y+G;RYN%36)\-G>
M1O'I2I:,^"@T:KA0 F>:=YN]C& (XU&X>]?;S?LU^%FX^R+C_=%5]0_9U\,1
MV['[*N5''RBON(\7872,8L^&J<)UXWJ2/AOQ"Q_L>X_W#7D:L=S5[YXTTV"U
M\0:EID:YB25D [ 9Z5R8\':>C$&,;OI7WV%Q,<124TF?)3_V:JX,TOV5FSX_
MGYS^[_K7VRQY_"OBWPG"G@V_>^TX>7.1@[:])TSXY:K;2+]HC61.A.23]:^/
MSC+*V)J^UIGU&6YI2@O9S/H=6ST]:Z;P';F;4'<C[HS7E_A/XAZ=XKA4HZPW
M&,>7TR:]P\$:?]ET\2,H$DG4^U?F^9JKAH\E16/OLIE3K5+P9T_2E6FGK[4Y
M<5\F?<#J*** "BBB@ HHHH **** "BBDH 1NM--.[TUCWI=F)]CR_P 8P^3K
M+MZFOB[]MCFZT\^S5]R?$"S,<RSA>">:^&_VUP?M6GD="&KZ%3YL/8\",7'%
M7/J?]BC/_"BM$_W#_,UZE\2->OO#/A*[U#3K9KN[C("Q*"2<_2O+?V+0?^%$
M:*N0,(?F'U->Z28D4@#=GUZ5XGVTWT/9J7Y9)=3\_=7\<:UJ'Q$_MF>SDBU)
M23]E(()/TK[+^#_B?4O%WA&WO=5LFL;IEYB92/YUD:E\"=,U'QTOB:2XD653
MGR0!@UZ;;Q*L0 &U5&!Q7N9ACJ.(I0A3CJCYW+<#7H5Y5*CT9G3Q_OC\JTWR
M@S=%_.M!]/69L[F%']EITW&O!YD?4F?M!X"*U)Y+\X@%:2:>D+9!-61C;CFC
MF&8?V>3C$(7FKLFG0W,(2>)<8YJ^<'KDTUO]GK[USU*<*JM.-Q\\]XLYV7P'
MHMTV[[#&!WR*^$?VVKR?P;X[TRRTB9K6!H]S1KP.M?HB,<?-SWQ7YT_\% EW
M?%#1P1A3!D?]]5YT,FP52?-[-7-7BJT8M7/>_A'(+CX<Z1),FZ6:!26/TKTC
MP?X*T[49)6NK=9#VR*\W^$#'_A6^B$G(6W4 ?A7N?@:S>'3S+(.6.1FOH\9E
MN#>'24%<\*AC*\JSBWH;FFZ9;Z7;BWMX]B>PJ]& JX%(K4Y>M>;""I144>N]
M[CJ***U$%%%% !1110 4444 %%%% !313J* &G[I-<[XRMC-I+..J<FNB[57
MO;9;JVDB895A@BKIOEE<RJQYHV,7P4P_L>/ZFM_&&_K7->#YA$LMDPP\3$C\
MZZ/<'4L.>V**S]ZXJ/NQL<S\1M(U/7O!>I6.DSF'4)8R(W)QS]:_/.Z_9@^.
M1NKAOM[ M(Q!68_,,]Z_1/Q]XJ'@GPE?ZW)%YQM8]PC[&OABX_X*9:U#<3(O
MAVS*)(R@DMG@XYII<R-5>Y/\&?V<?C+HOCZQNM2UB6VM(FW2[920P]*^W/$_
M@NR\5:6+34(5F 0+O89(..37PQ_P\VUO_H7+/\VH/_!337&0G_A'+,X]VK6F
MZM.2E3=FC"OAH8B+C-73/8/%G[)-TNH--HLX$;'.UCC%8B_LG^(MO^N5F/4%
MJ\Y_X>::[\[CPS9>6OJ6KZ'_ &6_VI)/C]#>+=:9]BFM\?-$IVG/K7T,.(,?
MAXVYCYFIPU@JDKN)Y\/V3?$?_/6/_ONJUU^RYXAM,;I(RIZ_/7V@,JK9.?YU
MS/B&Z;<^&PJ]*VI\1XZI+61S5.%<"ES):GQS=? ?6+7?AE.W^$-7G^M:/=Z%
M</;7,'DG/#>M?8L\QDN&(KE/&W@2R\5:>X>-1<K]R3'-?887.ZK:]J?$XW)8
M0NJ9\@^*M<_L.S:5$WMCK6Q\&/A*_P 7I!J6I7)-E$>8<]:N?$OX.^)$22RL
M;?SPQX<YKVK]G'P#?> _!YBU,".>3!&#7O9AFD'A6Z3]X\G+\MJ4ZWOK0]2^
M''A33O#+0:;IMN(X8\ E5Q7M\:@1A!T48K@?A_IK?:'N#\P[9KT%>IK\5S&K
M*M4=V?MF5T51I62,V9=LA%.@?;*!3KM=KDU!&?G!KP-I6/6M8UU.12TR,Y04
M^NI.XPHHHI@%)WI:2@".3F-OI7%72[;E_K7;UQFH(5O9?3<:Y:NQE/8KT445
MRV,3OJ***]0ZPHHHH **** "BBB@!HI<8S2TE"8#:H+>?\3)H36@,8%<UJTK
M6>I"8<#/6J0,Z5:1SW]*AM+L74(=:EX=>?E-+8#F-3NWDNB&.!V%/T_3GNI
M7&$'-:\VCQ32^8>35V.-8T"KQBKY[;#T&QQK&@5!P*<WW:B:X6.4*<"I1][V
MK/2]R5HQ1]W/2FXR>E2;11M%'6X]1G.>M4M8_P"/&7UVFKQXS5/5.=/F_P!T
MU5/XTSGQ"YJ,O0_._P >Y'C752F ?/?G\:P7_=Y/WCCJ*W?'O_(ZZKZ>>W\Z
MPAE7^7@U_266-K#07D?S1F7^]299TVQEUC4;>PLU_?7!" MQR:].U+]F?Q/I
M^E_;4,,^U-QC#9;\J\RTO4IM&U2WOH3^]MV$@_"OK;X)_&H>.HWM+]([>2-.
M,\%C^-?-YYBL;A)*K0UBMSZ')L+A*ZM5=I,^2[>>_P#"6KB3+174#;FBZ5]R
M_!+Q]#XV\*V\P;_2$&UU^@KY:_:.M[.U^)3/9(NV2)=_ECC/>M?]EWQI_8?C
MAM(,KNEYA5C/123UKQLWH?VAERQ;5FCW,FQ"P68.@G='VJ3FG**9R5&*>,@5
M^4'["G<?13,TX=*!BT444 %%%% !1110 4AI:*3V 92?=SFGM32-W!X%+=6#
MK<R/$6G#4+&12,GJ*_//]ME#;ZC:0NV,;@*_2#9YARWW?3UKPGXT?LNZ9\8]
M42ZN;E[=%/W4Q7=3K<JY6<DJ-Y\Z/'_V9_VH/!7PY^%&F:)JTTRWENN'"*#W
MKU=OVW/AOQMNKC'^X/\ &N$;_@GCX>=LG4[A3W(Q1_P[P\-\;=3N/KQ6,K.5
MSJZ:G=C]MSX<22<7,X [E1_C0O[;WPY;<6N;@8Z#:.?UK@_^'=_ALCG4K@_E
M1_P[Q\.?]!*X_2E:&XFV=Z/VW_AP3C[3<?\ ? I6_;>^&X_Y>KC_ +X'^-<#
M_P .\?#G_03N/S%!_P"">'AQO^8G<9^HI+E+6IWO_#<'PX_Y^;C_ +X%'_#<
M'PX/'VFX_P"^!_C7!-_P3P\.GIJ=P/RI?^'>/AW;_P A.XS^%.T>HF=[_P -
MO?#C_GYN/^^1_C33^VY\..]S<8_W!_C7"?\ #O'P[_T$KC]*/^'>/AW_ *"5
MQ^E-\B^$6O0[M?VV_AMNXN9^><[!_C7QS^UO\5-$^*_CO3;_ $>61XX4V'<,
M#&:^BC_P3Q\-XQ_:5Q^E-/\ P3U\/P[6&IS@*<\D5=.2B[D3ORLZCX*6_P!N
M\ Z B<AH4KZ,L+?[+:PQ 855Q7#?"SP!;^#=+2Q3=-':CRHV<=0.]>AJN!US
M6F(K.>ARX>ERRYF*HIXIM*M<6^YWCJ***!!1110 4444 %%%% !1110 4444
M ,I&/&.YZ4_%-P.I[4P,)]-:UUR.>+A9#AJV?N9P.!3FC#X([=*7V-#U,^4I
MZEIMKK%B]I>P)=6DHQ)'*."*\S?]E?X922O(?"UCN<[C^[KUGAAV/K3=K9["
ME=K1&AY/_P ,J_#'_H5K'_OW1_PRO\,D/_(KV0^D=>LX/K1D=#S34IQ6C#4\
MB;]E7X9@-GPS9D-V\NNQ\$_#7PY\-[=X?#VD6NFK)_K&A7!;ZUUA!Q[52O+R
M*",LV&?L*I.4]QZ6U8W4+S[-$P0XD;UKBM=OO+BP[9=NM:.IZH#F:1N1T4UQ
MEY>-?3NS#CL*]G"T>5IGCXJO",6D]2%2.6I2=RX[GO1MPN!2+7T%NI\G?WM0
M;:N&(#_A2PPFYE6)06W$8'I36)CV@#KV%=KX-\/$9N)EZG(S7%BJRIQN=F&P
MKJ31TGAW3AINGHA&&(YK5Y#4FW# ]J7UKY*I)SES'V<(*,4D5KU?E)JDGK6E
M<+NC/%9GW>*Y)Z:FC-.V^:,5/52S;Y<5:%:PV 6BBBM "DI:3O0 VN3UI=M\
MWOS76L*YGQ,NVXC(&/6L)K0SGL9-%.XST[45R&!WE%%%>D=84444 %%%% !1
M110 4E+12 ;CY<>E8_B&T\ZSW@<BMFHY(UD0HPR#VJD!QVFZI+8L ?N5U%KJ
M4%ZHP>:YK6-,EM9BRKF.J,,AB;*.5SV%:\H'?KCM0?EZ"N.AUVXMVP"SCU:K
M)\27/&T*:GV; LZ[*]K<))_#FM73[Y+R)2IYQ7*7FH37QQ+@KZ5';WDEFX*,
MP [#I5^R%<[JEKG;?Q,,?.M65\20=^*S=-H#6)YJGJWRV,W^Z:J_\)#!UJIJ
MWB"!M.N&YX0U=&$Y36AS8E\M*:/@3Q]_R.NJ_P#7=OYUS[ [CS@5#\0/'UC%
MXVU=2C$K._./>L%O'UAM! 8@]>*_I#+J<O80]#^;LQC+ZQ)VZG3;@&5=ISU+
M>U6=-U2_T>0S65RT$N?E*G%<@WQ"L@N KMVZ53O/B%%LS#$Q<=!BN^K1C4CR
M2B<%-5(U%),[#6O$4@,E_J-T]Q<$8^8YKI/V0K.X\8?%XZA&S&&SQ(P]LU\^
MZEK%[K%XLBB21I#L2WCYRWTK]#/V.?@X?A_X,&JW</EZGJ W.&&"$."!7Q7$
MN*H87!>PBM6?>\/X.>(Q?M3Z-7[M*QZ445^'G[7$4"G4@I:"@HHHH **** "
MBBB@ HHHH 1J;3Z2D UE)[X'I4;8;C!4^U3$9J-LDU0>AAZEXH726VS1,5_O
M8JG_ ,)]98^56 ^E;.I:;'JD+)(@/N17GFM^&9=-E9D4O%7=AZ=*II)GE8BM
M5I[(ZO\ X6!9_P!UORH_X3ZS;C:P_"O.]J[BHX;T:D:.16P$W,> %%>K]1HV
MYKGF+,*M[-'I%OXXM+B3:%;/TJ^?$5NN/E;\JYGP?X;"KYUPIR>@:NN_L>W_
M +N:\6O""=HGN8>7M5=E1O$]M'&6*M@>U4/^$^LU)^5C^%:L^C6S0L"G45YQ
MKFCR:==L0C&,GCBM\/2IU'RLPQ.(=!71V/\ PG]G_<;\J/\ A/K7^ZWY5YY]
MWJ,?6@ L<1J78]J]-X&C%:L\E9A6F[)'H;?$"SVY*MGZ5<L=6;7C\D96''+$
M5ROA_P 'R7C++<+A.N#7?6=FEC"(HUVI7D5HTZ;M$]FA.I4^(EBC\N/:@X7@
M>]/0;5]^]*O04\ >E<+=ST+6$ I:6B@ HHHI@%%%% !1110 4444 %%%% !1
M110 4PX"DT^DP* ,FZU@VS8 S5&35IYN%7K6W+9Q2'F-2?I0MK'%@^6HH YI
MM4GL9-TS;1[U=M?$D4BDD[_I6CJ&E0:A"0Z@FN*U3PK=Z=NDM'8ANJBNRFH3
MT9QU92@[HZY?$$)_A/Y4-KL2CY4R?I7G:ZS>6:E)(_F'=A2?\)%=,OW8Q76L
M&I;'/]<Y5[QW%SKCNI&=@K!O]9CM_P!X9/-;^[G-<Y-?W-UUD('H#5/C<=Q8
MGUKMIX&,=SCK8^,E9%G4+^34)#(?E']VH%^5<DY)I0H4<M^=-.?0$?[->E%0
MIH\*;E5EH.YI&;) 7[U7+'2[J_D BC.WU(KJ]-\(Q6.))_G8\C/:N6OBHQ5D
M=-'"RD]3-\->&VN)%FNQA>HS7H%O&L<02,84=*HJ56,*J_(*?'*T;<,<5\K6
MQ3G*S/I\/05-7--?NX[T#YC4$=P#]:GZX(K)2N=PC_,I%9LR;9*T\9JC=QGS
M-W:HFM".H6+9DQ6@.]9ELW[SC@UIK]VJ@4+1116@!2?Q4M%)@(U<[XF7E#71
M-6%XD3="#64]B)['/J<M^%%(OW1ZT5QG.=_1117I'6%%%% !1110 4444 %%
M%% !24M% $,D:2 K( 5-8%]X;Q(7AZ&NC*[N#R* N/I5*30'$3:?=VQVF/<O
MKBHOLK]HG+>PKO64-U&::(47HBC\*T50#C+72+F9^59?K5A]!NESC&*ZP+CI
M1MI>T8K'%OI%S&,F/]*B^R2M_P LN?I7=$!N",TWR4_NC\J?M .&^R3?\\C^
M55]4M9VTRZ58228R  *[_P M/[@H\E&XV#\JN%=PDI+H93I\Z:?4_)GQ[\/_
M !+_ ,)UJTL>D3RQ23O@^63WK"_X5OXG$C#^Q[@<9QY9K]<Y/#&ERN7:P@9B
M<DE!DTP^%=)+9_LZWSZ[!7WU'B^5*"@H/0^(K<,^UFY\R/R07X<^*BORZ)<9
M_P"N1K=\._ ;QSX@F1(]'GC#'&\QG K]5!X7TL=+"'_O@5;M]/@LUQ!$L0]%
M&**G&5:4;0CJ31X6C&5ZDKH^4/@#^QS!X1OHM9\1;;NXP"MN_(5OI7UA;PI;
MQI%&H1%& !TQZ5-@>E+@5\1C,=6QU3GK.Y];@\#1P2M3044NTT;:\\](=111
M0 4444 %%%% !1110 4444 %%%% !32M.I#0 QCVZ5%-#'*I21 RGVJ?;1MH
M7N[":4E9G*ZMX+M[[+P_N7]N*YR30-0TF3,<7G$=&QFO3/+I&08YZ5UQQ$XZ
M,X9X6$MCS-O%6IVOR& +CV-)_P )QJ7]P8KT632[6;EX48^XJLWA^R;_ )8)
MCZ5LJU)[Q.?ZK5C\$C@O^$RU)DPJ9(IK:UJ6L+M^S;\>BFO0$T"S0Y$*?E5J
M#3[>WYBB5#["F\13CK&(_JDY?&SS>U\'WFH2!Y5\M?3I77:7X3M;':S ,X'>
MNBVTFSVKGGB)SZG13PL($<:J%V*-H%/(VJ!U%.VTNWUKFW.U*VPVG9HI:0PH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FM],TIZ4V@ XICK],=
M\T^E !ZBEKT$TGN95YH=I> AHAD]P*P[SP#;2?ZEV4]Q78[?3BD"XY[UT0K5
M(=3FEAX2W//&^'\\;'9)Q[FF_P#" W1.2Z_G7HVVC%;_ %RIW.;ZA2. M_AZ
M[,/-<X]C6W9^"[.SY;YCZ&NBYIVW=@UE+$5)=3:&$I0U2*EO9P0KB.,1X]J?
M-"'C((R>U3[*4+AJYI.4NIU*G%;(R#E?DVXHV]LU>NX=WS"J7KV-<<XE!RO-
M6[2XSP:JA>.3FFJVULCBB$K#-<?>S4=PFY33;>8,N">:F(Z]ZZ7[R RH_P!W
M+6K&<J*H74>) 0,5<B;<BU*T EHI**U 6BBB@!&K)U]=UIGWK5:J6K)NLY/I
M64UH3)71Q_844#[ISUS17'8PL=_1117HG2%%%% !1110 4444 %%%)0 M%1Y
M((8G  YHWM@$#*_K0!)13%'<]?:D1C\V><=* )**87^7=S2%CM! )/M0!)14
M7S+T8'US2G//8>M $E)3=QVYZ^N*"QV@]!WS0 44B[L$D9]-M'S9W=%QTH =
MDTE1S3)#&'E<*N?O=J59!*H((*]0PZ&@!^:,TTMV )'J*.V ?KZT#'Y'I2Y%
M1JV5)/&*7/W?>@1)13,MNP< 4H;/ .: '4444 %%%% !1110 4444 %%%-:@
M!U%,W%22?N]J0-C 8C<>@% $E%1Y*J."?I0=YY!&>WI0!)2&F;R5'9O>E;IS
M0 NZC/J*.F>GM3%8XW8*Y_O4 2<>E)D4W.]3UQ[4FX-_]>@"3BBF;3PO('7(
MI><Y_*@!]%1[LY!.3GHM*S[>/UH ?14>[:,$Y(YXH5NAYRW;N* )**;NQP::
MS]1]W!X)[T 245&6X!')]!2[LX.<"@!]%,+]B#]:7/H>* '44E+0 4444 %%
M%% !1110 444UFQ0 ZBF9;!.1CM2;F[]?TH DI-M1^9R<?,>^*7G:0#0 _;1
MC%-.[C';K2;B[8##'?UH >:!46YOE+<'M_\ 7J3.['!% #J*8#RW.?3%)RH
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MB@#ZW\/^*-(\50&?1]0@OX\X8QMN IMYXPT6RFF@N-4MX9(%WR!GP5%?)_\
MPB=U^S9^T/H$&D:A=3>&_$4R6GV6:0L$<Y)('2N7\3>#]2\?_MDW6E_VC<6^
MB_9XS=0QR$ IN.<"@#['T?XF^%=?OC9Z?KEK=7(_@20$UU2;N,[<>U?'/[1G
M[/VG?"GPFGC+PC>WECJ6ER><R-+\DH'8@#FOISX5^*1XS\!:)JH.7EM8_,_W
M]HW?K0!UU%%% !1110 4444 %%%% !5>^D:*SN'3[ZQL1]<58JIJ/_(/N_\
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MRU-W$#N19!D8KY5_: \4:I\2?V=?A[?6M\UEJ>I7%MYDJL5PQ.*[N#]G31/
MOPMU#6Y;F[NO$#:<[S7#2[@9-N21QP* /HC2]:L]8A,]A.MRJML)4Y&:%US3
MY-2-@+N-[]5W& -R/?%> ?L+W5U>?#?5I+J=[B3[>0'D.>-O2LWPW=3M^VA<
MQ//(T']E2'RU;Y-V[KB@#Z&U#QMH.DO(EWJUK;2QC+J[@$8JMHOQ"\,^((9I
M]/UJUN8X2?,*2 A<5\>V?P[D^*7[7FN6>HZE=1Z5#;R,;:.3"G#>E9?Q?^"9
M^'_QJ\.:%X6UF[L=)UET2\B:8YPS8.,=\4 ?:&F_%+PGK&IM866O6<]VIP8E
MD!.:ZD,2PQ@J1D$5\)_M5?!/2/@OH_AO7?#%]J%OJ:ZA&DKF7AUZ_-BOLWX=
MWLNJ>!- NIFW2S6<<CD]R5% '1TM)TI: "BBB@ HHHH **** "F2L%7)!..P
M[T^F9^8<9H ^'_VBOVI?%WPA_:HTC0K40R^$MD+WBL"2H9>?;K7VGH^I0ZUI
M=I?0,&CN8EE7\1FOB_XS> X/B5^TQXOT.6.,S3:3:^2[#E2!GC\J]B_9>^)4
M.H_#6\LM4F\B_P!"DEBF$AQMC4[5/XXH \I_;L_:NU?X0WVC:'X,EA;6?/'V
MV-N2J-C'2OJKPUXA1? >E:KK%W#:^;:1S32LV "5!//UK\ZOB?X-?QMX5\5_
M%75!YTEY<_9;?/)412X!'X5]<?$/POI_B[X,^%8]8UXZ#I4=K&TX67RY)AL'
M ]: /5=/^+7@_5+U+2V\064D['"()1EC7!?M>?$+5_AA\#=;\0:!C^UK<(T1
MYQRP_I7RG\8KSX3:#X42;PI?:I!XDM706TGG#:S;@"6QUXKW#]I#7)O$W[(:
MWTBCSIH[=7+=#AE!)H [']DS]HB'XY> [=M1VVOB6W4?:[-N&&>AQ[UD?M-?
M%KQ#X"\7^%+#1Y(UMKV4K.&SDC(Z5Y=XY\%WWP+F\+_%;P=:L^F^1%_;%K"O
M#J550<#ZGK5C]I+Q=8>/M9^&NN:5,LEK=R$GG)1N,@_C0!]AWFO6&B:3!?ZG
M=Q647EJS22-@<BLC1_BEX4UZ\^QZ?KMG<76<+&) 2WTKS/\ :"\'Z+XFTS19
M?$7B0Z-I-O$#+;QS;'FX'0=Z^5OBYK'PV\/S:)<^!;S58-;AN$59#*/+8;@#
MG'7B@#[1_:"^,4/P<\!S:FJ>=>R8CMX@,[F)P./J:\3\(^ OCA\1-#CU_4?$
M%OHLLX,D%IN="H[;A^5<[^TYK5QXE^*'PNM;L,NB7"[WCDZ,P"D?K7VM;@1V
MMNJKA1&H'H.* /E[X._&;QOX<^(\GP^^(EINE9L6NI0*0D@'/+'K5MO%=[9?
MM??8;F_:#2$MY6*.^$'[O(KZ)N/#NG7UY%?75A;SWD9^6=D!9?H>U?'7Q*\!
M77Q(_;*T_3UOY-/L(X93<>2Y5Y!L!P*&!]8:-\4/"?B*^-GIVMV5S<]/+CD!
M-;>H:I::1:-/J%Q';6\8RTDAP*^(/VKO@_I_P,L]!\5^$KR\M+VWN8TDC,O$
MH9P"3@<U[5\4]-LOB=\+_#VIZ_X@/A^QDA62X6.;RVEP>@I@>HV'Q4\(>(+I
M(+/7[.6Z;A(UD&37"?M&?&RV^"_A47RSPF_DGC01,>2I.":^2?CGJWPK\*^%
M;2X\&7NK6^OVMW$(I?. #?-SNQ7IW[2?ANP\=?LP^&O%&K^8VIR/;JTB'@[F
M(/\ *LI1N!](?#'XB:3\0O#%A=Z?>0W-_-%OEC5LE#WKK\]B &'4BO+/V>?A
M;HO@?P+H]]I1E6XN[?>S2G(KU/<NW !SW)[UA)<JN!=M+@;=II\PVD'UJ@K;
M3Q5]6\Z/CJ*VA("6)LK3Q5>W;YBIX-6!6MP%I/XJ6B@!I^\*;-]QOI4E,?O]
M*B6P'$WZE+E_K14FJ1E;Q^>]%<EC)G:T445W&H4444 %%%% !1110 54U8%M
M+O !DF%\ ?[IJW3&YR#R* /B[]D3P]J"_$[XH6^H:;<6EK?7,B)+(N%8%,9K
MS'4_A_XX7XX2?#$6-PW@NYNQ>&X"G9\AZ9K]%K?3[2SD>2"UCA=SEF1 "?K2
MM8VS7 N#;1FX P)=HW?G0!\R_'WPR^C^*OAMIVFZ?/<6=@\,6^)<K&!)WKS;
M]H"UO_ _[1EKXF\5V%[K7@]HRJ0P#=&"2,$@\5]R36=O=,K301RLO(+J#BH-
M2T73]:A$6H6-O>QCHD\8<?D: /@'XOZU:?$CQ!X8O/ W@:2TTV&[B$]PML 3
M\W7(]J[+]K31]2OO&WPJ-II=U=0PFW\R6)<B,A^]?95GX<TK3X1#:Z;:V\0.
M0D<04?D!4]QI=I=%#-:Q2F/E-Z [?I0!R?CCX?:?\2_ #Z+J4 D,D/[MW',<
MF, U\0?L]>$?&W@_]K/^Q/$EG<W&B:?;-'9W@4[2H;Y>37Z)[>!@8%5_[/M/
MM7VG[-%]IQCS=@W?G0!\%>.OM/PM_::UK6OB'I5YKGAB^WM9-&NZ.,%OE7GO
M4/C+4%\>?%OP9JOA3P0^E>'XKB%7G2V",?FSG(]J^]-5\/Z9KT:IJ6GVU^J\
MA;B(.!^8I8-#TVSB2."PMX8TY54C "_2@#YF^-GC;XC?!GXA:;XIL[>35_ S
MPK#<6<*EI4;.2WITKG_BA^V5X>^(/@._\/:/X;OM0U;5(&MXX9(PXB9AC)'M
M7U_>6-MJ%LUO>6\=S;MUCD4,OY&L+3_AKX4TNZ-U:^'].AG)R)$MU##]* /E
M+P_\*M<^'?[&/BK3[VT+ZC?P23K:Q+AL,O"@>M?17[.MO/8_!?PG#<0R0RI8
M0AHI!\RG9T->AS6L-U#Y,T*RQ8QL9<C'TI\,4=O&L<48C11@*HP * /BW]FW
MPI?ZA\8/BE9:AI\]O:7S7"QSR+A&R]0?##XN:E^RQJNN>#O%V@WEQILE[+>V
MEY;Q\%7/ R?85]IV^G6EI*\L%K%#(_+.B %OK5;5/#>D:ZP;4=,M;Y@, W$*
MOC\Q0!\C>%=6\0_M-?';2O$1TJ;3/">AR+/;?:4P6<<9S]*XSQIXHU3P/^V%
MJ6K:9;37UE:VL<EU'&-Q9=QR!7WGINEV>DP^386D-G%_<B0*/TKPC0/@;J-E
M^T%JWBZZ\N?3KNV6(Q2#*G#9Z4 >3_&+]H:Y^/VGQ^ _"/AS48KN_81S3W48
M*(#]*^M_ASX97P;X+T?2-H66WMHTE"CC>% )_.KUEX7T73;K[1::39VUQG/F
MPP*K?F!6H,[LT 24444 %%%% !1110 4444 %5-0S_9]UCKY3X_(U:-,8 @@
MC(]* /E?X(_#]O&WPM\9>'-8L)K6*ZE8J)UY)#,01^.*\5^!/@OQGXL^-">$
M]?M+F#PYX7E;R)KA3MD#<C:?PK]#8+6"U#"&%(@W78N,TR/3[2WF>:*VBCF?
M[TBH 3]30!\D>--+U";]L32YH=,N/LJ0R(+@K^[!\O /YUQG]K6_PG^,OB*X
M^)NA7NO)>N&M)]@>$ +T&ZONIM/M9+E;A[:)IUZ2E!N'XU7U7P[I.N,K:CIM
MK?%?NFXA5\?3(H ^!(+^3QQ^U!X"U_0/!4F@^&@DV)OLX3T'S$5ZQ)I-^?VT
M'N_L$XL]C8NMO[L_(.]?4T&AZ;:K$L-A;Q+%Q&$C "_3TJ;[#:_:/M'V:/S_
M /GIL&[\Z /*_P!H[X*V_P 9/!$]LCO;:O8KYMI<H<,&'S8!]R*^8OV$]!\:
MV'C'Q]:^*;2>#4R6CANI%(#G80#D_A7WQGVJO#86MK,\T5M'%*_WG5 "?J:
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M:T R]<7=:K_O45<O(1+&!16=A6+-%%%:#"BBB@ HHHH **** "BBB@ HHHH
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MXJA%U):OH?)9A@*F'K226B*[,0W R*<JQA@<$>M#$FEW';BOHE&FXZ'SGO\
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M'HQQ"E3EU1\2?M0>#I_#OCZ2]";;&YRRMCCDUR_@37MRFQE^Y_"37UW^T+X
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M/0A3Z8O4TX=Z^4/LA:***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-I_E7M38KA?BQIBS^$[^0+EE0G]*]7+JWLZ\+]SQ<SH\U";78_.KQT?]!O\
M_?\ ZUY3'U;ZUZ[K"IKD-\D?WMQ_G7D]Y:R:;=2Q2J=Q/RMBOZ3PC4Z$6C\
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M91P,U\)_M*?\EIM^Y,D?\Q7Z4>)M"34;9Y0/WBBOS9_:<ADM?C9;I)QB2/\
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M@T+12 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK2TM%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***:QH 7-&:Q?$7BG2O"L,<VIW<=G'*P4%V R3TZUHVMS'=6Z3PNKPR#<A4\
M$>M %FC-4=1U.TT>S>[O9UAMD&YI)#@+5?0_$FF^)K47FFW*7EMT$D1##]*
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MW<S-O=F&2#[T ?7GPE^-&B?%S39GTQ6@O+<_Z1:S+L9>QXZ]:]"'RR G[I&
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MRQN;;0KFZ\.JBJUV(6)' Y]*]!\2_&2RU7X'ZCXO\.1F_CFMF5(XQDJ64C)
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M>RL-(G"";)X?&W&: /0_^&S(898[^X\.7:^'W; O/(?=C.,^E>R?\+<\,_\
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M*3.WT'6J?Q+^%GC#QOK_ ,*-058O.T6??J!9^VP#(]>:^CER*7F@"&)76.$
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MXO)R'B0G/&/K7=^'_P!D\ZE\-]8M/$FI377B'6")IIB=WEN < 'TKZ8S28-
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M HHHH **** "BBB@ HHHH *2EHH 2EHHH *2EHH *3TI:* "D]:6B@ HHHH
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M129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC-
M"T4F:,T +129HS0 M%)GZ4?E0 9I:;^5'/8B@!U%,Y]12C/J* '44F?I1F@!
M:*3-&: %I*,T?E0 9I:;^5+0 M%)FB@#"_X28?\ /G/_ -\T?\)./^?.?_OB
MK.:,T^52>H-<BTU,VX\<6EF 9XI(0W0N,9J#_A8VF;L%CGTKD/BY\.=5\>0V
MZZ?J L1'GA7VUYH?V<?%!R6\029]?-->MA\/AY+WYV/!Q6,Q%-VA ][_ .%A
MZ5_>-+_PL/2?[Q_2O!/^&<?%'_0P/_W^-'_#./BC_H8'_P"_QKI^JX+_ )^'
M']>QO\A[S_PL32O4_I2_\+$TKU->#?\ #-_BG_H89/\ O\:/^&;_ !5_T,,G
M_?XT?5<%_P _!_7L;_(>\?\ "QM,S]YJ7_A8^E_WFKP-?V<O%";M_B"3/_78
MT+^SEXEV_-XAF _ZZFE]5P;^V+^T,3'>![Y_PL;3#_$U)_PL;3/[YKP/_AG'
MQ,&^3Q#,5_ZZFG+^SAXG9C_Q4$O_ ']-4L+@^LP^OXJ6T#WO_A8VF?WC1_PL
M;2_[QKP4?LX^*/\ H87_ ._QH_X9Q\4?]#"__?XTOJN"_P"?@_KV-_D/>/\
MA9&E>I_2E_X6/I7J?TKP?_AG'Q-_T'W_ ._IIK?LY^*,?\A]P/\ KJ:/JN"_
MY^!]>QO\A[U_PL;2A@%B#^%36_CJRNVVP122M_L#-?/W_#./B=F&_P 0R#T/
MG&O0/A1\+=6\!WTLNI:FU\C@A=SEJYZV'P\5[DKG5A\9B)RM.-CTO_A)L?\
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M)-_TY3_]\4?\)-_TY3_]\59W'UHW'UH K?\ "3?].4__ 'Q1_P )-_TY3_\
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M:L,QZ;5I-K+CE<>E %?_ (2I?^?.?_OFG#Q0.]E/_P!\58!W<;1^%+N [YH
MK?\ "4#_ )\Y_P#OBC_A*!_SY3_]\5:W"DW>AH K?\)0/^?*?_OFD_X2@?\
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M&3Z4 !;&,]^E ?OZ4W9N8;3N&<G_ &:YCQYX\M? NF^:P$U].3';V_4NWTH
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M'M4FTB3(/MFO*/C'KLFK7=CX1TR1A<W+!IY(CR #R/RH ]#7Q=HC?=U& _\
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MI&]N:6BG**6P6]I%095U74%TC39KJ0;]BDX]*^:=4\5>(_B!XBFMM)F=8<D
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M@^>..0%<L.E 'L7AE/[2\,6@G^<M;X8K_$,5YQ\(V-CXR\2Z?"2+07+,$/\
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MX&(RJ->I>]CYID\!^,[I51FN"&.&Y->M_##X=_\ "'PBXG8/<2#YAWKO-W/
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M#0 ]F$<>>A->;?%S3]9EO-,U#1K-KNX@4Y 7('->DJ1*=F.%[TS>%Y5CU]:
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M/EAN2/3FLI8?EC<VI8Z4Y6L>H4HI**\Z6]CV^EQ=M&VCFD.:"1V!ZTF!244
M%%%% "[>*%^7FER?2@?,<'I0!6U+48-'LYKNX8+#&NXD]!7GTGQDN%+W":;(
M]DG_ "V &-OK5SXSM<-X-G2#(A)(D?T%;/@^WTR3P/9(R0R6H@7S"0,DXY%
M&KHNM6_B#3H[^W<1QL,M[5:ANK6XD=8)UF*CG::\W\92PPZ596&@3_9[:[N3
M%(V?N^M4?%=C)X%UCPW]AO&9[F18YD+$[N.M 'JTMU!;KF694'N:>&62,2(P
M*'HV:\MTW3[CQ-XNUA)KLI#%:AUCR>#FJG@V75+SPQKEC!=&:YC=Q$Q)..:
M/6H+JWNF*0S+(Z]5!IZ2(VX!AE>OM7C^FZC!I_B'2X-4GDLKMV"EM^%8X]*V
M_"NI7-QX[\1VTLXEMXK97B8'"C)H ZWQ5XA7PWI+ZBG[XQ_>C%4(?B!8QZ+;
MZE=2+ +D[5#=C7F+:E<WGAWQ0;N;S4C'R<]/FJ3Q'IL-U\._#[L&4K*3UZ]*
M /:X[R&ZLTNBX6,C(;M4L-Q%=Q!X9%E7U6N!\::1J<>DZ8FDS!HUC5I(NY&!
M5;X>ZII\FNRVD,\D=U@![>1R>?84 >E $]*/:D&48TJ^M !MHVTN3Z4<T )M
M]Z,4+UH_BH 3[T@]*P/&WC"+P7I_]H38\H,%Y[Y.*W^L?'6N ^,UJEUH-M;2
M+O$G&/?/% '::7J=KJ6DC4(\/$R;]PZ5SOA/XB6WB_5[FP@PQMVPQ7M7GNA^
M*+CP9X7N/#=UN:_9U6$=RI//\Z?\/;6+POXF\1&5A;@_?=NV5H ]G:\MMTD2
M7*>9G[N>:YCQA\1+'P7JVEZ?=X07@(5V[\XKRWQ%J3Z;H\5_I[S9:X11,[Y#
M9:M/XGZ3'XH\2>&+:X;=(ULQ+?W6XQ0!Z?XH\50>%M&CNV_>))(D>0>FXUK*
MT'V>*=I?)1UWC<:\%\4:Y-HND6WAS5I,W$5W"(&?_EHNX<UVGC"6VFU[3[9Y
MI7E:+*VT+[3]: /0[C4H(=,DOFD5HHU+<=P*X.3XO3M$+R+3WDT[=M\U0,?6
MLOP3,^I77B+2[ZY\NW5R@#G_ %8V]*K6^F^)/ .E3_9!:ZIH!RRMY8;"?C0!
MV>N?$6#2M/TJ[B0L+UT0'V8XKJH[BWE:003+(0<N ?NUXQX^N8/$?A/PT\,9
MM4FGBP>F/F[5O:IIMQX3\4:=+;3N590LB,Q(<DT >DS7EO:QJ\TRQJW0DU)Y
ML>Q7WC8PR&SUKRO0["3QMXLUR>ZN'@2T+1I!NP.G7%9AU>^M?!^OQK=;GM[@
MQQL23@8H ]C^V6Q8*LZECT&:FZ':>#7B][H,FG_#O3=>%]))?"-9617/S'KB
MO5?"M])J7A72[N4%9;B%9&#=1F@#3Q[T8]Z2B@!<>](V<<'CO12@=?04 <MX
MV\?VG@::SCN<(D[ !FZ<U?UKQ!#8:/;ZE&XD@N0 ,=.>:X#XWZ=!KNM:-8SD
M+%,RJK>A-<_JFH3>#;&'PSJ1:6)YLV\Q/ SP* /;[>[CN+"VN6811X#%C4L=
MQ!<9>*031KR=I[5Y1JTUSK7BC1-!6X,-L((W8J<!NV*OVEO<>&_B VBQ7#7%
MO<0C*@GY,F@#K]"\9Z;XFO+ZTL95,]MD;?<&FCQ(^GZ3?WNH@1BV!*D]\5YU
M\'](A;Q%XDEC<QR0S2 C/)PU"R3:QX'\7":1F6'S"K,?>@#L-!\;7?B?P[/J
M$$15D8A5]0*ZJQNC-ID5Q=CR..2U>16>[0_@A)=VLQ649)8'Z54U+Q!?:A<>
M&]%\]DM[@(TDN2,Y7UH ]QAN(9D#12*Z'@$5&U];+(8_M*!SQMS7+6N@6_AG
M5+J\&KKL:W53;NQ.W'\6/>O.+RX,7A_5KZSDFEDC=F%P7ROWN@H ]>UGQ/9:
M#?6UI/*L<EP<+N_BI;[4+F.^M5ME\V*0\D=J\N\5VJZQ_P (;<7$C/)<2;2Z
MG&,+6]X\N)M'\6^$+.VE98#*=V&Z_+WH ]%FO;>UP99XXR?6GM)'MW&1=G7-
M>5^'[:7QAXPUJ2ZN]JP1C;!G&/>LAM7OK7P;K=M'<M*EJV4FR2>6Z9H ]H6Z
MMVD\M9E,G]W-.DEBA_UKB/TR:\=UG2[G0_!MCK9N93< @M\QYR15_P :V.LW
M.M:7J$+2/I\<0:2-#@G*T >J1O')$)4<-$W1ATIV/FQWKA?A;>6UU#?+!-(Y
M4C,,C;BO-=Q\P^7.0.] "T4<]Z* "BBB@!<>] 7#9!YQTI*#GHIPW:@#)\2>
M(%\,Z/->LN0O6N+L_C*H6UEO]/DBM)>%N. O6MKXNOM\&REL<,N1CK7#WEOJ
M?C#P#I.DV5@JJY5O/V#@!J /8;?5+.[M([J.54BD&02:<;B%HC()%,1YW]J\
M?U31;ZU\4:#HC7OE0QQD2 $C/-6?%T]S-XZT[P['.UM8,,F3.-V".,T >JBX
MMYX5EAE66%1EF!X%<E:_$%]3\076F:<$E6-6/F8SC':N4:[N/"OQ&GT6"1I;
M.ZC8D$Y"\8IOP]T..S\0>))8F8F))-K9Z_+UH [:[\676EZ(^H7D _=2!.G6
MM[2=535-+BU"3$2RC=@]J\<LK^YO?AYJAN7:7_2UQD].*N:[J5V;'PUI4!9(
MIH1(^TX+8/K0![##-#=)OAD611U*T]<=CFO,_#NEZII7BY94D>'3BA!24[J]
M,9@6RIR#W% "TJTG)I>@H 6BFBG4 1M10U% #UH:A:&H 6BBB@!E+N/I111?
M4:BFCGM;\'P:]JT%]-(5> Y4 XS5GQ1X=C\56/V667RD5@WY5KTVNCVCB<SH
M1D<1K_PML=<MK>,3-!<VZXCG1B,5'X=^%EOHL=S)<737EW<(8_,9B=JD8/6N
MYVT;:OZQ4[G-]2I'$:?\)[+3?"]]H:SEH;M]^\,?EI][\++/4/#>FZ*UP52Q
MV[9,]<'-=MMXI%7FH^L5$:_4Z5CB-=^%MMK/V22&;[+>6J>6)LX#"MCPCX1;
MPN)6ENS=RR'[V20*Z.DH^L2DK,(X.,'S!1117/\ $[G9?2P[=32>:** "BBB
M@!<&CI2K2-0 NZC=3:* *^I:=!JUA-97*[K>5<$5P3_!^92UO!K+0Z>?^608
M@CVKT6B@#FKKX?Z?>:#'IF]D2/E9 WS;L=<UEZ/\)X;'4(;J^OVOS =T.YB=
MGYUW6W%)0!A:7X7ATG4K_4,[Y+M/**#L,]:I:/\ #^'0K._BM[K#7A9BV3\N
M3FNJVYHQVH X2V^%-N-0ANKZZ%W+$VY&YXJ36OA9;:AK1U"VO'M)&4(^UR P
M'TKN-E&V@#@].^#UA9:-J&FFZ:07@^:0L?7-7M0^'-KJGA6#1))61+<Y64'%
M==C%)0!R]QX%EFTF"S742LD0P)<GI4?A?X=V7AW6)=28F:\8 "0'CBNLHH -
MQ9B2*<O>FT4 .W4;J;10 HZT,<<CFDI10 ,H$G!^6L7Q'X;C\26\$4S[0C9^
MF#6WMIM '(ZA\,]-OO$EAK,K&26S!79G[^>]32?#RQDU;4;]I"1??>CS]WC%
M=11UH \WN/@G:7EI'97%^S6Z.)$",0%(.0#70W7@&VOM6TR_,X673T,8S_'F
MNGV>U&SVH Y+QI\-=+\=3VMS=?N[JVD5XW''0YIGB#X;0ZUJD.H1W/D74*[%
M;)Z=Z[+;3: ..T3X9V>B&_E6X:22^.9MS$GICBLMO@_(%DM5UF4Z<[;O),C<
M#TKT8 4E '(ZE\-;+4M/TZU:;RX=/96C4'KM.16KJGAN/6[JVNI9-CVY& >X
M%;-)B@#B/$'PNM]8U9[^SO)-/ED!63:Y ;/?BJGB+P.FB^";C3K%6NIYCEGS
MDDXZUZ%MI"!W7<* /,=!^$1O-)TMKR_D"PQJ7MBYZCM7IEO$EK;Q6T2[88UP
MJ^GM4B+@<#:*..G>@ HHHH */0YZ<X]:** .?\2>#(/$NI6=Y+*$^SL'5>^1
M4?C+P#IOCBWM5N@8I;9@4<'!R*Z2B@#E/$7P]M-?M;.-)6M+JT156Y4D;L#I
MQ1X7^'\?AN_:\GNFOKG;@2,Q)^G-=710!R&F_#2#2?$%SJUK=F-;C)D@R>23
MDU-;_#^VM=-U2R6;]UJ&[?D],G-=30>: .4?X>VTGA&;PYYP%NX_UG:HM0^&
M=A?Z':66_9<6?^KG4X)P,5U^VE Q0!Q^A_#6#2FN)KN\>^EGC"'+$X'XUF?\
M*9@6TN[1+_;:W)SY>3\ISFO0Z6@#D]:^'-KK&CV5@9C&UGS'*IQ@XI;SX>P7
M\^C7%Q<M))I;ET^8Y?(Q75T$8H X?7/A7#J>L/J5I?-923 +(J,1D#Z587X9
MZ?'X;ET,2-Y<QRTV[DG.>:Z^B@#G=6\&PZUX?@TN2;;%'@<]\5#K7@>35UMA
M;ZA]F^SKM 8G#<8KJ** .>\(^";3PB'=&,UU-]^13\OY5T7S+QP?<4E+NH 3
M<32TE+0 E%%% !2X!4\'=V-)10!E^(O#\/B32GT^=MJ,0=Q/I5K1=/BT/3+?
M3XL-';KA7%6L9I=NT4 <Y>^"X-0\00:S)*?-C!_=YYIGC'P-;>,727S?L<\?
M*R X(Q[BNF6FXR: .3\+^ K;P_<RW5S-]MNY 1YCG) /UJQHO@NTTBZU*=)&
M;[<&!7=]W(Q71.G>A5VT <=8_#"SLM%N--\]FCN)/,+9/RU8U3X=6FHZ;:62
MRF*:U7;'<9[#M754Y: .:\,^"6\/W!FGOFO-W&TL3C\ZZ?><E3C:O"X':FT4
M +NI0=PIM.6@!,&G&BD:F QJ*2BG8"6DXH!I:D HINZC=0 JTAI**7F &FX-
M.89-+3>I-AE%%%.[*%S0HI*=2 ****>PA=IHQ244@04444#%VFC::,FC<: %
M6AJ-U&Z@!M+244 .XHXIM% "YI>*;10 ]12,*;10 X9I33** %SZTI%-I<T
M)1110 4444 +M-&TTE% "[32J.>:;10 ^BF44 .R*.M-I5ZT %)3FIM "Y-+
MQ3:* %HXQ[TE% !3N*;10 IQ2444 # [OO<4IQZ?C244 %*/>DHH =Q2'':D
MHH *44E*.] "\4<4BT4 +M%! IM% "\>M%)10 4H&:2EH ,444E !0<CM12Y
MH 3GTI5[YI** %I*** '<8IM%% !1110 4X+ZTVG-0 M%-R:,T *O2F=&I5:
MD;K0 C>U%%% !3EI%I: "BBB@ IRTVG+0 M(U+130$1HI6HJ@)*0YHR*,BH
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MO@G_ -#U9_\ ?+?X4O\ PVM\$_\ H>K/_OEO\*_G;^T3_P#/63_OHT?:)_\
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M_P#OEO\ "C_AMCX)_P#0]6?_ 'RW^%?SM_:)_P#GK)_WT:/M$_\ SUD_[Z-
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M 3_H7F_[_M1_P[+^ ?\ T+S?]_VKZDVFC:: /EO_ (=E_ /_ *%YO^_[4?\
M#LOX!_\ 0O-_W_:OJ3::,4 ?+G_#LGX"?]"ZW_?]J/\ AV3\!/\ H7F_[_M7
MU(>E"T ?+7_#LOX!_P#0O-_W_:C_ (=E_ /_ *%YO^_[5]2\&C:.PH ^6O\
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MRW_P[+^ ?_0O-_W_ &H_X=E_ /\ Z%YO^_[5]2;31MH ^6_^'9?P#_Z%YO\
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MHH 1J2BB@ H/2BB@!5[4ZBB@ HHHH *1NE%% "TT_=HHH :M/7I110 M%%%
M!1110 4444 1M3OX:** $I5HHH =2-110 BTK444 -I5HHH =1110 4444 %
M%%% !1110 4444 %%%% !1110 C=*;W-%% #Z9110 4^BB@ HHHH *1J** !
M:6BB@!K=:2BB@!M*M%% "MTIM%% !1110 JTM%% !1110 C4E%% $BTE%% #
&**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>formdrs_13.jpg
<TEXT>
begin 644 formdrs_13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %' EH# 2(  A$! Q$!_\0
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M):6I8!UMQY;85<YV*TFT=@"H]*Y+X=_MN6/B1?BX-=TN+29?!375Q:1I*?\
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M+_CA\7/V@&_9_P##[?$.Z\*-XLT;Q"FLZMI-C;F6]^Q7(CBN8=Z$1NZI]X#
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M,#=LR2<T@/T'HK'\':U:^(_".B:M8WK:E97]C!=07KIL:>-XU99"N!@L"#C
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M%/0D#IGWKR>W_:@O]<^#$/B;3-%@3Q#/JT>AK:32DVZW$F-LF1R4P1QUSWK
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M^'#,6XPG&\([1;O%=[+K?L[VZ6,S]@WP3JVJ7&N?$S5--DT32[^W72_#VFR
M[ELA(96E)(RQ=BOS_P 14GIMK$\'?L/ZYXAA\/ZKXFEB\/:I9^*[_4-3LTD$
MZZEILMTMQ'$2C;<[T4X;. QR,@5]M001VL*10QK%%&H5(T "JH&  !T %25\
M?4S*O*K.K'1R_2Z_77SU/M*6!HTZ4**6D3X;M_@!\8M%^&D6EV>GS^4?'5_K
M&HZ'INO)837^GR@&,+<H?D&[)*Y!Y'I2>$?V7?B#I'A'PA;R:!#:36_Q,'BB
MXL7U6.XDL]/V!1OE)_>N,<X))Z]:^Y:*/[2K6:LM=>O^?_!*^IT^[/BSQ5\
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MZ?<7U_<PV=E;QF6:XG<)'&@&2S,>  .YH LT5\,_&3_@J'X>\,WTUAX!T/\
MX27RFVG5M0E-O:.1U\M0-[CW.VO%9?\ @JA\3))&:/1_"\:$Y"?9;AL#Z^;S
M2N.Q^J%%?E9_P].^)_\ T"_"_P#X!W'_ ,=H_P"'IWQ/_P"@7X7_ / .X_\
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MYYOFQLS28+,)&#<$$$$'C! Z5S7B+X.^#_%WA34O#>L:/'?:/J$+02PS,7*
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M/[.CP<^OR\U^?SX'Q"^"O%_)K_,^WCQC0?Q46OG_ , ^7/L.H,"!JW/^XO\
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M/%05KFQC@"0M'MA1\,"#G.XFO4O^"56K&Q^-&O:>90JWFAR$1L?O&.>,@CW
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M!/>OU^K\BK/C_@I5:@C!_P"$[F_]#:DP/U0^PVW_ #[0_P#?M?\ "C[#;?\
M/M#_ -^U_P *GHJKF1#]AMO^?:'_ +]K_A1]AMO^?:'_ +]K_A4U% :&)JUK
MJ$<B_P!F6&GRJ5 /VA0N#GD\#G [57O(=;4XMM)TAQYG_+5RN4]>%X-;&H7C
M6J*$'SMT]JS8=7FN$#Q2QRI_>3##CKR*+L+"0VNIOY!EL=-CX)E54! .XX /
MTQ^-0*FNXYT71P=W_/4_=[G[O6IFUQU;:UQ$K;@FUBH.X]!CU/I3CK$RE094
M#,2JCC)(Z@>]%V%BSI5K/)"_]I6%C#+N^06X# K[Y'6KWV&V_P"?:'_OVO\
MA65_:EQ_>'_?(H_M2X_OC_OD4786-7[#;?\ /M#_ -^U_P */L-M_P ^T/\
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MPTA;ZJ*CTR2[DTVT>_CCAOFA0W$<+%D63:-P4GJ <XJS2L(X?XH_$+PO\&/
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M&2A"G(+< UNJGN*%VK.^C]-/P_$YY4VYN6FJMJK]_P#,[R^_Y%?Q!_UY3_\
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MW<02/:@163PWXR+E9/%\7E9_@T]-Y&!WZ#O^=6)/#_B?>IB\4!5^7*-9(>@
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M4L.A^Q%)47ES_P#/9?\ OW_]>CRYO^>R_P#?O_Z]49$M+4/ES?\ /9?^_?\
M]>CRYO\ GLO_ '[_ /KT ,OK/[9&,':R]#6=_8LN<_N\^N.:U/+G_P">R_\
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M***D9F^)O^18UK_KPN/_ $4U?D3^P;_R<Q\//^ON;_TGEK]=O$W_ "*^M?\
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M/AZ![QIYH+?R)!;SRS1[0&9B "V.A*GD\5?L+K2=;C>2RDL[Z.)MC/#M=5.
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MH9(R64.I4E3@C(QD'L:Y.S^',-C<02IK6K'RB"8C<#RWY!Y4#V_4U1)Y=>?
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MQP>,OAO%$BQ1II=TJQHH55&\< #I7UO^Q8N[]E3X4#.,Z2HR?]^2@GJ=I/\
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MQ/M7Q;HX5?\ @I#8!22O_"<S8W#!^^U?I1\(_P!E[X4_ RUCB\%^"-)TF=0
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M]_R*WB#_ *\9_P#T4U?F'_P3-_Y.7T7_ +!=_P#^@+7Z=WW'A7Q!_P!>,_\
MZ*>OS$_X)G_\G,:)_P!@N_\ _0%KC9VQZGZ\)CJ:AOH7F18XI/)DSG>.PJ3[
MJY.,"EA!Y)&&;GZ>U6,>.@'6C:/2EHY]J0"TT<<?E2TV0[5+>G- 'SE_P4*_
MY-2\5_\ 7>R_]*HZ\@_X)7_\D7\8?]C$W_HB.O7/^"@TGF?LH>*CC'[^R_\
M2J.O(O\ @E?_ ,D8\8?]C$W_ *(CI=0?PGV9=1":%@7,>/F$@/W<=ZH(MWYG
M%];L<'"[>"!U/6M&X@2ZMY8)!NBE0QLOJI&"/R-<._P0\(./^/&Z3Y!&I2^F
M4JHR<+\W .3GU[U1D>7>-OV;?$GCSXAZGXAMO&-CIVCZD52:.TMG:<P[%21
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M[L_^/BOJG]C%BO[*?PK8 _+I*G@?[<E,CJ>O:=K&F:K*T5EJ,5W(H+%89PQ
M!P3Q[G%:'DC^\_\ WT:P]+\)Z)H]_P#;+'34M+H[LR0JR[MV-V1T.<#KZ5MB
M8>C?]\FD4.$0[L__ 'T:7R5_O/\ ]]&F^:/1O^^31YP_NM_WR: '>2/[S_\
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MKQ;5UY+5_@&,2IX"=:+LU_2/I7_ANWXG?W="_P#  _\ Q=)_PW=\3?[FA?\
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M^@NI]^2*67(^\.12JVY010OI59I)8[SRXXMT3#+-GH:0RUWK\B+/_E)9:_\
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M/^OX_P#HMZY,=3E]2KN5U[DNM_LL]3+Z,_K%.52ZLU]J]]>I1_:D/_&PP?\
M81T+^4%?K,WWC]:_)G]J3_E(8H_ZB.A?R@K]9)B02!U)K^=UN?L/1"K)N8''
M"\#ZU+NV]>AY%,6$;1@\4VXV@*#DGH O4FF(_+__ (*]3";QSX 90P!T>[/S
M#'_+05]9?L6_\FH?"[_L#)_Z,>ODS_@KPIC\;?#Y2.1HUV#_ -]BOK+]BO\
MY-/^%O\ V!D_]&/3Z"ZGM6:7--HI#'T4W-+NH 6BC-% !1110 4449H *<.E
M,W4;J /Q_P#VU(_^,R/&;_WM1T\?^0K>OVH9N<#K7XO_ +:\>/VMO%4G][5K
M)?RAM?\ &OV?\L"3=38H]1^VG4E+2&<9\:/^2.^._P#L W__ *3O7Y3_ /!+
MD_\ &3%]_P!BK/\ ^C8:_5CXT_\ )'?'?_8!O_\ TGDK\IO^"7'_ "<S>_\
M8JS_ /HV&F)[GZOTNZFT4ACZ*92[J '44F12T %%%% !111F@ I1UINZC<:
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MVR^4;QCH_(XO4-'>VM6>ZNK\6J,L99XE('4J,;_7^=8WEV7EJ?/FWG=N'E#
M_N\YYSW]*]!UKX16VEVY*:P+A]C."F&5<?WO2O,OI7J8.K#$P;A4;MY6_0[<
M-C,-B7*-!?#O\PKU+]E[_DX#P1_U_'_T6]>6UZY^RY9'_A>W@N9^/]-)4?\
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M3;\?:"RL.A5@!D@CTKPCXR?\%"/"7@?PWJ.C_"RY?Q3XDNRRIJQ@:+3]/!&
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MUW:O'9^#?"NFS,"!<,;B?;[[2X!K"_X<_P#CUF5C\2+(LO0FTER/_'JGM_\
M@C]XWDD N?B/;/#_ !+';29/YL11J%D?-7Q0^,FM?$'Q2=:\6ZU/XD\02XA@
MMXAQ&"?ECBC7A 2>% R3ZFOU'_X)U_LSZI\#?ASJ/B7Q?:_9/&_BQHY[BS<#
M?86J ^3;GT;YBS#L2 >5K-_9?_8"\-?L[ZE#K9TBQ\0^*(CF/6M4=II(#ZPQ
M[0D9_P!H M[U]?VOGE?WH7=WVYH O1GK4E1Q5)3 **** "BBB@ HHHH SO$F
MH2Z3X>U2^@:V6:VM99HVO9?*@#*A(\Q_X4R.6[#)KYNTK]I+7/ASIEY-X_EN
MKW59EMQ;Z)/HXL9Q/+)L/DS1O)%-:@_\M 6=<#=G<!7T[=6L-[;2V]Q$D]O,
MACDBE4,CJ1@J0>"".,5YE_PHWX7^&+%M-?1K:SBUB:*TA$UY,9=Z;I(HK=VD
MWQ;=K,JQ%0-I( Q0!Y[J?[7MMI;6&LR:7=_V5J>FVXL]*EA,=Q]N:ZN8G#/@
MXC"V[$-MY ! ^:NFTK]I9O%=JEQX<\':IJ$$5A%=:A+<S16OV"24R+%&R2,K
M."T1RRCA64C=G Z;7OA=\.K>WTG2-3TV.)KW9IE@3<3B=FC\VY4),&WJX_?/
MYFX,<M\W-7G^!W@:35-(U!_#UO)=Z3$D-J[R2,-J%BGF*6Q*59F96D#%2Q((
M))IO8.IS4GQRO-!^!_A+QIK6B1C6=:MK5CI4-XBCS98MY",<EA@$[5#-[<$C
M2C^-]OJ7PU\)>*M(T.^U&Y\4/##IVDL\<,IE='D97=CM0*D<A)_V< 9(%;%U
M\&O!][X1TCPQ+I)_L;2'$FGPI=SI):D!E&R57$@&UV7&[&TE>G%2S?"+PA-X
M$LO!IT2%/#=B$^R64<CI]GV'*&-U8.A!Z%6!&<=*!'E?@W]IJ_DT*TGUKPU>
M3_973^WK^&2&-=+$]Y+!;J8]V92 @WE,@#D;B<5;NOVC-<OH_"U[I?@J>#1M
M;UBV@AO[^]A FT^19B]PJ*Q97 B#;&'W7'.<@=1J?P;^%W@O3K'7+S0;/3K'
MPS!YL4QDE\N&..1IE+H&Q*$=F==X;:22N#4F@_!?X93SZA<:1HMD\J:HD\TE
MM<2'[/=V\AD")A_W05W8F-,+EFRIR:.HSEE_:BD>WT\#P/JBWFM"SGT.U>\M
MP;^VN7*1RLP8B$@[2R-R XQDY L?$3XO>)?!WQ<M--32GN/#\6BQW'V6U>$S
MW^H7-VEK;P;G(\M0[ E^G))X&*WO"OPN^&&FZI(FA:1:&Z6^\XF!Y95M[BU?
M(C!W%8A&TI(B&U06.%ZUUGB;X<>&O&37CZUI,.H-=VBV,S2%@6A602JHP1@B
M0!@PPP(!!&*.P=SB_!WQVF\8>,K3PQ'X3O;/4XUN3JWG74)CTYH75"-P)\W<
M9(RNWLV3@C%>L5RWA/X7^%_ LD$NAZ1'8S0V\ELLP=WD9'D\U][,Q+LS_,68
MEB>]=32 **** "BBB@ HHHH ^2]#^/WCK3[G4?$=R^K>(]!T^[U9M5TUO#9L
M[2TL[5KD(]M?MM6:3=#$@7+;M[?=VY'J,O[0-]:ZE]EN? ^H1QV]Q::?J%PE
M[;NMK?72HUO!@-F0'S8 SJ,*91U 8CT3_A ] /A.\\,G38_["O%G2>RW-LD$
MSL\H)SGYF=R>>]9U]\(O!^I>,K3Q5<Z'!+KMKY?EW19P-T8(C=HPVQW0$A79
M2R]B*%M8#SJ\_:BT8PV6J0VFHC2(X/.NFB2)]TQL9+IK4@G(D0+&#C^)U!XS
M6!K'[5^H> ]4UJV\5>%KJWU(Z@EM8:+!+'*\<2V4,\SM-'N5N9,+QDDXX S7
ML-O\&_!5K:S6T?ARR%M->WFH2PE24>>Z5DN792<'>KN"#Q@\ 5A:7\ _AO=:
M";6ST&1+1[LW)F^UW<5R9E3R"WFEQ+RB!#\V&51U&*?<.QC?%3XV:QH.C^$+
M_P -:6LMCXATW4+Y[B^'ERV:Q:>]S$3$>2VX ,O;!'>N;F_:\3PWX;LQX@\*
M7]IXFF>UBCT_SHV6=9;5KCSM\>X(-L<@*D$AL#H<UZ=#HW@+XP:3;"*VAUG3
MM!NY[&!XQ+$D,JQO;S(C#;O78[QG!*GD<D<6=8^"_@S7HG2[T5=S?9_WT%Q-
M!,GDHT<6R1'5DPCNORD9#$'(-'H'8QM8^-S+X7\%:KX?\,:CKUUXL.++3Y)(
M[*6+%M)<'S3*0$PL3#')R17&V?[97A>\\3:9IB:1JBVES:VUQ<WGE%OLC3V_
MVA4=5!R%0KN8' )'4<U[1_PAVC8T0"PC T0DZ?@G_1\Q-$<<\_NW9><]:X[1
M_AS\-X_$EA+IFG0G4=-3^SD2UEF:&/R(PH29 WELZ(Z@&0%@#@&CJ!Q&O?M;
M1>%_#^D:AJO@O5+&ZULK-I-H]S#(;JU,1E\XM&6\LA1@HP^\P )&2-.Q_:DT
M[4/$TNF1>&=72(Z1_:UH;A5AN;[_ $87'EP6[D-(VTE/E)(=6!  W5TD/[./
MPZM=,DL+?PVEM"\ZW >WNYXYHV52BK'*L@>- K,HC5@@#$;<$UHR?!#P/-K3
M:K)X>MY+MK<VI5Y)&AV&+R2?*+>6',7[LOMW%>,XH \OO_VQ],T_X?V_B5O#
MTDTQFN$N-,@U")[B%(8UD<[!\^[:Z_(R+@_>*@@GH9/VF+&SN-2N[_P_>V/A
MFSNY[ :U)/$5DGCM3<[!&#N 9054GJ^!W&=FZ_9G^&M[I8T^X\-+/;YE\QI+
MVY:6=955)$ED,F^5"J(-CEEPB\<"I_%OP,T+Q-H5KH,$<.G:"VL6^L:C9B'S
M3>O"T;HN]F_=Y>&+) )*J5XW$T =UH>H2ZMHNGWT]G)I\]S;QS26DQ!>!F4$
MHQ'&5)P<>E7J**0!1110 4444 %%%?,OB&[\/K\3/%A\=WNOP>+8M6MQX6MM
M)FN5E>R,4/E?9$4^6Y:7SQ+D'OOPH%'6P'TU3=H#$XYKY2C^.?Q$U":]MK+4
MK)]5N)?*N]/;19/^*8D_M&"VC21MP\[S(I)6YQDQ[U^2LWQ-J'C;4/$UMJ>L
MZJ^K2>&K75;-;9--:&WO)$U&U@2Y95?B0Q2G@97Y6(P":?8#[ HKY:U?XF?%
M:/1;_5K36K.,Q66MZM'9R:&77;97J006N0X8^8FXL_WN?E'%>AVOC/Q/IGP]
M^)W]M/<:]J/AZXN+>UNM*M#:3W$1M89E9$&_#(9F7<N>(P<$Y!GI<=M;'L5(
M%"DD#DU\V_L8^)Y'\/>)/"MS/<:E=Z3<+.=9B>9]-OA*N-]BTI+E!Y8,F3Q,
M\H'&*\I^&-CXU^'%OX5\3_V-#%<S^&+^^L1I]U?W,FOWJV[.ME>I*=L3\><"
MH)9HV52N,-5A'W517R%I'[0?CVZ\'PW>H:_I6EZ>U[(I\4"P^V(&6V$JVKQ1
M$(K-(2@();"[2!(16MI?[2GBN;2]&M_(BO\ Q1?3V%Q%I4-C(IN;271A<LRG
M&%5KD,@8G@_+UHZV%TN?4]%?%\?[2'Q+E^&MQK#ZCI$+I?VX>\6%#)&'@DDD
MM0#B%75UC4"5U8AF4D/MS[9\ ?$FL>(_$/Q"FUC6+R[+WUC<VFEWUE]E?3X)
M=/MY-H4DD*7,@P2<,C<DYHMN![)1112&%%%% !1110 5Q7Q/\3:GX.M] U>T
M>+^RH]6M[?5TE4$_99B8?,#?P[)9(G)_NJU=K5#7M!L/%&AW^CZK:I>Z9?P/
M;7-O)G;)&ZE64XYY!/3F@#Q*S^/VHVNJW4T]G/JRZI(__"/:5:+%$LT1NUM8
M"TKG(,A627<?E",.I !QK/\ :]7P_=66E>)- U"36Y[Z\^U6UI&':PMEU":U
MA!V;A*X\LYVD9"D]\5[)JGP@\'ZUIL5A>:'#):PV$>F1*KNABMXW5XT1E8%2
MK(K!@0P*@@UGV_P#\!6<>DI;^'TMUTMW>V\FYF3[\IF828?]ZID)?;)N&XDX
MR::L#*7@7XX1>-/$UKIS:!>Z9I^J1W4VBZG--$Z:A';2+',2BL6BY=64,.5/
M8\5Q_B+]HC7;O3=/O_#OA*[-A>:[;V&GW4UQ;XU2/[7]GG55+[H3D9#./N\\
M'Y:]0\-?"?PEX/\ $=_KVCZ)#9:K>[_-G5W8*'??((T+%8@[X9@@4,1DY-8:
M_"SX:Z#XUMW&C6EMXAU:=M1MUWR$F2"197>)<[8\2.KL%"AF.2":78.YQVO?
MM:Z;X;TKP_>WGAR]5[^22.^M%N8GGL3'=FUD^12?, D5_F^52J_>SQ74>&_B
M]J7_  @.I>)?$NAKIT5GX@NM*D%O<+(L=K'?-;"Y8^B@;F'7"L1QQ5_7/V>_
MA]XD:%M0\-Q3^69#M6XF17WSM<-O"N X\YVD ;.UF)7%:^C>$?".H>'?$.G:
M=:VUYHVM7=X=3@65I8IIY&9+I2"QVDL&#*N!NW'&2:$!YA??M/1:K:6[:'HU
M\+Q6N/,AN#$JK(J79AAE).5$JVQE#+R%*?WJK?"[]HGQ'KFN6EKXG\,/:VFI
MWEC8PWMK/$T5I<3Z7#>"$KNWN"QD^<#C<@YP37K4?PJ\)0W$LR:#:+)+<1W<
MC!3\\L=M]E1CSSB$E,'C!]:KZ#\'?!WAFRL;33=$CMX+*[BOK=6FDD*3Q0>1
M&^YF))6(!!DXP!5*PG?H>:^,/C?XVTGXN7'AK2O"L>J6%OJEK9P"*[BCDO1+
MIMU<LI+D"+:\*'=W (P<T[0_VP/#OB'QEX>T&ST757&J161EN/*W?9);J,/&
MC*H(( *AWSA=PZC)'JLWPU\-3^,U\6/I:'Q NS%YYCCE(Y(U8KNVE@DTB[L9
MPV,\"LW3?@IX*T?5M*U*QT-+2ZTR&."V\FXE6,+&"(]\8?;(5!(5G#%>Q%(;
M.XHHHI %%%% !1110 45YE_PTU\)_P#HH_AG_P &<7_Q5'_#37PG_P"BC^&?
M_!G%_P#%5O\ 5ZW\C^YF7M:?\R^\]-HKS+_AIKX3_P#11_#/_@SB_P#BJ/\
MAIKX3_\ 11_#/_@SB_\ BJ/J];^1_<P]K3_F7WGIM>6?'OX:WOQ$L_"3Z99V
MUSJ&CZVE]%/<.$:TS;SPBXCR.6C>5)-O&?+('.*F_P"&FOA/_P!%'\,_^#.+
M_P"*H_X::^$__11_#/\ X,XO_BJ/J];^1_<P]M3_ )E]YXKX#_9O^(&CZ"MN
MU^VD:DMP6^T/>Q2HEQ_9MY;F^C6.)3N:6XB)+$NP7+8(YK^'OV<O&>E>$8+;
M4-%77=/CU%;B]\(W6LQPP7Q%J\7G*\42JI\UUD^?);8'.' !]R_X::^$_P#T
M4?PS_P"#.+_XJC_AIKX3_P#11_#/_@SB_P#BJ?L*W\C^YA[6G_,OO/&]4_9\
M\>WUUK 6TLX-8N8+O/B:'6YW>6UDT]X(M,".-^Q)60B1CTC$GWV.(_B!^S%X
MC_LF\T[PKI\(TU=1AOK"P.H_N(YC8I%)+)'*"&'G*6)5ED!)=#N)S[1_PTU\
M)_\ HH_AG_P9Q?\ Q5'_  TU\)_^BC^&?_!G%_\ %4_8UOY']S%[6G_,OO/)
M_%7P;^)>O?VII!M-/>Q>XU6]745U-ML[7=B8DB$3+N54E8Y+$\!2,Y..8^(W
M[,_CB^_X2&S\->'],M(;K6=4U:TOK?4$AE^U7#Q20W+%D;R]H5D)1?,W*,,%
M8FO?_P#AIKX3_P#11_#/_@SB_P#BJ/\ AIKX3_\ 11_#/_@SB_\ BJ7L:W\C
M^YC]K3_F7WGD>J?L[^*DN]?_ +)TJQM+&ZUO4M5NK2+46@76H;BXL9C#(R#,
M9=(9XF)R/^ L:@;]F7Q'JNF7TMQI]O820Z?=GP[IL>JR,NB7#W:2P(CC RBH
M2&'";RB_+U]C_P"&FOA/_P!%'\,_^#.+_P"*H_X::^$__11_#/\ X,XO_BJ/
M85OY']S#VM/^9?>>FT5YE_PTU\)_^BC^&?\ P9Q?_%4?\--?"?\ Z*/X9_\
M!G%_\52^KUOY']S#VM/^9?>>FT5YE_PTU\)_^BC^&?\ P9Q?_%4?\--?"?\
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M#/$7&2 ^X9S7K/\ PTU\)_\ HH_AG_P9Q?\ Q5'_  TU\)_^BC^&?_!G%_\
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M<7_Q5'U>M_(_N8>UI_S+[STVBO,O^&FOA/\ ]%'\,_\ @SB_^*H_X::^$_\
MT4?PS_X,XO\ XJCZO6_D?W,/:T_YE]YZ;17F7_#37PG_ .BC^&?_  9Q?_%4
M?\--?"?_ **/X9_\&<7_ ,51]7K?R/[F'M:?\R^\]-HKS+_AIKX3_P#11_#/
M_@SB_P#BJ/\ AIKX3_\ 11_#/_@SB_\ BJ/J];^1_<P]K3_F7WGIM%>9?\--
M?"?_ **/X9_\&<7_ ,51_P --?"?_HH_AG_P9Q?_ !5'U>M_(_N8>UI_S+[S
MTVBO,O\ AIKX3_\ 11_#/_@SB_\ BJ/^&FOA/_T4?PS_ .#.+_XJCZO6_D?W
M,/:T_P"9?>>FT5YE_P --?"?_HH_AG_P9Q?_ !5'_#37PG_Z*/X9_P#!G%_\
M51]7K?R/[F'M:?\ ,OO/2I8EFB>-QN1P58>H/6JVCZ/9^'](LM+T^!;6PLH$
MMK>%22(XT4*JC//  '->??\ #37PG_Z*/X9_\&<7_P 51_PTU\)_^BC^&?\
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MS#VM/^9?>>FT5YE_PTU\)_\ HH_AG_P9Q?\ Q5'_  TU\)_^BC^&?_!G%_\
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M^BC^&?\ P9Q?_%4OJ];^1_<P]K3_ )E]YZ;17F7_  TU\)_^BC^&?_!G%_\
M%4?\--?"?_HH_AG_ ,&<7_Q5'U>M_(_N8>UI_P R^\]-HKS+_AIKX3_]%'\,
M_P#@SB_^*H_X::^$_P#T4?PS_P"#.+_XJCZO6_D?W,/:T_YE]YZ;17F7_#37
MPG_Z*/X9_P#!G%_\51_PTU\)_P#HH_AG_P &<7_Q5'U>M_(_N8>UI_S+[STV
MBO,O^&FOA/\ ]%'\,_\ @SB_^*H_X::^$_\ T4?PS_X,XO\ XJCZO6_D?W,/
M:T_YE]Y^*>T>@HVCT%+17[(? B;1Z"C:/04M% ";1Z"C:/04M% ";1Z"C:/0
M4M% ";1Z"C:/04M% ";1Z"C:/04M% ";1Z"C:/04M% ";1Z"C:/04M% ";1Z
M"DVKZ"NT^#7@./XH?%;PMX4GN'M+;5;U89YX\;TB +.5SQNVJ<>^*Z3QAK_P
MJ\0Z7J^F:'X.OO"6LV<RPZ)?1:A)=#41YFQA>K)PC%?F#1X /&*YIUE&?LTF
M_P!+Z?U8UC3YH\U['E&T>@HVCT%?4,G@#X6Z3\9+7X(W7A:^NM0DN8=)N/&J
MZC(MVFH2(IWQV^/*\@.P7:06(R<UC#]G32];^ MG?Z1.Y^)L5WK+_8?,)CU2
MUL9A',L2G_EJBE751RRANI%<WU^DK<R:O:WH[V?II\C7ZM/6UG;].GXGSOM'
MH*-H]!7UBW[._P /+CQQ\0-$O+J;P[96.A:%-I>H2SLT=K?7J(-TV>L;2. <
M_=#'&,53^'?[-^C'Q1\)- \8:+<PZKJ^IZ]8Z[:FZ:,N;15,(4@_*.<[A]X$
M&I_M&BHWUVO_ .2\WY?B5]5J7M_6]CY:VCT%&T>@KZ1TWX-Z-X_^*W@WPK-X
M,A^'MC>O=3WEUIOB(:M+<6\$1D=5&YA&V%P">N[OBN%U[QA\)=<TF2:S\"7?
MAC5M/NX3965KJ4MS;ZO:AOWJ73N=T4FT AXQC)(Q6L<6IM*,6_N=KMI=?+IM
MUL9NBXJ[:_'_ "/*-H]!1M'H*]^^+-C\.M'^#/@K7]%^'G]F:OXNMKQUG.N7
M$RZ>T$XC!56XDR,_>QUKMI/V;O 6H>/OC-X<:[;PY'HIT>UT"^NKEFAMKJZB
M4A9B>J/(0N3]W=Q4/'0C'FE%K?MT:B]F^K*6&E)VBT_^"F_R1\E[1Z"C:/05
M])>'?V;]*N(OAO9>([74-$OYV\03^)EC<^>8M/.[RXE;A6*C ('.[-<MXJT?
MPUXT^$]_XN\/_"[6?!J6-PB6NIV-U)?:=<P;]CBZ:0YCE!*X9/E).,"K6,IR
MDDEI>U].[2Z];/:^@OJ\DKO^M$_U/%MH]!1M'H*]A^"7PITGXY:#JOA;3Y(-
M)^(-K/'?6-]=W)6WO+'(6YB92<!X@?-!')56!Z5T;>%?A?I=KX[\<0:)<^(?
M"'AJ^M/#^D::;]XUU>\=6+W=Q(/F6)@C,$3'51[TY8N$9.%G=?K:WWWT]'V%
M&A*24KJW]7^[_(^>]H]!1M'H*^E_"GPG\!_$KQ+\+/$&FZ-<Z-X>\47VH:7J
MOA_[:\B6UU;0F3,$Q^?RF#*<$D@@C->6^"?!NE:W\(?BAK]W"[ZGH7]F_8)%
MD*K'YUPT<F5'#94#KTHCBX2Z/2WXOE_-"=&2_'\%<\ZVCT%&T>@KVW]F/1?!
M/C;Q+-X9\4^#CK4[VE]J*:FFJ36S1K!;-*(O+3Y2"4/S'GYO:G>%['X?W?@O
MQ;\4+[P2[:9IM[8Z3IOA%=6F-LT\T;L\L\^/-*@(2%7')QG%.6*49./(]+=M
M;NRZ_F.-'F2=UU[]/D>'[5]!2[1Z"O5/C)X3\,P>$_ WC7PK83Z'8^*8;S[1
MHLMP9TLKBWE$;B*1AN:-MP(W9(]:[7P-\)_A_P"+O!>C_$6Y>2S\,^';6:/Q
MKH\=T1.]V@_T46^26Q<EE''"E7QBE+%PC!5&G9W7S73[U9>8E1DY.*:_X']:
MGSMM'H/RHVCT%>Z36?P[^%?@/P5J_B#P3)XQU;QA:S:K+!+J<MK#IEGY[QQI
M;F/EY<*26<D# XYK:\;?L_\ AGP5:?&^.*2ZU'_A&[+1[_0[JXD*211WCHQ6
M55^5V"/M^HS2^N0O9I^7GJHOKT;_ ,BO82M>_P#5K_DCYQVCT%&T>@KZ,^$O
MP9\*>+)O@0NHV$]Q_P )9>ZU#JJI<NGGK;?ZE5P?DQW(ZUE?&CX7Z-X<^%NE
M>)G\'7OPU\27.KO8IX?O-2:[%Y:+%N-T@<;T"OA"?NG/%)8VFZBI6=WZ=VN]
M^CZ>H?5YJ'/T_P" G^IX1M'H*-H]!7OWP-TOX>>*/A_XWN->\ ?VGJGA+1&U
M9KQ=:N(?M[><%",B\1@!ARN>GO6[\-?A?X>\9?".X\7:7\)K[QGJ5YXJETR/
M2;'6)XOL%GY*.N''WB&8C<WKS1/&1IN7-%Z.W3K\_P PC0<[6:U]?\CYDVCT
M%&T>@KW_ .)GP;\&^$] ^,$^A7,NJ#PUKNE6&FWC7(D\M)U<SQ,5^60JR[-V
M/X35CPG\)_ $VH?!P^(;A=-M/$?AV]U&\:ZOS;0WE['/(D$+3'(A1]JJ2/YF
MCZ[3Y.>SM_\ :\WY!]7E?ET_IV/GC:/04;1Z"O>OBOX:T/X:7?AW6=?^$,ND
M"X%PLVF6>N/-HNHQA1Y4UM=HSN'!SN3)!&#QFNH\:> _AK#\</A_\/\ 3? [
MZ;!K4^C7-WJ/]L7$LAANE5I8 C<#[^ X.>*7UV-DU%V:;Z=-^H_J[NTVM++K
MU^1\N[1Z"C:/05]'^+/AGH*_$OPEX=_X5W:^%],OO%46ERWMKXG.H2W5N9MA
M0QAR8B5^;=P0>*AU3P!X!^(%S\4M$\,^%[OPEX@\%VUY?VMPNK/=VU]!:S;)
M5E6091RO*E3C/!H^NPLGRNWRTUMT8WAY*ZNOQ_R/G;:/04;1Z"O=OV>OAQHO
MB[X<_$;Q!>>";WQ]K&AMIXT_1[&YGB:032.LAQ""S8 !Z=J[VQ_9_P#"MIXZ
M\6V\7@S4=;N;'P7:>(8_!4VI.+JQOI9E5[22:/#,54[L$9 89YI5,=3ISE!I
MZ>GEY^:U=EYBCAISBI+K_P '_(^3-H]!1M'H*^G]0_9_\(MX\\/+J.G:GX1M
M5\,7_B;Q-X36^%Q>:<EMDI$DC#<IF78P#\J"?:N7MM/^'GQ(\">(/%VE^"6\
M)3>#;BQNM0TNWU.:YM]3TV:<1."SG>DZD]5.#Z"FL;"5G&+:T[=79=>K[777
M8'AY+1M?\-J>$;1Z"C:/05]$>+?@9X<\!ZM\9-3OHYKKPOH>FV\_AAFF91/-
M?E6LLMP7V1[R1WV'.:W&^#_@/PSJVMW=]X>FUG3]*^&FG^*?[/;4)81->RM&
M)"9%^8*=Y^4<"E]>IVNDWM^-O/S0?5IWL]/Z?^1\M[1Z"C:/05]2?#OX(^ ?
MBGK'PN\2:;I5_I/ASQ!KUSH&L>'[B_:?RYX[=IE>"? ?RV &0W((ZU4TOX5^
M'?$'QJ\ ^&;_ .'5OX6TK4M2N+>X%CXG.HO>QK&Q"G:Y,6" <\9SCM1]>IW:
ML]$V]NE_/7;I</JT[7OOZ^7EYGS-M'H*-H]!7TGX]^#WA+3_  1I&O:YX7OO
MA'J$_B6#2CIMUJ377VS3FQY]XBRC>OE@_>'R\8ZTOQZ^%'A[POX1UF^T/P+Y
M&BV5W'#HOC+0-<&IVM]"6P3?C>?*D88*[54!CC%$<=3DXI)ZNW3_ #U^5QO#
M3BFWT]?\OSL?->T>@HVCT%+17I'()M'H*-H]!2T4 )M'H*-H]!2T4 )M'H*-
MH]!2T4 )M'H*-H]!2T4 )M'H*-H]!2T4 )M'H*-H]!2T4 )M'H*-H]!2T4 )
MM'H*-H]!2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!K>$/%
M6H^!?%>D>(M(E6'5-+NDN[9W7<H=3D!AW!Z$>A-=WXP^-6F:_HFNV>B_#KP_
MX4OM>D634M2LY)KB5@'WE(!*2+=6?YCLY[9Q116$J,)R4Y+5?U\_F:1J2BG%
M;&_;_M1RKK-IXINO F@W_P 1+6V6WB\63RS[RZQ[$N7MPWEM.J@8<]QG%<4O
MQDUZUT+P/963"RO_  CJ%YJ=IJT<C&>::XE21S(#QP4_X$&.:**SCA:,=H_U
MJONU>FQ3K5'N_P"OZ1O_ !%_:-U?XE:EX\O;[1;"TE\86FG6ETMO(^VW%HRL
MK1@_WMO(/3/%:VF_M;>*+;5/AMJ.H:;9ZS?>!XKN""XNII ]^D\8C_?L/XE1
M0 PY.!FBBE]3H.*ARZ+_ "Y?RT'[>I?FOK_P;_F<Y#\:+'PSXM\/^)? G@72
M? >KZ3.\S26=[<W:7BLNTQRK,Q^0@L#MQG<?:F^+/C#I>L>%]4T/P]\/M!\'
MQ:M<1W&H75K++=3R%"66.)IB?(CW')5.O3..***OZO3NG;;S?KKKK;I?87M9
MV:_1&!XJ^(UWXL\">"_"T]E!;VWA>*ZB@N8W8O.)Y?,8N#P,'@8[5TOC3X_:
MGXV?XBM<Z/9VO_";/ISW7DRN?LOV,*$\O/7=M&<].U%%/V%/33;]6G^:3%[2
M>NO]6M^1KZA^UEXTU2_^'NI74=E<:OX.BFMTO)E9_P"THI5".ERG1LQC82#E
MLY/-8OB;XU6E]X-U7PSX6\$:5X(T[69XI]4:QN9[F2Y$;;TB4RD^7$'^;8O<
M#GBBBH6%HQM:-K?YW_/5=NA3K5'>[_K8YOX7_$*Z^%OC&'Q%9V4&H3Q6US:B
M"X9E0B>%X6.1SD!R1[BKGPS^*#_#[2];T2]T.Q\5>&-:CB2^T?47>-2\9S'-
M'(A#1RKDX8=B1116LZ,*E^9;V_#;[B(SE&UF=%>?M%:O;^)?!&H>'=$TSPOI
M?@UWDTG1;7S)8-TAS,\SN=TCR#Y68D<=,57\6?&RSU7P7J_ACPWX&TGP7I^M
M7D5[JDEC<SW$MR\9+)&ID/[N,,Q.P#KWHHK/ZK233MMZ][Z]]==>I7MIZZ_U
ML<U\+_B)=?"WQ8->LK.&_G^Q75EY-PQ5=L\+1,V1SD!R1]*O_#?XJ'P'X?US
MPYJ/A_3_ !;X7UHPR7>EZA))"5FBSY<T4L9#1N,D=P0:**N5&G._,M[?AJON
M)C.4;6?],;\3?BI<?$:/0;&+1['PYX>T"V>UTO1]/+O';J[;Y&9W)9W9N2Q]
M*HZ'\0KK0OASXK\'QV4$UIXAN+*XFNG9A)";9G90H'!#;SG/3'%%%-48*"@E
MHM?G>_YZASROS7U_I'4Z!\<K6'P;H/AKQ5X%T?QO9^'Y)&TF>^N9[::W1VWM
M"YB8>;%NYVMTZ58L_P!I+79O%GC/5_$6DZ;XGL/%\$=MJVCW.^" Q1D&!8FC
M.Z/R]H"X)X'.:**S^JT=7R[^O>^G;773J5[:>FO]?K\R>W_:2O-)\:>!]8T;
MPMI>D:-X-2X32_#\$TK19G#":229B7=V+9)_V0*XW5OB7=Z[\,=$\&:A807(
MT2]FN=/U9I&^TPQ2\R6WH8RWSCT-%%..'I1::6J_X/\ F_O!U9M6;_K3_)">
M!/B5=^ M#\9Z9;6,%W'XHTK^R9Y)G96@3>'WH!U.1T/%7M#^,VM>&? >B^&M
M*CCLI-(\1?\ "2VVJ1R-YPG$:H$*_=V_*#[Y(HHJI4:<FVUOK^A*J26S-Z']
MH!&\0^-Y[WP3H][X;\82QW6I>&S/-' ERA++/!*N'C;<SM@<?.1TJ+5/C\VK
M>*M#OIO!7AV7PWHNE-HMGX7G226U2U8DM^\8^9YI8[O-!!!_&BBL_JM'>WXO
MM;[[:7W*]M/O_7]=#%^('Q4A\7>#=(\(:-X9L_"7AC3+J:^CLK:ZFNGDN)5"
M-(\DI)^ZH 4 "KNJ?'+4M4^+7A?Q^VE6D5_H":>D-FLC&*7[(JJA9NHW;1G'
M2BBJ6'I)6MW_ !W^\7M)WO?M^&Q/JWQDT.;Q;HWB;0OAIH_AC6]/UE-9EN;7
M4;J?[6ZR>88W61B%4OSE1FK_ (L_:(76-(\46?AWP)H?@RX\4,W]LZE8SW%S
M=W2-)YCQAY6(C1FY95'/2BBI^JTM+J]O-_YE>VJ:J^_DCF/!7Q>UCP#X$\7^
M&=)4V_\ PD;6C2:E!<R0W%MY#EP(RA'#;B#D]*I^$_B-?^%=)\:V2PK?MXJT
MS^S+JYN)G\V)?-24R _Q-E .3WHHK3V--W=M]7\K?Y(CVDM-=CJH/VC=>@\8
M>&/%9TZPN?$&DZ8='OKJZW2)K=KL,82Z3C)\L["P.2 ">153Q5\9K;4O!-]X
M3\+>#-+\#Z-J5S'=:FMC<S7,UZT9)CC:24DK$A.0@[XHHJ/JM%--1V_I?=T[
M="O;3LU<C\;_ !UUOQY\*_#'@:_M+6.VT,C.I1D_:+U41D@6;L?*1RJ^U=#9
M?M-7*ZS=W>J>$-,UJQO/"EKX1N=-FNYHHY;: J1)O3#!VV#('%%%+ZK1MR\N
MG^>H_;5+WN)8_M/:EHGB[P7J6B>%]'T+0?"=Q+=V'ANQ>46\DTBE7EFD8L\D
MA!QN/88QUK.T[XW:+X9\?>'?%OA;X::-X9U#2+J6[DCM]1NIUO2Z%=K^8QV@
M%B?E]:**/JM'MY;O7??77=[A[:??\OZZ&)'\7+Q_ ND>&K[2;+51HVLG5]-O
M;XM(]NKD-+:E3P\#L Q4GKGUK:\0_'*RO/"GB;1/#?@+1_!@\3M$VL3Z?=3R
MB58Y/,6.*)SLA3> <#)[ XHHJOJ])N]NM^OK^>OJ+VL[6N>54445TF(4444
?%%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>formdrs_14.jpg
<TEXT>
begin 644 formdrs_14.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 07 @$# 2(  A$! Q$!_\0
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MU2U2ZA2088*PR,^]?FS_ ,%!M6/[2WC;Q)I.G7)N/!?PQ\,-K=Y)"04EU"X
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M>G)Y=CIUM':PK_L(H4?CQ5^WMXK>WBABC6**-0B(HP%4#  ]L5+TH *6BB@
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M@!]%,\L_WVH\L_WVH ?13/+/]]J/+/\ ?:@!]%,\L_WVH\L_WVH ?13/+/\
M?:CRS_?:@!]%,\L_WVH\L_WVH ?13/+/]]J/+/\ ?:@!]%,\L_WVH\L_WVH
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MM5:* +7]IS>BT?VG-Z+56B@"U_:<WHM']IS>BU5HH M?VG-Z+1_:<WHM5:*
M+7]IS>BT?VG-Z+56B@"U_:<WHM']IS>BU5HH M?VG-Z+1_:<WHM5:* +7]IS
M>BT?VG-Z+56B@"U_:<WHM']IS>BU5HH M?VG-Z+1_:<WHM5,BEH M?VG-Z+1
M_:<WHM5:* +7]IS>BT?VG-Z+56B@"U_:<WHM']IS>BU5HH M?VG-Z+1_:<WH
MM5:* +7]IS>BT?VG-Z+56B@"U_:<WHM']IS>BU5HH M?VG-Z+1_:<WHM5:*
M+7]IS>BT?VG-Z+56B@"U_:<WHM']IS>BU5HH M?VG-Z+1_:<WHM5:* +7]IS
M>BT?VG-Z+56B@"U_:<WHM']IS>BU5HH M?VG-Z+1_:<WHM5:* +7]IS>BT?V
ME-C)"FJM% %^'5-QQ(FWWJ^C!E!%8/X5I:7(7A*D]* +U%%% !1110 4444
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ME9V^I709BC.$SAB!Q2ZEX'\/Z#?WVHZ>%TR_DTZ:,V<#!4N%VGYC'[>M<-X
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MT5VV^YMK*7;'(>Y [$^U=_2T 9VA:%:^'=)@TVR5EMX5P-S%F/J23U-:-%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5_2_NO6?@LP
M4#)/05KV-N8(>?O'K0!:HI!2T %%%% !15;SIO\ GV/_ 'V*/.F_Y]C_ -]B
M@"S44D$<WWU!J/SIO^?8_P#?8H\Z;_GV/_?8H 3[!!_<H^P0?W*7SIO^?8_]
M]BCSIO\ GV/_ 'V* $^P0?W*/L$']RE\Z;_GV/\ WV*/.F_Y]C_WV* $^P0?
MW*/L$']RE\Z;_GV/_?8H\Z;_ )]C_P!]B@!/L$']RC[!!_<I?.F_Y]C_ -]B
MCSIO^?8_]]B@!/L$']RC[!!_<I?.F_Y]C_WV*/.F_P"?8_\ ?8H 3[!!_<H^
MP0?W*7SIO^?8_P#?8H\Z;_GV/_?8H 3[!!_<H^P0?W*7SIO^?8_]]BCSIO\
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M:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI-P]:,T +129'K1D4 +129'K1D4
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M9V*3U..AJG_;'BW_ * %G_X%5?T_)O(_\]JVL5Y^(Z&$MSE/[7\7?] &S_\
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M?37PAF\N)I#P%R>GK5*/NMW-%%V;N>I4445F9A1110!9T[_C]B^M;-8VG?\
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M&@=PV_,3M&3U;'-#*IP&4/SD;AFHA?VYO#:^:GV@)YAB!^;;ZX]*E\P*I+<
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MPEN%&1N&>F>:*3OG%<AF?/&N>+M2TWQOXGU'QA=>*=#T:SOXDTJ[TN/-BT&
M"' YW%NI85#HWCJ;XHW7B36K_7/$6B:;I][+965GH\)40QQ@$RRD?>=LYP>
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M0Y='TY+-YS<2.Y;(Z)G^%?0"NZBC\N-5_N@"L_3+$P_O7^\>@]*TZ0"4444
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MC(S,<DD]ZF@7RU##IVS4$,)D8#H,9)J2:3Y25^Z,**WV(\V7UC:\9(TR2W/
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ME'J?ANW,MQ9@\/\ :&)*@CL%!ZUTT[,P<G'0[S0_ACX>^"/@FUT6SGGM88(
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M6V7L#AO][K7["=S774E=(\6IK9BT445D9!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !4-Y=QV-I-<3,%CC4LS'L!UJ:N%^+.I-;Z-%91G
M!NG^?UVCK6=27+&YK2C[2:1YEXF^(EKXDU(R2W\208+11E\!4!QD_C6?)J=C
M'&LK7<"QGD/Y@PW../6N2OOA1I=Q&Q@EFLI'5DDDC/+@MNYK&O/AWX=MKB'2
MKC6;B&[V)-")'Z*K -@?[1QFO&D_::GTD$Z:M8]"DUG3X;EX);Z!)45696<9
M ;H?Q[5(FI6<^[R[R"4J2#M<'&.N?3BN0NO#WAW4+Z"=M4A*[H4,:LI\QHN0
M,_GQ61_PAN@JQ,?B5[>60F*.164!D964K[D!CDU/*A\[Z'>V/C#35DBNK348
MED6<1*T;\JV<8->]^ _%\/B_1UGCFCEEC^60QMD$^M?)FF_"W0YO,LHM:ENC
M" /+B=0R ,#\V.O(Z^]>L_!.PC\#:A;:9%+)/!<91G?@EL<$UU4:G)-(XL13
M]I!R/?PW%9/BK0(?%'AZ^TR8?+<1D*W]UNQ^N<5K8H[5ZC]Y'AQ?*</\*O$4
MVH:1+I.H?)J^DO\ 9IE;JP'"M^587QMO#:R:4H;Y?F)]^E7_ !]H][X=UF#Q
MEHL9EE@'EZA;*/\ 70]SCU%<9\:-;@\06NEWVGLMU:30$KDX*'T/O11=I<C+
MK13]Z)Q$T@N)2C#=N//M5_1=)NK>1DM+IH58Y\MAE<^H]#6!93//:12/\DBC
M! ]:ZW0=2OFD1 L4@]67FO32U.2YA?%3X<:CXH\.W,J*IO886.Z3!5U"Y))^
ME>7>&?V3/A5XV\(>'?$^L^'HI-5)\EW1RB2D\ N!U.:^L=-66\!BF$:1.I1A
MC.[(P<U\[^./%T/PWM3X60;+K[43!".PW;EP/2G/E@G)CA>4U%%'XB>"],/B
M#PYX"T6U2WTC08]S0I]T2N<G]*ZSXTZC'X5\ :!X?B9B^H2;/^ (,_SJI\*]
M+N-8UZXUG46,MY.V^5FY_"I/VCHA+;^%VPOG":61<GD+C&:^?CS59N43Z"5J
M,%%G??LSZQY9-G,P!DC^4=B1VKZ#X7WKXK^'/BY- U73.2'29)"O;!.W&:^T
M\B10PZ,-P_'FNF,9<NIYM=IST.#^*?Q&E\%6]O;V2+)J-UG:6Z1@=\5X%J6K
M3WNI^==S-<3 [B7/4GO73?'K59(?'C*RLPAA38OL>I%>87E_<3292%MO4R/P
M!70HG)S'96L]QJDPB@B)7H91P%J<6,'A>UDN-0\10VMMN+,+AMQS7&7FN'1]
M/AN+ZXE6UDD6%1#G&6.!TZUY1^T%XZT+1?.T".ZDNKZ.1995C!8=,!![FM/A
M1G=D'QF^/$3:KI_@KP_=R3V=Q<"2:\BROF@G[@]%KU_P.EIX=LH4N$^\H*D=
MJ^:_A=\+[BX\0?\ "4:XO[]@!:6/:$>K^YKZ2\/Z!=ZU)\SYP.?05G&][L1[
M+I?]A>,-/-OB"23;S%,H(/%>(ZY\!?"5_P#%72+J&P:WFM[D2S0GF)U4YQCT
MR*['3?"MWI]TDD%SY3JV593Q79NUG<>*%GD95E:WVO(O8XZ_G6MN9W [S_A,
MTNK@VV6C484LO QC@5WO@NTBAMY98\GS""68]:\ TFXN(9)(KB#?YYS',O0G
MTKV[X:2,+6X@,C-Y84 -72GH3U.W3I3J1>.*6I*"BBB@ I#2T4 >5_M!2M#X
M1AV'!,ZC^=?DG_P4 U""\C\/Z;YBO>!I)V&>53@ U^J'[6GB!/"OPHNM4>-I
M5MY-^Q.I.#P*_,K7OV3OB)\1O$L?C/Q$(Y9[BZC/]EJP9!:D@JJG/7'45YCP
M\JF)YULCUZ=6V&]FNIX ZC_A =& 0HJ18"D=1ZU])_L0^(H[S3]6T,70MKF&
M4RJO^\.#^=<Y^V!X-C\&^)+2SM;6.UM5M$5(X5PHQVKYT\%_$+5/A5XTLO$%
MAO*1/LGBSQ)'W'U%7.G?FB=7M'3Y6?HI:ZY>R>.+VPU;3XEEM\&.ZDFVK.AZ
M;3Z^U:>J>,+W1=033K#24N;J=OE6UER(Q_>)JK\+?&FB?%S0;75[(P7N\9*M
M@O&WH1ZBO0-06UT6)IY(X8I .9!@$UY[2C=,]93YXKE,[5IIK[15GOI1&J1D
MR>@P.:^!/C%\0)?%VEWB17=F=)M=7,-O H_?OA>7)_NU])?'[XI.O@W4=.TA
M\221.'F3L,5^>)G6*X\O.2IY)[UT897NSSL5-I*+/K[_ ()\S1P_M'>&Y ,;
MRX_'&*_8[[K,*_%O_@G_ ''G?M%>%U7!Q,3Q]*_:0_ZQOK77)W/)JKE22[!1
M114'.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !KS'XO;
MOMFFG&1Y;?SKTXUQ7Q2TE[_1([J,$O:ON(]5/7\JYZRO#0ZL,^6HKGD<TR0P
MM([[449)/I7)^(+'PUX@FDGO+Z,L]O\ 9<QN-P7>&.WN#G%=5<0)>6\L$J[H
MI$*G'H:\^U3POX0\+PW!DN)K::)5D+1N6=!GL/?//TKQHZ'T<G<SW\#^$1Y=
MN?$4P*L3M5D&02#G.. /7WK5E\/^#VF3?J$9.Q[9(PZ\9!#$#L<$\U#]G\$6
MMS;V7F*RW,,D22,V5V@>8P)]<+5?1-+\"-!/<6]UP&D4^<V&4/E2.?7)Q6IA
MI<T/"^@V/@G6[N>ZUJ.1/LXAMX9,#RXL@Y)[GZ^M>G>%9!<:]IK0G<K2J4/J
M/7\J\W_X1KPOXCOC;I>-<.J)NMU?*DJN%;W(%>Q_#/1_MGB"*8KB"S4'\>BT
M13<U851J,&>R'.>*.M'3@]:*]P^;>HUHP=P8 JPP01U'<5\M^/-0T;3=:U&/
M1VN)8#(<6I3Y(Y/XL>U?3U_N^PW.S_6>4VWZX.*^85:6Z682VBQMYC*SL/?D
MFMJ<%)\Q#DXJQQ>FZT/M_ELS,DO'(P%;VKK]%U,P3 ;]ISS7&>*)+2WDD>.=
M5;J B\YI-"\2)JUOO3<LD1V.&&"3ZUVHQ/H+0;PW6TYXZY%>6?$?X2V7B3XO
M/KXN'^U?9DB"-\T8/?CL:W/!OB5I&\LG:VX+D>M7=#NC/XFU5IG!8R\>A4#M
M[BJG%3CR@I.$E)#]&TE=!B:,KL=\* .]>"?M!>(YY/'6F+=#[/;Q*]K%&3Z<
MEOJ:^KM/TV+6+JV=Q\MNV_*]#[5\U>/?AM??M#3>*V\.&/\ MK3+XRV22-A9
M IVN@/X<5R4<.J"9U5\1[:R1Q_@EFU?QIH.CVP8M=WD8D53DX!S^5?HJ%VJ%
M]!M_+BOE/]E3]G+7_"6N#Q3XPB%C>VZ>7:V6[<0QX+L:^K>YZ_CUK&HUT,HW
MW//_ (H?"2U^(7DW<4PLM5MUVQSL"T;K_=<#M[UXI>? OXB1W4L4&E:!+#_!
M-YSD?D37U7^%&*GF8^5'SAX'_9GU[[!=1>+]6@NC<R"3;:K@6X'0(/ZUE_'S
MX(^$/AY\)YY='TF-;ZXOXY+K4+@>;<3$<_>/3\*^H^F>.>M?*_[7D^N:EXF\
M/P:==O%I.F'S]0LU7/G(PQNQZBFFVQ-6/,O#3::UNA53'/W$E>PS^&Y=/TRV
MN=/DWV<B@F2,9P<<YKR6VTU;B)7B3>&&05KH?#^I^*/#O_(/+2V_4V\GS*?P
MK<R/0O#,*R2-'<$F3.1@US7B*-[.:XFPZG>VQL\<=JZKPSXQTWQ,6@NK)=*U
MD(0G9')_D:Z?Q5X+2X\.&U5&,VSRRX&[C^]]:T2T \P^'>K7$-Q#%<.SQ,_F
MA6YV,?2OISP"R317++C<<9Q7S5:^%+S1I+?[02K^:J^8/ND9ZU]#?#3[='<:
ME#>6L<:KM\JXC/$BX[CUJX[".^7I2TB]/6EI#"BBB@ HHI#0!XW^T]LD^'Z6
MDT:2P75P(7CD&0P(/%>):5\0-'\,:9#8RPRPQ0*%!9MPX'J:]Q_::LVU#P#"
MBML"W4<C-C[H4Y)K\^OB5XD3QA)>VMI))%))NC1%;[@ X.?>G2<G)I+0W4G&
M*:/,/VO?C5H?Q'\7&#2?GM]/3RGDZEGSSCV%?+U])$RD']['FJ7BBUNM#U"6
MWG62*9)6+[\AL[NIJ'05NM4F:"&W\Y1R3TQS6#CJY=3M]MS))GO/[*&GZFVJ
MW\>EW<UNA/F;8V(_2OJ!M+O+Z9QJVHW$J1 EDW?I7FO[./@>;P%H,NIS#_2K
MM?E7V[5O_'C5KZ'P;!IFF2^7J^J/\\F=IC3JQS7C5E*4]$>]AVJ=-:G'?%[Q
M)HZZ?<6=O<PH-I#!&R5XZ'W-?'5]:-)>2O"ZLF[@]*ZWQA9+9;;&&Z,I'S2O
MNW%C[U>^%_@6/Q)JQO-1#1:7:\X(/[QNPKTL/0Y58\C%XA29]0?\$R?AS=7_
M ,7+77G&+>QR<D]217Z[_P 1K\S?V3K&+P?\5/#+V=S)8?;+CRS:J2(W0CH0
M>]?IG_$WUK:O3]FD><ZGM-0HHHKF)$)/:HOM<7G&(2H95&XIGG'KBO-OV@/B
M%>_#OP;%=:=(L-Y<3B-)'7(48R1^E?.OPG\9?\)-XV@EUCQ%?6IO9E>>2$-F
MZF)^6(L.$11CCO2OK8^EP>1UL5A)XQNT$?:L=Q'(K,KJP7J01@?6CSTV!]Z>
M7_>W#'YUSWB3PW:WND^0]TVG6 D$UUY;;?-4=06SP*\GT"P_MKQTNF1F=/!E
MTTD]M;O(P$S1J S#G.S)Z=\4SS*.&C5C*2E:Q[X&!P1RO6F/.D6-[JG^\0*\
MAT77]6TOQ'J?A#1)(R8KDM!/>9=8(2H8C'5L$X KDM6O-9U#XI26.MV+:P\"
MJ@MK.78D@*YWX8C:?:F=%'+)56XM[*Y]&A\C(Y&,\4ZO/_@UJ$UUX?OK6X5X
M+JUO)4-G,VY[5"<HA/?CH:] I'E5:?LIN 4FZE_BKS77OV@O"GAS6KW3+HWT
MES:2F&3R;9F7>!DKGUQS6]*C4K75-;'%5Q%.@DZKM<])YHS7 S_&[PK;WVGV
MLEU*!J$2S03",["&&0,^N.U0:;\>O"VJV^H2P276;*/S6C:W(:1,XW)ZC-;?
M4L1_*<JS#"7MSH]%R:.U>6ZS\;;"]T&UF\,^9=WU]&9(GDA)2! VUWD'&-IS
MQ5/P=\8+A?$&I:7KDQO+:$1F'4H[,PH6=<[6!)_ UHL!6<>:QA+-L+"?*Y?,
M]?S2;O:N"C^-7AJ:RNK@27*>0H<QM$=[J3M!7UYKJ?#/B6R\6:3'J-@[/;N2
M!O7:01V(KFG0J4US26AU4<?AL1-0IR39JT445SG?OJ'XTR:%;B%XI%#HPP0>
MXI]+2M=#3:=T>(^,/"5QX=OG9%WV<AS'(!D+[&N U'P=I^J75Q/,9!]H $L(
M;Y6QT-?4]Q:QW431RHLD;#!5AFN'UCX4VMV[2V$[6K'K&PW#/]*\ZIAY+6)[
M%'&1^"IN?/\ /\*?#]U<-.T,WF,78%9.A=2"<?0TU?A5H*V4]L8YI//F2X:1
MGRV]26!_6O9)/A7JZL<36[ ]\G_"KVG?"2=Y U]>*H!SL@&2:P5.H]T=4J]*
M.MSROPS\/[--2M8]*M6,\18J!_M#!W>U?0_A7PW%X=TM+=<-,W,C'N:J*_AW
MP##!%-/!8M.VU'F;#.>_-;]M=0W47FP2I-&>CHP85V4:2AJWJ>7B,1*II%:$
MU%%'8_I7:<!S_CG5O[$\,W-WNV %5)]C7SQXD6XU3<]O<".W/W0O<FO7OB)J
MRZA-)8=8H>J^IKQ:XWPZA)$,Q(P/EJWK7726AG(YEO#:6GSS3*['AF]*YC5+
M^W\.W EL]TTA.''8K_C797FE7-U(PW$]_:LR3P^L,F^>,,<?>QTKH,PTOQ)]
MGN+:_M6WQ1@R%1[#)!]ZZKX;ZR^K7-VFXE;XF]LY,=#G#1_7%>3V>G7T-]=/
M;[EB)(*,/E;/I7T!\ _A[?Z;8P:AJ2B.%26AMEYQ[YK6$>9W9G(]4L=/?3?#
MDBGY+B2"23/H0AP*\/\ V.S(=6U?S>9=TGF'U;<>:^B+J#[='<)NVAXFC7CN
M017@O[+-G+HWCKQ;I5Q@S6LK X[C/!JJR7(PCN?3OH>II*6DKQ3L"BBCMTR:
M *.MZO;Z#ILU]=-B*(9QW/M7S9KVH7/B#6;C5)"OG2-G:>5V]E(],4_]L[X^
M:1\*;'1K*>[AO+J:0M)I<$H^TX[-M]![U\W:#^V5X3O)4BN;+4[1F.T*(Q(V
M?HN2:TBTA.$Y*Z6A]/:#HVA3 YB^QRCEH?X<^U=MIN@Z>8Q]E\OS%&2N:\%T
M3XCZ3KA#Z;J<%T<!VAWA94'^TAY!KJ6U:.^M\QW4EC>=4?)"D^E;*2L9<K70
MZWQ-I=M_PD6CJUJL4DER@+J, \]Z[;4KNXN[A[:VF:"14W;QC\*\%F^(&HC4
M=+L=9B-PL5TCQW4?48/?U%>OW&K6NH3"_MFWED 8*>0!TXJZ<EJ28NL^.-4\
M/1NNK6$=[;=&94P<9ZUZQ\)?%5KXHLYI+-6^S[4='8Y!SVS[5Y'K^HB]A9)0
MLB\YR*Z7]F&W-E+XC@C8_8_,5XX^RD]0*JX'O2]*6D%+3 **** "D;I2T4 >
M"_ME7EU:_!RZ6TD\J>655#;MO'/?M7YN6EB;C4(4D,MG>/S*QY!'<GZU^AG[
M<DQB^%>G#S&2-]2C#B/JP.>W>OC,-9S6$DP,<LMP=B+(OSJH]C_0UUT?A(D?
M/?QF^&5YX^OYM1TM4N)84V[8P,LH[XKBOA)X0N]/\416UYI\Z1L^9-T>1Q_2
MOJK_ (1FVM-)GN8_,MKBX_=Q["2 OK@X:JFAZ#<Z+:W5XAANPH\N'<?F8_0\
MTW23=S15&D7[75;>2&3R9DBAC"QHB-W] IQ_.N)^,6EW6O7UE%9PX6*+YI@Q
M##^]E3G%;6F:/=7EYF]T[:L),KLH/+'MBJ$ELFK:F%DAFMS.^P 'E8UZG&*'
M2C+H4JU3N<7X)_9]LDT^?6-9F=Y)2?+A4#!';)SW^E=YH7PW&G26L$$D:)'^
M]>$J0 .PSTQ6CK5U'"]M:VU^R);KYC++T]AQFI+"36%T.XO99(OM$YQ&H(SC
ML!5QIQCL92J.1V_P8MS-\<O"<US-&B1W@2%=I.YL=B!BOTA;_6-VYK\Z?@?#
M*_Q7\"DV_F;;K,DP&.<'C':OT6_B->?BNAI3V"BBCCUK@-CQW]JCP3=>-/A3
M?+8QM)>6;"X2->K8Z@?A7S1\$?BAI7AOPK+:2O#9ZO8"22%;E!B9ST&>Y![5
M][21I(A5E#*1@@\@UY;/^S1X#N/%@U]M(7[8'\WR]V(]_7=M]:EK6Y][D^>X
M?#8"> Q<7RWNK=^P7\=]XZ^%>B-KSS65_>1QRW"VK^7\W7!S_#[51GL]-M--
MMI)]4U,74.'M9\*LD&1C8,+@@XZ<UZIJ6EB^T_[+$P@X 5@@.T#V-8-QX'FO
MO),^J22R0R;XRT*?+QTZ51\S'&1UC9I7.-CT_P .K:PM%=:C;ZC%*TCW\7,S
M,0-Q.1@@C'&*J?\ "(Z%:ZQ_:UOJ^K+J+X:6]CPQR1_%D8%>A?\ "'W/EN/[
M7DW,^]9!"FX?I35\(WD8VIK3HO)($"8/UXIE1Q[C?EO^ SX<V=E:Z;>S6?VB
M:2:X9I[BZ.9)G QN)],<5UM4-%T]]+L1!)/]H8$DR>6%SGV%7_J>:1Y=6HZD
MW(IZQJ2:/I\MW(-RQC./Y5X0/#.F:IXBGOKQ9E%Y?->2K&PR'=/+/X8KWC5+
M&/5+.:UD_P!7(NW-<?I_PV>#4%DN+I7MT;("CYCSGFNS#UY44^1V9YV(P]/$
M:5%<PE_9R\,BZL;E;J_VVJH%C\Q<-M& >G!P>U4O%'P9\.:/I"N9;UI%MQ9Q
M%9 O&[?N/'/->RCC&!C' K+\0:+%KUB;>1BC [E?J<UNLRQ/-\9R+*\):_(C
MY_M_ :?V?;V.F7%Q%=HK1(R2 >:K/O*/D8ZUW/A/X5SS7%P=52ZLK#>LJVTL
MRR23S!<&1V Z#/ Z5U'A_P !G3;Y;F[G67RSE%0<?C79[AUP >O%7+,*MK)G
M-+),+.7,XZ=CSW2_@/H8MYX'N+RYWJJ"21QF- V[8M=IX=\&V?@S1Q8V#2&W
M5RX61LD9.<5HP3>0P('%37-YYJ;4& >M<TL34J0Y9,[*&7X?"S4Z,+,K9SS7
M.^,/%1\.PQ)%&'N)ONAN@'K715A>*O#*>(H(\2>3/'G:W;'O7)&U]3TW<S/"
M/C2;6;IK.ZC7S2-R2)W]B*["N4\*^#/["NFNKB99+C;M7:#A175_P^E$[=!*
MYROC#Q<^@RI;VR*UPR[F9^50=N*?X/\ %DGB RPW,86X09!3H1_C3O%GA(>(
M6CFBF$%P@VY894CWI_A/PHOAQ999)%EGD&T[1P![5?N\H.]SH6Q[UQWBWQK+
MI%XMG9HIE49=W&<?2NSKD_%/@O\ MNY-S;SK#,1A@V=IJ(6ZA+8X;Q2\_CBX
M\.7"V*7$]M=-#-&R[H]K*<,?3FKWPC^R:9K&H:;<Q2:9K<8*O9F0^2ZY^_&#
MZBN[\+^&U\.VLB^9YTTI!=@,"J'C;P+#XJ2.ZMY6L-9MOFMKV/@@^C>JUA4A
M:7-$Z*<_=Y&9OB#Q_<V.IRVUI&@CB.TF0$EC74>&]:&O::ET%V.#M=?>O(;.
M6>_UYM+UYTTC62<%YLB&X']]&]3Z5Z@S67@#PG=W5Q-Y=M:1-/-,W0X':NA.
M,TK;F,HN+\CRCX@74^G^+KL*PPS DD\ 8KC=2\5:!?L$N782QYQ+%V-8GQ+^
M/_P\TG3XM1UO7F:2[==MK:)YEPV>^T= ,_E7-ZQ\5_!NCZ?'<Z+X7UCQ4DPR
MDD$052?Q->E"G*VQRRJ11W^G>)]"C;:+F2X)X/[K%:UY?:%>V9: --<XVK#L
M.6/Y5\QW7[8VM:+?2V[?#V_TJR7[KK:K(X^M<VW[=FI2:ABWT.\DP3Q.JQ'/
MX9XKKAAYRV,)5HQ/MOP[X%LK6SMY=1$-O+,WF&.1@.>PS7HT:20VJ*D]O'$N
M-JJX.!7Y:Z[^UWK/Q#\0PQ:G8WFGF'++'#)A=O0'GKS7<:+\=/$.FZ0VH:==
MW#_/L$<DP./SKOAA';<XYXN-[6/THCO%DC41D,2.2:^?_P!G*>1?C=X]M;H8
MN#(SGUV[N*X/X:_M0>,[V&);W15U&W(P?,B:-^G4-C!%>C?LS?;O$7Q%\8^)
M=1M;?3YI@J101R[F*GN:XL33<(/L=5"I&;T/I4TE'Z45\Z>F+SD#&<U\>?&S
M]M"+P?\ $S4/#MA<"WATF01S-Q\\G4U]7>)O%6F^"-#N]<UBY6TTZS7?)(1G
M/L!W)Z"OS#N/@MX=^(7Q$UWQ5J2W-]_:=[)<JDQ*A%8_*" ?2JBB3%\1?#GX
M=?%WQ=J?BF_\7WLNKZC(99%NKH,B$_PH.P%<IJ7[.MQX1U2'5] U"2\ABW$;
M'$O4<-QR/RKW]OV9? ]_ L(T6.(J,&2-F&/IBO/_ !=^S/=^#5>]\.ZSJ-A&
M@W!%G8I[YYXXJG3OJ;1K3BK'SSX=^&OBGP_=7>HRO/<:@[,QN+:<F0\DY/>O
M1?A[\4_'EOK;:=-K1^Q6\#7$\>H1;SL3J!T.:[#3'\8:6L1D2U\26VW=Y5Q'
MY<V/9Q]ZNAC\+^&/B)ILUU:FZT37+5&1[=@#*N1@@J1AA6+I._-%G5'$Q<.2
M<3DK/]H+4]4OA-9K#$RC/V2<_>]T;/'T->U_!/\ :B\.>)-:CTF]N&L=34[-
MDR[1GO[$>]>->-_V3O%^EZ(FJ^%$@UVXV*S6RN(')[_*>#^!'T->%^)+66QF
MMK+Q1INI>$=;@.$GFC,>3[/T-*,JE)^\KHOV.'Q'\*6I^KFO:6MY:?:+1U>-
MA]Z-LCZUUW[-=G-9W'B!93GYDQ^M?FG\'_VF/%OPT\-3C5==;5=$M[F.V%Q(
MP)4-G!?@\<=J^^OV*?BY:_%23Q3+:R6THM_*)>VEWJ<@UZ$91DKH\FI3E2GR
MR/J9?NBEI%^Z*6K("BBB@ HHHH ^<?VWM+FU;X::3!!&7/\ :L3'T& 3S[5\
M,ZS#_:WB#[*\)CBC.W>@X"CKQ_A7ZM^)?#5AXNT>XTS48!-;3+M([CW![&O'
MF_8Y\%;90DU^HE&&_> \>G3BMZ=115F)H_/G4-4NK[4%ATZZCDMT;R8X9#CG
M/)P?Z5IZYK\VG>58M:!XX8]\A7(.3T'H*^X(?V%OAY;W:W$+:A$RJ0%648^O
M3K42_L)^ 1=-<?:M4WLX<CSA@X[=*U]K$GE/C%_$%OI6@Q0RI+#=7A^8\,1G
MG';M5GPWK&F2-<7LERJV\(V*)%8=!ZD$9_&OM"^_8E\$:A*LD]UJ+;1@#>./
MTH_X8A\ ?V:;+=?B$]=LF#_*CVL0Y3XCM='MO%6JQ321PLEP^2(MK (.@(#
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MHHH 2BEHH 3 I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4(P& <]Z /F#]G+P!H7[67[6GQ>UKXE:?_PD%OX==;/3=,NF)M[:,.R*H3T
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M_>5>A8#H?:M3]GO]BGQA\*?VDO$OC?Q%KT'B31M6TZ>VFNI7/VJXDEVEF*]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M3-+7/^-/&.G^!- N-6U.1EMX>-JC+.W91]:\7_X;'TC_ *%G4/\ O\E%@/HB
MBOGC_AL?2?\ H6M0_P"_T='_  V/I/\ T+6H?]_HZKE8'T/17SQ_PV/I/_0M
M:A_W^CH_X;'TG_H6M0_[_1T<K ^AZ*^=_P#ALC2O^A9O_P#O^E._X;&TG_H6
MK[_O^E'*P/H:BOGG_AL;2?\ H6M0_P"_R4O_  V)I7_0MW__ '_2ERL#Z%HK
MYZ'[8FDG_F6[_P#[_)1_PV)I/_0MW_\ W^2CE8'T+17SPW[8^DC_ )EK4/\
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M0_M9?^>9H_M9?^>9HL!?HJA_:R_\\S1_:R_\\S18"_15#^UE_P">9H_M9?\
MGF:+ 7Z*H?VLO_/,T?VLO_/,T6 OT50_M9?^>9H_M9?^>9HL!?HK/.JK_P \
MV-6K>X6X0E>*0$U%)2T %%%% !1110!XC^UB#_PKFW_Z^T_K7R%7U_\ M8_\
MDY@_Z^U_D:^0*TCL 4**,_A2_P 57J <GH:2GTW;3 "M+C_.*6G9XH 3;1BC
M?^=+Q4W 10%H;[PI#@M3J0#6IFTT]A29Z58#>132,L#3B*3%38!#13J3BC4
M6ES29%-IZ@.[T?C2+3@N:-0$W"EQQFEVXI:8##Q2TNW-)28!1QZ444(#;\"?
M\CSX?_Z_8O\ T(5^B%?GAX$_Y'GP_P#]?L7_ *$*_0^LY;@%8U[_ ,?3ULUC
MWO\ Q]/4H3*]%%%4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT/K*6X!6->_\?3ULUCWO_'T]2A,KT4451(4444 %%%% !1110 4444 %%%%
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MEQ#?++?^:%2 9QLQR3[^E9NC*_Q?@"QU/JOQ.8D^#^I(Q U'2I6P2-EV"#Z
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M=WO@\8J-?AMIVFV=KKOB-9KU]42:]G\E2$A7HBYZ ^_3CI7CQS5)VJ*Q]-/
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M6^@&_BG*OM6(GC/1"N3J,('U_K3U\::(O!U* ?C2L^PKFV%I=HK%7QEHK?\
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M]ISGP'!_U\K_ "KY:'R_2N:IN:1V';J3;N:GA1C-!^7FLS0-IZ4HIRKNI#0
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M *Q[W_CZ>MA>E9%[_P ?3UTHX65Z***HD**** "BBB@ HHHH **** "BBB@
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M][_Q]/6R,V5Z***HD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI&$D1?ID=C7SG_PH7QNK$?V2K =Q.O- '!_Q4[BN\_X43XW_ .@0O_?]:/\
MA1'C?_H$+_X$+2L*YP$G?BEBB"+\I-=__P *)\;_ /0(7_O^M*/@5XV'32%_
M[_K189PP-+GBNX_X47XW_P"@0O\ W_6E_P"%%^-_^@0O_?\ 6D!PNZC=7<_\
M*+\;_P#0(7_O^M+_ ,*+\;?] A?^_P"M '#49%=U_P *-\;_ /0(7_O^M)_P
MHOQM_P! A?\ O^M.P'"[J,UW?_"C/&W_ $"%_P"_ZT?\*+\;?] A?^_ZTK <
M(#Q3,\UWO_"B_&__ $"%_P"_ZTA^!?C?_H$+_P!_UHL!P>ZD-=Y_PHOQO_T"
M%_[_ *TA^!/CEO\ F$)_X$+0!P3-3:[S_A0_CG_H$+_W_6C_ (4/XY_Z!"_^
M!"T <"S5&S5Z ?@+XY_Z Z_^!"U&WP%\='_F#+_X$+2L!Y^33&)STKT$_ /Q
MU_T!E_\  A::WP#\=G_F#+_X$+3-+GGK,:9QNKT,_ 'QY_T!5_\  A*;_P ,
M_P#CS_H"K_X$)04F>>%L4W=^%>B?\,_^/.G]BK_X$)2?\,^^//\ H"K_ .!*
M4!S'+^!V/_"::%_U^1_^A"OONOE+X;_L]>)XO%EE>:S;QZ=96DBS$^8'9R#D
M  5]6+3,@W5CWA_TJ2MC;6;>6,CS%TYSVJD(I45/]AG[)Q1]AG_N4R2"BI_L
M,_\ <H^PS_W* (**G^PS_P!RC[#/_<H @HJ?[#/_ '*/L,_]R@""BI_L,_\
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M=1DM9=2#-:1P6[SM*% +$! ?6HOAO\?O!OQ8U.ZT_P .7EU<W5K'YLBSV4L
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M7P;\-K'QQYMQK&AWTD45LVFQF5Y6D.% 7US75^#X=)C\$Z/'I8C_ +#^P1"
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MVBC:*6B@!,#THP*6B@!,48I:* $HQ2T4 )2T44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 E+44TRPQEFZ54_M4?W#0!H
M450_M9?[GZT?VLO]S]:=A%^BJ']K+_<_6C^UE_N?K18"_15#^UE_N?K1_:R_
MW/UHL!?HJA_:R_W/UH_M9?[GZT6 OT50_M9?[GZT?VLO]S]:+ 7Z*H?VLO\
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MJ7^H ]ZS*U-2_P!2/K6930F)12T51(E%+10 E%+10 E%+10 E%+10 E%+10
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M)(/]='_O5N5AP_ZZ/_>%;=2RD+6->_\ 'T];&:Q[[_CZ>A R"BBBJ)"BDS2T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNQH6 E_S\C]X/,H_\^Y?<>L\^M%>2_VY\:/^A6T?_O\ FC^W/C/_ -"MH_\
MW_-/ZB_YX_>3_:2_Y]R^X]9;UI>E><>&-5^*=QXAL8M9\/:7;:6TF+B:&4ET
M7U%>MKIT..5(_&N*M3=!V;3]#OP]98B/,DUZF916J-.A]#^=+_9L/]T_G6-S
MK,FBM;^S8?[I_.C^S8?[I_.BX6,FBM;^S8?[I_.D_LZ'^Z?SHN%C*HK4^P0>
MA_.E&GPG^$_G1<+&516M_9L/]T_G1_9L/]T_G1<+&316M_9L/]T_G1_9L/\
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M?I4G6D;I1U)?F?%?Q:TF9OC1>:1X;TRWBU2X8%)AP<D9) Z ^]<UXR\)^*_
M-M%J6LZ7;V5Q.WDB_5MSD_3H#_M5Z=K&W_AKFQSSEEZ_[AZ5TG[9&W_A"]*7
M.,W9&?\ @-?J.'S"=.MA<+%)J45?N?DF(RVG6I8K%-V<9:'DFD_"CQ[K%G#J
MUCHMMYUQ'E+Y9 '*GOCH#[UO_ [19;;XW1Z9X@TFV_M:UADD:4#)W #!QTS[
MUT7@O]JK0/#?A73=+FTZ\DEM85B9D () K-^#_BZV\<?M)7NLVBO%;W5JY6.
M3[PPH'-3B*N/G2Q"KT^6"3L_R#"T<OIUL,Z,[S;5U^9]:+PHIU(O2EK\P/UT
M**** "BBB@ HHHH :S!<YKSBSN!>?':_\K]Y%:Z,L<S*<JCF0$*?0X%>BN"=
MV#MXZ^GO7D/A^U\8?#N?4K:V\+IX@-U=/<'5%O%C>4,<@,#SD#C\* /7U'>L
MSQ1;M>>'=5A5=SO:RJ%QG.4.!^=>;:'\7O%FO2WT-KX'S/8RF">.348U9&'L
M>WO1H?Q>\6>))+T6'@4SK9SF"207\>TN.H4]\4 =;\)=3BU+X<Z%)$VXQVXB
M=>ZNO!4^X-=B*\_^&'AW5=+FUK4-2LX]'&I7 ECTN&7S%A('S-GIEN^*] 7[
MHH 6BBB@ HHHH **** "O-?VA+>6Y^%.K^6F_P MX97&<?*LBEB?;%>E52U7
M3[?5K"ZL;N,2VUS&T4J'NI&#0!R'C#QY+HNG:59Z%;KJ6NZM&HL8F;$87:"9
M7/\ = Y]ZY&R_9ZFN&U"]U/Q;JD6IZF,WG]EL+>#<>NU1_/O63X/AN/AQ\2H
M-/\ %4X6PM;,V>C:I-]R6(MD*S= P&!7O$,L<T8>.1)$(X9""#^5 'D?AR+4
M?@=<:;H5_,FH^$KN7R+;41&$FMI6/"S8^\&/\5;%\INOCYI9A;<+71Y?.53]
MW<XVY^N*A^/&N:6O@/4=*>9;G5+H*+2Q@.Z624,"H '(Y'6M+X5^%=3L8KW7
M_$6T>(=6V&:)>1;1J,)$/H.OO0!WXI:0<"EH **** "BBB@ HHHH ***3F@!
M&<#K7/>,/ ^C>.K%+36+/[0L;;XY%8H\9]58<BLN'XDVSZ7XCNY5C@ETF::%
M86F ,OEC(/\ P*I(?B9I,.AZ1?ZC*;66_MTN1 BES&K#J<=![T <\/V<?"'&
MXZM(N>5;4I2#]>:]"T'P_8^&]-@T_3;6.SLX1A(HQ@#U/N:R=4^(N@:/+''=
M7X5GB6<%%+#RV. V1VJ73?'6B:K-=Q6]\I:UC\V0N"HV?W@3U'O0!T=%86@^
M,M*\222QV%P9)(QN*NA0D>HSU'O6[0 4444 %%%% !2;A2UB>+/$47A719M0
MF1I=C!$B0X+N3A5S]: -K<*6N1TCQ#KB:BL&NZ1':12QF1+JUE\R./ R5D]#
MCOTJ?3?B'H6JS3PV]]EH49R70J'5>K*3]X#VH U=>T&U\1Z/=Z9?*TEG=(8Y
M55L$J>V:;H.@V/AO2;?3-,MDM+.W4+'$@P !W]S[UFZ3\0M"UNX:&TO=SB(S
M@NA4,@ZL">H%+9^/M%OK>YN8;EC#;IYCNT; ;>FX>H^E '1*0HI=U<IXM\<6
M^BZ5>M:21S:C%8M?PPR9"M&#C-5--^(]O<Z]9Z1-"\=S-IZWK3*#Y:L1G;[#
M'>@#N**PM#\8:7XBFDBL9VE9!NR8R Z],J3U'TK<7I0 M%%% #=U-W"E:N8^
M(7BYO GA6\UA;5KTV^T^0K8+9('7\:J,7)J,=R)SC3BYRV1T^['_ -:DW9KS
MSQ/\6;;0O#VBZG!:R7K:I)&D<*M@JK8W,?9<\ULW'Q&T2SU>+3+BZ,5Y(54;
MD.S<>B[NF:T="HK-HYHXRC)_$3R^ /#\OB9-??2X&U=#Q=$?./QJQXG\'Z-X
MRM8[?6;&'4((VWHDHR ?6N7TWXM07VM:_I<]FUM<Z;O:#<W%TJ#+%?<'J*T7
M^*&D6.C:9>ZBS6C7T0E$:H7V#N20.![UKRXA23UNMC&-3"2C):6>Y3_X43X%
MS_R+EF3_ +G_ ->M'P_\+_"_A34A?Z3H]O8W84H)8A@[3UK&\0_$ZZM_$*:5
MHMG:W;_9DN_/N[@1)(C' 6,_Q&FZQ\5FT'Q%I%KJ5L+.UNK"2ZF4 R2)(K ;
M1MZC%;REC*D>5S;3\SFC' 4I<T8)->1Z4IXI=U<CJ7Q,\/:3865W/>[HKQ=\
M'DH79U'4X'.!WINI?%#P[I4=H\U]D7<+7$"QH7,B#J0!Z5P^RGV/3^L4OYCL
M*,UFZ'KEGXATV&_L)A/:S#*2"M 'FH:<=&;*2DKH?3=U**P?&GB-O"?AV[U1
M;5KQK< ^2AP7R<8'O2*-W<*7=7*6?CJWU"ZT-((]T6I)*S.S8,!1<LI'J#Q4
MNG_$#0]3O)K6VNS)<1(S[2A'F!?O;"1\WX4 =+3#UZ8/-<)IOQ*CU[2]-OK0
M)9K<:B+-X[M6RPR1\F/XCBJ=O\3KG4(=>N8C:VEM87D=I"UPK\Y;!+>Y[4 ;
M7B3X5^'O%>H_;KRVEBNR 'FM)FA:4#L^T_-^-;^B:'8^']-BL-.MH[6TB&$B
MC'3USZGWK-F\>:):ZLNF27H6[W",C82@<]%+= :DD\<:-%K0TE[HQWC-M 9"
M%9L?=#="?:@#=Z8_PIZ]*\\G^*$%YH=_>V31V4EG>QVKM?(P0AG R,=S6_<>
M/=#M-873)KW9=E@A^4[ QZ*6Z ^U '2T5R\_Q$T&VU4Z<]Z5NEG^SL-AVK(>
MBD]!FK/_  FVD+KG]E?:2UYO\LA4)56QG:6Z ^U &_12 YI: "BBB@!-P%-.
M"1ZT,#NXX->?:C\2+_2_[3O'TB)]*L+H6\LJW(\WD@;@N/<4 =IJ^BV.O6+V
MFHVD-Y:O]Z.9 RFN&D^!/AGS";>75+"-O^6-K?NB#V KI%\>Z&VJ76G?;#]J
MM1F<%#B(;=WS'H.*K1_$C1+RPO[BVN'E^R1&5HS&59U'=<CD>XH 7PS\-?#O
MA.;S]/T\?:\8-W<,99<?[S5U07 K@/!_CJ\\0:7IMW,;6(WB32B!8W5E"C*@
M9Z^Y]ZL:-\2K/_A%-*U36)!;W%[&S^5 A;@$@G'7% '=456L;V&_M8KFWE6:
M"50Z2*<@@U8H 6BBB@ HHHH **** "D]*6B@#S&+X4I+IGBI;RVM9M0U*YN)
M;68Y^0.,*"?:H8? 7B#0[>R>P2QO+AM(33+B.Y<A(RH^^IQR.>E>I;: N._-
M 'F]K\-;VQM9[=)H9E_L;^SHY&X)DY))XX7FIM2^'-SJL9MVECMX6T<:>SQD
MAED!!S[CBO0MM&T^M '!>!_!]_I.I"[U"SMK>2.W%NCPSM*SX[\XP/:N^I-M
M+0 M%%% !1110 5SWC7PV_BC0IK.*3R+@,LT$AZ"13D9]JZ&DVT <3#8>*O$
M'GVVKBSTNR-LT++:N9&G<C ;.!M ZXK&@\"Z_?2:<NH+8VT6DVDUO;O;N?W[
M.NT%AC@8YQ7IVW\*-I]: .#C\$7T;^&R!:E=.LY8)T;.&9E  XZC/6LK3? &
MN"VU*V8V^EV4UHT$=K',TJ&3.0XR,J/:O4=IHV_G0!Y3>>!?$VM?;)+Q+&WD
M?1VTV-8Y"V7S]XG' -;D'A'5;77],ND%K-:KI T^Y21CD,.01Z@FNZVT;: /
M/_!/A'6=$UIIIUAL-.6)D%G!*95=R>'7(^0 =J] 4;5I=M% "T444 ,/>N9^
M(/AVY\4>&YK"T:,3M)&P\T_+@,"1^0KI\4549.,E);F<X*I%QEL>-R?!_5&;
M4U:Y@D@4HFF1,3B!"X>0GWXQ^ J#Q!\,?%.M:RK/+;3V\>H174=P\Q4B-3]S
M8!C(]:]K*Y%)Y?3FNQ8VJG<\V664))(\OUCX5W6K^'=9@\^.VU22\FN]/NHS
MS%N&,'V(ZBLG7OAKXIO=+T^QBFMIH%TW[))&9C&(Y>\@P/F!]*]FHVX_PJ8X
MNK%W1<LOHRCRGD.K> =?_LG3]/&FZ3K=O%9K!MN9#&\$H&"RMC)4]<5;TGX9
MZK9:QH5U<W$-V+'2YK.21V)?S'.1CV XSUKU,*:-I]:7UJH']GT3QC2?AIXE
M\,0:3=626%_>V]O-:36\SE4"NY8,C8X]QWK/;P;KGAOQ1X5M]/AM[Z\M;"Z+
M^;E8=SMD@-VZ_I7NY4]::(0&W=ZM8N?4F674GL<U\/O#=UX9\.I;7KQ-=R2O
M/((,[%9CG"^PKIU7H?2E4<<]:6N.4G-\S/1A!4XJ*V0"L+QEHMQKVA36=L46
M9G1@7. ,,"?Y5O4A&:DT//;WX;W#>.(M3M+A8=*E@G%Q;'JDTB;=Z?GS5?P]
MX'UJWOM!BU!;.&QT-9!#- Q,EP6&T;AC@8//K7I6*3;_ )Q0!YK:> ]933M)
MLYOLH73]8^VAU8_/%N)Z8X;G%2:EX!U*\T+5K-&@$MWJBWL?S' C# X/'7 K
MT;;[TN/RH X"T\,Z]I.K7L5I%I\^FWMX+M[BY),D><94+CD\<'-8^H?#WQ%J
M7B:PNYY+>6WM-4%[Y[3'<T0'"!,8!%>K;:7;VH \RUWP'K>J:-J^FI]E6.74
MXKVWD+D%E#AF##'!XXIFJ> =<O'O]+C^Q_V1?7Z7CWC,?.CP02H7')R.N:]/
MVT;>W:@#SC6_A[J&I:5KUM&;=9;[48[J)F8\(K \G'!P*?=>#=8;QDE]9QVM
ME;FX26:ZAE;,J 8*O'C!8_WJ]$VGUS1MH 5>*6DI: "BBB@!K?>!SBN$TGX8
MV?\ :VI7^J0BYDGO#<0Q^8Q0#C&5Z9%=Y1MH X%? -W<+XVBFFCB36Y,P2+\
MQ4;,?-QZBJ^F^$-=O+@7.J165J]OICZ?"ELQ82DC&YN.!TXKT7;1MH XC2O!
MM_8VWAR.1H=VGV4EO,58\L5P"/:N;;X8:O9Z?H#(EO>W5C:R6LL)G:)?F8D,
M& Z>HKUO;1MZT 8_A'0O^$=\.V.G;(T\A,%(L[02<D#/;)K9H%+0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4E+10 4444 %%%% "<TM%% "8HQ2T4 %%%% !1110 4444
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M[-W_ $46/_P6W?\ \:H_X><_LW?]%%C_ /!;=_\ QJOCG_AR#KW_ $5#3_\
MP6/_ /%T?\.0=>_Z*AI__@L?_P"+H ^QO^'G/[-W_118_P#P6W?_ ,:H_P"'
MG/[-W_118_\ P6W?_P :KXY_X<@Z]_T5#3__  6/_P#%T?\ #D'7O^BH:?\
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M ^I*6D P,4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (
M5!HHHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M I,<T44 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
(0 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>formdrs_15.jpg
<TEXT>
begin 644 formdrs_15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $M EH# 2(  A$! Q$!_\0
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M^+KY1HH^KT?Y4'MJG\S/J[_AYY\=_P#H)>'_ /P4#_XNC_AYY\=_^@EX?_\
M!0/_ (NOE&BCZO1_E0>VJ?S,^KO^'GGQW_Z"7A__ ,% _P#BZ/\ AYY\=_\
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MKY1HH^KT?Y4'MJG\S/J[_AYY\=_^@EX?_P#!0/\ XNC_ (>>?'?_ *"7A_\
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MW_X!P4?\1&X1_P"?K_\ !<__ )$/[(S/M^*_S/-_^'GGQW_Z"7A__P % _\
MBZ/^'GGQW_Z"7A__ ,% _P#BZ](_X=L^&?\ H>M;_P# ."C_ (=K^&CP/'6M
M9][."C_B(W"/_/U_^"Y__(A_9&9]OQ7^9YO_ ,///CO_ -!+P_\ ^"@?_%T?
M\///CO\ ]!+P_P#^"@?_ !=?.'Q \)R> O'.O^&Y;A;M]*O9+0W"KM$FUL!L
M=LC'%8%?J%&&&KTXU:<4XR2:=NCU1X4JE6,G&3=T?5W_  \\^.__ $$O#_\
MX*!_\71_P\\^._\ T$O#_P#X*!_\77RC16OU>C_*B?;5/YF?5W_#SSX[_P#0
M2\/_ /@H'_Q='_#SSX[_ /02\/\ _@H'_P 77RC11]7H_P J#VU3^9GU=_P\
M\^.__02\/_\ @H'_ ,71_P ///CO_P!!+P__ ."@?_%U\HT4?5Z/\J#VU3^9
MGU=_P\\^._\ T$O#_P#X*!_\71_P\\^._P#T$O#_ /X*!_\ %U\HT4?5Z/\
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M>G?LBIK?C+Q5X?TWQ5<7"Z%=RZ4=4DTH16L^H112RR6XW3;\!(A\RJQ^8G
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M4]QQUKA:_P!#LIBXY=AHR5FH0_\ 24?C6(UK3:[O\PHHHKU3 **** "BBB@
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MGM\Z/^^OYBCSH_[Z_F*_H2_X5+X&_P"A,\/_ /@K@_\ B*/^%2^!O^A,\/\
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M *$SP_\ ^"N#_P"(H_M*/\H?4W_,?SV^='_?7\Q1YT?]]?S%?T)?\*E\#?\
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MVDOY?Q%]2?\ ,?SV>9%_?7_OJCS(O[Z_]]5_0G_PJ7P-_P!"9X?_ /!7!_\
M$4?\*E\#?]"9X?\ _!7!_P#$4?VDOY?Q#ZD_YC^>SS(O[Z_]]4>9%_?7_OJO
MZ$_^%2^!O^A,\/\ _@K@_P#B*/\ A4O@;_H3/#__ (*X/_B*/[27\OXA]2?\
MQ_/9YD7]]?\ OJCS(O[Z_P#?5?T)_P#"I? W_0F>'_\ P5P?_$4?\*E\#?\
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M /X*X/\ XBC^TH_RA]3?\Q_/;YT?]]?S%'G1_P!]?S%?T)?\*E\#?]"9X?\
M_!7!_P#$4?\ "I? W_0F>'__  5P?_$4?VE'^4/J;_F/Y[?.C_OK^8H\Z/\
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M:E_S^_\ D)?\*/M&I?\ /[_Y"7_"BP7.DHKF_M&I?\_O_D)?\*/M&I?\_O\
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M[1J7_/[_ .0E_P */M&I?\_O_D)?\*+!<Z2BN;^T:E_S^_\ D)?\*/M&I?\
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M_9T_]T?G1_9T_P#='YUKT47"QD?V=/\ W1^=']G3_P!T?G6O11<+&1_9T_\
M='YT?V=/_='YUKT47"QD?V=/_='YT?V=/_='YUKT47"QD?V=/_='YT?V=/\
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MK/X;?]!.^_\ !?)_A7PK11_JS@>\OO7^0?VUB>R^Y_YGW5_PUG\-O^@G??\
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M_B:?^L."_O?=_P $/[-KOL?(M%?6MQ^R[X+BZ'5/_ H?_$U4;]F?P:O?4O\
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M# 9=JR-W('?%&A:'%>SV\UXHVH99I<_Q@?,<UST?B WFLB<LQCC?_5G@;>P
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M3]:]+HKKHXE48\O*GUO_ %T.:I1=27-S'$WFG:G>>+K^XADD@@M3!(LAEDY
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MM'L?G.2O&:X?XS_!8?89=4TV-=I&9./3-;W[/-PTWP]:$PM$D%RR)D]L X_
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MIU% !7B'Q,_Y'R7_ '8?Y"O;Z\S\;>%XM2\6?:VF9.(]Z 9SCT/:@#K*6/\
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M;<&K*P[<<4V'H*G9J]:&QX4D1%<&GJ_RTF[=2]>E7*7048D,R[F'UKM_@_\
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MZ',L#,\B#:=Y*A@.F3C\. 7Q1\,=1T6'4K?PG>W&^WDU*WAD4HS?8QL4+E\
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MQM/M[=*Z>H9.M5]8K.]YO7S8O8TU:T5]Q@ZIX#\-ZQ<6<]]HMG=36:JD#R1
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MX'^(TFK:9X9U!=6NM/XN;B!#Y*,>,!\8;\*SOA5H8U(FZN5WOYI8'%:'@_\
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M081AV./3UJ^7 ^R]K[!?^ ^=NUB;XKVGL_:O_P "\K]S-_X:D^)W_0RM_P"
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MT>8__/%OS'^- '.2?"[PA,M@K^&M+9;#/V5?LJ8BR_F':,?W_F_WN>M6=3\
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M3>2@S2M)U_O,3_6N3+,LKY@INE))1MO<O'XREAN55$W?L?:]M\3K"3&+A/\
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MN2:T*6/_ %B_4?SK2+Y6F9M75C\YH?@?\0%B0'P=JX(4#_CV-/\ ^%(>/_\
MH3M7_P# 8U^FM%?9_P"M6(_Y]K\3YW^PJ7\[_ _,K_A2'C__ *$[5_\ P&-'
M_"D?'_\ T)VK_P#@,:_36BC_ %JQ'_/M?B']A4OYW^!^9/\ PH_Q]_T)VK_^
M QI?^%(>/_\ H3M7_P# 8U^FM%'^M6(_Y]K\0_L*E_._P/S*_P"%(>/_ /H3
MM7_\!C1_PH_Q_P#]"=J__@,:_36BC_6K$?\ /M?B']A4OYW^!^97_"D/'_\
MT)VK_P#@,:3_ (4?X_\ ^A.U?_P&-?IM11_K5B/^?:_$/["I?SO\#\RO^%'^
M/_\ H3M7_P# 8TA^"/CX<'P?J_\ X#&OTVJ*4GL<4?ZU8C_GVOQ#^PZ7\[_
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M^_\ X!/]K8==_N/0&CYJ6W7;(#VKRN7XE:RO3[/_ -^O_KU6D^*FNQG@VO\
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M_"C^S++_ )\K7_OPG^%'^M4?^?/_ )-_P _L)_\ /S\/^"?E[@_W6_(T8/\
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6JL:G+RV5M[_Y'M8'!_4Z;AS7N[G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !7 IX# 2(  A$! Q$!_\0
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MFG&_ZWPNLD8=/NDMC@CHQ'&>W'![C!'6G2%0N6SC(Z=<Y_SQWK\-?A__ ,%
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M:[=6\3W2'3=*5D-Y>6-;_@HY_P %#_!W[$/@RWLM/L+/QI\<_'5G??\ "O/
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M?&SXF>,[/2_#/AV2+X@_M"_'[QT[6'@OX:>&H[B0I!8Q)<PIK&K6^G6,NB>
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M_;FJ6-YJNC^;X*L;C3<Z1+:2:?'IGVY9$EN9)4_<J12J D AMO 9E)4D$@$
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MW6E:'\/?AU\/M)&A?%[XP:1H^N>#_AAIEE'\,-1\36GA[Q_8:+\1=8\&6=O
M?"/C3QC:^(=?TRWN;D6.MLEY/]H_*?X?_M3_ +9'Q^_9L_;-U+QC\3?@_P")
M/!#_ +&GQ,^+3:CHOB']E'XK3?#[Q!::)J6IVGP]F^%GA&RU.5_AA\2O"^F>
M-?">KZ1\>=+\4^,M-NH+^.^U.SU33I+*?T3P3^UC^TQXE_;%^%/[._A[XLZ)
MX2\):#XR_9TTZY^'>@:=^S'X;\!ZI\&M1^"_@'XH>)+236_$FO?\+ZF^+M]<
M7-[IT?@+X9_#*;P$O@J\M([;7]%:[35]%[(9!G6%J1E0S2$*^7XBIS0PV-DZ
M4EA<NS#$PJ2=.*G!4:N&Q/LY0BUR5J,DW*NY+SJG$7#&/P]+$ULDQ%;+\QH+
M"4I8K T(5XXG$X[ X:&&K0G+V<H5UF.%JN2G.5'$X+$X&O"GB\+B(1_;#QM\
M/_A/\;X?A[J?B+['XLM_A7\4-,^(7@S4=(\3ZI%!H_Q+^'^IZEI-I+=7GAC6
M+>+5;OP_J0U31=5\/:[+J&G/J<=S9:WIDMQ!Y<7E/BK]BO\ 9F\8V7CG3->\
M#7]NGQ ^)8^,^LS^'/B)\2_ ^LV7Q870CH][\1/ ^M>#/&.B:G\,/%6OZ2AB
M\3:C\.]0\,2>*HKF\;Q&+R6ZO!/^77[,'B#X_P#P[M/V>M&T'X\Q'X6?M,?'
M;]N/X.Z5\.%^&/@(O\)]8\(7G[2OQ!T#XC^$_%D]G>^(?%^MKXE\!W%G?Z)X
MSN-7\&W^F:KIMM;:/I\]C*VL^;?#+XX_%GX5?\$[?@GXT\-?MV^$M0L/#7B2
M>+XSWCK^RTGQP^'&E:7X*N[MO@Q\/O#OQ3N=%\$^./B&_B[1;WQCXPTSXJ^)
M+3XMZ[HNNZO-X5UK4]1M-,TW4O+HY5CL/1]C0S6I["DLO5&FL3B%3EBL9C/:
MU:DW&4>2I2QV6O24$L175&LI)SE"MV_VYEU;$2J8KAB<L77PF8U,56E_9$*G
ML\OHQP:H3A7JPKSIULNQ,Z%5SFG1PU7$X:,7A9QIU/U>\2?\$XOV./$OAWPM
MX9O?@_/9Z#X3\(ZWX"LM.\,?$WXN^"SKO@_Q)K%_X@\0:'X_F\(^.-$G^)UM
MJVN:OK/B+46^(4GBJ>\\1:C>ZS<22ZI<37$EGXC?\$^/V3/B?JNFZOXR^'6N
M2:C8^%?!WP]FFT+XO?&/P7#XO\*^ 8XXO VF?$:S\+>/M!L_BA)X72RCDT+4
M/'UOXCU2VEB::UN?M#2RR?2OPS^)_A#XAZ+X<OM!\36.J:MJO@+P;X\FT6[:
MTTKQA#X:\9:5'JOA[Q!X@\',R:YX836!)<"&UU.PM(HKRWO[&",26$RU^4W[
M0<G[+/BW]M7X]^%O^"A>M?#S2_ /@SX/?!OQ-^RU9?&'QE=^!O"EKH5S9>.S
M\8O&?PYNGUW0]-N_BO9>+([/3[C7=#E?XB:'I%CI%OHEU9:?(#<Y4*N8SQE:
MC4QV-A' T:^.Q?L5*=2G2HU*,\35PL*E6"Q-64_9.492BU%2DY<\(M>CF%/*
M*.687$8? 8"K+-*N!RVG/&>QR^E"E*&)^K4,?BXQY\/@\)3HUG@J,$JD<94P
ME!U9T:^)B_TU\#?"J]\)_%'XR_$C4/'/B#6;?XJ:GX*FL?"=SJ-_<>%?!%CX
M-\,KX=AM_#]CJFIZHEIJ&OR37.H^)9],30]/N[B'2%M=),HU&ZU#FKW]D7X!
M:G\;F^/]WX0UC5_B-'JEOXBB;4/B)\2-2\#6?BS3M,BT"P\76?PIN_%L_P +
M+3Q?8Z/&+.T\4P^"3KUE&TYM[^%Y[EI/QX_;!_;&LM#_ &I_AK\0? .I_%;Q
M+\+/V'M"^'.O:SJ?@GX9_$CX@^ /&D/QLL[2/XTR_$/XFZ'H.N^$O#"?#7]F
M?5_#/C_1;SQYXAT"]O-;UN:[2:Z*6@O/U8_;:^'WC+XZ?LI^/?"?PQU#0KG4
MM;?P)XF-AJ_BRZ\'>&OB'X"\/^,_"GC+QCX U/QQHS-=>'-$^)O@?2=<\(3^
M(%9=+6+66DU&X7299YQGBL!C\OHX#$U\14P[Q^'K87W(PE4HPQLI?5YS49N5
MW@ZU&M4IRY$I7IR;C%MZ8/-\LS3$YSE^%P\<77RG$+&1HT:]*O4ECL-2H1Q4
MW*G^XI5*69P>78=4Y.G+%1Q+IPI8>,1!^P=^RM=>'/B!X0'@/79?#7Q*^(2_
M$S6=)C^+7QC6W\/?$.RU+5=7@\7?"Q[?QV7^#&M#5=<UF^FNOA-<>#/.NM5O
MI9TE>\F1O?/A;\+_  =\&O ND?#CP%;:K;^%] EO9;6'Q-XQ\7>/==DN-<NK
MK4]1N]7\6^.M=\2^+-<U&^U&^N9;FZU;7+V5A<2#?Y:QHOXO?LM^&_&'C#]A
M7]L_7_!MMKW[)7P0USQA\1O%_P"S[X&^$'CS2-8_X17P-X'^%MC!XGC^&_Q#
MMK34-&TOX;?$#QYH6HW]CJ/@.#3+06$OB+4/!E_::9K]AK$GI?Q;\.? W4O^
M"8O[-'BGXN_ GX=_'WQOIGP5^!OA/]G?P%X^T+3O$MKJGQP^*_@7PKX,\!V5
ME;ZQ,(O*U#59;&;Q)/+(JS^&M-URZNML)N93W8["5:4JN'KX^5>-3,<%@W"+
MA4<JM3+:>-]K+]ZZ<JL&YT*D5*<(2C.49NRB>=EV;8.K@<%F6#RJA2G5R?/<
M1@\1'VU++5@LLS3$8.O%5:M*GBZ> Q$H3S' QE2IUZ^)G"<N3VL:#_4>U^$'
MPXA^(WC[XJCP\L_CGXE^"?#?PX\<:C?:CJFHV&N>$/!T^OS^'M"N?#=SJ=YX
M=MH;,^+O$)N;BPTNWGU.*^NDU:>YCBAAB\^^ G[(?[/7[.=QKFK_  <\%S^'
MM0\0:5::#]LU3QGXW\=S:3X5TNYN+S2O!7A"7QOXH\4-X/\ !&EW=W--:^"O
M![Z-X8M[PI):Z6HM[8Q_E1^U%X*^)'['?[%.A?L<_ 'X4?'6Z^'OA;X _$;6
M?C#\?_@=X8^'$]G8:K<:7KVJ>(]**>(_B'X#N_!5AXW\7W6N^,_B-XJ\+Z-K
MGB'PA\.XCX;\ >&KS7O%JZ_X)^,?VR-:\,>+F^#?B/Q'+X=\!7WPI_8(_9V\
M8:5X4^-/B4^&/C-:2ZUX^L';5OV%['PWJ-QHTG[1EKX8\+ZWH.M7RWM_/?77
MBCX9^&Q9VD%SJ:VN]'*ZV(:A2S14\NQ6(J94HM)RJX'"9<L31=>DL0YT:3TH
M4U%5(QINE&2O-3P_'C.),)@U]8Q&37S' 859M6C3AB)0HX_%XK+\)BZ%*K*A
M3C5K8:$<OJXZ4ZT:,L<\7A\-5K3RK%0K_P!#/C']E_PEJ/PC^,_PH^%^J^(?
MA=/\;?&NM?$'Q?XK\.^)?%<GBBQ\6^+]7TK5?%WBKPOJ2>)[6?0-;U#^S0^C
MZ=::A8^#+2^VQWFB76CRZKI=_P#5VFVQM;-;4M-(+<B));AWFGG4(K^=--(3
M+<32%V:>>18VEFWOY:@C.5X=N!=VVG7D,4EM:W^DVU]%:7<;0WT/VJ"RN%6X
MB(PEP@G*7J@MLG5 6:1I3745\[4J8F7/"K6<YJI)<S49/W'[-1;NU-P5%0YK
MNZC:\N55*GW>#I4/9T\12H1HNM'VRC'FY;5W+$.2BU%6J3Q56JVHQ4G6<U&G
MS^RI X 'I1114'8%%%% !1110 4444 %(QP./51^; ']#2TUL':IZ,V/R5F[
M=.5SF@#^.#_@OMH%WIO[:'A3Q!//<FS\0? ;PC%I\:\0V[Z'XJ\<07TRJR%)
M78W47[U?WEN5(9_)DDB;X6_;;?Q9)\,_^"?G[.7PDTG5KCP#XP_9S\ ?%>V^
M'_A'2IS<?$S]H;QOKVN:%XM\0:A8Z'9SZQXH\5+XAL(/!?AZQO#J%CI5C!9Q
MZ"VD"ZN9Y?V7_P"#A[P19O#^S'\38X$%ZFH?$GX=:E.\FQ9+22+POXIT0')4
M!;4VWBCS,-F5;S:00GS?D)>_MOW%I^S-\%/@QX5^'^C^$OBQ\)_#?Q ^'-Y^
MTF;FQ?Q^?A+X_P#%U_XJ/@/P#?DZ3>^$(3:ZA?:/XOU"VNDU.3188-,T#5+*
MV\1>*WM/HN(N%<?QYX>83AW 8BM@:<\VPWU_%T9^RE3POUB$<5)2O&]J*FXZ
MZ.S:<4TM_ 7QKX>^C5X_9OXM<1<+4.*UDO#'$W]A8#$U7A:-+.<TR'!4<MQM
M.K*G7JQJ8+,:TL3/$X&G/$TE#$O#*GB81E3\FTF+1/V0_#6K^%O"L^B>)?VH
M]>LVTCQ]\6-.O(=2TO\ 9^T2]TV\M=4^$WPEU:W-UILWQ$U#3=5-A\6?BWIB
M"Z\,2K>_#CP!+"=/UCQ-KDVA^&_!/P#\'^&?C?\ '32-*\37OB:SN=?^ _[-
M^I7=XNK?$Z:WG,>B?$GXF64/F:GX3^!,.NQ6MW%/N/BKXDWNE6OA_0M#N+&[
MUC74@T?1OA_\ O ?A?XX_'/25\4^)_%^GOJ_[._[.\DTEFWBF/19&G@^+/QI
MM+>/3-;T'X,)K%O#)X%TC3KV?7_C1=:7=1Z3>>'O!?FZV?,/A%\*/B+^W#\7
M_B1\5/BMX]3PUX+T+=XY_:,_:%U[3VG\/>!_#@E>&U\/^%],TJUAT/5/%LUK
M8R^$?AC\(="2PMVLY+2UTS3].\.: R6GPG$W%&4\!Y;AO"SPJH3S'B#,,/#!
MYEC?92E6CB914*N(G6I1J324W\<G%-RN[72/[/\ !7P/XD^E#Q/G/TTOIKY_
M+A7P8X?GB,TR[+LZS+-\EPV=9/@)U,11R'AG+81Q-6GP;E_+A*-##8'!4<7Q
M#C\35PF4TXX[-<SSBA!\,OA!\7?VW_B9\0?BU\2?'-MX>\!Z"]MXC^/W[1GC
MG3TM/ _P^\.7#7%KH.FZ'8:990Z=?>(LQVFD?"7X6^$XX9KI+;3](MH$\-PK
MJ&G_ $%\4OBT/B['\/OV9_V8?AKXC\)? OPUKMKH_P -?AAID7]L_$7XQ^/Y
MDO-*'Q;^+!T5);G7/BGXK@'GOIZ7]UH_P_,[Z-X;ELK(:KK55OB5\5[[XOVO
MP[_9J_9[\'^(_#7P \#:TMC\&O@[I.;_ ,:_$#Q=XAD^Q7/Q.^*$MF;P^*_B
MSXMFA%Q-/+=7/ASX?64HTCPE>3>'-.U36=7_ *B_^"9'_!+W1?V/M.C^*7Q0
MFTKQ3^T+XAT."SDN=,MPV@_"O2;VQ1-1\+>%KQ_+?5=8N?.6VUKQ.UND/V6&
M71= %MH<21W/O\$\#9=X<Y=6SG.56S;C#-J,I8ESK4Y2P]>45-PC*:E6IJG*
M<ESITVW*Z=TTOY^^E)]*CB/Z5G$F5\)\$8*7 G@)P%B9X7AOA6C4Q&'S#'X3
M!X:MD^6YOF=&A2P>6T,?5P5*G6IY+A</5R_(:5>CAJ<<7CHXO.\;V'_!*;]A
MKQ;^Q?\ "#Q6?B5?V%U\2_C#J^B>(O%NDZ/<C4]*\):9H=CJ-IX9\(0ZTT,#
M:WJ%F=;U/4]:OHK=+..^O+F&TEN+:*&6:[_P5!_8*U?]N'X4^&H? FN:)H?Q
M=^&6LZCK7@B;Q5<7^G^&=;L=<M[6RU_POK&J:)9W^HZ6D\=G:ZOI-^FCZ\(=
M;TRR26P$4[7ME^J6SY%PC9$813CD?* "<GV'RYQTSG%?B_\ M<ZO_P %@/!W
MQZ\6^*OV5_#?@/QA\"[O1_#6F>&_"-XG@G6;^+4K2"Y?6-:U&VU[4/"_B>QO
MM0U+47CE33-8U'1;6PTRT<6CSR28]'!8K%X_,ZF.6)I87%<LI<^.G3C2DXTY
M+DJ.I%JI:G'V<-&YRC!J3E)2?X)CL'E669'ALIJX/%XC X=4:<:>$PU7$5*7
M(Z455C3P].;4G42G4DHM+GJRY(Q2C#X7_8<_;U_:0_9A^//AW]@[]M;PWXDU
M2"YU?PMX$\%Z]?K82^*_A_)JLEMH?@V*;5K-HX/''PJU54MHM-UB;4M2\2Z6
M;V..%]5TUS9Z+S/[8T$/[1'_  7*_9_^'*Z6NI6OPGO/@IX59EMX-0*P^&GU
M;XX^*-59V1[GS+.'Q!=:5>B:9O+ATD7<8A-C+-+]"_L]_P#!.W]L'X]?M=>&
M_P!LO]OB^\/^'KOP=>^&?$'ASP'X8N-%FU6_U7PG!?1>%=(N].T"2]T'PWX4
M\./J<^JJG]N:KXEU+6?/>^9!<N%]9_9._8P_:-TG_@I?\?\ ]KSX[?#[2M \
M%Z\/B*?A=?6_BSPYXAU!KW7/$&B^&?"VJ3:?8:E)>:<__"I]/U*ROK>Y1Q82
MZ[J5C 6FD6<>_+$9;3Q&(QM&OA'BGD-15U1I*E2683:ITY4>=_O:_O5)/V44
MU=R<%>Y\O2P6<XFC@\!46+G@O[?CBZ4\1&M&I_9.#7//"8A<M-0I5W5IJ$)<
MCG[*2A-\LD?FM\>_AOXL_:L_X+7_ !'\"?#SQ=J/@6_@G@\,:W\1-*ABGUWP
MEX \'?!KPWH?Q)7P].D<K17FIV=UK'AF(PS6%U#JVLVTT=]#=K"5\0TG]D'4
M?!O_  5)\0?LE_LQ?%+QQX(TVVNM6\):E\2AJEK-\0=+^'6N_#S0O%_Q;CEU
M+3;&STW4;VVL[C5/#GVB.SL+N_\ $6G:)<F9+^VGO+K]@?\ @G5^P[^T;\+O
MVU_VD_VIOVA/"L?AQ?'5I\0+7P3;KXG\/^*Y[X_$_P"*&C>,;V:YN-&UK4I+
M230M#\+Z+I4:W.FVHV7=XD,I^RAGE_8H_8M_::\*_P#!2#]HC]KGX[>"[/PS
MX1\8V7Q3_P"$!EC\0>'-8OKV]\;>-_"Y\-S3Z?H_B#5+C3TTGX>Z'J>G7L4T
M<#B_U;=AB,AK-(X:C7I4JM#V>'R2C&E!.BXRQU>E&<IQ23YJT)UGS)-N$X-2
MA>,K80R?$8BIE^,Q>78ZK6Q_%^*>*FZU:#HY/2HRC0HU8/EE3P2C0C&"G&*G
M*UJS<XJ7YA?!OX#V/[,7_!;#P3\"?@1K7BS4/#'@KQOI%O<ZCJUY;WWB6^\*
M:U\(M+\;?$FQ\5:CIFF6&GZO9KJ.JW:WD[VL826T@>:(W6GC4(_7_BCX@\3?
M\%8O^"C&H_LXGQEXC\._LP_"-_$MU+X?TV2&+^T=)^&<MAHWB[Q%;V<4!^V>
M+_%7B75+/2M$GU\36_A33IXX6M9]9L;J*?[<_9;_ &,/VF-+_P""I7QQ_:Z^
M,?PZTWPQ\-]?MOBK<_#[4X_&OA_Q!J$E]K&L>'/#_A2T?3-(U%[Z :EX NM?
MN9_MNFP1Z5=Z<UO)>%I(%N? _'7["_[</[%?[7WCW]I;]ACP=X4^*OA[XBR>
M( -"\37^F37^F:7X]U:RUWQAX7\4Z=J&K>'-0GT^V\9Z3I.N^&]=\-ZE>8TR
MU2RU)-&6%I+D>+P<\5-T<30H9A3R? 1PU>JH3PTLPJ07UBI*>M*-;F2YYMV@
M^;FC&]G$,!F%+"TH/!8JKDV)XHQ-3&X6*KTL5_9M*5;ZO'V<[5GAM=(^[SKD
MM4EHSYLD^%EG_P $\_\ @KW\#_A1^SOXL\42>!OB)J_P7TCQ1X?U#4HM6U&Z
M\-?%?76\,^)/"_B.\AL+>UUC3=+AT]O&=C=7EG;ZCI%K-;Q64K+(\[V_VJ/!
M7CC]JO\ X+3:SX&^"WB*W\.^*/!$'A?P3+\2H+6PN;OP%X9T?X8VT'Q9\1Z0
M\EM,L?B3P^GC+Q/IVB1L8KI?$Y@%I=6,R17-K]__ +'_ /P3S_:)\2?M9ZM^
MWA^W5>>%1\4'O(M1\#_#[PU<6NHIH.J_V-%X6L-6U9[ WV@Z):>$?"]K9V/A
MGP[IVI>)+K[;%!K6J^)VOXM1BU&W^PI^Q)^T3\/?V^/VF_VH_C5X'LO"V@?$
M&'XBS>"KJ/Q-X=U2^U+5OB!X_P!%UPW4FG^'M9U);&.VT+3;[[2;[3X9H[F_
M@MX)/*2X0T\PPM&K+&2Q&%QF88/)I8?&-TXJCBL=B<15IP=)<T%BEAZ<H57.
MFK*:CS>ZI7ZJ.5XO$4\'E\<'BL)E..XIPU>E3<JDJF'RNA0Q$Z\<4ES2PM/$
M2I4Z3C5G%.+@E)2<>;\E_$'[.NF_LG?\%>O@#\)_@3XC\;Z[=GXI_L\WFL:]
MXBOX-2\;"V\4:UI.K?$VRU[4[*VMAKFFOX.76_$%]%J44PL[&YDAN9[Z2%[R
M7]J?^"NG[3WC/X$>"_@'X;T#XDZE\*O"/Q/^+%OI'QE\8^"-4TG_ (7-H/PK
MTQ+"ZUJ\\!:)J,9U-_,TYM<%YXDTDSII&H6&CZ?]ON#KR(_D7P]_8K_:FUO_
M (*]>*OVP/B;\/=(\._!^U\2>,F\(ZW9^+O#NK7U_H^@_#5OA7\.KR;P_9WU
M]J&E/JV@65MJFH0R1Q2IJ5]<DQ0JWE))^U;^QQ^TAJG[9GQ@^-VA?L\^"/VK
MOA9\=?@C8_!.T\.ZW\1M)\#:O\)M/U/0]&T?Q1=:7>^*([R+P[>F\\/V6M:5
MK_A/2;YH)M5U&[:.WU>Q@>[X:U?"UL5D\JE:$Y8?*H+$^_2Y*F)ITTN6I)KD
MYHRUBI.[<5[K;*H4,?EV49LJ&#Q'L\7F[AAZ-.CB95:.%K5JEZL:2C.KRM1C
MSSM:TTW**/;/^":WQ<^).BZ1K/A+X]_%#79]&^,OQ(\::M^PMX;^-^K03?M#
M^-_@1X<2ZO1KOB*SB@MY[BSF\.7/AGQ+:2W0-S;17>OW,4=GH9TFQL_R*_;_
M (/C/^T%_P %=X_ OP ;3M1^*OPXL_ 6E_#]]7NM#72M#UWX>^!W^+MW=32>
M(H+OPREM87=[J&H?8==ANHM1U"[-I)87$9=&_1K_ ()F_L(?M#_ OXT>*?&O
M[5_AZ[\2ZOX2^%/ACX;_ +/_ (UM_B-I_CGP]X#\$S7.LZSXJ\!:4L]W9>*D
MO+>XU:QTBSU>_P!'L-*BL-(OM,TVV33KNRG?XLOOV*_^"K7@+]M'XO?M;?!O
MX7^#+?Q/XM^)7QGU/PIJ/B3QM\,=;AM?!GCC7]231E?0=2U>&"RO?^$5.E6$
M<LLLFH6T44UM<A5,B/U97+#8?.,95IXS 4JD<NK3P]7$^SGA:U2K"4%0Y^=P
M4FK.>BFVYVBD^4,X^O5LARO#XS!8[ZG4S.G'&O X;$ULQI4*<8SC/V5.C4K0
M7M-%)4^6,5%.;:9^@'[*UA_P5L\(_%N3Q;^VW\1O"MU^SQX5\"^/?$?BK3]%
MT_X&2:A?7]AH<\VBB%OA[X.TGQ/";"7S=5::TUBPAE72TM[I[J:>*.3\X?@E
MX&\2?\%I?VK/B_\ $#XO^._%^D?LR?#)[63PGX T*[33[V#P[XAO]0D\">'=
M.9+:ZT32]4O[335\1>+_ !)/9ZIJ>J,_]G:+<W=A<O<:?^K'[,'AO_@IO\3+
M[XI^#_V[HO!F@_"GQ3\)-=\*Z/'X2T?X<3:S=>*/%<#:/=RFZ\*:W?W%O;:+
MHEQJ4R1W4"6NH7,L%K(Z[N/S>_9A_8<_X*L?LA?$[XF_"OX(6OPRTOP'\5I[
M#3/$7QXUJ71=6T;2_#NBZAKZ^'_&WAS2FU:P\36?C6SLM8UBX?P_J6A>((8]
M2UE%5+6-7UQ>7#5X*6-G*668?,'1H>PJ8;DI86BHI\]2CSSJP5><=:ME-\]K
M03?*^JM1E-9)".$SK'932QF,=95Y58XFK&56,J<<51G2I5W2AM2<^2+@GR[(
M\W_X)Y_ 7P/X0_X+(^-O GPQ34KGX<?LYS?&RYT;^VKT:EJ-BFEZ._PB5+^>
MTM;?399]/UOQ#J-II!:)#]E@FE6".:WCFFZ;]EGXKZ!^QY^U5_P6#^,.J:='
M;:?\.!\0]?2&"!$;5]7UCXY^))/ ^A(TX*VUA-X@\6V9,4+_ &Q/[0GDLX[J
M&!;)/N/_ ()/?L*?'S]E7XP?M)^,OC3X=^S6_C"VL=)\$^+;_P 4:!XAUSQG
M:1>+]?U>_P!<URUTRYU.]TO6-6A&FZUJRWM_*TNH7\EN&D%G T?S)\5/^"6_
M[3WQ<_;O^+>J:OH*Z3^R1\:/COHGQ \=:Y!XH\*O<ZSX:\+PKK%K;MHQUA_%
M,-P^J2:G;:7Y5J(HK_4X]1DCAFL+:XA].MBL'B<PS2AB<10G"GP_@)+$NK2E
M&OB:&(I5IPI24O9SQ$E&494Z2YM6G3T9YM'"9K0P&55L+@JD:LN(<??"TU/#
MSP^%KX>I1IU:DIQ3IT82:G&=6\'9)3NT?+__  3G^,FL?LB^._VZ_BY\7-UY
MXZNOV8-"^/&LS@QG6_$_B_QEK?A_Q)X7:\%[%"+FY\1:S\7M!N-1>1!;6,E\
M8[:RD$2VU0?!Z[\3?L"_L'>*_P!LN>.>W_:Q_;9\8W7@[P!XVU2WTU]=\+_#
MRSN=1\2>*/B+/%K*3VM_>>*M9L]0UVSAO(/-NI-4\&7PN"\K0'[*_;-_X)E?
MM3?M"_MR>.O$7@G3=%\-?LU?&:S^"/A[XA>*AK>@6]W#X.\$:=X G\2Z9#X>
MBU"V\3M):ZYX)T:;1+6S@M+1+NQ6]\M[2WECF^O?^"J_[ _CO]I7]GWX3^&?
MV>=$TP:Y\!M0NK?P]X GU:+0X-4\#ZEX8B\,RZ?X?U"^FBL3XA\/V^CZ#+I5
MMK6IZ=8W4*7KOJ1OX;*VO,J^.RZOC,"J<J%-9A+"5L3S.FJ=%8:A*E*E7G91
M@JE>4:C525--+9)NV5++L\P^ SN4\%C,1B,!1QL,'"&,E+ZU+%XNE6GB</&#
M3GB*5",Z=+D4Y*+<5"3M)?C3\<_^"?6E?#G]@.^_;(_:7^*'C;QO^T5\3F\!
MZIX(T:ZUBUO=#L-5^*%_INHQ6>N3>+-(F\0>-?$TGA^74/$FJ/I"^%;31X[:
M^T^RL+J#27O[[W+7_"-K\!?^""&F6OB!+>'Q!^TO\1= \16NE32R0Q7,_C3Q
MS;:EX:TRTC#!X9T^%OPXTG5;ZVM88H$G759T@DDCDFDVOCU^QI_P5A_:F_9L
M^%OA;XK^%/ +1_"G6O"FB?#GX2Z/J_A?PWJLNFVO@SQ/H]S\6OB+JT6N:AIO
M_"1>%](ATSPCHWA[1M2MC>77BS4[R33;*&RFN[[ZD_X* ?L0_M1_&?\ 8V_8
MI_9\^$G@"SUC6?A-:>'==^)MDWBOPAIUAH>N^"?A;_PB.E6%EJ&L:GIJZMG5
MO$OB,6\^BAY9K:WN3%<Q07F^33Z]24<!AL5BL-./]M5,;B94ZE&<*>'PTHRI
MT(3CRI0Y::]FG=2G-1BYO:J.6XM?VU5R_*LQPU..08/"X.5>M4A7K8S$P<<1
MBY4ZG/.>(C*K-UK>\H4HWA"ZO\T_\$]OV-/$-I\+_@=_P4!_:,^*<NG?"K]G
MGP?XV\:_"+X.6GAZ&32]'^&OA^Q\?2R:[J8N+C3-,TC6O$>JZOKGCBT72='O
M[S5I]0TJ:YU:%IK6RMN#_9*_9NU[_@L-\7?B[^T[^UEXT\5V?PN\*>)(O#?@
MKX>>']4BL?[&O-2@;5X/".AO?6>H6?A?P[X9\.MX;FUG5+>PEUSQ'K>LWC)J
M$!MY+FY_HGO_ -FK1+S]D2?]D]+B;3M"N?@'-\#HM4TZ.1Y=.A3P&WAB/Q%;
MQSSR3K-:ZFJ:K:V\=U,[SQVH\P;YR?P9_93_ &//^"NG[/=M\1OV;OA];_"O
MX9?#+QWJTEYXJ^-.IR:#XE_L2%["#1YO$/PH@ANI-4N=?U#0;:*UM]%\1>%]
MMOJ6^]N-9T"_\S5;SEH8^EBZ.:UY8NA@\Q^NTZ>"E6C3]G'+)59NK4I6B[8E
M2]D[J,I.#J+KS1[\1D]3!XG)\.L+C,QRJ>75ZN:48.LY5\SCAK4:5?X92H-^
MT?*JE/WXT[;<DN'_ .",/PJ\#WW_  4#_:(\2^!8-7?P!\$/"_CO0O ,VOSV
MM]J\</BCQ['X9\-2ZQJ5FD=OJ%[<^$='UZ>Y:WC@L_M]S/+96ZJ68_U@P%E'
MS,V,9)9 NQ% 41Q[0!L51D!M[?,Q+-D5_*E\(O _Q9_X)2?L5_MK^/?C%;-X
M!^+?QOG\)?"[X'I8>)/#FL:Y]LB\*^*;2R\1VUWI.N:C]@OO#L?B;6_%BQWT
MLS6ESH]@UT+D7$*R_L)_P2V^"WQ3^%7[,NB>(OCCXO\ '?B[XL?%R2W^('B"
M+QUX@UG6[WPCI.J6D#>%?",8U/4;V.PGL-'6'5_$<5G#!YNOZQ?PC?;VUN!Y
MG$4(XN>)QD,7"O3PU7!X2E4C'D53V4(SKRIIV3@G4E[2?O*3=TX['9P=6EA,
M'@\LE@JV&Q%>EC\=7HU+R6'C5JSCAJ6(GRWI55&BN6E4E&I&#BVI*2D?DE_P
M5BM+_P".W_!33]E'X V=V[VUI:?##P_Y#+)<6VF7/Q)^)\VIZ_J,L<:2&(77
MA[2='N[_ "IW6GANW55VQ,TG]2("PA8X@42+9#;1X(5%3:D:'@D1@HH).0J$
MDD $#^8G]IG]BG_@HYK7_!0SX@_M>? OX8Z%?R:9XWT>^^%6M>)_&7P\?3$T
M3P]X!MO NCW(\-:UXFCE,"?9=:U:2QU>"VGL]0URPU.R@5S=00?>O[+^H?\
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M0\)+$8_#9-C7EE5T\/*O'#0K8_"X;!NC">-GB<'GWM*%.>24X5/U.NX_V?/
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M644JM/E:DI4JBM.%2+2E"491<9*+4DTFOR=_; _X)X?\$UO$$/Q#_:A_:?\
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M))7:CK9);)+=MM]& R_#X"@Z%&$*5XQ3E25K24(P=I63E:-.'OR7-+6Z220
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M ."=_P"Q;^S?IESX!U3X-ZKXL_9<\;? #P-KNC?%GX7:M;_$?XD>"X+?X?\
MQ;U[Q5H_BE_$/PIU/Q'8:EK?@S5].\;Q3)H_@75+T&?JC^US^U)X7_9$^ 'B
M[X\^(?"7B[X@QZ'J'A'PWX5^''P^CTJZ\>?$OQW\0O&.B> _ G@GP7:ZYJ&D
MZ;=ZUXC\1^(=-@A:>^CMXK);N_C>YMX0TG3:)^TK\%=5^!WP\_:)U?Q]X1\#
M?"7XG> _ 7Q"\.>,OB+XJT#P1HSZ%\2O#=GXI\+-=ZGXAU&QTZWNKW2;Q9A"
M]R&DDBF2U%PT%QY'S)^U[\#/CQ\?OB[^R)H/@'QEJGP?^&'PN\1_%+XX_$3X
MEZ#HWPS\5:Y9?$;PGX1T[P%\"O!NF>$?B?X2\<>&-674+SXG>/?&[:P_A:\_
MX1>^^'6D2Z#>6>N76@:E%\'_  [_ &4/VH?V>?$7[+5QJ_PP\3?M,_"_]A[X
M_?ME^%_"&AZ5>?"/3_'/BSX4?M)2>%/&?P"^/7@[P[KFL^ _ =IXA_9R@U3Q
MC\#M>\/V-[X,U?2M%O/$>J_#KPN^C-I6@Q@'[1:G^T/\ ]#B\!G6_C1\(-&/
MQ2L]+U+X7C5OB?X)TU?B9I^N-IL>B:C\/6N];A;QEIVM2ZUHL>CWFA)>0:G_
M &QI)LFF_M"T$NGI_P :OA!K/CK4OA9HGQ2^&VK?%'2+>2ZU/X9Z;X]\*W_C
M[3;6)#)-<:CX1M-5N/$5A%&BEGDN=,6) 0S2+$'DC_/SP+X<^*GPY_:^^*?Q
M>UC]DWQSXT\*?M3^"/V9+;0?&.C7_P (KCQC^S]H_@+PE)HGBGX ?%_P_KGQ
M#TBPT_PKX0\2ZEJOQ0TK4_@]K'Q$\/:KXB\2>.+6ZN+F^TSP3:^+_EKX5?LD
M_M!:7HO[(_P"UWX(:OX?\;_LR?MN>)_VE_B/^W8^N?#-M/\ BYX9O/%WQ$\3
M^)O&'AP:)XKG^+.H?$S]K7P[XITWX:?&;PGXD\(^&]$\*Z1K7C.&^UC6/"_A
MSP3#KP!^V-C\8OA-JNG^#M3T?XE?#O5+'XCP:O=?#B^T_P ;^&KNP^(%KH.F
M76N:U=>";^#4I+7Q5:Z/HEE>ZOK-QH$FHQZ3IEE>W]Z8[6TFE' Q?M6?LUZE
MHOC+7M%^/WP6\0:5\/O!\7C[QO=^'/BIX$U__A%/!-U:7%YI_BK7H](UZ];2
MM U1+2=-+U:_-O8:C,D<=C<7(>0Q_BS^SS^R5^U/X.MO^":/P1\2? ?6M'TG
M]@:Q_:]\">/_ (RW'BWX?-X$^(%OXX^!GQ2^&OPS\6_"C2],\5ZIXYN]'\;7
M&O\ AR_NX/&OA'POJ7A6?4Y]'O;+4)]/FU!M'X4_L!_''POHO_!'_0+3X4Z/
MX,@^ G[&'[2OP/\ VFUTW5O#=EI7A;6?BK^S_P"'=+TWPIJFF6%S>1^)],UG
MXNV5MK=TUA!J^G_VKID>MZXUU>V&GSP G"#5K/[O^"?K/X,_;C_9$\;?#+X9
M_%[2_P!I'X'V7P]^+NCVFJ_#[7_$GQ5\#>&&\1"]L-.U5M+@L=;URRN(?$>F
MVVJ:>FN>&I<:WH%Y=16&M6-C>&2"/U/7_P!H#X'^$O$%OX/\9_&+X3^$/%]W
MK&C>'(?"?B7XD^#M"\23>(O$$,%UHWA^#0]9U;3]7GU?5[&ZM+W2=/2Q^V:M
M9WEI=:9!=PW$+O\ @7XA^ W[=7B7]A?]GS]DN+X(?&KX?>']-_8)U']GWXD:
M#\'[C]CR;Q?XF^/F@^!=.\ :AHGQ(\?_ !JU?QKIGAG]F3Q]9B76]'\2_"/3
MA\5]:N[#4[;Q%<>&0GA_3_$[+;_@GQ^TCK_[,G_!2O2O'7P?L==^.WQ]_P""
M?O[&GPD^&.N:UK/@_6O$WBKXO_"#]DRTT/Q9I7_":37U[JT$OAKX]Z3I>IG5
M?$&IK:ZGXBTRR\0:=]I>*'49048J-^7J?MMX5_;&_9B\4?$WXU?"/2?CC\-;
MKQ]^S_;V5Y\6O#LGC#P_:S>"K.[TG3=9N+W4Y;K4((8M/T.UUG2;?Q1J,CQ6
M/AC4]7TK2=:N+34]1@MCUVL_M$_".U^!_BW]HG0_&F@^/OA/X+\!>-_B'=^*
MOAGK6C?$'3]7\/?#W2-9UGQ-_P (W?>%[_4]+UR_M8_#FLZ>MK87TP;5K*;3
M6E2Z5HQ^:GQP_97USQM\4?\ @I=X9^(_P*^,WQ-^#_[6?@C]FSQEX.\5_ WQ
M#\)='\40ZQ\)='\'^ ]5\'Z#>_$#Q[X/;3/B1X<\2^']!^+>CVWB.POOAQXD
M\->'KW3=3U:ZU58?".J]:_@/]OKX@_\ !.SXC>"?'%GHNG_M.>(-9\66.CVV
MF77@OX=>/OB#\"?^%HO>:AI'C36/ KW_ ,+OAG^TK\<?@ROB?2]>\1^ I/\
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M66^\.ZI\)O&:>+!KFI^(_#6G6NC67Q+F\<:C?>';CPW?^%X[3]/='T;4-?\
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MX!^,7C/X@?#;X[?"'5O@CH7@WQ5XC^%OQ,\%>'M*^)?B+P?\1=6'ASX9>*?
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M4?\ PXXG_P">Q_4A_P -Z_L.?]'E?LI_^)%?!S_YM*/^&]?V'/\ H\K]E/\
M\2*^#G_S:5_+?_Q#G?MD_P#17/V8_P#PH?B]_P#.EH_XASOVR?\ HKG[,?\
MX4/Q>_\ G2T?ZN<"_P#1<5/_  RXC_Y(/]=_%[_HU5'_ ,..)_\ GL?U(?\
M#>O[#G_1Y7[*?_B17P<_^;2C_AO7]AS_ */*_93_ /$BO@Y_\VE?RW_\0YW[
M9/\ T5S]F/\ \*'XO?\ SI:/^(<[]LG_ **Y^S'_ .%#\7O_ )TM'^KG O\
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MUW\7O^C54?\ PXXG_P">Q_4A_P -Z_L.?]'E?LI_^)%?!S_YM*/^&]?V'/\
MH\K]E/\ \2*^#G_S:5_+?_Q#G?MD_P#17/V8_P#PH?B]_P#.EH_XASOVR?\
MHKG[,?\ X4/Q>_\ G2T?ZN<"_P#1<5/_  RXC_Y(/]=_%[_HU5'_ ,..)_\
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M_9C_ /"A^+W_ ,Z6C_B'._;)_P"BN?LQ_P#A0_%[_P"=+1_JYP+_ -%Q4_\
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M/^(<[]LG_HKG[,?_ (4/Q>_^=+5?ZN<"VM_KO+:W_(DQ&W:_-<E\:>+CY?\
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M>S26:+]VH^^H_P#/Q*5^A_4A_P -Z_L.?]'E?LI_^)%?!S_YM*/^&]?V'/\
MH\K]E/\ \2*^#G_S:5_+?_Q#G?MD_P#17/V8_P#PH?B]_P#.EH_XASOVR?\
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M_P !C_D&Q/[J_P#?(_PHV)_=7_OD?X4447?=_>_\PY(?R1_\!C_D&Q/[J_\
M?(_PHV)_=7_OD?X4447?=_>_\PY(?R1_\!C_ )!L3^ZO_?(_PHV)_=7_ +Y'
M^%%%%WW?WO\ S#DA_)'_ ,!C_D&Q/[J_]\C_  HV)_=7_OD?X4447?=_>_\
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:&/\ D* !T 'T&/Y4M%%(I)+1))=EHOP/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex23-1_002.jpg
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !, >$# 2(  A$! Q$!_\0
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MB?QMXFT#PAX;TPQ?;-5UF_BL;*T\R18HS)-*RH@:1U4%B 2P%?F?_P '"_\
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M[>W_ (]%QX@CU/4_-DFUQ6NIXIKSSI!F?-U#=(\G.9(903D&@#^]*BOY2/\
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M7ACXD:GINEZ%YJ21RWW]F"\^T7*;D"26YDO?*62-V!DM[A2 4&?V\H ^3?\
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M\06D/AI5TOX;ZE-,;:QU&>:.ZM]4NDBSOG\J-H[=)#^XS/< !YHB8 #]:O\
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M0_Q*)U;XJ_M$"'7(-0O;U-2OH=$F4744DEPR&99[Z:5KF93-('5++>%FC<
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M.H1ZE<7MI#?>>;BY1)Y9&%T#(TB E]Q^;@U_6+_P3F_X(7_LY_\ !,=+;4?
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M1XITZ[>4P01_;)(;>XM)"8)[<7%V97""&X;8%%R@H _G*_X(X_\ !3/X<?\
M!+AOBK\1=3^%Z>-?CE<:3;67POU"Z3.DZ!,_GQW\UP?.5X]Z&'_41F215F@$
MMM'-(Q_HU_X(B>/?VQ?BG\+O'/BK]K31M#\._P#"3:I!JO@K2([)++5-)LIX
MFEEM9X(RPBMXRT*0I<L;Y66Y%P3B&I?^";/_  ;\?LY_\$P?')\8>"=&U[Q-
MX\B6X@L_$OBJ^2]OM-@FCC22&W2&.&WCR$<>:(?/VW$T?FF)_+'V[0!\ ?\
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M4?B/H(M+NTU;Q')&MAI>HPH^^[LK&%5CCW2.)$%PUR\#0P-'(LB&1L[]M?\
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MX8WVV@Z=>6\LK0RRW$J+<WF"MG.H"6P62%DD%S&>0#\S_P#@ZH_: \>?$_\
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M\(_ 6EW<$FJ31:U::AJ^L6Y60M'8I:M<0(^Z-4,MPR>7]H$@CN-IBH ^E/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S
M?P[^$7A/X2'7&\+>&?#_ (:;Q-JT^NZP=+T^*S.JZA.1YUY<>6J^;/)M7=*^
M7;:,DX%=)110 4444 %%%% !1110 4444 %<=\$_V=_ '[-7ABYT3X=>!_"'
M@'1;RZ-]/I_AW1[?2[66<HB-*T4"(A<K&@+8R0@'85V-% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
